<SEC-DOCUMENT>0001554859-25-000011.txt : 20250228
<SEC-HEADER>0001554859-25-000011.hdr.sgml : 20250228
<ACCEPTANCE-DATETIME>20250228163218
ACCESSION NUMBER:		0001554859-25-000011
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		121
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Semler Scientific, Inc.
		CENTRAL INDEX KEY:			0001554859
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				261367393
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36305
		FILM NUMBER:		25690962

	BUSINESS ADDRESS:	
		STREET 1:		2340-2348 WALSH AVENUE, SUITE 2344
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95051
		BUSINESS PHONE:		408-627-4557

	MAIL ADDRESS:	
		STREET 1:		2340-2348 WALSH AVENUE, SUITE 2344
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95051
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>smlr-20241231x10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.9.0.3 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 2/28/2025 9:05:28 PM -->
<!-- iXBRL Library version: 1.0.9062.16423 -->
<!-- iXBRL Service Job ID: 9e54d175-4b53-4850-b227-a4ecf0f5615a -->
<html xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:smlr="http://semlerscientific.com/20241231"><head><meta content="text/html" http-equiv="content-type"/><title>SEMLER SCIENTIFIC, INC._December&#160;31, 2024</title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" xs:nil="true" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" name="us-gaap:CommitmentsAndContingencies" id="Hidden_24f232MLf0WXAte3iLkz3Q"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" xs:nil="true" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" name="us-gaap:CommitmentsAndContingencies" id="Hidden__xwFuu4OhUO3C5yv5wtpCw"></ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityCentralIndexKey" id="Tc_4TGcvSMJT0OuhTrANG1qtw_2_1">0001554859</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentFiscalPeriodFocus" id="Tc_kyzR9Ok4HE2b2eJaV_cpaw_3_1">FY</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="Hidden_UxmnUabbx06ExZiBAzKhVw">http://fasb.org/us-gaap/2024#Revenues</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="Hidden_s161mzV-yUKVK4TP47TOUQ">http://fasb.org/us-gaap/2024#Revenues</ix:nonNumeric><ix:nonNumeric contextRef="Duration_4_1_2024_To_6_30_2024_mJl5Eq6K00aJS7N8C_Ue-w" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="Hidden_J8wOH7bw2UqoKIsy6ORpDQ">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202308Member</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CryptoAssetNameExtensibleEnumeration" id="Hidden_EtskwuOt8E-UAPDIhjG0PQ">http://semlerscientific.com/20241231#BitcoinMember</ix:nonNumeric><ix:nonNumeric contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Hidden_xVAitRPWgkWwaTzZPw38ow">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Hidden_ZCznBrDkRkiZHIq0TZrasQ">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Hidden_2GncPSotZkeJ6j2K3RM9Gw">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_S8qckvwft0-ZA0tONRcfFw" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_Tzy6P97uHUaeUF-cBrMSEA">0.25</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_YXae_MH-f0WF5pBOJi-pJQ" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_V32SFWmW3EWJ45UKw92nEg">0.0208</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_vvjiTdI4e0mUIjbWLapyOw" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_8RoI3HM5VE6VepajHbnVVQ">0.0417</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_vvjiTdI4e0mUIjbWLapyOw" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Hidden_r6U7ShkGaEyl2_KE4RIe3w">0.0417</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:AmendmentFlag" id="Narr_rCwS5hUxaE-W79mE8GBaZQ">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="smlr-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_8Bg3PzLN0UiL0idVDay18A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_dQ8SZLQckkq01f6d8teuYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_7MdStRIh3kKwwzJPpWFxcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_eItsRBJS3UqRPJXG0t2wwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_SU2XSK94YkGDlZDDBasXLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mDqBkPVNkU2MWw6rn8s8lA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_eBCEoRryQ0WqACbtbHRW9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KsDbaHOEh0G1GZmuHINO9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_PP2-ruBZD0aQuxrVIVT55A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUJvfYZkXkeH62F-h-9aEw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_jPaHxANL9EC28M6jZYsdEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_X8BtSj_gKEOEIpqdtxsxfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_0xY6gnE8qUybhgz-gxdNDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_JOF9RAV_fkuKYUMpAYeQQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_KeyPersonStockOptionPlan2007Member_6IjDjCrPDUm7EkmgVITtGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:KeyPersonStockOptionPlan2007Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_14_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_Hkgpul5BI0mLKNUjZAN8IA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_GbmeNOsf7EaK071-nE3ADg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_dA41U23jbUaIgfrnIFaEkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_vvjiTdI4e0mUIjbWLapyOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_YXae_MH-f0WF5pBOJi-pJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_S8qckvwft0-ZA0tONRcfFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate202308Member_ErqcZCu5GEuuVGLzwhazqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202308Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_4CDoFoOHw0GbAdFoHlt6Mg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_KiuY18k-9k-jS6iTZaYS0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_aqZhN0s0ZEyt9Xlfg5w8DA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_MakASwJL4Euo7dVHvkl2rA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">smlr:PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_aCUWSs44WUuNTnqFFLPMZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_f0cWWAE48EORHBh0d2T8Nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_mGIHHxS_ZEuc6ViWxpMJ9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_W64GlRtDm0icy9iIeB1Rwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">smlr:PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_SubsidiarySaleOfStockAxis_smlr_AtMarketOfferingMember_YtursobFMki79XI5UpMKsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smlr:AtMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_10_2023_To_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_wO80u8v0nkaVj9-6hCzGng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-10</xbrli:startDate><xbrli:endDate>2023-10-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_muDgxFIJQE6WabppUkvg4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_ESWGS2AUDEyJokJaRyrByQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lEsvR7g5ukqjO6r8JvkH_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_g8RrY9ouOk6oIzBWDC62Bg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_nLhO4YNRgkCweluz_hqEUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_gI7SLj8d7kuf0rI7GEXCEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_crjDA4QUWkmjptpBegjFlA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ZO7co7_VOEuQO3x8dm2CXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_kIbRkUOXhkOuBCEbOunDpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyThreeMember_cSzr6YVDeUWRSAU2M9evow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">smlr:InvestmentInPrivateCompanyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_XS97Wf2QpUu9KcNGDWoQlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">smlr:InvestmentInPrivateCompanyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_1wPfvi5hA0-P18KQ9-gxVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">smlr:InvestmentInPrivateCompanyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_G3Anxea5Bk2Jp-whqZzF4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_BtMLgU4xhEumEB1mwGdN_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_Eph_Oj-oC0KZYpPYtIryAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_Y3YjBPtUtEWAFrFVUBX28A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_x1XWviIRvEuBTZOXDrOPnA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_ozb1tohPX0S-2MLZNTW-lw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_85lUGANk9Uq8MoWX1Ze-rw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_PxnEcaDrekmg5pbwORI6uA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_aDCxvJtt3Eygu9BuFeJ9gg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_WP1fZf0Tz0eBBidX-O4OKw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_5rkmbl4o0EOgcPQtPW8OMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_f78XzEjJR0SR98o4mMWU-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_zHwOkX4VfkWPEeVs-Z6SyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_hGBEk459TU6iXePXuBf5Gw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:PromissoryNoteFromPrivateCompanyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_-L_MetT9sEqjsLb_hMB9Gw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:PromissoryNoteFromPrivateCompanyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_X9WpoJSxJEq9lfFuf9gDtg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:PromissoryNoteFromPrivateCompanyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_IcqC7PE9WUiygajKvbmwNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_652Bp3qhNUmUqYY-FX1Hug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorThreeMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_UUFOL2wzP06GTw4gaa2_sg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_etSv0JRJJUqLQpa2cgChVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_jjGYmF79EUmReh8pp371Ww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mGWVZoMD_0y5pa9bpBTRRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_sK_zCKyn3kegXLMJPUXfnw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerThreeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HyuAP9W00kqM60O3G6Ge3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_GNA9FYtql0C57IuiRvUncQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_Ii5xiNTqQk2AGTOsoCMLWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:CryptoAssetProviderTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">smlr:IntangibleDigitalAssetBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">smlr:InvestmentHoldingConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_264-qjtGnkenys3niqGP3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:CryptoAssetProviderOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">smlr:IntangibleDigitalAssetBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">smlr:InvestmentHoldingConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H04TlYqfWUuaMfxorUQLQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_O9-jwnOv6kOR0Av4_jnsew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_gghWsAhy2kyMxuzQyS23Xw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kWVgDU2vA0uq6eMrmrdy-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Y3y-lLd5iky9-ATGWL0gvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerThreeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_xdNkBEAT8k670omsTTSlEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mhgf8VqFf0-ZFpiL5hlFcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_AUjfPFddUEiqVflwrXAltw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2013_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_ZY7-89lwZU2bZhYnLrUgKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_7_2012_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_nK7KeWh1p0uNi8atNqQgfg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-06-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_KNM3WXi-TU6wCTDDF5i12Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_uk7mInBKCUiVA3vFkCN5Vw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_9BDTT4lyYkSv1F0eAQlnCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_iI2SdgF49U2GUm8sENchpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_j-idL8uTrE-R6vTgZEwaLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_vC_VgO3t6kyazyC5VS8ocA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_cISDtiIR7ESd_y3U1MPmAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">smlr:EngineeringAndProductDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_XwzfHWNHj0GlezhAcZYaZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_VkzoijKppEGZkDNPtg0efA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SyC6bd2xmUme3HPXw5Pazw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_aUVxgJ1xTECBjIC1ZpWucg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">smlr:EngineeringAndProductDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2024_To_6_30_2024_mJl5Eq6K00aJS7N8C_Ue-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_14_2022_kTG5qkwiMUq6Eg2gYGvIGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_VVd0MeR2FUGoVh93N0DsZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_IRpa9_pYhEyV44mQzXmw2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b8wtJ_BsM0unZVLTihfH6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ypheC2QZukKv7Unwz7OIBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_24_2024_UDRPHzEdyk6NV0QD-mKyjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_10_1_2024_To_10_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_sIz0OcvO7UGv2AJKDirvCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_L_t0elWRT0eyWfqFYrXTgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smlr:SingleReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smlr:SingleReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_StateAndLocalJurisdictionMember_l7TBs0ibWkKMa4_wC7X-XQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_FOoH5YxHtkWAVEIxCeAZTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_pgr5YBHMBk-EMl7wkzobAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-15</xbrli:startDate><xbrli:endDate>2025-01-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_FPkR1egt1k-R8EHqo0rVVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_PWcdPDmgeEWckhHocD2-3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_28_2025_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_ovxYPgBkWZ0i_kIROisQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:ConvertibleSeniorNote4.25Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:ConvertibleSeniorNote4.25Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-28</xbrli:startDate><xbrli:endDate>2025-01-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:ConvertibleSeniorNote4.25Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_2_14_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Mua0Ot9Ko0CU_qSEjW_8uA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-14</xbrli:startDate><xbrli:endDate>2025-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_rF8xp9fd-0m4m_wVJU1ZfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2025_To_1_31_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Vh5xue5y_kiCARvRzIwtZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_a8zmf1i8pUefeL-g8olIgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H35aj8_a3U6JSHnHW9KxbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_fFOkoCt7H0Slv5JGrDqlBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HybD8uTHQkyIAhllhH3uCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tugyvnYiKEKXu7Ct7IkWtg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kPVNPU9aQEmGmH7B8LA6Hg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_PHgDVn-5Okel_mz_sU2Iaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">smlr:IntangibleDigitalAssetBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">smlr:InvestmentHoldingConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_17_2023_To_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_GRfbzrpKSkafNwd0txmuIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-17</xbrli:startDate><xbrli:endDate>2023-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2024_geCWm453AUejs3C95T9_VA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_21_2025_aVqGtO1X_0mJsQc_NJ90xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001554859</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q"><xbrli:measure>smlr:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w"><xbrli:measure>smlr:customer</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w"><xbrli:measure>smlr:D</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Vote_fmvi7R5wJUe0Kn3AIo8T4g"><xbrli:measure>smlr:Vote</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_segment_Ijr0hkbG8kGjCrFIHbBeqw"><xbrli:measure>smlr:segment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 15pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:8.05pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="color:#231f20;font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_75e5e5f2_435b_4723_9878_7a475470a71b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 1pt 0pt;"><b style="color:#231f20;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><b style="color:#231f20;font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><b style="color:#231f20;font-size:7pt;font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentType" id="Narr_Ltq9RhrQ_UGsAou9M_O2Zg"><b style="color:#231f20;font-size:7pt;font-weight:bold;">10-K</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:4pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"><a id="_bd54f335_d037_4125_ba83_40ec97679c0e"></a><a id="Tc_IeZ2Ya-1SEqCFd_2xBaUXQ_1_1"></a><a id="Tc_9pQ6YtBsEkS8WD89KPNRtw_3_1"></a><a id="Tc_L8nAsMk160CFKocNQzE1bw_5_1"></a><a id="Tc_PZR75CSLPke13WDBRiAVPQ_7_1"></a></div></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentAnnualReport" id="Tc_XCXX3bqGu0SFdSci_MqfzA_1_0"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;">For the fiscal&#160;year ended: </span><ix:nonNumeric format="ixt:date-monthname-day-year-en" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentPeriodEndDate" id="Narr_IzAJ5F_fb0ierSp6pQQBPw"><ix:nonNumeric format="ixt:date-monthname-day-en" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:CurrentFiscalYearEndDate" id="Narr_CPni8b6K5kO-GhZ_pomXUA"><span style="color:#231f20;font-size:7pt;">December&#160;31</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;">, </span><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentFiscalYearFocus" id="Narr_IwxmQei2o0yf8DPlvUQj6Q"><span style="color:#231f20;font-size:7pt;">2024</span></ix:nonNumeric></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;">or</span></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentTransitionReport" id="Tc_SK0uoZv6L0idyu6wBaDBzQ_7_0"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:94.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">For the transition period from:</span><span style="color:#231f20;text-decoration-color:#231f20;text-decoration-line:underline;text-decoration-style:solid;white-space:pre-wrap;">            </span><span style="color:#231f20;">to</span><span style="color:#231f20;text-decoration-color:#231f20;text-decoration-line:underline;text-decoration-style:solid;white-space:pre-wrap;">          </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;text-decoration-color:#231f20;text-decoration-line:underline;text-decoration-style:solid;">Commission file number: </span><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityFileNumber" id="Narr_wEUX8d1-4EOTpAXBLLo6eA"><span style="color:#231f20;font-size:7pt;text-decoration-color:#231f20;text-decoration-line:underline;text-decoration-style:solid;">001-36305</span></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:4pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityRegistrantName" id="Narr_U7SvYFRMLEusSSD-ayfxVA"><b style="color:#231f20;font-weight:bold;">SEMLER SCIENTIFIC, INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">(Exact name of registrant as specified in its charter)</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:5pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"><a id="_88e42d5f_94b0_49ab_a8c2_c8c40d03babc"></a><a id="Tc_z2AiFbhioEicTWDW9Oj5mw_1_0"></a><a id="Tc_oRBZmD0QJEK7OtHP6C9AyQ_1_2"></a><a id="Tc_gowSfmVgx0yHfeMXl3IP7A_2_0"></a><a id="Tc_kCcFwvoNSUeoyVriqVnaDA_2_2"></a><a id="Tc_IeOIQBK7RE66SxQORBpS3w_4_0"></a><a id="Tc_8Eiea3Z_BE6pAaPRf-Ljtw_4_2"></a><a id="Tc_ShLXdBkjLEiXxHPQOPyJdQ_5_0"></a><a id="Tc_RCA604rDhkeEW_znZKIWjg_5_2"></a></div></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;"><tr><td style="vertical-align:top;width:33.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityIncorporationStateCountryCode" id="Tc_brVmd9cGc0-4-X1lQhkDxQ_0_0"><b style="color:#231f20;font-size:7pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityTaxIdentificationNumber" id="Tc_Bk0MHUQkakm4kAuwB6dXTw_0_2"><b style="color:#231f20;font-size:7pt;font-weight:bold;">26-1367393</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:33.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;">(State or other jurisdiction</span></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 3pt;"><span style="color:#231f20;">(I.R.S. Employer</span></p></td></tr><tr><td style="vertical-align:top;width:33.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;">of incorporation or organization)</span></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;">Identification No.)</span></p></td></tr><tr><td style="vertical-align:top;width:33.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:33.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityAddressAddressLine1" id="Narr_Li6m-NeHe0uMbY-53mHBMQ"><b style="color:#231f20;font-size:7pt;font-weight:bold;">2340-2348 Walsh Avenue, Suite 2344</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityAddressCityOrTown" id="Narr_vU8EqBDwqUuOsyRP9qhZxg"><b style="color:#231f20;font-size:7pt;font-weight:bold;">Santa Clara</b></ix:nonNumeric><b style="color:#231f20;font-size:7pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityAddressStateOrProvince" id="Narr_cvf8UzS4TEKa2V-yIk9TUA"><b style="color:#231f20;font-size:7pt;font-weight:bold;">CA</b></ix:nonNumeric><b style="color:#231f20;font-size:7pt;font-weight:bold;"> </b></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityAddressPostalZipCode" id="Narr_lh_Ny_sNQUq8PoAemwKV_A"><b style="color:#231f20;font-size:7pt;font-weight:bold;">95051</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:33.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">(Address of principal executive offices) </span></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;">(Zip Code)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-size:7pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:CityAreaCode" id="Narr_Z74RUI5bhUeOxn_PCAqg_A"><b style="color:#231f20;font-size:7pt;font-weight:bold;">877</b></ix:nonNumeric><b style="color:#231f20;font-size:7pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:LocalPhoneNumber" id="Narr_hlemJOnxrkmeXvFVaYt9aw"><b style="color:#231f20;font-size:7pt;font-weight:bold;">774-4211</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">(Registrant&#8217;s telephone number, including area code)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e9ba0263_5f3e_4071_883f_30bebddd3663"></a><a id="Tc_PQcO3zR-WkuTeHvpzzEdcg_1_0"></a><a id="Tc_4YV1iYj9ZUau71pmXOj-fw_1_1"></a><a id="Tc_Bc1Jsh6zEUSX_P_D2QG1ZQ_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:39.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:14.54%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:39.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:top;width:14.54%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Trading Symbol</b></p></td><td style="vertical-align:top;width:45.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:39.55%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:Security12bTitle" id="Tc_ijdOq2u090SLtfO7MM1AEQ_2_0"><span style="color:#231f20;font-size:7pt;">Common Stock, $0.001 par value</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:14.54%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:TradingSymbol" id="Tc_ldgLSl-mWkucESJiaVZytg_2_1"><span style="color:#231f20;font-size:7pt;">SMLR</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:45.89%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:SecurityExchangeName" id="Tc_dyJDuKQ23EGY4-fLkUUm3g_2_2"><span style="color:#231f20;font-size:7pt;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Securities registered pursuant to Section&#160;12(g)&#160;of the Act: None</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:7.0pt;margin-bottom:4pt;margin-left:18pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span><span style="color:#231f20;font-size:7pt;"> </span><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityWellKnownSeasonedIssuer" id="Narr_0tywfMTxPUuboi2hgp8cgA"><span style="color:#231f20;font-size:7pt;">No</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span><span style="color:#231f20;font-size:7pt;"> </span><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityVoluntaryFilers" id="Narr_8xy-iFzYRkWwrSrMcDojbQ"><span style="color:#231f20;font-size:7pt;">No</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityCurrentReportingStatus" id="Narr_tJIJ-jjBwEyDtqGiCwr2MQ"><span style="color:#231f20;font-size:7pt;">Yes</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-size:7pt;">No </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityInteractiveDataCurrent" id="Narr_zXiCtlAOl0GyVaXofesmBg"><span style="color:#231f20;font-size:7pt;">Yes</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-family:'Times New Roman';font-size:7pt;">&#8999;</span><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-size:7pt;">No </span><span style="color:#231f20;font-family:'Times New Roman';font-size:7pt;">&#9723;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><a id="_9486f38d_66c7_404a_8904_0299ab54a24e"></a><a id="Tc_D6eBxcxF4Uq4dlLe-4A9YA_0_0"></a><a id="Tc_3hP50ve620OmpaZYvvEI5g_0_1"></a><a id="Tc_YfnLdx3i0UK9qoGijU6Qkg_0_2"></a><a id="Tc_b2WaviU3CkSTv5QRdhFpNw_0_3"></a><a id="Tc_pa5nrnx2xUy7byBePCEa8Q_1_1"></a><a id="Tc_pQI-7OW5x0egGENB4QPLXA_1_2"></a><a id="Tc_80f7n3poTU2EiZmjc1p_SQ_1_3"></a><a id="Tc_PySs7CGbEEmrnEraRoSkWg_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:top;width:43.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 66.95pt;"><span style="color:#231f20;">Large accelerated filer</span></p></td><td style="vertical-align:top;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 13.85pt;"><span style="color:#231f20;font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:43.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 66.95pt;"><span style="color:#231f20;">Accelerated filer</span></p></td><td style="vertical-align:top;width:6.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 13.85pt;"><span style="color:#231f20;font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr><tr><td style="vertical-align:top;width:43.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 66.95pt;"><ix:nonNumeric format="ixt-sec:entityfilercategoryen" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityFilerCategory" id="Tc_MGYeUpicCEGDHpo2dlTONg_1_0"><span style="color:#231f20;font-size:7pt;">Non-accelerated filer</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 13.85pt;"><span style="color:#231f20;font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:top;width:43.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 67.1pt;"><span style="color:#231f20;">Smaller reporting company</span></p></td><td style="vertical-align:top;width:6.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 13.85pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntitySmallBusiness" id="Narr_Bbce-tCk1ESGhD7r9CVFNQ"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;"> </span></p></td></tr><tr><td style="vertical-align:top;width:43.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 13.85pt;"><span style="color:#231f20;font-size:7pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:0pt;margin:0pt 0pt 0pt 67.1pt;"><span style="color:#231f20;">Emerging growth company</span></p></td><td style="vertical-align:top;width:6.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 13.85pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityEmergingGrowthCompany" id="Tc_jROR1rLJlE2bh7FCMt-9Dg_2_3"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#231f20;font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:IcfrAuditorAttestationFlag" id="Narr_0MgkbcsmIE2WRELYHRGCmw"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.&#160; </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:DocumentFinStmtErrorCorrectionFlag" id="Narr_sTjh1cUkL02bm2XfdEcbsg"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).&#160; </span><span style="color:#231f20;font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;font-size:7pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:EntityShellCompany" id="Narr_N8Sokzv6eUOS5fOJ62Sf7Q"><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9744;</span></ix:nonNumeric><span style="color:#231f20;font-size:7pt;"> </span><span style="color:#231f20;font-size:7pt;">No </span><span style="color:#231f20;font-family:'Segoe UI Symbol';font-size:7pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">The aggregate market value of the voting and non-voting stock held by non-affiliates of the registrant was approximately </span><span style="color:#231f20;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" format="ixt:num-dot-decimal" scale="0" contextRef="As_Of_6_30_2024_geCWm453AUejs3C95T9_VA" decimals="0" name="dei:EntityPublicFloat" id="Narr_KsL99MFD0US7R423ylXCZg">164,913,715</ix:nonFraction></span><span style="color:#231f20;"> as of June 30, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 4pt 0pt;"><span style="color:#231f20;">The number of shares of the registrant&#8217;s common stock outstanding as of February 21, 2025 was </span><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" format="ixt:num-dot-decimal" scale="0" contextRef="As_Of_2_21_2025_aVqGtO1X_0mJsQc_NJ90xg" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" id="Narr_7UQagh_tkU25xcGvTHW_wQ">9,596,486</ix:nonFraction></span><span style="color:#231f20;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:18pt;margin:0pt;"><span style="color:#231f20;">None.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#231f20;font-size:4pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="color:#231f20;font-family:'1';font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_6d7dfdc8_1c44_428d_b25c_278094f22b90"></a><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2024 ANNUAL REPORT ON FORM 10-K</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">TABLE OF CONTENTS</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a href="#PARTI_810283"><span style="font-style:normal;font-weight:normal;">PART I</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cautionary Note Regarding Forward Looking Statements and Industry Data</p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk Factor Summary</p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM1BUSINESS_20591"><span style="font-style:normal;font-weight:normal;">Item 1.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM1BUSINESS_20591"><span style="font-style:normal;font-weight:normal;">Business</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#Risk_factors"><span style="font-style:normal;font-weight:normal;">Item 1A.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Risk_factors"><span style="font-style:normal;font-weight:normal;">Risk Factors</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">2</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM1BUNRESOLVEDSTAFFCOMMENTS_174587"><span style="font-style:normal;font-weight:normal;">Item 1B.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM1BUNRESOLVEDSTAFFCOMMENTS_174587"><span style="font-style:normal;font-weight:normal;">Unresolved Staff Comments</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">61</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM1CYBERSECURITY"><span style="font-style:normal;font-weight:normal;">Item 1C.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM1CYBERSECURITY"><span style="font-style:normal;font-weight:normal;">Cybersecurity</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">61</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM2PROPERTIES_635474"><span style="font-style:normal;font-weight:normal;">Item 2.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM2PROPERTIES_635474"><span style="font-style:normal;font-weight:normal;">Properties</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">62</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM3LEGALPROCEEDINGS_580083"><span style="font-style:normal;font-weight:normal;">Item 3.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM3LEGALPROCEEDINGS_580083"><span style="font-style:normal;font-weight:normal;">Legal Proceedings</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">62</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM4MINESAFETYDISCLOSURES_215265"><span style="font-style:normal;font-weight:normal;">Item 4.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM4MINESAFETYDISCLOSURES_215265"><span style="font-style:normal;font-weight:normal;">Mine Safety Disclosure</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">62</p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a href="#PARTII_948696"><span style="font-style:normal;font-weight:normal;">PART II</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM5MARKETFORREGISTRANTSCOMMONEQUITYREL"><span style="font-style:normal;font-weight:normal;">Item 5.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM5MARKETFORREGISTRANTSCOMMONEQUITYREL"><span style="font-style:normal;font-weight:normal;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">62</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM6SELECTEDFINANCIALDATA_498329"><span style="font-style:normal;font-weight:normal;">Item 6.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">[<a href="#ITEM6SELECTEDFINANCIALDATA_498329"><span style="font-style:normal;font-weight:normal;">Reserved</span></a>]</p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">63</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM7MANAGEMENTSDISCUSSIONANDANALYSISOFF"><span style="font-style:normal;font-weight:normal;">Item 7.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM7MANAGEMENTSDISCUSSIONANDANALYSISOFF"><span style="font-style:normal;font-weight:normal;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">63</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM7AQUANTITATIVEANDQUALITATIVEDISCLOSU"><span style="font-style:normal;font-weight:normal;">Item 7A.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM7AQUANTITATIVEANDQUALITATIVEDISCLOSU"><span style="font-style:normal;font-weight:normal;">Quantitative and Qualitative Disclosures about Market Risk</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">70</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM8FINANCIALSTATEMENTSANDSUPPLEMENTARY"><span style="font-style:normal;font-weight:normal;">Item 8.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM8FINANCIALSTATEMENTSANDSUPPLEMENTARY"><span style="font-style:normal;font-weight:normal;">Financial Statements and Supplementary Data</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">70</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM9CHANGESINANDDISAGREEMENTSWITHACCOUN"><span style="font-style:normal;font-weight:normal;">Item 9.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM9CHANGESINANDDISAGREEMENTSWITHACCOUN"><span style="font-style:normal;font-weight:normal;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">70</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM9ACONTROLSANDPROCEDURES_698121"><span style="font-style:normal;font-weight:normal;">Item 9A.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM9ACONTROLSANDPROCEDURES_698121"><span style="font-style:normal;font-weight:normal;">Controls and Procedures</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">71</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM9BOTHERINFORMATION_170525"><span style="font-style:normal;font-weight:normal;">Item 9B</span></a>.</p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM9BOTHERINFORMATION_170525"><span style="font-style:normal;font-weight:normal;">Other Information</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">71</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM_9C"><span style="font-style:normal;font-weight:normal;">Item 9C.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM_9C"><span style="font-style:normal;font-weight:normal;">Disclosure Regarding Foreign Jurisdictions the Prevent Inspections</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">71</p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a href="#PARTIII_829453"><span style="font-style:normal;font-weight:normal;">PART III</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM10DIRECTORSEXECUTIVEOFFICERSANDCORPO"><span style="font-style:normal;font-weight:normal;">Item 10.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM10DIRECTORSEXECUTIVEOFFICERSANDCORPO"><span style="font-style:normal;font-weight:normal;">Directors, Executive Officers and Corporate Governance</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">72</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM11EXECUTIVECOMPENSATION_727083"><span style="font-style:normal;font-weight:normal;">Item 11.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM11EXECUTIVECOMPENSATION_727083"><span style="font-style:normal;font-weight:normal;">Executive Compensation</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">75</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM12SECURITYOWNERSHIPOFCERTAINBENEFICI"><span style="font-style:normal;font-weight:normal;">Item 12.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM12SECURITYOWNERSHIPOFCERTAINBENEFICI"><span style="font-style:normal;font-weight:normal;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">79</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM13CERTAINRELATIONSHIPSANDRELATEDTRAN"><span style="font-style:normal;font-weight:normal;">Item 13.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM13CERTAINRELATIONSHIPSANDRELATEDTRAN"><span style="font-style:normal;font-weight:normal;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">81</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM14PRINCIPALACCOUNTINGFEESANDSERVICES"><span style="font-style:normal;font-weight:normal;">Item 14.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM14PRINCIPALACCOUNTINGFEESANDSERVICES"><span style="font-style:normal;font-weight:normal;">Principal Accountant Fees and Services</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">82</p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a href="#PARTIV_516456"><span style="font-style:normal;font-weight:normal;">PART IV</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:3pt;"><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM15EXHIBITSFINANCIALSTATEMENTSCHEDULE"><span style="font-style:normal;font-weight:normal;">Item 15.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM15EXHIBITSFINANCIALSTATEMENTSCHEDULE"><span style="font-style:normal;font-weight:normal;">Exhibits, Financial Statement Schedules</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">83</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#ITEM16FORM10KSUMMARY_694484"><span style="font-style:normal;font-weight:normal;">Item 16.</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:81.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ITEM16FORM10KSUMMARY_694484"><span style="font-style:normal;font-weight:normal;">Form 10-K Summary</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">85</p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:90.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#sig"><span style="font-style:normal;font-weight:normal;">SIGNATURES</span></a></p></td><td style="vertical-align:bottom;white-space:normal;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">61</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#231f20;background:#ffffff;">In this report, unless otherwise stated or as the context otherwise requires, references to &#8220;Semler Scientific,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar references refer to Semler Scientific, Inc. The Semler Scientific logo, QuantaFlo and other trademarks or service marks of Semler Scientific, Inc. appearing in this report are the property of Semler Scientific, Inc. This report also contains registered marks, trademarks and trade names of other companies. All other trademarks, registered marks and trade names appearing in this report are the property of their respective holders.</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">i</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_2762e866_c469_436d_945d_da3cbd5c80a8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This annual report on Form 10-K contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In some cases, you can identify forward-looking statements by terminology, such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; &#8220;could&#8221; or the negative of such terms or other similar expressions. The forward-looking statements in this annual report on Form 10-K include, but are not limited to, statements regarding:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">implementation of our bitcoin treasury strategy and its effects on our business;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our seeking to obtain a new U.S. Food and Drug Administration, or FDA, 510(k) clearance for expanded use of QuantaFlo; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the effects of the 2024 Medicare Advantage and Part D Final Rate Announcement issued by the Centers for Medicare and Medicaid Services, or CMS, on our revenues; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the risk that the U.S. Department of Justice, or DOJ, will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages for tests performed using our device, and the risk of other litigation.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this annual report on Form 10-K. These forward-looking statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">You should read this annual report on Form 10-K and the documents that we reference herein and therein and have filed as exhibits, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this annual report on Form 10-K is accurate as of the date on the front cover of this annual report only. Because the risk factors referred to herein could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. These risks and uncertainties, along with others, are described under the heading &#8220;Risk Factors.&#8221; in Part I, Item 1A as well as under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this annual report on Form 10-K, and particularly our forward-looking statements, by these cautionary statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This annual report on Form 10-K includes statistical and other industry and market data that we obtained from industry publications and research, surveys and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. While we believe these industry publications and third-party research, surveys and studies are reliable, we have not independently verified such data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_94347f9f_c80f_4e5c_905d_5099f4d9d49e"></a><a id="Risk_factors"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;background:#ffffff;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br/></b><b style="font-weight:bold;background:#ffffff;">RISK FACTOR SUMMARY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business involves significant risks. Below is a summary of the material risks that our business faces, which makes an investment in our common stock speculative and risky. This summary does not address all these risks. These risks are more fully described below under the heading &#8220;Risk Factors&#8221; in Part I, Item 1A of this annual report on Form 10-K. Before making investment decisions regarding our common stock, you should carefully consider these risks. The occurrence of any of the events or developments described below could have a material adverse effect on our business, results of operations, financial condition, prospects and stock price. In such event, the market price of our common stock could decline, and you could lose all or part of your investment. In addition, there are also additional risks not described below that are either not presently known to us or that we currently deem immaterial, and these additional risks could also materially impair our business, operations or market price of our common stock.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we do not successfully implement our business strategy, including our bitcoin treasury strategy, our business and results of operations will be adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We predominantly market only one FDA-cleared vascular testing product; it may not achieve broad market acceptance or be commercially successful. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in the regulatory reimbursement landscape, such as the </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0.2pt;">final 2024 rate announcement with payment changes for the Medicare Advantage and Part&#160;D prescription drug programs</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> issued by CMS has impacted the perceived profitability of using our products to aid in the diagnosis of peripheral arterial disease, or PAD.</span><span style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have ceased marketing of QuantaFlo as an aid in the diagnosis of heart dysfunction and there is no guarantee that we will obtain clearance of a premarket notification, or 510(k), by the FDA for the expanded use.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If healthcare providers are unable to obtain adequate coverage and reimbursement, it is unlikely that our product will gain widespread acceptance. QuantaFlo is not specifically approved for reimbursement under any third-party payor codes. We are experiencing and expect to continue to experience decreased usage due to the current CMS reimbursement landscape, which is having a negative effect on our revenues.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We rely heavily upon the talents of a small number of key personnel, the loss of whom could severely damage our business.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We do not require our customers to enter into long-term licenses or maintenance contracts for our products or services and may therefore lose customers on short notice; and a significant portion of our revenues and accounts receivables are with a limited number of customers.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We rely on a small number of independent suppliers and facilities for the manufacturing of QuantaFlo. Any delay or disruption in the supply of the product or facility including as a result of recently announced tariffs may negatively impact our operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may not be sufficiently insured against product liability risk and may be subject to substantial claims.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may implement a product recall or voluntary market withdrawal or stop shipment of our product due to product defects or product enhancements and modifications, which would significantly increase our costs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">An information security incident, including a cybersecurity breach, could have a negative impact on our business or reputation.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our future financial performance will depend in part on the successful improvements and software updates to our vascular testing product on a cost-effective basis, as well as our ability to develop new products and service offerings, and expand the indications for QuantaFlo.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We operate in an intensely competitive and rapidly changing business environment, and there is a substantial risk our products or service offerings could become obsolete or uncompetitive.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our business is subject to many laws and government regulations governing the manufacture and sale of medical devices, including the FDA&#8217;s 510(k) clearance process, and laws and regulations governing patient data and information, along with more general tax rules and regulations among others, all of which are subject to change.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Although part of our business strategy is based on payment provisions enacted under government healthcare reform, we also face significant uncertainty in the industry regarding the implementation, transformation or repeal and replacement of the Health Care Reform Law.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are subject to various healthcare fraud and abuse laws and regulations, and at risk that the DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages for tests performed </span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">using our device, which would adversely affect our business.  A civil suit by DOJ also exposes us to risk of other litigation.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our bitcoin treasury strategy exposes us to various risks associated with bitcoin.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Bitcoin is a highly volatile asset, and fluctuations in the price of bitcoin are likely to influence our financial results and the market price of our common stock.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Bitcoin and other digital assets are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertainty.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our historical financial statements do not reflect the potential variability in earnings that we may experience in the future relating to our bitcoin holdings.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The availability of spot bitcoin exchange traded products, or ETPs, may adversely affect the market price of our common stock.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our bitcoin treasury strategy subjects us to enhanced regulatory oversight.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Due to the currently unregulated nature and lack of transparency surrounding the operations of many bitcoin trading venues, bitcoin trading venues may experience greater fraud, security failures or regulatory or operational problems than trading venues for more established asset classes, which may result in a loss of confidence in bitcoin trading venues and adversely affect the value of our bitcoin.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The concentration of our bitcoin holdings enhances the risks inherent in our bitcoin treasury strategy.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The emergence or growth of other digital assets, including those with significant private or public sector backing, could have a negative impact on the price of bitcoin and adversely affect our financial condition and results of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our bitcoin holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we or our third-party service providers experience a security breach or cyberattack and unauthorized parties obtain access to our bitcoin, or if our private keys are lost or destroyed, or other similar circumstances or events occur, we may lose some or all of our bitcoin and our financial condition and results of operations could be materially adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We face risks relating to the custody of our bitcoin, including the loss or destruction of private keys required to access our bitcoin and cyberattacks or other data loss relating to our bitcoin.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Regulatory change reclassifying bitcoin as a security could lead to our classification as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended, or the 1940 Act, and could adversely affect the market price of bitcoin and the market price of our common stock.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our bitcoin treasury strategy exposes us to risk of non-performance by counterparties.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our custodially-held bitcoin may become part of the custodian&#8217;s insolvency estate if one or more of our custodians enters bankruptcy, receivership or similar insolvency proceedings.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A blockchain &#8220;fork&#8221; to bitcoin or other crypto assets could adversely affect our business.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The due diligence procedures conducted by us and our liquidity provider to mitigate transaction risk may fail to prevent transactions with a sanctioned entity.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have issued $100.0 million of senior convertible notes due 2030, which exposes us to risks associated with such indebtedness.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our executive officers, directors and significant stockholders, if they choose to act together, have the ability to significantly influence all matters submitted to stockholders for approval.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have had material weaknesses in our internal control over financial reporting. Although we have remediated our prior material weaknesses, if we identify additional material weaknesses in the future, or if our former material weaknesses recur, it could have an adverse effect on our company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Provisions in our corporate charter documents and under Delaware law could make an acquisition of our company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Recent geopolitical events, as well as the recent change in the U.S. administration is creating significant uncertainty, which could impact our business.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_e4c9aa85_740b_4b3e_817d_8c062ace6481"></a><a id="PARTI_810283"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;font-weight:normal;"> </span>PART I</p><a id="ITEM1BUSINESS_20591"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 1.&#160;&#160;&#160;BUSINESS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">General</p><a id="_Hlk91830447"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a company developing and marketing technology products and services that assist our customers in evaluating and treating chronic diseases. Our patented and FDA cleared product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of PAD. We also invest in bitcoin and have adopted bitcoin as our primary treasury reserve asset. As an operating business, we use cash flows as well as proceeds from equity and debt financings to accumulate bitcoin. Our healthcare technology solutions business is our predominant operational focus, providing cash flows and enabling us to pursue our bitcoin strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are currently seeking a new 510(k) clearance from the FDA for the expanded use of QuantaFlo, which is intended to enable expanded labeling as an aid in the diagnosis of other cardiovascular diseases in addition to PAD. We continue to develop additional complementary proprietary products in-house and seek out other arrangements for additional products and services that we believe will bring value to our customers and to our company. We believe our current products and services, and any future products or services that we may offer, position us to provide valuable information to our customer base, which in turn permits them to better guide patient care.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the year ended December 31, 2024, we had total revenues of $56.3 million and net income of $40.9 million compared to total revenues of $68.2 million and net income of $20.6 million in 2023. </p><a id="_Hlk186635920"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Bitcoin Treasury Strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WE ARE NOT REGISTERED AS AN INVESTMENT COMPANY UNDER THE INVESTMENT COMPANY ACT OF 1940 AND STOCKHOLDERS DO NOT HAVE THE PROTECTIONS ASSOCIATED WITH OWNERSHIP OF SHARES IN A REGISTERED INVESTMENT COMPANY NOR THE PROTECTIONS AFFORDED BY THE COMMODITIES EXCHANGE ACT.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In May 2024, we adopted bitcoin as our primary treasury reserve asset on an ongoing basis, subject to market conditions and our anticipated cash needs. Our strategy includes acquiring and holding bitcoin using cash flows from operations that exceed working capital requirements, and from time to time, subject to market conditions, issuing equity or debt securities or engaging in other capital raising transactions with the objective of using the proceeds to purchase bitcoin.  For example, we began issuing shares under an &#8220;at-the-market&#8221; offering program in the second half of 2024, and in January 2025 issued convertible bonds, and used proceeds from both of these capital market transactions to acquire additional bitcoin along with cash generated from operations, as well as proceeds from monetization of a minority investment. We view our bitcoin holdings as long term holdings and expect to continue to accumulate bitcoin. We have not set any specific target for the amount of bitcoin we seek to hold, and we will continue to monitor market conditions in determining whether to engage in additional bitcoin purchases. This overall strategy also contemplates that we may periodically sell bitcoin for general corporate purposes or in connection with strategies that generate tax benefits in accordance with applicable law, enter into additional capital raising transactions, including those that could be collateralized by our bitcoin holdings, and consider pursuing strategies to create income streams or otherwise generate funds using our bitcoin holdings.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">This section summarizes our current treasury strategy for bitcoin, including our bitcoin holdings, trading execution, custody, storage, and accounting considerations. We reserve the right to update and alter our treasury strategy from time to time. We view bitcoin as a reliable store of value and a compelling investment. We believe it has unique characteristics as a scarce and finite asset that can serve as a reasonable inflation hedge and safe haven amid global instability. Bitcoin is often compared to gold, which has been viewed as a dependable store of value throughout history. Gold&#8217;s value has appreciated substantially over time. For example, 25 years ago, the price of gold was approximately $500 per ounce. In 2024, the price of gold has traded higher than $2,700 per ounce. As of December 31, 2024, the total market capitalization of gold was approximately $18.0 trillion compared to approximately $1.9 trillion for bitcoin. Bitcoin is a highly volatile asset that has traded below $51,800 per bitcoin and above $106,000 per bitcoin on Coinbase </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">in the 12 months preceding the filing date of this annual report on Form 10-K. While highly volatile, bitcoin&#8217;s price has also appreciated significantly since bitcoin&#8217;s inception in January 2009 (at zero per bitcoin). We believe that a substantial portion of bitcoin&#8217;s appreciation is attributable to the view that bitcoin is or will become a reliable store of value. Like gold, bitcoin is also viewed as a scarce asset; the ultimate supply of bitcoin is limited to 21 million coins and approximately 94% of its supply already exists. We believe that bitcoin&#8217;s finite, digital and decentralized nature as well as its architectural resilience make it preferable to gold, which, as noted above, has a market capitalization over 10 times higher than the market capitalization of bitcoin as of December 31, 2024. Given our belief that bitcoin is a comparable and possibly better store of value than gold, we believe that bitcoin has the potential to approach or exceed the value of gold over time. Given the substantial gap in value between gold and bitcoin based on current market capitalization, we believe that bitcoin has the potential to generate outsize returns as it gains increasing acceptance as &#8220;digital gold.&#8221; We believe that the growing global acceptance and &#8220;institutionalization&#8221; of bitcoin supports our view that bitcoin is a reliable store of value. We believe that bitcoin&#8217;s unique attributes discussed above not only differentiate it from fiat money, but also from other cryptocurrency assets, and for that reason, we have no plans to purchase cryptocurrency assets other than bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Institutionalization of Bitcoin</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are encouraged by the growing global acceptance and &#8220;institutionalization&#8221; of bitcoin &#8211; reflected by the January 2024 Securities and Exchange Commission, or SEC, approval of 11 bitcoin exchange-traded funds. These funds have reported billions of dollars of net inflows, with investments from a large number of institutions, including global banks, pensions, endowments and registered investment advisors. It is currently estimated that more than 10% of all bitcoins are now held by institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Our Bitcoin Holdings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024, we purchased a total of approximately 2,298 bitcoins at an aggregate purchase price of approximately $189.7 million for an average purchase price of approximately $82,538 per bitcoin, inclusive of fees and expenses. We did not sell any bitcoin during 2024. During the period January 1, 2025 and February 14, 2025, we purchased a total of approximately 894 bitcoins at an aggregate purchase price of approximately $90.7 million for an average purchase price of approximately $101,532 per bitcoin. Refer to Note 9 to financial statements &#8220;Intangible Digital Assets&#8221; section included in Part IV item 15 of this annual report in Form 10-K for further information regarding our bitcoin purchases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of February 14, 2025, we held approximately 3,192 bitcoins that were acquired at an aggregate purchase price of $280.4 million and an average purchase price of approximately $87,854 per bitcoin, inclusive of fees and expenses. As of February 14, 2025, at 4 p.m. Eastern Time, the market price of one bitcoin reported on the Coinbase exchange (our principal market) was $97,505.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Accounting</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Bitcoin accounting guidance has been evolving. According to the American Institute of Certified Public Accountants &#8220;Accounting for and auditing of Digital Assets practice aid,&#8221; bitcoin would satisfy the definition of an indefinite-lived intangible asset and would be accounted for under ASC 350, Intangibles &#8212; Goodwill and Other issued by the Financial Accounting Standards Board, or FASB. Under these guidelines, bitcoin holdings would be accounted for initially at cost and subject to impairment losses if their fair value fell below carrying value. In December 2023, the FASB issued Accounting Standards Update No. 2023-08, Accounting for and Disclosure of Crypto Assets (ASU 2023-08), which revised bitcoin accounting treatment. Under this new guidance, the valuation of bitcoin is to be measured based on fair value.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Hedging Strategy</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not currently intend to hedge our bitcoin holdings and have not adopted a hedging strategy with respect to bitcoin. However, we may from time to time engage in hedging strategies as part of our treasury management operations if deemed appropriate.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Overview of the Bitcoin Industry and Market</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Bitcoin is a digital asset that is issued by and transmitted through an open-source protocol, known as the bitcoin protocol, collectively maintained by a peer-to-peer network of decentralized user nodes. This network hosts a public transaction ledger, known as the bitcoin blockchain, on which bitcoin holdings and all validated transactions that have ever taken place on the bitcoin network are recorded. Balances of bitcoin are stored in individual &#8220;wallet&#8221; functions, which associate network public addresses with one or more &#8220;private keys&#8221; that control the transfer of bitcoin. The bitcoin blockchain can be updated without any single entity owning or operating the network.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Creation of New Bitcoin and Limits on Supply</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">New bitcoin is created and allocated by the bitcoin protocol through a &#8220;mining&#8221; process that rewards users that validate transactions in the bitcoin blockchain. Validated transactions are added in &#8220;blocks&#8221; approximately every 10 minutes. The mining process serves to validate transactions and secure the bitcoin network. Mining is a competitive and costly operation that requires a large amount of computational power to solve complex mathematical algorithms. This expenditure of computing power is known as &#8220;proof of work.&#8221; To incentivize miners to incur the costs of mining bitcoin, the bitcoin protocol rewards miners that successfully validate a block of transactions with newly generated bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The bitcoin protocol limits the total number of bitcoin that can be generated over time to 21 million. As part of bitcoin&#8217;s coin issuance, miners are rewarded a certain amount of bitcoins whenever a block is produced. When bitcoin first started, 50 bitcoins per block were given as a reward to miners. After every 210,000 blocks are mined (approximately every four years), the block reward halves and will keep on halving until the block reward per block becomes 0 (approximately by year 2140). The block reward as of February 14, 2025 is 3.125 coins per block and will decrease to 1.5625 coins per block post halving.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Modifications to the Bitcoin Protocol</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Bitcoin is an open-source network that has no central authority, so no one person can unilaterally make changes to the software that runs the network. However, there is a core group of developers that maintain the code for the bitcoin protocol as well as various bitcoin end-user software, and they can propose changes to the source code and release periodic updates and other changes. Unlike most software that has a central entity that can push updates to users, bitcoin is a peer-to-peer network in which individual network participants, called miners or nodes, decide whether to upgrade the software and accept the new changes. As a practical matter, a modification becomes part of the bitcoin protocol only if the proposed changes are accepted by participants collectively having the most processing power, known as hash rate, on the network. If a certain percentage of the nodes reject the changes, then a &#8220;fork&#8221; takes place and participants can choose the version of the software they want to run.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Forked or Airdropped Asset Policy</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We intend to recognize forked and airdropped assets consistent with our custodians. We may not immediately or ever have the ability to withdraw a forked or airdropped bitcoin by virtue of bitcoins that we hold with our custodians. Future forks may occur at any time. A fork can lead to a disruption of networks and our information technology systems, cybersecurity attacks, replay attacks, or security weaknesses, any of which can further lead to temporary or even permanent loss of our and our assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Forms of Attack Against the Bitcoin Network and Wallets</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Blockchain technology has many built-in security features that make it difficult for hackers and other malicious actors to corrupt the protocol or blockchain. However, as with any computer network, the bitcoin network may be subject to certain attacks. Some forms of attack include unauthorized access to wallets that hold bitcoin and direct attacks on the network, like &#8220;51% attacks&#8221; or &#8220;denial-of-service attacks&#8221; on the bitcoin protocol.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Bitcoin is designed to be controllable only by the possessor of both the unique public key and private key(s) relating to the local or online digital wallet in which the bitcoin is held. Private keys used to access bitcoin balances are not </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">widely distributed and are typically held on hardware (which can be physically controlled by the holder or by a third party such as a custodian) or via software programs on third-party servers. One form of obtaining unauthorized access to a wallet occurs following a phishing attack where the attacker deceives the victim and manipulates them into sharing their private keys for their digital wallet or other sensitive information. Other similar attacks may also result in the loss of private keys and the inability to access, and effective loss of, the corresponding bitcoin. See Item 1A. &#8220;Risk Factors&#8212;Risks Related to Our Bitcoin Treasury Strategy and Holdings&#8212;We face risks relating to the custody of our bitcoin, including the loss or destruction of private keys required to access our bitcoin and cyberattacks or other data loss relating to our bitcoin.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A &#8220;51% attack&#8221; may occur when a group of miners attain more than 50% of the bitcoin network&#8217;s mining power, thereby enabling them to control the bitcoin network and protocol and manipulate the blockchain. A &#8220;denial-of-service attack&#8221; occurs when legitimate users are unable to access information systems, devices, or other network resources due to the actions of a malicious actor flooding the network with traffic until the network is unable to respond or crashes. The bitcoin network has been, and can be in the future, subject to denial-of-service attacks, which can result in temporary delays in block creation and in the transfer of bitcoin. See Item 1A. &#8220;Risk Factors&#8212;Risks Related to Our Bitcoin Treasury Strategy and Holdings&#8212;Bitcoin and other digital assets are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertainty.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Bitcoin Industry Participants</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The primary bitcoin industry participants are miners, investors and traders, digital asset exchanges and service providers, including custodians, brokers, payment processors, wallet providers and financial institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Miners</i>. Miners range from bitcoin enthusiasts to professional mining operations that design and build dedicated mining machines and data centers, including mining pools, which are groups of miners that act cohesively and combine their processing power to mine bitcoin blocks. See &#8220;Creation of New Bitcoin and Limits on Supply&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Investors and Traders</i>. Bitcoin investors and traders include individuals and institutional investors who, directly or indirectly, purchase, hold, and sell bitcoin or bitcoin-based derivatives. On January 10, 2024, the SEC issued an order approving several applications for the listing and trading of shares of spot bitcoin ETPs on U.S. national securities exchanges. While the SEC had previously approved exchange-traded funds where the underlying assets were bitcoin futures contracts, this order represents the first time the SEC has approved the listing and trading of ETPs that acquire, hold and sell bitcoin directly. ETPs can be bought and sold on a stock exchange like traditional stocks, and provide investors with another means of gaining economic exposure to bitcoin through traditional brokerage accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Digital Asset Exchanges. </i>Digital asset exchanges provide trading venues for purchases and sales of bitcoin in exchange for fiat or other digital assets. Bitcoin can be exchanged for fiat currencies, such as the U.S. dollar, at rates of exchange determined by market forces on bitcoin trading platforms, which are not regulated in the same manner as traditional securities exchanges. In addition to these platforms, over-the-counter markets and derivatives markets for bitcoin also exist. The value of bitcoin within the market is determined, in part, by the supply of and demand for bitcoin in the global bitcoin market, market expectations for the adoption of bitcoin as a store of value, the number of merchants that accept bitcoin as a form of payment, and the volume of peer-to-peer transactions, among other factors. For a discussion of risks associated with digital asset exchanges, see Item 1A. &#8220;Risk Factors&#8212;Risks Related to Our Bitcoin Treasury Strategy and Holdings&#8212;Due to the currently unregulated nature and lack of transparency surrounding the operations of many bitcoin trading venues, bitcoin trading venues may experience greater fraud, security failures or regulatory or operational problems than trading venues for more established asset classes, which may result in a loss of confidence in bitcoin trading venues and adversely affect the value of our bitcoin.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Service providers</i>. Service providers offer a multitude of services to other participants in the bitcoin industry, including custodial and trade execution services, commercial and retail payment processing, loans secured by bitcoin collateral, and financial advisory services. If adoption of the bitcoin network continues to materially increase, we anticipate that service providers may expand the currently available range of services and that additional parties will enter the service sector for the bitcoin network.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Other Digital Assets</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the date of this annual report on Form 10-K, bitcoin was the largest digital asset by market capitalization. However, there are numerous alternative digital assets and many entities, including consortia and financial institutions, are researching and investing resources into private or permissioned blockchain platforms or digital assets that do not use proof-of-work mining like the bitcoin network. For example, in late 2022, the ethereum network transitioned to a &#8220;proof-of-stake&#8221; mechanism for validating transactions that requires significantly less computing power than proof-of-work mining. Other alternative digital assets that compete with bitcoin in certain ways include &#8220;stablecoins,&#8221; which are designed to maintain a peg to a reference price because of their issuers&#8217; promise to hold high-quality liquid assets (such as U.S. dollar deposits and short-term U.S. treasury securities) equal to the total value of stablecoins in circulation. Stablecoins have grown rapidly as an alternative to bitcoin and other digital assets as a medium of exchange and store of value, particularly on digital asset trading platforms. As of the date of this annual report on Form 10-K, two of the seven largest digital assets by market capitalization are bitcoin and ethereum.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, central banks in some countries have started to introduce digital forms of legal tender. For example, China&#8217;s central bank digital currency, or CBDC, project was made available to consumers in January 2022, and governments including the United States and the European Union have been discussing the potential creation of new CBDCs. For a discussion of risks relating to the emergence of other digital assets, see Item 1A. &#8220;Risk Factors &#8212;Risks Related to Our Bitcoin Treasury Strategy and Holdings&#8212;The emergence or growth of other digital assets, including those with significant private or public sector backing, could have a negative impact on the price of bitcoin and adversely affect our financial condition and results of operations.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Execution of Bitcoin Transactions </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have purchased bitcoin through multiple bitcoin trade execution, or liquidity providers, who may also serve as custodians of our bitcoin, and expect to continue to do so in the future. We may also in the future acquire or dispose of bitcoin via trade orders executed on exchanges such as Coinbase. Our liquidity providers and custodians, or our BTC Service Providers, are regulated and licensed entities that operate under high security, regulatory, audit and governance standards. We transact with multiple BTC Service Providers for both trade execution and custodial services to spread our risk and to limit our exposure to any single service provider or counterparty. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In selecting our liquidity providers, we evaluate regulatory status, pricing, annual trading volume, security and customer service. We also leverage the due diligence we conduct in connection with our custodial arrangements when conducting due diligence on our liquidity providers. Our current agreements with our liquidity providers are non-exclusive, may be terminated by us at any time, do not impose any requirements for minimum purchases or volumes with such providers, and generally provide that we are responsible for the costs associated with transfers of bitcoin. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, our liquidity providers, acting as our agents, have executed trades of bitcoin on our behalf using time-weighted average price over a prearranged time period, or TWAP, pricing and purchasing methodology, and we expect them to continue to do so in the future. The prearranged periods over which trades may be executed vary in length depending on the amount of bitcoin to be purchased and other factors, and are selected because they are expected to have lower price volatility and higher market liquidity, thereby limiting cost and pricing risks. Our liquidity providers use TWAP in their trading algorithms to execute large orders of bitcoin, without significantly affecting market price, by breaking large orders into several smaller orders that are independently traded at different time intervals in a generally linear fashion across different trading venues our liquidity providers select. Our liquidity providers execute trades based on the best possible terms reasonably available, taking into consideration all relevant facts and circumstances. As our agents, our liquidity providers use their discretion to select the counterparties to the transactions as well as the trading venues and platforms on which they execute trades on our behalf, and they may execute trades via cryptocurrency exchanges or in over-the-counter transactions. Our liquidity providers may calculate time-weighted average price using any number of resources, including various trading platforms. Our liquidity providers have policies and procedures pursuant to which they conduct trades with institutions that possess licenses or registrations to the extent required by their activities and have been AML/KYC approved pursuant to our liquidity providers&#8217; internal programs. We may in the future utilize TWAP pricing or another pricing methodology in connection with the execution of our bitcoin trades. </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Custody of our Bitcoin </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We currently hold and intend to continue to hold all of our bitcoin in custodial accounts at U.S.-based, institutional-grade custodians (who may hold our bitcoin in the United States or other territories) that have demonstrated records of regulatory compliance and information security. Our custodians may also serve as liquidity providers. As of December 31, 2024, we have entered into custodial agreements with Coinbase Custody Trust Company, LLC, or Coinbase Custody, a subsidiary of Coinbase Global,&#160;Inc., or Coinbase, and NYDIG Trust Company LLC, or NYDIG, a subsidiary of New York Digital Investment Group LLC. As we further execute on our strategy, we intend to include additional custodians. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We carefully select our custodians after undertaking a due diligence process pursuant to which we evaluate, among other things, the quality of their security protocols, including the multifactor and other authentication procedures designed to safekeep our bitcoin that they may employ, as well as other security, regulatory, audit and governance standards. Our custodians are required to hold our bitcoin in trust for our benefit in segregated accounts which are not commingled with their assets or the assets of their affiliates or other clients. Should we enter into custodial agreements with additional custodians, such agreements may not prohibit such custodians from commingling our bitcoin with the digital assets of others. Our custodial agreement with NYDIG provides that NYDIG will store our bitcoin in offline, or &#8220;cold&#8221; storage, and our custodial agreement with Coinbase Custody provides that Coinbase Custody will hold our bitcoin in an online &#8220;hot&#8221; wallet until it receives an instruction from us to effectuate a transfer of our bitcoin into cold storage. Cold storage is designed to mitigate risks that a system may be susceptible to when connected to the internet, including the risks associated with unauthorized network access and cyberattacks. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our custodians have access to the private key information associated with our bitcoin, or private keys, and they deploy security measures to secure our bitcoin holdings such as advanced encryption technologies, multi-factor identification, and a policy of storing our private keys in redundant, secure and geographically dispersed facilities. We never store, view or directly access our private keys. The operational procedures of our custodians are reviewed periodically by third-party advisors. All movement of our bitcoin by our custodians is coordinated, monitored and audited. Our custodians&#8217; procedures to prove control over the digital assets they hold in custody are also examined by their auditors. Additionally, we periodically verify our bitcoin holdings by reconciling our custodial service ledgers to the public blockchain. Our custodial agreements are terminable by us at any time, for any or no reason, upon advance notice given to the custodian. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risk Mitigation Practices Related to Our Liquidity and Custodial Arrangements </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that our primary counterparty risk with respect to our bitcoin holdings is performance obligations under our various custody arrangements. We intend to custody our bitcoin with multiple custodians to diversify our potential risk exposure to any one custodian. Our custodial services contracts do not restrict our ability to reallocate our bitcoin among our custodians or require us to hold a minimum amount of bitcoin with any particular custodian. Our bitcoin holdings may be concentrated with a single custodian from time to time, particularly as we negotiate new arrangements or move our assets among our various service providers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As regulated entities, our BTC Service Providers have policies, procedures and controls designed to comply with the Bank Secrecy Act, as amended by the USA PATRIOT Act, the implementing regulations of the U.S. Treasury Department&#8217;s FinCEN, the Executive Orders and economic sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control, or OFAC, as well as state Anti-Money Laundering, or AML laws. Pursuant to these policies, procedures and controls, our BTC Service Providers use information systems developed in-house and by third-party vendors to conduct know your customer, or KYC, identification verification, background checks and other due diligence on counterparties and customers, and on the affiliates, related persons and authorized representatives of their customers, and to screen these parties against published sanctions lists. These checks may, where appropriate, assess financial strength, reputation, trading capabilities and other risks that may be associated with a given customer or counterparty. Our BTC Service Providers perform these checks and screenings during initial onboarding or in advance of a transaction, as applicable, and periodically thereafter, particularly when the sanctions lists that they monitor are updated. Our BTC Service Providers also utilize systems that monitor and screen blockchain transactions and digital wallet addresses in their efforts to detect and report suspicious or unlawful activity. </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our due diligence process when selecting BTC service providers involves giving consideration to their reputation and security level, confirming their internal compliance with applicable laws and regulations and ensuring their undertakings of contractual obligations on compliance. With respect to our custodians, we also conduct due diligence reviews during the custodial relationship to monitor the safekeeping of our bitcoin. As part of our process, we obtain and review our custodians&#8217; services organization controls reports if available. We are also contractually entitled to review our custodians&#8217; relevant internal controls through a variety of methods. We have in the past conducted, and expect to conduct in the future, supplemental due diligence when we believe it is warranted by market circumstances or otherwise. For example, we obtained supporting documentation to verify certain factual information, including documentation and analysis regarding financial solvency, exposure to troubled exchanges, regulatory compliance, security protocols and our ownership of our bitcoin. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We negotiate liability provisions in our custodial contracts pursuant to which our custodians are held liable for their failure to safekeep our bitcoin. For example, our custodial agreement with Coinbase Custody provides that Coinbase Custody will be liable to us for up to an amount equal to the greater of the aggregate amount of fees paid in the 12 month period preceding a liability event or the value, at the time of a liability event, of the supported digital assets in our vault account that are directly affected by the liability event, in either case subject to a cap of $100&#160;million. Our custodial agreement with NYDIG provides that NYDIG will be liable to us for up to an amount equal to the greater of the fair market value of the custodied assets at the time the events giving rise to such liability occurred and the fair market value of the custodied assets at the time we are notified or otherwise have actual knowledge of the events giving rise to such liability. In addition to custodial arrangements, we also intend to utilize affiliates of our bitcoin custodians to execute bitcoin acquisition and disposition transactions on our behalf (who may be our liquidity providers discussed elsewhere). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We also negotiate specific contractual terms and conditions with our custodians that we believe will help establish, under existing law, that our property interest in the bitcoin held by our custodians is not subject to the claims of the custodian&#8217;s creditors in the event the custodian enters bankruptcy, receivership or similar insolvency proceedings. Our current custodians, and intended future custodians, are U.S.-based and are subject to U.S. regulatory regimes intended to protect customers in the event that a custodian enters bankruptcy, receivership or similar insolvency proceedings. Our custodians are required to comply with the Bank Secrecy Act, as amended by the USA PATRIOT Act, the implementing regulations of the U.S. Treasury Department&#8217;s FinCEN, the Executive Orders and economic sanctions regulations administered by the OFAC, as well as state AML laws. However, applicable insolvency law is not fully developed with respect to the holding of digital assets in custodial accounts. If our custodially-held bitcoin were nevertheless considered to be the property of our custodians&#8217; estates in the event that any such custodians were to enter bankruptcy, receivership or similar insolvency proceedings, we could be treated as a general unsecured creditor of such custodians, inhibiting our ability to exercise ownership rights with respect to such bitcoin and this may ultimately result in the loss of the value related to some or all of such bitcoin. Even if we are able to prevent our bitcoin from being considered the property of a custodian&#8217;s bankruptcy estate as part of an insolvency proceeding, it is possible that we would still be delayed or may otherwise experience difficulty in accessing our bitcoin held by the affected custodian during the pendency of the insolvency proceedings. Additionally, the bitcoin we hold with our custodians and transact with our trade execution partners does not enjoy the same protections as are available to cash or securities deposited with or transacted by institutions subject to regulation by the Federal Deposit Insurance Corporation or the Securities Investor Protection Corporation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regardless of efforts we have made to securely store and safeguard assets, there can be no assurance that our crypto assets will not be subject to loss or other misappropriation. Although our custodians carry insurance policies with policy limits ranging from $320&#160;million to $500&#160;million to cover losses for commercial crimes such as asset theft and other covered losses, such policy limits would be shared among all of their affected customers and subject to various limitations and exclusions (such as if a loss arises due to our failure to protect our login credentials and devices). As such, the insurance that covers losses of our bitcoin holdings may cover only a small fraction of the value of the entirety of our bitcoin holdings, and there can be no guarantee that our custodians will maintain such insurance policies or that such policies will cover any or all of our losses with respect to our bitcoin. For a discussion of risks relating to the custody of our bitcoin, see Item 1A. &#8220;Risk Factors&#8212;Risks Related to Our Bitcoin Treasury Strategy and Holdings&#8212;Our bitcoin treasury strategy exposes us to various risks associated with bitcoin,&#8221; and &#8220;&#8212;Our bitcoin treasury strategy exposes us to risk of non-performance by counterparties.&#8221;</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Potential Advantages and Disadvantages of Holding Bitcoin</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that bitcoin is an attractive asset because it can serve as a store of value, supported by a robust and public open-source architecture, that is untethered to sovereign monetary policy. We also believe that, due to its limited supply, bitcoin offers the potential to serve as a hedge against inflation in the long-term and, if its adoption increases, the opportunity for appreciation in value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Bitcoin exists entirely in electronic form, as virtually irreversible public transaction ledger entries on the blockchain, and transactions in bitcoin are recorded and authenticated not by a central repository, but by a decentralized peer-to-peer network. This decentralization mitigates the risks of certain threats common to centralized computer networks, such as denial-of-service attacks, and reduces the dependency of the bitcoin network on any single system. The decentralization of user nodes and miners also mitigates the risk of a 51% attack, which would be very costly and difficult to execute with respect to bitcoin because the bitcoin network is open source and widely distributed, and transactions on the blockchain require significant computing power to be validated. However, while the bitcoin network as a whole is decentralized, the private keys used to access bitcoin balances are not widely distributed and are susceptible to phishing and other attacks designed to obtain sensitive information or gain access to password-protected systems. Loss of such private keys can result in an inability to access, and effective loss of, the corresponding bitcoin. Consequently, bitcoin holdings are susceptible to all of the risks inherent in holding any electronic data, such as power failure, data corruption, security breach, communication failure and user error, among others. These risks, in turn, make bitcoin substantially more susceptible to theft, destruction, or loss of value from hackers, corruption, viruses and other technology-specific factors as compared to conventional fiat currency or other conventional financial assets. See Item 1A. &#8220;Risk Factors&#8212;Risks Related to Our Bitcoin Treasury Strategy and Holdings&#8212;If we or our third-party service providers experience a security breach or cyberattack and unauthorized parties obtain access to our bitcoin, or if our private keys are lost or destroyed, or other similar circumstances or events occur, we may lose some or all of our bitcoin and our financial condition and results of operations could be materially adversely affected.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the bitcoin network relies on open-source developers to maintain and improve the bitcoin protocol. Accordingly, bitcoin may be subject to protocol design changes, governance disputes such as &#8220;forked&#8221; protocols, competing protocols, and other open source-specific risks that do not affect conventional proprietary software. Unless and until a forked asset is deemed by our custodians to be an eligible asset, we may not immediately or ever have the ability to withdraw a forked asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that in the context of the economic uncertainty precipitated by escalating geopolitical tensions and central banks having adopted inflationary measures at various times in recent history, as well as the breakdown of trust in and between political institutions and political parties in the United States and globally, bitcoin represents an attractive store of value, and that opportunity for appreciation in the value of bitcoin exists in the event that such factors lead to more widespread adoption of the use and acceptance of bitcoin and the adoption of bitcoin as a treasury reserve alternative by institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Healthcare Technology Solutions Products and Services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We currently market a patented and FDA-cleared, vascular testing product, QuantaFlo, to our customers, who include insurance plans, physician groups, risk assessment groups, hospitals and retailers.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:219pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">QuantaFlo</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient&#8217;s vascular condition, including assessments of patients who have vascular disease. The following diagram illustrates the use of QuantaFlo:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="smlr-20241231x10k006.jpg" alt="Graphic" style="display:inline-block;height:218.6pt;left:0%;padding-bottom:0.4pt;position:relative;top:0pt;width:478.5pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is &#8216;sensed&#8217; by the sensor. A blood flow waveform is instantaneously constructed by our proprietary software algorithm. Both index fingers and both large toes are interrogated, which takes about 30 seconds for each.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have primarily developed a license model rather than an outright sales model for QuantaFlo. This license model eliminates the need to make a capital equipment sale. Consequently, we generally require no down payment or long-term commitment from our customers. QuantaFlo has an expected average lifetime of at least three years. To date, we roughly estimate that routine office usage of the QuantaFlo has ranged from a few tests per week up to 10 tests per day. We also offer contracts in which we invoice on a per test basis for use of QuantaFlo.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have placed our QuantaFlo product with healthcare insurance plans, integrated delivery networks, independent physician groups, hospitals and companies contracting with the healthcare industry such as risk assessment groups and retailers in addition to doctors&#8217; offices. Our two largest customers are U.S. diversified healthcare companies and affiliated plans, and in the year ended December 31, 2024, they accounted for 43.1% and 27.6% of our revenues, respectively, compared to 36.0% and 34.9%, respectively, in the prior year.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Other Blood Flow Testing Methods</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Blood flow is the amount of blood delivered to a given region per unit time, whereas blood pressure is the force exerted by circulating blood on the walls of arteries. Given a fixed resistance, blood flow and blood pressure are proportional. The ABI with Doppler test uses a blood pressure cuff to measure the systolic blood pressure in the lower legs and in the arms. A blood pressure cuff is inflated proximal to the artery in question. Using a Doppler device, the inflation continues until the pulse in the artery ceases. The blood pressure cuff is then slowly deflated. When the artery&#8217;s pulse is re-detected through the Doppler probe the pressure in the cuff at that moment indicates the systolic pressure of that artery. The test is repeated on all four extremities. Well-established criteria for the ratio of the blood pressure in a leg compared to the blood pressure in the arms are used to assess the presence or absence of flow obstruction. Generally, these tests take 15 minutes to perform and require a vascular technician to be done properly. Like QuantaFlo, the traditional analog ABI test with Doppler is a non-invasive physiologic measurement that may be abnormal in the presence of PAD. Alternatively, primary care physicians may palpate the pedal pulses to assess blood flow in the lower extremities. However, pulse palpation is generally not sensitive for the detection of vascular disease. Other options to detect arterial obstructions or hemodynamic problems are imaging systems that use ultrasound, x-ray technology or magnetic resonance to obtain anatomic information about blood vessels in the legs. However, as compared to QuantaFlo, imaging tests are much more expensive, time consuming and are performed by specialists in special laboratories or offices. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Market Opportunity</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">QuantaFlo</span></p><a id="_Hlk60296864"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;">Fee-for-service is a payment model where services are unbundled and paid for separately. Fee-for-service reimbursement may incentivize physicians to provide more treatments because payment is dependent on the quantity of care, rather than quality of care. Capitation is a payment arrangement where a managed care organization, physician or group of physicians, receives a fixed payment amount for each enrolled person assigned to them, per period of time, regardless of whether that individual seeks care. Under Medicare Advantage, participating health plans, commonly referred to as Medicare Advantage Organizations, or MAOs, receive a monthly per-member payment from CMS commonly referred to as a capitated payment. The capitated payment amount is based on the average expected healthcare utilization for a given patient. Under Medicare Advantage, CMS uses risk adjustment to adjust capitated payments to MAOs, either higher or lower, to account for the differences in underlying health status and expected healthcare costs of individuals. Accordingly, CMS provides MAOs with higher capitated payments for sicker patients who have conditions that are codified.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Undiagnosed cardiac and vascular diseases are major under-diagnosed health problems in the United States. These conditions are common and deadly cardiovascular disease is often undiagnosed. As with clogged arteries in the heart, clogged arteries in the legs place patients at an increased risk of heart attack and stroke. Published studies have shown that persons with PAD are four times more likely to die of heart attack, and two to three times more likely to die of stroke. According to a study by P.G. Steg published in the JAMA, patients with PAD have a 21% event rate of cardiovascular death, heart attack, stroke or cardiovascular hospitalization within 12&#160;months. The SAGE Group has estimated that as many as 20&#160;million people are affected with PAD in the United States alone and A.T. Hirsch et al. in a JAMA published article further estimate that only 11% have claudication (pain on exertion), a classic symptom of PAD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The spectrum of heart dysfunction includes heart failure. Published studies have shown that there are over one million hospitalizations per year in the United States from heart failure and the annual cost of care exceeds $30 billion. According to a study published in AHA Journals by S.L. Jackson, et al, heart failure affects ~approximately 6.5 million adults in the United States and the lifetime risk of heart failure is estimated to be one in five at 40 years of age. The study also notes persons with heart failure have mortality rates 20% to 25% higher after hospitalization within one year after diagnosis.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;">Many people affected with cardiac and vascular diseases do not have noticeable symptoms. When symptoms are present, they often include fatigue, heaviness, cramping or pain during activity, leg or foot pain, sores, wounds or ulcers on the toes, feet, or legs, which are slow to heal, shortness of breath, peripheral edema, or enlarged liver. Persons with cardiac and vascular diseases may become disabled and not be able to work. </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;">Risk factors for developing cardiac and vascular diseases include: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Age (over 50&#160;years) </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:20.15pt;text-indent:-20.15pt;margin:0pt 0pt 0pt 20.15pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Race (African-American) </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:20.15pt;text-indent:-20.15pt;margin:0pt 0pt 0pt 20.15pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">History of smoking </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:20.15pt;text-indent:-20.15pt;margin:0pt 0pt 0pt 20.15pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Diabetes </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:20.15pt;text-indent:-20.15pt;margin:0pt 0pt 0pt 20.15pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">High blood pressure </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:20.15pt;text-indent:-20.15pt;margin:0pt 0pt 0pt 20.15pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">High blood cholesterol </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:20.15pt;text-indent:-20.15pt;margin:0pt 0pt 0pt 20.15pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:20.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:20.15pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Personal history of vascular disease, heart attack, or stroke. </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;">We believe medical personnel and insurance plans who deliver care for individuals over the age of 50&#160;represent the target market for QuantaFlo. Based on U.S. Census data, we believe there are more than 80&#160;million older Americans who could be evaluated for the presence of cardiac and vascular diseases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;">There are over 400,000 medical professionals practicing primary care in the United States. In addition, based on American Heart Association data, there are over 30,000 cardiologists and 7,000 vascular and cardiovascular surgeons. Also, there are millions of diabetic patients seen routinely by endocrinologists. Many podiatrists who see patients with these problems and orthopedic surgeons may see value in screening patients for circulation issues prior to leg procedures. Neurologists may need a tool to differentiate leg pain from vascular versus neurologic etiology. Nephrologists see patients with kidney disease, who have a higher frequency of cardiac and vascular diseases. Wound care centers need to know the adequacy of limb perfusion. We expect that each physician will have many patient visits annually from people older than 50&#160;years. While it is standard practice to ask about symptoms of cardiac and vascular diseases and to look for signs on physical exam, we believe that it is often the case in busy practices that the questions go unasked. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Other Products and Services</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition to our internal research and development efforts, from time to time, we may make investments in, or distribute products from other companies that we believe are complementary to QuantaFlo. For example, we previously made an investment in Mellitus Health, Inc, or Mellitus, and had an exclusive agreement to market and distribute its product, Insulin Insights. Due to slow uptake of the product despite our marketing efforts, we wrote off our prepaid licenses and a portion of our investment as of December 31, 2023.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In October 2020, we invested in<span style="background:#ffffff;"> SYNAPS</span>, whose product, Discern, is a test for early Alzheimer&#8217;s disease. In December 2022, we purchased <span style="background:#ffffff;">a senior secured convertible promissory note </span><span style="white-space:pre-wrap;">of Monarch Medical Technologies, LLC, or Monarch, (as amended in December 2024 and January 2025), maker of EndoTool, a technology-enabled approach to inpatient glycemic management. We do not have a distribution agreement for Discern or EndoTool.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We continue to evaluate other investment and distribution opportunities for other products and services, and recently entered into distribution arrangements for other products that we believe would be of interest to our customers given the patient populations they serve, as we seek to complement our existing product offering.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our mission is to develop, manufacture and market products and services that assist healthcare providers in evaluating and treating chronic diseases. We intend to do this by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Targeting customers with patients at risk of developing</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">PAD and other cardiovascular diseases (subject to FDA clearance).</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Healthcare providers use blood flow measurements as part of their assessment of a patient&#8217;s cardiac and vascular condition. Our strategy is to keep marketing QuantaFlo on a recurrent revenue model to insurance plans and medical personnel who care for those older than 50 years, including cardiologists, internists, nephrologists, endocrinologist, podiatrists, and family practitioners. Specifically, we believe there are more than 400,000 physicians and other potential customers in the United States alone, many of whom care for patients older than 50 years old and at increased risk of developing PAD and other cardiovascular diseases. Based on U.S. Census data, the evaluable patient population for QuantaFlo is estimated to be more than 80 million patients in the United States annually.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Expanding the tools available to internists and non-peripheral vascular experts.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Our intention is to provide a tool to internists and non-cardiovascular experts, for whom it was previously impractical to conduct a blood flow measurement unless in a specialized vascular laboratory. For cardiovascular specialists, QuantaFlo does not require the use of blood pressure cuffs (which should not be used on some breast cancer patients), and measures without blood pressure in obese patients and patients with non-compressible, hard, calcified arteries. Currently, these patients often are unable to be measured satisfactorily with traditional devices.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Developing additional product and service offerings that allow healthcare providers to deliver cost-effective wellness and receive increased compensation for their services.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> In March 2015, we received FDA 510(k) clearance of our product, QuantaFlo, to aid clinicians in the diagnosis and monitoring of PAD. The cleared device reflected several updates and modifications to the original model that were developed in conjunction with our consultant engineering groups. We are seeking a new 510(k) clearance for the expanded use of QuantaFlo following correspondence with the FDA. The new 510(k) is intended to enable expanded labeling for QuantaFlo as an aid in the diagnosis of other cardiovascular diseases in addition to PAD. Further, we continue to explore potential new product and service offerings through our research and development programs. Our goal is to provide cost-effective wellness solutions for our growing, established customer base, achieve a reputation for outstanding service, all while leveraging our gains in the marketplace for such product and service offerings.</span><span style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Exploring additional product and service offerings through arrangements.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> In addition to our in-house research and development efforts, we are also seeking out opportunities to expand our product and service offerings through marketing, distribution and licensing arrangements. Such arrangements will allow us to sell products related to chronic disease management through our network of physicians and other customers. </span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Sales and Marketing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We provide our QuantaFlo product and any other products for which we have distribution rights to our customers through our salespersons, who have experience selling products and services to our anticipated market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">We deliver QuantaFlo directly to our customers, and in-service training to the customers is provided either on-line or in person. Because QuantaFlo is relatively easy to use, training can generally be accomplished in less than one day.  We are currently test marketing the other products we distribute, </span>products in the cardiovascular care space that we believe are attractive to our current customer base. We do not currently have any material revenues from these initial test marketing efforts, which will inform our sales and marketing strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Customers who have licensed our QuantaFlo product may pay by credit card or check generally on the 15<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> of each month as an advance for usage during the next 30 days. In some cases, customers prefer an annual or quarterly license paid in advance. We provide technical support daily, coupled directly to the manufacturing operation so that replacement products, if needed, can be shipped overnight directly to the customer. The majority of the support is over the telephone </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">and focuses on software and connectivity issues, rather than hardware. We upgrade QuantaFlo operating systems as appropriate by direct shipments or electronically.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to the license model with a fixed monthly fee, we also have contracts that charge a variable monthly fee, in which we invoice based on the number of tests performed with QuantaFlo. In addition to licensing the QuantaFlo software, we have sold QuantaFlo equipment and accessories.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Manufacturing</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">We manufacture our product, QuantaFlo, in the United States through independent contractors whom we pay for finished goods. Our contracts provide for subassemblies, product final assembly, test, serialization, finished goods, inventory and shipping operations. Our current contracts will remain in force until terminated by us upon three months written notice, or until terminated by either party for cause. Although we believe we have a good working relationship with our current contract manufacturers, there are many such qualified contract manufacturers available around the country should we need to replace them or if they are not able to meet demand as we grow our business as anticipated. While our current independent contract manufacturers source some supplies from China, we believe QuantaFlo</span><sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;"> </sup><span style="font-size:10pt;">is relatively easy to manufacture, and should we encounter issues due to supply chain disruptions as a result of the recent tariff proposals of the current U.S. administration, or a global health emergency, such as the COVID-19 pandemic or any other global supply chain constraints, we believe alternative sources should be available. We employ a consultant vendor qualification expert to monitor and test the quality controls and quality assurance procedures of our contract manufacturer.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Competition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The principal competitor for QuantaFlo is the standard blood pressure cuff ABI device. QuantaFlo does not include a blood pressure cuff. There are several companies that manufacture the traditional ABI device, which range in price from $2,500 to $20,000. Some of these companies are much larger than us and have more financial resources and their own distributor network. The traditional ABI devices are differentiated by the degree of automation designed into each product. ABI devices that rely more heavily on operator assessment (<i style="font-style:italic;">i.e.</i>, listening to the return of pulse while decreasing cuff pressure), are thought to have less objectivity in their measurement. Because standard ABI devices require a better trained operator, the products are usually sold to specialized vascular labs that are supervised by a vascular surgeon, with the tests performed by a licensed vascular technician. It is not uncommon for such ABI devices to be marketed to the offices of internists, podiatrists, endocrinologists or most cardiologists.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our intention is to provide a tool to internists and non-cardiovascular experts, for whom it was previously impractical to conduct a blood flow measurement unless in a specialized vascular laboratory. For cardiovascular specialists, QuantaFlo does not require the use of blood pressure cuffs (which should not be used on some breast cancer patients), and measures without blood pressure in obese patients and patients with non-compressible, hard, calcified arteries. Currently, these patients often are unable to be measured with traditional devices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Competitors are marketing competing digital devices seeking to provide fast results that may be used outside of a specialized vascular laboratory. Given the potential size of the market, we expect competitors to continue to enter the space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development Program</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have dedicated engineering consultants that are well integrated into our overall business, ranging from customer requirements to technical support. The engineering group uses our in-house quality system as its framework for new product development and release. The majority of the engineering is circuit design and software development. We are currently developing several updates and modifications to QuantaFlo in conjunction with our consultant engineering groups, as well as exploring potential new product and service offerings. These product and service offerings are being designed to provide cost-effective wellness solutions for our growing, established customer base. The new products and service offerings under development or that may be developed may incorporate some of our current technology or new technology. We are also directing much of our activity to building our trade secrets and protecting proprietary positions.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Clinical Experience</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Several studies of our blood flow measurement products have been conducted by our customers or authors facilitated by access to our database. Other studies were conducted by our customers using their own independently generated datasets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">One of these studies, the results of which were compiled in 2012 and published in a peer reviewed journal in 2013, sought to determine the frequency of finding undiscovered vascular disease in primary care practices using our vascular testing product. In the study of 632 patients at 19 office practices, the frequency of flow obstruction was 12% and of these patients, 75% did not have classic symptoms of PAD. Among other limitations of the study, the publication mentioned the study&#8217;s retrospective design, no direct comparison to other vascular tests and passive data collection such that 8% of patients had one or more missing data fields.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Another study was designed to assess the side-by-side performance of our vascular testing product compared with traditional analog ABI with Doppler measurements in medical practices. In the study of 181 limbs from 121 patients at 5 medical practices during 2012 and 2013, three techniques were used on all limbs: our test, traditional analog ABI with Doppler, and Duplex ultrasound imaging as a gold standard. Traditional analog ABI with Doppler was unable to perform a conclusive study in 8.7% of limbs. In the remaining limbs, our vascular testing product and the ABI with Doppler measurements were in agreement, or in other words concordant, in 78% of limbs. Among the discordant limbs, Duplex imaging judged that the true positive rate of our vascular testing product was significantly higher than that of ABI with Doppler by a 2 to 1 margin. The results of the study are available as a white paper that may be shown to potential customers or other interested parties. Among other limitations of the study, the study had a small sample size, was conducted at specialty practices not primary care practices, had a retrospective design with incomplete collection of demographic information and clinical characteristics of the population, and was not peer reviewed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Another study also was designed to assess the side-by-side performance of our vascular testing product compared with traditional analog ABI with Doppler measurements in medical practices. In this prospective study at five medical practices during 2013 through 2015, 360 limbs from 180 patients were examined with three techniques: Our vascular testing product, traditional analog ABI with Doppler, and Duplex ultrasound imaging as a gold standard. Results demonstrated that our test demonstrated greater sensitivity, greater accuracy and equivalent specificity compared to ABI with Doppler measurements. The results of the study are available as a white paper. Among limitations of the study are that it had a small sample size, was conducted at a mix of primary care and specialty practices, had no formal tracking of consecutive patients, and was not peer reviewed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Another study, the results of which were compiled and published in a peer reviewed journal in 2018, reported an analysis of a registry of screening PAD testing with our product between January 2017 and July 2017. In this study, 226,565 patients were tested and 31.3% had moderate to severe flow impairment in the lower extremities. Further analysis of a subset of 26,459 patients for whom clinical characteristics were recorded showed that 95% were asymptomatic. The authors concluded that earlier recognition of PAD may lead to earlier secondary preventive measures and improved outcomes for a population with a high-risk of cardiovascular mortality and morbidity. Among other limitations of the study, the publication mentioned the study&#8217;s retrospective design and that clinical factors were recorded for only approximately 10% of patients. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A retrospective case series compiled and published in a peer reviewed journal in 2018 reported on 48 patients that were tested with our product and subsequently had a contrast angiography procedure for clinical indications. Using contrast angiography as the gold standard for determining PAD, the author concluded the data supports the use of our product as an aid for practicing physicians to accurately diagnose PAD in combination with clinical judgment. Among other limitations of the study, the sample size was small, tests were performed at specialty centers, and the analysis was done retrospectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Certain racial and economic groups in the United States are underserved by the medical community with limited access to specialists, a lack of early detection programs and inadequate preventive disease management. There is abundant evidence that certain ethnic populations are more at risk for cardiovascular disease and suffer sequelae of untreated PAD. A study was compiled and published in a peer reviewed journal in 2018 that presented a retrospective </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">analysis of 1,901 patients tested with our product at 22 medical practices that serve predominately lower-income, non-white populations. The author concluded that our product can be effectively utilized by primary care clinicians in poor and underserved communities to identify PAD. The author posited that identifying PAD earlier in the disease process can be an important step towards filling the unmet need of higher intensity vascular care for minority populations. Limitations of the study include that it was a retrospective analysis and that there was no protocol to unveil the identity or ethnicity of any of the individual patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Women may lack early detection programs and have inadequate preventive disease management. A study was compiled and published in a peer reviewed journal in 2019 that presented a retrospective analysis of 68,402 female patients tested with our product at primary care medical practices in the United States. The author concluded that our product was an efficient means to aid in the diagnosis of PAD in vulnerable women who are currently underserved by their health care providers. Limitations of the study include that it was a retrospective analysis with self-reporting of clinical characteristics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A February 2022 published peer-reviewed study analyzed point-of-care tests using QuantaFlo for asymptomatic patients in a Medicare Advantage population between January 2016 and December 2016. In this study, 13,971 patients were tested and 31.6% had a positive result for PAD. Almost 60% had lower socio-economic income level with 15.1% living under the poverty level. The risk associated with detecting PAD was substantial with a 60-70% increased risk of all-cause mortality or morbidity at one year and a 40-50% increased risk of all-cause mortality or morbidity at three years. The risk was not modified by a history of coronary or cerebrovascular artery disease. The authors concluded that these findings highlight an enormous potential to realize cost-savings by reducing cardiovascular event rates and deploying population-based PAD risk mitigation strategies. Among other limitations of the study, the publication mentioned that they were not able to study the potential impact of PAD risk management strategies used after a positive PAD screen was communicated with the primary care provider and patient. This may have led to an underestimation of the true risk as targeted PAD risk management and behavior modification strategies may have been initiated at the discretion of the provider and patient.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A September 2022 peer-reviewed study under real-world conditions, illustrating the benefits of PAD in-home screening was published. The study analyzed screening tests using QuantaFlo for Medicare Advantage beneficiaries aged &#8805;65 years participating in the Optum HouseCalls program in the United States between April 1, 2017 and February 1, 2019. Of the 192,500 patients tested in their homes, 27.7% had a positive result for PAD. One-year all-cause mortality, 1- and 2-year major adverse cardiovascular events or MACE, and major adverse limb events or MALE, in the PAD positive patients were all significantly increased versus those patients who screened negative for PAD (p &lt;.001). Moreover, the severity of the test results was associated with worse outcomes. The authors stated, &#8220;Detecting previously undiagnosed peripheral artery disease is a way to risk stratify a population that would benefit from further cardiovascular risk management.&#8221; Among other limitations of the study, the publication mentioned that the findings are only generalizable to individuals aged &#8805;65 years and the study could not assess the proportion of deaths due to cardiovascular causes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="font-weight:normal;">A February 2023 peer-reviewed study was published assessing the accuracy of our vascular testing product using cardiac echocardiography or Echo, as a gold standard of heart failure. Results were that our test showed a significant correlation with Echo (p&lt;.01). Among other limitations of the study, the publication mentioned that data on severity were not including and outcomes following preventative measures were not studied.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Patents and Licenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have been issued one patent for our apparatus, U.S. Patent No. 7,628,760, which expires December 11, 2027.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Government Regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Bitcoin Regulation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The laws and regulations applicable to bitcoin and digital assets are evolving and subject to interpretation and change.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Governments around the world have reacted differently to digital assets; certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions, such as the United States, digital assets are subject to overlapping, uncertain and evolving regulatory requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As digital assets have grown in both popularity and market size, the U.S. Executive Branch, Congress and a number of U.S. federal and state agencies, including the Financial Crimes Enforcement Network, the CFTC, the SEC, the Financial Industry Regulatory Authority, the Consumer Financial Protection Bureau, the Department of Justice, the Department of Homeland Security, the Federal Bureau of Investigation, the IRS and state financial regulators, have been examining the operations of digital asset networks, digital asset users and digital asset exchanges, with particular focus on the extent to which digital assets can be used to violate state or federal laws, including to facilitate the laundering of proceeds of illegal activities or the funding of criminal or terrorist enterprises, and the safety and soundness and consumer-protective safeguards of exchanges or other service-providers that hold, transfer, trade or exchange digital assets for users. Many of these state and federal agencies have issued consumer advisories regarding the risks posed by digital assets to investors. In addition, federal and state agencies, and other countries have issued rules or guidance regarding the treatment of digital asset transactions and requirements for businesses engaged in activities related to digital assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Depending on the regulatory characterization of bitcoin, the markets for bitcoin in general, and our activities in particular, our business and our bitcoin acquisition strategy may be subject to regulation by one or more regulators in the United States and globally. Ongoing and future regulatory actions may alter, to a materially adverse extent, the nature of digital assets markets, the participation of industry participants, including service providers and financial institutions in these markets, and our ability to pursue our bitcoin strategy. Additionally, U.S. state and federal and foreign regulators and legislatures have taken action against industry participants, including digital assets businesses, and enacted restrictive regimes in response to adverse publicity arising from hacks, consumer harm, or criminal activity stemming from digital assets activity. U.S. federal and state energy regulatory authorities are also monitoring the total electricity consumption of cryptocurrency mining, and the potential impacts of cryptocurrency mining to the supply and dispatch functionality of the wholesale grid and retail distribution systems. Many state legislative bodies have passed, or are actively considering, legislation to address the impact of cryptocurrency mining in their respective states.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The CFTC takes the position that some digital assets, including bitcoin, fall within the definition of a &#8220;commodity&#8221; under the Commodities Exchange Act of 1936, as amended, or CEA. Under the CEA, the CFTC has broad enforcement authority to police market manipulation and fraud in spot digital assets markets in which we may transact. Beyond instances of fraud or manipulation, the CFTC generally does not oversee cash or spot market exchanges or transactions involving digital asset commodities that do not utilize margin, leverage, or financing. In addition, CFTC regulations and CFTC oversight and enforcement authority apply with respect to futures, swaps, other derivative products and certain retail leveraged commodity transactions involving digital asset commodities, including the markets on which these products trade.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The SEC and its staff have taken the position that certain other digital assets fall within the definition of a &#8220;security&#8221; under the U.S. federal securities laws. Public statements made by senior officials and senior members of the staff at the SEC indicate that the SEC does not consider bitcoin to be a security under the federal securities laws, and the approval of the spot bitcoin ETPs support this view. However, such statements are not official policy statements by the SEC and reflect only the speakers&#8217; views, which are not binding on the SEC or any other agency or court and cannot be generalized to any other digital assets. In addition, in January 2025, the SEC acting Chairman announced a new Crypto Task Force dedicated to developing a comprehensive and clear regulatory framework for digital assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition, because transactions in bitcoin provide a degree of anonymity, they are susceptible to misuse for criminal activities, such as money laundering. This misuse, or the perception of such misuse, could lead to greater regulatory oversight of bitcoin and bitcoin platforms, and there is the possibility that law enforcement agencies could close bitcoin platforms or other bitcoin-related infrastructure with little or no notice and prevent users from accessing or retrieving bitcoin held via such platforms or infrastructure. For example, a January 2021 nomination hearing before the Senate Finance Committee, it was noted that cryptocurrencies have the potential to improve the efficiency of the financial system but that they can be used to finance terrorism, facilitate money laundering, and support activities that threaten U.S. national security interests and the integrity of the U.S. and international financial systems. The OFAC has </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">issued updated advisories regarding the use of virtual currencies, added a number of digital asset exchanges and service providers to the Specially Designated Nationals and Blocked Persons list and engaged in several enforcement actions, including a series of enforcement actions that have either shut down or significantly curtailed the operations of several smaller digital asset exchanges associated with Russian and/or North Korean nationals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Activities involving bitcoin and other digital assets may fall within the jurisdiction of more than one financial regulator and various courts and such laws and regulations are rapidly evolving and increasing in scope. On March 9, 2022, an executive order relating to cryptocurrencies was signed. While the executive order did not mandate the adoption of any specific regulations, it instructed various federal agencies to consider potential regulatory measures, including the evaluation of the creation of a U.S. CBDC. On September 16, 2022, the White House released a framework for digital asset development, based on reports from various government agencies, including the U.S. Department of Treasury, the Department of Justice, and the Department of Commerce. Among other things, the framework encourages regulators to pursue enforcement actions, issue guidance and rules to address current and emergent risks, support the development and use of innovative technologies by payment providers to increase access to instant payments, consider creating a federal framework to regulate nonbank payment providers, and evaluate whether to call upon Congress to amend the Bank Secrecy Act and laws against unlicensed money transmission to apply explicitly to digital asset service providers. There have also been several bills introduced in Congress that propose to establish additional regulation and oversight of the digital asset markets. With the recent change in the U.S. administration, there is uncertainty about future regulatory oversight and enforcement and what rules and regulations may ultimately govern. For example, in January 2025, an executive order was issued that revoked the prior administration's executive order and Treasury Department's framework, and established the Presidential Working Group on Digital Asset Markets that will be tasked with developing a federal regulatory framework governing digital assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">U.S. Food and Drug Administration Regulation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">QuantaFlo is a medical device subject to extensive regulation by the FDA and other federal, state, local and foreign regulatory bodies. FDA regulations govern, among other things, the following activities that we or our partners perform and will continue to perform:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product design and development;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product testing;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product manufacturing;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product safety;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">post-market adverse event reporting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">post-market surveillance;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product labeling;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product storage;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">record keeping;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">premarket clearance or approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">post-market approval studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">advertising and promotion; and</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product sales and distribution.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">FDA&#8217;s Premarket Clearance and Approval Requirements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To commercially distribute QuantaFlo or any future medical device we develop requires or will require either prior 510(k) clearance or prior approval of a premarket approval, or PMA, application or de novo classification from the FDA. The FDA classifies medical devices into one of three classes. Devices deemed to pose lower risk are placed in either class I or II, which requires the manufacturer to submit to the FDA a premarket notification requesting permission for commercial distribution. This process is known as 510(k) clearance. Some low risk devices are exempt from this requirement. Class I devices are those for which safety and effectiveness can be reasonably assured by adherence to FDA&#8217;s &#8220;general controls&#8221;, which include compliance with the applicable portions of the FDA&#8217;s Quality System Regulation, or QSR, facility registration and product listing, reporting of adverse medical events and malfunctions through the submission of medical device reports, and appropriate, truthful and non-misleading labeling, advertising and promotional materials. Class II devices are subject to FDA&#8217;s general controls and any other &#8220;special controls&#8221; deemed necessary by FDA to ensure the safety and effectiveness of the device, such as performance standards, special labeling requirements, patient registries or post-market surveillance. Devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a previously cleared 510(k) device are placed in class III, requiring approval of a PMA application. To market low to moderate risk devices that are automatically placed into class III, a manufacturer may request a de novo classification from FDA. Premarket notifications, PMA applications and de novo classification requests are subject to the payment of user fees, paid at the time of submission for FDA review. The FDA can also impose restrictions on the sale, distribution or use of devices at the time of their clearance or approval or authorization, or subsequent to marketing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">510(k) Clearance Pathway</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To obtain 510(k) clearance, a medical device manufacturer must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of a PMA application or a device that has been reclassified from class III to class II or class I. A device is substantially equivalent if, with respect to the predicate device, it has the same intended use and has either (i) the same technological characteristics, or (ii) different technological characteristics, but the information provided in the 510(k) submission demonstrates that the device does not raise new questions of safety and effectiveness and is at least as safe and effective as the predicate device. The FDA&#8217;s 510(k) clearance pathway usually takes from three to 12 months from the date the notification is submitted, but it can take significantly longer, and clearance is never assured. Although many 510(k) premarket notifications are cleared without clinical data, in some cases, the FDA requires significant clinical data to support substantial equivalence. In reviewing premarket notification, the FDA may request additional information, including clinical data, which may significantly prolong the review process. After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, will require a new 510(k) clearance or could require a PMA application or de novo request for classification. The FDA requires each manufacturer to make this determination initially, but the FDA can review any such decision and can disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination regarding whether a new premarket submission is required for the modification of an existing device, the FDA can require the manufacturer to cease marketing and/or recall the modified device until clearance or approval is obtained.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Premarket Approval Pathway</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">A PMA application must be submitted if the device cannot be cleared through the 510(k) clearance process and requires proof of the safety and effectiveness of the device to the FDA&#8217;s satisfaction. Accordingly, a PMA application must be supported by extensive data including, but not limited to, technical information regarding device design and development, preclinical studies and clinical trials, data and manufacturing and labeling to support the FDA&#8217;s determination that the device is safe and effective for its intended use. After FDA determines that a PMA application is sufficiently complete to permit a substantive review, the FDA begins an in-depth review of the submitted information, which generally takes between one and three years, but may take significantly longer. During this review period, the </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">FDA may request additional information or clarification of information already provided. Also, during the review period, an advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. In addition, the FDA will conduct a preapproval inspection of the manufacturing facility to ensure compliance with the QSR, which impose elaborate design development, testing, control, documentation and other quality assurance procedures in the design and manufacturing process. The FDA may approve a PMA application with post-approval conditions intended to ensure the safety and effectiveness of the device including, among other things, restrictions on labeling, promotion, sale and distribution and collection of long-term follow-up data from patients in the clinical study that supported approval. Failure to comply with the conditions of approval can result in materially adverse enforcement action, including the loss or withdrawal of the approval. New PMA applications or PMA application supplements are required for significant modifications to the manufacturing process, labeling and design of a device that is approved through the PMA process. PMA supplements often require submission of the same type of information as a PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA application, and may not require as extensive clinical data or the convening of an advisory panel.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">De Novo Classification Pathway</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Device types that the FDA has not previously classified as class I, II or III are automatically classified into class III regardless of the level of risk they pose. To market low to moderate risk devices that are automatically placed into class III due to the absence of a predicate device, a manufacturer may request a de novo classification. This procedure allows a manufacturer whose novel device is automatically classified into class III to request classification of its device into class I or II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA application. The FDA is required to classify the device within 120 days following receipt of the de novo classification request, although in practice, the FDA&#8217;s review may take significantly longer. If the manufacturer seeks reclassification into class II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the device. The FDA may reject the de novo classification request if it identifies a legally marketed predicate device that would be appropriate for a 510(k) or determines that the device is not low to moderate risk or that general controls would be inadequate to control the risks and special controls cannot be developed. In the event FDA determines the data and information submitted demonstrate that general controls or general and special controls are adequate to provide reasonable assurance of safety and effectiveness, FDA will grant the de novo request for classification. When FDA grants a de novo request for classification, the device is granted marketing authorization and further can serve as a predicate for future devices of that type through a 510(k) premarket notification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Clinical Trials</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Clinical trials are typically required to support a PMA and often for a de novo classification request, and are sometimes required to support a 510(k) submission. All clinical investigations of devices to determine safety and effectiveness must be conducted in accordance with the FDA&#8217;s investigational device exemption, or IDE, regulations which govern investigational device labeling, prohibit promotion of the investigational devices, and specify an array of recordkeeping, reporting and monitoring responsibility of study sponsors and study investigators. If the device presents a &#8220;significant risk,&#8221; as defined by the FDA, to human health, the FDA requires the device sponsor to submit an IDE application to the FDA, which must be approved prior to commencing human clinical trials. A significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a patient and either is implanted, purported or represented to be used in supporting or sustaining human life, is for a use that is substantially important in diagnosing, curing, mitigating or treating disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. An IDE application must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. A clinical trial may begin 30 days after receipt of the IDE application by the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval. Acceptance of an IDE application for review does not guarantee that the FDA will approve the IDE and, if it is approved, the FDA may or may not determine that the date derived from the trials support the safety and effectiveness of the device or warrant the continuation of clinical trials. An IDE supplement must be submitted to, and approved by, the </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">FDA before a sponsor or investigator may make a change to the investigational plan that may affect its scientific soundness, study plan or the rights, safety or welfare of human subjects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the study must be approved by, and conducted under the oversight of, an institutional review board, or IRB, for each clinical site. The IRB is responsible for the initial and continuing review of the IDE, and may pose additional requirements for the conduct of the study. If an IDE application is approved by the FDA and one or more IRBs, human clinical trials may begin a specific number of investigational sites with a specific number of patients, as approved by the FDA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the device is considered a &#8220;non-significant risk,&#8221; an IDE application to the FDA is not required. Instead, only approval from the IRB overseeing the investigation at each clinical trial site is required. Abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping requirements also apply to non-significant risk device studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During a study, the sponsor is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping and prohibitions on the promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators in the clinical study are also subject to FDA&#8217;s regulations and must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of the investigational device, and comply with all applicable reporting and record keeping requirements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the anticipated benefits. Even if a clinical trial is completed, there can be no assurance that the data generated during a clinical study will meet the safety and effectiveness endpoints or otherwise produce results that will lead the FDA to grant marketing clearance or approval. Information about certain device clinical trials must be posted on clinicaltrials.gov. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Pervasive and Continuing FDA Regulation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">After a device is placed on the market, regardless of its classification or premarket pathway, numerous regulatory requirements apply. These include, but are not limited to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishment registration and device listings with the FDA;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">QSR, which require manufacturers to follow stringent design, testing, process control, documentation and other quality assurance procedures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">labeling regulations, which prohibit the promotion of products for uncleared or unapproved, </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">i.e.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, &#8220;off-label,&#8221; uses and impose other restrictions on labeling;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">corrections and removal reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the U.S. Federal Food, Drug, and Cosmetic Act, or FDCA, that may present a risk to health; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">requirements to conduct post-market surveillance studies to establish continued safety data.</span></td></tr></table><div style="margin-top:12pt;"></div></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA enforces these requirements by inspection and market surveillance. Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">untitled letters or warning letters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fines, injunctions and civil penalties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recall or seizure of our products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">operating restrictions, partial suspension or total shutdown of production;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refusing our request for 510(k) clearance or premarket approval or de novo classification of new products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">withdrawing premarket approvals that are already granted or reclassifying the devices; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">criminal prosecution.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are subject to unannounced device inspections by the FDA and the California Food and Drug Branch. These inspections may include our suppliers&#8217; facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Third-Party Coverage and Reimbursement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot control whether or not providers who use QuantaFlo will seek third-party coverage for such procedures or reimbursement. If providers intend to seek third-party coverage or reimbursement for use of QuantaFlo, the success of our product could become dependent on the availability of coverage and reimbursement from third-party payors, such as governmental programs including Medicare and Medicaid, private insurance plans and managed care programs. Reimbursement is contingent on established coding for a given procedure, coverage of the codes by the third-party payors and adequate payment for the resources used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Physician coding for procedures is established by the American Medical Association. CMS, the agency responsible for administering Medicare and Medicaid, and the National Center for Health Statistics, are jointly responsible for overseeing changes and modifications to billing codes used by hospitals for reporting inpatient procedures, and many private payors rely on coverage decisions and reimbursement rates established by CMS as benchmarks for determining their own coverage and reimbursement policies. All physician and hospital coding is subject to change, which could impact coverage and reimbursement and physician practice behavior. We do not track denial of requests for reimbursement made by the users of QuantaFlo. It is our belief that such denials have occurred and might occur in the future with more or less frequency. We are not in the business of performing QuantaFlo measurements that require us to seek reimbursement from third-party payors, including governmental healthcare programs, such as Medicare and Medicaid, commercial health insurers, including those that offer Medicare Advantage plans, and managed care programs. Many of our customers are third-party payors who pay us directly for use of our product and services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Independent of the coding status, third-party payors may deny coverage based on their own criteria, such as if they believe that the clinical efficacy of a device or procedure is not well established and is deemed experimental or investigational, is not the most cost-effective treatment available, or is used for an unapproved indication. We will continue to provide the appropriate resources to patients, physicians, hospitals and insurers in order to promote the best in patient care and clarity regarding reimbursement and work to obtain appropriate coverage policies. For some governmental programs, such as Medicaid, coverage and reimbursement differ from state to state, and some state Medicaid programs may not pay an adequate amount for the procedures performed with our products, if any payment is made at all. As the portion of the U.S. population over the age of 65 and eligible for Medicaid continues to grow, we may be more vulnerable to coverage and reimbursement limitations imposed by CMS. National and regional coverage policy decisions are subject to unforeseeable change and have the potential to impact physician behavior. For example, if CMS decreases the monthly payment for a 65-year-old patient, then the provider will have to decide which steps to eliminate from his or her routine office visits in order to maintain a profitable business model. If the time of an office </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">visit will need to be reduced to maintain a profitable business, a provider may decide to eliminate certain services or conducting certain procedures, such as deciding not to use a thermometer, take someone&#8217;s blood pressure or use a QuantaFlo to run an ABI test. Thus, reimbursement limitations imposed by CMS on providers may affect their decision making about which services to provide during an office visit, which could affect our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Particularly in the United States, third-party payors carefully review, have undertaken cost-containment initiatives, and increasingly challenge the prices charged for procedures and medical products as well as any technology that they, in their own judgment, consider experimental or investigational. In addition, an increasing percentage of insured individuals are receiving their medical care through managed care programs, which monitor and often require pre-approval or pre-authorization of the services that a member will receive. Many managed care programs are paying their providers on a capitated basis, which puts the providers at financial risk for the services provided to their patients by paying them a predetermined amount per member per month. The percentage of individuals covered by managed care programs is expected to grow in the United States over the next decade.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There can be no assurance that third-party coverage and reimbursement will be available or adequate, or that future legislation, regulation, or coverage and reimbursement policies of third-party payors will not adversely affect the demand for our products or our ability to sell these products on a profitable basis. The unavailability or inadequacy of third-party payor coverage or reimbursement could have a material adverse effect on our business, operating results and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Healthcare Fraud and Abuse</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our operations may be subject to federal and state healthcare laws and regulations including fraud and abuse laws, such as anti-kickback and false claims laws, data privacy and security laws and transparency laws related to payments and/or other transfers of value made to physicians and other healthcare professionals and teaching hospitals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The federal Anti-Kickback Law prohibits unlawful inducements for the referral of business reimbursable under federally-funded healthcare programs, such as remuneration provided to physicians to induce them to use certain tissue products or medical devices reimbursable by Medicare or Medicaid. The federal Anti-Kickback Law is subject to evolving interpretations. For example, the government has enforced the federal Anti-Kickback Law to reach large settlements with healthcare companies based on, among other things, inappropriate consultant arrangements with physicians or questionable joint venture arrangements. The majority of states also have anti-kickback laws, which establish similar prohibitions that may apply to items or services reimbursed by any third-party payor, including commercial insurers. Further, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the Health Care Reform Law, among other things, amended the intent requirement of the federal Anti-Kickback Law and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation. In addition, the Health Care Reform Law provided that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Law constitutes a false or fraudulent claim for purposes of the civil False Claims Act and certain criminal healthcare fraud statutes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Additionally, the civil False Claims Act prohibits knowingly presenting or causing the presentation of a false, fictitious or fraudulent claim for payment to the U.S. government. Actions under the False Claims Act may be brought by the U.S.Attorney General or as a qui tam action by a private individual in the name of the government. The federal government is using the civil False Claims Act, and the accompanying threat of significant liability, in its investigations of healthcare providers and suppliers throughout the country for a wide variety of Medicare billing practices and has obtained multi-million and multi-billion dollar settlements in addition to individual criminal convictions. The federal False Claims Act provides for treble damages and per-claim penalties. We have been cooperating with civil investigative demands from DOJ since 2017 related to claims for reimbursement related to our QuantaFlo device, and are at risk of civil suit by DOJ resulting therefrom. See Item 3. &#8220;Legal Proceedings&#8221; and Item 1A. &#8220;Risk Factors&#8212;We are subject to various healthcare fraud and abuse laws and regulations, and at risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages for tests performed using our device, which would adversely affect our business. A civil suit by DOJ also exposes us to risk of other litigation.&#8221; for more information. In addition, off-label promotion has been pursued as a violation of the federal False Claims Act. Pursuant to FDA </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">regulations, we can only market our products for cleared or approved uses. Although physicians are permitted to use medical devices for indications other than those cleared or approved by the FDA based on their independent medical judgment, we are prohibited from promoting products for such off-label uses. Given the significant size of actual and potential settlements, it is expected that the government will continue to devote substantial resources to investigating healthcare providers&#8217; and suppliers&#8217; compliance with the healthcare reimbursement rules and fraud and abuse laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the majority of states in which we market our products have similar fraud and abuse laws, such as anti-kickback, false claims, anti-fee splitting and self-referral laws, which may apply to items or services reimbursed by any third-party payor, including commercial insurers, and violations may result in substantial civil, criminal and administrative penalties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Health Care Reform Law also included the federal Physician Payments Sunshine Act, which requires device manufacturers for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to disclose annually to CMS any &#8220;transfer of value&#8221; made or distributed to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other licensed health care practitioners, and teaching hospitals. Such information is now made publicly available in a searchable format, and device manufacturers are now required to report and disclose any investment interests held by physicians and their family members during the preceding calendar year. Failure to submit required information may result in significant civil monetary penalties for all payments, transfers of value or ownership or investment interests not reported in an annual submission. Additionally, the commercial compliance environment is continually evolving in the healthcare industry, and some states, including California, Massachusetts and Vermont, mandate implementation of corporate compliance programs, along with the tracking and reporting of gifts, compensation and other remuneration to physicians and other healthcare providers. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply in multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business operations may also be subject to certain federal and state laws regarding the use and disclosure of individually identifiable health information, such as the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, which impose obligations on certain entities with respect to safeguarding the privacy, security and transmission of individually identifiable health information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To enforce compliance with the federal laws, the DOJ has also increased its scrutiny of interactions between healthcare companies and healthcare providers, which has led to an unprecedented level of investigations, prosecutions, convictions and settlements in the healthcare industry (including our company). Dealing with investigations can be time- and resource-consuming. Additionally, if a healthcare company settles an investigation with the DOJ or other law enforcement agencies, the company may be required to agree to additional compliance and reporting requirements as part of a consent decree or corporate integrity agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The U.S. and foreign government regulators have increased regulation, enforcement, inspections and governmental investigations of the medical device industry, including increased U.S. government oversight and enforcement of the Foreign Corrupt Practices Act. Whenever a governmental authority concludes that we are not in compliance with applicable laws or regulations, that authority can impose fines, delay or suspend regulatory clearances, institute proceedings to detain or seize our products, issue a recall, impose operating restrictions, enjoin future violations and assess civil penalties against us or our officers or employees and can recommend criminal prosecution. Moreover, governmental authorities can ban or request the recall, repair, replacement or refund of the cost of devices we distribute.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a governmental authority were to conclude that we are not in compliance with applicable fraud and abuse laws and regulations, we and our officers and employees could be subject to severe penalties including, for example, civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from participation as a supplier of product to beneficiaries covered by Medicare or Medicaid, additional reporting obligations and oversight if subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, contractual damages, reputational harm, diminished profits and future earnings, and curtailment or restructuring of operations, any of which could adversely affect our ability to operate our business and the results of our operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">It is uncertain whether and how future legislation, whether domestic or foreign, could affect prospects for QuantaFlo or what actions foreign, federal, state or private payors for health care treatment and services may take in response to any such health care reform proposals or legislation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Healthcare Reform</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Political, economic and regulatory influences are subjecting the healthcare industry to fundamental changes. For example, the Health Care Reform Law significantly changed the health care industry and brought a new way of doing business for providers and health insurance plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There have been executive, judicial and Congressional challenges to certain aspects of the Health Care Reform Law. For example, several executive orders were issued along with other directives designed to delay the implementation of certain provisions of the Health Care Reform Law or otherwise circumvent some of the requirements for health insurance mandated by the Health Care Reform Law. Concurrently, Congress considered legislation that would repeal or repeal and replace all or part of the Health Care Reform Law. While Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the Health Care Reform Law such as removing penalties, effective January 1, 2019, for not complying with the Health Care Reform Law&#8217;s &#8220;individual mandate&#8221; to carry health insurance, delaying the implementation of certain Health Care Reform Law-mandated fees, and repealing the medical device excise tax. In June 2021, in an appeal from a lower court decision holding that the individual mandate under the Health Care Reform Law is unconstitutional, the United States Supreme Court ruled that the plaintiffs lacked standing to challenge the law as they had not alleged personal injury traceable to the allegedly unlawful conduct. As a result, the Supreme Court did not rule on the constitutionality of the Health Care Reform Law. It is unclear how additional litigation or executive orders will impact the Health Care Reform Law and our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Other legislative changes have been proposed and adopted in the United States since the passage of the Health Care Reform Law. For example, through the process created by the Budget Control Act of 2011 and subsequent legislation, there are automatic reductions of Medicare payments to providers of generally 2% per fiscal year; these reductions went into effect in April 2013 and will remain in effect through fiscal year 2031 unless additional Congressional action is taken.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, there has been increasing legislative and enforcement interest in the United States with respect to cost-containment initiatives within the health care industry. We cannot predict what healthcare reform initiatives may be adopted in the future, particularly in light of the new presidential administration. Further, it is possible that additional governmental action is taken in response to pandemics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Human Capital Management</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">As of December 31, 2024, we had 79 employees, all of which were full-time. None of our employees are represented by a labor union, and we consider our relationship with our employees to be positive. We also regularly engage consultants and subcontractors on an as-needed basis.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. We use different incentive plans such as annual cash bonuses, no-cost healthcare for employees and their families, paid vacation for employees ranked below director and generous referral </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">bonuses to attract, retain and motivate our employees. From time to time, we may also provide equity incentives, such as stock option grants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Governance and Culture</span> - Our board of directors, including committees thereof, and executive management team are actively involved in overseeing our employee-related strategies and practices as well as our company culture. Our director of human resources and her team are also actively involved in implementing these decisions. We believe our company culture has been a critical component of our success in attracting and retaining personnel.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Inclusion</span> - We aim to create an inclusive working environment where all employees are respected and treated equally. Our policy is that we do not discriminate based on race, religious creed, color, national origin, ancestry, physical disability, mental disability, medical condition, genetic information, marital status, sex, gender, gender identity, gender expression, age, military and veteran status, sexual orientation or any other protected characteristics established by federal, state or local laws. This message is emphasized from the top of our organization down to all of our employees. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Health, Safety and Well-Being</span><span style="white-space:pre-wrap;"> - The safety and well-being of our employees is critical to our successful operation.  Our health and safety activities are overseen by our board of directors, executive management team and director of human resources. Most of our employees work remotely, with the exception of a few employees who work in the office.  These employees are generally in fulfillment and sales support roles. Our human resources department coordinates on-line training programs with the help of outside consultants. We believe that this model of training better fits our business operations and needs.</span></p><a id="_e0dfeee7_a2af_4d96_9675_9fc88cba4a9e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ITEM 1A. RISK FACTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Any investment in our securities involves a high degree of risk. Investors should carefully consider the risks described below and all of the information contained in this annual report on Form 10-K before deciding whether to purchase our common stock. Our business, financial condition or results of operations and trading price or value of our securities could be materially adversely affected by these risks if any of them actually occur. This annual report on Form 10-K also contains forward-looking statements that involve risks and uncertainties. See &#8220;Cautionary Note Regarding Forward-Looking Statements and Industry Data.&#8221; Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks we face as described below and elsewhere in this annual report on Form 10-K.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks Related to Our Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we do not successfully implement our healthcare solutions strategy, our business and results of operations will be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our business strategy was formed based on assumptions about the cardiac and vascular diseases market and healthcare reform that might prove wrong. We believe that various demographics and industry-specific trends, including the aging of the general population, growth of capitated payment programs, numbers of undiagnosed patients with cardiac and vascular or other diseases and the importance of codifying vascular disease and potentially other diseases will help drive growth in the cardiac and vascular diseases market and our risk assessment business. However, these demographics and trends, and our assumptions about them, are uncertain. Actual demand for our products and service offerings could differ materially from projected demand if our assumptions regarding these factors prove to be incorrect or do not materialize, or if alternatives to our products or other risk assessment service providers gain widespread acceptance. Moreover, if our customers do not receive increased capitated payments for providing care to patients for PAD using our products, it would have material and adverse effect on our business, financial condition and results of operations. For example, CMS revised the hierarchical condition category, or HCC, codes for vascular disease and created uncertainty in the future whether identifying patients with PAD will qualify for an increased capitated payment. More specifically, i<span style="background:#ffffff;">n late March 2023, CMS issued a final 2024 rate announcement with payment changes for the Medicare Advantage and Part D prescription drug programs and under which CMS is phasing in a new&#160;Medicare Advantage risk adjustment model (2024 model) from the previous model (2020 model) over a three-year period.&#160;The 2024 model did not include risk adjusted payments for PAD without complications, which payments many health insurers have previously relied upon for their Medicare Advantage patients under the previous 2020 model. These </span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">changes are being phased in as follows: in&#160;calendar year 2023, full payment under the 2020 model continued; in calendar year 2024,&#160;67% of the 2020 model is available; in calendar year 2025,&#160;33% of the 2020 model will be available</span>. Such changes in the regulatory landscape for HCC codes has impacted the perceived profitability of using QuantaFlo to aid diagnosis of cardiovascular diseases. We are experiencing and expect to continue to experience decreased usage due to the current CMS reimbursement landscape, which is having a negative effect on our revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In addition, we may not be able to successfully implement our business strategy. To implement our business strategy, we need to (among other things) find new applications for and improve our products and service offerings and educate healthcare providers and plans about the clinical and cost benefits of our products, all of which we believe could increase acceptance of our products by physicians. We have ceased marketing of QuantaFlo as an aid in the diagnosis of heart dysfunction and there is no guarantee that we will obtain a new FDA 510(k) clearance for the expanded use.  Although we have the right from time to time to distribute other third-party products, there is no guarantee that we will be successful. For example, although we had a distribution agreement for Insulin Insights from Mellitus, we were not able to generate significant revenue and wrote off the entire balance of our $2.5 million investment in December 2023. We may also need to develop or acquire rights to other products and services that would be of interest to our customers given the patient populations they serve. In addition, we are seeking to increase our sales and, in order to do so, might need to continue to expand our direct and distributor sales forces in existing and new territories, which could subject us to additional or different regulatory requirements with which we may not be able to comply. Moreover, even if we successfully implement our business strategy, our operating results may not improve or may decline. We may decide to alter or discontinue aspects of our business strategy and may adopt different strategies due to business or competitive factors not currently foreseen, such as new medical technologies that would make our products obsolete or changes in the regulatory landscape that may undermine the economic rationale for QuantaFlo or difficulties in obtaining a new 510(k) clearance, which could cause us to cease efforts to expand the indications for QuantaFlo. Our attempts to alter aspects of our business strategy, such as our prior entry into an exclusive marketing and distribution agreement and our investments in private companies, may not yield positive effects on our business, results of operations and financial condition. Any delay or failure to implement our business strategy may adversely affect our business, results of operations and financial condition.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We predominantly market only one FDA-cleared vascular testing product; it may not achieve broad market acceptance or be commercially successful. We may also fail to generate meaningful benefit from our recent investments in other companies developing complementary products or distribution agreements for complementary products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We currently actively market only one vascular testing product, QuantaFlo and have a distribution agreement for a third-party product. Although we had an exclusive marketing and distribution agreement for another product (Insulin Insights), we did not generate meaningful distribution revenues and we wrote off our prepaid licenses and a portion of our investment in December 2023. We also have a few minority investments in other companies but we do not distribute their products (see Note 6 to our audited financials appearing elsewhere in this annual report on Form 10-K for additional information relating to these minority investments). There is a risk that we may never receive repayment of our loans, nor receive any benefit from our equity investment, nor that we will generate meaningful revenues from our existing distribution arrangement. Accordingly, we expect that revenues from our vascular testing product will account for the vast majority of our revenues for at least the next several years.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">QuantaFlo, and any other products we may be offering in the future, may not gain broad market acceptance unless we continue to educate physicians and plans of their benefits. Moreover, even if insurance plans, home health care providers and physicians understand the benefits of cardiovascular and other risk assessment testing, they still may elect not to use our products for a variety of reasons, such as familiarity with other devices and approaches, or the impact of CMS regulatory revisions, which revised the regulatory landscape for HCC codes and has impacted the perceived profitability of using QuantaFlo to aid diagnosis of cardiovascular diseases. We may not be successful in gaining market acceptance of a technique measuring comparative blood flows using our proprietary algorithm to indicate flow obstruction as opposed to existing techniques that measure comparative blood pressures using well-accepted criteria to indicate flow obstruction, or imaging techniques that visualize anatomy of the arteries. Providers may also object to renting an examining tool with ongoing monthly payments rather than making a one-time capital purchase or be reluctant to pay monthly fees for tools in the examining room when they have many such tools, such as thermometer and stethoscope that only required one-time minimal purchases. Providers may also not synch their devices as required per their service contracts in the fee-per-test (variable license fees) model, and thus we may not capture all revenue to which we are entitled.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If QuantaFlo or other products we may offer are not viewed as an attractive alternative to other products, procedures and techniques, we will not achieve significant market penetration or be able to generate significant revenues. To the extent that any products we offer are not commercially successful or are withdrawn from the market for any reason, our revenues will be adversely impacted, and our business, operating results and financial condition will be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Physicians and other customers may not widely adopt our products unless they determine, based on experience, long-term clinical data and published peer reviewed journal articles, that the use of our products provides a safe and effective alternative to other existing ABI devices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that physicians and other customers will not widely adopt our vascular testing product or our other products in development or products we distribute unless they determine, based on experience, long-term clinical data and published peer reviewed journal articles, that the use of such product provides a safe and effective alternative to other existing ABI devices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot provide any assurance that the data collected from our past, current and any future clinical trials will be sufficient to demonstrate that our products are an attractive alternative to other ABI devices or procedures. If we fail to demonstrate safety and efficacy that is at least comparable to other ABI devices that are available on the market, our ability to successfully market our products will be significantly limited. Even if the data collected from clinical studies or clinical experience indicate positive results, each physician&#8217;s actual experience with our products will vary. We also believe that published peer-reviewed journal articles and recommendations and support by influential physicians regarding our vascular testing product and our other products in development will be important for market acceptance and adoption, and we cannot assure you that we will receive these recommendations and support, or that supportive articles will be published. Accordingly, there is a risk that our products may not be adopted by many physicians, which would negatively impact our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, for any complementary products for which we have (or acquire) exclusive distribution rights, we may not be able to convince potential customers of their benefits, and these rights and potential future rights may not generate any meaningful revenues for our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If healthcare providers are unable to obtain adequate coverage and reimbursement either for procedures performed using our product or patient care incorporating the use of our product, our product might have difficulty gaining widespread acceptance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Maintaining and growing revenues from our products and service offerings depends on the availability of coverage and adequate reimbursement from third-party payors, including government programs such as Medicare and Medicaid, private insurance plans and managed care programs. Healthcare providers that use medical devices such as QuantaFlo to test their patients generally rely on third-party payors to pay for all or part of the costs and fees associated with the procedures performed with these devices, or to compensate them for their patient care services. The existence of coverage and adequate reimbursement for the procedures or patient care performed with QuantaFlo by third-party payors </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">is central to the acceptance of QuantaFlo and any future products. During the past several years, third-party payors have undertaken cost-containment initiatives including different payment methods, monitoring healthcare expenditures, and anti-fraud initiatives. We may not be able to achieve or maintain profitability if third-party payors deny coverage or reduce their current levels of payment, or if our costs of production increase faster than increases in reimbursement levels. Further, many private payors use coverage decisions and payment amounts determined by CMS, which administers the Medicare program, as guidelines in setting their coverage and reimbursement policies. Those private payors that do not follow the Medicare guidelines may adopt different coverage and reimbursement policies for procedures or patient care performed with our vascular testing product. Future action by CMS or other government agencies may diminish payments to physicians, outpatient centers and/or hospitals or may undermine the economic rationale for using QuantaFlo if there is no increased capitated payment for the vascular diseases it helps diagnose. For example, the final 2024 CMS rate announcement for Medicare Advantage and Medicare Part D did not include risk-adjusted payments for PAD without complications, which is leading to decreased usage of our product and negatively affecting our revenues. For some governmental programs, such as Medicaid, coverage and reimbursement differ from state to state, and some state Medicaid programs may not pay an adequate amount for the procedures or patient care performed with QuantaFlo if any payment is made at all. As the portion of the U.S. population over the age of 65 and eligible for Medicare continues to grow, we may be more vulnerable to coverage and reimbursement limitations imposed by CMS. Furthermore, the healthcare industry in the United States has experienced a trend toward cost containment as government and private insurers seek to control healthcare costs by imposing lower payment rates and negotiating reduced contract rates with service providers. Therefore, we cannot be certain that the procedures or patient care performed with our product will be reimbursed at a cost-effective level.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">QuantaFlo is not specifically approved for reimbursement under any third-party payor codes; if third-party payors refuse to reimburse our customers for their use of our product, it could have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">QuantaFlo is licensed by healthcare providers. They may bill various third-party payors, including governmental healthcare programs, such as Medicare and Medicaid, private insurance plans and managed care programs for procedures in which our testing product is used. Reimbursement is a significant factor considered by healthcare providers in determining whether to license medical devices or systems such as QuantaFlo. We cannot control whether or not providers who use QuantaFlo will seek reimbursement. Therefore, our ability to successfully commercialize our vascular testing product could depend on the coverage and adequacy of reimbursement from these third-party payors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently, our QuantaFlo device is not specifically approved for any particular reimbursement code. Although some of our customers report being covered and reimbursed by third-party payors for procedures, we have not offered any reimbursement guidance, therefore there is a risk that third-party payors may disagree with the reimbursement under a particular code. In addition, some of our potential customers might have deferred renting our product given the uncertainty regarding reimbursement. We do not track denial of requests for reimbursement made by the users of our product. It is our belief that such denials have occurred and might occur in the future with more or less frequency. Even if our product and procedures are often currently covered and reimbursed by third-party payors and Medicare, problems for customers to receive reimbursement or adverse changes in payors&#8217; coverage and reimbursement policies that affect our product could harm our ability to market our vascular testing product. Obtaining approval for a particular reimbursement code is time consuming and can be costly. Accordingly, at this time, and given the way we intend our QuantaFlo to be used, we do not intend to pursue formal approval for QuantaFlo for any particular code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, we are unable to predict what changes will be made to the reimbursement methodologies used by third-party payors. We cannot be certain that under current and future payment systems, in which healthcare providers may be reimbursed a set amount based on the type of procedure performed, such as those utilized by Medicare and in many privately managed care systems, the cost of our product will be justified and incorporated into the overall cost of the procedure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We rely heavily upon the talents of a small number of key personnel, the loss of whom could severely damage our business.</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our performance depends to a large extent on a small number of key scientific, technical, managerial and marketing personnel. We do not maintain key man insurance for any of our personnel. The loss of the services of any of these key personnel could still severely damage our business prospects, which could have a material adverse effect on our financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We rely on a small number of employees in our direct sales force and face challenges and risk in managing and maintaining our distribution network and the parties who make up that network.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We face significant challenges and risks in managing our distribution network and retaining the parties who make up that network. We had 45 sales and marketing employees as of December 31, 2024. If any of our sales or marketing force were to resign, our sales could be adversely affected. We may need to seek out alternatives, such as increasing our direct sales and marketing force or contracting with an independent distributor. There is no guarantee that we would be successful in our efforts to find an independent distributor, or that we would be able to negotiate contract terms favorable to us. Failure to hire or retain qualified direct sales and marketing personnel or independent distributors would prevent us from expanding our business and generating revenues, which would have a material adverse effect on our ability to achieve or maintain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">To adequately commercialize our products and any new products we add, we may need to increase our sales and marketing network, which will require us to hire, train, retain and supervise employees and other independent contractors<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are currently exploring other sales models to generate revenues from our products in addition to the leasing model, such as our fee per test model. We have and also may in the future acquire rights to other complementary products. As we increase our marketing efforts to pursue these new strategies and expand our efforts to target insurance plans that serve Medicare Advantage members, we may need to increase our sales and marketing network. Our future success will depend largely on our ability to continue to hire, train, retain and motivate skilled direct sales representatives, or independent distributors with significant technical knowledge about our product and complementary products we distribute, in addition to coordinating networks of contract medical assistants and other personnel to staff health and wellness fairs and physicians&#8217; offices in fee-for-service models. New hires and independent distributors require training, supervision and take time to achieve full productivity. If we fail to train and supervise new hires adequately, or if we experience high turnover in our sales force or trained professionals in the future, we cannot be certain that we will maintain or increase our sales. If we are unable to expand our sales and marketing capabilities, we may not be able to effectively commercialize QuantaFlo or our other products and service offerings in development or that we distribute, which would adversely affect our business, results of operations and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We do not require our customers to enter into long-term licenses or maintenance contracts for our products or services and may therefore lose customers on short notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Our business is primarily based on a leasing model rather than an outright sale of our products although we also generate variable fee revenues, which are based on usage (fee-per-test). Our pricing is based on data collected on use rates and third-party payment rates to physicians and facilities for the use of our product. We require no down payment, long-term commitment or maintenance contract or fees from our customers and may replace damaged products free of charge in the service model. If we lose current customers on short notice, we may not be able to find new customers to replace them with in a timely manner and that could adversely affect our business, results of operations and financial condition. In addition, our business model of replacing damaged products free of charge may prove to be costly and affect the profitability of our service model. In our fee-per-test model, we rely on our customers to comply with the terms of service that require them to synchronize devices on a regular and routine basis such that we are able to invoice them for the tests done using our device. There is a risk that customers use our device without synching as agreed, which could lead to inadequate billing and failing to capture revenue based on actual usage.  Although we have procedures in place to limit usage of our device if it has not synchronized for a period of time, there is no guarantee that our customers will act in compliance with their terms of service and we may not appropriately capture all per-test fees to which we are entitled.</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We are exposed to risk as a significant portion of our revenues and accounts receivables are with a limited number of customers.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">A limited number of customers account for a significant portion of our revenues and accounts receivable. F<span style="background:#ffffff;">or the year ended December 31, 2024,&#160;two&#160;customers (including their affiliates) accounted for&#160;43.1% and&#160;27.6% of our revenues, respectively. </span>As of December 31, 2024, three customers accounted for 33.9%, 28.7% and 14.0% of our accounts receivable. If our largest customers were to cease using or stop payment for our vascular testing devices or leverage their market share to negotiate reduced pricing terms, it would have a material adverse effect on our revenues and/or our accounts receivable. Our efforts to diversify and potentially expand our product offering are preliminary in nature. This concentration of revenues and accounts receivable among a limited number of customers represents a significant risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We rely on a small number of independent suppliers and facilities for the manufacturing of QuantaFlo. Any delay or disruption in the supply of the product or facility may negatively impact our operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We manufacture QuantaFlo through a small number of independent contractors based in the United States. We also have a distribution agreement for a third-party complementary product that they are contractually obligated to supply to us. The loss or disruption of our relationships with outside vendors and suppliers, including failure to adhere to contractual terms, could subject us to substantial delays in the delivery to customers. Our current contractor manufacturers source some supplies from China and should these outside vendors encounter issues due to supply chain disruptions as a result of the recent tariff proposals of the current U.S. administration, or a global health emergency such as COVID-19 pandemic or otherwise, we believe alternative suppliers should be available. However, significant delays in the delivery of our product or inventory to us could result in possible cancellation of orders and the loss of customers. Although we expect our vendors and suppliers to comply with our contract terms, we do not have control over such parties. Our inability to provide a product that meets delivery schedules could have a material adverse effect on our reputation in the industry, which could have a material adverse effect on our financial condition and results of operations<span style="font-size:12pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, QuantaFlo is manufactured in the United States in a limited number of facilities. If an event occurred that resulted in material damage to these manufacturing facilities or our manufacturing contractors lacked sufficient labor to fully operate their facilities, we may be unable to transfer the manufacture of QuantaFlo to another facility or location in a cost-effective or timely manner, if at all. This potential inability to transfer production could occur for a number of reasons, including but not limited to a lack of necessary relevant manufacturing capability at another facility, or the regulatory requirements of the FDA or other governmental regulatory bodies. Even if there are many qualified contract manufacturers available around the country and our product is relatively easy to manufacture, such an event could have a material adverse effect on our financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We will need to generate significant revenues to remain profitable<i style="font-weight:normal;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> We will need to generate significant sales to maintain profitability in our healthcare solutions business and we might not be able to do so. Even if we do generate significant sales, we might not be able to sustain or increase profitability on a quarterly or annual basis in the future. If our sales decline or grow more slowly than we anticipate or if our operating expenses exceed our expectations, our financial performance from our operating business will likely be adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our future financial performance will depend in part on the successful improvements and software updates to QuantaFlo on a cost-effective basis<i style="font-weight:normal;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our future financial performance will depend in part on our ability to anticipate, identify and respond to changing user preferences and needs and the technologies relating to the care and treatment of vascular problems. We can provide no assurances that QuantaFlo will achieve significant commercial success and that it will gain meaningful market share. We may not correctly anticipate or identify trends in user preferences or needs or may identify them later than competitors do. In addition, difficulties in manufacturing or in obtaining regulatory approvals may delay or prohibit </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">improvements to QuantaFlo or our other products in development. Further, we may not be able to develop improvements and software updates to QuantaFlo at a cost that allows us to meet our goals for profitability. Service costs relating to our product may be greater than anticipated, rentals may be returned prior to the end of the license term, and we may be required to devote significant resources to address any quality issues associated with QuantaFlo.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Failure to successfully introduce, improve or update our products on a cost-effective basis, or delays in customer decisions related to the evaluation of our products could cause us to lose market acceptance and could materially adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">One of our business strategies is developing or distributing additional products and service offerings that allow healthcare providers to deliver cost-effective wellness programs and receive increased compensation for their services. The development or distribution of new products and service offerings involves time and expense and we may never realize the benefits of this investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As part of our business strategy, we intend to develop or distribute additional products and service offerings that allow healthcare providers to deliver cost-effective wellness programs. Such new product and service offering may require substantial investments and we may commit significant resources and time before knowing whether our efforts will translate into profits for our company. We may continue to choose to invest some of our cash resources in other entities that may have complementary technologies or product offerings and may not realize the benefit of such investments. For example, in December 2023, we wrote off the $2.5 million prepayment for Insulin Insights software licenses as we were not able to generate meaningful revenues, and also took a $0.6 million impairment charge on our investment in Mellitus. It is possible that our development or distribution efforts will not be successful and that we will not be able to develop new products or service offerings, either alone or in partnership with others, or if developed that we will obtain the necessary regulatory approvals for commercialization. Even if we receive necessary regulatory approvals, there is no guarantee that such approved products or any new service offerings or any third-party products that we distribute will achieve market acceptance and we may never realize the benefits of any investment in this strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We have used our cash resources to invest in other companies, and there is no guarantee that we will be repaid on maturity nor realize any other expected benefits from such investments, which could harm our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From time to time, we have invested, and may in the future invest, in other companies with potentially complementary products or technologies. For example, in September and October 2020, we made investments in Mellitus and SYNAPS Dx, two private companies working in other product areas, Insulin Insights and Discern, and in December 2022, we extended a loan to Monarch, maker of the software product EndoTool and such loan as amended in December 2024 and January 2025. There can be no assurance that the businesses we invest in will become profitable or remain so or that we will realize any financial benefit from our investments, including whether or not we will distribute Discern and EndoTool or that we will be repaid upon maturity of our loans. Notably, in the year ended December 31, 2023, we wrote-off our $2.5 million prepayment for Insulin Insights software licenses as we were not able to generate meaningful revenues, and also took a $0.6 million impairment charge on our investment in Mellitus. Additionally, investments in privately held companies are inherently risky, in some instances because the markets for the technologies or products these companies have under development may never materialize or achieve expectations. If these companies do not succeed, we may be forced to record additional impairment charges and could lose some or all of our investment in these companies. Further, we may need to divest our investments or increase our investment to become a controlling interest sooner than we may like in order to comply with regulations regarding the amount of our assets represented by minority investments. These regulatory requirements may not always coincide with our business objectives and could adversely affect our investments and strategy.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks Related to Our Legal and Regulatory Environment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our business is subject to many laws and government regulations governing the manufacture and sale of medical devices, including the FDA&#8217;s 510(k) clearance process, and laws and regulations governing patient data and information, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our vascular testing product and any future medical devices that we may develop or services that we may offer are subject to extensive regulation in the United States by the federal government, including by the FDA. For example, our operations are subject to regulations governing packaging and labeling requirements, adverse event reporting, quality system and manufacturing requirements, clinical testing and recalls. For a discussion of the relevant regulatory regime, see &#8220;Business&#8212;Government Regulation&#8221; in Item 1 of this annual report on Form 10-K. We cannot assure that any new medical devices or new uses or modifications for QuantaFlo that we develop, including our planned 510(k) for the use of QuantaFlo to enable expanded labeling as an aid in the diagnosis of other cardiovascular diseases in addition to PAD, will be cleared or approved in a timely or cost-effective manner, if cleared or approved at all. Even if such clearances or approvals are received, they may not be for all indications. Because medical devices may only be marketed for cleared or approved indications, this could significantly limit the market for that product and may adversely affect our results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Furthermore, although QuantaFlo has received FDA clearance, we must make our own determination regarding whether a modification to the device requires a new clearance. For example, we are seeking a new 510(k) clearance from the FDA for the expanded use of QuantaFlo intended to enable expanded labeling as an aid in the diagnosis of other cardiovascular diseases in addition to PAD. We cannot guarantee that the FDA will agree with our decisions not to seek clearances for particular device modifications or that we will be successful in obtaining 510(k) clearances for modifications. Any such additional clearance processes with the FDA could delay our ability to market a modified product and may adversely affect our results of operations. We also may need to undertake a recall of any modified product that has been distributed.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The FDA may change its policies, adopt additional regulations, or revise existing regulations, in particular relating to the 510(k) clearance process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA may change its policies, adopt additional regulations, or revise existing regulations, each of which could prevent or delay premarket approval or 510(k) clearance of a device, or could impact our ability to market our currently cleared device. For example, in February 2024, the FDA published a final rule to amend its QSR, requirements to align more closely with the international consensus standards for medical devices by converging with quality management system, requirements used by other regulatory authorities from other countries. Specifically, the final rule does so primarily by incorporating by reference the 2016 edition of the International Organization of Standardization, or ISO, ISO 13485 standard. The amended regulation is referred to as the Quality Management System Regulation, and is effective February 2026. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing authorization that we may have obtained, which could have a material adverse effect on our business, prospects, results of operations, financial condition and our ability to achieve or sustain profitability. Further, future reforms could require us to file new 510(k)s and could increase the total number of 510(k)s to be filed. We cannot predict what effect these reforms will have on our ability to obtain 510(k) clearances in a timely manner. We also cannot predict the nature of other regulatory reforms and their resulting effects on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our business is subject to unannounced inspections by FDA to determine our compliance with FDA requirements<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">FDA inspections can result in inspectional observations on FDA&#8217;s Form-483, warning letters, untitled letters or other forms of more significant enforcement action. More specifically, if FDA concludes that we are not in compliance with applicable laws or regulations, or that our vascular testing product or any future medical device we develop is ineffective or poses an unreasonable health risk, the FDA could:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">require us to notify health professionals and others that our devices present unreasonable risk of substantial harm to public health;</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">order us to recall, repair, replace or refund the cost of any medical device that we manufactured or distributed;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">detain, seize or ban adulterated or misbranded medical devices;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refuse to provide us with documents necessary to export our product;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refuse requests for 510(k) clearance or premarket approval of new products or new intended uses;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">withdraw the premarket approvals we may receive or reclassify our device;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">impose operating restrictions, including requiring a partial or total shutdown of production;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">enjoin or restrain conduct resulting in violations of applicable law pertaining to medical devices; and/or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assess criminal or civil penalties against our officers, employees or us.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following correspondence from FDA questioning our reliance on letters-to-file for the expansion into heart dysfunction, we are now seeking a new 510(k) clearance from the FDA for the expanded use of QuantaFlo to enable expanded labeling. If the FDA concludes that we failed to comply with any regulatory requirement during an inspection or otherwise, it could have a material adverse effect on our business and financial condition. We could incur substantial expense and harm to our reputation, and our ability to introduce new or enhanced products in a timely manner could be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may rely on third parties to support certain aspects of our clinical trials and regulatory processes. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory clearance or approval or commercialize our products, and our business could be substantially harmed<i style="font-weight:normal;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may retain the services of knowledgeable external service providers, including consultants and clinical research organizations, to develop and supervise our clinical trials and regulatory processes. These third-party contract research organizations and consultants may carry out portions of our clinical and preclinical research studies and regulatory filing assistance and as a result, if retained, we will have less control over the conduct of the clinical trials, the timing and completion of the trials, the required reporting of adverse events, and the management of data developed through the trials than would be the case if we were relying entirely on our own staff. Outside parties may have staffing difficulties, may undergo changes in priorities or may become financially distressed, adversely affecting their willingness or ability to conduct our trials. Failure by these third parties to comply with regulatory requirements or to meet timing expectations may require us to repeat clinical trials or preclinical studies, which would delay the regulatory clearance or approval process, or require substantial unexpected expenditures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we are found to have improperly promoted our products for off-label uses, we may become subject to significant fines and other liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">FDA and other regulatory agencies strictly regulate the promotional claims that may be made about medical devices. For example, devices cleared under section 510(k) cannot be marketed for any intended use that is outside of FDA&#8217;s substantial equivalence determination for such devices. Physicians nevertheless may use our products on their patients in a manner that is inconsistent with the intended use cleared by FDA. If we are found to have promoted such &#8220;off-label&#8221; uses, we may become subject to significant government fines and other related liability. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in off-label promotion. FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Although part of our business strategy is based on payment provisions enacted under government healthcare reform, we also face significant uncertainty in the industry regarding the implementation, transformation or repeal and replacement of the Health Care Reform Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Political, economic and regulatory influences are subjecting the healthcare industry to fundamental changes. For example, the Health Care Reform Law brought a new way of doing business for providers and health insurance plans, shifting the focus from fee for service programs to capitated programs that pay a monthly fee per patient. The Health Care Reform law also provided for higher risk factor adjustment payments for sicker patients who have conditions that are codified, as well as economic benefits for achieving certain quality of care measurements. For a discussion of healthcare reform activity, see &#8220;Business&#8212;Government Regulation&#8212;Healthcare Reform&#8221; in Item 1 of this annual report on Form 10-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that the Health Care Reform Law measures are mainly positive for our business given the ability of QuantaFlo to measure blood flow in an in-office setting, which can assist doctors and other providers to suspect PAD and other vascular diseases. However, we cannot predict what changes will now be made, and if these features will be repealed. If changes are made to the Health Care Reform Law, or it is repealed altogether without a comparable replacement, such that there are no incentives for identifying sicker patients, it would negatively affect our business prospects and strategy, and could materially adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, the Health Care Reform Law encourages hospitals and physicians to work collaboratively through shared savings programs, such as accountable care organizations, as well as other bundled payment initiatives, which may ultimately result in the reduction of medical device acquisitions and the consolidation of medical device suppliers used by hospitals and health systems. Changes to or repeal of the Health Care Reform Law could adversely affect our financial results and business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">We are subject to various healthcare fraud and abuse laws and regulations, and at risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages for tests performed using our device, which would adversely affect our business.  A civil suit by DOJ also exposes us to risk of other litigation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are subject to various healthcare fraud and abuse laws and regulations, as described &#8220;Business&#8212;Government Regulation&#8212;Healthcare Fraud and Abuse&#8221; in Item 1 of this annual report on Form 10-K. We may be subject to liability under such laws and may also be subject to liability for any future conduct that is deemed by the government or the courts to violate these laws, including significant administrative, criminal and civil penalties, damages, fines, disgorgement, imprisonment, exclusion from participation as a supplier of product to beneficiaries covered by Medicare or Medicaid, additional reporting obligations and oversight if subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, contractual damages, reputational harm, diminished profits and future earnings, and curtailment or restructuring of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the government has continued to pursue an increasing number of enforcement actions. This increased enforcement environment may increase scrutiny of us, directly or indirectly, and could increase the likelihood of an enforcement action targeting us, either due to our actions, those of any distributor (including our former distributor), or our customers or those of our distributors. These customers include parties that bill Federal healthcare programs for use of our product or for caring for patients with conditions diagnosed with the aid of our product, all of whom may be subject to government scrutiny. For example, DOJ has been investigating improper reimbursement of claims for testing using our QuantaFlo device. See Item 3 &#8220;Legal Proceedings.&#8221; There is a risk that the DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages for tests performed using our device, which would adversely affect our business. The federal False Claims Act provides for treble damages and per-claim penalties. A civil suit by DOJ also exposes us to risk of other litigation. Finally, to the extent that any of the agreements are breached or terminated, our business may experience a decrease in revenues. In addition, to the extent that our customers, many of whom are providers, may be affected by this increased enforcement environment, our business could correspondingly be affected. It is possible that a review of our business practices or those of our customers by courts or government authorities could result in a determination with an adverse effect on our business. We cannot predict the effect of possible future enforcement actions on our business.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We have had material weaknesses in our internal control over financial reporting. Although we have remediated our prior material weaknesses, if we identify additional material weaknesses in the future, or if our former material weaknesses recur, it could have an adverse effect on our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In prior years, we have identified certain material weaknesses in connection with management&#8217;s evaluation of our internal control over financial reporting that we have remediated. These weaknesses have included issues arising from our size and inability to segregate duties; ineffective design of certain of our information technology and change management controls; insufficient controls to validate the completeness and accuracy of underlying data; insufficient protocols and procedures to retain adequate documentary evidence related to the timely review and approval of manual journal entries and those supporting the design and operating effectiveness of certain important management review controls; a lack of controls to identify and analyze related party transactions; a lack of technical accounting competence; and inadequate procedures and controls to appropriately comply with, and account for, certain payroll tax withholdings and related expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we have remediated our prior material weaknesses, we cannot assure you that we have identified all material weaknesses or that we will not in the future have additional, or recurrence of our prior, material weaknesses in our internal control over financial reporting. If we have additional material weaknesses in our internal control over financial reporting in the future, or if our former material weaknesses recur, it could have an adverse effect on our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks Related to Our Intellectual Property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our success largely depends on our ability to obtain and protect the proprietary information on which we base our product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our success depends in large part upon our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to license from others&#8217; patents and patent applications necessary to develop our product. If our patent or any future patents are successfully challenged, invalidated or circumvented, or our right or ability to manufacture our product was to be limited, our ability to continue to manufacture and market our product could be adversely affected. In addition to patents, we rely on trade secrets and proprietary know-how, which we seek to protect, in part, through confidentiality and proprietary information agreements. The other parties to these agreements may breach these provisions, and we may not have adequate remedies for any breach. Additionally, our trade secrets could otherwise become known to or be independently developed by competitors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2024, we have been issued, or have rights to, one U.S. patent (which expires on December 11, 2027). The patent we hold may be successfully challenged, invalidated or circumvented, or we may otherwise be unable to rely on this patent. These risks are also present for the process we use for manufacturing our product. In addition, our competitors, many of whom have substantial resources and have made substantial investments in competing technologies, may apply for and obtain patents that prevent, limit or interfere with our ability to make, use and sell our product, either in the United States or in international markets. The medical device industry has been characterized by extensive litigation regarding patents and other intellectual property rights. We may institute, become party to, or be threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our product and technology, including interference or derivation proceedings before the U.S. Patent and Trademark Office, or USPTO. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future. If we are found to infringe a third party&#8217;s intellectual property rights, we could be required to obtain a license from such third party to continue developing and marketing our product and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product or force us to cease some of our business operations, which could materially harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business. The defense and prosecution of intellectual property suits, USPTO proceedings and related legal and administrative </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">proceedings are both costly and time consuming. Any litigation or interference proceedings involving us may require us to incur substantial legal and other fees and expenses and may require some of our employees to devote all or a substantial portion of their time to the proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may need to license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A third party may hold intellectual property, including patent rights that are important or necessary to the development of our vascular testing product or any future products. It may be necessary for us to use the patented or proprietary technology of a third party to commercialize our own technology or products, in which case we would be required to obtain a license from such third party. A license to such intellectual property may not be available or may not be available on commercially reasonable terms, which could have a material adverse effect on our business and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may be subject to claims by third parties asserting that our employees or we have misappropriated their intellectual property, or claiming ownership of what we regard as our own intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we try to ensure that we and our employees and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or that these employees or independent contractors have used or disclosed intellectual property in violation of the rights of others. These claims may cover a range of matters, such as challenges to our trademarks, as well as claims that our employees or independent contractors are using trade secrets or other proprietary information of any such employee&#8217;s former employer or independent contractors. Although we do not expect the resolution of the proceeding to have a material adverse effect on our business or financial condition, litigation to defend ourselves against claims can be both costly and time consuming, and divert management&#8217;s attention away from growing our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, while it is our policy to require our employees and independent contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own. Our and their assignment agreements may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims they may bring against us, to determine the ownership of what we regard as our intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to management.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to seeking patents for some of our technology and product, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties. We also generally enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party infringed a patent or illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Risks Related to Our Bitcoin Treasury Strategy and Holdings</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:12pt 0pt 0pt 0pt;"><b style="font-weight:bold;letter-spacing:-0.2pt;">WE ARE NOT REGISTERED AS AN INVESTMENT COMPANY UNDER THE INVESTMENT COMPANY ACT OF 1940 AND STOCKHOLDERS DO NOT HAVE THE PROTECTIONS ASSOCIATED WITH OWNERSHIP OF SHARES IN A REGISTERED INVESTMENT COMPANY NOR THE PROTECTIONS AFFORDED BY THE COMMODITIES EXCHANGE ACT.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our bitcoin treasury strategy exposes us to various risks associated with bitcoin.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Bitcoin is a highly volatile asset.&#160;</i>Bitcoin is a highly volatile asset that has traded below $51,800 per bitcoin and above $106,000 per bitcoin on the Coinbase exchange in the 12 months preceding the date of this annual report on Form 10-K. The trading price of bitcoin significantly decreased during prior periods, and such declines may occur again in the future. Notwithstanding this volatility, we do not currently intend to hedge our bitcoin holdings and have not adopted a hedging strategy with respect to bitcoin. However, we may from time to time engage in hedging strategies as part of our treasury management operations if deemed appropriate.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Bitcoin does not pay interest or dividends.&#160;</i>Bitcoin does not pay interest or other returns and we can only generate cash from our bitcoin holdings if we sell our bitcoin or implement strategies to create income streams or otherwise generate cash by using our bitcoin holdings. Even if we pursue any such strategies, we may be unable to create income streams or otherwise generate cash from our bitcoin holdings, and any such strategies may subject us to additional risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Our bitcoin holdings may significantly impact our financial results and the market price of our common stock.&#160;</i>Our bitcoin holdings may significantly affect our financial results and if we continue to increase our overall holdings of bitcoin in the future, they will have an even greater impact on our financial results and the market price of our common stock. See &#8220;&#8212;Our historical financial statements do not reflect the potential variability in earnings that we may experience in the future relating to our bitcoin holding<i style="font-style:italic;">s</i>&#8221; below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Our bitcoin treasury strategy has not been tested over an extended period of time or under different market conditions.&#160;</i>We only recently adopted our bitcoin treasury strategy and will need to continually examine the risks and rewards of this new strategy. This new strategy has not been tested over an extended period of time or under different market conditions. For example, although we believe bitcoin, due to its limited supply, has the potential to serve as a hedge against inflation in the long term, the short-term price of bitcoin declined in recent periods during which the inflation rate increased. Some investors and other market participants may disagree with our bitcoin treasury strategy or actions we undertake to implement it. If bitcoin prices were to decrease or our bitcoin treasury strategy otherwise proves unsuccessful, our financial condition, results of operations, and the market price of our common stock could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">We are subject to counterparty risks, including in particular risks relating to our custodians.&#160;</i>Although we have implemented various measures that are designed to mitigate our counterparty risks, including by storing substantially all of the bitcoin we own in custody accounts at U.S.-based, institutional-grade custodians and negotiating contractual arrangements intended to establish that our property interest in custodially-held bitcoin is not subject to claims of our custodians&#8217; creditors, applicable insolvency law is not fully developed with respect to the holding of digital assets in custodial accounts. If our custodially-held bitcoin were nevertheless considered to be the property of our custodians&#8217; estates in the event that any such custodians were to enter bankruptcy, receivership or similar insolvency proceedings, we could be treated as a general unsecured creditor of such custodians, inhibiting our ability to exercise ownership rights with respect to such bitcoin and this may ultimately result in the loss of the value related to some or all of such bitcoin. Even if we are able to prevent our bitcoin from being considered the property of a custodian&#8217;s bankruptcy estate as part of an insolvency proceeding, it is possible that we would still be delayed or may otherwise experience difficulty in accessing our bitcoin held by the affected custodian during the pendency of the insolvency proceedings. Any such outcome could have a material adverse effect on our financial condition and the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">The broader digital assets industry is subject to counterparty risks, which could adversely impact the adoption rate, price, and use of bitcoin.&#160;</i>A series of recent high-profile bankruptcies, closures, liquidations, regulatory enforcement actions and other events relating to companies operating in the digital asset industry, including the filings for bankruptcy </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">protection by Three Arrows Capital, Celsius Network, Voyager Digital, FTX Trading and Genesis Global Capital, the closure or liquidation of certain financial institutions that provided lending and other services to the digital assets industry, including Signature Bank and Silvergate Bank, SEC enforcement actions against Coinbase,&#160;Inc. and Binance Holdings Ltd., the placement of Prime Trust, LLC into receivership following a cease-and-desist order issued by Nevada&#8217;s Department of Business and Industry, and the filing and subsequent settlement of a civil fraud lawsuit by the New York Attorney General against Genesis Global Capital, its parent company Digital Currency Group,&#160;Inc., and former partner Gemini Trust Company, have highlighted the counterparty risks applicable to owning and transacting in digital assets. Although these bankruptcies, closures, liquidations and other events have not resulted in any loss or misappropriation of our bitcoin, nor have such events adversely impacted our access to our bitcoin, they have, in the short-term, likely negatively impacted the adoption rate and use of bitcoin. Additional bankruptcies, closures, liquidations, regulatory enforcement actions or other events involving participants in the digital assets industry in the future may further negatively impact the adoption rate, price, and use of bitcoin, limit the availability to us of financing collateralized by bitcoin, or create or expose additional counterparty risks.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Changes in our ownership of bitcoin could have accounting, regulatory and other impacts.&#160;</i>While we currently own or will own bitcoin directly, we may investigate other potential approaches to owning bitcoin, including indirect ownership (for example, through ownership interests in a fund that owns bitcoin). If we were to own all or a portion of our bitcoin in a different manner, the accounting treatment for our bitcoin, our ability to use our bitcoin as collateral for additional borrowings, and the regulatory requirements to which we are subject, may correspondingly change. For example, the volatile nature of bitcoin may force us to liquidate our holdings to use it as collateral, which could be negatively effected by any disruptions in the crypto market, and if liquidated, the value of the collateral would not reflect potential gains in market value of bitcoin, all of which could negatively affect our business and implementation of our bitcoin strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Changes in the accounting treatment of our bitcoin holdings could have significant accounting impacts, including increasing the volatility of our results.&#160;</i>In December&#160;2023, the FASB issued ASU 2023-08, which we early adopted as of January 1, 2024, and which requires us to measure in-scope crypto assets (including our bitcoin holdings) at fair value in our statement of financial position, and to recognize gains and losses from changes in the fair value of our bitcoin in net income each reporting period. ASU 2023-08 requires us to provide certain interim and annual disclosures with respect to our bitcoin holdings. Due in particular to the volatility in the price of bitcoin, we expect the adoption of ASU 2023-08 to have a material impact on our financial results in future periods, increase the volatility of our financial results, and affect the carrying value of our bitcoin on our balance sheet, and could have adverse tax consequences, which in turn could have a material adverse effect on our financial results and the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The broader digital assets industry, including the technology associated with digital assets, the rate of adoption and development of, and use cases for, digital assets, market perception of digital assets, and the legal, regulatory, and accounting treatment of digital assets are constantly developing and changing, and there may be additional risks in the future that are not possible to predict.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Bitcoin is a highly volatile asset, and fluctuations in the price of bitcoin are likely to influence our financial results and the market price of our common stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Bitcoin is a highly volatile asset, and fluctuations in the price of bitcoin are likely to influence our financial results and the market price of our common stock. Our financial results and the market price of our common stock would be adversely affected, and our business and financial condition would be negatively impacted, if the price of bitcoin decreased substantially (as it has in the past, such as during 2022), including as a result of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">decreased user and investor confidence in bitcoin, including due to the various factors described herein;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">investment and trading activities such as (i)&#160;trading activities of highly active retail and institutional users, speculators, miners and investors, or of the U.S. or state governments, (ii)&#160;actual or expected significant dispositions of bitcoin by large holders, and (iii)&#160;actual or perceived manipulation of the spot or derivative markets for bitcoin or spot bitcoin ETPs;</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negative publicity, media or social media coverage, or sentiment due to events in or relating to, or perception of, bitcoin or the broader digital assets industry, for example, (i)&#160;public perception that bitcoin can be used as a vehicle to circumvent sanctions, including sanctions imposed on Russia or certain regions related to the ongoing conflict between Russia and Ukraine, or to fund criminal or terrorist activities, such as the purported use of digital assets by Hamas to fund its terrorist attack against Israel in October&#160;2023; (ii)&#160;expected or pending civil, criminal, regulatory enforcement or other high profile actions against major participants in the bitcoin ecosystem, including the SEC&#8217;s enforcement actions against Coinbase,&#160;Inc. and Binance Holdings Ltd.; (iii)&#160;additional filings for bankruptcy protection or bankruptcy proceedings of major digital asset industry participants, such as the bankruptcy proceeding of FTX Trading and its affiliates; and (iv)&#160;the actual or perceived environmental impact of bitcoin and related activities, including environmental concerns raised by private individuals, governmental and non-governmental organizations, and other actors related to the energy resources consumed in the bitcoin mining process;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in consumer preferences and the perceived value or prospects of bitcoin;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">competition from other digital assets that exhibit better speed, security, scalability, or energy efficiency, that feature other more favored characteristics, that are backed or held in large amounts by governments, including the U.S. government, or reserves of fiat currencies, or that represent ownership or security interests in physical assets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease in the price of other digital assets, including stablecoins, or the crash or unavailability of stablecoins that are used as a medium of exchange for bitcoin purchase and sale transactions, such as the crash of the stablecoin Terra USD in 2022, to the extent the decrease in the price of such other digital assets or the unavailability of such stablecoins may cause a decrease in the price of bitcoin or adversely affect investor confidence in digital assets generally;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the identification of Satoshi Nakamoto, the pseudonymous person or persons who developed bitcoin, or the transfer of substantial amounts of bitcoin from bitcoin wallets attributed to Mr.&#160;Nakamoto or other &#8220;whales&#8221; that hold significant amounts of bitcoin;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">disruptions, failures, unavailability, or interruptions in service of trading venues for bitcoin, such as, for example, the announcement by the digital asset exchange FTX Trading that it would freeze withdrawals and transfers from its accounts and subsequent filing for bankruptcy protection and the recent SEC enforcement action brought against Binance Holdings Ltd., which initially sought to freeze all of its assets during the pendency of the enforcement action;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the filing for bankruptcy protection by, liquidation of, or market concerns about the financial viability of digital asset custodians, trading venues, lending platforms, investment funds, or other digital asset industry participants, such as the filing for bankruptcy protection by digital asset trading venues FTX Trading and BlockFi and digital asset lending platforms Celsius Network and Voyager Digital Holdings in 2022, the ordered liquidation of the digital asset investment fund Three Arrows Capital in 2022, the announced liquidation of Silvergate Bank in 2023, the government-mandated closure and sale of Signature Bank in 2023, the placement of Prime Trust, LLC into receivership following a cease-and-desist order issued by the Nevada Department of Business and Industry in 2023, and the exit of Binance Holdings Ltd. from the U.S. market as part of its settlement with the Department of Justice and other federal regulatory agencies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory, legislative, enforcement and judicial actions that adversely affect the price, ownership, transferability, trading volumes, legality or public perception of bitcoin, or that adversely affect the operations of or otherwise prevent digital asset custodians, trading venues, lending platforms or other digital assets industry participants from operating in a manner that allows them to continue to deliver services to the digital assets industry;</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">further reductions in mining rewards of bitcoin, including block reward halving events, which are events that occur after a specific period of time that reduce the block reward earned by &#8220;miners&#8221; who validate bitcoin transactions, or increases in the costs associated with bitcoin mining, including increases in electricity costs and hardware and software used in mining, that may cause a decline in support for the Bitcoin network;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">transaction congestion and fees associated with processing transactions on the bitcoin network;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">macroeconomic changes, such as changes in the level of interest rates and inflation, fiscal and monetary policies of governments, trade restrictions, and fiat currency devaluations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developments in mathematics or technology, including in digital computing, algebraic geometry and quantum computing, that could result in the cryptography used by the bitcoin blockchain becoming insecure or ineffective; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in national and international economic and political conditions, including, without limitation, the adverse impact attributable to the economic and political instability caused by the current conflict between Russia and Ukraine and the economic sanctions adopted in response to the conflict, and the potential broadening of the Israel-Hamas conflict to other countries in the Middle East, as well as expectations regarding changes to the regulatory environment, including for the U.S. digital asset industry.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Bitcoin and other digital assets are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertainty.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Bitcoin and other digital assets are relatively novel and are subject to significant uncertainty, which could adversely impact their price. The application of state and federal securities laws and other laws and regulations to digital assets is unclear in certain respects, and it is possible that regulators in the United States or foreign countries may interpret or apply existing laws and regulations in a manner that adversely affects the price of bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The U.S. federal government, states, regulatory agencies, and foreign countries may also enact new laws and regulations, or pursue regulatory, legislative, enforcement or judicial actions, that could materially impact the price of bitcoin or the ability of individuals or institutions such as us to own or transfer bitcoin. For example, the U.S. executive branch and SEC, among others in the United States and abroad, have been active in recent years, and laws including the European Union&#8217;s Markets in Crypto Assets Regulation and the U.K.&#8217;s Financial Services and Markets Act 2023 became law. It is not possible to predict whether, or when, any of these developments will lead to Congress granting additional authorities to the SEC or other regulators, or whether, or when, any other federal, state or foreign legislative bodies will take any similar actions. It is also not possible to predict the nature of any such additional authorities, how additional legislation or regulatory oversight might impact the ability of digital asset markets to function or the willingness of financial and other institutions to continue to provide services to the digital assets industry, nor how any new regulations or changes to existing regulations might impact the value of digital assets generally and bitcoin specifically. The consequences of increased or different regulation of digital assets and digital asset activities could adversely affect the market price of bitcoin and in turn adversely affect the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Moreover, the risks of engaging in a bitcoin treasury strategy are relatively novel and have created, and could continue to create, complications due to the lack of experience that third parties have with companies engaging in such a strategy, such as increased costs of director and officer liability insurance or the potential inability to obtain such coverage on acceptable terms in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The growth of the digital assets industry in general, and the use and acceptance of bitcoin in particular, may also impact the price of bitcoin and is subject to a high degree of uncertainty. The pace of worldwide growth in the adoption and use of bitcoin may depend, for instance, on public familiarity with digital assets, ease of buying, accessing or gaining exposure to bitcoin, institutional demand for bitcoin as an investment asset, the participation of traditional financial institutions in the digital assets industry, consumer demand for bitcoin as a means of payment, and the availability and popularity of alternatives to bitcoin. Even if growth in bitcoin adoption occurs in the near or medium-term, there is no assurance that bitcoin usage will continue to grow over the long-term.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Because bitcoin has no physical existence beyond the record of transactions on the bitcoin blockchain, a variety of technical factors related to the bitcoin blockchain could also impact the price of bitcoin. For example, malicious attacks by miners, inadequate mining fees to incentivize validating of bitcoin transactions, hard &#8220;forks&#8221; of the bitcoin blockchain into multiple blockchains, and advances in digital computing, algebraic geometry, and quantum computing could undercut the integrity of the bitcoin blockchain and negatively affect the price of bitcoin. The liquidity of bitcoin may also be reduced and damage to the public perception of bitcoin may occur, if financial institutions were to deny or limit banking services to businesses that hold bitcoin, provide bitcoin-related services or accept bitcoin as payment, which could also decrease the price of bitcoin. Similarly, the open-source nature of the bitcoin blockchain means the contributors and developers of the bitcoin blockchain are generally not directly compensated for their contributions in maintaining and developing the blockchain, and any failure to properly monitor and upgrade the bitcoin blockchain could adversely affect the bitcoin blockchain and negatively affect the price of bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Recent actions by U.S. banking regulators have reduced the ability of bitcoin-related services providers to gain access to banking services and liquidity of bitcoin may also be impacted to the extent that changes in applicable laws and regulatory requirements negatively impact the ability of exchanges and trading venues to provide services for bitcoin and other digital assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">In addition, while the current administration has expressed support regarding the development and use of digital assets as the industry has anticipated, the specific regulatory frameworks are still to be developed.  Expectations around U.S. digital asset policy, including potential sentiments that the U.S. government is not moving quickly enough or not meeting policy expectations, may adversely affect the price of bitcoin.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our historical financial statements do not reflect the potential variability in earnings that we may experience in the future relating to our bitcoin holdings.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our historical financial statements do not reflect the potential variability in earnings that we may experience in the future from holding or selling significant amounts of bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The price of bitcoin has historically been subject to dramatic price fluctuations and is highly volatile. We determine the fair value of our bitcoin based on quoted (unadjusted) prices on the Coinbase exchange, and following our early adoption of ASU 2023-08 we are required to measure our bitcoin holdings at fair value in our statement of financial position, and to recognize gains and losses from changes in the fair value of our bitcoin in net income each reporting period, which may create significant volatility in our reported earnings and decrease the carrying value of our digital assets, which in turn could have a material adverse effect on the market price of our common stock. Conversely, any sale of bitcoins at prices above our carrying value for such assets creates a gain for financial reporting purposes even if we would otherwise incur an economic or tax loss with respect to such transaction, which also may result in significant volatility in our reported earnings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Due in particular to the volatility in the price of bitcoin, we expect our early adoption of ASU 2023-08 to increase the volatility of our financial results and it could significantly affect the carrying value of our bitcoin on our balance sheet. As of December&#160;31, 2024, we held 2,298 bitcoins, which we acquired for $189.7 million during the year, inclusive of fees and expenses, with an aggregate value of $214.6 million due to an adjustment in their fair value of $24.9 million, and $9.0 million in cash, cash equivalents and restricted cash, compared to carrying no digital assets and having $57.3 million in cash, cash equivalents and short-term investments as of December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Because we intend to purchase additional bitcoin in future periods and increase our overall holdings of bitcoin, we expect that the proportion of our total assets represented by our bitcoin holdings will increase in the future. As a result, and in particular with respect to the quarterly periods and full fiscal year with respect to which ASU 2023-08 applies, and for all future periods, volatility in our earnings may be significantly more than what we experienced in prior periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">The availability of spot bitcoin ETPs may adversely affect the market price of our common stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Although bitcoin and other digital assets have experienced a surge of investor attention since bitcoin was invented in 2008, until recently investors in the United States had limited means to gain direct exposure to bitcoin through traditional investment channels, and instead generally were only able to hold bitcoin through &#8220;hosted&#8221; wallets provided by digital asset service providers or through &#8220;unhosted&#8221; wallets that expose the investor to risks associated with loss or hacking of their private keys. Given the relative novelty of digital assets, general lack of familiarity with the processes needed to hold bitcoin directly, as well as the potential reluctance of financial planners and advisers to recommend direct bitcoin holdings to their retail customers because of the manner in which such holdings are custodied, some investors have sought exposure to bitcoin through investment vehicles that hold bitcoin and issue shares representing fractional undivided interests in their underlying bitcoin holdings. These vehicles, which were previously offered only to &#8220;accredited investors&#8221; on a private placement basis, have in the past traded at substantial premiums to net asset value, or NAV, possibly due to the relative scarcity of traditional investment vehicles providing investment exposure to bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On January&#160;10, 2024, the SEC approved the listing and trading of spot bitcoin ETPs, the shares of which can be sold in public offerings and are traded on U.S. national securities exchanges. The approved ETPs commenced trading directly to the public on January&#160;11, 2024, with a trading volume of approximately $4.6 billion on the first trading day. To the extent investors view our common stock as providing exposure to bitcoin, it is possible that the value of our common stock may also have included a premium over the value of our bitcoin due to the prior scarcity of traditional investment vehicles providing investment exposure to bitcoin, and that the value declined due to investors now having a greater range of options to gain exposure to bitcoin and investors choosing to gain such exposure through ETPs rather than our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Although we are an operating company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, and we believe we offer a different value proposition than a passive bitcoin investment vehicle such as a spot bitcoin ETP, investors may nevertheless view our common stock as an alternative to an investment in an ETP, and choose to purchase shares of a spot bitcoin ETP instead of our common stock. They may do so for a variety of reasons, including if they believe that ETPs offer a &#8220;pure play&#8221; exposure to bitcoin that is generally not subject to federal income tax at the entity level as we are, or the other risk factors applicable to an operating business, such as ours. Additionally, unlike spot bitcoin ETPs, we (i)&#160;do not seek for our shares of common stock to track the value of the underlying bitcoin we hold before payment of expenses and liabilities, (ii)&#160;do not benefit from various exemptions and relief under the Securities Exchange Act of 1934, as amended, or the Exchange Act, including Regulation M, and other securities laws, which enable spot bitcoin ETPs to continuously align the value of their shares to the price of the underlying bitcoin they hold through share creation and redemption, (iii)&#160;are a Delaware corporation rather than a statutory trust, and do not operate pursuant to a trust agreement that would require us to pursue one or more stated investment objectives, and (iv)&#160;are not required to provide daily transparency as to our bitcoin holdings or our daily NAV. Furthermore, recommendations by broker-dealers to buy, hold, or sell complex products and non-traditional ETPs, or an investment strategy involving such products, may be subject to additional or heightened scrutiny that would not be applicable to broker-dealers making recommendations with respect to our common stock. Based on how we are viewed in the market relative to ETPs, and other vehicles that offer economic exposure to bitcoin, such as bitcoin futures ETFs and leveraged bitcoin futures ETFs, any premium or discount in our common stock relative to the value of our bitcoin holdings may increase or decrease in different market conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As a result of the foregoing factors, availability of spot bitcoin ETPs on U.S. national securities exchanges could have a material adverse effect on the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our bitcoin treasury strategy subjects us to enhanced regulatory oversight.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As noted elsewhere in these Risk Factors, several spot bitcoin ETPs have received approval from the SEC to list their shares on a U.S. national securities exchange with continuous share creation and redemption at NAV. Even though we are not, and do not function in the manner of, a spot bitcoin ETP, it is possible that we nevertheless could face regulatory scrutiny from the SEC or other federal or state agencies due to our bitcoin holdings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition, there has been increasing focus on the extent to which digital assets can be used to launder the proceeds of illegal activities, fund criminal or terrorist activities, or circumvent sanctions regimes, including those sanctions imposed in response to the ongoing conflict between Russia and Ukraine. While we have implemented and maintain policies and procedures reasonably designed to promote compliance with applicable anti-money laundering and sanctions laws and regulations and take care to only acquire our bitcoin through entities subject to anti-money laundering regulation and related compliance rules&#160;in the United States, if we are found to have purchased any of our bitcoin from bad actors that have used bitcoin to launder money or persons subject to sanctions, we may be subject to regulatory proceedings and any further transactions or dealings in bitcoin by us may be restricted or prohibited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We may consider issuing debt or other financial instruments that may be collateralized by our bitcoin holdings. We may also consider pursuing strategies to create income streams or otherwise generate funds using our bitcoin holdings. These types of bitcoin-related transactions are the subject of enhanced regulatory oversight. These and any other bitcoin-related transactions we may enter into, beyond simply acquiring and holding bitcoin, may subject us to additional regulatory compliance requirements and scrutiny, including under federal and state money services regulations, money transmitter licensing requirements and various commodity and securities laws and regulations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Additional laws, guidance and policies may be issued by domestic and foreign regulators following the filing for Chapter 11 bankruptcy protection by FTX Trading, one of the world&#8217;s largest cryptocurrency exchanges, in November&#160;2022. U.S. and foreign regulators have also increased enforcement activity thereafter, and regulatory requirements continue to evolve in response to FTX Trading&#8217;s collapse as well as changes in government policies regarding cryptocurrencies. Changes in the regulatory environment, including changing interpretations and the implementation of new or varying regulatory requirements by the government or any new legislation affecting bitcoin, as well as enforcement actions involving or impacting our trading venues, counterparties and custodians, may impose significant costs or significantly limit our ability to hold and transact in bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In addition, private actors that are wary of bitcoin or the regulatory concerns associated with bitcoin may in the future take further actions that may have an adverse effect on our business or the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Due to the currently unregulated nature and lack of transparency surrounding the operations of many bitcoin trading venues, bitcoin trading venues may experience greater fraud, security failures or regulatory or operational problems than trading venues for more established asset classes, which may result in a loss of confidence in bitcoin trading venues and adversely affect the value of our bitcoin.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Bitcoin trading venues are relatively new and, in many cases, currently unregulated. Even if regulated, such venues may not be complying with such regulations. Furthermore, there are many bitcoin trading venues that do not provide the public with significant information regarding their ownership structure, management teams, corporate practices and regulatory compliance. As a result, the marketplace may lose confidence in bitcoin trading venues, including prominent exchanges that handle a significant volume of bitcoin trading and/or are subject to regulatory oversight, in the event one or more bitcoin trading venues cease or pause for a prolonged period the trading of bitcoin or other digital assets, or experience fraud, significant volumes of withdrawal, security failures or operational problems.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In 2019 there were reports claiming that 80-95% of bitcoin trading volume on trading venues was false or non-economic in nature, with specific focus on currently unregulated exchanges located outside of the United States. The SEC also alleged as part of its June&#160;2023, complaint that Binance Holdings Ltd. committed strategic and targeted &#8220;wash trading&#8221; through its affiliates to artificially inflate the volume of certain digital assets traded on its exchange. Such reports and allegations may indicate that the bitcoin market is significantly smaller than expected and that the United States makes up a significantly larger percentage of the bitcoin market than is commonly understood. Any actual or perceived false trading in the bitcoin market, and any other fraudulent or manipulative acts and practices, could adversely affect the value of our bitcoin. Negative perception, a lack of stability in the broader bitcoin markets and the closure, temporary shutdown or operational disruption of bitcoin trading venues, lending institutions, institutional investors, institutional miners, custodians, or other major participants in the bitcoin ecosystem, due to fraud, business failure, cybersecurity events, government-mandated regulation, bankruptcy, or for any other reason, may result in a decline in confidence in bitcoin and the broader bitcoin ecosystem and greater volatility in the price of bitcoin. For example, in 2022, each of Celsius Network, Voyager Digital, Three Arrows Capital, FTX Trading, and BlockFi filed for </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">bankruptcy, following which the market prices of bitcoin and other digital assets significantly declined. In addition, in June&#160;2023, the SEC announced enforcement actions against Coinbase,&#160;Inc., and Binance Holdings Ltd., two providers of large trading venues for digital assets, which similarly was followed by a decrease in the market price of bitcoin and other digital assets. These were followed in November&#160;2023, by an SEC enforcement action against Kraken, another large trading venue for digital assets. As the price of our common stock is affected by the value of our bitcoin holdings, the failure of a major participant in the bitcoin ecosystem could have a material adverse effect on the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">The concentration of our bitcoin holdings enhances the risks inherent in our bitcoin treasury strategy.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December&#160;31, 2024, we held an aggregate 2,298 bitcoins, which we acquired for $189.7 million, inclusive of fees and expenses, and we intend to purchase additional bitcoin and increase our overall holdings of bitcoin in the future. The concentration of our bitcoin holdings limits the risk mitigation that we could take advantage of by purchasing a more diversified portfolio of treasury assets, and the absence of diversification enhances the risks inherent in our bitcoin acquisition strategy. Any future significant declines in the price of bitcoin would have a more pronounced impact on our financial condition than if we used our cash to purchase a more diverse portfolio of assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">The emergence or growth of other digital assets, including those with significant private or public sector backing, could have a negative impact on the price of bitcoin and adversely affect our financial condition and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As a result of our bitcoin treasury strategy, the majority of our cash is now concentrated in our bitcoin holdings. Accordingly, the emergence or growth of digital assets other than bitcoin may have a material adverse effect on our financial condition. While bitcoin is the largest digital asset by market capitalization as of the date of this annual report on Form&#160;10-K, there are numerous alternative digital assets and many entities, including the U.S. government, consortiums and financial institutions, are researching and investing resources into private or permissioned blockchain platforms or digital assets that do not use proof-of-work mining like the bitcoin network. For example, in late 2022, the Ethereum network transitioned to a &#8220;proof-of-stake&#8221; mechanism for validating transactions that requires significantly less computing power than proof-of-work mining. The Ethereum network has completed another major upgrade since then and may undertake additional upgrades in the future. If the mechanisms for validating transactions in Ethereum and other alternative digital assets are perceived as superior to proof-of-work mining, those digital assets could gain market share relative to bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Other alternative digital assets that compete with bitcoin in certain ways include &#8220;stablecoins,&#8221; which are designed to maintain a constant price because of, for instance, their issuers&#8217; promise to hold high-quality liquid assets (such as U.S. dollar deposits and short-term U.S. treasury securities) equal to the total value of stablecoins in circulation. Stablecoins have grown rapidly as an alternative to bitcoin and other digital assets as a medium of exchange and store of value, particularly on digital asset trading platforms. As of the date of this annual report on Form&#160;10-K, two of the seven largest digital assets by market capitalization are U.S. dollar-backed stablecoins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Additionally, central banks in some countries have started to introduce digital forms of legal tender. For example, China&#8217;s CBDC project was made available to consumers in January&#160;2022, and governments including the European Union and Israel have been discussing the potential creation of new CBDCs. Whether or not they incorporate blockchain or similar technology, CBDCs, as legal tender in the issuing jurisdiction, could also compete with, or replace, bitcoin and other digital assets as a medium of exchange or store of value. As a result, the emergence or growth of these or other digital assets could cause the market price of bitcoin to decrease, which could have a material adverse effect on our financial condition, and operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our bitcoin holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Historically, the bitcoin markets have been characterized by significant volatility in price, limited liquidity and trading volumes compared to sovereign currencies markets, relative anonymity, a developing regulatory landscape, potential susceptibility to market abuse and manipulation, compliance and internal control failures at exchanges, and </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">various other risks inherent in its entirely electronic, virtual form and decentralized network. During times of market instability, we may not be able to sell our bitcoin at favorable prices or at all. For example, a number of bitcoin trading venues temporarily halted deposits and withdrawals in 2022. As a result, our bitcoin holdings may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents. Further, bitcoin we hold with our custodians and transact with our trade execution partners does not enjoy the same protections as are available to cash or securities deposited with or transacted by institutions subject to regulation by the Federal Deposit Insurance Corporation or the Securities Investor Protection Corporation. Additionally, we may be unable to enter into term loans or other capital raising transactions collateralized by our unencumbered bitcoin or otherwise generate funds using our bitcoin holdings, including in particular during times of market instability or when the price of bitcoin has declined significantly. If we are unable to sell our bitcoin, enter into additional capital raising transactions using bitcoin as collateral, or otherwise generate funds using our bitcoin holdings, or if we are forced to sell our bitcoin at a significant loss, in order to meet our working capital requirements, our business and financial condition could be negatively impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">If we or our third-party service providers experience a security breach or cyberattack and unauthorized parties obtain access to our bitcoin, or if our private keys are lost or destroyed, or other similar circumstances or events occur, we may lose some or all of our bitcoin and our financial condition and results of operations could be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.4pt;margin:0pt;">Substantially all of the bitcoin we own is held in custody accounts at U.S.-based institutional-grade digital asset custodians. Security breaches and cyberattacks are of particular concern with respect to our bitcoin. Bitcoin and other blockchain-based cryptocurrencies and the entities that provide services to participants in the bitcoin ecosystem have been, and may in the future be, subject to security breaches, cyberattacks, or other malicious activities. For example, in October&#160;2021 it was reported that hackers exploited a flaw in the account recovery process and stole from the accounts of at least 6,000 customers of the Coinbase exchange, although the flaw was subsequently fixed and Coinbase reimbursed affected customers. Similarly, in November&#160;2022, hackers exploited weaknesses in the security architecture of the FTX Trading digital asset exchange and reportedly stole over $400 million in digital assets from customers. A successful security breach or cyberattack could result in:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:20.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a partial or total loss of our bitcoin in a manner that may not be covered by insurance or the liability provisions of the custody agreements with the custodians who hold our bitcoin;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:20.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">harm to our reputation and brand;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:20.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">improper disclosure of data and violations of applicable data privacy and other laws; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:20.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, contractual and financial exposure.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Further, any actual or perceived data security breach or cybersecurity attack directed at other companies with digital assets or companies that operate digital asset networks, regardless of whether we are directly impacted, could lead to a general loss of confidence in the broader bitcoin blockchain ecosystem or in the use of the bitcoin network to conduct financial transactions, which could negatively impact us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Attacks upon systems across a variety of industries, including industries related to bitcoin, are increasing in frequency, persistence, and sophistication, and, in many cases, are being conducted by sophisticated, well-funded and organized groups and individuals, including state actors. The techniques used to obtain unauthorized, improper or illegal access to systems and information (including personal data and digital assets), disable or degrade services, or sabotage systems are constantly evolving, may be difficult to detect quickly, and often are not recognized or detected until after they have been launched against a target. These attacks may occur on our systems or those of our third-party service providers or partners. We may experience breaches of our security measures due to human error, malfeasance, insider threats, system errors or vulnerabilities or other irregularities. In particular, we expect that unauthorized parties will attempt to gain access to our systems and facilities, as well as those of our partners and third-party service providers, through various means, such as hacking, social engineering, phishing and fraud. Threats can come from a variety of sources, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, and insiders. In addition, certain types of attacks could harm us even if our systems are left undisturbed. For example, certain threats are designed to remain dormant or undetectable, sometimes for extended periods of time, or until launched against a target </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">and we may not be able to implement adequate preventative measures. Further, there has been an increase in such activities due to the increase in work-from-home arrangements. The risk of cyberattacks could also be increased by cyberwarfare in connection with the ongoing Russia-Ukraine and Israel-Hamas conflicts, or other future conflicts, including potential proliferation of malware into systems unrelated to such conflicts. Any future breach of our operations or those of others in the bitcoin industry, including third-party services on which we rely, could materially and adversely affect our financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">We face risks relating to the custody of our bitcoin, including the loss or destruction of private keys required to access our bitcoin and cyberattacks or other data loss relating to our bitcoin.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We hold our bitcoin with regulated custodians that have duties to safeguard our private keys. Our custodial services contracts do not restrict our ability to reallocate our bitcoin among our custodians, and our bitcoin holdings may be concentrated with a single custodian from time to time. In light of the significant amount of bitcoin we hold, we continually seek to engage additional custodians to achieve a greater degree of diversification in the custody of our bitcoin as the extent of potential risk of loss is dependent, in part, on the degree of diversification. If there is a decrease in the availability of digital asset custodians that we believe can safely custody our bitcoin, for example, due to regulatory developments or enforcement actions that cause custodians to discontinue or limit their services in the United States, we may need to enter into agreements that are less favorable than our current agreements or take other measures to custody our bitcoin, and our ability to seek a greater degree of diversification in the use of custodial services would be materially adversely affected. In addition, holding our bitcoin with regulated custodians could affect the availability of receiving digital assets that may result from &#8220;forks&#8221; of the bitcoin blockchain if our custodians are unable to support or otherwise provide us with such digital assets, thereby reducing the amount of digital assets we may hold as a result. While our custodians carry insurance policies to cover losses for commercial crimes, cyber and cold storage, the policy limits vary per provider and would be shared among all of their customers, and subject to various limitations and exclusions (such as if a loss arises due to our failure to protect our login credentials and devices). The insurance that covers losses of our bitcoin holdings may cover only a small fraction of the value of the entirety of our bitcoin holdings, and there can be no guarantee that such insurance will be maintained as part of the custodial services we have or that such coverage will cover losses with respect to our bitcoin. Moreover, our use of custodians exposes us to the risk that the bitcoin our custodians hold on our behalf could be subject to insolvency proceedings and we could be treated as a general unsecured creditor of the custodian, inhibiting our ability to exercise ownership rights with respect to such bitcoin. Any loss associated with such insolvency proceedings is unlikely to be covered by any insurance coverage we maintain related to our bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Bitcoin is controllable only by the possessor of both the unique public key and private key(s)&#160;relating to the local or online digital wallet in which the bitcoin is held. While the bitcoin blockchain ledger requires a public key relating to a digital wallet to be published when used in a transaction, private keys must be safeguarded and kept private in order to prevent a third party from accessing the bitcoin held in such wallet. To the extent the private key(s)&#160;for a digital wallet are lost, destroyed, or otherwise compromised and no backup of the private key(s)&#160;is accessible, neither we nor our custodians will be able to access the bitcoin held in the related digital wallet. Furthermore, we cannot provide assurance that our digital wallets, nor the digital wallets of our custodians held on our behalf, will not be compromised as a result of a cyberattack. The bitcoin and blockchain ledger, as well as other digital assets and blockchain technologies, have been, and may in the future be, subject to security breaches, cyberattacks, or other malicious activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Regulatory change reclassifying bitcoin as a security could lead to our classification as an &#8220;investment company&#8221; under the 1940 Act and could adversely affect the market price of bitcoin and the market price of our common stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Under Sections 3(a)(1)(A)&#160;and (C)&#160;of the 1940 Act, a company generally will be deemed to be an &#8220;investment company&#8221; for purposes of the 1940 Act if (1)&#160;it is, or holds itself out as being, engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting or trading in securities or (2)&#160;it engages, or proposes to engage, in the business of investing, reinvesting, owning, holding or trading in securities and it owns or proposes to acquire investment securities having a value exceeding 40% of the value of its total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. We do not believe that we are an &#8220;investment company,&#8221; as such term is defined in the 1940 Act, and are not registered as an &#8220;investment company&#8221; under the 1940 Act as of the date of this annual report on Form 10-K.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">While senior SEC officials have stated their view that bitcoin is not a &#8220;security&#8221; for purposes of the federal securities laws, a contrary determination by the SEC could lead to our classification as an &#8220;investment company&#8221; under the 1940 Act, if the portion of our assets consists of investments in bitcoins exceeds 40% safe harbor limits prescribed in the 1940 Act, which would subject us to significant additional regulatory controls that could have a material adverse effect on our business and operations and may also require us to change the manner in which we conduct our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We monitor our assets and income for compliance under the 1940 Act and seek to conduct our business activities in a manner such that we do not fall within its definitions of &#8220;investment company&#8221; or that we qualify under one of the exemptions or exclusions provided by the 1940 Act and corresponding SEC regulations. If bitcoin is determined to constitute a security for purposes of the federal securities laws, we would take steps to reduce the percentage of bitcoins that constitute investment assets under the 1940 Act. These steps may include, among others, selling bitcoins that we might otherwise hold for the long term and deploying our cash in non-investment assets, and we may be forced to sell our bitcoins at unattractive prices. We may also seek to acquire additional non-investment assets to maintain compliance with the 1940 Act, and we may need to incur debt, issue additional equity or enter into other financing arrangements that are not otherwise attractive to our business. Any of these actions could have a material adverse effect on our results of operations and financial condition. Moreover, we can make no assurance that we would successfully be able to take the necessary steps to avoid being deemed to be an investment company in accordance with the safe harbor. If we were unsuccessful, and if bitcoin is determined to constitute a security for purposes of the federal securities laws, then we would have to register as an investment company, and the additional regulatory restrictions imposed by 1940 Act could adversely affect the market price of bitcoin and in turn adversely affect the market price of our common stock.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As bitcoin and other digital assets are relatively novel and the application of state and federal securities laws and other laws and regulations to digital assets is unclear in certain respects, it is possible that regulators in the United States or foreign countries may interpret or apply existing laws and regulations in a manner that adversely affects the price of bitcoin. The U.S. federal government, states, regulatory agencies, and foreign countries may also enact new laws and regulations, or pursue regulatory, legislative, enforcement or judicial actions, that could materially impact the price of bitcoin or the ability of individuals or institutions such as us to own or transfer bitcoin. For examples, see &#8220;Bitcoin and other digital assets are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertainty&#8221; elsewhere in these Risk Factors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If bitcoin is determined to constitute a security for purposes of the federal securities laws, the additional regulatory restrictions imposed by such a determination could adversely affect the market price of bitcoin and in turn adversely affect the market price of our common stock. See &#8220;Regulatory change reclassifying bitcoin as a security could lead to our classification as an &#8220;investment company&#8221; under the 1940 Act, and could adversely affect the market price of bitcoin and the market price of our common stock&#8221; elsewhere in these Risk Factors. Moreover, the risks of us engaging in a bitcoin treasury strategy have created, and could continue to create, complications due to the lack of experience that third parties have with companies engaging in such a strategy, such as increased costs of director and officer liability insurance or the potential inability to obtain such coverage on acceptable terms in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our bitcoin treasury strategy exposes us to risk of non-performance by counterparties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our bitcoin treasury strategy exposes us to the risk of non-performance by counterparties, whether contractual or otherwise. Risk of non-performance includes inability or refusal of a counterparty to perform because of a deterioration in the counterparty&#8217;s financial condition and liquidity or for any other reason. For example, our execution partners, custodians, or other counterparties might fail to perform in accordance with the terms of our agreements with them, which could result in a loss of bitcoin, a loss of the opportunity to generate funds, or other losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our primary counterparty risk with respect to our bitcoin is custodian performance obligations under the various custody arrangements we have entered into. A series of recent high-profile bankruptcies, closures, liquidations, regulatory enforcement actions and other events relating to companies operating in the digital asset industry, the closure </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">or liquidation of certain financial institutions that provided lending and other services to the digital assets industry, SEC enforcement actions against other providers, or placement into receivership or civil fraud lawsuit against digital asset industry participants have highlighted the perceived and actual counterparty risk applicable to digital asset ownership and trading. Although these bankruptcies, closures and liquidations have not adversely impacted our bitcoin (which was only recently acquired), legal precedent created in these bankruptcy and other proceedings may increase the risk of future rulings adverse to our interests in the event one or more of our custodians becomes a debtor in a bankruptcy case or is the subject of other liquidation, insolvency or similar proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">While our custodians are subject to regulatory regimes intended to protect customers in the event of a custodial bankruptcy, receivership or similar insolvency proceeding, no assurance can be provided that our custodially-held bitcoin will not become part of the custodian&#8217;s insolvency estate if one or more of our custodians enters bankruptcy, receivership or similar insolvency proceedings. Additionally, if we pursue any strategies to create income streams or otherwise generate funds using our bitcoin holdings, we would become subject to additional counterparty risks. Although no such strategies are contemplated at this time, we will need to carefully evaluate market conditions, including price volatility as well as service provider terms and market reputations and performance, among others, prior to implementing any such strategy, all of which could effect our ability to successfully implement and execute on any such future strategy. These risks, along with any significant non-performance by counterparties, including in particular the custodians with which we custody substantially all of our bitcoin, could have a material adverse effect on our business, prospects, financial condition, and operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Our custodially-held bitcoin may become part of the custodian&#8217;s insolvency estate if one or more of our custodians enters bankruptcy, receivership or similar insolvency proceedings.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">If our custodially-held bitcoin are considered to be the property of our custodians&#8217; estates in the event that any such custodians were to enter bankruptcy, receivership or similar insolvency proceedings, we could be treated as a general unsecured creditor of such custodians, inhibiting our ability to exercise ownership rights with respect to such bitcoin and this may ultimately result in the loss of the value related to some or all of such bitcoin. A series of recent high-profile bankruptcies, closures, liquidations, regulatory enforcement actions and other events relating to companies operating in the digital asset industry, including the filings for bankruptcy protection by Three Arrows Capital, Celsius Network, Voyager Digital, FTX Trading and Genesis Global Capital, the closure or liquidation of certain financial institutions that provided lending and other services to the digital assets industry, including Signature Bank and Silvergate Bank, SEC enforcement actions against Coinbase,&#160;Inc. and Binance Holdings Ltd., the placement of Prime Trust, LLC into receivership following a cease-and-desist order issued by Nevada&#8217;s Department of Business and Industry, and the filing and subsequent settlement of a civil fraud lawsuit by the New York Attorney General against Genesis Global Capital, its parent company Digital Currency Group,&#160;Inc., and former partner Gemini Trust Company, have highlighted the counterparty risks applicable to owning and transacting in digital assets. Although these bankruptcies, closures, liquidations and other events have not resulted in any loss or misappropriation of our bitcoin, nor have such events adversely impacted our access to our bitcoin, they have, in the short-term, likely negatively impacted the adoption rate and use of bitcoin. Additional bankruptcies, closures, liquidations, regulatory enforcement actions or other events involving participants in the digital assets industry in the future may further negatively impact the adoption rate, price, and use of bitcoin, limit the availability to us of financing collateralized by bitcoin, or create or expose additional counterparty risks. Any loss associated with such insolvency proceedings is unlikely to be covered by any insurance coverage we maintain related to our bitcoin. Even if we are able to prevent our bitcoin from being considered the property of a custodian&#8217;s bankruptcy estate as part of an insolvency proceeding, it is possible that we would still be delayed or may otherwise experience difficulty in accessing our bitcoin held by the affected custodian during the pendency of the insolvency proceedings. Any such outcome could have a material adverse effect on our financial condition and the market price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">A temporary or permanent blockchain &#8220;fork&#8221; to bitcoin or other crypto assets could adversely affect our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Blockchain protocols, including bitcoin, are open source. Any user can download the software, modify it, and then propose that bitcoin or other blockchain protocols users and miners adopt the modification. When a modification is introduced and a substantial majority of users and miners consent to the modification, the change is implemented and the bitcoin or other blockchain protocol networks, as applicable, remain uninterrupted. However, if less than a substantial majority of users and miners consent to the proposed modification, and the modification is not compatible with the software prior to its modification, the consequence would be what is known as a &#8220;fork&#8221;,&#160;<i style="font-style:italic;">i.e.</i>, &#8220;split&#8221; of the impacted blockchain protocol network and respective blockchain, with one prong running the pre-modified software and the other running the modified software. The effect of such a fork would be the existence of two parallel versions of the bitcoin or other blockchain protocol network, as applicable, running simultaneously, but with each split network&#8217;s crypto asset lacking interchangeability. A &#8220;hard fork&#8221; &#8211; where there is disagreement among the users about the rules&#160;of the network &#8211; can have a significant negative impact on value of the crypto asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The bitcoin has been subject to &#8220;forks&#8221; that resulted in the creation of new networks, including bitcoin cash ABC, bitcoin cash SV, bitcoin diamond, bitcoin gold and others. Some of these forks have caused fragmentation among platforms as to the correct naming convention for forked crypto assets. Due to the lack of a central registry or rulemaking body, no single entity has the ability to dictate the nomenclature of forked crypto assets, causing disagreements and a lack of uniformity among platforms on the nomenclature of forked crypto assets, and which results in further confusion to customers as to the nature of assets they hold on platforms, and which can negatively impact the value of the crypto assets. In addition, several of these forks were contentious and as a result, participants in certain communities may harbor ill will towards other communities. As a result, certain community members may take actions that adversely impact the use, adoption, and price of bitcoin, or any of their forked alternatives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Furthermore, hard forks can lead to new security concerns. For instance, when the Ethereum and Ethereum Classic networks split in July&#160;2016, replay attacks, in which transactions from one network were rebroadcast on the other network to achieve &#8220;double-spending,&#8221; plagued platforms that traded Ethereum through at least October&#160;2016, resulting in significant losses to some crypto asset platforms. Similar replay attacks occurred in connection with the bitcoin cash and bitcoin cash SV network split in November&#160;2018. Another possible result of a hard fork is an inherent decrease in the level of security due to the splitting of some mining power across networks, making it easier for a malicious actor to exceed 50% of the mining power of that network, thereby making crypto assets that rely on proof-of-work more susceptible to attack, as has occurred with Ethereum Classic.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">We intend to recognize forked and airdropped assets consistent with our custodians. We may not immediately or ever have the ability to withdraw a forked or airdropped bitcoin by virtue of bitcoins that we hold with our custodians. Future forks may occur at any time. A fork can lead to a disruption of networks and our information technology systems, cybersecurity attacks, replay attacks, or security weaknesses, any of which can further lead to temporary or even permanent loss of our and our assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">The due diligence procedures conducted by us and our liquidity provider to mitigate transaction risk may fail to prevent transactions with a sanctioned entity.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We execute trades through our U.S.-based liquidity providers, and rely on these third parties to implement controls and procedures to mitigate the risk of transacting with sanctioned entities. While we expect our third party service providers to conduct their business in compliance with applicable laws and regulations and in accordance with our contractual arrangements, there is no guarantee that they will do so. Accordingly, we are exposed to risk that our due diligence procedures may fail. If we are found to have transacted in bitcoin with bad actors that have used bitcoin to launder money or with persons subject to sanctions, we may be subject to regulatory proceedings and any further transactions or dealings in bitcoin by us may be restricted or prohibited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks Related to Our Indebtedness</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our indebtedness and liabilities could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations and impair our ability to satisfy our obligations under our debt instruments when they come due.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024, we did not have any indebtedness. In January 2025, we issued $100.0 million aggregate principal amount of senior convertible notes. We may also incur additional indebtedness to meet future financing needs. Our indebtedness could have significant negative consequences for our security holders and our business, results of operations and financial condition by, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">increasing our vulnerability to adverse economic and industry conditions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">limiting our ability to obtain additional financing on acceptable terms or at all;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, which will reduce the amount of cash available for other purposes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">limiting our flexibility to plan for, or react to, changes in our business;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">diluting the interests of our existing stockholders as a result of issuing shares of our common stock upon conversion of the notes; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">placing us at a possible competitive disadvantage with competitors that are less leveraged than us or have better access to capital.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business may not generate sufficient funds, and we may otherwise be unable to maintain sufficient cash reserves, to pay amounts due under our indebtedness and our cash needs may increase in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may not have the ability to raise the funds necessary to settle conversions of the notes in cash or to repurchase the notes upon a fundamental change, and our future debt may contain limitations on our ability to pay cash upon conversion or repurchase of the notes.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Holders of our convertible senior notes will have the right, subject to certain conditions and exceptions, to require us to repurchase all or any portion of their notes upon the occurrence of a fundamental change at a fundamental change repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, upon conversion of the notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of notes surrendered therefor or pay cash with respect to notes being converted. In addition, our ability to repurchase the notes or to pay cash upon conversions of the notes may be limited by law, by regulatory authority or by agreements governing our future indebtedness. Our failure to repurchase notes at a time when the repurchase is required by the indenture or to pay any cash payable on future conversions of the notes as required by the indenture would constitute a default under the indenture. A default under the indenture governing the notes or the fundamental change itself could also lead to a default under agreements governing our future indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase the notes or make cash payments upon conversions thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Certain provisions in the indenture governing the notes may delay or prevent an otherwise beneficial takeover attempt of us.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain provisions in the indenture governing the notes may make it more difficult or expensive for a third party to acquire us. For example, the indenture governing the notes requires us, subject to certain conditions and exceptions, to repurchase the notes for cash upon the occurrence of a fundamental change and, in certain circumstances, to increase the conversion rate for a holder that converts its notes in connection with a make-whole fundamental change. A takeover of us may trigger the requirement that we repurchase the notes and/or increase the conversion rate, which could make it more costly for a potential acquirer to engage in such takeover. Such additional costs may have the effect of delaying or preventing a takeover of us that would otherwise be beneficial to investors.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">53</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The conditional conversion feature of the notes, if triggered, may adversely affect our financial condition and operating results.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the event the conditional conversion feature of the notes is triggered, holders of notes will be entitled to convert their notes at any time during specified periods at their option. If one or more holders elect to convert their notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Conversion of the notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The conversion of some or all of the notes may dilute the ownership interests of our stockholders. Upon conversion of the notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock. If we elect to settle our conversion obligation in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the notes may encourage short selling by market participants because the conversion of the notes could be used to satisfy short positions, or anticipated conversion of the notes into shares of our common stock could depress the price of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">The capped call transactions may affect the value of the notes and our common stock.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the pricing of the notes, we entered into privately negotiated capped call transactions with certain financial institutions (the &#8220;option counterparties&#8221;). The capped call transactions cover, subject to customary adjustments, the number of shares of our common stock that initially underlie the notes. The capped call transactions are expected to offset the potential dilution as a result of any conversion of notes. We expect that the option counterparties and/or their respective affiliates may modify or unwind their hedge positions by entering into or unwinding various derivative transactions and/or purchasing or selling our common stock or other securities of ours in secondary market transactions from time to time prior to the maturity of the notes (and are likely to do so on each exercise date of the capped call transactions, which are scheduled to occur during the observation period relating to any conversion of the notes on or after May 1, 2030 that is not in connection with a redemption, or following our election to terminate any portion of the capped call transactions in connection with any repurchase, redemption, exchange or early conversion of the notes). This activity could cause or avoid an increase or a decrease in the market price of our common stock or the notes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We are subject to counterparty risk with respect to the capped call transactions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The option counterparties are financial institutions, and we are subject to the risk that one or more of the option counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate, their obligations under the capped call transactions. Our exposure to the credit risk of the option counterparties is not secured by any collateral. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Past global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at the time under such transaction. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">54</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks Related to Our Common Stock</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our executive officers, directors and significant stockholders, if they choose to act together, have the ability to substantially influence the outcome of all matters submitted to stockholders for approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our executive officers, directors and significant stockholders beneficially own in the aggregate shares representing approximately 22.3% of our common stock as of January 31, 2025. If these stockholders choose to act together, they are able to substantially influence the outcome of all matters submitted to our stockholders for approval, as well as our management and affairs. For example, these persons, if they choose to act together, can impact the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This concentration of ownership control may:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delay, defer or prevent a change in control;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">entrench our management and the board of directors; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">impede a merger, consolidation, takeover or other business combination involving us that other stockholders may desire.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Provisions in our corporate charter documents and under Delaware law could make an acquisition of our company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management<span style="font-style:normal;font-weight:normal;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions in our corporate charter and our bylaws may discourage, delay or prevent a merger, acquisition or other change in control of our company that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our board of directors is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Among other things, these provisions:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">allow the authorized number of our directors to be changed only by resolution of our board of directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">allow for a classified board of directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish advance notice requirements for stockholders proposal that can be acted on at stockholder meeting and nominations to our board of directors; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">limit who may call stockholder meetings.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our amended and restated bylaws designate exclusive forums for the adjudication of certain disputes, which could limit our stockholders&#8217; ability to bring claims in a judicial forum it finds favorable for disputes with us or our directors, officers, or employees.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our amended and restated bylaws provide that a state or federal court located within the State of Delaware is the sole and exclusive forum for:</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">55</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any derivative action or proceeding brought on our behalf;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee or stockholder of our company to us or our stockholders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any action asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our charter or our bylaws, as to which the General Corporation Law of the State of Delaware confers jurisdiction on the Court of Chancery of the State of Delaware; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any action asserting a claim governed by the internal affairs doctrine.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our amended and restated bylaws further provide that a federal district court of the United States is the sole and exclusive forum for any complaint asserting a cause of action arising under the Securities Act of 1933, as amended or the Securities Act. These provisions further provide that any person or entity that acquires any interest in shares of our capital stock will be deemed to have notice of and consented to these provisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find any of these provisions to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">The price of our common stock has been and may continue to be volatile and fluctuate substantially, which could result in substantial losses for purchasers of our common stock<span style="font-style:normal;font-weight:normal;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Our stock price has been and is likely to continue to be volatile. The stock market in general and the market for smaller medical device companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. With the adoption of our new bitcoin strategy, we expect to see additional volatility.  As a result of this volatility, you may not be able to sell your common stock. The market price for our common stock may be influenced by many factors, including:</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our bitcoin treasury strategy; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the success of competitive products, services or technologies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory or legal developments in the United States and other countries;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developments or disputes concerning patent applications, issued patents or other proprietary rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the recruitment or departure of key personnel;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">variations in our financial results or those of companies that are perceived to be similar to us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in the structure of healthcare payment systems;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">market conditions in the medical device sector;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">general economic, industry and market conditions; and</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">56</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the other factors described in this &#8220;Risk Factors&#8221; section, including the risk that DOJ will file a complaint against our company.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. Due to the potential volatility of our stock price, including the risk that DOJ will file a complaint against our company, we may be the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management&#8217;s attention and resources from our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have never declared or paid cash dividends on our capital stock. We anticipate that we will retain our earnings, if any, for future growth and therefore do not anticipate paying cash dividends in the future. As a result, only appreciation of the price of our common stock will provide a return to stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">General Risk Factors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Because we operate in an industry with significant product liability risk, and we may not be sufficiently insured against this risk, we may be subject to substantial claims against our product or services that we may provide<span style="font-style:normal;font-weight:normal;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The development, manufacture and sale, lease or use of products or provision of services in a medical setting entails significant risks of product liability or other negligence or malpractice claims. Although we maintain insurance to cover us in the event of liability claims, and as of the date of this annual report on Form 10-K, no such claims have been asserted or threatened against us, our insurance may not be sufficient to cover all possible future liabilities regarding our product, or from performing tests with our product or other non-proprietary products. Accordingly, we may not be adequately protected from any liabilities, including any adverse judgments or settlements, we might incur in connection with the development, clinical testing, manufacture and sale, lease or use of our products or the provision of services. A successful product liability or negligence or medical malpractice claim or series of claims brought against us that result in an adverse judgment against or settlement by us in excess of any insurance coverage could seriously harm our financial condition or reputation. Moreover, even if no judgments, fines, damages or liabilities are imposed on us, our reputation could suffer, which could have a material adverse effect on our business, financial condition and results of operations. In addition, product liability and other malpractice insurance is expensive and may not always be available to us on acceptable terms, if at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">We may implement a product recall or voluntary market withdrawal or stop shipment of our product due to product defects or product enhancements and modifications, which would significantly increase our costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The manufacturing and marketing of QuantaFlo and any future products that we may develop involves an inherent risk that our products may prove to be defective. In that event, we may voluntarily implement a recall or market withdrawal or stop shipment or may be required to do so by a regulatory authority. A recall of QuantaFlo or one of our future products, or a similar product manufactured by another manufacturer, could impair sales of the products we market as a result of confusion concerning the scope of the recall or as a result of the damage to our reputation for quality and safety. Further any product recall, voluntary market withdrawal or shipment stoppage of our product could significantly increase our costs and have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">If we fail to properly manage our operations, our business could suffer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our operations have placed, and will continue to place, a significant strain on our management and on our operational and financial resources and systems. Failure to manage our operations effectively could cause us to over-invest or under-invest and result in losses or weaknesses. Additionally, our anticipated operations will increase the demands placed on our suppliers, resulting in an increased need for us to carefully monitor for quality assurance. Any failure by us to manage our operations effectively could have an adverse effect on our ability to achieve our development and commercialization goals.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">57</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">An information security incident, including a cybersecurity breach, could have a negative impact on our business or reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">To meet business objectives, we rely on both internal information technology systems and networks, and those of third parties and their vendors, to process and store sensitive data, including confidential research and patient data that may be subject to legal protection. The extensive information security and cybersecurity threats, which affect companies globally, pose a risk to the security and availability of these information technology systems and networks, and the confidentiality, integrity, and availability of our sensitive data. We continually assess these threats and make investments to increase internal protection, detection, and response capabilities, as well as ensure our third-party providers have required capabilities and controls, to address this risk. To date, we have not experienced any material impact to our business or operations resulting from information or cybersecurity attacks; however, because of the frequently changing attack techniques, along with the increased volume and sophistication of the attacks, there is the potential for us to be adversely impacted. This impact could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults, or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and our financial condition and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or FDIC, as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership. Although we took steps to diversify our banking relationships and are not a borrower or party to any such instruments with SVB, Signature or any other financial institution currently in receivership, if any of our lenders or counterparties to any financial instruments (such as letters of credit) were to be placed into receivership, we may be unable to access such funds. In addition, if any of our customers, suppliers or other parties with whom we conduct business are unable to access funds pursuant to such instruments or lending arrangements with such a financial institution, such parties&#8217; ability to pay their obligations to us or to enter into new commercial arrangements requiring additional payments to us could be adversely affected. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Although the U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by certain of such government securities held by financial institutions to mitigate the risk of potential losses on the sale of government securities with interest rates below current market interest rates, widespread demands for customer withdrawals or other liquidity needs of financial institutions for immediately liquidity may exceed the capacity of such program. Additionally, there is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a timely fashion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect our company, the financial institutions with which we have credit agreements or arrangements directly, or the financial services industry or economy in general. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fluctuations in insurance cost and availability could adversely affect our profitability or our risk management profile<span style="font-style:normal;font-weight:normal;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We hold a number of insurance policies, including product liability insurance, directors&#8217; and officers&#8217; liability insurance, and workers&#8217; compensation insurance. If the costs of maintaining adequate insurance coverage increase significantly in the future, our operating results could be materially adversely affected. Likewise, if any of our current insurance coverage should become unavailable to us or become economically impractical, we would be required to operate our business without indemnity from commercial insurance providers. If we operate our business without </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">58</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">insurance, we could be responsible for paying claims or judgments against us that would have otherwise been covered by insurance, which could adversely affect our results of operations or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Disruptions at the FDA, the SEC and other government agencies caused by the change in presidential administration, funding shortages or potential funding shortages could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner, or otherwise prevent those agencies from performing normal business functions, which could negatively impact our business and our timelines. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The ability of the FDA to review and clear or approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, shifting policy priorities as a result of changes in the Presidential administration and political appointees tasked to oversee the agency, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC, and other government agencies on which our operations may rely is subject to the impacts of political events, which are inherently fluid and unpredictable. Currently, federal agencies in the United States are operating under a continuing resolution that is set to expire on March 14, 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Disruptions at the FDA and other agencies may slow the time necessary for review and approval (including our expanded indication for QuantaFlo), which could adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA and the SEC to timely review and process our submissions, which could have a material adverse effect on our business and our timelines.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We operate in an intensely competitive and rapidly changing business environment, and there is a substantial risk our products or service offerings could become obsolete or uncompetitive.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The market for medical systems, equipment and other devices and services is highly competitive. We compete with many medical service companies in the United States and internationally in connection with our vascular testing product and products under development. We face competition from numerous companies in the diagnostic area, as well as competition from academic institutions, government agencies and research institutions. Most of our current and potential competitors have, and will continue to have, substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do. There can be no assurance that we will have sufficient resources to successfully commercialize QuantaFlo or any other future products, if and when they are approved for sale or license, or service offerings that we may develop. Our future success will depend largely upon our ability to anticipate and keep pace with developments and advances. Current or future competitors could develop alternative technologies or products or service offerings that are more effective, easier to use or more economical than what we or any potential licensee develop. If our technologies or products or service offerings become obsolete or uncompetitive, our related revenues would decrease. This would have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Changes in, or interpretations of, tax rules and regulations may adversely affect our effective tax rates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We are subject to income and other taxes in the United States. Significant judgment is required in evaluating our provision for income taxes or in claiming tax credits or taking other tax positions. During the ordinary course of business, there are many transactions for which the ultimate tax determination is uncertain or if we were to be audited, the Internal Revenue Service, or state tax authorities may not agree with our tax positions. For example, we are subject to various state sales and use tax audits and believe our current exposure could result in an estimated liability of up to $500,000. Further state sales and use tax audits could result in other potential liabilities. In addition, there could be changes in the valuation of our deferred tax assets and liabilities or changes in the relevant tax, accounting, and other laws, regulations, principles and interpretations. Although we believe our tax estimates and practices are reasonable, the final determination of tax audits and any related litigation could be materially different from our historical income tax provisions and accruals. The results of an audit or litigation, or the effects of a change in tax policy in the United States or a particular state, could have a material effect on our operating results in the period or periods for which that </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">59</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">determination is made. In addition, new income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of our earnings. Any new taxes could adversely affect our business operations, and our business and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We are currently a &#8220;smaller reporting company,&#8221; and the reduced disclosure requirements applicable to such companies may make our common stock less attractive to investors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a &#8220;smaller reporting company,&#8221; as defined in the Securities Exchange Act of 1934, as amended, or the Exchange Act, and will remain a smaller reporting company for so long as either our annual revenues are less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter, or our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter. For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not smaller reporting companies. These exemptions include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reduced disclosure obligations regarding executive compensation.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have taken advantage of reduced reporting burdens in this annual report on Form 10-K. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">We have incurred and will continue to incur increased costs as a result of operating as a public company, and our management has been and will continue to be required to devote substantial time to new compliance initiatives and corporate governance practices.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a public company, we have incurred and will continue to incur increased costs, and our management has been and will continue to be required to devote substantial time to new compliance initiatives and corporate governance practices. Moreover, after we are no longer a smaller reporting company, we will incur additional significant legal, accounting and other expenses to address compliance and corporate governance. The Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act and other applicable securities rules and regulations impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, the currently applicable rules and regulations have already increased our legal and financial compliance costs and made some activities more time-consuming and costly. We will need to continue to dedicate internal resources, potentially engage outside consultants and continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">You may experience future dilution as a result of future equity offerings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In order to raise additional capital or pursue strategic acquisition opportunities, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock.  For example, we entered into an &#8220;at-the-market&#8221; offering program in June 2024 and issued convertible notes in January 2025. We cannot assure you that we will be able to sell shares or other securities with conversion prices in any other offering at a price per share that is equal to or greater than the price per share paid by investors in such an offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders.</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">60</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The price per share at which we sell or issue additional shares of our common stock or other securities convertible into or exchangeable for our common stock in future transactions may be higher or lower than the price at which you purchased your shares.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_7813c64c_c27c_41e5_89ea_81ef41cc9928"></a><a id="ITEM1BUNRESOLVEDSTAFFCOMMENTS_174587"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 1B.&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_2e932846_66c3_4ddc_a913_366ca2bb625f"></a><a id="ITEM1CYBERSECURITY"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">ITEM 1C.   CYBERSECURITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Risk Management and Strategy</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_Hlk158636279"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="Tb_SEmH68gB7UqSsRUUXSzzsQ" escape="true"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="Tb_8hFEqMvSMkSIN2txX9Uo1w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">We regularly assess risks from cybersecurity threats; monitor our information systems for potential vulnerabilities; and test those systems pursuant to our cybersecurity policies, processes, and practices, which are <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" id="Narr_DOqUu5Cj60ugy0M5hiwgPA">integrated</ix:nonNumeric> into our overall risk management program. To protect our information systems from cybersecurity threats, we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner. Our Information Technology or IT, department assesses risks based on probability and potential impact to key business systems and processes. Risks that are considered high are incorporated into our overall risk management program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">All employees receive cybersecurity training with job-specific topic considerations. Our IT team engages <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" id="Narr_FItRS5_MbEyjm7TKSycCBQ">third-party vendors</ix:nonNumeric> to assist with providing timely cybersecurity threat alerts in addition to monitoring cybersecurity threats and our defenses against cyberattacks. This monitoring includes the proactive identification of vulnerabilities in our systems with threat intelligence. The employees within our broader IT team who specialize in cybersecurity operations are responsible for coordinating and overseeing the activities of these <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-true" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" id="Narr_vdEHupwODkGmJ3MPyQCPnw">third-party vendors</ix:nonNumeric>.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Cybersecurity threats, including those resulting from any previous cybersecurity incidents, have <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-false" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="Narr_lU_d1aWFBkqGPExxlOQT0w">not materially affected</ix:nonNumeric> our company, including our business strategy, results of operations, or financial condition. We do not believe that cybersecurity threats resulting from any previous cybersecurity incidents of which we are aware are reasonably likely to materially affect our company. Refer to the risk factor captioned &#8220;<i style="font-style:italic;">An information security incident, including a cybersecurity breach, could have a negative impact on our business or reputation&#8221;</i> in Part I, Item 1A. &#8220;General Risk Factors&#8221; for additional description of cybersecurity risks and potential related impacts on our company.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Governance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="Tb_bJxd3gDsEkmuz3f4P5ivWg" continuedAt="Tb_bJxd3gDsEkmuz3f4P5ivWg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our board of directors oversees our risk management process, including as it pertains to cybersecurity risks, directly and through its committees. <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="Tb_ptQrDBLeuUOPKy6jHezR4Q" escape="true">The audit committee </ix:nonNumeric>of the board oversees our risk management program, which focuses on the most significant risks we face in the short, intermediate, and long-term timeframe. <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="Tb_5Z2eHYHxAUiC41Frb04Z_A" escape="true">Audit committee meetings include discussions of specific risk areas throughout the year, including, among others, those relating to cybersecurity threats, and <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" id="Narr_q5D88fbwgkit3pgbAOGcAg">reports</ix:nonNumeric> from the <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="Tb_HnrW99YXZk-TQl9rtLxm_w" escape="true">chief technology officer</ix:nonNumeric> or CTO on our enterprise risk profile on an annual basis. The audit committee reviews our cybersecurity risk profile with management on a periodic basis using key performance and/or risk indicators. These key performance indicators are metrics and measurements designed to assess the effectiveness of our cybersecurity program in the prevention, detection, mitigation, and remediation of cybersecurity incidents.</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="Tb_U1Q7mqAlRUG2SYTT8gW1Ag" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="Tb_8U4fZJ7rLUi_beDk_WfQTw" escape="true">We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents</ix:nonNumeric>. <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="Tb_6fvN9xjCO0uJaDx95APOiA" escape="true">Our CTO is <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" id="Narr_B7xcopYp30-FTQhUQUrGwQ">responsible</ix:nonNumeric> for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors</ix:nonNumeric>.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_bJxd3gDsEkmuz3f4P5ivWg_cont1"></ix:continuation><a id="_e429c93f_a62c_450d_b2a1_574e98159fcc"></a><a id="ITEM2PROPERTIES_635474"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 2.&#160;&#160;&#160;PROPERTIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Because we outsource our manufacturing to &#8220;turn-key&#8221; manufacturers and have a geographically dispersed sales force and distributor arrangement, we have minimal needs for office space to conduct our day-to-day business operations. Our headquarters are located in Santa Clara, CA, where we lease an operations fulfillment space that also serves as our corporate headquarters address.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_b85097e4_acf4_4731_99f8_ce1d1adaeece"></a><a id="ITEM3LEGALPROCEEDINGS_580083"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 3.&#160;&#160;&#160;LEGAL PROCEEDINGS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. We are not currently a party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business, operating results, cash flows or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In July 2017, we received an initial civil investigative demand, or CID, from the DOJ pursuant to the federal False Claims Act investigating whether we and others may have violated the False Claims Act by marketing tests on devices that use photoplethysmography technology as reimbursable by Medicare in alleged contravention of applicable laws and regulations.&#160;We cooperated with the investigation, along with subsequent CIDs received in February 2019, December 2021, April 2022 and April 2023 addressed to our company or individual current or former employees related to the same investigation. In September 2024, DOJ shared certain information to which we responded in January and February 2025. On February 6, 2025, DOJ asked if we wished to engage in settlement discussions to resolve any potential claims by February 11, 2025 and if so that we make a settlement offer by such deadline.&#160;Prior to February 6, 2025, DOJ had not stated an intention to pursue a claim of wrongdoing against our company.&#160;On February 11, 2025, we began initial settlement discussions with DOJ, but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.&#160;We do not believe the amount of loss can be reasonably estimated. We intend to vigorously defend ourselves in any such action.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_2e5d23b8_57a7_4874_8c70_49cf56fffdf9"></a><a id="ITEM4MINESAFETYDISCLOSURES_215265"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 4.&#160;&#160;&#160;MINE SAFETY DISCLOSURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_461cb560_d9d2_44e0_b46a_3d9e87982405"></a><a id="PARTII_948696"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART II</p><a id="ITEM5MARKETFORREGISTRANTSCOMMONEQUITYREL"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt 0pt 12pt 0pt;">ITEM 5.&#160;&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Market Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our common stock has been trading on the Nasdaq Stock Market LLC under the symbol &#8220;SMLR&#8221; since September 27, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On January 31, 2025, the closing sale price of a share of our common stock was $51.96 per share and there were 9,596,486 shares of our common stock outstanding. On that date, our shares of common stock were held by approximately eight stockholders of record. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of our common stock whose shares are held in the names of various security brokers, dealers, and registered clearing agencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Dividends</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We have not declared or paid any cash dividends on our common stock, and we do not anticipate declaring or paying cash dividends for the foreseeable future. We are not subject to any legal restrictions respecting the payment of dividends, except that we may not pay dividends if the payment would render us insolvent. Any future determination as </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">62</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">to the payment of cash dividends on our common stock will be at our board of directors&#8217; discretion and will depend on our financial condition, operating results, capital requirements and other factors that our board of directors considers to be relevant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Securities Authorized for Issuance Under Equity Compensation Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Information about our equity compensation plans is incorporated herein by reference to Part III, Item 12 of this annual report on Form 10-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recent Sales of Unregistered Securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Not applicable.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Issuer Purchases of Equity Securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_fa631c2e_d710_4b9f_afaf_2797cb793f2e"></a><a id="ITEM6SELECTEDFINANCIALDATA_498329"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 6.&#160;&#160;&#160;Reserved</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_04059ade_3cb8_4396_ae6a_f736d71f7eda"></a><a id="ITEM7MANAGEMENTSDISCUSSIONANDANALYSISOFF"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt 0pt 12pt 0pt;">ITEM 7.&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">The following discussion and analysis should be read together with our financial statements and the related notes appearing elsewhere in this annual report on Form 10-K. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See &#8220;Cautionary Note Regarding Forward-Looking Statements and Industry Data&#8221; for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under &#8220;Risk Factors&#8221; in Item 1A and elsewhere in this annual report on Form 10-K.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a company developing and marketing technology products and services that assist our customers in evaluating and treating chronic diseases. Our patented and FDA cleared product, QuantaFlo measures arterial blood flow in the extremities to aid in the diagnosis of PAD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We also invest in bitcoin and have adopted bitcoin as our primary treasury reserve asset. As an operating business, we are able to use cash flows as well as proceeds from equity and debt financings to accumulate bitcoin. Our healthcare technology solutions business is our predominant operational focus, providing cash flows and enabling us to pursue our bitcoin strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are currently seeking a new 510(k) clearance from the FDA for the expanded use of QuantaFlo, which is intended to enable expanded labeling as an aid in the diagnosis of other cardiovascular diseases in addition to PAD. We continue to develop additional complementary proprietary products in-house and seek out other arrangements for additional products and services that we believe will bring value to our customers and to our company. We believe our current products and services, and any future products or services that we may offer, position us to provide valuable information to our customer base, which in turn permits them to better guide patient care.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In the year ended December 31, 2024, we had total revenues of $56.3 million and net income of $40.9 million compared to total revenues of $68.2 million and net income of $20.6 million in 2023. We had an income tax expense of $7.0 million in 2024, compared to $3.5 million in 2023. Our pre-tax net income was $47.9 million, including unrealized </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">63</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">gains from the change in fair value of bitcoin holdings of $24.9 million in 2024 compared to $24.1 million and no gains in 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Recent Developments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Bitcoin Treasury Strategy</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="white-space:pre-wrap;">In May 2024, we adopted bitcoin as our primary treasury reserve asset on an ongoing basis, subject to market conditions and our anticipated cash needs. As of December 31, 2024, we held an aggregate of 2,298 bitcoins, which we acquired for an aggregate purchase price of $189.7 million and an average purchase price of $82,538 per bitcoin. From January 1, 2025 through February 14, 2025, we have purchased an additional 894 bitcoins, at an aggregate purchase price of $90.7 million and an average purchase price of $101,532. All purchase amounts include fees and expenses.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;"><i style="font-style:italic;">ATM Offering</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>In June 2024, we entered into a Controlled Equity Offering<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">SM</sup> Sales Agreement with Cantor Fitzgerald &amp; Co., pursuant to which we may offer and sell from time to time our common stock in an at-the-market, or ATM, offering. Through December 31, 2024, we have issued and sold a total of 2,197,988 shares of our common stock for aggregate gross proceeds of approximately $119.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Offering of 4.25% Convertible Senior Notes</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January 2025, we issued $100.0 million aggregate principal amount of 4.25% convertible senior notes due 2030, or the notes, in a private offering, or the offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act, which included $15.0 million pursuant to the exercise in full of the initial purchasers option. The offering size was increased from the previously announced offering size of $75.0 million aggregate principal amount of notes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The notes are senior unsecured obligations and accrue interest payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2025, at a rate of 4.25% per year. The notes will mature on August 1, 2030, unless earlier converted, redeemed or repurchased. The initial conversion rate of the notes is 13.0826 shares of our common stock per $1,000 principal amount of such notes (equivalent to an initial conversion price of approximately $76.44 per share). The initial conversion price of the notes represents a premium of approximately 25% over the last reported sale price of our common stock on the Nasdaq Capital Market on January 23, 2025. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of its common stock, at its election.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We received approximately $91.0 million of net proceeds after deducting the initial purchasers&#8217; discount and other offering expenses payable by us. We used approximately $1.3 million for issuance expenses and approximately $7.7 million of the net proceeds to pay the cost of the capped call transactions that we entered into as described below and the remainder of the net proceeds for general corporate purposes, including the acquisition of bitcoin.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the pricing of the notes, we entered into privately negotiated capped call transactions, or the capped call transactions with certain financial institutions, or the option counterparties. The capped call transactions cover, subject to customary adjustments, the number of shares of our common stock that will initially underlie the notes. The capped call transactions are expected to offset the potential dilution to our common stock as a result of any conversion of notes, with such reduction subject to a cap. The cap price of the capped call transactions relating to the notes will initially be approximately $107.01, which represents a premium of approximately 75% over the last reported sale price of our common stock on the Nasdaq Capital Market on January 23, 2025, and is subject to certain adjustments under the terms of the capped call transactions. As the initial purchasers exercised their option to purchase additional notes, we entered into additional capped call transactions with the option counterparties on January 24, 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In connection with establishing their initial hedges of the capped call transactions, we expect the option counterparties and/or their respective affiliates may enter into various derivative transactions with respect to our </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">64</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">common stock and/or purchase our common stock in secondary market transactions concurrently with or shortly after the pricing of the notes, including with certain investors in the notes. This activity could increase (or reduce the size of any decrease in) the market price of our common stock or the notes at that time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, we expect that the option counterparties and/or their respective affiliates may modify or unwind their hedge positions by entering into or unwinding various derivative transactions and/or purchasing or selling our common stock or our other securities in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so on each exercise date of the capped call transactions, which are scheduled to occur during the observation period relating to any conversion of the notes on or after May 1, 2030 that is not in connection with a redemption, or following our election to terminate any portion of the capped call transactions in connection with any repurchase, redemption, exchange or early conversion of the notes). This activity could also cause or avoid an increase or a decrease in the market price of our common stock or the notes, which could affect a noteholder&#8217;s ability to convert its notes and, to the extent the activity occurs during any observation period related to a conversion of notes, it could affect the amount and value of the consideration that a noteholder will receive upon conversion of its notes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Neither the notes, nor any shares of our common stock issuable upon conversion of the notes, have been registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons, absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Bitcoin Acquisition Strategy </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May 2024, we adopted bitcoin as our primary treasury reserve asset on an ongoing basis, subject to market conditions and our anticipated cash needs. Our strategy includes acquiring and holding bitcoin using cash flows from operations that exceed working capital requirements, and from time to time, subject to market conditions, issuing equity or debt securities or engaging in other capital raising transactions with the objective of using the proceeds to purchase bitcoin. For example, we began issuing shares under our June 2024 &#8220;at-the-market&#8221; offering program in the second half of 2024, and in January 2025 issued convertible bonds, and used proceeds from both of these capital market transactions to acquire additional bitcoin. We view our bitcoin holdings as long term holdings and expect to continue to accumulate bitcoin. We have not set any specific target for the amount of bitcoin we seek to hold, and we will continue to monitor market conditions in determining whether to engage in additional bitcoin purchases. This overall strategy also contemplates that we may periodically sell bitcoin for general corporate purposes or in connection with strategies that generate tax benefits in accordance with applicable law, enter into additional capital raising transactions, including those that could be collateralized by our bitcoin holdings, and consider pursuing strategies to create income streams or otherwise generate funds using our bitcoin holdings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">65</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;">The following table presents a roll-forward of our bitcoin holdings, including additional information related to our bitcoin purchases and change in fair value within the period (in thousands, other than bitcoin and price per bitcoin and unless otherwise noted).</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Source of    </b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">         </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Approximate  </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Used to</b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Purchase </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Purchase</b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Digital Assets </b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Change in               </b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Digital Assets </b></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Approximate  </b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price Per</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Bitcoin</b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">at Cost</b></p></td><td style="vertical-align:bottom;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">at Fair Value</b></p></td><td colspan="2" style="vertical-align:bottom;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Bitcoin Held</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Bitcoin (in $)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Digital assets purchased</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Digital assets purchased</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 877</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 68,436</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of the digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (5,055)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (5,055)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of June 30, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (5,055)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 54,945</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 877</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 68,436</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Digital assets purchased</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(b)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 141</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 59,372</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of the digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,137</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,137</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of September 30, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 68,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (3,918)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 64,482</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,018</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 59,372</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Digital assets purchased</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(b)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 121,300</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 121,300</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,280</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 94,755</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of the digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 28,851</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 28,851</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 189,700</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 24,933</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 214,633</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,298</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.09%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 82,538</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash from operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash from operations and proceeds from ATM offering.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Sources of Revenues and Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We generate revenues primarily from the rental or license of our vascular testing product. We recognize revenues from the licensing of our vascular testing product pursuant to agreements that normally automatically renew each month with revenues recognized on a daily convention basis. Our arrangements with customers for our vascular testing product are normally on a month-to-month basis with fees billed at the rates established in our customer agreements, which are either fixed fees, or variable fees based on usage. We also recognize revenue for hardware and supplies sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cost of revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our cost of revenues for our vascular testing product consists primarily of five components: the depreciation expense of our vascular testing product for lease; the write-off of the residual value of our vascular testing products retired from active leasing; manufacturing oversight personnel costs; the cost of hardware and supplies sold; and other miscellaneous items, such as freight, that are not directly related to product production. Each vascular testing product unit has a depreciation schedule based on the cost of the unit. The cost of each unit is depreciated on a straight-line basis over 36 months. Each unit has its own cost of production, which varies from time to time. We believe that the cost of each unit is a function of manufacturing efficiencies, supply costs and fixed overhead expense as affected by volume of units produced, which change from time to time. When cost of production is lower, the new units have a lower monthly depreciation and decrease the average depreciation per unit per month, which means our cost of revenues is lower. Similarly, if cost of production is higher, the new units will have a higher monthly depreciation and increase the average depreciation per unit per month, which means our cost of revenues is higher. We believe growth in the number of monthly depreciation charges is predominately due to our sales and marketing efforts, which add new customers to an established customer base. The retirement of units from active leasing is primarily a function of the aggregate number of vascular testing units rented and the occurrence from time to time of system upgrades. The cost of hardware or supplies sold are the cost of production for the item sold. The other costs of revenue vary primarily as a function of the aggregate number of vascular testing units rented and changes in operations such as manufacturing, delivery or maintenance.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">66</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Engineering and product development expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our engineering and product development expense consists of costs associated with the design, development, testing and enhancement of QuantaFlo and other products in development. We also include salaries and related employee benefits, research-related overhead expenses and fees paid to external service providers in our engineering and product development expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Sales and marketing expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our sales and marketing expense consists primarily of sales commissions and support costs, salaries and related employee benefits, travel, education, trade show and marketing costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">General and administrative expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Our general and administrative expense consists primarily of salaries and related employee benefits, professional service fees, associated travel costs and depreciation and amortization expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Total other income and expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our total other income and expense primarily reflects other taxes and fees, interest and dividend income, as well as changes in value and impairments of our investments and digital assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Critical Accounting Policies and Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our accounting policies are more fully described in Note 2 of the financial statements. As disclosed in Note 2, the preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ significantly from those estimates. We do not believe that we have any critical accounting policies and estimates.<span style="background:#ffffff;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Factors Affecting Future Results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have not identified any other factors that have a recurring effect that are necessary to understand period to period comparisons as appropriate, nor any one-time events that have an effect on the financials. However, we are experiencing and expect to continue to experience decreased usage due to the current CMS reimbursement landscape, which is having a negative effect on our revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Results of Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Year Ended December 31, 2024 Compared to Year Ended December 31, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We had revenues of $56.3 million for the year ended December 31, 2024, compared to $68.2 million in 2023. Our revenues are primarily from fees charged to customers for use of our products and from sale of accessories used with these products. We recognized revenues of $53.4 million from fees for our products in 2024, consisting of $27.5 million from fixed-fee licenses and $25.9 million from variable-fee licenses, compared to $66.3 million in 2023, consisting of $37.3 million from fixed-fee licenses and $29.0 million from variable-fee licenses. The remainder was from other equipment/supply sales of accessories, which were $2.9 million in 2024 as compared to $1.9 million in 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Revenues from fees for products are recognized monthly, usually billed as a fixed monthly fee or as a variable monthly fee dependent on usage. The primary reason for the decrease in revenues was a decrease in testing volume and the introduction of volume pricing tiers for some of our largest customers, as well as the CMS rate announcement. We </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">67</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">expect to continue to experience decreased testing volume due to the CMS rate announcement, which we expect will have a negative effect on our revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Operating Expenses</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We had total operating expenses of $35.4 million for the year ended December 31, 2024, compared to $45.9 million in 2023. The primary reason for this change was a focus on cost control and strategic streamlining implemented in the third quarter of 2023. As a percentage of revenues, operating expenses, including cost of revenues, decreased to 63% in 2024, as compared to 67% in 2023. The changes in the various components of our operating expenses are described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Cost of Revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We had cost of revenues of $4.8 million for the year ended December 31, 2024, compared to $7.0 million for 2023. The primary reasons for this change were the lower personnel costs and lower scrap write-off expenses, partially offset by higher material cost. In 2023, there was a one-time write-off of $2.5 million related to the prepayment for Insulin Insights licenses. As a percentage of revenues, cost of revenues was at 8% in 2024, compared to 10% in 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Engineering and Product Development Expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We had engineering and product development expense of $4.8 million for the year ended December 31, 2024, compared to $5.8 million in 2023. The decrease was primarily due to lower personnel costs, consulting fees and other costs associated with our product development and customization efforts, which were partially offset by higher clinical studies expenses. As a percentage of revenues, engineering and product development expense was unchanged at 9% in both 2024 and in 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Sales and Marketing Expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We had sales and marketing expense of $13.1 million for the year ended December 31, 2024, compared to $18.1 million in 2023. The decrease was primarily due to lower personnel costs, consulting, trade show, travel and other expenses. As a percentage of revenues, sales and marketing expense decreased to 23% in 2024 compared to 27% in 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">General and Administrative Expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">We had general and administrative expense of $12.7 million for the year ended December 31, 2024, compared to $14.3 million in 2023. The decrease was primarily due to lower personnel costs, legal and professional and bad debt expenses, partially offset by higher insurance and dues and subscriptions expenses. As a percentage of revenues, general and administrative expense increased to 22% in 2024, compared to 21% in 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Strategic Operational Streamlining</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2023, we&#160;incurred severance cost of $0.7 million consisting of one-time termination benefits, which we have reported on the statement of income under &#8220;strategic streamlining&#8221;. We did not incur any strategic streamlining expenses during the year ended December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Other Income and Expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We had other income of $27.0 million for 2024, compared to $1.8 million in 2023. The change was<span style="background:#ffffff;"> primarily due to unrealized gains of $24.9 million from the change in fair value of our digital assets.</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">68</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Provision for Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2024, we recorded income tax expense of $7.0 million, compared to $3.5 million in 2023. In 2024, income tax expenses were partially offset by tax benefits related to employee stock option exercises. I<span style="color:#212529;background:#ffffff;">n 2023 lower income tax expense was due to tax benefits from employee stock option exercises and the $2.5 million write-off of the Insulin Insights prepaid licenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Net Income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the foregoing reasons, we had a net income of $40.9 million for the year ended December 31, 2024, compared to a net income of $20.6 million for the year ended December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity and Capital Resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We had cash, cash equivalents, restricted cash and short-term investments of $9.0 million at December 31, 2024, compared to $57.3 million at December 31, 2023, and total current liabilities of $6.3 million at December 31, 2024, compared to $6.2 million at December 31, 2023. As of December 31, 2024, we held 2,298 bitcoins with an aggregate fair value of $214.6 million at such date. Our bitcoin investment is remeasured at fair value at each reporting date with changes recognized in net income through &#8220;other income, net&#8221; in our statement of income. We recognized an unrealized gain of $24.9 million from the remeasurement of fair value of our digital assets for the year ended December 31, 2024. We did not have any digital assets as of December 31, 2023. As of December 31, 2024, we had working capital of approximately $16.4 million. We believe that our current sources of funds will provide us with adequate liquidity during the 12-month period following December 31, 2024, as well as in the long-term.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June 2024 we entered into a Controlled Equity Offering&#8480; Sales Agreement with Cantor Fitzgerald &amp; Co., pursuant to which we may offer and sell from time to time our common stock in an ATM offering. Through December 31, 2024, we have issued and sold a total of 2,197,988 shares of our common stock for aggregate gross proceeds of approximately $119.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Our cash is held in a variety of non-interest bearing bank accounts and interest bearing money market accounts. At December 31, 2024, we held approximately $3.6 million in government money market fund accounts and the remaining cash was held in non-interest bearing bank accounts.&#160;Our investment guidelines allow for holdings in bitcoins, U.S. government and agency securities, corporate securities, taxable municipal bonds, commercial paper, money market accounts and treasury bills. In addition, we have, and may in the future, choose to invest some of our cash resources in other entities that may have complementary technologies or product offerings</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Operating Activities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="background:#ffffff;">We generated $24.4 million of net cash from operating activities for the year ended December 31, 2024, compared to $21.3 million of net cash from operating activities for the same period of the prior year. Non-cash adjustments to reconcile net income to net cash from operating activities used net cash of $17.7 million and were primarily due to, an unrealized gain in fair value of bitcoin of $24.9 million, change in the fair value of notes held for investments of $0.1 million, allowance for credit losses of $0.1 million, partially offset by deferred tax income of $5.8 million, stock-based compensation expense of $0.9 million, depreciation of $0.6 million, and loss on disposal of assets for lease of $0.3 million.&#160;</span><span style="color:#231f20;background:#ffffff;">Changes in operating assets and liabilities provided $1.2 million of net cash. These changes in operating assets and liabilities included a decrease in accounts receivable of $1.8 million, an increase of accrued expenses of $0.7 million, a decrease in other noncurrent assets of $0.1 million and decrease in inventory of $0.1 million, partially offset by an increase in prepaid expenses and other current assets of $0.9 million, decrease in other current liabilities of $0.3 million and decrease in trade payable of $0.3 million.</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">69</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Investing Activities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We used $190.0 million of net cash for investing activities for the year ended December 31, 2024, compared to generating $18.4 million of net cash from investing activities for the year ended December 31, 2023. The increase in net cash used was primarily due to purchases of bitcoin of $189.7 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Financing Activities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We generated $117.2 million of net cash in financing activities during the year ended December 31, 2024, compared to net cash used of $5.4 million during the year ended December 31, 2023, primarily due to proceeds from the issuance of common stock of $119.6 million under our ATM offering program and proceeds from the exercise of stock options of $1.5 million, partially offset by<span style="background:#ffffff;"> </span>taxes paid related to equity awards of $0.9 million, and the payment of stock issuance expenses of $3.0 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Description of Indebtedness</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="white-space:pre-wrap;">As discussed above in &#8220;&#8212;Recent Developments&#8212;Offering of 4.25% Convertible Senior Notes,&#8221; in January 2025, we issued $100.0 million aggregate principal amount of 4.25% convertible senior notes due 2030.  For a description of the material terms of the notes and related capped call transactions, see above and Note 20 &#8220;Subsequent Events&#8221; to our audited financial statements appearing elsewhere in this annual report on Form 10-K</span><span style="font-size:12pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_dceab711_e596_4d33_8258_75412a959673"></a><a id="ITEM7AQUANTITATIVEANDQUALITATIVEDISCLOSU"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 7A.&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Bitcoin Market Price Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our bitcoin investment is measured using observed prices from active exchanges and adjustments are recorded in net income through &#8220;other income, net&#8221; on our statements of income. The bitcoin market price may fluctuate significantly and a decline in the market price of bitcoin could result in a material adverse effect on our financial results in future periods. See Part I, Item 1A, &#8220;Risk Factors Related to Our Bitcoin Treasury Strategy and Holdings.&#8221; for information regarding the risks related to our bitcoin holdings. As of December 31, 2024, the fair value of our bitcoin investment included in Intangible digital assets was $214.6 million, and for the twelve months ended December 31, 2024, we recognized a $24.9 million unrealized gain from the remeasurement of our bitcoin investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_43ca42ab_5f04_4f9d_8f4f_806cc3c15734"></a><a id="ITEM8FINANCIALSTATEMENTSANDSUPPLEMENTARY"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 8.&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The financial statements and supplementary data required by this item are included in Part IV, Item 15 of this annual report on Form 10-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_347552ea_71a6_4f7e_b40a_a295c6350cd8"></a><a id="ITEM9CHANGESINANDDISAGREEMENTSWITHACCOUN"></a><p style="font-family:'Times New Roman','Times','serif';font-size:5pt;font-weight:bold;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">ITEM 9.&#160;&#160;</b>&#160;<b style="font-size:10pt;font-weight:bold;">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND</b><b style="font-size:10pt;font-weight:bold;"> FINANCIAL DISCLOSURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">70</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_01be876b_37b1_4f46_8a52_9f6c3ec17e7b"></a><a id="ITEM9ACONTROLSANDPROCEDURES_698121"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 9A.&#160;&#160;&#160;CONTROLS AND PROCEDURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Evaluation of Disclosure Controls and Procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We maintain disclosure controls and procedures that are designed to ensure material information required to be disclosed in our reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required financial disclosure. In designing and evaluating the disclosure controls and procedures, we recognized that a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the supervision of and with the participation of our management, including our chief executive officer and chief financial officer, we evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2024. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Management&#8217;s Report on Internal Control over Financial Reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). We maintain internal control over financial reporting designed to provide reasonable, but not absolute, assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Therefore, internal control over financial reporting determined to be effective provides only reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the supervision and with the participation of our chief executive officer and chief financial officer, our management evaluated the effectiveness of our internal control over financial reporting as of December 31, 2024. In making its assessment of internal control over financial reporting, our management used the criteria described in the 2013 Internal Control &#8212; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Our evaluation included documenting, evaluating and testing the design and operating effectiveness of our internal control over financial reporting. Based on this evaluation, we concluded that we maintain effective internal control over financial reporting as of December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;background:#ffffff;">Changes in Internal Control over Financial Reporting</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;"> There were no changes in our internal control over financial reporting during the quarter ended December 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_0dcbd9a3_a50c_41bc_94b7_d084bd386ab9"></a><a id="ITEM9BOTHERINFORMATION_170525"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 9B.&#160;&#160;&#160;OTHER INFORMATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg" format="ixt:fixed-false" name="ecd:Rule10b51ArrAdoptedFlag" id="Narr_2HDJGQvJ6UKT3Sund3oEdw">N</ix:nonNumeric><ix:nonNumeric contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg" format="ixt:fixed-false" name="ecd:NonRule10b51ArrAdoptedFlag" id="Narr_N_t-6AQJ60uY4C_uT3wElw">o</ix:nonNumeric><ix:nonNumeric contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg" format="ixt:fixed-false" name="ecd:Rule10b51ArrTrmntdFlag" id="Narr_uvvSXd7DFU252zWEvm_GKA">n</ix:nonNumeric><ix:nonNumeric contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg" format="ixt:fixed-false" name="ecd:NonRule10b51ArrTrmntdFlag" id="Narr_y_smtFZDKk-KsmmLSfUVEg">e</ix:nonNumeric>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_96fcb3af_b019_474c_8788_2e52fee5d385"></a><a id="ITEM_9C"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">ITEM 9C.</b></span><b style="font-weight:bold;">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">71</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 9.1pt 0pt;">None.</p><a id="_d9922bf4_7b24_4670_9eef_aeee8ea1dbeb"></a><a id="PARTIII_829453"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART III</p><a id="ITEM10DIRECTORSEXECUTIVEOFFICERSANDCORPO"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 10.&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Board of Directors and Executive Officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following are our directors and executive officers and their respective ages and positions as of the date of this annual report on Form 10-K:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Director&#160;Since</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;Expires</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:18.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer and Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">September 2012</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:47.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:18.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">N/A</p></td></tr><tr><td style="vertical-align:bottom;width:47.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Daniel S. Messina</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">August 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:47.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Semler</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">April 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td></tr><tr><td style="vertical-align:bottom;width:47.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">William H.C. Chang</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">68</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">April 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Board of Directors</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Douglas Murphy-Chutorian, M.D.</span> &#8212; Dr. Murphy-Chutorian has served as a member of our board of directors since September 2012 and as our chief executive officer from October 31, 2012 to April 3, 2023 and since April 27, 2023. Dr. Murphy-Chutorian has had broad, diverse career experience in healthcare over the past 30 years, stretching from clinician, academician, inventor, entrepreneur, chief executive officer, chairman of the board, and consultant to financial firms. From 2005 to 2012, he was managing director of Select Healthcare Capital, LLC. Dr. Murphy-Chutorian is a named inventor on more than 30 patents, and has guided more than 50 products through various regulatory approval processes. His business career has included extensive involvement in all facets of the medical industry from financial, research and development, manufacturing, marketing and sales, regulatory, reimbursement, and clinical trials. His breadth of healthcare experience includes all major sectors of the industry: medical devices, health services, pharmaceuticals, biotechnology and managed care. He received his B.A. and M.D. from Columbia University. He completed his internal medicine residency at New York University/Bellevue Medical Center and his fellowship in cardiology at Stanford University Medical Center. He has served as a faculty member in interventional cardiology at both Stanford and Montefiore Medical Center. We believe Dr. Murphy-Chutorian&#8217;s experience as a cardiologist, inventor and executive, in particular serving as our chief executive officer, qualify him to be a director of our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Daniel S. Messina</span> &#8212; <span style="letter-spacing:0.2pt;">Mr. Messina has served as a member of our board of directors since August&#160;2020. Mr.&#160;Messina has nearly 40&#160;years of broad business experience as both a healthcare system professional and a technology solutions entrepreneur. Mr.&#160;Messina is the co-founder of HandsFree Health, the creator of WellBe&#174;, the premier voice enabled virtual health assistant platform designed to help individuals access their health and wellness resources from home. Prior to co-founding HandsFree Health in 2016, he was a partner of West Corporation&#8217;s health advocate division for ten&#160;years, and he concluded his time there as co-president. From 2002 to 2006, Mr.&#160;Messina was the president of Rendina Healthcare Real Estate. Before that, from 2000 to 2002, Mr.&#160;Messina served as chief executive officer and president of Magellan Health and from 1998 to 2000 as the chief financial officer and head of business strategy of Aetna Health. For the decade prior to that, he was vice president of financial reporting at Cigna Corporation. Mr.&#160;Messina began his career as a certified public accountant at Deloitte. Mr.&#160;Messina earned a Bachelor of Science in accounting from the University of Notre Dame. We believe Mr.&#160;Messina&#8217;s extensive experience in virtual health and healthcare systems qualifies him to be a director of our company.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Eric Semler</span> &#8212; <span style="background:#ffffff;">Mr. Semler has served as a member and chairperson of our board of directors since April 2023. Mr. Semler is a public and private market investor in technology and media. His long/short investment fund, TCS Capital Management, which he founded in 2001 and converted into a family office in 2017, was at its peak among the largest </span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">72</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="background:#ffffff;">independent technology, media and telecom investment funds worldwide. Mr. Semler has helped unlock value for several public companies as an active shareholder and/or board member. He currently serves on the board of Fundstrat Global Advisors - an independent financial services firm. Mr. Semler has previously served on three public company boards: Angie&#8217;s List, the Maven (now known as Arena Group Holdings, Inc.) and Geeknet.com. Mr. Semler began his career as a journalist working for the New York Times and for the Moscow News in Russia. He is the co-author of two books published by Harper Collins: The Language of Nuclear War and The Businessman&#8217;s Guide to Moscow. In 2019, Mr. Semler and his wife Tracy founded and developed the Raising Fame podcast franchise, partnering with NBA parents Dell and Sonya Curry to tell stories about raising extraordinary athletes. In 2024, they launched Raising Fame TV, hosted by Sonya Curry and Lucille O&#8217;Neal, the mother&#160;of Shaquille O&#8217;Neal; the show began&#160;airing on TV One in July 2024, and includes episodes&#160;on raising world renowned&#160;athletes and entertainers. </span><span style="background:#ffffff;">Mr. Semler received a B.A. from Dartmouth College and a J.D. and M.B.A. from Harvard University. We believe Mr. Semler&#8217;s deep expertise in capital allocation, corporate governance, strategic planning, and investment management qualify him to be a director of our company.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"> <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">William H.C. Chang</span><span style="letter-spacing:0.2pt;">&#8201;&#8212;&#8201;Mr.&#160;Chang has served as a member of our board since April&#160;2023 and previously served on our board from September&#160;2012 to June&#160;2014. Mr.&#160;Chang serves as chairman of Westlake Realty Group and Westlake International Group where he has worked for more than 40&#160;years. Mr.&#160;Chang is a partner in Digikey Investment Holdings. Mr.&#160;Chang is also a principal partner in the San Francisco Giants of Major League Baseball. Mr.&#160;Chang was former chairman of U.S. Rugby Football Union. Mr.&#160;Chang is currently on the board of Ensysce Biosciences, Inc. (since 2008) and previously served on the boards of the Asia Foundation and of the San Francisco Port and Social Services Commissions. Mr.&#160;Chang holds a bachelor&#8217;s degree in economics from Harvard University. We believe Mr.&#160;Chang&#8217;s involvement in numerous early stage medical and technology companies, with a particular focus on clean/green, M2M, mobile, and cloud-based applications, both as an investor and director qualify him to be a director of our company.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There are no family relationships among any of our directors or executive officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Executive Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Renae Cormier </span><span style="letter-spacing:0.2pt;">&#8212;</span><span style="font-style:italic;font-weight:bold;"> </span>Ms. Renae Cormier joined our company in May 2022 as head of corporate communications and business strategy. In July 2023, she was promoted to chief financial officer. As chief financial officer, she leads our accounting, finance, investor relations, bitcoin and business strategy efforts, and she plays a pivotal role in shaping the overall direction of our company. Ms. Cormier has extensive experience with investing, finance, and accounting. Prior to joining our company, she held numerous positions with investment management firms. Most recently she was a partner at Aravt Global from 2013 to 2022 where she was responsible for allocating investment capital in public and private companies across a variety of industries, as well as leading accounting-focused risk management across the portfolio&#8217;s holdings. From 1997 to 2001, Ms. Cormier was an auditor and provided mergers and acquisitions transaction advisory services at PricewaterhouseCoopers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Director Independence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">As required under the Nasdaq listing standards, a majority of the members of our board of directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the board of directors. Our board of directors consults with our outside counsel to ensure that its determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members and our company, our senior management and our independent auditors, our board of directors has affirmatively determined that the following three directors are independent directors within the meaning of the applicable Nasdaq listing standards: Messrs. Messina, Semler, and Chang. In making this determination, the board of directors found that none of these directors had a material or other disqualifying relationship with our company.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">73</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In making such determinations, our board of directors considered the relationships that each such director has with our company, including the relationships and transactions described in the section of this annual report on Form 10-K captioned &#8220;Certain Relationships And Related Transactions, And Director Independence,&#8221; and all other facts and circumstances that our board of directors deemed relevant in determining his independence, including the beneficial ownership of our capital stock by each director.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Changes to Procedures for Recommending Nominees to Board of Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Audit Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors has established a separately designated standing audit committee, which is currently comprised of Mr. Messina, who serves as both member and Chairman, Mr. Chang and Mr. Semler. Our board of directors has determined that Mr. Messina qualifies as an &#8220;audit committee financial expert&#8221; within the meaning of the SEC&#8217;s rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Delinquent Section 16(a) Reports</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the year ended December 31, 2024, all Section 16(a) filing requirements applicable to our officers, directors and greater than 10% beneficial owners were in compliance, other than two gift transactions that were inadvertently omitted from Form 4s filed by Mr. Chang on May 14, 2024, and November 12, 2024, respectively, which were subsequently reported in Form 4/As filed on January 7, 2025, reflecting the transfer of shares held by Mr. Chang to his family trust.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Code of Ethics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We have adopted a code of ethics that applies to our principal executive officer (our chief executive officer), our principal financial officer (our chief financial officer) and other officers performing similar functions, which we refer to as the Code of Business Conduct and Ethics. The Code of Business Conduct and Ethics is available on our website at http://www.semlercientific.com under the Corporate Governance section of the Investors portion of our website. Our Code of Business Conduct and Ethics is designed to meet the requirements of Item 406 of Regulation S-K. We will promptly disclose on our website (i) the nature of any amendment to the Code of Business Conduct and Ethics that applies to any covered person, and (ii) the nature of any waiver, including an implicit waiver, from a provision of the Code of Business Conduct and Ethics that is granted to one of the covered persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Insider Trading Policies and Procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We have <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="Narr_8h6TPbS66kqXEAwXGq_tgw">adopted</ix:nonNumeric> an insider trading policy that applies to any and all transactions by our directors, officers, employees, certain designated consultants and their affiliates (as defined in such policy) in our securities. A copy of the insider trading policy is filed as exhibit 19.1 to this annual report on Form 10-K. In addition, with regard to our trading in our securities, it is our policy to comply with the federal securities laws and the applicable exchange listing requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">74</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:11.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_5398c4f6_f433_4850_b779_01ad1929a15f"></a><a id="ITEM11EXECUTIVECOMPENSATION_727083"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">ITEM 11.</b></span>EXECUTIVE COMPENSATION </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Summary Compensation Table</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth the information as to compensation paid to or earned by (i) the individuals who served as our principal executive officer during any part of the year ended December 31, 2024, (ii) our most highly compensated executive officer other than our principal executive officer who was serving in such capacity as of December 31, 2024. There were no other individuals who would have been one of our most highly compensated executive officers as of December 31, 2024. These individuals are referred to in this annual report on Form 10-K as our named executive officers. As none of our named executive officers received any nonqualified deferred compensation, we have omitted that column from the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:28.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:28.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Non-Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Incentive Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">All Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fiscal </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Salary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Bonus </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Award(s)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name and Principal Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> ($)</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> ($)</b></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Douglas Murphy-Chutorian, M.D.,<sub style="font-size:6.75pt;vertical-align:sub;"> </sub><sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 450,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 224,550</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 400,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 35,111</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,109,661</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0pt 12pt;">Director and chief executive officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 488,508</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 400,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 40,389</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 928,897</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Renae Cormier <sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(7)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 374,375</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 90,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 224,550</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> -</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 42,024</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 730,949</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0pt 12pt;">Chief financial officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 273,724</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 72,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 95,200</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> 55,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 28,987</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 524,911</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(1)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">For each of Dr. Murphy-Chutorian and Renae Cormier&#8217;s salary 2023 includes a lump sum payment of accrued and unused vacation time due to a change of vacation policy applicable to director and higher $38,508 for Dr. Murphy-Chutorian and $3,724 for Ms. Cormier.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(2)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Represents the grant date fair value of the options awarded during the year as determined under FASB, Accounting Standards Codification Topic 718, Compensation&#8212;Stock Compensation, or ASC 718. See Note 16 to our audited financial statements included elsewhere in this annual report on Form 10-K for additional information.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(3)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Represents the grant date fair value of the stock awarded during the year as determined under FASB ASC 718. See Note 16 to our audited financial statements included elsewhere in this annual report on Form 10-K for additional information.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">The amounts represent performance-based cash incentives earned by Dr. Murphy-Chutorian based on the achievement of certain pre-defined company goals and his target incentive compensation amount. Incentive compensation awards are paid quarterly, based on the achievement of the objectives for that quarter set by the compensation committee of our board of directors at the beginning of the fiscal year.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(5)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Represents payment of health insurance premiums pursuant to the terms of employment. For Dr. Murphy-Chutorian, 2023 includes $20,213 as reimbursement of legal expenses incurred in connection with negotiating and execution of the interim employment agreement and the separation and release agreement.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(6)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Dr. Murphy-Chutorian, resigned as chief executive officer effective April 3, 2023, and then was reappointed to such position effective April 27, 2023. All amounts are prorated to reflect this period of non-employment.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(7)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Ms. Cormier was promoted to chief financial officer effective July 7, 2023 and 2023 compensation amounts are pro rata to reflect a salary increase in connection therewith.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Named Executive Officer Compensation Arrangements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We enter into individually negotiated compensation arrangements with each of our named executive officers. Our named executive officers may receive salary, bonus and other benefits, such as the payment of health insurance premiums or other individually negotiated health benefits pursuant to the terms of their negotiated compensation package. We may also grant our named executive officers awards under our equity incentive plans. Beginning February 1, 2023, due to a change in policy, we no longer accrue vacation for executive officers and in 2023, paid each employee ranked director or higher, which included all of our executive officers, their accrued but unused vacation pay as of January 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Douglas Murphy-Chutorian, M.D.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">In connection with Dr. Murphy-Chutorian&#8217;s reappointment as chief executive officer, on May 25, 2023, we entered into a new employment agreement with Dr. Murphy-Chutorian, providing for compensation and benefits consistent with his then role as chief executive officer. Under such agreement, Dr. Murphy-Chutorian provides services on an-at-will basis and is eligible to receive annual base salary of $450,000 and quarterly target bonus of $100,000 per quarter based on achieving certain pre-defined performance objectives established by our board of directors prior to the performance period. Under the terms of this new employment agreement, Dr. Murphy-Chutorian can be terminated at any time and his job titles, salaries and benefits modified from time to time as we deemed necessary.  Dr. Murphy-Chutorian remains </span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">75</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">eligible to continue to receive equity grants under our equity compensation plans and benefits on the same terms as other employees (including payment of life insurance policy, medical license fees and telecommunications charges)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Upon the recommendation of its compensation committee, our board of directors granted Dr. Murphy-Chutorian an option to acquire 15,000 shares of our common stock effective May 10, 2024. The option was granted under our 2014 Stock Incentive Plan, or the 2014 Plan, has an exercise price of $22.92 per share (the closing price on the grant date), a 10-year term, and is governed by our standard form of stock option agreement under the 2014 Plan.</span> Accordingly, u<span style="background:#ffffff;">pon the recommendation of its compensation committee, our board of directors granted Dr. Murphy-Chutorian an option to acquire 50,000 shares of our common stock effective January 6, 2025. The option was granted under our 2024 Stock Option and Incentive Plan, or the 2024 Plan, has an exercise price of $58.94 per share (the closing price on the grant date), a 10-year term, and is governed by our standard form of stock option agreement under the 2024 Plan except that vested options are not subject to the post-termination exercise provisions of the 2024 Plan and may be exercised at any time prior to expiration without the requirement for continuous service. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Dr. Murphy-Chutorian&#8217;s new employment agreement suspended severance payments under his April 2023 severance agreement unless and until his employment terminates and he signs a supplemental release, for which he will be paid $100 and it will provide for the following: (i) $450,000 in severance payments payable monthly for 12-months commencing 30 days after his last day of employment; (ii) up to nine months of COBRA reimbursement; (iii) the extension of his post-termination exercise period to the original expiration date for his outstanding options, all of which options outstanding at the time of entry into the agreement were fully vested except the option to purchase 15,000 shares of our common stock granted in May 2024. We also agreed to pay any agreed severance including his post termination exercise period to the original expiration date for his outstanding vesting options to Dr. Murphy-Chutorian&#8217;s spouse in the event termination of employment is due to his death.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Renae Cormier</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">On July 7, 2023, our board of directors promoted Renae Cormier to chief financial officer effective July 10, 2023 from her previous position as head of corporate communications and business strategy. In 2024, Ms. Cormier&#8217;s base salary was $375,000 with target incentive of $90,000. In addition, upon the recommendation of its compensation committee, our board of directors granted Ms. Cormier an option to acquire 15,000 shares of our common stock effective May 10, 2024. The option was granted under the 2014 Plan, has an exercise price of $22.92 per share (the closing price on the grant date), a 10-year term, and is governed by our standard form of stock option agreement under the 2014 Plan. Ms. Cormier&#8217;s employment and compensation continue to be governed by the terms of her May 2022 employment agreement. Under the terms of the agreement, Ms. Cormier can be terminated at any time and her job titles, salaries and benefits may be modified from time to time as we deem necessary. </span>Ms. Cormier remains eligible to continue to receive equity grants under our equity compensation plans and benefits on the same terms as other employees (including payment of life insurance policy and telecommunications charges). Accordingly, u<span style="background:#ffffff;">pon the recommendation of its compensation committee, our board of directors granted Ms. Cormier an option to acquire 40,000 shares of our common stock effective January 6, 2025. The option was granted under the 2024 Plan, has an exercise price of $58.94 per share (the closing price on the grant date), a 10-year term, and is governed by our standard form of stock option agreement under the 2024 Plan.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">76</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:11.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Outstanding Equity Awards at Fiscal Year-End</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table provides information about the number of outstanding equity awards held by our named executive officers at December 31, 2024. We have omitted certain columns from the table as our named executive officers do not have any outstanding stock awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:54.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unexercised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unexercised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options (#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options (#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unexercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> ($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2.56</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12/31/2025</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 125,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2.23</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">02/17/2026</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 125,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1.72</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">01/19/2027</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 125,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12/31/2027</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 15,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22.92</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">05/10/2034</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,226</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,774</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30.48</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">05/16/2032</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,770</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,230</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25.47</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">07/09/2033</p></td></tr><tr><td style="vertical-align:bottom;width:54.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 15,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22.92</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">05/10/2034</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">All the above options are fully vested.  </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><span style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Director Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table shows the compensation earned in the year ended December 31, 2024 by our non-employee directors. Our non-employee directors received only cash and equity compensation in 2023 and 2024, so we have omitted certain columns from the table. The compensation information for Dr. Murphy-Chutorian, our chief executive officer and a director, is set forth in &#8220;Summary Compensation Table.&#8221; Dr. Murphy-Chutorian does not receive additional compensation for his services as an employee director.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fees Earned or</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Paid in Cash</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total ($)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Daniel S. Messina<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 70,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 170,500</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Semler <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 108,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 279,450</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 488,200</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">William H.C. Chang <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 74,250</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 279,450</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 453,700</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(1)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Consists of the annual retainer fee for service as a non-employee member of the board of directors or any board committee. For further information concerning such fees, see the section below entitled &#8220;Non-Employee Director Compensation Policy.&#8221; </span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(2) </span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Mr. Semler and Mr. Chang each received an option to acquire 27,000 shares of our common stock on May 23, 2024 for serving as a member of our bitcoin committee. </span><span style="font-size:8pt;background:#ffffff;">The options were granted under the 2014 Plan and have an exercise price of $23.32 per share (the closing price on the grant date) with a 2-year term, and is governed by our standard form of stock option agreement under the 2014 Plan.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(3)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Represents the grant date fair value of the stock awarded during the year as determined under FASB ASC 718. See Note 16 to our audited financial statements included elsewhere in this annual report on Form 10-K for additional information.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Non-Employee Director Compensation Policy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our non-employee director compensation program for 2024 was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All non-employee directors are entitled to receive an annual $45,000 retainer for service as a board member ($82,500 for non-employee chairman of the board) and an annual retainer for each committee on which they serve as a member:</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">77</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$22,500 per year for service as chairman of the audit committee or $11,250 per year for service as a member of the audit committee;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$15,000 per year for service as chairman of the compensation committee or $7,500 per year for service as a member of the compensation committee;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$7,500 per year for service as chairman of the nominating committee or $3,000 per year for service as a member of the nominating committee;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash payments to non-employee directors are to be paid quarterly and will be pro-rated for directors who join the board or a board committee mid-year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May 2024, we provided equity compensation to each of our non-employee directors for service on our board consisting of 2,182 shares of our common stock, which awards were granted under the 2014 Plan. The number of shares of common stock awarded was determined based on $50,000 divided by the closing price on the grant date and such stock awards were fully vested on the grant date. In November 2024, we provided equity compensation to each of our non-employee directors for service on our board consisting of 1,318 shares of our common stock, which awards were granted under the 2024 Plan. The number of shares of common stock awarded was determined based on $50,000 divided by the closing price on the grant date and such stock awards were fully vested on the grant date. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We also granted Mr. Semler and Mr. Chang each an option to acquire 27,000 shares of our common stock effective May 23, 2024 for serving as a member of our bitcoin committee. <span style="background:#ffffff;">The options were granted under the 2014 Plan has an exercise price of $23.32 per share (the closing price on the grant date), a 2-year term, and is governed by our standard form of stock option agreement under the 2014 Plan.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January 2025, we updated our non-employee director compensation program to eliminate cash compensation for service on our board of directors in 2025 and granted each non-employee director equity compensation for 2025 service on our board of directors as follows: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Equity: Grants of stock options under the 2024 Plan, which options will generally vest monthly over 12 months, have a 10-year term from the grant date and be exercisable for the full 10 years (e.g., no 90-day post-termination exercise period) for any vested options following separation from service; in each case other than as indicated below, with option grants pro rated for directors that join the board (or any of its committees) mid-year:</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Annual grants: 5,000 options for service as a board member (or 6,000 for chairman of the board), which annual grants are in addition to any stock option grants for each committee on which they serve as a member:</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;background:#ffffff;">Audit committee:  750 options for service as member (or 1,500 for chairman)&#894;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Compensation committee: 500 options for service as member (or 1,000 for service as chairman)&#894;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Nominating and corporate governance committee: 375 options for service as member (or 750 for service as chairman);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Bitcoin strategy 1,000 for member (or 150,000 for service as chairman); which options will vest monthly over 24 months, and expire on last business day of the month that is 24 months after grant date.</span></td></tr></table><div style="margin-top:12pt;"></div></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">78</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Compensation-Related Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our board of directors is responsible for the oversight of our risk profile, including compensation-related risks. Our compensation committee monitors our compensation policies and practices as applied to our employees to ensure that these policies and practices do not encourage excessive and unnecessary risk-taking. Our management, together with the compensation committee, reviews of our compensation programs, including our executive compensation program, to determine if such programs create risks that are likely to have a material adverse effect on our company. Based on this review, our board of directors believes that the level of risk associated with our compensation programs is not reasonably likely to have a material adverse effect on our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="ecd:AwardTmgMnpiDiscTextBlock" id="Tb_l8c7ejviJEGb9XMthF-aCg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Equity Grant Policies and Procedures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From time to time, we award stock options to our employees, including our named executive officers, and have in the past also granted stock awards to consultants and our non-employee directors. We routinely re-evaluate the use of our equity incentive plans, including the administrative costs of such programs, when deciding the amount and types of equity awards to grant employees, consultants and our non-employee directors. Our current practice is to award certain key employees option grants on an annual basis, which are typically approved at a meeting of our compensation committee around the beginning of our fiscal year in connection with general compensation review. Non-employee directors receive annual grants as part of compensation under our non-employee director compensation policy. We do not routinely provide new hire grants to employees when they first join our Company, nor initial equity grants to non-employee directors when they first join our board, although we may choose to do so in the future. For additional information on our non-employee director compensation policy see above under the heading, &#8220;&#8212;Non-Employee Director Compensation Policy.&#8221; Other than our non-employee director compensation policy, we do not otherwise maintain any policies on the timing of awards of stock options, stock awards, stock appreciation rights, or similar instruments with option-like features. <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="ecd:AwardTmgMethodTextBlock" id="Tb_G_V_J85kfEewrJhErCE6-w" escape="true">Our compensation committee considers whether there is any material nonpublic information, or MNPI, about our company when determining the timing and terms of stock option awards and, where appropriate, has provided for grants to be effective after our public disclosure of MNPI (such as our 2024 non-employee director grants, which were bifurcated due to the expiration of the 2014 Plan prior to stockholder approval of the 2024 Plan, and thus timed to be effective after publication of our quarterly report on Form 10-Q for the quarter ended September 30, 2024).</ix:nonNumeric> Our company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</p></ix:nonNumeric><a id="_304f1542_b1c8_4515_a98f_a8a489cff693"></a><a id="ITEM12SECURITYOWNERSHIPOFCERTAINBENEFICI"></a><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:54pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">ITEM 12.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth certain information with respect to the beneficial ownership of our common stock as of January 31, 2025 of:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person who is known by us to be the beneficial owner of more than 5% of our outstanding common stock;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our named executive officers; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all of our current directors and executive officers as a group.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to our common stock and is based on 9,596,486 shares of common stock issued and outstanding as of January 31, 2025. Shares of our common stock subject to options that are currently exercisable or exercisable within 60 days after January 31, 2025 are considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as otherwise noted, the persons and entities in the following table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable. Information with respect to beneficial ownership </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">79</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:11.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">has been based on information filed with the SEC pursuant to Section 13(d) or Section 13(g) of the Exchange Act, as well as our records.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;"> Except as otherwise set forth in the footnotes to the following table, the address of each beneficial owner is c/o Semler Scientific, Inc., 2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA 95051.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:66.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Shares&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percentage&#160;of&#160;Shares&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name and Address of Beneficial Owner</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Beneficially&#160;Owned</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Beneficially&#160;Owned</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">&gt;5% stockholders:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Capital International Investors <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 570,610</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">6.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:66.13%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Susquehanna Advisors Group, Inc. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 550,292</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">5.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Named Executive Officers and Directors:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">William H.C. Chang<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 898,543</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eric Semler <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 732,615</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Daniel S. Messina <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 18,627</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 590,313</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,620</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">All directors and executive officers as a group (5 persons)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,245,718</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:8pt;">*</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:8pt;">Less than 1%</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(1)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Based on a Schedule 13G filed on February 14, 2025.&#160; Capital International Investors, or CII, is a division of Capital Research and Management Company, or CRMC, as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 570,610 shares.&#160;The principal business address of CII is 333 South Hope Street, 55th Fl, Los Angeles, CA 90071.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(2)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;white-space:pre-wrap;">Based on a Schedule 13G filed with the SEC on February 13, 2025.  Includes (i) 498,675 shares beneficially held directly by Capital Ventures International, a Cayman Islands company, or CVI, (ii) 3,291 shares beneficially held directly by G1 Execution Services, LLC, an Illinois limited liability company, or G1, and (iii) 48,326 shares beneficially held directly by Susquehanna Securities, LLC, a Delaware limited liability company, or SS LLC (which includes options to buy 29,900 shares. Susquehanna Advisors Group, Inc., or SAG Inc., is a Pennsylvania corporation and is deemed to beneficially hold the securities held directly by each of CVI, G1 and SS LLC.  G1 and SS LLC are affiliated independent broker-dealers which, together with CVI and SAG, Inc., may be deemed a group.  SAG, Inc. is the investment manager to CVI and as such may exercise voting and dispositive power over the shares directly owned by CVI. Each person disclaims beneficial ownership of the shares owned directly by the other persons.  The address of the principal business office of (i) CVI is P.O. Box 897, Windward 1, Regatta Office Park, West Bay Road, Grand Cayman, KY1-1103, Cayman Islands, and of (ii) G1 is 175 W. Jackson Blvd., Suite 1700, Chicago, IL 60604, and (iii) of SAG, Inc. and SS LLC is 401 E. City Avenue, Suite 220, Bala Cynwyd, PA 19004.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(3)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;white-space:pre-wrap;">Includes (a) 199,596 shares held in three grantor retained annuity trusts  (b) 443, 160 shares of our common stock held by W&amp;D Chang Family Trust (c) 241,508 shares of our common stock held by Chang 2020 GP LP, for which Mr. and Mrs. Chang are the managing members of its general partner, Chang 2020 GP, LLC, and share voting and investment control and (d) 14,279 shares underlying options to purchase shares of our common stock held directly by Mr. Chang. The address for the Chang Family Trust, Chang 2020 GP LP, Mr. Chang and Mrs. Chang is 520 El Camino Real, 9th Floor, San Mateo.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(4)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Includes 25,248 shares underlying options to purchase shares of our common stock.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(5)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Includes 6,716 shares underlying options to purchase shares of our common stock. </span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(6)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Includes 435,000 shares underlying options to purchase shares of our common stock and 155,313 shares of common stock are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities.</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(7)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Represents shares underlying options to purchase shares of our common stock.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity Compensation Plan Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth information about our equity compensation plans as of December 31, 2024. We do not have any equity compensation plans that have not been approved by securityholders.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">80</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Securities&#160;&#160;&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining&#160;Available&#160;for</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;Issuance&#160;Under</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity&#160;Compensation</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">to be&#160;Issued&#160;Upon&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted&#160;Average&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plans&#160;(Excluding</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise&#160;Price&#160;of&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities&#160;Reflected&#160;in</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding&#160;Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding&#160;Options&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Column&#160;(a))</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;(#)</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(a)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(b)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(c)</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Equity Compensation Plans Approved by Securityholders:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">2014 Stock Incentive Plan <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 691,450</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8.86</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">2024 Stock Option and Incentive Plan <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,155,895</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 691,450</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8.86</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,155,895</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 18pt;"><span style="font-size:1pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;background:#ffffff;">As of December&#160;31, 2024, 691,450 shares of our common stock were available for issuance under the 2014 Plan. The 2014 Plan expired on July 23, 2024 and no future securities are available for future issuance thereunder.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">On August 14, 2024, our&#160;</span><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;letter-spacing:0.2pt;">board of directors adopted the 2024 Plan, which was subsequently approved by our stockholders at the annual meeting of stockholders held on October 4, 2024. The 2024 Plan is the successor to the 2014 Plan. </span><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The maximum number of shares of common stock to be issued under the 2024 Plan is&#160;1,916,011, plus on January 1, 2025 and on each January 1 thereafter prior to the expiration of the 2024 Plan, the number of shares of common stock reserved and available for issuance under the 2024 Plan being automatically and cumulatively increases by 4% percent of the number of shares of common stock issued and outstanding on the immediately preceding December 31 (inclusive of the number of shares issuable pursuant to the exercise of any outstanding, pre-funded warrants to acquire common stock for a nominal exercise price), or such lesser number of shares as approved by our board of directors or its compensation committee. </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;background:#ffffff;">Accordingly, on January&#160;1, 2025, the share reserve under the 2024 Plan was increased by 382,259 shares. </span><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Shares underlying awards under the 2024 Plan or the 2014 Plan that are tendered, canceled or held back upon an exercise of an option or settlement of an award to cover the exercise price or tax withholding after August 1, 2024, will be added back to the reserved pool under the 2024 Plan. Upon the exercise of a stock appreciation right that is settled in shares of common stock, the full number of shares underlying the award will be added back to the reserved pool under the 2024 Plan. </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;background:#ffffff;">As of December 31, 2024, no options were issued under 2024 Plan.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><span style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_50e126fd_77a2_41a5_ad9d_99f0ecd56675"></a><a id="ITEM13CERTAINRELATIONSHIPSANDRELATEDTRAN"></a><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:54pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">ITEM 13.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following includes a summary of transactions since January 1, 2023 to which we have been a party in which the amount involved exceeded or will exceed the lesser of (x) $120,000 or (y) 1% of our average total assets at year-end for the last two completed fiscal years, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other arrangements, which are described under Item 11 &#8220;Management &#8212; Summary Compensation Table &#8212; Named Executive Officer Compensation Arrangements.&#8221; We also describe below certain other transactions with our directors, executive officers and stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Warrants Acquired</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May 17, 2023, we acquired outstanding warrants to acquire&#160;76,875&#160;shares of our common stock from our chief executive officer for $1.9 million in cash. The warrants were originally issued on June 7, 2012 (16,875&#160;shares) with an exercise price of $4.00&#160;per share and on July 31, 2013 (60,000&#160;shares), with an exercise price of $4.50&#160;per share, were amended in September 2015 and, as amended, had an expiration date of July 31, 2023. The $1.9 million&#160;aggregate cash purchase price reflects the difference between the aggregate exercise price of the warrants and the aggregate fair market value of the shares of common stock underlying the warrants, based on the closing price of a share of our common stock on May 16, 2023, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrants were cancelled and are no longer issued and outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Review, Approval or Ratification of Transactions with Related Persons</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our board of directors has adopted a written related person transaction policy setting forth the policies and procedures for the review and approval or ratification of related-person transactions. This policy covers, with certain </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">81</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 (or if we are a &#8220;smaller reporting company&#8221; at such time, the lesser of (x) $120,000 or (y) 1% of our average total assets at year-end for the last two completed fiscal years) and a related person  had or will have a direct or indirect material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. In reviewing and approving any such transactions, our audit committee is tasked to consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction and the extent of the related person&#8217;s interest in the transaction.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_1fcace9c_c309_4194_89fb_0e5f4921437f"></a><a id="ITEM14PRINCIPALACCOUNTINGFEESANDSERVICES"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">ITEM 14.</b></span>PRINCIPAL ACCOUNTING FEES AND SERVICES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table presents fees for professional audit services rendered by BDO USA, P.C., or BDO, for the audit of our financial statements for the years ended December 31, 2024 and 2023. In addition to retaining BDO to conduct an audit of the financial statements, we engage the firm from time to time to perform other permissible non-audit services. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth all fees incurred in connection with professional services rendered to us by BDO during each of the last two fiscal years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fee Type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 807,658</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 473,070</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit-related Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 28,016</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 22,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 835,674</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 495,070</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Audit Fees</span>. This category consists of the annual audit of our financial statements and the interim reviews of the quarterly financial statements as well as work related to SEC filings such as consents, comfort letters, etc. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Audit-related Fees</span>. This category consists of the annual audit of our 401K Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Audit Committee Pre-Approval Policies and Procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our audit committee charter provides that the audit committee will approve the fees and other significant compensation to be paid to our independent auditors, and pre-approve all audit services and all non-audit services of independent auditors permitted under applicable law. The charter also provides that the audit committee may establish other pre-approval policies and procedures for the engagement of independent auditors to render services to us, including without limitation policies that would allow the delegation of pre-approval authority to one or more members of the audit committee, provided that any pre-approval decision is reported to the audit committee at its next scheduled meeting. The audit committee has approved all audit and audit-related work covered by the audit fees, and all other fees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">82</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_eb5ff9b2_33d3_4794_b552_39b520e9da20"></a><a id="PARTIV_516456"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART IV</p><a id="ITEM15EXHIBITSFINANCIALSTATEMENTSCHEDULE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial Statements and Financial Statement Schedules</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Financial Statements:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial statements are shown in the Index to Financial Statements included beginning on page F-1 after Item 16 below and are incorporated by reference herein and into Part II, Item 8 of this annual report on Form 10-K.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Financial Statement Schedules:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial statement schedules have been omitted because either they are not applicable or the required information is included in the financial statements or the notes thereto.</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">(3)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Exhibits</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:8.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit No. </b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:1.77%;border-bottom:1px solid #ffffff;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:89.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:0.06%;border-bottom:1px solid #ffffff;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"></th></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:1.89pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">3.1 </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:1.89pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:1.89pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104915008686/t1502471_ex3-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of our Form 8-K filed with the Securities and Exchange Commission on November 2, 2015).</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:1.89pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">3.2 </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/0001554859/000110465921129682/tm2130833d1_ex3-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of our Form 8-K filed with the Securities and Exchange Commission on October 23, 2023</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">).</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">3.3</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000022/smlr-20230418xex3d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Third </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 of our Form 8-K filed with the Securities and Exchange Commission on April 19, 2023).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">4.1 </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104913001230/t1300651_ex4-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Specimen Common Stock certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 1 of our Form S-1 Registration Statement filed with the Securities and Exchange Commission on December 6, 2013).</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">4.2*</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485922000008/smlr-20211231ex423d89fdf.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Description of Capital Stock.</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">10.1&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104914004381/t1401685_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">2014 Stock Incentive Plan, dated August 26, 2014 (incorporated by reference to Exhibit 10.1 of our Form 8-K filed with the Securities and Exchange Commission on September 2, 2014).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">10.2&#8224; </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104915008704/t1502425_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of 2014 Stock Incentive Plan Stock Option Grant Notice and Option Agreement (incorporated by reference to Exhibit 10.1 of our Form 10-Q filed with the Securities and Exchange Commission on November 3, 2015).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.3</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.1 of our Form 8-K filed with the Securities and Exchange Commission on October 8, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.4</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Incentive Stock Option Agreement under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.2 of our Form 8-K filed with the Securities and Exchange Commission on October 8, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.5</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Non-Qualified Stock Option Agreement for Company Employees and Consultants under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.3 of our Form 8-K filed with the Securities and Exchange Commission on October 8, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.6</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000034/smlr-20241004xex10d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.4 of our Form 8-K filed with the Securities and Exchange Commission on October 8, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">83</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:8.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit No. </b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:1.77%;border-bottom:1px solid #ffffff;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:89.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:0.06%;border-bottom:1px solid #ffffff;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"></th></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000155485924000034/smlr-20241004x8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.7</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000155485924000034/smlr-20241004x8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Restricted Stock Unit Award Agreement for Company Employees and Consultants under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.5 of our Form 8-K filed with the Securities and Exchange Commission on October 8, 2024)</span></a>.</p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000155485924000034/smlr-20241004x8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.8</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000155485924000034/smlr-20241004x8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10.6 of our Form 8-K filed with the Securities and Exchange Commission on October 8, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000053/smlr-20230630xex10d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.9</span></a>&#8224; </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000053/smlr-20230630xex10d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Separation Agreement and Release, dated April 1, 2023 by and among Semler Scientific, Inc. and Douglas Murphy-Chutorian (incorporated by reference to Exhibit 10.3 of our Form 10-Q filed with the Securities and Exchange Commission on August 14, 2023).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000053/smlr-20230630xex10d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.10</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000053/smlr-20230630xex10d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment agreement dated May 25, 2023 by and among Semler Scientific, Inc. and Douglas Murphy-Chutorian (incorporated by reference to Exhibit 10.4 of our Form 10-Q filed with the Securities and Exchange Commission on August 14, 2023)</span></a>.</p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000010/smlr-20231231xex10d7.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.11</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485924000010/smlr-20231231xex10d7.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment agreement dated May 2, 2022 by and among Semler Scientific, Inc. and Renae Cormier (incorporated by reference to Exhibit 10.7 of our Form 10-K filed with the Securities and Exchange Commission on March 6, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104914003382/t1401398_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.12</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104914003382/t1401398_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Indemnification Agreement, approved and entered into between the Semler Scientific, Inc. and each of the its directors and executive officers as of July 24, 2014 (incorporated by referenced to Exhibit 10.1 of our Form 8-K filed with the Securities and Exchange Commission on July 29, 2014).</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104913001230/t1300651_ex10-8.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.13</span></a>&#8224; </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000157104913001230/t1300651_ex10-8.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Service &amp; Supply Agreement between Semler Scientific, Inc. and Phoenix DeVentures, Inc. dated as of April 28, 2011(incorporated by reference to Exhibit 10.8 to Amendment No. 1 of our Form S-1 Registration Statement filed with the Securities and Exchange Commission on December 6, 2013).</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000022/smlr-20230418xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.14</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000155485923000022/smlr-20230418xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Cooperation agreement, dated April 19, 2023, by and among Semler Scientific, Inc. and the investors (incorporated by reference to Exhibit 10.1 of our Form 8-K filed with the Securities and Exchange Commission on April 19, 2023).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465923061823/tm2316043d2_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.15</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465923061823/tm2316043d2_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Warrant Repurchase Agreement between Semler Scientific, Inc. and the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, dated May 16, 2023 (incorporated by reference to Exhibit 10.1 of our Form 8-K filed with the Securities and Exchange Commission on May 17, 2023).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465924069148/tm2416433d2_ex1-2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.16</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465924069148/tm2416433d2_ex1-2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Controlled Equity Offering</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&#8480;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&#160;Sales Agreement, dated June 6, 2024, by and between Semler Scientific, Inc. and Cantor Fitzgerald &amp; Co (incorporated by reference to Exhibit 1.2 of our Form S-3 (333-280013) filed with the Securities and Exchange Commission on June 6, 2024).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465925006705/tm254669d1_ex4-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.17</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465925006705/tm254669d1_ex4-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Indenture, dated as of January 28, 2025, by and between Semler Scientific, Inc. and U.S. Bank Trust Company, National Association, as Trustee (incorporated by reference to Exhibit 4.1 of our Form 8-K filed with the Securities and Exchange Commission on January 28, 2025).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000110465925006705/tm254669d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.18</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000110465925006705/tm254669d1_8k.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Global Note, representing Semler Scientific, Inc.&#8217;s 4.25% Convertible Senior Notes due 2030 (incorporated by reference to Exhibit 4.2 of our Form 8-K filed with the Securities and Exchange Commission on January 28, 2025).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465925006705/tm254669d1_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">10.19</span></a>&#8224;</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1554859/000110465925006705/tm254669d1_ex10-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Confirmation for Capped Call Transactions (incorporated by reference to Exhibit 10.1 of our Form 8-K filed with the Securities and Exchange Commission on January 28, 2025)</span></a>.</p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex19d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">19.1</span></a>*</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex19d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Semler Scientific, Inc. Insider Trading Policy.</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">23.1* </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex23d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of BDO USA, P.C.</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">24.1*</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a href="#Power_of_attorney"><span style="font-style:normal;font-weight:normal;">Power of Attorney (included on the signature page attached hereto).</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">31.1* </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex31d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Principal Executive Officer pursuant to Rules 13a-14 and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">31.2* </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex31d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Principal Financial Officer pursuant to Rules 13a-14 and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">84</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:11.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:8.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit No. </b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:1.77%;border-bottom:1px solid #ffffff;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:89.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:0.06%;border-bottom:1px solid #ffffff;margin:0pt;padding:0pt 0pt 2.5pt 0pt;"></th></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">32.1*(+) </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex32d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Principal Executive Officer </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">pursuant </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a> </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">32.2*(+)</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="smlr-20241231xex32d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;"> Principal Financial Officer pursuant </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">97.1*</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Compensation Recovery Policy<span style="font-size:12pt;"> </span>(incorporated by reference to Exhibit 97.1 of our Form 10-K filed with the Securities and Exchange Commission on March 6, 2024).</p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:2.15pt 0pt 0.85pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">101.INS </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Inline XBRL Instance Document </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"/></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">101.SCH </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Inline XBRL Taxonomy Extension Schema </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"/></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">101.CAL </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Inline XBRL Taxonomy Extension Calculation Linkbase </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"/></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">101.DEF </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Inline XBRL Taxonomy Extension Definition Linkbase </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"/></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">101.LAB </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Inline XBRL Taxonomy Extension Label Linkbase </p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"/></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">101.PRE </p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Inline XBRL Taxonomy Extension Presentation Linkbase</p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"/></tr><tr><td style="vertical-align:top;width:8.85%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 2pt 0pt;">104.1*</p></td><td style="vertical-align:top;width:1.77%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:89.31%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).</p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:3.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Filed herewith</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8224;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Indicates a management contract or compensatory plan or arrangement</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">(+)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">The certifications attached as Exhibit 32.1 and 32.2 accompany this annual report on Form 10-K pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed &#8220;filed&#8221; by Semler Scientific, Inc. for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_ac78e301_a09d_4780_952b_4510b293c504"></a><a id="ITEM16FORM10KSUMMARY_694484"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">ITEM 16. FORM 10-K SUMMARY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not Applicable.</p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">85</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_ebc19a13_bbd0_4a8d_936f_32b014202d9e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">INDEX TO FINANCIAL STATEMENTS</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.25pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.25pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:4.25pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.25pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial Statements:</b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.25pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:6.84%;border-top:1px solid #000000;margin:0pt;padding:4.25pt 0pt 2.5pt 10.5pt;"/></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ReportofIndependentRegisteredPublicAccou"><span style="font-style:normal;font-weight:normal;">Report of Independent Registered Public Accounting Firm</span></a>-(BDO USA, P.C.; New York, NY; PCAOB ID# <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:AuditorFirmId" id="Narr_h_q5g96cU02nkKnvQGpmeA">243</ix:nonNumeric>)</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"/><td style="vertical-align:bottom;width:6.84%;margin:0pt;padding:4.5pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">F-2</p></td></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#BalanceSheets_620767"><span style="font-style:normal;font-weight:normal;">Balance Sheets as of December 31, 2024 and 2023</span></a></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"/><td style="vertical-align:bottom;width:6.84%;margin:0pt;padding:4.5pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">F-4</p></td></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#StatementsofIncome_747832"><span style="font-style:normal;font-weight:normal;">Statements of Income for the years ended December 31, 2024 and 2023</span></a></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"/><td style="vertical-align:bottom;width:6.84%;margin:0pt;padding:4.5pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">F-5</p></td></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#StatementsofStockholdersEquity_313903"><span style="font-style:normal;font-weight:normal;">Statements of Stockholders&#8217; Equity for the years ended December 31, 2024 and 2023</span></a></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"/><td style="vertical-align:bottom;width:6.84%;margin:0pt;padding:4.5pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">F-6</p></td></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#StatementsofCashFlows_410902"><span style="font-style:normal;font-weight:normal;">Statements of Cash Flows for the years ended December 31, 2024 and 2023</span></a></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"/><td style="vertical-align:bottom;width:6.84%;margin:0pt;padding:4.5pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">F-7</p></td></tr><tr><td style="vertical-align:bottom;width:91.09%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#a1TheCompany_862479"><span style="font-style:normal;font-weight:normal;">Notes to Financial Statements</span></a></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:4.5pt 0pt 2.5pt 0pt;"/><td style="vertical-align:bottom;width:6.84%;margin:0pt;padding:4.5pt 0pt 2.5pt 10.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">F-8</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_f2290bd9_071b_4e13_8115_536f9a6b7289"></a><a id="ReportofIndependentRegisteredPublicAccou"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">Report of Independent Registered Public Accounting Firm</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Shareholders and Board of Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Semler Scientific, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Santa Clara, California</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Opinion on the Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We have audited the accompanying balance sheets of Semler Scientific, Inc. (the &#8220;Company&#8221;) as of December 31, 2024 and 2023, the related statements of income, stockholders&#8217; equity, and cash flows for each of the years then ended, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis for Opinion</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Bitcoin Treasury Strategy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As described in Note 9 to the financial statements, the Company adopted bitcoin as its primary treasury reserve asset. Under this new treasury strategy, the Company purchases and holds bitcoins for long term investment purposes.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Critical Audit Matter</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Intangible Digital Assets</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As described in Note 2 and Note 9 to the financial statements, under a new treasury strategy, the Company purchases and holds bitcoins for long-term investment purposes. The Company accounts for its bitcoin as an indefinite-lived intangible </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">asset. The bitcoin purchases are initially recorded at cost, inclusive of transaction costs and fees. Subsequently, the Company remeasures its bitcoin investment at fair value at the end of each reporting period with changes recognized in net income. &#160;The Company has ownership of and control over its bitcoins and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoins. As of December 31,2024, the Company held approximately 2,298 bitcoins with a cost basis of $189.7 million and a fair value of $214.6 million. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:0pt;margin:0pt;">We identified the evaluation of the existence and rights and obligations of the bitcoins held by the Company as a critical audit matter due to the subjective auditor judgment involved in determining the nature and extent of audit evidence required to address the risks of material misstatement related to the existence and rights and obligations of the bitcoins held offline in cold storage with multiple third-party providers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The primary procedures we performed to address this critical audit matter included:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Confirming the balance of the Company&#8217;s bitcoins in the custody of the third-party providers and reconciling them to the Company&#8217;s records. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Testing the Company&#8217;s control over its wallets, for a selected third-party custodian, by observing a transaction initiated and processed by the Company between all the wallets held by this selected custodian. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Corroborating the observed transaction by using independent public blockchain explorers to verify the movements among the wallets.&#160;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">/s/ <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:AuditorName" id="Narr_oZB1nnZl8UqrDBbDKtfGbA">BDO USA, P.C.</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We have served as the Company&#8217;s auditor since 2013.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="dei:AuditorLocation" id="Narr_GN3cGft5MEq8AG5hnQR-GQ">New York, NY</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">February 28, 2025</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_2754866e_f9db_48fc_b5d8_5759302c0f2e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">Semler Scientific,&#160;Inc.</p><a id="BalanceSheets_620767"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">Balance Sheets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(In thousands of U.S. Dollars, except share and per share data)</p><a id="_7900c58c_63de_4c03_a4b4_0fb51a8fbe69"></a><a id="Tc_-NPEAI-09keLnaTMV6aSxQ_1_2"></a><a id="Tc_sQBEnro230mInYH2Mv93Ug_1_5"></a><a id="Tc_K1zI5fBJxkWPpBkUBBq72w_2_2"></a><a id="Tc_B23yO_Mqqk2UJOKF7mc8iw_2_5"></a><a id="Tc_asJ5Z7rMs06dZVlLBOmaoQ_3_0"></a><a id="Tc_-mQCeYNnqki45-d-R8FRmQ_4_0"></a><a id="Tc_HX6izKNz8kiL_RrsOQeiDg_5_0"></a><a id="Tc_8d_JP9oWnUi7X4XiMFc5Bw_5_2"></a><a id="Tc_a9LcgxtkZEG4oXZD90PTHQ_5_5"></a><a id="Tc_pOv_K81XoUGY1ItAkFdj1A_6_0"></a><a id="Tc_oHE3fxf-EkalX3ZDi1JnFQ_7_0"></a><a id="Tc_7h4YibE4Z0q7YP1few0J3g_8_0"></a><a id="Tc_vNFZiQsb50ywuqSVZR035Q_8_6"></a><a id="Tc_HA7U64e2yE2QFxv0ZBq6xQ_9_0"></a><a id="Tc_QxX6J95vLEWozE56Q8NR5g_10_0"></a><a id="Tc_27BWBZFRCEKHn-CC29PsIQ_11_0"></a><a id="Tc_HrXT7KjNok6Bx8jFDzJkmQ_12_0"></a><a id="Tc_zOwQ03blQESYLDkmssxpzA_13_0"></a><a id="Tc_oxueoTefYES1d62nQzDT9w_14_0"></a><a id="Tc_UEx4ALWz4ESty61omcBggA_15_0"></a><a id="Tc_dztDNZ6rrUqORTWcK00B4g_15_3"></a><a id="Tc_llxHUHmTk0Csh0rfwqsbbQ_16_0"></a><a id="Tc_Vzmb7VYsQE69rLPjGwinfA_16_6"></a><a id="Tc_TTsyWL2pi0SdCmXUkPq-Rg_17_0"></a><a id="Tc_hpAp_8ovYU6YE-EDtiWJvA_18_0"></a><a id="Tc_6fe4LUOagUuvnoHHxxV0uQ_18_3"></a><a id="Tc_feNOGcFlzEu7823VOUu_hw_19_0"></a><a id="Tc_TD68TTuEgUaa03Fmfk-A6w_19_2"></a><a id="Tc_d0v2A94OkUyrtmuoQqcqHg_19_5"></a><a id="Tc_trkQAbFDYEWQgiPPwIZjrA_21_0"></a><a id="Tc_QyNhBAPo60id2lfMOvfPWg_22_0"></a><a id="Tc_X-0TMvNJxUe3Ne1EIeLOjg_23_0"></a><a id="Tc_M1FIpKYUck-AuggiTuARdw_23_2"></a><a id="Tc_zXs7YMY2MUOMvcY6oXWKng_23_5"></a><a id="Tc_CxfHoMPhZU-ITloxOFBF3w_24_0"></a><a id="Tc_YIXV7PKUaUyk65Y0XlXi3w_25_0"></a><a id="Tc_wL4i9BA3fEKMPp_x-q-vHA_26_0"></a><a id="Tc_U3bzGAzzski9W3ymcTxBRQ_27_0"></a><a id="Tc_C1fqaMKa0EKuec0zJjKuEw_29_0"></a><a id="Tc_oy8U6FxySke2z8dKhXvVzA_30_0"></a><a id="Tc_q0QK2fixhUWhRgmq9FZz_Q_30_6"></a><a id="Tc_xSlWWuctkkumbaY8z3XIqA_31_0"></a><a id="Tc_aYU5o-AYTEG1hBcnjWHJ7g_31_3"></a><a id="Tc_JvuLvBSbHEqnthI57ysdEQ_32_0"></a><a id="Tc_MP2aFWBivEmvEqVV7Jf8bw_33_0"></a><a id="Tc_JKqezi4d40ivjAiMZg6Xvw_34_0"></a><a id="Tc_0m0ShwipEkWyTx_U8r-67Q_35_0"></a><a id="Tc_BMn6N0JpUUCZGXnZQLmlbQ_36_0"></a><a id="Tc_kZeJErtRUEmcK1N_4Lt1EQ_37_0"></a><a id="Tc_dBCVVB6NdU-2oF4IF7FT4A_38_0"></a><a id="Tc_qOiB6iuPYECniHdf8JoEOg_40_0"></a><a id="Tc_-j-4DnCZu0KYjONsbzzFig_40_2"></a><a id="Tc_3UN2_BYG0k6UGGtxa-pWqw_40_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_ii3qDDAN9kG0NH2CZy38hA_5_3">8,819</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_vqa35Uc29kOX-fPcyQoz9g_5_6">57,200</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Restricted cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="Tc_03elHA6MjECBzomCFwK5FA_6_3">133</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="Tc_nlkHHBYMJEmsd9YpPOfYMA_6_6">132</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Trade accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="Narr_dB-njaWIHk6NjbhAKxv88Q">199</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="Narr_MIppjHGSwUuILHJaovB-8Q">287</ix:nonFraction>, respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Tc_LMiVuGaNiUON_Xh1_1eolQ_7_3">4,378</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Tc_vER9aRRQ-0aNquAGJrjESg_7_6">6,125</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Short-term notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="Tc_a3D_OM-hMUWzjF6Wp0DNeA_8_3">6,100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventory, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="Tc_raNvlpOVyk2dfnE_t9iQlQ_9_3">358</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="Tc_7RyzYdABKkW9ow7cCTt8wg_9_6">445</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="Tc_wdJ8ScsmF0q6fIK_tKgYOA_10_3">2,900</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="Tc_4nPaxr3UBEiOb3pw0opzUw_10_6">2,042</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="Tc_0zCKbF1hy0qyZttjADzjvg_11_3">22,688</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="Tc_N8K1qiNWb0iYVTiCh6F30w_11_6">65,944</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet" scale="3" id="Tc_1s0Fkzt1lUuC7R4hlPal-w_12_3">1,423</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet" scale="3" id="Tc_DDFO8O9eSES62QyGFTB0WA_12_6">2,285</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" scale="3" id="Tc_SvhvX_lYFUW-P3NpGBdiEw_13_3">487</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" scale="3" id="Tc__7G8NXFuD0O1UbFvZCD0OQ_13_6">720</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Tc_ARo4VTWdWU6jtNP9Iqv4oQ_14_3">512</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Tc_ND9ns2qYAkm0IiQOEQN5Sg_14_6">512</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Notes held for investment </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="Tc_yTkiHF5Ug0WBRZCueR1CsQ_15_6">5,372</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValueNoncurrent" scale="3" id="Tc_teReYf9fI0WwXEe_gZ1rbw_16_3">214,633</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="Tc_rpUa5656CUqtlMwr-2cW2A_17_3">85</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="Tc_s7aXIa3GAUKfgiBILKaLCg_17_6">270</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="Tc_5uEfIcCn8kijb7ikMTSqFA_18_6">2,962</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="Tc_gpPeSx2Lf0qKVWgifPGa8A_19_3">239,828</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="Tc_eq65dfaQX0m41UumPLGOKQ_19_6">78,065</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Liabilities and Stockholders&#8217; Equity</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> Current liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accounts payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="Tc_gLSAKp_6o0ybWFsWkGygVg_23_3">140</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="Tc_RQbU-XpPg0uJnNIon6agYg_23_6">402</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_lUAkGflbF0yQxMsNErQzpQ_24_3">5,173</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_bTfNUR9RzEm3TeCo1MAbyA_24_6">4,502</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="Tc_wmWw-Uru2UWjBq5KBhW6SA_25_3">774</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="Tc_XTBhRY8XrUuksj_qBxAVUQ_25_6">1,120</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other short-term liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="Tc_7d4EqdqR30qNjlbHCGMzCQ_26_3">226</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="Tc_ts1ByeTeE0eqIwrFXBmk0w_26_6">176</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="Tc_Ykctx_mp-EGnu9AtJJa7nA_27_3">6,313</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="Tc_-kmDU2wE1UamKkAtFE8LOw_27_6">6,200</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="Tc_LZ5lWXTE10WXdroumlRREA_30_3">2,765</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other long-term liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="Tc_vQFtMM6TeEO8hXvpIQPGEw_31_6">70</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total long-term liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="Tc_CZ-Vj1M2-E2zmUp0NdDhmQ_32_3">2,765</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="Tc_1QOsSGA230-yfW6jh2nd2Q_32_6">70</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Commitments and contingencies (Note 14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stockholders&#8217; equity: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Common stock, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_7Z5FmGy5Rk2vDrAuO2fSJQ"><ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_rnDsdzw_lUWnjkFDR_V-lA">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_JbAH1mcmAUaqZP-2Peb_DA"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_lVUQii0BMU2PWau5O59xtQ">50,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_jb5F46zaMEm1ruKmkg9vIQ">9,770,908</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_vrFG3vQmVEOyKCaVFdjjhQ">7,099,441</ix:nonFraction> shares issued, and <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_j-LEyzalHESBDXC3MRFybg">9,556,486</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_qKA3JclOTkywcRCNkD-oUw">6,885,019</ix:nonFraction> shares outstanding (treasury shares of <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Narr_bmCwL2JuMUq_yekNbDEv4w">214,422</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Narr_n30apIuMQEq0ulIQ7Csuaw">214,422</ix:nonFraction>), respectively</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" id="Tc_0Ajwc11fNESueqVVUI0nog_35_3">9</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" id="Tc_IwEu9xXS-U-6HHgfc_g4iQ_35_6">7</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Additional paid-in capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="Tc_HwcwlctrH0-JKicHhVAi7Q_36_3">130,039</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="Tc_1PtJki88IUSDyIS5wRKzsQ_36_6">11,985</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Retained earnings </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="Tc_fCnTpkyyOkSU-VnDSQV4ig_37_3">100,702</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="Tc_oGIm6ez2jUycbJyy7UeBjw_37_6">59,803</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total stockholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_vP_u7b0Qs0q_IF_lNun4rA_38_3">230,750</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_k8KuUumvVUe0f6efQUwTug_38_6">71,795</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total liabilities and stockholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="Tc_2rW449lZvk6Qe6IhhA1RgA_40_3">239,828</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="Tc_bqgArbRex0qi3n5b64HmNw_40_6">78,065</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;">(See accompanying notes to financial statements)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_f9f9fd1d_12b5_4b9f_8230_a6847718059c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">Semler Scientific,&#160;Inc.</p><a id="StatementsofIncome_747832"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">Statements of Income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(In thousands of U.S. Dollars, except share and per share data)</p><a id="_61124d02_bb3d_43c5_b7c6_c6ec7824b8cd"></a><a id="Tc_SiVoIxMbgUO-P4NO4WYeRQ_1_2"></a><a id="Tc_zDp0zMHruEek0FAPlzoZPw_2_2"></a><a id="Tc_6J-I_8TjbEiQTrbLRdTI9A_2_5"></a><a id="Tc_2ADJWLAkak6vZuE-CZfpZg_4_0"></a><a id="Tc_EAsBvPEfMkumfl4TF6X_6g_4_2"></a><a id="Tc_mX8cmOa35EGA5HH2-OoXRQ_4_5"></a><a id="Tc_ikjSctEfsEeYGfTn_BuCzQ_5_0"></a><a id="Tc_sDVbt6LzPEe7I_4DPNxG2Q_6_0"></a><a id="Tc_HRD-QjBp6E-cY-Sol4nsLg_7_0"></a><a id="Tc_On1bjLLTQUeUVx94QamYYA_8_0"></a><a id="Tc_A0tsLHPfKkWawuJmQQVBvA_9_0"></a><a id="Tc_EcoKvJGeCkSaVCmZtsRzeA_10_0"></a><a id="Tc_Bdr4NLJS0kamrUuXQhvMOg_10_3"></a><a id="Tc_jZRv7mGMZ0C8r499l9rOYA_11_0"></a><a id="Tc_dfwKmElrV0aeBQc208wHRQ_12_0"></a><a id="Tc_4JqvGBEgp0GUdBID2M_6kA_13_0"></a><a id="Tc_uPCJl6rOl0-U1auLyMnDUw_14_0"></a><a id="Tc_J3R8YaufGku0Qd_Rfll8wA_14_3"></a><a id="Tc_uGLb7bLgS0aeDoxw90w9Ow_15_0"></a><a id="Tc_8ldPF0_wQkye5QrjVx8-tg_16_0"></a><a id="Tc_0YmI4EMHzECRSSsZE1hZqA_16_6"></a><a id="Tc_ZsovaphgCUiLwAuIX1OJcA_17_0"></a><a id="Tc_oNeo2BChAk6F2paiyIPJHA_18_0"></a><a id="Tc_VzbaaKASCUyNTgYUAGLVEg_19_0"></a><a id="Tc_eUzqXmkWy0CN6e095pOE0A_20_0"></a><a id="Tc_0kc4cBG8pEekNa0ZTModzA_21_0"></a><a id="Tc_LaZzMHjLMkGW9anitYoBgg_21_2"></a><a id="Tc_wUUFZR-HcE2jMgruLZX9Rw_21_5"></a><a id="Tc_OSXm9sROjEOY2LdZpWUZ5w_22_0"></a><a id="Tc_o_TCrjg_lU2H2YtSLKSgPA_22_2"></a><a id="Tc_GPcXV5JsQU25AtUSK8RdUQ_22_5"></a><a id="Tc_x28EUzI_rk6OFc1jTL-LcQ_23_0"></a><a id="Tc_whT1S6Aj8EGgr5kwpbWbbg_24_0"></a><a id="Tc_m2b0GTs730eJ64Lz02Bsdw_24_2"></a><a id="Tc_NkU83wlwy027ORIPfVtwrA_24_5"></a><a id="Tc_568i6oNy_kO-okEQ8ki2-g_25_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the year ended December&#160;31,&#160; </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="Tc_qX4uzbcGSkyfQGv4cAm0uQ_4_3">56,294</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="Tc_Czn5LRYhWkuAK1n-AhcQuQ_4_6">68,184</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating expenses:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cost of revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="Tc_jNVZYpo13U2lh8niSacG8w_6_3">4,759</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="Tc_gudVPIY_YE67xPKMAWgmCg_6_6">6,984</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Engineering and product development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="Tc_ojMmBKTKt0K7IF091iu7tQ_7_3">4,792</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="Tc_rrBXkRpPX0qbrVRwQiAvqg_7_6">5,773</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="Tc_f6oTOAmop0yyho98gZWSmA_8_3">13,078</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="Tc_eyUCpf1AHUyHqbW2cK1aZQ_8_6">18,147</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="Tc_SnCY0ZQTU0y9LKicbgKbeg_9_3">12,732</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="Tc_0Y9rZZkEk0OprlCRcqAHiw_9_6">14,290</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Strategic streamlining</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="3" id="Tc_IEq8sW06hEWwjdj9wbFrvQ_10_6">734</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="Tc_9m-aHykuu0uGqOs92xUHow_11_3">35,361</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="Tc_JGQFp0Ea8UaKl34Lig0cCQ_11_6">45,928</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_f4NMhyEHs0Kcgv8Cyapc5A_12_3">20,933</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_-DGtuOc1AEuWid_VToM1-Q_12_6">22,256</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest and dividend income, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="3" id="Tc_Mcn3z1ZKsUyLm4RSqByFKw_13_3">1,877</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="3" id="Tc_CYDnK8cx2kyub907TiDR0g_13_6">2,471</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Impairment of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ImpairmentLossesInvestments" scale="3" id="Tc_VXbqAT31I0eOemDjl47PBg_14_6">337</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:FairValueAdjustmentOfNotesHeldForInvestment" sign="-" scale="3" id="Tc_OGJsLeg5dkCoMCV6xPfYYQ_15_3">128</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:FairValueAdjustmentOfNotesHeldForInvestment" scale="3" id="Tc_2ajKgo10FUKOZtplXNnL5g_15_6">307</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetUnrealizedGainLossNonoperating" scale="3" id="Tc_hi4kkC3AbUKYUKngr3Mabw_16_3">24,933</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="Tc_V8Y7dvX1tEGM-8dTy2BRRg_17_3">13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="Tc_9NbU9xh2rUSGDPfw5pwr2Q_17_6">17</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Other income, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="Tc_TCBXoRU8ckmrndT3WiN_SQ_18_3">26,951</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="Tc_Rd0SDbGjd0Cq5k17h80U5g_18_6">1,844</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pre-tax income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_SRfmqXFaP0-XY2VgQugBqg_19_3">47,884</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_GM3c2Ywj5U6Y0j16U8pUZA_19_6">24,100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_U6aigezmPE2WWdjwwIAl7Q_20_3">6,985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_XeHw8VX1z0eWo-64v3AitA_20_6">3,517</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_G3QaZoT40k2KZOik62oYiw_21_3">40,899</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_elCFGpt6z0mhxObAQXzKWQ_21_6">20,583</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income per share, basic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_3o5Tgx6iT06gtur3uOL71g_22_3">5.66</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_zzCBTLbHskWJoLrdDn-GhQ_22_6">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares used in computing basic net income per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_EAm5g-XOQUSLq5tGVJCbPQ_23_3">7,228,961</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_BomMB_uKJ0SUhjaQCcor0g_23_6">6,732,806</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income per share, diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_mrCMTokr4Ee3sjjhRKd4uA_24_3">5.13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_S9FO-35LvE2XDBh5GDJ1sw_24_6">2.63</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares used in computing diluted net income per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_iwhbR2kosUq18xGDmN4nmA_25_3">7,980,118</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_k5IGvTLL0kCVpc_EuS4NbQ_25_6">7,819,159</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;">(See accompanying notes to financial statements)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_a951d0e5_63db_4cd3_abe0_6005907d2e07"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">Semler Scientific,&#160;Inc.</p><a id="StatementsofStockholdersEquity_313903"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">Statements of Stockholders&#8217; Equity </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(In thousands of U.S. Dollars, except share and per share data)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_8a4c7782_b2cc_4f8c_bb3f_6dae62192ccc"></a><a id="Tc_nutycZA0ikyMkQ_FSxhYYg_1_2"></a><a id="Tc_6glFrU0dFkSgvfSb0-0NGQ_2_2"></a><a id="Tc_h5i9F29G2kWyjew-8nayzg_2_7"></a><a id="Tc_uujD5s20pk6wjF1TIIaN2g_2_9"></a><a id="Tc_SxQeBRy-UEqodIiGVOccDw_2_15"></a><a id="Tc_1A6oe7A5VESglNl2j7RBjQ_3_4"></a><a id="Tc_8U9gf6DM5UCQE2Y63XwOlw_3_9"></a><a id="Tc_2t5aXjvSi0Cdu21coyP2YA_3_12"></a><a id="Tc_dvhb4YC1SkmU4Z6PYS4XNw_3_15"></a><a id="Tc_hN-5y-p6gEehsjgkqAHILQ_4_2"></a><a id="Tc_VF1xZngwi0eIJMH2Fmd0Yg_4_4"></a><a id="Tc_hW_pznjGAkK_niOPfjJYzw_4_7"></a><a id="Tc_IYRjqIVUzUaStU9dInJxXw_4_9"></a><a id="Tc_fNqLtPWYDUeT-P957_-mjA_4_12"></a><a id="Tc_7ds8iFuqVEi3ZF_WtWEw7g_4_15"></a><a id="Tc_tN5W-0nqK0iWG9hnseHgTg_5_0"></a><a id="Tc_rxC73MS1wE-zQnwZvfE4qg_5_4"></a><a id="Tc_zYJvJ74N3UOYmVB8ucSiMg_5_9"></a><a id="Tc_CYXz5kGFDUe1QiXW1RLfDA_5_12"></a><a id="Tc_idyzUyTo1EyPcC6ZbQW-8Q_5_15"></a><a id="Tc_HjDpqOSYCEGXoF4u66lp1A_6_0"></a><a id="Tc_W9b2V1kPnU6kKn9TlBCH0g_6_2"></a><a id="Tc_4DOfoGtMB0S_2Uia0qML4g_6_5"></a><a id="Tc_FuDntmNURE2NYAZN0rn3qg_6_7"></a><a id="Tc_bbHjQ_7n106KpLMSmZ5n-A_7_0"></a><a id="Tc_-KbwQFLI2k-hlfcJVHwqbw_7_5"></a><a id="Tc_yDONQASLukS5G6v6SVAK8w_7_7"></a><a id="Tc_ItMmIKGjl0K597jUEw6H8A_7_13"></a><a id="Tc_RdmfDDoEg0mMevE184HTYQ_8_0"></a><a id="Tc_m-7-AHjaqkiZv7My8Lc1pQ_8_5"></a><a id="Tc_nf4EZ3Jr7kictKjBd2OFyg_8_7"></a><a id="Tc_yFzC-q4T1k-CrygR4KSYOw_8_13"></a><a id="Tc_uN-BJeGYYEGrDzIG8vR6xA_9_0"></a><a id="Tc_2XQmZhBAtUil388KGXRRBA_9_5"></a><a id="Tc_c1ommKuM3kGIT7J5uwm7ow_9_7"></a><a id="Tc_BVlrwqJTTUe1IEO96RCa9g_9_13"></a><a id="Tc_NjAgrYVISUCZApWx1HdE_Q_10_0"></a><a id="Tc_FyqpuVeKXUCdpf1YmP4MAA_10_2"></a><a id="Tc_IeN6b6u4Pkmg0_OmImKJwQ_10_5"></a><a id="Tc_IAqqMaV-c0uYM7Nyx7eEIg_10_7"></a><a id="Tc_ekAUbPOWWkSle7TxglvPzQ_10_13"></a><a id="Tc_Lt08ggagq0y4_ILNP3DAAw_11_0"></a><a id="Tc_raqQE0T4p0CEDCVuLGxzgA_11_2"></a><a id="Tc_RfsoK1rmfk-kawmNn3vIAw_11_5"></a><a id="Tc_0hF2tpqbBEurHEue1nK-7Q_11_7"></a><a id="Tc_OVeEjz5MhkW9FtEz1F91hQ_11_10"></a><a id="Tc_sgdSdx6KjkOPBcvE39jH9g_12_0"></a><a id="Tc_M5dSzOQlWU62P9FhaLJaQw_12_4"></a><a id="Tc_kB5ZW4rehkq-CPTaf_qALQ_12_9"></a><a id="Tc_1q8RTPiwFE2hc0YcCFVVMg_12_12"></a><a id="Tc_CTBX_mXDEEGbDdBiboaVGQ_12_15"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:64.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended December&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:22.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid-In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders'</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;Issued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" id="Tc_NGMQ9hpocEm06V_AV3l8uw_5_2">6,906,544</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_M5gkn0lLlk2OrG5mf3npAw_5_5">7</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_7MdStRIh3kKwwzJPpWFxcg" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Tc_3G9klJcBHUCDBrn6S3pjaw_5_7">214,422</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_PP2-ruBZD0aQuxrVIVT55A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_-64sstefm0W9aDr2ybL0Tw_5_10">16,449</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KsDbaHOEh0G1GZmuHINO9A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_2xku9NrloEKFvRV4nMPqCQ_5_13">39,220</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_aGAg_GdfZk-RaiPy-wUfZw_5_16">55,676</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Common stock warrants acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" scale="3" id="Tc_bqTAFkksQEunK2eJtV0Eeg_6_10">1,949</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" scale="3" id="Tc_FVrX_qn04Eq2klUneg4lag_6_16">1,949</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Employee stock grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="Tc_HH1Jmwa7t0iDaqDZiMK-Ag_7_2">24,295</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="Tc_5tmZNL4lTkiZBaAjKreJsw_7_10">860</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="Tc_evHXIcMhf0WK1kIAToxiZA_7_16">860</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Taxes paid related to net share settlement of equity awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw" decimals="INF" format="ixt:num-dot-decimal" name="smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" sign="-" scale="0" id="Tc_WoCMaDru_kiV38TPM22NIA_8_2">114,970</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards" sign="-" scale="3" id="Tc_DWk8vihWJk-dOnEljdGA1Q_8_10">3,510</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards" sign="-" scale="3" id="Tc_90EIirtJHESI5CV9M1Afjg_8_16">3,510</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Stock option exercises</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_MqHtdmzR10-A4PSwW-vWew_9_2">283,572</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc__rgF_HlCpUSjlFTJuJN3lg_9_10">51</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_cfA8Yk8_7EGwtmZrM3Z6Bw_9_16">51</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;">&#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_Ro1egOD9QEiTMAM1va0Dwg_10_10">84</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_hspxpbrrK0GL11V64hetxQ_10_16">84</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> Net income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;">&#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;">&#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_kIbRkUOXhkOuBCEbOunDpA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_hJ7VUXTw4kuCnmZE-GG3PQ_11_13">20,583</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc__SM3mWKRoEmN8OGcEsoi6A_11_16">20,583</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:33.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" id="Tc_gK-mzWucrkGbW3oWHwZgTw_12_2">7,099,441</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_UbRiONE6M0qLUukx4T8kkw_12_5">7</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_dQ8SZLQckkq01f6d8teuYA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Tc_gzbSqeesD0eQSmgGEcY8Jg_12_7">214,422</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_eBCEoRryQ0WqACbtbHRW9A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_MDcVGUYQPkuPV0v_2oq5cQ_12_10">11,985</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mDqBkPVNkU2MWw6rn8s8lA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_ggeu7TeqFkKM3_2OxhETYw_12_13">59,803</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_TvYbtVq4E0GV8hXqVG-6Vg_12_16">71,795</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_54a416f6_99ee_4ccf_9471_b0e5e133ae6d"></a><a id="Tc_tXvaiNIAsk6GS3qdYuQExg_1_2"></a><a id="Tc_ATzJa2x-JUGmpS_Y0HzzcA_2_2"></a><a id="Tc_1LFARd4SQUuBFLU0HUcvdQ_2_7"></a><a id="Tc_cE-nzWy_RkK2NZ5chQ-TPg_2_9"></a><a id="Tc_nLsbOWs76ECqnZuTAIwPxg_2_15"></a><a id="Tc_CWb6QNcj-E6PdBA2rq27Zw_3_4"></a><a id="Tc_en02suk2D0WJeIz7wUXcnw_3_9"></a><a id="Tc_wCByBElBxkOlMAmN6_5wkg_3_12"></a><a id="Tc_2R2bXpRrc06gxmODLphTRQ_3_15"></a><a id="Tc_lzb7-MsNXkGoED5mr4CGcA_4_2"></a><a id="Tc_gMkTRWpZwUOl-KIzk-O9Vg_4_4"></a><a id="Tc_5alktTX9yUOTbkpTAqBAyg_4_7"></a><a id="Tc_tNgbwSAfGkCUp8ORc0LBmA_4_9"></a><a id="Tc_ylLouzlLN02nX-aM_tE00Q_4_12"></a><a id="Tc_X9r9zDBNtUaOLUf2wOxZzw_4_15"></a><a id="Tc_H3aKSKQeCUq37ngXAxw7bw_5_0"></a><a id="Tc_EjlLTYhrfkmZ1YGlrpzNQg_5_4"></a><a id="Tc_E9a2lnru8k6yWOnwLDxM7g_5_9"></a><a id="Tc_Ny_8NSzxLki9k3hbjTVmPw_5_12"></a><a id="Tc_kKUZrQ2M0kiuSM1d-71tLw_5_15"></a><a id="Tc_6XZfHmblb06npLb-DxaUFw_6_0"></a><a id="Tc_ZIb7lYj0pUKqxFGPOdXkiQ_6_5"></a><a id="Tc_LdolhPxmZkurvr1CRKTaoA_6_7"></a><a id="Tc_CTx4XByk6USf34aHJlP56A_6_13"></a><a id="Tc_3gRdufmreU-LQ3EjTXbTgg_7_0"></a><a id="Tc_aLk8Ya3rk0yNo115p25EaQ_7_7"></a><a id="Tc_TctRowlsvkWmo9ylaCqX6A_7_13"></a><a id="Tc_iJZ6pGr0EUSfdh6qvT9n6w_8_0"></a><a id="Tc_MAcqkwWk8EWT85Xs-yRIfw_8_2"></a><a id="Tc_og7Hrcjo80K5WtPbA9Gqrw_8_5"></a><a id="Tc_4_1Gj3s6_0C3hk73KQ55sw_8_7"></a><a id="Tc_V6uDGRgUq0O0VlG8ivb1IA_8_13"></a><a id="Tc_d4QbpnEQAEO95pM7BNFbRA_9_0"></a><a id="Tc_8fbBNxsKFUa_OEsqOA-rGA_9_5"></a><a id="Tc_JddqVU2UwEae471X3jnCxA_9_7"></a><a id="Tc_wx5uOgnev0-5GmB1rosAMg_9_13"></a><a id="Tc_RTmraUMOsECFVoisihOI2A_10_0"></a><a id="Tc_A3iBSq5K8Ei9dcIQMapapA_10_5"></a><a id="Tc_uV3tskH8NkqSG5sljqk3lQ_10_7"></a><a id="Tc_EmfcpPcVXkGyNimFJwVIJQ_10_13"></a><a id="Tc_mjzALqRg6U6nfDt32IRknw_11_0"></a><a id="Tc_EIjw3y0pPkWosuT1FpzF5w_11_2"></a><a id="Tc_lMuDKpbnokeeijzm5jLE0Q_11_5"></a><a id="Tc_EXfsahr8Ukq3QOhuxDj42w_11_7"></a><a id="Tc_IaeEQTm_h0SSwGSVPWcNZA_11_13"></a><a id="Tc_X2eTSWs8i0eh8vH7ke4r-w_12_0"></a><a id="Tc_dKhXu991EEaxGb4d6SJ6Ow_12_2"></a><a id="Tc_rdW_-S0jG0KkaFpnaM5LZA_12_5"></a><a id="Tc_0_FMQkotVk-isiPYNiU5_g_12_7"></a><a id="Tc_QQ_TIFDfyEGKL3dn47OVZQ_12_10"></a><a id="Tc_XXC6Onw8lkSX430Vx0v-Tg_13_0"></a><a id="Tc_tBQ7AqY-e0uElaTDLo2N6g_13_4"></a><a id="Tc_3GPXiCSg_kSpr6ZUfoUjdQ_13_9"></a><a id="Tc_hDUqOCuFVkuak4SpySZk_A_13_12"></a><a id="Tc_hqvPA6232UyvN007p4yCCQ_13_15"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:64.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended December&#160;31,&#160;2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:22.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid-In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders'</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;Issued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" id="Tc_nPykaY0jBUGWrWdOSEHd3Q_5_2">7,099,441</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_2LIxJfKj4EugvlVl8QvlXg_5_5">7</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_dQ8SZLQckkq01f6d8teuYA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Tc_jlmzNj3sWUGQbfcsXn2Eaw_5_7">214,422</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_eBCEoRryQ0WqACbtbHRW9A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_dNDxBlFoL0uQ6zGrfLnd7Q_5_10">11,985</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mDqBkPVNkU2MWw6rn8s8lA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_dJRuWF3RX0qXtYqJk0euyQ_5_13">59,803</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_O_ikLeEGRk69bQ8NXLUMqw_5_16">71,795</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Directors stock grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="Tc_Wp3YisTFP0-fo_cveWVSdA_6_2">10,500</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="Tc_3ufTSX0f5Uez8Z6FWv9t0Q_6_10">300</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="Tc_IBl-VHTZ9ESSyuZzGB0_xA_6_16">300</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Tc_07dankq-iEG1nzb4EQ8e4A_7_2">2,197,988</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="Tc_RtBqlaZBIEyMtvRgnjuieQ_7_5">2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="Tc_EGfQdrQOQ0a6WORBMAE0aw_7_10">119,602</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="Tc_d9aBx9iFgEW6ddLmO7XXwQ_7_16">119,604</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Stock issuance expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="Tc_RKDuDhmLzkKLRm0fw8DUyg_8_10">3,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="Tc_HL5bvfVUtkGFA4ZZQPjOSQ_8_16">3,000</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Taxes paid related to net share settlement of equity awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ" decimals="INF" format="ixt:num-dot-decimal" name="smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" sign="-" scale="0" id="Tc_FPxH6vu3MkOD_YaBs8N22Q_9_2">34,406</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards" sign="-" scale="3" id="Tc_f2c8P6esbUm0screJoHQzQ_9_10">874</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards" sign="-" scale="3" id="Tc_1KoZbrev-EKojXBqYYTD8A_9_16">874</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Stock option exercises</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_SQdoaQ3N-UWtxc52hvNbLQ_10_2">497,385</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_ccZ8j7iWYEm9uqAoJ4F60g_10_10">1,464</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_QFInOohw60aoH4BkCWPJtw_10_16">1,464</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_dzdA0zDcLUCDqkanK7gGyQ_11_10">562</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_ET4msWZU6Umj9cSSWUIaEg_11_16">562</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ZO7co7_VOEuQO3x8dm2CXQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_A1uVsM1j70uVSuQWaat8Kg_12_13">40,899</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc__tL0pM8J3kaWYgUf_BKXLw_12_16">40,899</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUJvfYZkXkeH62F-h-9aEw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" id="Tc_Ru9meTnerUSaomQUfK7mNw_13_2">9,770,908</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUJvfYZkXkeH62F-h-9aEw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_viBs7vuWAkC34Q6A1BXnpg_13_5">9</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_8Bg3PzLN0UiL0idVDay18A" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Tc_mavkLrMjEkSYTdJ2pvAfTw_13_7">214,422</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_SU2XSK94YkGDlZDDBasXLw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_FQ2hj8HHw0-n44RjJowdnw_13_10">130,039</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_eItsRBJS3UqRPJXG0t2wwg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_iFrtpwSLU0y7Ajm7xUue5Q_13_13">100,702</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.7pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_kp73nCpmiEWqKCSytCcGAg_13_16">230,750</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;">(See accompanying notes to financial statements)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_18fd84be_b161_49d1_a3d6_ebdb3015873a"></a><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;text-align:center;margin:0pt;">Semler Scientific,&#160;Inc.</p><a id="StatementsofCashFlows_410902"></a><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;text-align:center;margin:0pt;">Statements of Cash Flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">(In thousands of U.S. Dollars)</span></p><a id="_e32f1636_de41_4fcb_a5fa_c71050a3313a"></a><a id="Tc_HUErcU91d0-xps0uhRIRFw_1_2"></a><a id="Tc_jSBF093RBkaWwyxg5wypww_2_2"></a><a id="Tc_UZVuAtXq3Ee6Zbohgal5TQ_2_5"></a><a id="Tc_gKyobxQOQEuNjtCh4e02yQ_3_0"></a><a id="Tc_v0pT6S6-VkW9dEIr9zzpAg_4_0"></a><a id="Tc_Qbt0URaCqkGJJu6uxq9kGA_4_2"></a><a id="Tc_sLe8-Z1Va0yVobA5vFYVcw_4_5"></a><a id="Tc_iph2EqJVl0mki5sMKQczSA_6_0"></a><a id="Tc_8tOLjS7Co0ebnmXRATkC0A_7_0"></a><a id="Tc_QL9hrKv_xEeTSFx_17w0Kg_8_0"></a><a id="Tc_xryLU4vtKkaW_t-75wpGjQ_9_0"></a><a id="Tc_vuq4dOYF50ye7fWWXol-Cw_10_0"></a><a id="Tc_9ONrEy3VqUqrmruzfmT9Cg_10_3"></a><a id="Tc_cPSUTp9wqUuVmvyPfKgK3Q_11_0"></a><a id="Tc_K4l_me8pM0aJj3Is7Mw12Q_11_3"></a><a id="Tc_t5Dyy38VhE-3wkEDdPxzZg_12_0"></a><a id="Tc_tl9Sao4UOU2iefQjufZArQ_13_0"></a><a id="Tc_izh1adfgEEKW34Ys--RqyA_14_0"></a><a id="Tc_pkSSZuaS7UeWOe0NdhMVtg_14_6"></a><a id="Tc_YzxAAwXF3UuSKLtSyth5_Q_15_0"></a><a id="Tc_FmwfKCV9rEGUa-EoeVXhnw_16_0"></a><a id="Tc_QnF_MTxqBkWoMyNFjvd5Yw_16_3"></a><a id="Tc_zUAdg0jV_EGU00Vw2tPjYA_17_0"></a><a id="Tc_pFx-f0S8FkikVCWifoo51Q_18_0"></a><a id="Tc_m6jML3nYPU2inmEb_fT00Q_19_0"></a><a id="Tc_ou57FleeU0K9teEySIhd-Q_20_0"></a><a id="Tc_w_HYDx6XWEWN3nbllYUXkQ_21_0"></a><a id="Tc_WpY2hnw2bU-4Oja8f_47ig_22_0"></a><a id="Tc_BBLiIour3UOC9rJZ7r6M6g_23_0"></a><a id="Tc_uA7gBgzt4U6UlXsQuuviUw_24_0"></a><a id="Tc_sHAYLufWx0ymEtEwoFF-ng_25_0"></a><a id="Tc_Ct6zYa4nkUO7VHOLvxklRA_27_0"></a><a id="Tc_C1CfTCZyb0-YdrJd_folAg_28_0"></a><a id="Tc_Kj60yRv09US27S9Vy2m6WA_29_0"></a><a id="Tc_kIatUCI0jUO53OHVLcdQJQ_30_0"></a><a id="Tc_xOu3IxgjqU-xr1dOuMpMiw_30_6"></a><a id="Tc_iEL6Gn-FlEq2scFRJP865Q_31_0"></a><a id="Tc_Pt6PTyKXfUWuG_F1BjxPnQ_31_3"></a><a id="Tc_GP4H7wgN3U6FW0DF8BANXA_32_0"></a><a id="Tc_xvu54vXGhUq4fSFCLiNlzQ_32_3"></a><a id="Tc_C-7t3_EbIkmkRELhb60uUw_33_0"></a><a id="Tc_dlgxl9dDlEygfYVhAJORnA_34_0"></a><a id="Tc_vzrysLosHEiOE1TcqPdbgg_36_0"></a><a id="Tc_AB9hjy2rR06SA8-fTC0TSg_37_0"></a><a id="Tc_lXmqcF2Igk-Ts1KiPHKFpQ_37_6"></a><a id="Tc_lQFQYRyM0ka2GhNIJ4wr0g_38_0"></a><a id="Tc_ue5zFrH870-YVhDBlADzDw_39_0"></a><a id="Tc_4Yz3Eb2kXEGaZUok9mhDHw_39_3"></a><a id="Tc_m0Hz7G9b2USsll5EGOYoWg_40_0"></a><a id="Tc_3J82KKneuU2QMfv20ut7FA_40_6"></a><a id="Tc_R0MEgi8Op0SnZaK-t0qhrw_41_0"></a><a id="Tc_nO1TmkUVnUOGJaHohBS2Xg_42_0"></a><a id="Tc_Qbgyyp4q00qh1PeiquY5NQ_43_0"></a><a id="Tc_f0YRfuYJ4UKQngtARRNebQ_44_0"></a><a id="Tc_UnV5611HrUqILxbnAg-6Vg_45_0"></a><a id="Tc_nF-C80fpd0yW0vJersfJAA_45_2"></a><a id="Tc_4f3RDT6Ut0u5B_wIZC4Dhw_45_5"></a><a id="Tc_PISona-_1UepfqCYdkoe2Q_46_0"></a><a id="Tc_TEaqHWjWzU2uZdtojXGWSA_47_0"></a><a id="Tc_so6Aw4bZbUSSuoe2GzIbMA_47_2"></a><a id="Tc_VmWj5pmO1UqaWe5L5x1nVA_47_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the year ended December&#160;31,&#160; </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">CASH FLOWS FROM OPERATING ACTIVITIES:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Net income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="Tc_SJ7j3X9mVkakcS_5abMXqA_4_3">40,899</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="Tc_KTRBtS3v3UebYndCIH7IFA_4_6">20,583</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-size:9pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Reconciliation of Net Income to Net Cash Provided by Operating Activities: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="Tc_eNtf2Rkbq0OQ5cYoA1d8dQ_7_3">579</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="Tc_L9oc5lVrLkqNhLrnNCRq6Q_7_6">599</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Deferred tax expense (income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="Tc_6hS3Vwr9YEWsWSkQmBRqsQ_8_3">5,727</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_RThs7KOSl0Oauf2Yj-73Ag_8_6">664</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Loss on disposal of assets for lease</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" sign="-" scale="3" id="Tc_I4rm7jcBRkKUp3yd0NZc-g_9_3">298</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" sign="-" scale="3" id="Tc_S1G6YNy8iE-LDr7T9oYtbA_9_6">369</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Write off of prepaid software licenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:PrepaidLicensePurchasesWriteoff" scale="3" id="Tc_fBr9IQDmikuHzrgkQXLlpg_10_6">2,476</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Gain on short-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="3" id="Tc_8CVz8ao_pESX24Tk3C1qog_11_6">151</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Allowance for credit losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" sign="-" scale="3" id="Tc_dWWNuQk9xU-Bi0Ldt2_0BA_12_3">88</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="Tc_STgV2uH_yEy4xTIcFZX-zg_12_6">268</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Change in fair value of notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:FairValueAdjustmentOfNotesHeldForInvestment" sign="-" scale="3" id="Tc_Vpc9k5vwnEOli3thJcvmtQ_13_3">128</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:FairValueAdjustmentOfNotesHeldForInvestment" scale="3" id="Tc_bzdyuvvRIECRY-JgsSFuWA_13_6">307</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetUnrealizedGainLossNonoperating" scale="3" id="Tc_-bSybWROLEK_GAxyGqIg3w_14_3">24,933</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="Tc_P_GMA3igh0imd91016Vn5g_15_3">862</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="Tc_QZDUtrF5UEOVbA1SE39kcQ_15_6">944</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Impairment of long-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ImpairmentLossesInvestments" scale="3" id="Tc_3an2R0TWMU2npswjabe2Mw_16_6">337</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Changes in Operating Assets and Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Trade accounts receivable </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" sign="-" scale="3" id="Tc_gtwKLp-fh0myioR1C_5idQ_18_3">1,844</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="Tc_v4XsTgtdl0Ch9wOC0H0BNw_18_6">2,508</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Inventory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" sign="-" scale="3" id="Tc_mLu-ZViFy0mYlQ3aCv0e3Q_19_3">88</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" sign="-" scale="3" id="Tc_zAxiRH-9QE2bbyMK-mRlnA_19_6">24</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Prepaid expenses and other current assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="Tc_1KQP5h3Wj0av1JxjwQKV9g_20_3">865</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="Tc_cYwnzI2kJkCY8oS03-FNsQ_20_6">603</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Other non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" sign="-" scale="3" id="Tc_xMokTKKaSkOMl6xSnMIX3A_21_3">85</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" sign="-" scale="3" id="Tc_MBk3-PKsckGepL9Tf1o0JQ_21_6">96</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Accounts payable </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" sign="-" scale="3" id="Tc_CtWeixsJ3kujMjcYDc8KjA_22_3">262</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" sign="-" scale="3" id="Tc_-a7lCid-dUGYBr4VlP1sRw_22_6">433</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="Tc_QB3YcEpe-029ucl4gx_8wQ_23_3">671</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" sign="-" scale="3" id="Tc_hB33Q9gteUetEC32MXTQPQ_23_6">246</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 12pt;">Other current and non-current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" sign="-" scale="3" id="Tc_WFc0o0hJ80aaZUwWA96BPw_24_3">367</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" sign="-" scale="3" id="Tc_vK9T1h74fUyjSajyfYn_UQ_24_6">68</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 18pt;"><b style="font-weight:bold;">Net Cash Provided by Operating Activities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_GXezlOhTJ0WKataRfrc4cg_25_3">24,410</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_LmqLMrl8VUybNTDfwzuHtw_25_6">21,330</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;"><span style="font-size:9pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">CASH FLOWS FROM INVESTING ACTIVITIES: </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Additions to property and equipment </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_349_ShYcm0mFf1VnQ_a7gQ_28_3">51</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_G69O1ivdeUesAhg4YmGMag_28_6">345</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Purchase of notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="Tc_4YZFlsF2y0KRED0qFE22eA_29_3">500</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="3" id="Tc_oGOI6m4XokGiFayFr9wklQ_29_6">1,000</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Purchase of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentForAcquisitionCryptoAsset" scale="3" id="Tc_aWfNM0xa8UuM43IUVK6EDg_30_3">189,700</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds from maturities of short-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="Tc_OErqNrJlL06ZwEiuNUPTdA_31_6">78,093</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Purchase of short-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="Tc_tNBOAsQId0akVUHrSxntzw_32_6">57,869</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds from sale (purchase) of assets for lease </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ProceedsFromPaymentsForEquipmentForLeases" sign="-" scale="3" id="Tc_GUVUZ0xVn02MV40pe84KKQ_33_3">269</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ProceedsFromPaymentsForEquipmentForLeases" scale="3" id="Tc_sJHLPKiYBUCiVMLu6mMEfA_33_6">483</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 18pt;"><b style="font-weight:bold;">Net Cash (Used in) Provided by Investing Activities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="3" id="Tc_c-LkYD5Uc0-RjVDikmeyWg_34_3">189,982</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="Tc_f9PKiWunNUSqAjzft5wBeA_34_6">18,396</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">CASH FLOWS FROM FINANCING ACTIVITIES:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="Tc_Em7jhUqhQ0KkRaDNirXvVA_37_3">119,602</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Taxes paid related to net settlement of equity awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="Tc_QzYBm1TgkkC-Y6No3lJYGg_38_3">874</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="Tc_rtjpNIjvpkebCJiGu8Jghg_38_6">3,510</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Common stock warrants acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="3" id="Tc_-J1_bTyF80urFOuhvLpXIA_39_6">1,949</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Stock issuance expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="Tc_kddbQIYhyEWNbD8KCrwGUQ_40_3">3,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds from exercise of stock options </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="Tc_LuXtQ2W96UOZrjsfJd6g1g_41_3">1,464</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="Tc_92n8x9kY6kyvCciyeGvlpw_41_6">51</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 18pt;"><b style="font-weight:bold;">Net Cash Provided by (Used in) Financing Activities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="Tc_eCo7hvdx-0KoUnAXhxKebQ_42_3">117,192</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" sign="-" scale="3" id="Tc_4cUKATLmFUWqbqCdvwIg2A_42_6">5,408</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" sign="-" scale="3" id="Tc_dJT0mlor_0C-sFVIIkkkQg_43_3">48,380</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="Tc_iuV_9mKQfkmBIgOxtkDu9g_43_6">34,318</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_fKOON5WAFUexZk6qS7zSDg_44_3">57,332</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_leQRdcV4rkCI8NN3EV0CaA_44_6">23,014</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_-fZcppec3kyi9sCAOHLtww_45_3">8,952</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_E7g1RWAHHUCIxsCijYWB0g_45_6">57,332</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:70.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Supplemental Disclosure of Cash Flow Information:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for taxes </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="Tc_6vaXR-_AoEasgWim7TxBCQ_47_3">2,260</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="Tc_LsTrbZASgUGbACbanXyk0A_47_6">4,060</ix:nonFraction></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;">(See accompanying notes to financial statements)</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="a1TheCompany_862479"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:NatureOfOperations" id="Tb_814XYBOMlEWFmmUCMR5LFQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">1.&#160;&#160;&#160;&#160;The Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Semler Scientific Inc. (the &#8220;Company&#8221;) is a company developing and marketing technology products and services that assist its customers in evaluating and treating chronic diseases. The Company&#8217;s patented and FDA cleared product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of PAD. The Company also invests in bitcoin and have adopted bitcoin as its primary treasury reserve asset. As an operating business, the Company uses cash flows as well as proceeds from equity and debt financings to accumulate bitcoin. The Company&#8217;s healthcare technology solutions business is its predominant operational focus, providing cash flows and enabling it to pursue its bitcoin strategy.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="Tb_Gv6NkqkDfU61zVFD0_CeAQ" continuedAt="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies and Estimates</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Tb_2XeINhyGaESDe0lE9cZBjQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis for Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:UseOfEstimates" id="Tb_-EPIZkvnBEapaBLOZl5CGg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">The preparation of the accompanying financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses, and related disclosures during the reporting period. Significant items subject to such estimates include allowance for credit losses, valuation of equipment on lease, recognition and measurement of current and deferred income taxes, valuation and recognition of investments and intangible assets and valuation of inventory. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ConcentrationRiskCreditRisk" id="Tb_dIFfhBNGzU-Dv-agWKvFAA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, bitcoin, accounts receivable and trade payables. The Company maintains its cash and bitcoins with major financial institutions and reputed bitcoin traders. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The cash and cash equivalents also include U.S. government money market fund accounts. Our bitcoins are held offline in cold storage with multiple third-party providers. The Company manages its accounts receivable credit risk through ongoing credit evaluation of its customers&#8217; financial conditions. The Company generally does not require collateral from its customers.&#160;For information regarding the Company&#8217;s significant customers and vendors, see Note 12 to financial statements.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="Tb_iSvfcVYAQEigtndx68QXFA" continuedAt="Tb_iSvfcVYAQEigtndx68QXFA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue Recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company generates revenues primarily from the rental or license of its vascular testing product. The Company recognizes revenues from the licensing of its product primarily pursuant to agreements that automatically renew each&#160;month with revenue recognized on a daily convention basis or when the test is performed. The Company&#8217;s arrangements with customers for its vascular testing product are normally on a&#160;month-to-month basis with fees billed at the rates established in the customer agreement, either on a fixed or variable (e.g. fee per test) basis, as earned. The </p></ix:nonNumeric></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont1" continuedAt="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont2"><ix:continuation id="Tb_iSvfcVYAQEigtndx68QXFA_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company also recognizes revenue for hardware and supplies sales as of the date of shipment. Shipping and handling costs are included in cost of revenues in the statement of income. Payment terms of the customers are net <ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt:num-dot-decimal" name="smlr:RevenuePerformanceObligationPaymentTermsNumberOfDays" scale="0" id="Narr_35F9E4jtwkGGbp72nNh2VA">30</ix:nonFraction> days. Semler replaces the defective sensors with <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt-sec:numwordsen" name="smlr:DefectiveProductReplacementCost" scale="3" id="Narr_7je6ECJXaE62PyGherG-IQ">no</ix:nonFraction> charge. Other than replacing the defective sensors there are no other obligations to the customers. </p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Tb_RQq3bmHna0-DBhB3w7MNcg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Cash and cash equivalents are comprised of highly liquid investments purchased with an initial maturity date of three&#160;months or less. Funds held as investments in money market funds are included within cash and cash equivalents.</span>&#160;Restricted cash represents amounts pledged as cash security related to the use of credit cards.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy" id="Tb_-yotMJXkJ0WGpQcyyPrydQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Short-Term Notes Held for Investments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#111111;background:#ffffff;">Short-term notes held for investments are</span><b style="color:#111111;font-weight:bold;background:#ffffff;">&#160;</b><span style="color:#111111;background:#ffffff;">those</span><span style="color:#111111;background:#ffffff;"> investment instruments that will mature within one year or which are expected to be liquidated within one year.</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="Tb_CconJ8IGP0-X3lUjFJLauQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Accounts Receivable and Allowance for Credit Losses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Accounts receivables are recorded at the invoiced amount, net of allowances for credit losses. T<span style="background:#ffffff;">he allowance for credit losses is based on management&#8217;s assessment of the collectability of accounts. The Company regularly reviews the adequacy of this allowance for credit losses by considering historical experience, the age of the accounts receivable balances, the credit quality of the customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect customers&#8217; ability to pay to determine whether a specific reserve is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for credit losses when identified. Accounts receivable, net as of December 31, 2024, December 31, 2023 and December 31, 2022 was </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Narr_cKiJPDRSYE-e8N234dZXlQ">4,378</ix:nonFraction></span><span style="background:#ffffff;">, </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Narr_QGZwHa2j2kGlGIqpA7W8BQ">6,125</ix:nonFraction></span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Narr_HhuroLLR9kmDRGUqW7rNoQ">3,884</ix:nonFraction></span><span style="background:#ffffff;">, respectively, include </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ContractWithCustomerAccountsReceivableNet" scale="3" id="Narr_xX_f_S5TNEa-M_DPBVLlqw">2,067</ix:nonFraction></span><span style="background:#ffffff;">, </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ContractWithCustomerAccountsReceivableNet" scale="3" id="Narr_iRZp_fZfYECK_LBNESaiAQ">5,966</ix:nonFraction></span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ContractWithCustomerAccountsReceivableNet" scale="3" id="Narr_Rv1tmsCZt06S6ncEzaDGLw">1,735</ix:nonFraction></span><span style="background:#ffffff;">, respectively, related to revenue recognized under ASC 606.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2024, the allowance for credit losses was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="Narr_UyhUT4sXQkmkXqwDz3gmlw">199</ix:nonFraction>. During t<span style="color:#212529;background:#ffffff;">he year the Company provided an additional reserve of&#160;</span><span style="color:#212529;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AccountsReceivableAllowanceForCreditLossAdditionalReserve" scale="3" id="Narr_2_Pd7dJ1r0evUYrBVQ9How">135</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">&#160;and recovered&#160;or expensed credit losses of </span><span style="color:#212529;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="3" id="Narr_E_n-2kAkQEubW9pk8CTFYQ">223</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">&#160;from customers. The allowance for credit losses as of December 31, 2023 was&#160;</span><span style="color:#212529;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="Narr_Ori9yOm150alvl482kMONw">287</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">. </span>Credit losses related to ASC 606 receivables were $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" scale="3" id="Narr_BaslISXMIkWyeSuXM-onqQ">113</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" scale="3" id="Narr_B87ekxVVe0eQ7KFNrcAzzg">6</ix:nonFraction> as of December 31, 2024 and December 31, 2023, respectively.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;background:#ffffff;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:InventoryPolicyTextBlock" id="Tb_K-0mSLsgh02hFlVGuPKysQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Inventory</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inventory, which is made up of finished goods, is recorded at the lower of cost or net realizable value. Cost is determined on the first-in, first-out method. The Company periodically analyzes its inventory levels to identify inventory that has a cost basis in excess of its estimated realizable value and writes down such inventory as appropriate.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:LessorLeasesPolicyTextBlock" id="Tb_Gi2gPl2aNEOHR43h1YHq_Q" continuedAt="Tb_Gi2gPl2aNEOHR43h1YHq_Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Assets for Lease</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Assets for lease are recorded at cost. At December&#160;31, 2024 and 2023, assets for lease consisted of vascular testing devices, which are primarily leased to customers. The cost of such assets for lease is depreciated on a straight-line basis over <ix:nonNumeric contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_W64GlRtDm0icy9iIeB1Rwg" format="ixt-sec:durmonth" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_R95EeqOS6E-H0FOn7xV-5Q"><ix:nonNumeric contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_MakASwJL4Euo7dVHvkl2rA" format="ixt-sec:durmonth" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_fOrX2G_4-0C-l5b4A0IvrA">36</ix:nonNumeric></ix:nonNumeric> months for the units outstanding and recorded as cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of assets may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected undiscounted net cash flows associated with the related assets over their estimated remaining lives against their respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its assets for lease in this analysis. Impairment, if any, is </p></ix:nonNumeric></ix:continuation></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_7543645b_12c9_45a0_aba7_5b4b19d38946"></a><a id="Tc_Np_5w5w24Uq4W8vOjrsVdQ_1_0"></a><a id="Tc_aiUhC2wSAEGLjCY_RXGSdQ_1_2"></a><a id="Tc_QtRSobhlqkWvdX01HWxxGA_2_0"></a><a id="Tc_moIBJbdfNUmThZnHdAy0yQ_3_0"></a><a id="Tc_9D9kI0Rz4EW52YgHrl66ig_4_0"></a><ix:continuation id="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont2" continuedAt="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont3"><ix:continuation id="Tb_Gi2gPl2aNEOHR43h1YHq_Q_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="smlr:IntangibleDigitalAssetsPolicyPolicyTextBlock" id="Tb_7yMOEfsasEWfkoSVWgdO2w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Intangible Digital Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 350, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other</i>. The Company has ownership of and control over its bitcoin and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoin. The Company&#8217;s digital assets are initially recorded at cost and subsequently remeasured to fair value at the end of each reporting period, with changes recognized in other income, net.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company purchases bitcoins for long term investment. It intends to hold its digital assets for long term gains and treats them as long term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. A valuation allowance is recorded for unrealized capital losses. Bitcoins are stored in cold wallets. Average cost of wallet is used for calculating the unrealized gains or losses. See Note 9 to Financial Statements for additional information regarding the Company&#8217;s purchases and sales of digital assets. </p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="Tb_XtOeX9BHj0CZKhhllu7Pow" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Capital assets are recorded at cost. The cost of such capital assets is depreciated on a straight-line basis over a term depending on the assigned category (described below) and recorded as depreciation for capital assets recorded in engineering and product development, sales and marketing and general and administrative expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are classified into one of the following categories:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;">Category Name</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:48.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;">Description</p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Manufacturing, R&amp;D, or other non-office equipment</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Software, computers, monitors, printers and other related equipment.</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Office equipment and furniture owned by the company</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="smlr:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="Tb_ysmB9l1fQUypiNSM-c8fVw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Account Name</b></p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Useful Life </b></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_aCUWSs44WUuNTnqFFLPMZQ" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_n0nildnlwEemUwutvVsqmA_2_2"><ix:nonNumeric contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_4CDoFoOHw0GbAdFoHlt6Mg" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_n0nildnlwEemUwutvVsqmA_2_2_2">Five years</ix:nonNumeric></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_mGIHHxS_ZEuc6ViWxpMJ9Q" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_oGQxYOTIHEKL4sjfnsY3_w_3_2"><ix:nonNumeric contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_aqZhN0s0ZEyt9Xlfg5w8DA" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_oGQxYOTIHEKL4sjfnsY3_w_3_2_2">Three years</ix:nonNumeric></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_f0cWWAE48EORHBh0d2T8Nw" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_hKcQqcZp1USyPr2-q-WOag_4_2"><ix:nonNumeric contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_KiuY18k-9k-jS6iTZaYS0Q" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_hKcQqcZp1USyPr2-q-WOag_4_2_2">Five years</ix:nonNumeric></ix:nonNumeric></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of capital assets, may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected fair value of the related asset over the estimated remaining life against the respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its capital assets in this analysis. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont3" continuedAt="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont4"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="Tb_yHtli0_LCUKZ3WruM-T-Ag" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Impairment of Long-Lived Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-15, &#8220;Impairment or Disposal of Long-Lived Assets.&#8221; ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals. </p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Tb_tvDx57qGvEOO_GLgXXJUlQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of the fair value hierarchy under Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, Fair Value Measurement, are described as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 1 </i>&#8212; Unadjusted quoted prices in active markets for identical assets or liabilities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 2 </i>&#8212; Inputs other than quoted prices included in Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 3 </i>&#8212; Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own models.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The financial instruments of the Company consist primarily of cash, U.S. government money market fund accounts, trade receivables, trade payables, bitcoins, and debt securities. Because carrying values of cash, trade receivables, and payables are equal to or approximate their fair value, the Company excluded them from the leveling requirements. U.S. government money market fund accounts are classified as Level 1&#160;due to their short-term nature, their market interest rates and also based on the fact that they are publicly traded. Bitcoins purchased for investments, which are included in Intangible digital assets are classified as Level 1 as the unadjusted quoted prices in active markets are used for the fair valuation. The Company also invests in non-convertible promissory notes and equity securities in a privately held company, which were recorded on cost basis. See Notes 7 and 8 to Financial Statements for more information.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="background:#ffffff;">The Company's privately held debt security is recorded at fair value on a recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company deems these assets as Level 3 within the fair value measurement framework. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">As of December 31, 2024, the Company valued the debt security at face value of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecurityFaceValue" scale="3" id="Narr_yyfKhodQx0mYn4cOu1ZIsg">5,000</ix:nonFraction></span><span style="background:#ffffff;">. The original maturity date of December 6, 2024 was extended to January 17, 2025 and a partial amount of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA" decimals="-5" format="ixt:num-dot-decimal" name="smlr:ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" scale="6" id="Narr_fmyrg6p3ZUGKr59w_unVIA">3.5</ix:nonFraction></span><span style="background:#ffffff;"> million along with transaction fee of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ProceedsFromTransactionFeeOfDebtSecurities" scale="3" id="Narr_pESamiXsdEy2jveoUhE9Cw">100</ix:nonFraction></span><span style="background:#ffffff;"> and accrued interest of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ProceedsRelatingToAccruedInterestOfDebtSecurities" scale="3" id="Narr_9rX0Pj6T40KKTrGUf4uukA">47</ix:nonFraction></span><span style="background:#ffffff;"> was collected on January 15, 2025. A new amended and restated secured convertible note for the balance of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lEsvR7g5ukqjO6r8JvkH_g" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="6" id="Narr_Uu94bUFjtEOGlqnmklpohw">1.5</ix:nonFraction></span><span style="background:#ffffff;"> million was signed on January 15, 2025 with new terms (see note 20 for the details). The fair value of the Company&#8217;s privately held debt security was estimated at&#160;</span><span style="background:#ffffff;">$</span><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecurities" scale="3" id="Narr_uLtmNMC6Gk2WFNE5UMGLbw">5,000</ix:nonFraction> as of December 31, 2024, in view of partial payment and a new note for the balance was signed<span style="background:#ffffff;">.</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></ix:continuation></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont4" continuedAt="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont5"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:InvestmentPolicyTextBlock" id="Tb_JftLfFRCyUCfttiOQCiq9Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Investment Valuation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s investments in equity in privately held companies without readily determinable fair values, which are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. As part of its assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If its qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgment and subjectivity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> The Company did not record any impairment during the year December 31, 2024. The Company recorded an impairment of </span>$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="3" id="Narr_iiwXAJ8iLEmWrOmHy7R48A">309</ix:nonFraction> for the preferred stock investment in Mellitus Health, Inc (&#8220;Mellitus&#8221;) during the year ended December 31, 2023. </p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="Tb_R8OAZvcn4U2VdGzft10GYg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Deferred Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;">Deferred revenue represents amounts billed to or collected from customers for which the related revenues have not been recognized because one or more of the revenue recognition criteria have not been met. The full amount is expected to be recognized as revenues within one&#160;year from the balance sheet date and, therefore, such deferred amounts have been classified as current liabilities in the balance sheets presented. The Company generally invoices its clients in advance of a rental period with payment due upon receipt of the invoice. Revenue recognized for the year ended December&#160;31, 2024 from amounts included in deferred revenue as of December 31, 2023 was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="Narr_Qvvq1BENjESoLMtdeIZnCQ">1,120</ix:nonFraction>. Revenue recognized for the year ended December&#160;31, 2023 from amounts included in deferred revenue as of December 31, 2022 was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2022_To_12_31_2022_IcqC7PE9WUiygajKvbmwNg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="Narr_ly8avF1qEUiE39RjeDHrww">1,160</ix:nonFraction>.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="Tb_cVUaU9UEYUueNGhg8U25uQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Advertising Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company expenses advertising costs as incurred. Advertising expense incurred during the years ended December 31, 2024 and 2023 was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="3" id="Narr_39TCRU9QpES6345lorjMbA">167</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="3" id="Narr_aMcOES85XkqTaxsZbFglQA">319</ix:nonFraction>, respectively. These costs are included in sales and marketing expenses in the statements of income.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="Tb_f1KWc_kzkUCcV19D12eSTQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company expenses costs related to the research and development associated with the design, development, testing and enhancement of its products and services. Such expenses include salaries and related employee benefits, and fees paid to external service providers. The Company incurred Research and development expenses of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="Narr_mNlsiAeRNky5E4G7-qtbuQ">4,792</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="Narr_1XO2R-27REeP5nGFPmI1wA">5,773</ix:nonFraction> for the year ended December 31, 2024 and 2023, respectively.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="Tb_s-nBoWBQ9UGYQ5KIncwmqw" continuedAt="Tb_s-nBoWBQ9UGYQ5KIncwmqw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock-Based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock-based compensation expense is measured based on the grant-date fair value of the stock-based awards. The Company recognizes stock-based compensation expense for the portion of each option grant or stock award that is expected to vest over the estimated period of service and vesting. The Company uses the Black-Scholes option pricing model as the method for determining the estimated grant-date fair value of stock options. The Black-Scholes option pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected volatility. Forfeitures are recognized as incurred. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the grant. See Note 16 to financial statements for the details.</p></ix:nonNumeric></ix:continuation></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont5" continuedAt="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont6"><ix:continuation id="Tb_s-nBoWBQ9UGYQ5KIncwmqw_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:EmployeeStockOwnershipPlanESOPPolicy" id="Tb_Ho9_9hviPU2DxnzSXLpTgA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Employee Benefit Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company has a savings plan that qualifies under Section&#160;401(k)&#160;of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Effective January 1, 2022, the Company started to match&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="Narr_gyFNN0eETUKSkFHeU5Bi1g">50</ix:nonFraction>% of employee&#8217;s 401(k) deferral up to a maximum of&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="Narr_JhxHcQxsR0GR1sU6J2uIWw">6</ix:nonFraction>% of the employee&#8217;s eligible earnings.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:IncomeTaxPolicyTextBlock" id="Tb_LCzwpfLJz0Sj81nIlsIpuQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the expected tax consequences attributable to the differences between financial reporting and the tax bases of existing assets and liabilities and net operating loss (&#8220;NOL&#8221;) carryforwards, and they are measured using enacted tax rates expected to be in effect when differences are expected to reverse. </p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Tb_QDcwtcjKoUO9PuDOs1A7TA" continuedAt="Tb_QDcwtcjKoUO9PuDOs1A7TA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recently Issued Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Accounting Pronouncements Recently Adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In November 2023, the FASB issued <span style="background:#ffffff;">Accounting Standards Update</span> (&#8220;ASU&#8221;)&#160;2023-07&#160;&#8220;Segment Reporting: Improvements to Reportable Segment Disclosures&#8221;. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an entity&#8217;s financial statements. The Company adopted the new accounting standard for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s financial statements related disclosure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-08, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets</i> (&#8220;ASU 2023-08&#8221;). ASU 2023-08 requires in-scope crypto assets to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning after December 15, 2024, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company <ix:nonNumeric contextRef="As_Of_6_30_2024_geCWm453AUejs3C95T9_VA" format="ixt:fixed-true" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" id="Narr_H_Mlo678kEGT5v5M2UKhOg">early</ix:nonNumeric> adopted <span style="-sec-ix-hidden:Hidden_J8wOH7bw2UqoKIsy6ORpDQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ASU 2023-08</span></span> in the second quarter ended June 30, 2024, effective retroactively as of January 1, 2024 with <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate202308Member_ErqcZCu5GEuuVGLzwhazqA" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="Narr_Ee0ThvbcbUeW3uI9vjbgSA">no</ix:nonFraction> cumulative-adjustment to the retained earnings as of the beginning of the annual period of adoption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements not yet adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:6pt;text-indent:18pt;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-09,<i style="font-style:italic;"> Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning after December 15, 2024 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. Adoption of this update is not expected to have a significant impact on the Company&#8217;s financial statements and related disclosures.</p></ix:nonNumeric></ix:continuation></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_Gv6NkqkDfU61zVFD0_CeAQ_cont6"><ix:continuation id="Tb_QDcwtcjKoUO9PuDOs1A7TA_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">In November 2024, the FASB issued ASU 2024-03,</span><i style="font-style:italic;background:#ffffff;">&#160;"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.</i><span style="background:#ffffff;">" This standard requires entities to disaggregate operating expenses into specific categories such as employee compensation, depreciation, and intangible asset amortization, by relevant expense caption on the statement of operations. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, which means that it will be effective for the Company&#8217;s annual and interim reporting for the fiscal year ending December 31, 2028. Early adoption is permitted on either a prospective or retrospective basis. The Company is currently evaluating the impact of adopting ASU 2024-03 on its financial statements and related disclosures.</span></p></ix:continuation></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="Tc_uQxAVM-Pfk2NoatWf17Ecw_1_2"></a><a id="Tc_9if65cXqr0atC1dvTBhjxw_2_2"></a><a id="Tc_o1HActcn2EWix-Q3OOMlXw_2_5"></a><a id="Tc_CwpgtRXm_0mUSmsYWRXrug_3_0"></a><a id="Tc_kWQzBsSJqUamHOW5CKkUEg_3_2"></a><a id="Tc_UzijPIF4-keTLK1tU8SF7Q_3_5"></a><a id="Tc_VsKfBAUax02hIOavLrLi4A_4_0"></a><a id="Tc_VjNmgRE1lEWA7b3YjE89rw_5_0"></a><a id="Tc_49T5NpUsdUqUmp9nM2pZQQ_5_2"></a><a id="Tc_YrJVrtTCIEqX1lXctYTbCw_5_5"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="smlr:AssetsForLeaseNetTextBlock" id="Tb_R2LoiuOOCkmrFRR5sCaXrg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">3.&#160;&#160;&#160;&#160;Assets fo<span style="font-weight:normal;">r</span> Lease, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company provides financing of certain equipment through operating leases (see Note 13 to the financial statements). Assets for lease consist of the following:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="smlr:ScheduleOfAssetsForLeaseNetTableTextBlock" id="Tb_25LWuDiQcUqZtU0uoIy0Yg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross" scale="3" id="Tc_T0YaJz-nPUmmNgOnf_L4Tg_3_3">2,522</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross" scale="3" id="Tc_9cxmj7JOHEec4XB0JQP0rA_3_6">3,375</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" scale="3" id="Tc_o1MQDEvA3kqA9DM2bsXVRQ_4_3">1,099</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" scale="3" id="Tc_12BBy_28UEW0rLk8W8rrpA_4_6">1,090</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease, net </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet" scale="3" id="Tc_AVl3XoozzE6K3N08A2gHzg_5_3">1,423</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet" scale="3" id="Tc_pDP7i_3RlEGGfWkcniSE_A_5_6">2,285</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Depreciation expense amounted to $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease" scale="3" id="Narr_ddAgcSZNWESejRUyRBkU6g">296</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease" scale="3" id="Narr_M9IWMXOPK0KpRzyCES1yXw">307</ix:nonFraction> for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Reduction to accumulated depreciation for returned items was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AssetsForLeaseReductionToAccumulatedDepreciation" scale="3" id="Narr_rnkZfTMRUkqycpDeafA6UQ">279</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AssetsForLeaseReductionToAccumulatedDepreciation" scale="3" id="Narr_NQwgeE99gEi5i0ECLJxdTA">441</ix:nonFraction> for the&#160;years ended December&#160;31, 2024 and December&#160;31, 2023, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" sign="-" scale="3" id="Narr_4KFD1WgSFUuusmb-Ncz1Ig">298</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" sign="-" scale="3" id="Narr_IQ9IeIvgd0-JOnMCWlhRdw">369</ix:nonFraction> for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, total assets for lease, net, in use at customer locations were $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AssetsForLeaseCustomerLocation" scale="3" id="Narr_2Z_EU36l-0ecAeuT9RA5_A">295</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:AssetsForLeaseCustomerLocation" scale="3" id="Narr_ljqWYLhAYkmgdJ6LEBZ_Pg">489</ix:nonFraction>, respectively.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:InventoryDisclosureTextBlock" id="Tb_xHsXs6zwD0m_rV0PvFyQTg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">4.&#160;&#160;&#160;&#160;Inventory</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">As of December 31, 2024 and 2023, the inventory balance was </span><span style="font-weight:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="Narr_TuMza-JIFUqO1tzBzaZmdw">358</ix:nonFraction></span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="Narr_LBCG_JFQnkujaMUsLNfOBQ">445</ix:nonFraction></span><span style="font-weight:normal;">, respectively. Inventory includes finished goods of sensors, light blocking bags and heel warmers.</span></p></ix:nonNumeric><a id="Tc_vDEzNpcgEEm8I-7S-RtBpw_1_2"></a><a id="Tc_Zkm6R78alUaOjBqyxSs_2w_2_2"></a><a id="Tc_RV_vk45Yskqa-ONvQil3JQ_2_5"></a><a id="Tc_ZHkxEUGvG0eiMr-C8wExeA_3_0"></a><a id="Tc_EGT_-U8cJ0Gu68q6Pdja_w_3_2"></a><a id="Tc_7LeCl13EF0yTfrYBPvywTA_3_5"></a><a id="Tc_dgTmtjkzcUORoGk4-TB0Fg_4_0"></a><a id="Tc_I0kNsKUdzE60jpEfuo2bLQ_5_0"></a><a id="Tc_l4abs40GdkWHfWFZSeJyjA_5_2"></a><a id="Tc_3-V9ZGIBBkOrn8bD3imECw_5_5"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="Tb_KO7ktiYD9022rNq1_MMRMw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">5.&#160;&#160;&#160;&#160;Property and Equipment, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Capital assets consist of the following:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="Tb_xYHs-ND-h0SEaZTWYND8ZQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, gross</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" scale="3" id="Tc_2BJSysQaSEGl2yTft4JoQw_3_3">1,467</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" scale="3" id="Tc_vVapmHuKoU6GkwE0gekIjQ_3_6">1,544</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" scale="3" id="Tc_kU4_Z5Oy2UW6GcTw8SUSUQ_4_3">980</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" scale="3" id="Tc_YpKgZoFpeUOB7YHX8thC4g_4_6">824</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" scale="3" id="Tc_zQDjv1vdp0CvG9Oqn3WHuw_5_3">487</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" scale="3" id="Tc_jQLyByDy-UOEl2iFwIk6yw_5_6">720</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Depreciation expense amounted to $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" scale="3" id="Narr_HFRhriccPEibSkJHsfFdUA">283</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" scale="3" id="Narr_FjF62Nw4TEiOk0mn7n6cfg">292</ix:nonFraction> for the years ended December 31, 2024 and 2023, respectively.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_zFs9MufA40-kZspcPOOSBg_1_2"></a><a id="Tc_IZrkV-J9NEinQUhSEr1G-g_1_5"></a><a id="Tc_D38SLC3fh0GnCqJBNQFOBQ_2_2"></a><a id="Tc_WVng_rIgzkOD_Oq-3MlyEA_2_5"></a><a id="Tc_4gZ-eCrPykOyzYdRe5UhuA_3_0"></a><a id="Tc_17Dm89lTWUyE9AP-MFAuAw_3_2"></a><a id="Tc_t2yFjRKak0qLc1YnVzzzYg_3_5"></a><a id="Tc__eRuXrPpnU-gnJ1wav_6SQ_4_0"></a><a id="Tc_EB--mTOehEKduJWLS9tz8w_4_2"></a><a id="Tc_f0hAtlK5t0Cun6i_-tVCBw_4_5"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="Tb_frVN8W4bR0ufIFHokkUTqA" continuedAt="Tb_frVN8W4bR0ufIFHokkUTqA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">6.&#160;&#160;&#160;&#160;Long-Term Investments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Carrying value of non-marketable securities is measured as the total initial cost plus the cumulative net gain (loss). Carrying value of non-marketable equity investments consist of the following for the periods presented:</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" id="Tb_-3gPIoszA0ajVJjP8Vh08Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in SYNAPS Dx</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_XS97Wf2QpUu9KcNGDWoQlQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Tc_iGtSG9-CbECg3FAlRSTBYg_3_3">512</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_1wPfvi5hA0-P18KQ9-gxVw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Tc_Lb8R81JFbEuoWzhxpDA4vQ_3_6">512</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total long-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Tc_CiPms6-fC0qQtHBziwPivA_4_3">512</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Tc_3P0ERkYYJESAEVzCBurIVQ_4_6">512</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September 2020, the Company acquired a promissory note from NeuroDiagnostics Inc., which is doing business as SYNAPS Dx, in the principal amount of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_9_30_2020_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_hGBEk459TU6iXePXuBf5Gw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="Narr_zkUk7sXgsUqaRfLCMH-HfQ">500</ix:nonFraction>. Subsequently, in December 2020, the Company agreed to convert the promissory note, together with all accrued interest thereon, into shares of preferred stock of SYNAPS Dx as repayment in full of the promissory note. The value of the note exchanged for the shares of preferred stock of SYNAPS Dx held by the Company as of December 31, 2024 and 2023 was approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_X9WpoJSxJEq9lfFuf9gDtg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="3" id="Narr_xrb8btcuZES5OB_j27iwsw"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_-L_MetT9sEqjsLb_hMB9Gw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="3" id="Narr_FXHm96OcgUirbW3_oiApbg">512</ix:nonFraction></ix:nonFraction>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The investments in SYNAPS Dx as of December 31, 2024 were recorded in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 321, <i style="font-style:italic;">Investments &#8211; equity securities,</i> which provides that investments in equity securities in privately-held companies without readily determinable fair values are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. The Company elected the practical expedient permitted by ASC 321 and recorded the above investments on a cost basis. As a part of the assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgement and subjectivity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company assessed the investment for impairment in accordance with ASC 321. As of December 31, 2024, the Company determined that there was <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="3" id="Narr_Kju9t7qbY0qZiYpxZIMKJA">no</ix:nonFraction> impairment. A<span style="color:#212529;background:#ffffff;">s of December 31, 2023, the Company determined that there was an impairment to the preferred stock investment in Mellitus and recorded an impairment of </span><span style="color:#212529;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="3" id="Narr_ZIeSg0ZH2E2NJyP93VUraA">309</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">&#160;due to the following factors: 1) due to continued operating losses; 2) due to lack of revenue growth; and 3) delayed capital raise. The cumulative recorded impairment as of December 31, 2024, was </span><span style="color:#212529;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" scale="3" id="Narr_gncWHk88rEy6k6pI0sFacQ">309</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;background:#ffffff;">&#8203;</span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_frVN8W4bR0ufIFHokkUTqA_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_37b7ef06_5ff6_4201_b0a7_a2b493ef5996"></a><a id="Tc_6nC0U49f2ECO-gHZeNtmDw_1_1"></a><a id="Tc_StpxdBEY9E-j2SFB82UWyQ_2_1"></a><a id="Tc_hq1W6bdZxUiAxoV45rdddQ_2_4"></a><a id="Tc_57rcXaESV0qaKQO7jhtBgQ_2_7"></a><a id="Tc_mlE4lmneyEi_OOdxTMKLuQ_2_10"></a><a id="Tc_82-TWSmf_EOAt0bdQeuMsQ_3_0"></a><a id="Tc_xSqjBeLV7Euf6zkqzlfjxw_4_0"></a><a id="Tc_wzPf4g-ArUyovokpFhY-2g_4_1"></a><a id="Tc_F3JYCq_eNE2OrwI0H9j8yw_4_4"></a><a id="Tc_uG0--nXay0yp4UdRLs8M1A_4_7"></a><a id="Tc_s-NwDU1kcEaLNpclbzGwTQ_4_10"></a><a id="Tc_FY49SGcqS027SJGeSBJ-EA_5_0"></a><a id="Tc_3cPtVQeuO0aoPtCHhNU1DA_6_0"></a><a id="Tc_DvKNmssHZUi4nnJfhoBPvA_7_0"></a><a id="Tc_T4k9chRu_Uefmyk49yrnvg_8_0"></a><a id="Tc_q_TQjv2QYkOxEPPIjb1DeQ_8_1"></a><a id="Tc_HqVCvuRGtU-nNBNsdNQFsA_8_4"></a><a id="Tc_pkBoSPBQfESt-LNOuxLBKQ_8_5"></a><a id="Tc_hsG0QVrv8Eivzgadw4U_Xg_8_7"></a><a id="Tc_bSBXdlSCMUKmb9ATvOHxpw_8_8"></a><a id="Tc_DUi4A7KeIkWxnY3M0YVtwA_8_10"></a><a id="_03ed9c3b_57f0_405e_928a_0eec70af7a75"></a><a id="Tc_8P9o-7FtvUuR_OVokRSmOA_1_1"></a><a id="Tc_GIF5D5yej0qrg7fRT-0Kwg_1_4"></a><a id="Tc_l7FCNScq9Eioo77Zbp103A_1_7"></a><a id="Tc_-XPFr2OxHESP0wCOIk7CYg_1_10"></a><a id="Tc_boL7fLxA5UiyU_XL79cRbw_2_0"></a><a id="Tc_lWm6qyU0mUi8JYPv2IUQHw_3_0"></a><a id="Tc_ibaWklGtbkG0XK2meZSd8A_3_1"></a><a id="Tc_kAE_OXGGBUO8TDjz8jXQ9g_3_4"></a><a id="Tc_RLKDIoEcQEux84XWAViJ1A_3_5"></a><a id="Tc_T5VprTzwiEKJTfcqV5Cx_A_3_7"></a><a id="Tc_uuLfIYW87EWk2Giub8ehQw_3_8"></a><a id="Tc_Wk0N-lZ-rEiHL4vXO_kAkQ_3_10"></a><a id="Tc_FD6HVPQGP0yiG30XHc8Ssg_4_0"></a><a id="Tc_iSj7qGZUsEy7zF3BVY8Yyg_5_0"></a><a id="Tc_ezVpsrnXwEKaNFjovDIC7w_5_2"></a><a id="Tc_3Lyc3GEvGEmEPP2uOSIkhA_5_8"></a><a id="Tc_mEV_fUYY5EWzZAD9G_-unw_6_0"></a><a id="Tc_RY2I-hIt20W9fOssL8zsdw_7_0"></a><a id="Tc_nz6VedI8CkeJ4LiGTBEPIA_7_2"></a><a id="Tc_GAJ-K6BhVEytkPAdX5GLJg_7_5"></a><a id="Tc_7M0f7vEJKECC976whVN5Wg_8_0"></a><a id="Tc_9ULri4bnwkahvIPX2bQGYg_9_0"></a><a id="Tc_NKkh0hG9e02B5rVkgIj2uw_9_1"></a><a id="Tc_UATEOBjta0W4TH56RLnGXg_9_4"></a><a id="Tc_n14sLKhpFU-brPNDE5VBmA_9_7"></a><a id="Tc_IsEWoNvyd0y_fiQObWH2PQ_9_10"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FairValueDisclosuresTextBlock" id="Tb_DGUG8RKG_kmTX-QSfCacaQ" continuedAt="Tb_DGUG8RKG_kmTX-QSfCacaQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">7.    Fair Value Measurements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The following table presents fair value hierarchy of the Company&#8217;s financial assets measured at fair value on a recurring basis:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="Tb_SLbiRcHiPUe6gKljnj2vDw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:46.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value Hierarchy</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Government money market fund accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="3" id="Tc_W9XmQ6LiT0KZx0qxrZAJFw_4_2">3,638</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="3" id="Tc_dUAXLZv4HEmNXMV1Tk7Huw_4_11">3,638</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bitcoin investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValue" scale="3" id="Tc_x4OnpeY79kmOPP8uuR_w8Q_6_2">214,633</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValue" scale="3" id="Tc_7Ust-N_UJEeHxIgq4n7B7g_6_11">214,633</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in intangible digital assets)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="Tc_-BuwFnFx20uKQrXa2wWS_w_8_2">218,271</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="Tc_hzPvRP9YcEOu2YRvWDyiig_8_11">218,271</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18pt;"></span> <span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.12%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.24%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Government money market fund accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_9BDTT4lyYkSv1F0eAQlnCg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="3" id="Tc_GvVjtr_pXUy27N-cp6J-Yw_3_2">41,373</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="3" id="Tc_bNgLhe-eKEiFymS4tTfHHQ_3_11">41,373</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Treasury bill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_uk7mInBKCUiVA3vFkCN5Vw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TradingSecuritiesDebt" scale="3" id="Tc_yHJNWO4_L0Ok6vSNbOLF1g_5_5">10,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TradingSecuritiesDebt" scale="3" id="Tc_P5zh7J8sokqL-GY6aQz-vw_5_11">10,494</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment in debt securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_KNM3WXi-TU6wCTDDF5i12Q" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="Tc_59o-yA8UAEG0Xl4Z9vFziA_7_8">4,372</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="Tc_zpOIosT0I0qSjIqbLx6jfA_7_11">4,372</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in notes held for investment)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_9BDTT4lyYkSv1F0eAQlnCg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="Tc_U0Lkb6xgGUiDb1nhuMOPoQ_9_2">41,373</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_uk7mInBKCUiVA3vFkCN5Vw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="Tc_pz4D_b3Dyki24ZlrrYB7NQ_9_5">10,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_KNM3WXi-TU6wCTDDF5i12Q" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="Tc_ZT9NYo0hckOtPI9GWjMPjw_9_8">4,372</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="Tc_yYdBI1T-TE2D2C4c7y8-iQ_9_11">56,239</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Treasury bill was purchased on October 10, 2023, at a cost of&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_10_10_2023_To_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_wO80u8v0nkaVj9-6hCzGng" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="Narr_2R3vX-ZJ7E-3qXselJoi1Q">10,414</ix:nonFraction>, and fair value accretes to maturity date at an interest rate of&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_G3Anxea5Bk2Jp-whqZzF4Q" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" id="Narr_ojbtchFojUSj0BO6rNaZiw">5.35</ix:nonFraction>%. The treasury bill was classified as Level 2 as it is considered &#8220;off the run&#8221; because similar treasury bills were issued before the most recent issue and were outstanding as of December 31, 2023 and therefore not considered as liquid as other treasury bills with the same maturity date. As of December 31, 2023, the interest income recorded on these bills was&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_85lUGANk9Uq8MoWX1Ze-rw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="3" id="Narr_o-E8xignAkK9vfm2M4axBg">80</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company valued the debt securities at face value as of December 31, 2024 because the debt was to be repaid in January 2025. As of December 31, 2023, the Company valued the debt securities using a bond plus call option model reflecting the cash flow from the debt securities and assuming a&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="smlr:PercentageOfProbabilityOfEquityFinancing" scale="-2" id="Narr_X6831wgDn0mfCZuCixcSEA">5</ix:nonFraction>%&#160;probability of an equity financing, a&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="smlr:PercentageOfProbabilityOfChangeOfControl" scale="-2" id="Narr_H8oAJZMGo0eIx6GZdSWS6g">75</ix:nonFraction>%&#160;probability of a change of control, and a&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="smlr:PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" scale="-2" id="Narr_3hUpWdxzz0GYoX6KLTFPDw">20</ix:nonFraction>%&#160;probability of payment at maturity or an insolvency event. As of December 31, 2023, the fair value of the Company&#8217;s privately held debt securities was estimated at $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecurities" scale="3" id="Narr_xk87vLkdLEufyp3poIPJxQ">4,372</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_0XXBOOaM-U6pBNnOqupz6Q_1_3"></a><a id="Tc_xtPjMLPZ7kyTMeflzWl4rQ_2_3"></a><a id="Tc_tFhI_v3hIU60MXvQMy2Gfg_3_0"></a><a id="Tc_vEx7XFeUoUqfpGYf5MnXdw_3_4"></a><a id="Tc_2ldL8Fmnq0mlocrdvkAsNA_4_0"></a><a id="Tc_hdXz9eAmVE6e6VW_hpXZUw_5_0"></a><a id="Tc_Hu62CJieKUmrMDty8U4pQA_5_4"></a><a id="Tc_t4bV-MYb3kGI6AbxgNAxyg_6_0"></a><a id="Tc_Fq1ubkiN50G26cAES8iohw_1_2"></a><a id="Tc_pcIQSQJ53k6wy9liOT_9JA_2_0"></a><a id="Tc_Syd5E4IH5EClULpF8GKkdQ_2_2"></a><a id="Tc_fUBKvcg3fE6rXDCzr3db4Q_3_0"></a><a id="Tc_USJpjYWpZUeA_-3L3vF6Bw_4_0"></a><a id="Tc_GppiXwAvLkSAqOnf8VRK9g_5_0"></a><a id="Tc_qqc4MU_w80O_M-y3uTMOCA_5_2"></a><ix:continuation id="Tb_DGUG8RKG_kmTX-QSfCacaQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The key inputs for the valuation model are:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="Tb_s-UG3RevAk-rU0_MNUEWnQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_PxnEcaDrekmg5pbwORI6uA" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="Narr_dJkGze4q3kqZCRsXNqfbZw">3.94</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_WP1fZf0Tz0eBBidX-O4OKw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="Narr_8nlXgOFJnEuVXXg3aw0AYQ">5.26</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cashflow discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_zHwOkX4VfkWPEeVs-Z6SyQ" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentMeasurementInput" scale="0" id="Tc_fj1NvmCgZEeRrezxz6Rfcg_4_4">27.8</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_aDCxvJtt3Eygu9BuFeJ9gg" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentMeasurementInput" scale="0" id="Narr_A2fAlzj7D0G17BkCYFLK2A">0.25</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_5rkmbl4o0EOgcPQtPW8OMA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentMeasurementInput" scale="0" id="Narr_GQhv3QO_6kOaXygAr3UWvQ">2.92</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_f78XzEjJR0SR98o4mMWU-w" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentMeasurementInput" scale="0" id="Tc_44oxUHA9DUyJ9BVCofKFVA_6_4">120</ix:nonFraction>%</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:69pt;"></span><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The following table represents changes in the notes held for the investments with significant unobservable inputs:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="Tb_MkQ9AF2ZGEW-xNkzwkI2wQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.11%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Convertible Notes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_x1XWviIRvEuBTZOXDrOPnA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="3" id="Tc_JcajdmyhL06sTvcxwmGkzw_2_3">4,372</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchased </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_ozb1tohPX0S-2MLZNTW-lw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="3" id="Tc_J8UbxTtAJkuaz9Yke5oiBw_3_3">500</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of the notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_ozb1tohPX0S-2MLZNTW-lw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="Tc_SUfU1hLIzk2poWes8tQijA_4_3">128</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_Y3YjBPtUtEWAFrFVUBX28A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="3" id="Tc_iXNaSpbDJ0K2HkJGpqfV0g_5_3">5,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_KyMqMObU_ki0-KBoLNZ_Xw_1_2"></a><a id="Tc_s-JYqkusOU2Hr7qf90iYjA_1_6"></a><a id="Tc_ZKvh7UUYYE2iSsItsb83nQ_2_2"></a><a id="Tc_dbACvuBoiE-QPHt4Fx4CKA_2_6"></a><a id="Tc_4Lc_I_uEL0qp-dmFmwO4gQ_3_0"></a><a id="Tc_YnIiVhwsd0C-MnUP5ztdZQ_3_2"></a><a id="Tc_Pl5VAeVe1EClKnBXBZYu6g_3_5"></a><a id="Tc_to6wBxERc0-Elc_VntGXVQ_4_0"></a><a id="Tc__q-OsW9cXU6QnxdGtoVvBQ_5_0"></a><a id="Tc_V70m1qT3G0ODLfJM8E5jHQ_5_2"></a><a id="Tc_j7DpDmhlC02HVrOd1EF2cA_5_5"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:FinancingReceivablesTextBlock" id="Tb_qipC-leulU2gEjNzw2-JYg" continuedAt="Tb_qipC-leulU2gEjNzw2-JYg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">8.    Notes held for investment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">Notes receivable consist of the following for the periods presented:</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="Tb_OtfOn2ybBkK-rOnrLvDslQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior secured promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_g8RrY9ouOk6oIzBWDC62Bg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Tc_wY8W0iUUTE-IzhJiWBH2Dg_3_3">1,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_gI7SLj8d7kuf0rI7GEXCEg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Tc_plR0m_jG2kaZm_SlaNmgXQ_3_6">1,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_nLhO4YNRgkCweluz_hqEUw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Tc__pKRgsizOE-XSHaSCA2uKQ_4_3">5,100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_crjDA4QUWkmjptpBegjFlA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Tc_QE_-pQ2HMke1WdZ8kmEdOg_4_6">4,372</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Tc_Mk7wlcAvOki4rmLbaVrHug_5_3">6,100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Tc_W6E_g68CPE-1Rm3Kns-lzg_5_6">5,372</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;">In June 2022, the Company loaned Mellitus an aggregate of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="Narr_-iRPAQv6k06MCAusJtflCg">1,000</ix:nonFraction>&#160;through the purchase of&#160;<ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="As_Of_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_L_t0elWRT0eyWfqFYrXTgw" decimals="INF" format="ixt-sec:numwordsen" name="smlr:NumberOfNotesReceivable" scale="0" id="Narr_8lILxu1eZUyg-mteSKiNWA">two</ix:nonFraction>&#160;senior secured promissory notes that bear interest at a rate of&#160;<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag" decimals="2" format="ixt:num-dot-decimal" name="smlr:NotesReceivableInterestBearingInterestRate" scale="-2" id="Narr_pdvRRGrJskyyHYCR5guviQ">5</ix:nonFraction>% per annum, and mature in&#160;<ix:nonNumeric contextRef="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag" format="ixt-sec:durwordsen" name="smlr:NotesReceivableTerm" id="Narr_4gE_x-G2lki-OfQxywfoDA">three years</ix:nonNumeric>&#160;<span style="white-space:pre-wrap;">unless accelerated due to an event of default as provided in the notes. Repayment of notes is secured by a first priority interest in all of Mellitus&#8217; assets.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="background:#ffffff;">In December 2022, the Company entered into a senior convertible promissory note (also referred as debt security) arrangement with Monarch, providing Monarch with up to </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_pgr5YBHMBk-EMl7wkzobAA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecurityMaximumAmountOfAvailableFunding" scale="3" id="Narr_d1Clnv_mx0KFBcIVhLy1Ow">5,000</ix:nonFraction>&#160;</span><span style="background:#ffffff;">in available funding, of which </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_muDgxFIJQE6WabppUkvg4A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="Narr_Ns9NaqCOtE-3Foz2MiZ5lw">5,000</ix:nonFraction></span><span style="background:#ffffff;">, in principal was drawn as of December 31, 2024. The Monarch debt security accrues interest at&#160;</span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA" decimals="2" format="ixt:num-dot-decimal" name="smlr:DebtSecurityInterestRate" scale="-2" id="Narr_Q67_15OEXUOW-YaIU5Z2Og">10</ix:nonFraction>%</span><span style="background:#ffffff;"> per annum, payable monthly, and the principal balance was originally due December 6, 2024, with such due date extended to January 17, 2025 (refer to note 20 for additional information). The note along with up to </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecuritiesTransactionFee" scale="3" id="Narr_3oY38ZgLH0efqJK-2R9f6Q">100</ix:nonFraction></span><span style="background:#ffffff;">&#160;of transaction expenses is due and payable on the occurrence of an event of default or change of control unless accelerated due to the conversion into preferred stock prior thereto at the option of the Company. The Company has the option to extend the maturity date for&#160;</span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:NumberOfConsecutiveTermsOptionToExtendMaturityDate" scale="0" id="Narr_O4FbiS03NEePWza69nypgQ">two</ix:nonFraction></span><span style="background:#ffffff;">&#160;consecutive&#160;</span><ix:nonNumeric contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA" format="ixt-sec:durwordsen" name="smlr:ExtensionPeriodOptionToExtendMaturityDate" id="Narr_g05k_VFHCk-B9U-PC1OIuQ"><span style="background:#ffffff;">one-year</span></ix:nonNumeric><span style="background:#ffffff;"> terms. The Monarch debt security can be converted into Monarch&#8217;s shares at the Company&#8217;s option upon (a) an equity financing at Monarch, (b) upon a change of control at Monarch, or (c) at the Company&#8217;s option at any time prior to the maturity date. If converted upon a change of control, the Company has the right to receive a cash payment equal to the balance of the Monarch debt security or the amount payable upon conversion into Monarch&#8217;s shares. The Monarch debt security is redeemable at any time at Monarch&#8217;s option or automatically upon an event of default (as defined in the note)</span>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The Company made an irrevocable election to account for the Debt Securities using the fair value option under ASC 825 &#8211; <i style="font-style:italic;">Financial Instruments</i> (&#8220;ASC 825&#8221;) and will measure the fair value of the Debt Securities in accordance with ASC 820. The Company made the fair value option election to present the Debt Securities in its entirety at fair value, which it </p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_qipC-leulU2gEjNzw2-JYg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">believes to be preferable to recognizing the host instrument at fair value under ASC 320 and potentially separately recognizing certain embedded features as bifurcated derivatives under ASC 815. As of December 31, 2024, the Company assessed and estimated the fair value of the Debt Security of Monarch to be $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_BtMLgU4xhEumEB1mwGdN_A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="Narr_pKfg70i2ZkyPY6Vy0fEtOg">5,000</ix:nonFraction> and Mellitus senior secured promissory notes to be $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyThreeMember_cSzr6YVDeUWRSAU2M9evow" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="Narr_mRNSPDq6Y0iWrRoQ2Hf-tA">1,000</ix:nonFraction>. A<span style="background:#ffffff;">s of December 31, 2023, the Company estimated the fair value of the Monarch debt security to be </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_Eph_Oj-oC0KZYpPYtIryAA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="Narr_TCbOwmp7vEeUmV0jMfq6oQ">4,372</ix:nonFraction></span><span style="background:#ffffff;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The Company recognizes interest income on the Monarch debt security, which is included in interest and dividend income in the statements of income. Accrued interest on the Monarch convertible promissory note was included in prepaid and other current assets. For the year ended December 31, 2024 and 2023, the Company recognized </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecurityInterestIncome" scale="3" id="Narr_Rh4a9Te3jEaCuJOiaJbaeQ">483</ix:nonFraction></span><span style="background:#ffffff;">&#160;and </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecurityInterestIncome" scale="3" id="Narr_8k30niYTokyWzFAkCVFNEQ">449</ix:nonFraction></span><span style="background:#ffffff;">, respectively, of interest income from Monarch debt security. The Company recognizes changes in fair value of the notes in the statements of income separately from the interest income. For the year ended December 31, 2024 and 2023, the Company recorded&#160;a change in fair value of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_FPkR1egt1k-R8EHqo0rVVg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecurityChangesInFairValue" scale="3" id="Narr_vtVaOKIhyEGbplgfbOnBJQ">128</ix:nonFraction></span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_PWcdPDmgeEWckhHocD2-3Q" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtSecurityChangesInFairValue" scale="3" id="Narr_OuZd5MOm2UCzlHyKwwFidg">307</ix:nonFraction></span><span style="background:#ffffff;">, respectively, for the Monarch debt security</span>.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_b91de117_f20f_48c8_a8ab_93e0df28bbd7"></a><a id="Tc_Tn47GTBo2Ee_dQYGb1mHJw_1_1"></a><a id="Tc_pBYdt6jrqUmvxFarwFkJ8w_1_3"></a><a id="Tc_6RV5MARW0k6vZle2Z33x4A_1_6"></a><a id="Tc_ce49dVvY8E-rCiUS6HVqbA_3_0"></a><a id="Tc_EqpX814t7EqFYGwI890big_4_0"></a><a id="Tc_OPnoSISY0kyDgAllCIPBlA_4_3"></a><a id="Tc_KOvxnPjWJ0m4Uog6AJeAIg_4_6"></a><a id="Tc_ziJ_Y7qCskqRwUdpChXx2Q_5_0"></a><a id="Tc_VMuU9bXw7kO7XR6IOYpOUQ_5_1"></a><a id="Tc_zhJGEH8zhkaSzbHwuvJBEw_5_4"></a><a id="Tc_9uOaKO759kq_ioYhc8AH_w_5_7"></a><a id="Tc_Nwj9W4KEo0mrzLgoya3l8A_6_0"></a><a id="Tc_zFT9vb218kmemgvPrYnpVA_6_3"></a><a id="Tc_o1AgDQCgxkeSJUDcRd9jZA_6_6"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CryptoAssetTextBlock" id="Tb_Xrwe2Q3Ce0KaPPrClDy0eQ" continuedAt="Tb_Xrwe2Q3Ce0KaPPrClDy0eQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span><b style="font-weight:bold;">Intangible Digital Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In May 2024, the Company announced that its board of directors adopted bitcoin as its primary treasury reserve asset. Under this new treasury strategy, the Company purchases and holds bitcoins for long term investment purposes. The Company accounts for its bitcoin as an indefinite-lived intangible asset in accordance with ASC 350, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other</i> and has ownership of and control over its bitcoin, which are included in Intangible digital assets in the Balance Sheets. As of December 31, 2024, there were no contractual restrictions on the sale of bitcoins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Bitcoin Investment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Company early adopted ASU No. 2024-08 in the second quarter of 2024 effective retroactively as of January 1, 2024. See <i style="font-style:italic;">Recently Adopted</i> <i style="font-style:italic;">Accounting Pronouncement</i> in Note 2 to Financial Statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s bitcoin purchased for investment purpose are initially recorded at cost, inclusive of transaction costs and fees. Subsequently, <span style="-sec-ix-hidden:Hidden_EtskwuOt8E-UAPDIhjG0PQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company remeasures its bitcoin investment</span></span> at fair value at the end of each reporting period with changes recognized in net income through &#8220;Other income, net&#8221; in the Company&#8217;s Statements of Income. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Intangible Assets Cost Basis</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The Company uses average cost for computing capital gains or losses.</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CryptoAssetHoldingTableTextBlock" id="Tb_3Kzl_t5f6Uy5ycKakBdc-g" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth the units held, cost basis, and fair value of crypto assets held, as shown on the balance sheet as of December 31, 2024:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Units Held</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets held:</p></td><td style="vertical-align:bottom;width:13.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Third party bitcoin custodians</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetNumberOfUnits" scale="0" id="Tc_qrktr0OoD0G3R-Zb2ZeDdg_4_1">2,298</ix:nonFraction> </p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetCost" scale="3" id="Tc_hZQbmpBx6EykFUWJFtAgog_4_4">189,700</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValue" scale="3" id="Tc_Gwvpxv6DnUeDAOSy_cDI6w_4_7">214,633</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetNumberOfUnits" scale="3" id="Tc_W7mFGM3-UkiPxP5DZZT9SA_6_1">2,298</ix:nonFraction></p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetCost" scale="3" id="Tc_uG0Dn5EAx02zPvEl3PuNZA_6_4">189,700</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValue" scale="3" id="Tc_lZqdYnyBhkSP3crf69uRAQ_6_7">214,633</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_yAX1_DvDTUqYM5KsqXHIHw_3_2"></a><a id="Tc_h34Ftpfg60qgLK1wL4eaLA_4_2"></a><a id="Tc__71mVNhSck-kaQWvT9xMzQ_6_0"></a><a id="Tc_MzwOzhPcA0m7bjlxDs8zDg_7_0"></a><a id="Tc_7e_r6_HmFkGDyMBkXSbyvw_7_2"></a><a id="Tc_NbzYM-0c70KKK4uSnl6HUg_7_3"></a><a id="Tc_hdmAvcdG4E-AbLzd92t_-A_8_0"></a><a id="Tc_LJKN6wZfDEGpm9yjNobPFg_9_0"></a><a id="Tc_I_8gMln48UOt9wFCAMknDA_9_3"></a><a id="Tc_IN4b8-G8f0iH3L3B6tu-YQ_10_0"></a><a id="Tc_0k6tMBNNxkOz_m_a-Gj-yw_11_0"></a><a id="Tc_oTYbactOwUmb8srM-Hghkw_12_0"></a><a id="Tc_RXp_X07JrkqArJc3-w3bfg_12_2"></a><ix:continuation id="Tb_Xrwe2Q3Ce0KaPPrClDy0eQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reconciliation of fair value</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The following table represents a reconciliation of the fair values of the Company&#8217;s Intangible digital assets held for the year ended December 31, 2024:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CryptoAssetActivityTableTextBlock" id="Group_-CCdZ9x4SE-h9YmHfEjoAQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For The Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets held:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Beginning balance at fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetAddition" scale="3" id="Tc_Xc8hgurHuUyOuBVd781GJw_8_3">189,700</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrealized gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetUnrealizedGainNonoperating" scale="3" id="Tc_ZsHz1EIdfkuQiGOsyaZ-Ww_10_3">29,766</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrealized loss, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetUnrealizedLossNonoperating" scale="3" id="Tc_bmg4_soWH0esROHui8grXA_11_3">4,833</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValue" scale="3" id="Tc_vK7clI7JRU2zB0MFAJ0I_A_12_3">214,633</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:6pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="smlr:OtherNoncurrentAssetsTextBlock" id="Tb_OvZoZn-zq0iVcrTmOQdYmw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;background:#ffffff;">10.</b></span><b style="font-weight:bold;">Other non-current assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Other non-current includes right-of-use asset (&#8220;ROU&#8221;) of&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Narr_WS_aR4S4NkWyH7D02XCpEQ">65</ix:nonFraction></span><span style="background:#ffffff;"> and long-term deposits of&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:LongTermDeposits" scale="3" id="Narr_3mr9dZHbXE25-Wk9-JY0QA">20</ix:nonFraction></span><span style="background:#ffffff;">&#160;as of December 31, 2024. As of December 31, 2023, </span><span style="-sec-ix-hidden:Hidden_xVAitRPWgkWwaTzZPw38ow;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ROU asset</span></span><span style="background:#ffffff;"> of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Narr_kSYJ2qDW9E2h6FjtonD8HA">150</ix:nonFraction></span><span style="background:#ffffff;"> and miscellaneous receivable of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:MiscellaneousReceivables" scale="3" id="Narr_qN8Xsj-WxkaicAUl3qyToQ">100</ix:nonFraction></span><span style="background:#ffffff;"> and long term deposits balances of&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:LongTermDeposits" scale="3" id="Narr_I4qtNgcyzEa3JSfrLMvFDw">20</ix:nonFraction></span><span style="background:#ffffff;">, respectively.</span></p></ix:nonNumeric><a id="Tc_2gGV9kfP20W9P22xoVXYww_1_2"></a><a id="Tc_pDCgAi0PrkOSWjCBZ-LxcA_2_2"></a><a id="Tc_2ku87AvhDUqpTiNl6SX3xA_2_5"></a><a id="Tc_i9LqEANsgEy_K-j4tVnQfA_3_0"></a><a id="Tc_AQf2FUA2PkiadAZmG1IVlg_3_2"></a><a id="Tc_98y1IZ4MtEqSOhVYjsga4w_3_5"></a><a id="Tc_0azbNR8zLEmDl-fPiwvQKQ_4_0"></a><a id="Tc_KR3Xt1x_ikWKNNQNL81C1A_5_0"></a><a id="Tc_Z2OY4fvj8kC5Wo_WePhoZw_6_0"></a><a id="Tc_SA_R57tSN0yCDXdd4_6mrQ_6_2"></a><a id="Tc_rdD8r3MZ5Ea_2p-iVXhLEQ_6_5"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Tb_RbPeXPPi3Euyp5C6_FKQtg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">11.&#160;&#160;&#160;&#160;Accrued Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses consist of the following:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Tb_WFlucVv61kehFs8H1Esyuw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="Tc_hR0P8Fat0Eix2yXqbtTO0A_3_3">3,743</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="Tc_h1VW7hLc7UynlPC6qEOW7A_3_6">2,008</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued Taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="Tc_xWv8nhNIUE2wE0RZxPxsZQ_4_3">909</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="Tc_7k6pAywnG0GDCkUdk4JVZg_4_6">1,991</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Miscellaneous Accruals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="Tc_NEWJsmDqTEKMMqxcWocLDg_5_3">521</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="Tc_mvjyaPs9F0OsW56yOzoOCA_5_6">503</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Accrued Expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_jtJ05fU7dkGr58Kahe9DhQ_6_3">5,173</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_rN1RHJLfKEG2NJ6n4-xc-A_6_6">4,502</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="Tb_gQWIRwatUEqmUZ_h-qS0dQ" continuedAt="Tb_gQWIRwatUEqmUZ_h-qS0dQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">12.&#160;&#160;&#160;&#160;Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash, bitcoins and accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company maintains cash with major financial institutions. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. <span style="background:#ffffff;">The cash and cash equivalents also includes U.S. government money market fund accounts. As of December 31, 2024, the Company held deposits of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TimeDepositsAtCarryingValue" scale="3" id="Narr_BLi4wal8TU2qJlNznifx4A">5,314</ix:nonFraction></span><span style="background:#ffffff;">, which exceeded federal deposit corporation limits. The Company also invested in U.S. government money market accounts of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="3" id="Narr_Zbq3fmm4LUu-rSiK1-ktmg">3,638</ix:nonFraction></span>. The Company holds <ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetNumberOfUnits" scale="0" id="Narr_GzWStsRoaEiwUTYl3FM7JA">2,298</ix:nonFraction> bitcoins as of December 31, 2024, valued at $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetFairValue" scale="3" id="Narr_pQXbct47YUOmLSDe5j017w">214,633</ix:nonFraction>. As of December 31, 2024, <ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_PHgDVn-5Okel_mz_sU2Iaw" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskCryptoAssetNumberOfProviders" scale="0" id="Narr_YfCEuzK1B0WpdP0wIpPtaQ">two</ix:nonFraction> providers accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_264-qjtGnkenys3niqGP3A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_r_yO2fQ6_EiIZtr0EZUDOQ">60</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_Ii5xiNTqQk2AGTOsoCMLWA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_30oO9pNHM0G-vJ1nGeF69w">40</ix:nonFraction>% of the Company&#8217;s total bitcoin holdings. <span style="background:#ffffff;">Our bitcoins are held offline in cold storage with </span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_gQWIRwatUEqmUZ_h-qS0dQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="background:#ffffff;">multiple third-party providers. </span>The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the&#160;year ended December&#160;31, 2024, <ix:nonFraction unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_fFOkoCt7H0Slv5JGrDqlBg" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskNumberOfCustomers" scale="0" id="Narr_WYAXHKtfX0qX2WLMn-pvsA">two</ix:nonFraction> customers (including affiliates) accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HyuAP9W00kqM60O3G6Ge3A" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_qjvV2nUEckyaokrA7nXe9g">43.1</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_jjGYmF79EUmReh8pp371Ww" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_6u8JeA3TwUmq92hd5A5NBw">27.6</ix:nonFraction>% of the Company&#8217;s revenue. For the year ended December 31, 2023, <ix:nonFraction unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tugyvnYiKEKXu7Ct7IkWtg" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskNumberOfCustomers" scale="0" id="Narr_i55N87bwAk6XsecdQfFdgA">two</ix:nonFraction> customers accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_xdNkBEAT8k670omsTTSlEA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_xRES-WxAakSC4UOYsfN8IA">36.0</ix:nonFraction>%, and <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_gghWsAhy2kyMxuzQyS23Xw" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_br6CPmAfBESiPgpgNgV2ow">34.9</ix:nonFraction>% of the Company&#8217;s revenue. As of December 31, 2024, <ix:nonFraction unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HybD8uTHQkyIAhllhH3uCA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskNumberOfCustomers" scale="0" id="Narr_83k2ItPEoEKkCVY1UNyNlw">three</ix:nonFraction> customers accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_GNA9FYtql0C57IuiRvUncQ" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_skIgfuVuDEWSH0_TrNp2tQ">33.9</ix:nonFraction>%, <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mGWVZoMD_0y5pa9bpBTRRg" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_RODX1U3a9ka3bTghK7249g">28.7</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_sK_zCKyn3kegXLMJPUXfnw" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_LorTIn7t10S7Z9aOaDwWYg">14</ix:nonFraction>% of the Company&#8217;s accounts receivable. As of December 31, 2023, <ix:nonFraction unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kPVNPU9aQEmGmH7B8LA6Hg" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskNumberOfCustomers" scale="0" id="Narr_RVnPSajnM0qY4W9WfPBwdg">three</ix:nonFraction> customers accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mhgf8VqFf0-ZFpiL5hlFcA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_pV5I_UsNykW73pyxRcxHGw">27.5</ix:nonFraction>%, <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kWVgDU2vA0uq6eMrmrdy-g" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_FLbkPcDSx0yBGGUSuh34Bw">27.5</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Y3y-lLd5iky9-ATGWL0gvg" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_uRVz-B-qkkytFBltWrMv_g">23.6</ix:nonFraction>% of the Company&#8217;s accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2024, <ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_a8zmf1i8pUefeL-g8olIgA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskNumberOfVendors" scale="0" id="Narr_v8mgg1XhdECqyLx7RqNMkQ">three</ix:nonFraction> vendors accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_etSv0JRJJUqLQpa2cgChVA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_sV7oSOU6oUW5VK1HNEZ3DQ">29.4</ix:nonFraction>%, <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_652Bp3qhNUmUqYY-FX1Hug" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_ssF1pri1dkqQpP494udN3A">16.7</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorThreeMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_UUFOL2wzP06GTw4gaa2_sg" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_9OnOauWsXUq3vc338bKidg">15.6</ix:nonFraction>% of the Company&#8217;s accounts payable. As of December 31, 2023, <ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H35aj8_a3U6JSHnHW9KxbQ" decimals="INF" format="ixt-sec:numwordsen" name="smlr:ConcentrationRiskNumberOfVendors" scale="0" id="Narr_BwKME-b4ck6TqD2CLUIx5w">two</ix:nonFraction> vendors accounted for <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_O9-jwnOv6kOR0Av4_jnsew" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_OWMGdosc5kqyLDSsSk47rQ">24.0</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H04TlYqfWUuaMfxorUQLQA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_0BJqG6c9BUuCfc97tHjiYA">10.1</ix:nonFraction>% of the Company&#8217;s accounts payable.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_5Q73UAkTVUOiKR1hf-Kkqw_1_2"></a><a id="Tc_FETGg9Tu_ki3RczIfJbFhQ_2_0"></a><a id="Tc_lt1f6SjVDUiOIuUHFSKhBg_3_0"></a><a id="Tc_8ZKpF4RheU2eaO29QP9ReQ_4_0"></a><a id="Tc_4Y1u3cnjGUWteO6HECupig_5_0"></a><a id="Tc_0FUVgOO3jE29bLqqgGfwhQ_6_0"></a><a id="Tc_kYIc0tKnWkWr4HP6Ym62qA_7_0"></a><a id="Tc_ZKOFtBY67Ua48piwFRugrA_7_2"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="smlr:LeaseDisclosureTextBlock" id="Tb_lvRo7MEnH0Su3AEf2LoPbw" continuedAt="Tb_lvRo7MEnH0Su3AEf2LoPbw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">13.&#160;&#160;&#160;&#160;Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Lessee Arrangements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On July 31, 2020, the Company entered into a <ix:nonNumeric contextRef="As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Narr_by0AEV5Yp0SVNNnf7_oybQ">61-month</ix:nonNumeric> lease agreement for office space to use, as necessary, for office administration, lab space and assembly and storage purposes, located in Santa Clara, California. The Company took possession of the leased office space in September 2020, and the lease is effective through September 30, 2025. The discount rate determined for this lease was <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="Narr_DnqYnWfwe0SxZBvkNpQrHg">2.5</ix:nonFraction>%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024, the remaining lease term is <ix:nonNumeric contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="Narr_5fXENHGg3kqicezf2Mo4Zw">nine months</ix:nonNumeric> with <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt:fixed-false" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" id="Narr_ka8ZBvFlIEWFg19yWKo34Q">no</ix:nonNumeric> options to renew. The Company recognized facilities lease expenses of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" id="Narr_bU99oNPjY0GJq8CH7DdTOw">88</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" id="Narr_84a9J6gfgEy_spRvaRXLWw">88</ix:nonFraction> for the years ended December 31, 2024 and 2023, respectively. The following table summarizes the future minimum rental payments required under operating leases that had initial or remaining non-cancelable lease terms greater than one year as of December 31, 2024:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Tb_jjveoyylTU-7aCiA3LVLIw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="Tc_aMpQ9yszZkSamL5rj-Hyiw_2_3">71</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total undiscounted future minimum lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="Tc_oASUWk7ohUGfaVCpxYBe_w_3_3">71</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: present value discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="Tc_sXdk1GOcDUmpgCQHk9WyCA_4_3">1</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="Tc_sXQwvcphQUWkTftp200tpQ_5_3">70</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease expense in excess cash payment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:OperatingLeaseExpensesInExcessOfCashPayments" scale="3" id="Tc_afJzKOy8k0CKxNpR3eNxzw_6_3">5</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total ROU asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Tc_IPirrrqijkOunRQEpe5n9g_7_3">65</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024, the Company&#8217;s <span style="-sec-ix-hidden:Hidden_ZCznBrDkRkiZHIq0TZrasQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ROU asset</span></span> was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Narr_bZBTUMncV0yIY6RMyZd4Rg">65</ix:nonFraction>, which is recorded on the Company&#8217;s balance sheet as other non-current assets, and the Company&#8217;s <span style="-sec-ix-hidden:Hidden_2GncPSotZkeJ6j2K3RM9Gw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">current</span></span> lease liabilities were $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="Narr_O16tMEFqdEmNmPYJ3ASq7Q">70</ix:nonFraction>, which were recorded on the Company&#8217;s balance sheet as other short-term liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Lessor Arrangements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company enters into contracts with customers for the Company&#8217;s QuantaFlo<sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> product. The Company has determined these contracts meet the definition of a lease under Topic 842. The lease portfolio primarily consists of operating leases that are short-term in nature (monthly, quarterly or one year, all of which have renewal options). The Company made an accounting policy election to apply the <ix:nonNumeric contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" format="ixt:fixed-true" name="us-gaap:LeasePracticalExpedientLessorSingleLeaseComponent" id="Narr_r47F3pww2EGERAeNLoStzQ">practical expedient to not separate lease and eligible non-lease components</ix:nonNumeric>. The lease component is the predominant component and consists of fees charged for use of the equipment over the period of the arrangement. The nature of the eligible non-lease component is primarily software support. The assets associated with these leasing arrangements are separately identified in the Balance Sheet as Assets for Lease and separately disclosed in Note 3 to the financial statements. During the year ended December 31, 2024 and 2023, the </p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_1136386b_ded0_4d23_84d2_f5dd87102ba2"></a><a id="_1136386b_ded0_4d23_84d2_f5dd87102ba2_2"></a><a id="_1136386b_ded0_4d23_84d2_f5dd87102ba2_3"></a><ix:continuation id="Tb_lvRo7MEnH0Su3AEf2LoPbw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company recognized approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="Narr_O-yLR2ifFU6oPx1GH0DRbA">27,488</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="Narr_EFvbOBtljkW9yynBIlB8qA">37,262</ix:nonFraction>, respectively, in lease revenue related to these arrangements, which is included in revenues on the Statements of Income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Variable-fee Revenue</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company recognizes revenues from variable-fee licenses (e.g., fee per test) and sales of hardware equipment and accessories in accordance with Topic 606. Total revenues from variable-fee licenses were approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:VariableLeaseIncome" scale="3" id="Narr_9jTkgd0xkk2GcnNC7Hekew">25,955</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:VariableLeaseIncome" scale="3" id="Narr_u_SXuWbvJkefT0reI-8G_w">28,992</ix:nonFraction> for the years ended December 31, 2024 and 2023, respectively. Total revenues from sales of hardware and equipment accessories were approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalesTypeLeaseRevenue" scale="3" id="Narr_i0Lr5RQO2UCikpmf-bDzTQ">2,851</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalesTypeLeaseRevenue" scale="3" id="Narr_q0eUmdANaka4EyKkT5RDRw">1,930</ix:nonFraction> for the years ended December 31, 2024 and 2023, respectively.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Tb_z7l0-eOGhUKGxBR0x1_Hyw" continuedAt="Tb_z7l0-eOGhUKGxBR0x1_Hyw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">14.&#160;&#160;Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Indemnification Obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company&#8217;s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company&#8217;s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Other</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company is subject to various state sales and use tax audits and believes its current exposure could result in an estimated liability of up to $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:IncomeTaxExaminationsMaximumEstimatedLiability" scale="3" id="Narr_ci1pTc7x5E6dr66bRdQgvw">500</ix:nonFraction>. The Company did not record such estimated liability as of December 31, 2024, as it was not determined to be probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;background:#ffffff;">Legal Matters</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">From time to time, the Company may be subject to legal proceedings and claims in the ordinary course of business. The Company is not currently a party to any litigation the outcome of which, if determined adversely to it, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business, operating results, cash flows or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In July 2017, the Company received an initial civil investigative demand (&#8220;CID&#8221;) from the U.S. Department of Justice (&#8220;DOJ&#8221;) pursuant to the federal False Claims Act investigating whether the Company and others may have violated the False Claims Act by marketing tests on devices that use photoplethysmography technology as reimbursable by Medicare in alleged contravention of applicable laws and regulations.&#160;The Company cooperated with the investigation, along with subsequent CIDs received in February 2019, December 2021, April 2022 and April 2023 addressed to the Company or individual current or former employees related to the same investigation. In September </p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_z7l0-eOGhUKGxBR0x1_Hyw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024, DOJ shared certain information to which the Company responded in January and February 2025. On February 6, 2025, DOJ asked if the Company wished to engage in settlement discussions to resolve any potential claims by February 11, 2025 and if so that the Company make a settlement offer by such deadline.&#160;Prior to February 6, 2025, DOJ had not stated an intention to pursue a claim of wrongdoing against the Company.&#160;On February 11, 2025, the Company began initial settlement discussions with DOJ, but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.&#160;The Company does not believe the amount of loss can be reasonably estimated. The Company intends to vigorously defend itself in any such action.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Tb_FxEkMbVJMkqw3UaDhe6zTw" continuedAt="Tb_FxEkMbVJMkqw3UaDhe6zTw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">15.&#160;&#160;Stockholders&#8217; Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_WqAvDLEbskywy_xtdHCZ_A">50,000,000</ix:nonFraction> authorized shares of capital stock, all of which are designated as common stock with par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_xEkwWRbR3UaybTpfF7ZBBA">0.001</ix:nonFraction> per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">Each holder of shares of common stock is entitled to <ix:nonFraction unitRef="Unit_Standard_Vote_fmvi7R5wJUe0Kn3AIo8T4g" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:NumberOfVotesForEachShare" scale="0" id="Narr_2flBQ1ZZx0upDiTNCQ654A">one</ix:nonFraction> vote for each share held.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">At-the-Market Offering</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 24, 2024, the Company&#8217;s registration statement on Form S-3 became effective, which allowed it to offer and sell securities from time to time in one or more offerings, up to an aggregate value of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_8_24_2024_UDRPHzEdyk6NV0QD-mKyjA" decimals="-5" format="ixt:num-dot-decimal" name="smlr:SaleOfStockValueAuthorized" scale="6" id="Narr_jP4OQgDVakinuUx52H_Jng">150.0</ix:nonFraction> million, including under its June 2024 Controlled Equity Offering<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">SM</sup> Sales Agreement with Cantor Fitzgerald &amp; Co., pursuant to which the Company may offer and sell from time to time its common stock in an at-the-market (&#8220;ATM&#8221;) offering. <span style="background:#ffffff;">Pursuant to this agreement, the Company agreed to pay the sales agent commissions for their services in acting as agent with respect to the sale of shares through the ATM offering program.</span> <span style="background:#ffffff;">The sales commission and expenses related to each of the ATM equity offering program are considered direct and incremental costs and are charged against &#8220;Additional paid-in capital&#8221; on the Balance Sheet in the period in which the corresponding shares are issued and sold.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">Through December 31, 2024, the Company had issued and sold a total of <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_SubsidiarySaleOfStockAxis_smlr_AtMarketOfferingMember_YtursobFMki79XI5UpMKsQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_P-NcjuFcX0SSpf7ZY51ORw">2,197,988</ix:nonFraction> shares of its common stock for aggregate gross proceeds of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_SubsidiarySaleOfStockAxis_smlr_AtMarketOfferingMember_YtursobFMki79XI5UpMKsQ" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="Narr_vhZed-Yn6U61_4SLZ_MWOw">119.6</ix:nonFraction> million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Treasury Stock Acquired</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;">On March 14, 2022, the Company&#8217;s Board of Directors authorized a share repurchase program under which it may repurchase up to&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_3_14_2022_kTG5qkwiMUq6Eg2gYGvIGw" decimals="-5" format="ixt:num-dot-decimal" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="Narr_6nSLbjHBykeATWnJibJXMQ">20.0</ix:nonFraction>&#160;million of its outstanding common stock. Under this program the Company&#160;may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans or through the use of other techniques such as accelerated share repurchases. The timing and amount of any transactions will be subject to the discretion of the Company based upon market conditions and other opportunities that it may have for the use or investment of its cash balances. The repurchase program has no expiration date, does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="Narr_KjKenVaUPkG603Y04vIxbA"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="Narr_TP4Qg0-nnkae01mZwWN9nQ">No</ix:nonFraction></ix:nonFraction> purchases were made during the years ended December 31, 2024 and 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Warrants Acquired- Related Party Transaction</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">On May 17, 2023, the Company repurchased outstanding warrants to acquire <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_AUjfPFddUEiqVflwrXAltw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_hJcDkfmxtUOxCPmHKLJMbg">76,875</ix:nonFraction> shares of common stock from its chief executive officer at a cost of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_5_17_2023_To_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_GRfbzrpKSkafNwd0txmuIg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ClassOfWarrantOrRightValueRepurchased" scale="3" id="Narr_NPuuvTXzeECaVsgmaWDTDA">1,949</ix:nonFraction>. The warrants, which were originally issued on June 7, 2012 (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_6_7_2012_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_nK7KeWh1p0uNi8atNqQgfg" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_s3e0iKkgY0qAqr_D6c1WwQ">16,875</ix:nonFraction>&#160;shares) with an exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_6_7_2012_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_nK7KeWh1p0uNi8atNqQgfg" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr_v1fqXWPvQE200eoIDY4pJQ">4.00</ix:nonFraction>&#160;per share and on July 31, 2013 (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_7_31_2013_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_ZY7-89lwZU2bZhYnLrUgKg" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="Narr_hvJUi2B_wEO2yJXQVYg3Iw">60,000</ix:nonFraction>&#160;shares), with an exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_7_31_2013_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_ZY7-89lwZU2bZhYnLrUgKg" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr_-4jgk4mf30GFSjC3L9NbOw">4.50</ix:nonFraction>&#160;per share, were amended in September 2015 and, as amended, had an expiration date of July 31, 2023. The $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_5_17_2023_To_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_GRfbzrpKSkafNwd0txmuIg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ClassOfWarrantOrRightValueRepurchased" scale="3" id="Narr_URnexX5h2UCeEW4YQgDarw">1,949</ix:nonFraction>&#160;aggregate cash purchase price reflects the difference between the aggregate exercise price of the warrants and the aggregate fair market value of the shares of common stock underlying the warrants, based on the closing price of a share </p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_FxEkMbVJMkqw3UaDhe6zTw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">of the Company&#8217;s common stock on May 16, 2023, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrants were cancelled and are no longer issued and outstanding.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="Tc_2fRR8_3Qf0iNrt63rMYwNQ_1_2"></a><a id="Tc_S8WNsJegNU-sVTftUfqifQ_2_7"></a><a id="Tc_tfQmgQhl2kiTrNJElDrLPg_3_7"></a><a id="Tc_Rcy6LzFYi0Kf6wsf0OX4Qw_4_2"></a><a id="Tc_jRUrJpFb6ECdATlbQ9_Awg_4_4"></a><a id="Tc_nA2-8uNrAkWH_e4rnJ4rrA_4_7"></a><a id="Tc_-FSRczvVi0OKiK2PJUC1SA_4_9"></a><a id="Tc_RQeXMwgJdkKt0xHbjDpqRg_5_2"></a><a id="Tc_g1nDIBI0e0mECGE7rb6aqA_5_4"></a><a id="Tc_sJ0jdBZSA022uo__MZznQg_5_7"></a><a id="Tc_1KtM-UrEL0-41tPyqEbQ4g_5_9"></a><a id="Tc_65X1kwf-TUySMLjThdv9AA_6_2"></a><a id="Tc_vFpC12Py9kakrPlEQ0O_9A_6_4"></a><a id="Tc_WHwSW7_hv0iCr_PgsXMdaQ_6_7"></a><a id="Tc_Xmqh-erDu0-JM16YcSiFug_6_9"></a><a id="Tc_1JvwNwxVTkWg80-UMZMRXg_7_0"></a><a id="Tc_qW6ZNVaZLkSwcj7WNr7pOA_7_4"></a><a id="Tc_ycKBvlprJ0GABDVH4lCUxQ_7_9"></a><a id="Tc_8ZuBRMl9wkCXZSV1h7EPvw_8_0"></a><a id="Tc_xaRrfCW7QkWyPg9TTBhKZg_8_4"></a><a id="Tc_cXhkdRfl3kir1wvOHfxEMw_8_7"></a><a id="Tc_oZCcFe9mJki_IWlWhxrCiQ_8_10"></a><a id="Tc_PgninaExukGP64K1j-Z7lg_9_0"></a><a id="Tc_qOn1v4oGxUiCSOxWIy1G4g_9_5"></a><a id="Tc_lQoVVz8b0kiudieju1_FGg_9_7"></a><a id="Tc_yQ12gtr0rU2ausiv1JuSJw_9_10"></a><a id="Tc_iYOtx0a0pEGMLx4aIXFRNQ_10_0"></a><a id="Tc_09skagd02UqlzRHAV0a9Rg_10_4"></a><a id="Tc_uYVE0hP7zU27StWnVe5NhQ_10_7"></a><a id="Tc_4h_OMHdGNEGxaxnXbj82rA_10_10"></a><a id="Tc_ah7P_IIJOEmG9RL69vqmDg_11_0"></a><a id="Tc_cCZsz7VJ0U6YeDNLA4e92A_11_4"></a><a id="Tc__cKC-FioAkSzPqLal1EOlQ_11_9"></a><a id="Tc_oEyE80l4kkuvWmp9-iACzg_12_0"></a><a id="Tc_S2V9ugrkkUq7OdWCQT9V8w_12_4"></a><a id="Tc_rR3R-s9fxES0l4sqtIE8Mg_12_9"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Tb_18LmXezipkSmI_71vKTzXg" continuedAt="Tb_18LmXezipkSmI_71vKTzXg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">16.&#160;&#160;Stock Option Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company&#8217;s stock-based compensation program is designed to attract and retain certain key employees while also aligning employees&#8217; interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2014 Stock Incentive Plan (&#8220;2014 Plan&#8221;). Our board of directors adopted the 2024 Stock Option and Incentive Plan (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">2024 Plan</span>&#8221;) on August 14, 2024 and stockholder approval of the 2024 Plan became effective in October&#160;2024. In connection with expiration of the 2014 Plan in July 2024, the available share reserve (including any awards outstanding under the 2014 Plan that lapsed prior to stockholder approval of the new 2024 Plan) were transferred to the 2024 Plan upon stockholder approval thereof. The 2024 Plan provided that the aggregate number of shares of common stock that initially may be issued pursuant to awards granted under the 2024 Plan may not exceed <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_8_14_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_Hkgpul5BI0mLKNUjZAN8IA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_yeMuFvWZcESCT2x5uSOHJg">1,916,011</ix:nonFraction> shares (the &#8220;Share Reserve&#8221;), along with any awards that transfer over from the 2014 Plan. In addition, the Share Reserve automatically increases on January 1st of each&#160;year, for a period of not more than <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Narr_SuU5bcEljEWST2PRn8cjuQ">10&#160;years</ix:nonNumeric>, beginning on January 1st of the&#160;year following the&#160;year in which the 2024 Plan became effective and ending on (and including) January 1, 2034, in an amount equal to <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_10_1_2024_To_10_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_sIz0OcvO7UGv2AJKDirvCA" decimals="2" format="ixt:num-dot-decimal" name="smlr:PercentageOfSharesReserveIncrease" scale="-2" id="Narr_MwoL6yT8tkGS3Xj-Kp_NRA">4</ix:nonFraction>% of the total number of shares of common stock outstanding on December&#160;31st of the preceding calendar&#160;year. The Company&#8217;s board of directors may act prior to January 1st of a given&#160;year to provide that there will be no January 1st increase in the Share Reserve for such&#160;year or that the increase in the Share Reserve for such&#160;year will be a lesser number of shares of common stock than would otherwise occur. The Share Reserve is currently <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_pMErCBdgkkqw-G_QhIaG3Q">3,172,399</ix:nonFraction> shares as of December&#160;31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In light of stockholder approval of the 2024 Plan, the Company no longer grants equity awards under the 2014 Plan. As of December&#160;31, 2024, there were <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_KeyPersonStockOptionPlan2007Member_6IjDjCrPDUm7EkmgVITtGQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_8EvDINLeDUOIKsbUlbBJKw">no</ix:nonFraction> shares available for future stock-based compensation grants under the 2014 plan. <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr__--N3j_T7EiaVUVTV-kyRA">2,155,895</ix:nonFraction> shares of an aggregate total of <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_0Tk9vMqv10GTfQYXrrOvOA">3,172,399</ix:nonFraction> shares, are available for future stock-based compensation grants under the 2024 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Aggregate intrinsic value represents the difference between the closing market value as of December&#160;31, 2024 of the underlying common stock and the exercise price of outstanding options. A summary of the Company&#8217;s stock option activity and related information for 2024 and 2023 is as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Tb_6ebg1ptagk6SsyKFOh_ZSw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:60.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options&#160;Outstanding</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic&#160;Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;(In&#160;Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In&#160;Thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance, December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Tc_W6elFDvk1UCnbIkhSPKMow_7_2">1,021,785</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_7eHcLQs4K0qjpce1wMPs-g_7_5">3.84</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Tc_yZ8zifOt4UaL6IdVNw8b7g_7_7"><b style="color:#231f20;font-weight:bold;"> 3.76</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="Tc_zivOnEl2mEGcDBomzloPWA_7_10">41,333</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Tc_03tVD45RUUu4UXe5IF2Z8w_8_2">173,700</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_NSXGaMcrBEuBGBEsR8ORJw_8_5">23.04</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options forfeited/cancelled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="Tc_nF6NVoFKI0y2THbxVH_tqQ_9_2">6,650</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_YI7MFReaW0mpvERHnrEUEA_10_2">497,385</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_ewJ-zPPqJ0Cjav3w8wlYCQ_10_5">3.42</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance, December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Tc_i7xkmmrTm0Ovrr0h5qRV9w_11_2">691,450</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_pO1qCMZVm0eJzxbRVryM2g_11_5">8.86</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Tc_FASgkxWNAEe4CD5MfMmVfQ_11_7"><b style="font-weight:bold;"> 3.21</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="Tc_LGQ70j_lSkeVs5cKfeyhUw_11_10">31,209</ix:nonFraction></b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Exercisable as of December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="Tc_DpesNuPKz0SveS1dpZRUBw_12_2">528,867</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="Tc_-US3KoJIZESij-LdWsSINQ_12_5">4.43</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Tc_j0dE0eqcQ0SG8LyZZt6tIw_12_7"><b style="font-weight:bold;"> 1.88</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="Tc_oA_GQEAte0ul8V5jHeGQLQ_12_10">26,214</ix:nonFraction></b></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">As of December 31, 2024,&#160;the fair value of unvested stock options was approximately&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="Narr_a8Gk8CwRO0aBcGQ28xS7VQ">2,315</ix:nonFraction>. This unrecognized stock-based compensation expense is expected to be recorded over a weighted average period of&#160;<ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Narr_hEYBylgN4EWh9BTQF8TFKQ">3.35</ix:nonNumeric>&#160;years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;background:#ffffff;margin:0pt;"><span style="font-family:'inherit';">&#160;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="color:#231f20;">During the year ended December 31, 2024</span><span style="color:#231f20;">, the Company awarded&#160;stock options of&#160;</span><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_1F1mWPhOZUKAJLkO4CKwHg">173,700</ix:nonFraction></span><span style="color:#231f20;">&#160;to&#160;employees&#160;as compensation pursuant to the 2014 Plan. Of these </span><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_JOF9RAV_fkuKYUMpAYeQQg" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_hP4OSYnCi06fTW-u40zIzQ">119,700</ix:nonFraction></span><span style="color:#231f20;"> options,&#160;</span><span style="-sec-ix-hidden:Hidden_Tzy6P97uHUaeUF-cBrMSEA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">1/4</span></span>th vest&#160;<ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_S8qckvwft0-ZA0tONRcfFw" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_TbBSGZvsUkSNHvCBFF8BQA">one&#160;year</ix:nonNumeric> after the grant date and&#160;<span style="-sec-ix-hidden:Hidden_V32SFWmW3EWJ45UKw92nEg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">1/48</span></span>th for each month thereafter contingent upon the participant&#8217;s continued service beginning on the initial vesting date and </p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_Q-B7dhtNZka5PsZK1R2TzA_1_2"></a><a id="Tc_Oxs64dqCpUSva1vYwkLOLg_1_4"></a><a id="Tc_9I7xGQ26U0u5NLW1n0Gp6w_2_2"></a><a id="Tc_yK9gJSaZN0ONX7Qewa1NgA_2_4"></a><a id="Tc_QKaGx9OsoEq913o_CH-f1A_3_0"></a><a id="Tc_8IqlWyxUbkuOCeYUS2EJgA_3_2"></a><a id="Tc_8LAS1uAQ80mdxMejccUOjA_4_0"></a><a id="Tc_5c0qnhr_lEmQydGN7V7iTg_4_2"></a><a id="Tc_OR4qO7OiKUOMiSTgiU746Q_4_4"></a><a id="Tc_fOpmIQfJFU2QaSXSfWNwjw_5_0"></a><a id="Tc_-Wbsd_7euESrsNqjgpV_WQ_5_2"></a><a id="Tc_4thu13s-RUunOflSTF7IAw_5_4"></a><a id="Tc_OnmTydCAAUiyZmvFZ8kp1g_6_0"></a><a id="Tc_KD9BKrytEkGe0hIQJaRNDg_7_0"></a><a id="Tc_lwuKvD6oFECZTmP0xRqzUg_7_2"></a><a id="Tc_ZW9dCTm8QEKY4e-s8L8gXg_7_4"></a><a id="Tc_wWXIu-o1VEmgp2hi_hVe8Q_1_5"></a><a id="Tc_98QvJqt-AkWSqokMkfj77A_1_8"></a><a id="Tc_j_h7QBxVH06pxosrRG-i0w_2_4"></a><a id="Tc_-mKpVh2Yo0WfVTQ8g0pJIA_2_7"></a><a id="Tc_64n1Q-wY4EyhtofNVe7ofQ_3_0"></a><a id="Tc_Dpt8sdxLH0av1GauLDqn1w_3_4"></a><a id="Tc_tzJCUqL6BE20Soya_aiLDA_3_7"></a><a id="Tc_bbzIxYUzpES1CHDwUHccoA_4_0"></a><a id="Tc_CTHicqs9Qkuewll1owzqmw_5_0"></a><a id="Tc_aE3V3wjNb0qlhyH2Y85duQ_6_0"></a><a id="Tc_FEL7u7UYTUWVFxGgRXJYqw_7_0"></a><a id="Tc_k4f4vT4WcEKXjV6-F-vAwg_7_4"></a><a id="Tc_YNZIoL9y-0eBsPNCKf59Xw_7_7"></a><ix:continuation id="Tb_18LmXezipkSmI_71vKTzXg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;">ending when the Vested Ratio equals 1/1. Grant date fair value of options granted to the employees for the year ended December 31, 2024 and 2023 was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_IRpa9_pYhEyV44mQzXmw2g" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" scale="3" id="Narr_jgp5BHaEhESDTw1A5vHGjA">1,792</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ypheC2QZukKv7Unwz7OIBQ" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" scale="3" id="Narr_t8rvRdBQh0-ZTvMNiZvVtA">316</ix:nonFraction>, respectively. Also during the year ended December 31, 2024, the Company awarded stock options of <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_0xY6gnE8qUybhgz-gxdNDQ" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_HEUM_F2XH0OB4dvZ7G-OtA">54,000</ix:nonFraction> to members of the board of directors pursuant to the 2014 Plan (the &#8220;Director Options&#8221;). Of these options, 1/<span style="-sec-ix-hidden:Hidden_8RoI3HM5VE6VepajHbnVVQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">24</span></span> vested immediately on the date of grant and 1/<span style="-sec-ix-hidden:Hidden_r6U7ShkGaEyl2_KE4RIe3w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">24</span></span> for each month thereafter contingent upon participant&#8217;s continued service beginning on the initial vesting date and ending when the vested ratio equals 1/1. The Director Options will be cancelled if not exercised by May 23, 2026. Grant date fair value of options granted to the non-employee directors for the year ended December 31, 2024 and 2023 was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_VVd0MeR2FUGoVh93N0DsZA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" scale="3" id="Narr_94Cgxe12YkaztwVh9YuMBA">559</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b8wtJ_BsM0unZVLTihfH6w" decimals="-3" format="ixt-sec:numwordsen" name="smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" scale="3" id="Narr_nWOTMjbkzUK0Q7CDIzHEKw">zero</ix:nonFraction>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="color:#212529;">&#160;</span><span style="color:#212529;"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="Narr_7hNY9oxDB0Wpz8CohpoiWw"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="Narr_koSv66w8vEeLE9lMtZm_1w">No</ix:nonFraction></ix:nonFraction></span><span style="color:#212529;">&#160;stock-based compensation was capitalized or included in inventories for the years ended&#160;</span><span style="color:#212529;">December 31</span><i style="color:#212529;font-style:italic;">, </i><span style="color:#212529;">2024</span><i style="color:#212529;font-style:italic;">&#160;</i><span style="color:#212529;">and</span><i style="color:#212529;font-style:italic;">&#160;</i><span style="color:#212529;">2023</span><i style="color:#212529;font-style:italic;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><span style="color:#231f20;">The fair value of each option grant is estimated using the Black-Scholes option pricing model. The weighted-average assumptions used, and the calculated weighted average fair values of options are as follows:</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Tb_TqQuBybow0qeYHwBIedDgA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_GbmeNOsf7EaK071-nE3ADg" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_FxGKqH577UK3p05wNgcdHw">2</ix:nonNumeric>-<ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_dA41U23jbUaIgfrnIFaEkA" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_udqhVWHUsUaZm0di21tUZA">7</ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Tc_SIrqSr0wyk62kDR7xZxKLQ_3_4">7</ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_E_5gSNKzDkSnn2144MGcLA">4.5</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_YRtaghoR6E2of6IHVXnVMg">4.9</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_n0mxLiUhM0mVj1sW3-iTHg">4.14</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_Ku4ruNkCdESaPGDTQcRL9w">4.41</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_4TjxjYH_s0e9kvGWc9ypEA">62.3</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_8y9H30ZLkUaW5zGLOnoY5A">77.2</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_QYM0uehC9EGARkWWVcjPEQ">69.0</ix:nonFraction>%-<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_rUPlmYK-NkusGVuxz9w2yw">79.5</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividend rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="Tc_e6WiiAp3dESk4LaZ4FIDRA_6_2">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="Tc_G0qz0CJoaEOviE9BpS4Dww_6_4">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value of options granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_GbmeNOsf7EaK071-nE3ADg" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_YhZpe2TcPkCEIkEgkNLCVw">10.35</ix:nonFraction>-$<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_dA41U23jbUaIgfrnIFaEkA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_oqUH9zWodEqpYVGLFM_B-Q">14.97</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_jPaHxANL9EC28M6jZYsdEA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_mD59W3dC80em3gpcDaYSoQ">17.54</ix:nonFraction>-$<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_X8BtSj_gKEOEIpqdtxsxfw" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_7StjgUpAokqFbAizEZ9bwQ">19.04</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Total tax benefit from the exercise of stock options was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="3" id="Narr_OgIP7TPWOUqqqqmFdr-23A">4,428</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="3" id="Narr_xu7GGYqK5Euy1ZFYlB3kmw">2,133</ix:nonFraction> for the years ended December 31, 2024 and 2023, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> Stock grants</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company granted <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="Narr_d4HT4RgMRUGH9aa0egJj5w">10,500</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="Narr_vQJE0LEBGEaA7qNLCCTdKw">18,048</ix:nonFraction> shares of fully vested stock to employees and board of directors in the year ended December 31, 2024 and 2023, respectively. Grant date fair value of the stock was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" scale="3" id="Narr_T089l-CBkEGS0eQghyQAnQ">300</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" scale="3" id="Narr_0ft8dh03gUm2E9672jSecw">860</ix:nonFraction> for the year ended December 31, 2024 and 2023, respectively. <span style="display:inline-block;width:13.29pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has recorded an expense of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Narr_gv2j2qTWo0SnUYj_4jXg4w">862</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Narr_i0SNr7xXvk2DECJRlFcFKg">944</ix:nonFraction> as it relates to stock-based compensation for the&#160;years ended December&#160;31, 2024 and 2023, respectively, which was allocated as follows based on the role and responsibility of the recipient in the Company:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="Tb_9ETqhvx3h06rErkJIuqQrw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_vC_VgO3t6kyazyC5VS8ocA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_3sphbo6gHUC2-I9bA4pxEw_3_5">42</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SyC6bd2xmUme3HPXw5Pazw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_1wp-CUICPkGQMJrX13D7sA_3_8">8</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Engineering and Product Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_cISDtiIR7ESd_y3U1MPmAQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_H1v6XffKlkG7aGu3p5D7tA_4_5">43</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_aUVxgJ1xTECBjIC1ZpWucg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_6_rUcmKgrUe1HrAzCrO1SA_4_8">53</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales and Marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_iI2SdgF49U2GUm8sENchpQ" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_Dd38nOdsIUSzyB8bXOVXjQ_5_5">135</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_XwzfHWNHj0GlezhAcZYaZg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_e7L24uxFuECswlGaJdaeBA_5_8">317</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General and Administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_j-idL8uTrE-R6vTgZEwaLw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_tMD5SURXWkiaRRYXChjvcw_6_5">642</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_VkzoijKppEGZkDNPtg0efA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_nxHj0XZWvkapL6vt6vkKvA_6_8">566</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_fSCoxBEQ0UOAEi7uacqAhQ_7_5">862</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_ySwj1xehnk6Ggsc9Vh3nuw_7_8">944</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_krvUC76y4U2qxzdNyoM56g_1_2"></a><a id="Tc_6Ck5kvfzjEiE6CzcbHnyZQ_1_5"></a><a id="Tc_271iJNzc7Umnv0d3BGkVSA_2_0"></a><a id="Tc_kHpm_XPdYkeNOkR622haIg_3_0"></a><a id="Tc_G0WBXRO31EupL6K_3h8g4w_3_2"></a><a id="Tc_izkOeE3Rs0yIOwhaSASEhQ_3_5"></a><a id="Tc_rcz8vHmdxUO6QarSjFtc2Q_4_0"></a><a id="Tc_yrlFCcgot0y1cDxaPdrfNA_5_0"></a><a id="Tc_s54O8GPlSkaCHD7F9wo-bQ_6_0"></a><a id="Tc_YGy_ouLZUEW14xYwC-PrnA_7_0"></a><a id="Tc_ZKDx0nJ3Zky7z5ch-V2hCQ_8_0"></a><a id="Tc_6DY4hAqKJEGpNIxorZpItw_9_0"></a><a id="Tc_zGi7Bp3l8UG2A20ffUc8LA_10_0"></a><a id="Tc_4_07jndYFEaaHQxaEpkhVg_10_2"></a><a id="Tc_J2wdPjDRSUCKrwRcHBOfgA_10_5"></a><a id="Tc_H15xNgqi-0azZqSV1F1wFA_1_2"></a><a id="Tc_ka3DIkVOuUisMUFam9FxjA_1_4"></a><a id="Tc_7ygSCO1YxUGeyoymSNPTYg_2_0"></a><a id="Tc_ZQVYI1O0JEivwbptIwqVZQ_2_3"></a><a id="Tc_1a0N66C9HEa0jbdzsCj55Q_2_5"></a><a id="Tc_-u21-ZA4M0ODD3USHWvzww_3_0"></a><a id="Tc_SDpzd08VE0uD_FAzjcFs9Q_3_3"></a><a id="Tc__Y8B0Z3q30a0-jCsQFTE7w_3_5"></a><a id="Tc_y4S-h3YBTEuJwlxZ7lnBag_4_0"></a><a id="Tc_1oCE0qXPukumhllBkaF_FQ_4_3"></a><a id="Tc_hJjBlNot5kuS_2LCDGVc-g_4_5"></a><a id="Tc_A0UoQH7wF0uSO3nqEHOAxA_5_0"></a><a id="Tc_7Gak7tDpUESvWqdMApSmnw_5_3"></a><a id="Tc_rR-R5zK-zk-CNDk4f0gvGA_5_5"></a><a id="Tc_iXfeErZTJUyPhd6E-D4QZg_6_0"></a><a id="Tc_lXmEcmxgtU-S7-4MocCI3A_6_3"></a><a id="Tc_xVFGm28w0E6l9ME_YOBt4w_6_5"></a><a id="Tc_0X-J3_gthEWBbx6L3ZNqUg_7_0"></a><a id="Tc_Zrg_CffES0KEe9ii7reUAg_7_3"></a><a id="Tc_Pb6YkYXSNE6Q2yaAjNkNuw_7_5"></a><a id="Tc_ARZDgt6bXEicNR6Sh54CCw_1_2"></a><a id="Tc_aAVM8egrO0ipksDNm4XpUw_1_5"></a><a id="Tc_sf1jpzJkg06oiJEvaC7_jQ_2_0"></a><a id="Tc_FnSqR4GhY0CNvj7YuvsJDA_2_2"></a><a id="Tc_DwlnyHreQkuabGLCraBWaw_2_5"></a><a id="Tc_CU3MZekFCky5ew1x6cJAfA_3_0"></a><a id="Tc_ISk6hR7t-06kt1r5LPBkHQ_4_0"></a><a id="Tc_At8t9riZaUm2v8i6F5Ixjg_5_0"></a><a id="Tc_KVD0GlFCZUCaU9sYo04lTw_6_0"></a><a id="Tc_TirJKW1_WkCPCVRz7SzGBA_7_0"></a><a id="Tc_vbjWtrMMFkSVhLrnqCRo_w_8_0"></a><a id="Tc_EpBkDpUA8UyT9LluH8MAJQ_9_0"></a><a id="Tc_K_7qBFtBB0ewya_FBMBkHw_10_0"></a><a id="Tc_mZWEna74ZE2e-AKVTwlMgg_11_0"></a><a id="Tc_kD_M2fs340iYUq1pA49Gvg_11_3"></a><a id="Tc_k3qDsVF_G0aEGDquUKWdVw_12_0"></a><a id="Tc_n-eqN0UEx0yEq2GlCi-5HA_13_0"></a><a id="Tc_aWhSE9Nf80i78_bmYo8wGQ_14_0"></a><a id="Tc_rIUluqFhakySikvUBqVJvw_15_0"></a><a id="Tc_N_kfpkBCF0uD4NQYuQ7KxA_16_0"></a><a id="Tc_djnzimiY8EmP7SWkoBhJ4w_17_0"></a><a id="Tc_z6K6pvCXWkuQBMFrMOzRQQ_17_2"></a><a id="Tc_-tYK5PoEOki4QowM1-6s1A_17_5"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:IncomeTaxDisclosureTextBlock" id="Tb_Gzw3baExS0aYkUmZs4gC3g" continuedAt="Tb_Gzw3baExS0aYkUmZs4gC3g_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">17.&#160;&#160;<b style="font-weight:bold;white-space:pre-wrap;">  Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The components of the provision for income taxes are as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Tb_7-5MdDEQkUapwESgdPzs4A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current tax provision:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Federal </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="Tc_nJttjhIuB0S7APQPgXPwwQ_3_3">948</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="Tc_xggcG6ymik-5x3C0YEL5lQ_3_6">3,576</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="Tc_cMg34YZ5i0mS42w0Cxg6Zw_4_3">310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="Tc_rA66DlIppEmmy-eHUE2fvg_4_6">605</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total current tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="Tc_GmwyuAN6i0my8wQWD-ZIHQ_5_3">1,258</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="Tc_Yi6bO7-mj0WeMZrP8ZSWXw_5_6">4,181</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax provision:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Federal </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="Tc_JWlt1h_5E0KxIChADqxpIg_7_3">5,015</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_NTJ_diGZ4kedPuyZzeUNwg_7_6">680</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">State </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="Tc_Ql7r3Z8IR02JWsNxLcKtXQ_8_3">712</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="Tc_oTJeQfG4zE-LmA6GZvvp4w_8_6">16</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total deferred tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="Tc_PGoErxUSJ0yQzaX_YmomkQ_9_3">5,727</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_8hFgcr2wOkmuaPzyyPmcrg_9_6">664</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_L0hmWKXJgker2cK6G-v3xQ_10_3">6,985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_Aq20Ic5Dl0qI9WaUqxeI2g_10_6">3,517</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of the differences between the Company&#8217;s effective income tax rate and the federal statutory income tax rate for the&#160;years ended December&#160;31, 2024 and 2023 are as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Tb_MncvxaSFq02DSHAXmP2m7w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal statutory rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Tc_S84-oQi79UmryMa9D4mSSg_2_2">21.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Tc_uqBjEY78wk6mHgx0plIp_g_2_4">21.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income tax rate, net of federal benefit </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="Tc_ks65EGpv3ESZVT9z4tqr_A_3_2">1.96</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="Tc_U-oJ7-1yTU-8kGN-3q-ydw_3_4">2.04</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" sign="-" scale="-2" id="Tc_S8ZCfFMF9UGAItoQ18AypQ_4_2">8.32</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" sign="-" scale="-2" id="Tc_od9PsgW3b0OagfcxmQCcgw_4_4">7.98</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Permanent items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" sign="-" scale="-2" id="Tc_ZC90hhYgFE2E2PZ39NPrzw_5_2">0.03</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" sign="-" scale="-2" id="Tc_289_1sijakq_JF92bnac6A_5_4">0.71</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" sign="-" scale="-2" id="Tc_DM4DHS2EUUWpxH8s4zJxXQ_6_2">0.07</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="Tc_0h_ut_26hE6iRdLULcuU1w_6_4">0.24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Effective income tax rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="Tc_rx0f3K0gyUi0OSu9ddtmhw_7_2">14.54</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="Tc_--sf-W3J8kG6IeHknRIWTA_7_4">14.59</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax (liabilities) assets are comprised of the following at December&#160;31:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Tb_DJJWF5dqa0OpwuKT1xfaTw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="Tc_9byT2JijQkO7_EjdJdI8ww_2_3">185</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="Tc_xpfQw3hpHEyD16JeZEjcng_2_6">188</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="Tc_BTQJpZ2FGkirAC5NsFLZFw_3_3">185</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="Tc_CPMQMX4_LkuMmDZGE5ilOA_3_6">268</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="Tc_3MkGYMX8Mk2RUdwtYzatJQ_4_3">208</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="Tc_uMp7gTU0F0CozAs6RExwcQ_4_6">385</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrual and reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="Tc_PYCyq_zAkUSG7ccgOVF0QA_5_3">180</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="Tc_kAD0063Ev0OajuoOpUXV1Q_5_6">251</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="Tc_IvR5r3qQJE6mo0dzcw_aQw_6_3">251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="Tc_rINntO6ZZUKbEpMPoqXXeQ_6_6">262</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="Tc_I7vEV4VWzUaPJAti5ftPSg_7_3">179</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="Tc_uoTPf7AAHUW46Lna9tGE6g_7_6">156</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="Tc_4ujYs3AtY0aKbzU0Sg0KgQ_8_3">2,004</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="Tc_TffXqiuf3EypyX3s95rhdA_8_6">1,450</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DeferredTaxAssetsLeaseLiabilities" scale="3" id="Tc_cNj4w4PLGUGu5a3pieV-Jg_9_3">17</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DeferredTaxAssetsLeaseLiabilities" scale="3" id="Tc_e1x2MQu5lkGPLbNl1XjA1A_9_6">38</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">     Total gross deferred tax assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="Tc_MLcc1scCLEmWo1HAqvM6xA_10_3">3,209</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="Tc_NCe1kY4hI0aC1UXdFcl_Ww_10_6">2,998</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">     Less valuation allowance</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="Tc__CLj_OICTkS_SCEz31XQaQ_11_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="Tc_dg1FPjhhEEusU8B_ptcpqQ_12_3">3,209</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="Tc_Nfbh0a9sOUiibUtEscPGdA_12_6">2,998</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Right of use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DeferredTaxAssetsRightOfUseAssets" scale="3" id="Tc_lpoOHtCqq02olvsi1hX9oA_14_3">16</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DeferredTaxAssetsRightOfUseAssets" scale="3" id="Tc_uuT0Z28Lb0SLEl5JQhDkig_14_6">36</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" scale="3" id="Tc_bEwaDfTkAkmKhF7_awLvBQ_15_3">5,958</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:fixed-zero" name="smlr:DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" scale="3" id="Tc_Mtyu8E6HhkKN12DFEwds4Q_15_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="Tc_Rojli6UxIUCOl_57aa1ZWg_16_3">5,974</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="Tc_x0SEw5RUY0uuwc5wYxXVIg_16_6">36</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 24pt;"><b style="font-weight:bold;">Net deferred tax (liabilities) assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="Tc_qj-6mzHlBku_5gsAobU1hw_17_3">2,765</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="Tc_8aUZ7XNK-ESnymtHNzwqOA_17_6">2,962</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Federal and California tax laws imposes significant restrictions on the utilization of net operating loss (&#8220;NOL&#8221;) carryforwards in the event of a change in ownership of the Company, as defined by Section 382 of the Code (&#8220;Section 382&#8221;). The Company completed a formal 382 study for the period from January 1, 2012 through June 30, 2019 and concluded that a change in ownership has likely occurred. The Company has <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_ESWGS2AUDEyJokJaRyrByQ" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:OperatingLossCarryforwards" scale="3" id="Narr_u9b3LQBrVE2ULAspSWh1Fg">no</ix:nonFraction> NOL carryforwards for Federal income </p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_IxP65rCqjkyCSI0e26-C3w_1_3"></a><a id="Tc_SIBeVDJ4QEO-H68n3V0DJg_1_6"></a><a id="Tc_U1wTvyPlS06UEcd8HKJv2w_2_0"></a><a id="Tc_yt3Uz4EqIkCW9ddFiTB0Yw_2_2"></a><a id="Tc_x6GG9QlWI0K9kyguGAJ4YQ_2_5"></a><a id="Tc_dAodRXE6wUGvRPxPhuo-lg_3_0"></a><a id="Tc_fMcclL254km8jpbTh5BxXQ_4_0"></a><a id="Tc_gWp0xiHNtUeDDGCa-bZN0Q_5_0"></a><a id="Tc_ofWx1tDq1kee-mkmEjB1zw_6_0"></a><a id="Tc_rxwl0kZz50a-PZtQsP47Lg_6_2"></a><a id="Tc_YzAlEx0gDEm0_o7aMOsQ1g_6_5"></a><ix:continuation id="Tb_Gzw3baExS0aYkUmZs4gC3g_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">tax purposes and approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="3" id="Narr_R9KwZmAK2UeZv2d1XXfDZg">2,580</ix:nonFraction> for California income tax purposes as of December 31, 2024. The state NOL carryforwards, if not utilized, will expire beginning in 2035 and extended to 2038. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024 and 2023, the Company had $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="Narr_NOu70sMReUGYnBtGR-3oeQ">487</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="Narr_EY15Rx-QhkGe6L8JJngi-w">470</ix:nonFraction>, respectively, of unrecognized tax benefits (excluding interest and penalties) that, if recognized, would affect the effective tax rate. The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="Tb_unerUdHTLEyqjToWb2P9Ow" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Unrecognized Tax Benefits 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Unrecognized Tax Benefits 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits &#8211; January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_-Q1ReIQ0VkuR8kVyG14U2g_2_3">470</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_1WkRWHmyIUKlArgBtQMarg_2_6">401</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross increases related to prior tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:fixed-zero" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_auf8otFqWEG4JInPopQiBw_3_3">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_GShgM9_prkSG1qkRekYrew_3_6">4</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross decreases related to prior tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_JmBPUs7JiEm67xoHkXs58g_4_3">3</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:fixed-zero" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_w8cltVa7ekGQ4rCLjeMr-w_4_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross increases related to current tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="Tc_iUtnRcVRXkOWZA454s-ojQ_5_3">20</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="Tc_PWdnPBF2KUyZ8IZfNceuCw_5_6">65</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits &#8211; December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_kAGdMKEz3UOKXUMNpFDmXA_6_3">487</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_nN_icrfO2EmB2pMOR2MgCQ_6_6">470</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s policy is to recognize interest and penalty expenses related to uncertain tax positions in income tax expense, which was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="Narr_6BdM-SokXUyWFZtgfzlljA">155</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="Narr_ddLoRau5VkGdtmZXHNAg0A">87</ix:nonFraction> for the years ended December 31, 2024 and 2023, respectively. The Company files income tax returns in the U.S. federal and various state tax jurisdictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company&#8217;s tax years beginning in 2020 remain open for examination by the state tax authorities for <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_StateAndLocalJurisdictionMember_l7TBs0ibWkKMa4_wC7X-XQ" format="ixt-sec:durwordsen" name="smlr:ExaminationOfCompanyTaxYears" id="Narr_ef-dRvpejUiWRWu7Wnotpg">four years</ix:nonNumeric>. The Company&#8217;s tax years beginning in 2021 remain open for examination by the federal tax authorities for <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_FOoH5YxHtkWAVEIxCeAZTw" format="ixt-sec:durwordsen" name="smlr:ExaminationOfCompanyTaxYears" id="Narr_unbSWzOYt0qD6E0UDW5AgQ">three years</ix:nonNumeric>. Tax years beginning in 2018 will remain open for examination from the date of utilization of any NOL or credits. The Company does not have any tax positions for which it is reasonably possible the total amount of gross unrecognized tax benefits will increase or decrease within 12 months of the year-ended December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Before January 1, 2022, IRC &#167;174 provided a taxpayer may treat research or experimental expenditures which are paid or incurred by the taxpayer during the taxable year in connection with the taxpayer&#8217;s trade or business as expenses.  As amended by TCJA, IRC &#167;174 provides that in a case of a taxpayer's specified research or experimental expenditures for any taxable year beginning after December 31, 2021, no deduction is allowed for such expenditures.  The expenditures must be charged to capital account and allowed an amortization deduction of such expenditures ratably over the 5-year period (15-year period in the case of any specified research expenditures which are attributable to foreign research). The Company capitalized </span>$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ResearchAndExperimentalExpendituresCapitalized" scale="3" id="Narr_eEiNyIshQ0auGMhti_Go_g">4,153</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ResearchAndExperimentalExpendituresCapitalized" scale="3" id="Narr_6q8JwRlbtkC0sjfvZfsi1Q">4,610</ix:nonFraction> specified research or experimental expenditures for the year ended December 31, 2024 and 2023, respectively.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:EarningsPerShareTextBlock" id="Tb_9SDPHPgYk0G3-5bqJ3B_QQ" continuedAt="Tb_9SDPHPgYk0G3-5bqJ3B_QQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">18.&#160;&#160;<b style="font-weight:bold;white-space:pre-wrap;">  Net Income Per Share, Basic and Diluted</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Basic earnings per share (&#8220;EPS&#8221;) represent net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.<span style="background:#ffffff;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="Tc_6Awac1fhwUSuiCsz96Qy6w_1_2"></a><a id="Tc_fnFvsPcvLESrTq5LRl43kg_2_2"></a><a id="Tc_hGeernRQ3Eiw0UuSRRyQxw_2_10"></a><a id="Tc_QJpNsj4Tbkylai711AJvzw_3_2"></a><a id="Tc_aIGOcTrN9EWS8hT1l83_2g_3_4"></a><a id="Tc_psuIdImE8E6LiFTjZatrTg_3_7"></a><a id="Tc_uj2DnfWVs0W_HNNvvb7oZw_3_10"></a><a id="Tc_ifZymCzSAUyrbpgeRt-e_Q_3_12"></a><a id="Tc_HKWqxZiEikiZNW15MjOjuA_3_15"></a><a id="Tc_uNl1OuyTIUScAiJHYc9JeQ_4_0"></a><a id="Tc_dNiEmW7QxEisLKxFB9Vw-A_4_4"></a><a id="Tc_OExYXI-N2ki_CuJz0TQcNA_4_7"></a><a id="Tc_K_wwp3wmCEKCwJ9W1KC95g_4_12"></a><a id="Tc_ezAX_lLKYU6LiD7GGX4Gwg_4_15"></a><a id="Tc_VFh5fEvwM0m3c7zAGnHrjA_5_0"></a><a id="Tc_OXsM_vW_LUurBxDUKywKHQ_6_0"></a><a id="Tc_mQxvhJVq706FrVx0_1gW1w_6_4"></a><a id="Tc_f0Dq5Ac77ku5Y1v1pXDfbQ_6_7"></a><a id="Tc_6_yIVrcYykuJRK8XG1uomg_6_12"></a><a id="Tc_pgZOZItc4EeVCOjum0M6Zg_6_15"></a><ix:continuation id="Tb_9SDPHPgYk0G3-5bqJ3B_QQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Basic and diluted net EPS is calculated as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Tb_nLTpVbhBT0yGaCCH5TnUfQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:72.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:33.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EPS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EPS</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_XU3ZitmRlUGgOr53dDDBbA_4_2">7,228,961</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="Tc_1jIJX17hPES8cdQsNNOaOg_4_5">40,899</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_ZRjcg6ges0-BuGlkrLXm1g_4_8">5.66</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_FqZCW6mIcEabMJgvnj0KHw_4_10">6,732,806</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="Tc_CEOdYcGj5UirYM7JPvR3gw_4_13">20,583</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_JucC5PjMqUqnXNn4VCNQXA_4_16">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Common stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="Tc_Mb3hjlU9PECGl8dXDJoJLA_5_2">751,157</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" scale="3" id="Tc_--zpjwdydESGC19uakxdcQ_5_5">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="Tc_g3OtuXFXm0qGJm9CkuP93A_5_10">1,086,353</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" scale="3" id="Tc_YrCDUnpx7UejTKgeQTDUxA_5_13">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_zhwswxcQbk6nNR7ik3TX2w_6_2">7,980,118</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="Tc_NrvLpgIcpUKJH0oUuTxTJg_6_5">40,899</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_f17W-Xu-Q0encw17lEy7xg_6_8">5.13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="Tc_qoq5v6oRbUO0h2eeK0g1Ag_6_10">7,819,159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="Tc_PoTqxWTChUiLdqHnogAd1Q_6_13">20,583</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_l2HD3Jrc50C6wGHakWr7zg_6_16">2.63</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_65ca6174_a2fe_4e61_8c3a_ee472435cfc3"></a><a id="Tc_nrD6GBBFI0aY-FkeMwbhHw_1_4"></a><a id="Tc_1BVfsK8j7UqWofjC_j_RfA_1_7"></a><a id="Tc_HW0DOcdGwUWibt_V3E824A_2_3"></a><a id="Tc_TeMy3lKmikShRlj8u1Oy-w_2_6"></a><a id="Tc_yjebKfIEgUa0Ha80gSadjQ_3_0"></a><a id="Tc_cBtt5ZFs80G9f5dZ2d-h-w_3_3"></a><a id="Tc_DZaaf3ReWUmSgtJOW2LwxA_3_6"></a><a id="Tc_N5ScsCneHEirr5P8aGIgxQ_4_0"></a><a id="Tc_TS7hHPeKiUWtQfnLg-OPAw_5_0"></a><a id="Tc_NIkToRCd_USdJl_EnCvkkw_6_0"></a><a id="Tc_DXcwz6DGGESuP5XtMjG5CQ_7_0"></a><a id="Tc_8mzMLzwW30KoauU7MQWS2w_8_0"></a><a id="Tc_483-a2J7mkWBUCZRz_RoCQ_9_0"></a><a id="Tc_c1jmRnSpvkC6o1n0cUeIEw_10_0"></a><a id="Tc_OkD-TL_pukC92oyyDjyfUw_11_0"></a><a id="Tc_DgML-RH9skWq1fEYLTOtxA_12_0"></a><a id="Tc_L9CQ3foUp06k3JxhWhj6zQ_13_0"></a><a id="Tc_s887Ly_zYE6Js0uecGJIXg_14_0"></a><a id="Tc_5QzJBXrgZ0eW70apj7Xa4w_14_4"></a><a id="Tc_Q0tENjqENE6IRaLoSFFimg_15_0"></a><a id="Tc_6nTk16kAE0ykUW8DGjewvQ_16_0"></a><a id="Tc_S4gB20lNkkCKjXhrVGUPAg_16_7"></a><a id="Tc_AwVGexcdlUe6a9ZWTHpBHQ_17_0"></a><a id="Tc_B2mmr9Tu6EeygWGv7cXS_g_18_0"></a><a id="Tc_hxoeOMaCV0ayAPnhJ0LXTw_19_0"></a><a id="Tc_53rYrn4m0k-4RFKdNeFkqw_20_0"></a><a id="Tc_ETHoe6qMokafZR3upqmAYw_20_3"></a><a id="Tc_WMxfukt5_EeV3xiHbvwlnQ_20_6"></a><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:SegmentReportingDisclosureTextBlock" id="Tb_5LxwKWSbokiLgRs2nSIf2w" continuedAt="Tb_5LxwKWSbokiLgRs2nSIf2w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.</b></span><b style="font-weight:bold;">Segment Information</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">ASU No. 2023-07 topic 280, &#8220;Segment Reporting&#8221; establishes standards for reporting information about operating segments on a basis consistent with the Company&#8217;s internal organization structure as well as information about services categories, business segments and major customers in financial statement. </span><span style="background:#ffffff;">The Company manages its business in </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_segment_Ijr0hkbG8kGjCrFIHbBeqw" contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="Narr_RbM7ZjKNtka0t91gFgGqdg">one</ix:nonFraction></span><span style="background:#ffffff;"> reportable operating segment, which is engaged in the manufacturing, marketing, and sales of its</span><span style="color:#212529;background:#ffffff;">&#160;patented and FDA cleared product, QuantaFlo.</span><span style="background:#ffffff;"> </span><span style="color:#212529;">In accordance with the &#8220;Segment Reporting&#8221; Topic 280, the Chief Executive Officer and President has been identified as the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;), who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. The </span>CODM uses segment operating profit to allocate resources including employees, property and investments. The CODM also uses month-over-month expense variance analysis for cost control and for making decisions about allocating capital and personnel to the segment<span style="font-size:12pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">The following table breaks out the operations of the Company&#8217;s single reportable segment information.</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="Tb_0clUoy29tk6ZWNqIuiqHoA" continuedAt="Tb_0clUoy29tk6ZWNqIuiqHoA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="Tc_EWjKGJ5Shkib_U6cKX0aOQ_3_4">56,294</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="Tc_7_6INa_PC0ekdalW_q0r-g_3_7">68,184</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Less:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cost of revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="Tc_JOAK3pLoYEOaDMDUB987_Q_5_4">4,685</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="Tc_8OMiIaqFdk-jFfu2cqlAjA_5_7">6,923</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="Tc_xxPrnWpCzka_DGz1I7yhhQ_6_4">4,709</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="Tc_XmXSriES6UqdrkhZ-otMpA_6_7">5,674</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingExpense" scale="3" id="Tc_pwBgP2fCzUGoSxPBiXJULw_7_4">5,895</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingExpense" scale="3" id="Tc_9dVLevIB4kCEQqiQCpXO8w_7_7">7,777</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessDevelopment" scale="3" id="Tc_DwPRr-P9xECxpVaZXfh2VA_8_4">2,946</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessDevelopment" scale="3" id="Tc_Ds4uMb2JwEWQE4qTXSwZUw_8_7">3,702</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="Tc_foZzZwgl9E6LtFKa84rCpw_9_4">12,651</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="Tc_FJuL8u-w2EeR0Ui_lZdK4g_9_7">14,208</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_aROuwN7CjkuqTwFVK8h21Q_10_4">283</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_8Z5KuEax70SSbkoFiv2bFw_10_7">292</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other segment expenses <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SegmentReportingOtherItemAmount" scale="3" id="Tc_wFh5_Dbm6Uu4qKcIC94sAw_11_4">4,192</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SegmentReportingOtherItemAmount" scale="3" id="Tc_odZ3h2FxI0yxWv5DBfUC-g_11_7">7,352</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Segment operating profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_8VACoIApn0iwljYItVMdXA_12_4">20,933</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_vn8stx_5skCvixZwp2smuA_12_7">22,256</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest income, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="3" id="Tc_xRokIIKN9EWQdOWWWp75wQ_13_4">1,877</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="3" id="Tc_j3y1tj9NS0KOqI8TGwhK2Q_13_7">2,471</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Impairment of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ImpairmentLossesInvestments" scale="3" id="Tc_36CtJrkBsUqM4pCa_qkYzw_14_7">337</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:FairValueAdjustmentOfNotesHeldForInvestment" sign="-" scale="3" id="Tc_bvKmAwHlWESyiXwUiXXc7w_15_4">128</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:FairValueAdjustmentOfNotesHeldForInvestment" scale="3" id="Tc_e7X1Wdp4VEaJJ2ozj7iNPA_15_7">307</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetUnrealizedGainLossNonoperating" scale="3" id="Tc_7K6UfNlvEk-I-UMPbmeClw_16_4">24,933</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other corporate income <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="smlr:OtherCorporateIncomeExpense" scale="3" id="Tc_kVBAR9u5cUGIi4fGZG9yCw_17_4">13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="smlr:OtherCorporateIncomeExpense" scale="3" id="Tc_qbkIZNxKm0WITTX7l8ux7w_17_7">17</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income before taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><span style="font-size:11pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_MxS2Pcp3f0SpFqzXEbRuxw_18_4">47,884</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><span style="font-size:11pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_i6QrhWrjBUaNxbduu3c_ZA_18_7">24,100</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_k894c0g9jkmcV9cTjG5XAw_19_4">6,985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_c9f7bqZu2E-k9e0RM0djhw_19_7">3,517</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_bJSnFOIIOEOu1L_nsCxO-w_20_4">40,899</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_1GFvqJNlikC3cK4oaevXew_20_7">20,583</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Research and development include clinical affairs and HITRUST.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg" name="us-gaap:SegmentReportingOtherItemCompositionDescription" id="Narr_3x-r1RPoOEquBt6qz5n_8w"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw" name="us-gaap:SegmentReportingOtherItemCompositionDescription" id="Narr_ptKQMzOew0OFBWHmBQ4ufA"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other segment expenses include marketing, customer education, business development, and strategic streamlining.</span></ix:nonNumeric></ix:nonNumeric></td></tr></table></ix:nonNumeric></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_5LxwKWSbokiLgRs2nSIf2w_cont1"><ix:continuation id="Tb_0clUoy29tk6ZWNqIuiqHoA_cont1"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other corporate income represents unallocated income.</span></td></tr></table><div style="margin-top:12pt;"></div></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">See note 12 to the financial statements for the customers accounted for 10% or more of the revenues and receivables.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">As of December 31, 2024 and 2023, all assets of the Company were located in United States of America.</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A" name="us-gaap:SubsequentEventsTextBlock" id="Tb_WaMYY9fMskOgfSyRfZhqNQ" continuedAt="Tb_WaMYY9fMskOgfSyRfZhqNQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">20.</b></span><b style="color:#212529;font-weight:bold;">Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Offering of </b><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_QSDqEM4ASke8S1lBeYje-g">4.25</ix:nonFraction>%</b><b style="font-weight:bold;"> Convertible Senior Notes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">On January 28, 2025, the Company completed its previously announced private offering of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="Narr_yb562RDHP0ukFfPn0NU-3g">100.0</ix:nonFraction></span><span style="background:#ffffff;"> million aggregate principal amount of its </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_rkbu75gmmkePAW3cVbCIuw">4.25</ix:nonFraction>%</span><span style="background:#ffffff;"> Convertible Senior Notes due 2030, or the Notes, including the exercise in full of the initial purchasers&#8217; option to purchase up to an additional </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="-5" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" scale="6" id="Narr_-1BQtQZHz0SbvvpsYWugLg">15.0</ix:nonFraction></span><span style="background:#ffffff;"> million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated January 28, 2025, or the Indenture, between the Company and U.S. Bank Trust Company, National Association, as trustee.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">The Notes are general senior, unsecured obligations of the Company and will mature on August 1, 2030, unless earlier converted, redeemed or repurchased. The Notes bear interest at a rate of </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_NuRxlqo7tU-Q18BY7o9ZkQ">4.25</ix:nonFraction>%</span><span style="background:#ffffff;"> per year, payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2025. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 1, 2030, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2025 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock, par value </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_8-ktz7ESaUSM0eSG45hfXw">0.001</ix:nonFraction></span><span style="background:#ffffff;"> per share, or the Common Stock, for at least </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="Narr_l_47iiTZ7EuP_7zOR__8CQ">20</ix:nonFraction></span><span style="background:#ffffff;"> trading days (whether or not consecutive) during a period of </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="Narr_oPRbIkE2VUOGwL9ua-ImQA">30</ix:nonFraction></span><span style="background:#ffffff;"> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="Narr_gKBSB6nBgkqutzVVk_vlfA">130</ix:nonFraction>%</span><span style="background:#ffffff;"> of the conversion price for the Notes on each applicable trading day; (2) during the </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:DebtInstrumentConvertibleThresholdBusinessDays" scale="0" id="Narr_bCeL_-p1ykGxfyztpOJlVw">five</ix:nonFraction></span><span style="background:#ffffff;"> business day period after any </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" scale="0" id="Narr_EUCq6ydCK0e3LMxdCDxZoQ">10</ix:nonFraction></span><span style="background:#ffffff;"> consecutive trading day period, or the measurement period, in which the trading price (as defined in the Indenture) per </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" scale="3" id="Narr_QODY8r5pK02nwfRCQELi4w">1,000</ix:nonFraction></span><span style="background:#ffffff;"> principal amount of the Notes for each trading day of the measurement period was less than </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" scale="-2" id="Narr_-gD63_einU2d5c43JhzbJg">98</ix:nonFraction>%</span><span style="background:#ffffff;"> of the product of the last reported sale price of Common Stock and the conversion rate for the Notes on each such trading day; (3) if Semler calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after May 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company may satisfy its conversion obligation by paying and/or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company&#8217;s election, in the manner and subject to the terms and conditions provided in the Indenture</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">The conversion rate for the Notes will initially be </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="INF" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" scale="0" id="Narr_INs1siSxM0KfUtPzsA_WUg">13.0826</ix:nonFraction></span><span style="background:#ffffff;"> shares of Common Stock per </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" scale="3" id="Narr_lWI5KemlqUSjSXJ5-fxAAw">1,000</ix:nonFraction></span><span style="background:#ffffff;"> principal amount of Notes, which is equivalent to an initial conversion price of approximately </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="Narr_IQkGZxuiJE21W4RJcP4dUw">76.44</ix:nonFraction></span><span style="background:#ffffff;"> per share of Common Stock. The initial conversion price of the Notes represents a premium of approximately </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="3" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" scale="-2" id="Narr_7sFHa_GypEeCGJOG6l-IZg">25.0</ix:nonFraction>%</span><span style="background:#ffffff;"> over the last reported sale price of the Common Stock on the Nasdaq Capital Market on January 23, 2025. The conversion rate for the Notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, it will, in certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes in connection with such a corporate event or convert its notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be. Initially, a maximum of </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="INF" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" scale="0" id="Narr_PQXwNjkbt0GPHuwKyuLbTg">1,635,320</ix:nonFraction></span><span style="background:#ffffff;"> shares of Common Stock may be issued upon conversion of the Notes, based on the initial maximum conversion rate of </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg" contextRef="As_Of_1_28_2025_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_ovxYPgBkWZ0i_kIROisQ" decimals="INF" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" scale="0" id="Narr_WyVek2qvgkiCV4m0gO-3Zw">16.3532</ix:nonFraction></span><span style="background:#ffffff;"> shares of common stock per </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" scale="3" id="Narr_addGKhi4yEm8iyTOsnpQ3Q">1,000</ix:nonFraction></span><span style="background:#ffffff;"> principal amount of Notes</span>.</p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_WaMYY9fMskOgfSyRfZhqNQ_cont1" continuedAt="Tb_WaMYY9fMskOgfSyRfZhqNQ_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The Company may not redeem the Notes prior to August 4, 2028. The Company may redeem for cash all or any portion of the Notes (subject to the partial redemption limitation described in the Indenture), at its option, on or after August 4, 2028 and prior to the 21st scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Common Stock has been at least </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="Narr_Cr5t1JZDdEamIhDrzlQA4w">130</ix:nonFraction>%</span><span style="background:#ffffff;"> of the conversion price for the Notes then in effect for at least </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="Narr_wd6IQHSfMU2Ma78dj0LnnA">20</ix:nonFraction></span><span style="background:#ffffff;"> trading days (whether or not consecutive) during any </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="Narr_jXlGhhT1fkOkOmarfpnnVw">30</ix:nonFraction></span><span style="background:#ffffff;"> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="Narr_IggdENDV9Ey6nXbpupxpOg">100</ix:nonFraction>%</span><span style="background:#ffffff;"> of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as set forth in the Indenture, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentFundamentalChangeRepurchasePricePercentage" scale="-2" id="Narr_fbhP_OcRsU-vNc40WmP93A">100</ix:nonFraction>% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The following events are considered &#8220;events of default&#8221; under the Indenture:</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">default in any payment of interest on any Note when due and payable and the default continues for a period of </span><ix:nonNumeric contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" format="ixt-sec:durwordsen" name="smlr:DebtInstrumentConvertibleDebtDefaultInterestPeriod" id="Narr_9pVvmH4nBU2alBvNfCAkTA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">30 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">default in the payment of principal of any Note when due and payable at its stated maturity, upon optional redemption, upon any required repurchase, upon declaration of acceleration or otherwise;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to comply with its obligation to convert the Notes in accordance with the Indenture upon exercise of a holder&#8217;s conversion right, and such failure continues for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" scale="0" id="Narr_nNBw76L5kE-Qz_pG6p5YmA">three</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> business days;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to give (i) a fundamental change notice or notice of a make-whole fundamental change, in either case when due and such failure continues for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" scale="0" id="Narr_f62io00R6027HrfPnh60rQ">five</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> business days, or (ii) notice of a specified corporate transaction when due and such failure continues for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="INF" format="ixt-sec:numwordsen" name="smlr:DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" scale="0" id="Narr_cWLcMSjDFkC4LTeUuJu0Cw">one</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> business day;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to comply with its obligations in respect of any consolidation, merger or sale of assets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to comply with any of its other agreements in the Notes or the Indenture for </span><ix:nonNumeric contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" format="ixt-sec:durwordsen" name="smlr:DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" id="Narr_JKgiv3Nt80uJJYF7cSzDXA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">60 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> after written notice of such failure from the trustee or the holders of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" scale="-2" id="Narr_LpyhMCipLU2zvTHTTjcY-g">25</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> in principal amount of the Notes then outstanding;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">default by the Company or any of its significant subsidiaries (as defined in the Indenture) with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed with a principal amount in excess of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA" decimals="-5" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" scale="6" id="Narr_e4S7iUAbHEGAE_4l2KMAvQ">15.0</ix:nonFraction></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> million (or its foreign currency equivalent), in the aggregate of the Company and/or any such significant subsidiary, whether such indebtedness now exists or shall hereafter be created, (i) resulting in such indebtedness becoming or being declared due and payable prior to its stated maturity date or (ii) constituting a failure to pay the principal of any such indebtedness when due and payable (after the expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, and in the cases of clauses (i) and (ii), such acceleration shall not have been rescinded or annulled or such failure to pay or default shall not have been cured or waived, or such </span></td></tr></table></ix:continuation></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a><span style="display:inline-block;width:0.35pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Semler Scientific, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Notes to Financial Statements (continued)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(In thousands of U.S. Dollars, except share and per share data and bitcoin and bitcoin cost)</p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><ix:continuation id="Tb_WaMYY9fMskOgfSyRfZhqNQ_cont2"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">indebtedness is not paid or discharged, as the case may be, within </span><ix:nonNumeric contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" format="ixt-sec:durwordsen" name="smlr:DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" id="Narr_F5L4frlZxUe60zdSw69fMQ"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">30 days</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> after written notice to the Company by the trustee or to the Company and the trustee by holders of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA" decimals="2" format="ixt:num-dot-decimal" name="smlr:DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" scale="-2" id="Narr_bHBsjBD-WUWyX_3RZ1uISw">25</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> in aggregate principal amount of the Notes then outstanding in accordance with the Indenture; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">certain events of bankruptcy, insolvency or reorganization of the Company or any of its significant subsidiaries&#8217;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Neither the notes, nor any shares of the Company&#8217;s common stock issuable upon conversion of the notes, have been registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons, absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Repayment of Senior Convertible Senior Note</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On January 15, 2025, Monarch repaid $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA" decimals="-3" format="ixt:num-dot-decimal" name="smlr:ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" scale="3" id="Narr_LIrmp3JsY0qk7zJX07LGoA">3,500</ix:nonFraction>, along with the transaction fees and accrued interest. At the same time, the Company entered into an Amended and Restated Secured Convertible Promissory Note (&#8220;New Note&#8221;) and related subordination agreement for the outstanding balance of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lEsvR7g5ukqjO6r8JvkH_g" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableNet" scale="3" id="Narr_BA1wQ23uVUagz0dLyEGTew">1,500</ix:nonFraction> (&#8220;Principal Amount&#8221;). The New Note carries an interest rate of <ix:nonFraction unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA" contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA" decimals="2" format="ixt:num-dot-decimal" name="smlr:DebtSecurityInterestRate" scale="-2" id="Narr_SF4xy_kcBEuDNY7y6y8WqA">15</ix:nonFraction>% payable monthly on 5<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> day of each month. Unless earlier repaid or converted, the New Note will mature and the outstanding Principal Amount, together with accrued and unpaid interest thereon and the transaction expenses (the &#8220;Balance&#8221;), shall be due and payable on the first to occur of (i) the occurrence of an Event of Default (as defined in the New Note), (ii) a Change of Control (as defined in the New Note) unless converted as set forth in the New Note or (iii) February 15, 2028 (the &#8220;Maturity Date&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'TimesNewRomanPSMT';visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#212529;font-weight:bold;">Bitcoin Purchase Update</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the period January 1, 2025 and February 14, 2025, the Company purchased a total of approximately <ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA" decimals="INF" format="ixt:num-dot-decimal" name="smlr:CryptoAssetNumberOfUnitsPurchased" scale="0" id="Narr_3yp5Ode_bEuVIBbMXEy0_A">894</ix:nonFraction> bitcoins at an aggregate purchase price of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentForAcquisitionCryptoAsset" scale="6" id="Narr_NH3nRpeuQ0WYjcwjaEVcDw">90.7</ix:nonFraction> million for an average purchase price of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_2_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_rF8xp9fd-0m4m_wVJU1ZfQ" decimals="0" format="ixt:num-dot-decimal" name="smlr:CryptoAssetAveragePurchasePrice" scale="0" id="Narr_6N0jkfHqCEqKDVoXtZwAdw"><ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_1_1_2025_To_1_31_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Vh5xue5y_kiCARvRzIwtZQ" decimals="0" format="ixt:num-dot-decimal" name="smlr:CryptoAssetAveragePurchasePrice" scale="0" id="Narr_54HJkb2YDkGp67zMbDQNww">101,532</ix:nonFraction></ix:nonFraction> per bitcoin. See Note 9 to Financial Statements &#8220;Intangible Digital Assets&#8221; for further details.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of February 14, 2025, The Company held approximately <ix:nonFraction unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q" contextRef="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetNumberOfUnits" scale="0" id="Narr_2u6L4UT89UOGyLGShU_mdA">3,192</ix:nonFraction> bitcoins that were acquired at an aggregate purchase price of $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CryptoAssetCost" scale="6" id="Narr_sjJWrEGEYEGwZLs2P1wRuw">280.4</ix:nonFraction> million and an average purchase price of approximately $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="Duration_2_14_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Mua0Ot9Ko0CU_qSEjW_8uA" decimals="0" format="ixt:num-dot-decimal" name="smlr:CryptoAssetAveragePurchasePrice" scale="0" id="Narr__e0SM6uvd0-WVkhl0vPnMQ">87,854</ix:nonFraction> per bitcoin, inclusive of fees and expenses. As of February 14, 2025, at 4 p.m. Eastern Time, the market price of one bitcoin reported on the Coinbase exchange (the Company&#8217; principal market) was $<ix:nonFraction unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ" contextRef="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q" decimals="0" format="ixt:num-dot-decimal" name="smlr:CryptoAssetMarketPricePerCryptoAsset" scale="0" id="Narr_yjj-pC-iJEWHEWeZKEXdyA">97,505</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">F-30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_494c35fe_4b28_454e_a017_6d02af7506ba"></a><a id="sig"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:45.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 28, 2025 </p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:top;width:51.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Semler Scientific, Inc. </p></td><td style="vertical-align:top;width:0.21%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:top;width:45.86%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:3.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:47.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:0.21%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:top;width:45.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:47.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:45.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:47.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Douglas Murphy-Chutorian, M.D.</p></td><td style="vertical-align:top;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:45.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:47.85%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian, M.D.</p></td><td style="vertical-align:top;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:45.86%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:2.2%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:3.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:47.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td><td style="vertical-align:top;width:0.21%;margin:0pt;padding:0pt;"/></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="Power_of_attorney"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">POWER OF ATTORNEY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">KNOW ALL PERSONS BY THESE PRESENTS</b>, that each person whose signature appears below constitutes and appoints Douglas Murphy-Chutorian and Renae Cormier, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this annual report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:0.07%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:35.86%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:43.45%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:16.42%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:0.06%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:0.07%;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:35.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name </b></p></td><td style="vertical-align:bottom;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:43.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title </b></p></td><td style="vertical-align:bottom;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:16.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date </b></p></td><td style="vertical-align:bottom;width:0.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:35.86%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:16.42%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-bottom:1pt;text-align:center;border-bottom:1px solid #000000;margin:0pt;"><span style="font-size:9.5pt;">/s/ Douglas Murphy-Chutorian, M.D.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">Douglas Murphy-Chutorian, M.D. </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:9.5pt;">Chief Executive Officer and Director </span><span style="font-size:9.5pt;"><br/></span><span style="font-size:9.5pt;">(Principal Executive Officer) </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">February 28, 2025 </span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-bottom:1pt;text-align:center;border-bottom:1px solid #000000;margin:0pt;"><span style="font-size:9.5pt;">/s/ Renae Cormier</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">Renae Cormier </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:9.5pt;">Chief Financial Officer</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:9.5pt;">(Principal Financial Officer and Principal Accounting Officer) </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;white-space:nowrap;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">February 28, 2025 </span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">/s/ Daniel S. Messina</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:9.5pt;">Director </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">February 28, 2025 </span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Daniel S. Messina</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">/s/ William H.C. Chang</p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:9.5pt;">Director </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">February 28, 2025 </span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">William H.C. Chang</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:0.07%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:35.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-bottom:1pt;text-align:center;border-bottom:1px solid #000000;margin:0pt;"><span style="font-size:9.5pt;">/s/ Eric Semler</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">Eric Semler</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><span style="font-size:9.5pt;">Director </span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:16.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="font-size:9.5pt;">February 28, 2025</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9.5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.06%;margin:0pt;padding:0pt;"/></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>smlr-20241231xex10d7.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:26 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 10.7</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.54pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.5pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">SEMLER</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.25pt;"> </b><b style="font-size:12pt;font-weight:bold;">SCIENTIFIC,</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;">INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 87.4pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">AT-WILL</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.7pt;"> </b><b style="font-size:12pt;font-weight:bold;">EMPLOYMENT,</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.7pt;"> </b><b style="font-size:12pt;font-weight:bold;">CONFIDENTIAL</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.65pt;"> </b><b style="font-size:12pt;font-weight:bold;">INFORMATION, INVENTION ASSIGNMENT,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:14.65pt;text-align:center;margin:0pt 87.45pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">AND</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;"> </b><b style="font-size:12pt;font-weight:bold;">ARBITRATION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.25pt;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;">AGREEMENT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:11.94pt 8.7pt 12pt 38pt;">As a condition of my employment with Semler Scientific, Inc., its subsidiaries, affiliates, successors or assigns (together the &#8220;<b style="font-weight:bold;">Company</b>&#8221;), and in consideration of my employment with the Company<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>my<font style="letter-spacing:-0.35pt;"> </font>receipt<font style="letter-spacing:-0.4pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>compensation<font style="letter-spacing:-0.35pt;"> </font>now<font style="letter-spacing:-0.25pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>hereafter<font style="letter-spacing:-0.3pt;"> </font>paid<font style="letter-spacing:-0.4pt;"> </font>to<font style="letter-spacing:-0.4pt;"> </font>me<font style="letter-spacing:-0.3pt;"> </font>by<font style="letter-spacing:-0.35pt;"> </font>Company,<font style="letter-spacing:-0.35pt;"> </font>I<font style="letter-spacing:-0.35pt;"> </font>agree<font style="letter-spacing:-0.4pt;"> </font>to the<font style="letter-spacing:-0.25pt;"> </font>following<font style="letter-spacing:-0.25pt;"> </font>provisions<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>this<font style="letter-spacing:-0.25pt;"> </font>Semler<font style="letter-spacing:-0.1pt;"> </font>Scientific,<font style="letter-spacing:-0.15pt;"> </font>Inc.<font style="letter-spacing:-0.2pt;"> </font>At-Will<font style="letter-spacing:-0.25pt;"> </font>Employment,<font style="letter-spacing:-0.25pt;"> </font>Confidential<font style="letter-spacing:-0.15pt;"> </font>Information, Invention Assignment, and Arbitration Agreement (this &#8220;<b style="font-weight:bold;">Agreement</b>&#8221;):</p><div style="margin-top:12.1pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">At-Will</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Employment</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:12pt 8.7pt 12pt 38pt;">I UNDERSTAND AND ACKNOWLEDGE THAT MY EMPLOYMENT WITH THE COMPANY IS FOR NO SPECIFIED TERM AND CONSTITUTES &#8220;AT-WILL&#8221; EMPLOYMENT.<font style="letter-spacing:2pt;"> </font>I ALSO UNDERSTAND THAT ANY REPRESENTATION TO THE CONTRARY IS UNAUTHORIZED AND NOT VALID UNLESS IN WRITING AND SIGNED BY THE PRESIDENT OR CEO OF THE COMPANY.<font style="letter-spacing:2pt;"> </font>ACCORDINGLY, I ACKNOWLEDGE THAT MY EMPLOYMENT<font style="letter-spacing:-0.45pt;"> </font>RELATIONSHIP<font style="letter-spacing:-0.45pt;"> </font>MAY<font style="letter-spacing:-0.45pt;"> </font>BE<font style="letter-spacing:-0.45pt;"> </font>TERMINATED<font style="letter-spacing:-0.45pt;"> </font>AT<font style="letter-spacing:-0.45pt;"> </font>ANY<font style="letter-spacing:-0.45pt;"> </font>TIME,<font style="letter-spacing:-0.45pt;"> </font>WITH<font style="letter-spacing:-0.5pt;"> </font>OR<font style="letter-spacing:-0.55pt;"> </font>WITHOUT<font style="letter-spacing:-0.5pt;"> </font>GOOD<font style="letter-spacing:-0.45pt;"> </font>CAUSE OR FOR ANY OR NO CAUSE, AT MY OPTION OR AT THE OPTION OF THE COMPANY, WITH OR WITHOUT NOTICE.<font style="letter-spacing:2pt;"> </font>I FURTHER ACKNOWLEDGE THAT THE COMPANY MAY MODIFY JOB TITLES, SALARIES, AND BENEFITS FROM TIME TO TIME AS IT DEEMS NECESSARY.</p><div style="margin-top:11.94pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">2.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Confidential</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.4pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Information</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Company Information</i><font style="font-size:12pt;">. I</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">agree that during</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">and after my</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employment with</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the Company, I will hold in the strictest confidence, and will not use (except for the benefit of the Company during my employment) or disclose to any person, firm, or corporation (without written authorization of the President, CEO, or the Board of Directors of the Company) any Company Confidential Information.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that my unauthorized use or disclosure of Company Confidential</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">Information</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">during</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">employment</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">lead</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">disciplinary</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">action, up</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">including immediate</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">termination</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">legal</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">action</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">understand</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Company</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-size:12pt;font-weight:bold;">Confidential Information</b><font style="font-size:12pt;">&#8221; means any non-public information that relates to the actual or anticipated business, research or development of the Company, or to the Company&#8217;s technical data, trade secrets, or know-how,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">including,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">but</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">limited</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">to,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">research,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">product</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">plans,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">other</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">regarding</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">the Company&#8217;s products or services and markets therefor, customer lists and customers (including, but not limited</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">to,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">customers</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">called or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">become</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">acquainted during the term of my employment), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information; provided, however, Company Confidential Information does</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">include</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">foregoing</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">items</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">extent</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">same</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">have</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">become</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">publicly</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">known</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">and made</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">generally</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">available</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">through</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">no</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">wrongful</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">act</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">mine</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">others.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">understand</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">nothing</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">in</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 0pt 12pt 38pt;"><a name="_bookmark0"></a>this<font style="letter-spacing:1.4pt;"> </font>Agreement<font style="letter-spacing:1.7pt;"> </font>is<font style="letter-spacing:1.5pt;"> </font>intended<font style="letter-spacing:1.6pt;"> </font>to<font style="letter-spacing:1.7pt;"> </font>limit<font style="letter-spacing:1.6pt;"> </font>employees&#8217;<font style="letter-spacing:1.5pt;"> </font>rights<font style="letter-spacing:1.55pt;"> </font>to<font style="letter-spacing:1.55pt;"> </font>discuss<font style="letter-spacing:1.5pt;"> </font>the<font style="letter-spacing:1.55pt;"> </font>terms,<font style="letter-spacing:1.65pt;"> </font>wages,<font style="letter-spacing:1.65pt;"> </font>and<font style="letter-spacing:1.5pt;"> </font><font style="letter-spacing:-0.1pt;">working</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">conditions<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>their<font style="letter-spacing:-0.2pt;"> </font>employment,<font style="letter-spacing:-0.2pt;"> </font>as<font style="letter-spacing:-0.25pt;"> </font>protected<font style="letter-spacing:-0.1pt;"> </font>by<font style="letter-spacing:-0.35pt;"> </font>applicable<font style="letter-spacing:-0.05pt;"> </font><font style="letter-spacing:-0.2pt;">law.</font></p><div style="margin-top:11.94pt;"></div><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.85pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Former Employer Information</i><font style="font-size:12pt;">. I agree that during my employment with the Company, I will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former or concurrent employer or other person or entity.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">bring</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">onto</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">premises</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">transfer</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">onto</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Company&#8217;s technology</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">systems</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">unpublished</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">document,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">proprietary</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">information,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">trade</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">secrets</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">belonging to any such employer, person, or entity unless consented to in writing by both the Company and such employer, person, or entity.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.1pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><i style="font-size:12pt;font-style:italic;">Third</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-size:12pt;font-style:italic;">Party</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.1pt;"> </i><i style="font-size:12pt;font-style:italic;">Information</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">recognize</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">have</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">received</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">and in the future may receive from third parties associated with the Company, e.g., the Company&#8217;s customers, suppliers, licensors, licensees, partners, or collaborators (&#8220;</font><b style="font-size:12pt;font-weight:bold;">Associated Third Parties</b><font style="font-size:12pt;">&#8221;), their confidential or proprietary information (&#8220;</font><b style="font-size:12pt;font-weight:bold;">Associated Third Party Confidential Information</b><font style="font-size:12pt;">&#8221;). By way of example, Associated Third Party Confidential Information may include the habits or practices of Associated Third Parties, the technology of Associated Third Parties, requirements of Associated Third Parties,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and information related</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">to the business conducted between</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the Company and</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">such</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Parties.</font><font style="font-size:12pt;letter-spacing:1.85pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">at</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">times</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">during</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">employment</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">and thereafter to hold in the strictest confidence, and not to use or to disclose to any person, firm, or corporation,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">Party</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">Confidential</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Information,</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">except</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">necessary</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">carrying</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">out my work for the Company consistent with the Company&#8217;s agreement with such Associated Third Parties.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further agree to comply with any and all Company policies and guidelines that may be adopted</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">from</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">regarding</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Parties</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Party</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Confidential Information.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that my unauthorized use or disclosure of Associated Third Party Confidential Information or violation of any Company policies during my employment may lead to disciplinary action, up to and including immediate termination and legal action by the Company.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_bookmark1"></a></font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Inventions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.65pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Inventions Retained and Licensed</i><font style="font-size:12pt;">. I have attached hereto as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</u><font style="font-size:12pt;">, a list describing all inventions, discoveries, original works of authorship, developments, improvements, and trade secrets that were conceived in whole or in part by me prior to my employment with the Company and to which I</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">have any right,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">title, or interest,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">which are subject to California Labor Code Section 2870 </font><b style="font-size:12pt;font-weight:bold;">(</b><font style="font-size:12pt;">attached hereto as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u><font style="font-size:12pt;">), and which relate to the Company&#8217;s proposed business, products,</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">research</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">development</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">(&#8220;</font><b style="font-size:12pt;font-weight:bold;">Prior</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.65pt;"> </b><b style="font-size:12pt;font-weight:bold;">Inventions</b><font style="font-size:12pt;">&#8221;);</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">or,</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">if</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">no</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">such</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">list</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">is</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">attached,</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">represent and warrant that there are no such Prior Inventions.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Furthermore, I represent and warrant that if any</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Prior</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Inventions</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">are</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">included</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.45pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</u><font style="font-size:12pt;">,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">they</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">materially</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">affect</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">ability</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">perform</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">all obligations under this Agreement.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">If, in the course of my employment with the Company, I incorporate into or use in connection with any product, process, service, technology, or other work by</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">behalf</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Prior</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Invention,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">hereby</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">grant</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">non-exclusive, royalty-free, fully paid-up, irrevocable, perpetual, transferable, worldwide license, with the right to</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0.05pt 8.9pt 12pt 38pt;"><a name="_bookmark2"></a>grant and authorize sublicenses, to make, have made, modify, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Invention without restriction, including, without limitation, as part of or in connection with such product, process, service, technology, or other work, and to practice any method related thereto.</p><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Assignment of Inventions</i><font style="font-size:12pt;">. I agree that I will promptly make full written disclosure</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">hold</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">trust</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">sole</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">right</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">benefit</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">agree to assign and hereby do irrevocably assign to the Company, or its designee, all my right, title, and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">discoveries, ideas,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">trademarks, or trade secrets, whether or not patentable or registrable under patent, copyright, or similar laws, which I may solely or jointly conceive or develop</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">reduce</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">practice,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">cause</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">conceived</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">developed</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">reduced</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">practice,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">during the period of time I am in the employ of the Company (including during my off-duty hours), or with the use of Company&#8217;s equipment, supplies, facilities, or Company Confidential Information, except as provided in Section </font><font style="font-size:12pt;">3</font><font style="font-size:12pt;">.</font><font style="font-size:12pt;">F</font><font style="font-size:12pt;"> below (collectively referred to as &#8220;</font><b style="font-size:12pt;font-weight:bold;">Inventions</b><font style="font-size:12pt;">&#8221;).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further acknowledge that all original works of authorship that are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Company and that are protectable by copyright are &#8220;works made for hire,&#8221; as that term is defined in the United States Copyright Act.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand and agree that the decision whether or not to commercialize or market any Inventions is within the Company&#8217;s sole discretion and for the Company&#8217;s sole benefit, and that no royalty or other</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">consideration</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">due</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">me</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">result</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Company&#8217;s</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">efforts</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">commercialize</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">market any such Inventions.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.14pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><a name="_bookmark3"></a><i style="font-size:12pt;font-style:italic;">Moral</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-size:12pt;font-style:italic;">Rights</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Any</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">assignment</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Inventions</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">includes</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">world that may be known as or referred to as &#8220;moral rights,&quot; &#8220;artist&#8217;s rights,&quot; &#8220;droit moral,&quot;</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">like</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">(collectively,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Moral</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.3pt;"> </b><b style="font-size:12pt;font-weight:bold;">Rights</b><font style="font-size:12pt;">&#8221;).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">To</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">extent</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Moral</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Rights</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">cannot</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">assigned under applicable law, I hereby waive and agree not to enforce any and all Moral Rights, including, without</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">limitation,</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">right</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">identification</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">authorship</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">limitation</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">subsequent</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">modification that I may have in the assigned Inventions.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">D.</font><i style="font-size:12pt;font-style:italic;">Maintenance of Records</i><font style="font-size:12pt;">. I agree to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by me (solely or jointly with others) during the term of my employment with the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">The records will be in the form of notes, sketches, drawings, electronic files, reports, or any other format that may be specified by the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">The records are and will be available</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">to and remain</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">sole</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">property of the Company at all times.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">E.</font><i style="font-size:12pt;font-style:italic;">Further Assurances</i><font style="font-size:12pt;">. I agree to assist the Company, or its designee, at the Company&#8217;s expense, in every proper way to secure the Company&#8217;s rights in the Inventions and any rights</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">relating</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">thereto</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">countries,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">including</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">disclosure</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">all</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0.05pt 8.75pt 12pt 38pt;"><a name="_bookmark4"></a>pertinent<font style="letter-spacing:-0.6pt;"> </font>information<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>data<font style="letter-spacing:-0.65pt;"> </font>with<font style="letter-spacing:-0.6pt;"> </font>respect<font style="letter-spacing:-0.6pt;"> </font>thereto,<font style="letter-spacing:-0.6pt;"> </font>the<font style="letter-spacing:-0.5pt;"> </font>execution<font style="letter-spacing:-0.6pt;"> </font>of<font style="letter-spacing:-0.55pt;"> </font>all<font style="letter-spacing:-0.5pt;"> </font>applications,<font style="letter-spacing:-0.55pt;"> </font>specifications, oaths, assignments, and all other instruments that the Company shall deem proper or necessary in order<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>apply<font style="letter-spacing:-0.25pt;"> </font>for,<font style="letter-spacing:-0.05pt;"> </font>register,<font style="letter-spacing:-0.1pt;"> </font>obtain,<font style="letter-spacing:-0.2pt;"> </font>maintain,<font style="letter-spacing:-0.2pt;"> </font>defend,<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>enforce<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>rights,<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>order<font style="letter-spacing:-0.3pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>assign and<font style="letter-spacing:-0.4pt;"> </font>convey<font style="letter-spacing:-0.45pt;"> </font>to<font style="letter-spacing:-0.55pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>Company,<font style="letter-spacing:-0.45pt;"> </font>its<font style="letter-spacing:-0.45pt;"> </font>successors,<font style="letter-spacing:-0.45pt;"> </font>assigns,<font style="letter-spacing:-0.45pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>nominees<font style="letter-spacing:-0.55pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>sole<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>exclusive<font style="letter-spacing:-0.45pt;"> </font>rights,<font style="letter-spacing:-0.45pt;"> </font>title, and<font style="letter-spacing:-0.4pt;"> </font>interest<font style="letter-spacing:-0.35pt;"> </font>in<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>to<font style="letter-spacing:-0.4pt;"> </font>such<font style="letter-spacing:-0.25pt;"> </font>Inventions<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>any<font style="letter-spacing:-0.45pt;"> </font>rights<font style="letter-spacing:-0.35pt;"> </font>relating<font style="letter-spacing:-0.45pt;"> </font>thereto,<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>testifying<font style="letter-spacing:-0.45pt;"> </font>in<font style="letter-spacing:-0.4pt;"> </font>a<font style="letter-spacing:-0.3pt;"> </font>suit<font style="letter-spacing:-0.4pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>other proceeding relating to such Inventions and any rights relating thereto.<font style="letter-spacing:2pt;"> </font>I further agree that my obligations under this Section 3E shall continue after the termination of this Agreement.<font style="letter-spacing:2pt;"> </font>If the Company<font style="letter-spacing:-0.45pt;"> </font>is<font style="letter-spacing:-0.45pt;"> </font>unable<font style="letter-spacing:-0.55pt;"> </font>because<font style="letter-spacing:-0.4pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>my<font style="letter-spacing:-0.45pt;"> </font>mental<font style="letter-spacing:-0.4pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>physical<font style="letter-spacing:-0.3pt;"> </font>incapacity<font style="letter-spacing:-0.45pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>for<font style="letter-spacing:-0.4pt;"> </font>any<font style="letter-spacing:-0.6pt;"> </font>other<font style="letter-spacing:-0.4pt;"> </font>reason<font style="letter-spacing:-0.4pt;"> </font>to<font style="letter-spacing:-0.4pt;"> </font>secure<font style="letter-spacing:-0.4pt;"> </font>my signature<font style="letter-spacing:-0.05pt;"> </font>with<font style="letter-spacing:-0.05pt;"> </font>respect<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>any<font style="letter-spacing:-0.1pt;"> </font>Inventions,<font style="letter-spacing:-0.1pt;"> </font>including, without<font style="letter-spacing:-0.05pt;"> </font>limitation,<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>apply<font style="letter-spacing:-0.1pt;"> </font>for<font style="letter-spacing:-0.05pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>pursue<font style="letter-spacing:-0.05pt;"> </font>any application for any United States or foreign patents or copyright registrations covering such Inventions, then I hereby irrevocably designate and appoint the Company and its duly authorized officers<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.65pt;"> </font>agents<font style="letter-spacing:-0.55pt;"> </font>as<font style="letter-spacing:-0.55pt;"> </font>my<font style="letter-spacing:-0.7pt;"> </font>agent<font style="letter-spacing:-0.6pt;"> </font>and<font style="letter-spacing:-0.6pt;"> </font>attorney<font style="letter-spacing:-0.55pt;"> </font>in<font style="letter-spacing:-0.65pt;"> </font>fact,<font style="letter-spacing:-0.55pt;"> </font>to<font style="letter-spacing:-0.55pt;"> </font>act<font style="letter-spacing:-0.5pt;"> </font>for<font style="letter-spacing:-0.6pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>in<font style="letter-spacing:-0.5pt;"> </font>my<font style="letter-spacing:-0.7pt;"> </font>behalf<font style="letter-spacing:-0.45pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>stead,<font style="letter-spacing:-0.55pt;"> </font>to<font style="letter-spacing:-0.65pt;"> </font>execute and file any papers and oaths, and to do all other lawfully permitted acts with respect to such Inventions with the same legal force and effect as if executed by me.</p><div style="margin-top:12pt;"></div><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">F.</font><a name="_bookmark5"></a><i style="font-size:12pt;font-style:italic;">Exception to Assignments</i><font style="font-size:12pt;">. I understand</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">that the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">provisions</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of this</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Agreement requiring</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">assignment</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Inventions</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">do</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">apply</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">invention</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">qualifies</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">fully under the provisions of California Labor Code Section 2870 (attached hereto as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u><font style="font-size:12pt;">).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I will advise</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">promptly</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">writing</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">inventions</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">believe</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">meet</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">criteria</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">California Labor Code Section 2870 and are not otherwise disclosed on </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:12pt;">.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">4.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Conflicting</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.35pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Employment</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Current Obligations. </i><font style="font-size:12pt;">I agree that during the term of my</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employment with the Company, I will not engage in or undertake any other employment, occupation, consulting relationship, or commitment that is directly related to the business in which the Company is now involved or becomes involved or has plans to become involved, nor will I engage in any other activities that conflict with my obligations to the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.05pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;font-style:italic;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Prior Relationships</i><font style="font-size:12pt;">. Without limiting Section 4.A, I represent that I have no other</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">agreements,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">relationships,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">commitments</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">other</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">person</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">entity</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">conflict</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">my obligations to the Company under this Agreement or my ability to become employed and perform the services for which I am being hired by the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further agree that if I have signed a confidentiality agreement or similar type of agreement with any former employer or other entity, I will comply with the terms of any such agreement to the extent that its terms are lawful under applicable law.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I represent and warrant that after undertaking a careful search (including searches of my computers, cell phones, electronic devices,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and documents), I have returned all</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">property and confidential information belonging to all prior employers.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Moreover, I agree to fully indemnify the Company, its directors, officers, agents, employees, investors, shareholders, administrators, affiliates,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">divisions,</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">subsidiaries,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">predecessor</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">successor</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">corporations,</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">assigns</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">verdicts, judgments, settlements, and other losses incurred by any of them resulting from my breach of my obligations</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">under any</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">agreement</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">am</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">party</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">obligation</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">am</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">bound,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">well</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;letter-spacing:-0.25pt;">as</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 0pt 12pt 38pt;">any<font style="letter-spacing:1.25pt;"> </font>reasonable<font style="letter-spacing:1.25pt;"> </font>attorneys&#8217;<font style="letter-spacing:1.3pt;"> </font>fees<font style="letter-spacing:1.3pt;"> </font>and<font style="letter-spacing:1.2pt;"> </font>costs<font style="letter-spacing:1.3pt;"> </font>if<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.25pt;"> </font>plaintiff<font style="letter-spacing:1.4pt;"> </font>is<font style="letter-spacing:1.15pt;"> </font>the<font style="letter-spacing:1.25pt;"> </font>prevailing<font style="letter-spacing:1.15pt;"> </font>party<font style="letter-spacing:1.3pt;"> </font>in<font style="letter-spacing:1.35pt;"> </font>such<font style="letter-spacing:1.4pt;"> </font>an<font style="letter-spacing:1.4pt;"> </font><font style="letter-spacing:-0.1pt;">action,</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">except<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.25pt;"> </font>prohibited<font style="letter-spacing:-0.2pt;"> </font>by<font style="letter-spacing:-0.1pt;"> </font><font style="letter-spacing:-0.2pt;">law.</font></p><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">5.</font><i style="font-size:12pt;font-style:italic;">Returning Company Documents</i><font style="font-size:12pt;">. Upon separation from employment with the Company or on demand by the Company during my employment, I will immediately deliver to the Company, and will not keep in my possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Company Confidential Information, Associated Third</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">Party</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Confidential</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Information,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">well</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">devices</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">equipment</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">belonging</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">Company (including computers, handheld electronic devices, telephone equipment, and other electronic devices), Company credit cards, records, data, notes, notebooks, reports, files, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, photographs, charts, any other documents and property, and reproductions of any and all of the aforementioned items that were developed by me pursuant to my employment with the Company, obtained by me in connection with my employment with the Company, or otherwise belonging to the Company, its successors,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">assigns,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">including,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">without</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">limitation,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">those</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">records</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">maintained</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">pursuant</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">to Section </font><font style="font-size:12pt;">3.C</font><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I also consent to an exit interview to confirm my compliance with this Section 5.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:12.05pt 9.1pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">6.</font><i style="font-size:12pt;font-style:italic;">Termination Certification. </i><font style="font-size:12pt;">Upon separation from employment with the Company, I agree to immediately sign and deliver to the Company the &#8220;Termination Certification&#8221; attached hereto</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.15pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">C</u><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">also</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">keep</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">advised</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">home</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">business</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">address</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">for a period of three (3) years after termination of my employment with the Company, so that the Company can contact me regarding my continuing obligations provided by this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 10.95pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">7.</font><i style="font-size:12pt;font-style:italic;">Notification</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-size:12pt;font-style:italic;">of</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.1pt;"> </i><i style="font-size:12pt;font-style:italic;">New</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.15pt;"> </i><i style="font-size:12pt;font-style:italic;">Employer</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">In</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">event</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">leave</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">employ</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">I hereby grant consent to notification by the Company to my new employer about my obligations under this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:12.1pt 8.95pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">8.</font><i style="font-size:12pt;font-style:italic;">Solicitation</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.4pt;"> </i><i style="font-size:12pt;font-style:italic;">of</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.3pt;"> </i><i style="font-size:12pt;font-style:italic;">Employees</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">period</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">twelve</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">(12)</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">months</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">immediately following the termination of my relationship with the Company for any reason, whether voluntary or involuntary, with or without cause, I shall not either directly or indirectly solicit any of the Company&#8217;s employees</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to leave</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">their</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employment, or attempt to solicit</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employees of</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">the Company, either for myself or for any other person or entity.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I agree that nothing in this Section 8 shall affect my continuing obligations under this Agreement during and after this twelve (12) month period, including, without limitation, my obligations under Section 2A.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:11.94pt 8.85pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">9.</font><i style="font-size:12pt;font-style:italic;">Conflict of Interest Guidelines</i><font style="font-size:12pt;">. I agree to diligently adhere to all policies of the Company, including the Company&#8217;s insider&#8217;s trading policies and the Company&#8217;s Conflict of Interest Guidelines.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">A copy</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">of the Company&#8217;s current Conflict of Interest Guidelines is attached as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">D</u><font style="font-size:12pt;"> hereto,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">but</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">understand</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">these</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Conflict</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Interest</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Guidelines</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">revised</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">from</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">time during my employment.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:0.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.85pt;text-indent:0pt;white-space:nowrap;">10.</font><i style="font-size:12pt;font-style:italic;">Representations</i><font style="font-size:12pt;">. I agree to execute any proper oath or verify any proper document required</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">carry</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">out</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">terms</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">Agreement.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">represent</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">performance</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">terms of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Agreement</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">breach</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">agreement</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">keep</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">confidence</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">acquired</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">me in confidence or in trust</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">prior to my employment by the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I hereby represent and warrant that I have not entered into, and I will not enter into, any oral or written agreement in conflict </font><font style="font-size:12pt;letter-spacing:-0.1pt;">herewith.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 12.95pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">11.</font><i style="font-size:12pt;font-style:italic;">Audit. </i><font style="font-size:12pt;">I acknowledge that I have no reasonable expectation of privacy in any computer, technology system, email, handheld device, telephone, or documents that are used to conduct the business of the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">As such, the Company has the right to audit and search all such items and systems, without further notice to me, to ensure that the Company is licensed to use the software on the Company&#8217;s devices in compliance with the Company&#8217;s software licensing policies, to ensure compliance with the Company&#8217;s policies, and for any other business-related purposes in the Company&#8217;s sole discretion.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that I am not permitted to add any unlicensed, unauthorized, or non-compliant applications to the Company&#8217;s technology systems, including, without limitation, open source or free software not authorized by the Company, and that I shall refrain from copying unlicensed software onto the Company&#8217;s technology systems or using non-licensed software or websites.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that it is my responsibility to comply with the Company&#8217;s policies governing use of the Company&#8217;s documents and the internet, email, telephone,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">technology</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">systems</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">will have</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">access</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">connection</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">employment.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">12.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Arbitration</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.3pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">and</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.25pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Equitable</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Relief</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Arbitration</i><font style="font-size:12pt;">. IN CONSIDERATION OF MY EMPLOYMENT WITH THE COMPANY, ITS PROMISE TO ARBITRATE ALL EMPLOYMENT-RELATED DISPUTES, AND MY RECEIPT OF THE COMPENSATION, PAY RAISES, AND OTHER BENEFITS PAID TO ME BY THE COMPANY, AT PRESENT AND IN THE FUTURE, I AGREE THAT ANY AND ALL CONTROVERSIES, CLAIMS, OR DISPUTES WITH ANYONE</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">(INCLUDING</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">THE COMPANY AND ANY EMPLOYEE,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">OFFICER, DIRECTOR, SHAREHOLDER, OR BENEFIT</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">PLAN</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">COMPANY,</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">IN</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">THEIR</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">CAPACITY</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">SUCH</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">OTHERWISE),</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">WHETHER</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">BROUGHT ON</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">AN</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">INDIVIDUAL,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">GROUP,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">CLASS</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">BASIS,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">ARISING</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">OUT</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">OF,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">RELATING</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">TO,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">RESULTING</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">FROM MY EMPLOYMENT WITH THE COMPANY OR THE TERMINATION OF MY EMPLOYMENT WITH THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION UNDER THE ARBITRATION RULES SET FORTH IN CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 1280 THROUGH 1294.2, INCLUDING SECTION 1281.8 (THE &#8220;</font><b style="font-size:12pt;font-weight:bold;">ACT</b><font style="font-size:12pt;">&#8221;), AND PURSUANT</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">CALIFORNIA</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">LAW.</font><font style="font-size:12pt;letter-spacing:1.8pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">FEDERAL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">ARBITRATION</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">ACT</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">SHALL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">CONTINUE</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">APPLY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">WITH FULL</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">FORCE</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">EFFECT</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">NOTWITHSTANDING</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">APPLICATION</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">PROCEDURAL</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">RULES</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">SET</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">FORTH IN</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">ACT.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">DISPUTES</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">THAT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AGREE</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">ARBITRATE,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THEREBY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">AGREE</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">WAIVE</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">RIGHT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">TO A TRIAL BY JURY, INCLUDE ANY STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW, INCLUDING, BUT NOT LIMITED</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">TO, CLAIMS UNDER TITLE VII OF THE CIVIL</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">RIGHTS ACT OF 1964, THE AMERICANS WITH DISABILITIES ACT OF 1990, THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE OLDER WORKERS BENEFIT PROTECTION ACT, THE SARBANES-OXLEY ACT, THE WORKER ADJUSTMENT</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">RETRAINING</font><font style="font-size:12pt;letter-spacing:2pt;"> </font></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:0pt;margin:0pt 8.7pt 0pt 38pt;"><font style="font-size:12pt;">NOTIFICATION</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">ACT,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">CALIFORNIA</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">FAIR</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">EMPLOYMENT</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">AND</font></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0.05pt 8.8pt 12pt 38pt;">HOUSING ACT, THE FAMILY AND MEDICAL LEAVE ACT, THE CALIFORNIA FAMILY RIGHTS ACT, THE CALIFORNIA LABOR CODE, CLAIMS OF HARASSMENT, DISCRIMINATION, AND WRONGFUL TERMINATION, AND ANY STATUTORY OR COMMON LAW CLAIMS.<font style="letter-spacing:2pt;"> </font>I FURTHER UNDERSTAND THAT THIS AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH ME.</p><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Procedure</i><font style="font-size:12pt;">. I AGREE THAT ANY ARBITRATION WILL BE ADMINISTERED BY JUDICIAL ARBITRATION &amp; MEDIATION SERVICES, INC. (&#8220;</font><b style="font-size:12pt;font-weight:bold;">JAMS</b><font style="font-size:12pt;">&#8221;), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &amp; PROCEDURES (THE &#8220;</font><b style="font-size:12pt;font-weight:bold;">JAMS RULES</b><font style="font-size:12pt;">&#8221;).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND/OR ADJUDICATION, MOTIONS TO DISMISS </font><font style="font-size:12pt;letter-spacing:-0.1pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">DEMURRERS,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">MOTIONS</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">FOR</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">CLASS</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">CERTIFICATION,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">PRIOR</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">ANY ARBITRATION HEARING. </font><font style="font-size:12pt;">I ALSO AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">APPLICABLE LAW, AND THAT</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">THE ARBITRATOR</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">SHALL</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">AWARD ATTORNEYS&#8217; FEES AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">COSTS</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">PREVAILING</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PARTY,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">EXCEPT</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PROHIBITED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">BY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">LAW.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">AGREE</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THAT</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">DECREE OR</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">AWARD</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">RENDERED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">BY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ARBITRATOR</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">MAY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ENTERED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">A</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">FINAL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">BINDING</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">JUDGMENT IN</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">COURT</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">HAVING</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">JURISDICTION</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THEREOF.</font><font style="font-size:12pt;letter-spacing:1.8pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">UNDERSTAND</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THAT</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">COMPANY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">WILL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">PAY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">FOR ANY ADMINISTRATIVE OR HEARING FEES CHARGED BY THE ARBITRATOR OR JAMS EXCEPT THAT I SHALL PAY ANY FILING FEES ASSOCIATED WITH ANY ARBITRATION THAT I INITIATE, BUT ONLY SO MUCH</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">FILING</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FEES</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">WOULD HAVE</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">INSTEAD</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">PAID</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">HAD</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FILED</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">A</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">COMPLAINT</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">IN</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">A</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">COURT OF LAW.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THAT THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO RULES OF CONFLICT OF LAW.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT THE DECISION OF THE ARBITRATOR SHALL BE IN WRITING.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">ARBITRATION</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">UNDER</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">AGREEMENT</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">SHALL</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">CONDUCTED</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">IN</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">SANTA</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">CLARA</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">COUNTY, </font><font style="font-size:12pt;letter-spacing:-0.1pt;">CALIFORNIA.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.1pt 8.8pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><i style="font-size:12pt;font-style:italic;">Remedy</i><font style="font-size:12pt;">. EXCEPT AS PROVIDED BY THE ACT AND THIS AGREEMENT, ARBITRATION SHALL</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">THE SOLE,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">EXCLUSIVE,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FINAL</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">REMEDY</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FOR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">DISPUTE BETWEEN</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">ME AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">COMPANY.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">ACCORDINGLY,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">EXCEPT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">PROVIDED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">FOR</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">BY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">ACT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AGREEMENT, NEITHER</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">NOR</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">COMPANY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">WILL</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PERMITTED</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PURSUE</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">COURT</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ACTION</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">REGARDING</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">CLAIMS THAT ARE SUBJECT TO ARBITRATION.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12pt 8.8pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">D.</font><i style="font-size:12pt;font-style:italic;">Administrative Relief</i><font style="font-size:12pt;">. I UNDERSTAND THAT THIS AGREEMENT DOES NOT PROHIBIT ME FROM PURSUING AN ADMINISTRATIVE CLAIM WITH A LOCAL, STATE, OR FEDERAL ADMINISTRATIVE BODY OR GOVERNMENT AGENCY THAT IS AUTHORIZED TO ENFORCE OR ADMINISTER LAWS RELATED TO EMPLOYMENT, </font></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:0pt;margin:12pt 8.8pt 0pt 38pt;"><font style="font-size:12pt;">INCLUDING, BUT NOT LIMITED TO, THE DEPARTMENT OF FAIR EMPLOYMENT AND HOUSING, THE EQUAL EMPLOYMENT OPPORTUNITY COMMISSION,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">NATIONAL</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">LABOR</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">RELATIONS</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">BOARD,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">WORKERS&#8217;</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">COMPENSATION</font></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 9.8pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 9.8pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;">BOARD.</font><font style="display:inline-block;width:32.26pt;"></font>THIS<font style="letter-spacing:2pt;"> </font>AGREEMENT<font style="letter-spacing:2pt;"> </font>DOES,<font style="letter-spacing:2pt;"> </font>HOWEVER,<font style="letter-spacing:2pt;"> </font>PRECLUDE<font style="letter-spacing:2pt;"> </font>ME<font style="letter-spacing:2pt;"> </font>FROM<font style="letter-spacing:2pt;"> </font>PURSUING<font style="letter-spacing:2pt;"> </font>COURT<font style="letter-spacing:2pt;"> </font>ACTION REGARDING ANY SUCH CLAIM, EXCEPT AS PERMITTED BY LAW.</p><div style="margin-top:11.94pt;"></div><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">E.</font><i style="font-size:12pt;font-style:italic;">Voluntary Nature of Agreement</i><font style="font-size:12pt;">. I ACKNOWLEDGE AND AGREE THAT I AM EXECUTING</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">AGREEMENT</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">VOLUNTARILY</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">WITHOUT</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">DURESS</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">UNDUE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">INFLUENCE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">BY THE COMPANY OR ANYONE ELSE.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I FURTHER ACKNOWLEDGE AND AGREE THAT I HAVE CAREFULLY READ THIS AGREEMENT AND THAT I HAVE ASKED ANY QUESTIONS NEEDED FOR ME TO UNDERSTAND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">TERMS,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">CONSEQUENCES,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">BINDING</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">EFFECT</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">AGREEMENT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">FULLY UNDERSTAND IT, INCLUDING THAT </font><font style="font-size:12pt;font-style:italic;font-weight:bold;">I AM WAIVING MY RIGHT TO A JURY TRIAL</font><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">FINALLY, I AGREE THAT I HAVE BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF MY CHOICE BEFORE SIGNING THIS AGREEMENT.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12.1pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">13.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">General</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> Provisions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Governing Law; Consent to Personal Jurisdiction</i><font style="font-size:12pt;">. This Agreement will be governed by the laws of the State of California without giving effect to any choice-of-law rules or principles that may result in the application of the laws of any jurisdiction other than California.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">To the extent that any lawsuit is permitted under this Agreement, I hereby expressly consent to the personal</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">exclusive</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">jurisdiction</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">venue</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">state</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">federal</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">courts</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">located</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">California</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">for any lawsuit filed against me by the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Entire Agreement</i><font style="font-size:12pt;">. This Agreement,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">together</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">with the Exhibits herein and</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">any executed</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">written</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">offer</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">letter between</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">me</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">extent</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">such materials</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">are</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">not in conflict with this Agreement, sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein and supersedes all prior discussions or representations between us, including, but not limited to, any representations made during my interview(s) or relocation negotiations, whether</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">written or oral.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">signed</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">President</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">CEO</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">me.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Any</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">subsequent</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">change</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">changes in my duties, salary, or compensation will not affect the validity or scope of this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.05pt 9.05pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><i style="font-size:12pt;font-style:italic;">Severability</i><font style="font-size:12pt;">. If one or more of the provisions in this Agreement are deemed void by law, then the remaining provisions will continue in full force and effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12pt 8.95pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">D.</font><i style="font-size:12pt;font-style:italic;">Successors and Assigns</i><font style="font-size:12pt;">. This Agreement will be binding upon my heirs, executors,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">assigns,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">administrators,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">other</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">legal</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">representatives,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">benefit</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the Company, its successors, and its assigns.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">There are no intended third-party beneficiaries to this Agreement,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">except</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">as expressly</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">stated.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Notwithstanding</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">anything</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the contrary</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">herein,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">substantially</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Company&#8217;s</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">relevant</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">assets,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">whether</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">merger,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">consolidation,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">sale</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">assets or stock, or otherwise.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:0.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">E.</font><i style="font-size:12pt;font-style:italic;">Waiver.</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.7pt;"> </i><font style="font-size:12pt;">Waiver</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">breach</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">provision</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Agreement will not operate as a waiver of any other or subsequent breach.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 9.05pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">F.</font><i style="font-size:12pt;font-style:italic;">Survivorship. </i><font style="font-size:12pt;">The rights and obligations of the parties to this Agreement will survive termination of my employment with the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12pt 8.95pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">G.</font><i style="font-size:12pt;font-style:italic;">Signatures.</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.3pt;"> </i><font style="font-size:12pt;">This</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Agreement</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">signed</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">two</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">counterparts,</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">each</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">which shall be deemed an original, with the same force and effectiveness as though executed in a single </font><font style="font-size:12pt;letter-spacing:-0.1pt;">document.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p><div style="white-space:nowrap;"><div style="display:inline-block;padding-right:0.19%;vertical-align:top;white-space:normal;width:48.13%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:9.25pt 0pt 0pt 38pt;"><font style="font-size:12pt;vertical-align:sub;">Date:</font><font style="font-size:12pt;letter-spacing:-0.1pt;vertical-align:sub;"> </font><font style="letter-spacing:-0.1pt;">05/02/2022</font></p></div><div style="display:inline-block;padding-left:0.19%;vertical-align:top;white-space:normal;width:51.49%;"><p style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;line-height:17.5pt;margin:0pt;"><i style="text-decoration-color:#000000;text-decoration-line:none;"> </i><font style="font-size:17.5pt;text-decoration-color:#000000;text-decoration-line:none;visibility:hidden;">&#8203;</font></p><p style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;line-height:17.5pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:17.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.34pt 0pt 12pt 31.5pt;"><font style="letter-spacing:-0.1pt;">/s/Renae Cormier</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.34pt 0pt 12pt 31.5pt;"><font style="letter-spacing:-0.1pt;">Signature</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:1.89pt 0pt 0pt 33.45pt;"><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Renae</u><u style="font-size:12pt;letter-spacing:1.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cormier</u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:155.18pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.15pt 0pt 12pt 31.5pt;">Name<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.1pt;"> </font>Employee<font style="letter-spacing:-0.05pt;"> </font>(typed<font style="letter-spacing:-0.05pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">printed)</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:6.65pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0pt 38pt;"><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</b><font style="font-size:12pt;letter-spacing:-0.1pt;">:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">/S/ Lora Kelly</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;">Signature</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.1pt 278.85pt 12pt 38pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lora Kelly, Human Resources Generalist</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u> Name (typed or printed)</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:75.05pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.4pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:11.94pt 87.45pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">LIST</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-size:12pt;font-weight:bold;">OF</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-size:12pt;font-weight:bold;">PRIOR</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> INVENTIONS</b></p><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:7.88%;max-width:92.12%;position:absolute;top:74.55pt;width:157.7pt;z-index:251658240;"><div style="height:0.5pt;left:0pt;padding-bottom:0pt;position:relative;width:157.7pt;"><img src="smlr-20241231xex10d7001.jpg" alt="Graphic" style="height:0.5pt;width:157.7pt;"></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 87.65pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">AND</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-size:12pt;font-weight:bold;">ORIGINAL</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;"> </b><b style="font-size:12pt;font-weight:bold;">WORKS</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;"> </b><b style="font-size:12pt;font-weight:bold;">OF</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;">AUTHORSHIP</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:7.65pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><div style="padding-left:73.9pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:85.16%;"><tr style="height:28.3pt;"><td style="vertical-align:top;width:28.56%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:12.19pt 0pt 0pt 36.55pt;"><font style="font-size:12pt;letter-spacing:-0.1pt;">Title</font></p></td><td style="position:relative;vertical-align:top;width:30.47%;margin:0pt;padding:0pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:3.18%;max-width:96.82%;position:absolute;top:27.85pt;width:157.7pt;z-index:251660288;"><div style="height:0.5pt;left:0pt;padding-bottom:0pt;position:relative;width:157.7pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:0pt;position:absolute;width:157.65pt;"><img src="smlr-20241231xex10d7001.jpg" alt="Graphic" style="height:0.5pt;width:157.65pt;"></div></div></div></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:12.19pt 0pt 0pt 71.55pt;"><font style="font-size:12pt;letter-spacing:-0.2pt;">Date</font></p></td><td style="position:relative;vertical-align:top;width:40.96%;margin:0pt;padding:0pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:17.05%;max-width:82.95%;position:absolute;top:27.85pt;width:157.7pt;z-index:251662336;"><div style="height:0.5pt;left:0pt;padding-bottom:0pt;position:relative;width:157.7pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:0pt;position:absolute;width:157.65pt;"><img src="smlr-20241231xex10d7001.jpg" alt="Graphic" style="height:0.5pt;width:157.65pt;"></div></div></div></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:12.2pt;text-align:center;margin:0pt 0.05pt 0pt 34.85pt;"><font style="font-size:12pt;">Identifying</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">Number</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">Brief</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;text-align:center;margin:0pt 0pt 0pt 34.85pt;"><font style="font-size:12pt;letter-spacing:-0.1pt;">Description</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.64pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:24.05pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.1pt;left:7.13%;max-width:92.87%;position:absolute;top:17pt;width:12pt;z-index:251664384;"><div style="height:0.1pt;left:0pt;padding-bottom:0pt;position:relative;width:12pt;"><img src="smlr-20241231xex10d7004.jpg" alt="Graphic" style="height:0.1pt;width:12pt;"></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:12pt;left:7.38%;max-width:92.62%;position:absolute;top:2.1pt;width:12pt;z-index:-9223372036603109376;"><div style="height:10pt;left:0pt;padding-bottom:2pt;position:relative;width:10pt;"><img src="smlr-20241231xex10d7005.jpg" alt="Graphic" style="height:10pt;width:10pt;"></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 39.8pt;"><font style="font-family:'MS Gothic';font-size:10.5pt;vertical-align:super;">&#10004;</font>_<font style="letter-spacing:-0.2pt;"> </font>No<font style="letter-spacing:-0.2pt;"> </font>inventions<font style="letter-spacing:-0.3pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">improvements</font></p><div style="height:0pt;position:relative;width:100%;"><div style="height:12pt;left:7.67%;max-width:92.33%;position:absolute;top:12.05pt;width:12pt;z-index:-9223372036603107328;"><div style="height:10pt;left:0pt;padding-bottom:2pt;position:relative;width:10pt;"><img src="smlr-20241231xex10d7005.jpg" alt="Graphic" style="height:10pt;width:10pt;"></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:34pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u>Additional<font style="letter-spacing:-0.35pt;"> </font>Sheets<font style="letter-spacing:-0.35pt;"> </font><font style="letter-spacing:-0.1pt;">Attached</font></p><p style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;line-height:17.55pt;margin:21.7pt 0pt 0pt 154pt;"><font style="font-size:17.55pt;line-height:17.5pt;margin-left:0pt;text-decoration-color:#000000;text-decoration-line:none;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.35pt;margin:0pt 0pt 0pt 38pt;"><font style="font-size:12pt;">Signature</font><font style="font-size:12pt;letter-spacing:0.1pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:0.2pt;"> </font><font style="font-size:12pt;">Employee</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">:</u><u style="font-size:12pt;letter-spacing:0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> /S/ Renae Cormier</u><u style="color:#1372e5;font-size:6.5pt;text-decoration-color:#1372e5;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:63.46pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:1.29pt 0pt 0pt 38pt;"><font style="font-size:12pt;">Print</font><font style="font-size:12pt;letter-spacing:0.1pt;"> </font><font style="font-size:12pt;">Name</font><font style="font-size:12pt;letter-spacing:0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:0.2pt;"> </font><font style="font-size:12pt;">Employee:</font><font style="font-size:12pt;letter-spacing:2.3pt;"> </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;">Renae</u><u style="font-size:12pt;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;"> </u><u style="font-size:12pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;">Cormier</u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:72.81pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p><div style="white-space:nowrap;"><div style="display:inline-block;padding-right:0.19%;vertical-align:top;white-space:normal;width:12.08%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12pt 0pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;">DDate:</font></p></div><div style="display:inline-block;padding-left:0.19%;vertical-align:top;white-space:normal;width:87.54%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:7.69pt 0pt 0pt 3pt;"><font style="font-size:12pt;letter-spacing:-0.1pt;">05/02/2002</font></p><div style="height:0.85pt;left:12.58%;max-width:85.63%;position:relative;top:0pt;width:244.65pt;z-index:-9223372036603105280;"><div style="height:0.85pt;left:0pt;padding-bottom:0pt;position:relative;width:244.65pt;"><img src="smlr-20241231xex10d7007.jpg" alt="Graphic" style="height:0.85pt;width:244.65pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.6pt 0pt 12pt 0pt;"><font style="font-size:1.5pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.45pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">B</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:48.5pt;margin:11.94pt 95.45pt 0pt 132.2pt;"><b style="font-size:12pt;font-weight:bold;">CALIFORNIA LABOR CODE SECTION 2870 INVENTION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">ON</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">OWN</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">TIME-EXEMPTION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">FROM</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">AGREEMENT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 19pt 12pt 38pt;"><font style="display:inline-block;text-indent:0pt;width:36.05pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;">&#8220;(a)</font></font>Any<font style="letter-spacing:-0.2pt;"> </font>provision<font style="letter-spacing:-0.25pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>an<font style="letter-spacing:-0.25pt;"> </font>employment<font style="letter-spacing:-0.25pt;"> </font>agreement<font style="letter-spacing:-0.25pt;"> </font>which<font style="letter-spacing:-0.15pt;"> </font>provides<font style="letter-spacing:-0.3pt;"> </font>that<font style="letter-spacing:-0.25pt;"> </font>an<font style="letter-spacing:-0.25pt;"> </font>employee<font style="letter-spacing:-0.15pt;"> </font>shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply<font style="letter-spacing:-0.1pt;"> </font>to an invention that the employee developed entirely on his<font style="letter-spacing:-0.05pt;"> </font>or her own time without using the employer&#8217;s equipment, supplies, facilities, or trade secret information except for those inventions that either:</p><div style="margin-top:12.1pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:71.95pt;margin:0pt 18.2pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">(1)</font><font style="font-size:12pt;">Relate</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">at</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">conception</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">reduction</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">practice</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">invention</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer; or</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:110pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Result</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">from</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">work</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">performed</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">by</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">employee for the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> employer.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 33.7pt 12pt 38pt;"><font style="display:inline-block;text-indent:0pt;width:36.05pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;">(b)</font></font>To the extent a provision in an employment agreement purports to require an employee<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>assign<font style="letter-spacing:-0.2pt;"> </font>an<font style="letter-spacing:-0.15pt;"> </font>invention<font style="letter-spacing:-0.1pt;"> </font>otherwise<font style="letter-spacing:-0.2pt;"> </font>excluded<font style="letter-spacing:-0.15pt;"> </font>from<font style="letter-spacing:-0.15pt;"> </font>being<font style="letter-spacing:-0.2pt;"> </font>required<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>be<font style="letter-spacing:-0.1pt;"> </font>assigned<font style="letter-spacing:-0.15pt;"> </font>under subdivision (a), the provision is against the public policy of this state and is unenforceable.&#8221;</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.4pt 0pt 116.5pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">C</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:2.15;text-indent:14.4pt;margin:11.94pt 176.25pt 0pt 205.55pt;"><b style="font-size:12pt;font-weight:bold;">SEMLER SCIENTIFIC, INC. TERMINATION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.7pt;"> </b><b style="font-size:12pt;font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 0pt 12pt 38pt;">This<font style="letter-spacing:-0.1pt;"> </font>is<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>certify<font style="letter-spacing:-0.1pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>I do<font style="letter-spacing:-0.2pt;"> </font>not<font style="letter-spacing:-0.05pt;"> </font>have<font style="letter-spacing:-0.05pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>my<font style="letter-spacing:-0.2pt;"> </font>possession,<font style="letter-spacing:-0.2pt;"> </font>nor<font style="letter-spacing:-0.15pt;"> </font>have<font style="letter-spacing:-0.05pt;"> </font>I<font style="letter-spacing:-0.25pt;"> </font>failed<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>return,<font style="letter-spacing:-0.1pt;"> </font>any<font style="letter-spacing:-0.1pt;"> </font>devices, records,<font style="letter-spacing:-0.05pt;"> </font>data,<font style="letter-spacing:-0.05pt;"> </font>notes,<font style="letter-spacing:-0.05pt;"> </font>reports,<font style="letter-spacing:-0.05pt;"> </font>proposals, lists, correspondence,<font style="letter-spacing:-0.05pt;"> </font>specifications, drawings,<font style="letter-spacing:-0.1pt;"> </font>blueprints, sketches, materials, equipment, any other documents or property, or reproductions of any and all aforementioned items belonging to Semler Scientific, Inc., its subsidiaries, affiliates, successors or assigns (together, the &#8220;<b style="font-weight:bold;">Company</b>&#8221;).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12.1pt 19pt 12pt 38pt;">I further certify that I have complied with all the terms of the Company&#8217;s At-Will Employment,<font style="letter-spacing:-0.35pt;"> </font>Confidential<font style="letter-spacing:-0.2pt;"> </font>Information,<font style="letter-spacing:-0.35pt;"> </font>Invention<font style="letter-spacing:-0.3pt;"> </font>Assignment,<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.3pt;"> </font>Arbitration<font style="letter-spacing:-0.3pt;"> </font>Agreement<font style="letter-spacing:-0.2pt;"> </font>signed by me, including the reporting of any inventions and original works of authorship (as defined therein) conceived or made by me (solely or jointly with others), as covered by that agreement.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 9.8pt 12pt 38pt;">I<font style="letter-spacing:-0.2pt;"> </font>further<font style="letter-spacing:-0.15pt;"> </font>agree<font style="letter-spacing:-0.25pt;"> </font>that,<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>compliance<font style="letter-spacing:-0.3pt;"> </font>with<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>At-Will<font style="letter-spacing:-0.2pt;"> </font>Employment,<font style="letter-spacing:-0.2pt;"> </font>Confidential<font style="letter-spacing:-0.15pt;"> </font>Information, Invention Assignment, and Arbitration Agreement, I will preserve as confidential all Company Confidential Information and Associated Third Party Confidential Information, including trade secrets, confidential knowledge, data, or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, databases, other original works of authorship, customer lists, business plans, financial information, or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants, or licensees.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 9.8pt 12pt 38pt;">I also agree that for twelve (12) months from this date, I will not either directly or indirectly solicit any of the Company&#8217;s employees to leave their employment, or to enter into an employment, consulting, contractor, or other relationship with any other person, firm, business entity,<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>organization<font style="letter-spacing:-0.15pt;"> </font>(including<font style="letter-spacing:-0.1pt;"> </font>with myself).<font style="letter-spacing:2pt;"> </font>I<font style="letter-spacing:-0.2pt;"> </font>agree<font style="letter-spacing:-0.15pt;"> </font>that<font style="letter-spacing:-0.05pt;"> </font>nothing<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>this<font style="letter-spacing:-0.1pt;"> </font>paragraph<font style="letter-spacing:-0.15pt;"> </font>shall<font style="letter-spacing:-0.2pt;"> </font>affect<font style="letter-spacing:-0.15pt;"> </font>my continuing obligations under the At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement during and after this twelve (12) month period, including, without limitation, my obligations under Section 2A thereof.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12.1pt 0pt 12pt 74pt;">After<font style="letter-spacing:-0.15pt;"> </font>leaving<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.15pt;"> </font>employment,<font style="letter-spacing:-0.1pt;"> </font>I<font style="letter-spacing:-0.2pt;"> </font>will<font style="letter-spacing:-0.2pt;"> </font>be<font style="letter-spacing:-0.05pt;"> </font>employed<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:-0.1pt;"> </font><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:124.28pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">in<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>position<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.25pt;">of:</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:105.54pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</u></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:25.6pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:4.69pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1pt;text-indent:36pt;margin:0pt 0pt 12pt 254.05pt;"><div style="display:inline-block;height:0.85pt;width:216.05pt;"><div style="height:0.85pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.85pt;left:0pt;position:absolute;width:216.05pt;"><img src="smlr-20241231xex10d7008.jpg" alt="Graphic" style="height:0.85pt;width:216.05pt;"></div></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.85pt 0pt 0pt 75.1pt;"><i style="font-style:italic;">Signature</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">of</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;letter-spacing:-0.1pt;">employee</i></p><div style="height:0.75pt;left:47.66%;max-width:52.34%;position:relative;top:0pt;width:216.05pt;z-index:-9223372036603103232;"><div style="height:0.75pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><img src="smlr-20241231xex10d7009.jpg" alt="Graphic" style="height:0.75pt;width:216.05pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10.3pt 0pt 12pt 0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:1.04pt 92.25pt 0pt 116.45pt;"><i style="font-style:italic;">Print</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;letter-spacing:-0.2pt;">name</i></p><div style="height:0.75pt;left:47.66%;max-width:52.34%;position:relative;top:0pt;width:216.05pt;z-index:-9223372036603101184;"><div style="height:0.75pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><img src="smlr-20241231xex10d7009.jpg" alt="Graphic" style="height:0.75pt;width:216.05pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10.25pt 0pt 12pt 0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:1.04pt 3.3pt 0pt 0pt;"><i style="font-style:italic;letter-spacing:-0.2pt;">Date</i></p><div style="height:0pt;position:relative;width:100%;"><div style="height:0.85pt;left:47.66%;max-width:52.34%;position:absolute;top:24.75pt;width:216.05pt;z-index:251676672;"><div style="height:0.85pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><img src="smlr-20241231xex10d7009.jpg" alt="Graphic" style="height:0.85pt;width:216.05pt;"></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12pt 0pt 12pt 74pt;">Address<font style="letter-spacing:-0.2pt;"> </font>for<font style="letter-spacing:-0.05pt;"> </font><font style="letter-spacing:-0.1pt;">Notifications:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 87.4pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.75pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.4pt 0pt 116.5pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">D</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:2.15;text-indent:27.45pt;margin:11.94pt 143.55pt 0pt 192.45pt;"><b style="font-size:12pt;font-weight:bold;">SEMLER SCIENTIFIC, INC. CONFLICT</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.6pt;"> </b><b style="font-size:12pt;font-weight:bold;">OF</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.65pt;"> </b><b style="font-size:12pt;font-weight:bold;">INTEREST</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.6pt;"> </b><b style="font-size:12pt;font-weight:bold;">GUIDELINES</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 19pt 12pt 38pt;">It is the policy of Semler Scientific, Inc. to conduct its affairs in strict compliance with the letter<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>spirit<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>law<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>adhere<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>highest principles<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>business<font style="letter-spacing:-0.15pt;"> </font>ethics.<font style="letter-spacing:2pt;"> </font>Accordingly, all officers, employees, and independent contractors must avoid activities that are in conflict, or give the appearance of being in conflict, with these principles and with the interests of the Company.<font style="letter-spacing:2pt;"> </font>The following are potentially compromising situations that must be avoided:</p><div style="margin-top:12.1pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 10.45pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">1.</font><font style="font-size:12pt;">Revealing</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">confidential</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">outsiders</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">misusing</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">confidential</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">information. Unauthorized divulging of information is a violation of this policy whether or not for personal gain and whether or not harm to the Company is intended.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">(The At-Will Employment, Confidential Information,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Invention</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Assignment,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">and Arbitration Agreement</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">elaborates</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">principle</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">and is</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">a binding agreement.)</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 12.75pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">2.</font><font style="font-size:12pt;">Accepting</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">offering</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">substantial</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">gifts,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">excessive</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">entertainment,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">favors,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">payments that may be deemed to constitute undue influence or otherwise be improper or embarrassing to the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 44.25pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">3.</font><font style="font-size:12pt;">Participating</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">civic</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">professional</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">organizations</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">might</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">involve</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">divulging confidential information of the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 28.65pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">4.</font><font style="font-size:12pt;">Initiating or approving personnel actions affecting reward or punishment of employees</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">applicants</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">where</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">there</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">is</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">family</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">relationship</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">is</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">appears</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">personal</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or social involvement.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">5.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Initiating</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">approving</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">form</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">personal</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">social</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">harassment</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">employees.</font></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12.1pt 12pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">6.</font><font style="font-size:12pt;">Investing or holding outside directorship in suppliers, customers, or competing companies,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">including</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">financial</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">speculations,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">where</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">such</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">investment</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">directorship</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">might</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">influence in any manner a decision or course of action of the Company.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">7.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Borrowing</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">from</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">lending</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">employees,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">customers,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">suppliers.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">8.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Acquiring</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">real</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">estate</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">interest</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Company.</font></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 15.25pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">9.</font><font style="font-size:12pt;">Improperly</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">using</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">disclosing</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">proprietary</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">trade secrets of any former or concurrent employer or other person or entity with whom obligations of confidentiality exist.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:0.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 33.1pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">10.</font><font style="font-size:12pt;">Unlawfully</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">discussing</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">prices,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">costs,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">customers,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">sales,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">markets</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">competing companies or their employees.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">11.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Making</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">unlawful</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">agreement</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">distributors</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">respect</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">prices.</font></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 33.45pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">12.</font><font style="font-size:12pt;">Improperly</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">using</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">authorizing</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">use</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">inventions</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">are</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">subject</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of patent claims of any other person or entity.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">13.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Engaging</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">conduct</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">is</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">best</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">interest</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Company.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 19pt 12pt 38pt;">Each<font style="letter-spacing:-0.15pt;"> </font>officer,<font style="letter-spacing:-0.3pt;"> </font>employee,<font style="letter-spacing:-0.3pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>independent<font style="letter-spacing:-0.25pt;"> </font>contractor<font style="letter-spacing:-0.15pt;"> </font>must<font style="letter-spacing:-0.25pt;"> </font>take<font style="letter-spacing:-0.15pt;"> </font>every<font style="letter-spacing:-0.2pt;"> </font>necessary<font style="letter-spacing:-0.2pt;"> </font>action<font style="letter-spacing:-0.25pt;"> </font>to ensure compliance with these guidelines and to bring problem areas to the attention of higher management for review.<font style="letter-spacing:2pt;"> </font>Violations of this conflict of interest policy may result in discharge without warning.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>3
<FILENAME>smlr-20241231xex19d1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:27 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:2.21;text-align:right;margin:3.75pt 114.7pt 0pt 0pt;">EXHIBIT 19.1</p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:2.21;text-indent:2.25pt;margin:3.75pt 114.7pt 0pt 160.3pt;">SEMLER SCIENTIFIC, INC</p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:2.21;text-indent:2.25pt;margin:3.75pt 114.7pt 0pt 160.3pt;">INSIDER<font style="letter-spacing:-0.75pt;"> </font>TRADING<font style="letter-spacing:-0.75pt;"> </font>POLICY</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.79pt 11.1pt 12pt 0pt;">This memorandum sets forth the policy of Semler Scientific, Inc. (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221;) regarding trading in the Company&#8217;s securities as described below and the disclosure of information concerning the Company.<font style="letter-spacing:2pt;"> </font>This Insider Trading Policy (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Insider Trading</u> <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Policy</u>&#8221;) is designed to prevent insider trading or the appearance of impropriety, to satisfy the Company&#8217;s<font style="letter-spacing:-0.1pt;"> </font>obligation<font style="letter-spacing:-0.1pt;"> </font>to<font style="letter-spacing:-0.25pt;"> </font>reasonably<font style="letter-spacing:-0.1pt;"> </font>supervise<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.05pt;"> </font>activities<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>Company<font style="letter-spacing:-0.1pt;"> </font>personnel,<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>to<font style="letter-spacing:-0.1pt;"> </font>help Company<font style="letter-spacing:-0.2pt;"> </font>personnel<font style="letter-spacing:-0.2pt;"> </font>avoid<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>severe<font style="letter-spacing:-0.25pt;"> </font>consequences<font style="letter-spacing:-0.2pt;"> </font>associated<font style="letter-spacing:-0.2pt;"> </font>with<font style="letter-spacing:-0.2pt;"> </font>violations<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.25pt;"> </font>insider<font style="letter-spacing:-0.25pt;"> </font>trading laws.<font style="letter-spacing:2pt;"> </font>It is your obligation to understand and comply with this Insider Trading Policy.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:4.19pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:1.19;margin:0pt;">PART<font style="letter-spacing:-0.05pt;"> </font>I.<font style="letter-spacing:2.9pt;"> </font><font style="letter-spacing:-0.1pt;">OVERVIEW</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:4.19pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="color:#376092;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">A.</td><td style="padding:0pt;"><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">To</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.2pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Whom</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">does</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">this</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Insider</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Trading</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Policy</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> Apply?</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 9.05pt 12pt 0pt;">This<font style="letter-spacing:-0.2pt;"> </font>Insider<font style="letter-spacing:-0.25pt;"> </font>Trading<font style="letter-spacing:-0.2pt;"> </font>Policy<font style="letter-spacing:-0.2pt;"> </font>is<font style="letter-spacing:-0.2pt;"> </font>applicable<font style="letter-spacing:-0.25pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.2pt;"> </font>directors,<font style="letter-spacing:-0.2pt;"> </font>officers,<font style="letter-spacing:-0.2pt;"> </font>employees and certain designated consultants and applies to any and all transactions by such persons and their affiliates (as defined below) in the Company&#8217;s securities, including its common stock, options to purchase common stock, any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants, exchange-traded options or other derivative securities), and any derivative securities that provide the economic equivalent of ownership<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>any<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.05pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.1pt;"> </font>securities<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>an<font style="letter-spacing:-0.1pt;"> </font>opportunity,<font style="letter-spacing:-0.1pt;"> </font>direct<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>indirect,<font style="letter-spacing:-0.1pt;"> </font>to<font style="letter-spacing:-0.1pt;"> </font>profit<font style="letter-spacing:-0.1pt;"> </font>from any change in the value of the Company&#8217;s securities.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 9.05pt 12pt 5.95pt;">In addition, all directors, officers, employees and certain designated consultants must comply with the Trading Procedures set forth in Part II of this Insider Trading Policy (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Trading Procedures</u>&#8221;) (collectively, and solely for the purposes of this Insider Trading Policy, these persons are referred to as &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Insiders</u>&#8221;). Generally, the Trading Procedures establish trading windows<font style="letter-spacing:-0.15pt;"> </font>outside<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>which<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>persons<font style="letter-spacing:-0.15pt;"> </font>covered<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:-0.05pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Procedures<font style="letter-spacing:-0.05pt;"> </font>will<font style="letter-spacing:-0.15pt;"> </font>be<font style="letter-spacing:-0.2pt;"> </font>restricted<font style="letter-spacing:-0.15pt;"> </font>from trading in the Company&#8217;s securities and also require the pre-clearance of all transactions in the Company&#8217;s securities by such persons.<font style="letter-spacing:2pt;"> </font>You will be notified if you are required to comply with the Trading Procedures.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.45pt 12pt 0pt;">This Insider Trading Policy, including, if applicable, the Trading Procedures contained herein,<font style="letter-spacing:-0.2pt;"> </font>also<font style="letter-spacing:-0.2pt;"> </font>applies<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>following<font style="letter-spacing:-0.2pt;"> </font>persons<font style="letter-spacing:-0.2pt;"> </font>(collectively,<font style="letter-spacing:-0.2pt;"> </font>these<font style="letter-spacing:-0.25pt;"> </font>persons<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>entities<font style="letter-spacing:-0.2pt;"> </font>are<font style="letter-spacing:-0.25pt;"> </font>referred to as &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Affiliated Persons</u>&#8221;):</p><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">your</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">spouse,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">child,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">parent,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">significant</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">other</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">other</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">family</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">member,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">each</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">case, living in the same household;</font></td><td style="width:10.7pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">all</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trusts,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">family</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">partnerships</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">other</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">types</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">entities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">formed</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">for</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">benefit</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of an Insider or for the benefit of a family member over whom you have the ability to influence or direct investment decisions concerning securities;</font></td><td style="width:14.4pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12.05pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">all</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">persons</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">who</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">execute</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trades</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">on</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">your</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">behalf;</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;">and</font></td></tr></table><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="margin-top:3.9pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">all</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">investment</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">funds,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trusts,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">retirement</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">plans,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">partnerships,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">corporations</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">other types of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">entities over</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">which you have</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the ability to influence</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">direct investment decisions concerning securities.</font></td><td style="width:11.3pt;"></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.45pt 12pt 0pt;">You<font style="letter-spacing:-0.2pt;"> </font>are<font style="letter-spacing:-0.15pt;"> </font>responsible<font style="letter-spacing:-0.25pt;"> </font>for<font style="letter-spacing:-0.15pt;"> </font>ensuring<font style="letter-spacing:-0.2pt;"> </font>compliance<font style="letter-spacing:-0.25pt;"> </font>with<font style="letter-spacing:-0.1pt;"> </font>this<font style="letter-spacing:-0.2pt;"> </font>Insider<font style="letter-spacing:-0.25pt;"> </font>Trading<font style="letter-spacing:-0.2pt;"> </font>Policy,<font style="letter-spacing:-0.2pt;"> </font>including the Trading Procedures contained herein, by all of your Affiliated Persons.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">In the event that you leave the Company for any reason, this Insider Trading Policy, including, if applicable, the Trading Procedures contained herein, will continue to apply to you and your Affiliated Persons until the later of: (1) the second trading day following the public filing<font style="letter-spacing:-0.05pt;"> </font>of<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>quarterly<font style="letter-spacing:-0.05pt;"> </font>report<font style="letter-spacing:-0.05pt;"> </font>for<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>fiscal<font style="letter-spacing:-0.05pt;"> </font>quarter<font style="letter-spacing:-0.1pt;"> </font>(or<font style="letter-spacing:-0.1pt;"> </font>for<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>fourth<font style="letter-spacing:-0.05pt;"> </font>quarter, the<font style="letter-spacing:-0.1pt;"> </font>annual<font style="letter-spacing:-0.05pt;"> </font>report<font style="letter-spacing:-0.05pt;"> </font>for the<font style="letter-spacing:-0.15pt;"> </font>fiscal<font style="letter-spacing:-0.15pt;"> </font>year)<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>which<font style="letter-spacing:-0.05pt;"> </font>you<font style="letter-spacing:-0.15pt;"> </font>leave<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font>(2)<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>second<font style="letter-spacing:-0.15pt;"> </font>trading<font style="letter-spacing:-0.15pt;"> </font>day<font style="letter-spacing:-0.15pt;"> </font>after<font style="letter-spacing:-0.15pt;"> </font>any<font style="letter-spacing:-0.15pt;"> </font>material nonpublic information known to you has become public or is no longer material.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="color:#376092;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">B.</td><td style="padding:0pt;"><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">What</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">is</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Prohibited</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">by</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">this</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Insider</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Trading</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Policy?</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 5.95pt;">It is generally illegal for you to trade in the securities of the Company, whether for your account<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>for<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>account<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>another,<font style="letter-spacing:-0.1pt;"> </font>while<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.05pt;"> </font>possession<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>material,<font style="letter-spacing:-0.1pt;"> </font>nonpublic<font style="letter-spacing:-0.15pt;"> </font>information about the Company.<font style="letter-spacing:2pt;"> </font>It is also generally illegal for you to disclose material, nonpublic information<font style="letter-spacing:-0.15pt;"> </font>about<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>others<font style="letter-spacing:-0.15pt;"> </font>who<font style="letter-spacing:-0.15pt;"> </font>may<font style="letter-spacing:-0.15pt;"> </font>trade<font style="letter-spacing:-0.2pt;"> </font>on<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>basis<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>information.<font style="letter-spacing:2pt;"> </font>These illegal activities are commonly referred to as &#8220;<i style="font-style:italic;">insider trading</i>.&#8221;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 5.95pt;">When<font style="letter-spacing:-0.15pt;"> </font>you<font style="letter-spacing:-0.15pt;"> </font>know<font style="letter-spacing:-0.2pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>are<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>possession<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>material,<font style="letter-spacing:-0.15pt;"> </font>nonpublic<font style="letter-spacing:-0.2pt;"> </font>information<font style="letter-spacing:-0.15pt;"> </font>about<font style="letter-spacing:-0.15pt;"> </font>the Company, whether positive or negative, you are prohibited from the following activities:</p><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:41.95pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trading (whether for your account of for the account of another) in the Company&#8217;s securities, which includes common stock, options to purchase common stock, any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants, exchange-traded options or other derivative securities), and any derivative securities that provide the economic equivalent of ownership</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company&#8217;s</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">an</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">opportunity,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">direct</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">indirect,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to profit from any change in the value of the Company&#8217;s securities, except for trades made</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">compliance</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">affirmative</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">defense</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Rule</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">10b5-1</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">under</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Securities Exchange Act of 1934, as amended (the &#8220;</font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</u><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">&#8221;), such as when trades are made pursuant to a written plan that was adopted, or trading instructions that were given, before you knew or had possession of such material, nonpublic information and certain other conditions are satisfied;</font></td><td style="width:12.45pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.05pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">giving</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trading</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">advice</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of any kind</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">about</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company; </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;">and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.8pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">disclosing</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">such</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">material,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">nonpublic</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">information</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">about</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">whether</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">positive or negative, to anyone else (commonly known as &#8220;</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">tipping</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">&#8221;).</font></td><td style="width:8.5pt;"></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.45pt 12pt 0pt;">This Insider Trading Policy does not apply to:<font style="letter-spacing:2pt;"> </font>(1) an exercise of an employee stock option when payment of the exercise price is made in cash or (2) the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock<font style="letter-spacing:-0.15pt;"> </font>units<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>satisfy<font style="letter-spacing:-0.15pt;"> </font>applicable<font style="letter-spacing:-0.2pt;"> </font>tax<font style="letter-spacing:-0.15pt;"> </font>withholding<font style="letter-spacing:-0.15pt;"> </font>requirements<font style="letter-spacing:-0.15pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>(a)<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>withholding<font style="letter-spacing:-0.15pt;"> </font>is<font style="letter-spacing:-0.15pt;"> </font>required</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:3.95pt 11.1pt 12pt 0pt;">by<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>applicable<font style="letter-spacing:-0.2pt;"> </font>plan<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>award<font style="letter-spacing:-0.05pt;"> </font>agreement<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>(b)<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>election<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>exercise<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>tax<font style="letter-spacing:-0.15pt;"> </font>withholding right was made by the Insider in compliance with the Trading Procedures.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 7.8pt 12pt 5.95pt;">The policy does apply, however, to: the use of outstanding Company securities to pay<font style="letter-spacing:2pt;"> </font>part<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font>all<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.05pt;"> </font>exercise<font style="letter-spacing:-0.05pt;"> </font>price<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font>an<font style="letter-spacing:-0.1pt;"> </font>option,<font style="letter-spacing:-0.1pt;"> </font>any<font style="letter-spacing:-0.1pt;"> </font>sale<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>stock<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.1pt;"> </font>part<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.15pt;"> </font>broker-assisted cashless exercise of an option or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 13.65pt 12pt 0pt;">These<font style="letter-spacing:-0.2pt;"> </font>prohibitions<font style="letter-spacing:-0.15pt;"> </font>continue<font style="letter-spacing:-0.2pt;"> </font>whenever<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.05pt;"> </font>for<font style="letter-spacing:-0.2pt;"> </font>as<font style="letter-spacing:-0.15pt;"> </font>long<font style="letter-spacing:-0.15pt;"> </font>as<font style="letter-spacing:-0.15pt;"> </font>you<font style="letter-spacing:-0.15pt;"> </font>know<font style="letter-spacing:-0.2pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>are<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>possession of material, nonpublic information.<font style="letter-spacing:2pt;"> </font>Remember, anyone scrutinizing your transactions will be doing so after the fact, with the benefit of hindsight.<font style="letter-spacing:2pt;"> </font>As a practical matter, before engaging in any transaction, you should carefully consider how enforcement authorities and others might view the transaction in hindsight.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="color:#376092;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">C.</td><td style="padding:0pt;"><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">What</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">is</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Material,</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Nonpublic</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> Information?</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This<font style="letter-spacing:-0.15pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Policy<font style="letter-spacing:-0.15pt;"> </font>prohibits<font style="letter-spacing:-0.15pt;"> </font>you<font style="letter-spacing:-0.15pt;"> </font>from<font style="letter-spacing:-0.15pt;"> </font>trading<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.15pt;"> </font>securities<font style="letter-spacing:-0.15pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>you are in possession of information about the Company that is both &#8220;<i style="font-style:italic;">material</i>&#8221; and &#8220;<i style="font-style:italic;">nonpublic</i>.&#8221;<font style="letter-spacing:2pt;"> </font>If you have a question whether certain information you are aware of is material or has been made public, you are encouraged to consult with a Compliance Officer.</p><p style="color:#244061;font-family:'Cambria';font-size:12pt;line-height:1.19;margin:2pt 0pt 0pt 6pt;">&#8220;Material&#8221;<font style="letter-spacing:-0.2pt;"> </font><font style="letter-spacing:-0.1pt;">Information</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 7.65pt 12pt 0pt;">Information about the Company is &#8220;material&#8221; if it could reasonably be expected to affect the investment or voting decisions of a stockholder or investor, or if the disclosure of the information<font style="letter-spacing:-0.15pt;"> </font>could<font style="letter-spacing:-0.15pt;"> </font>reasonably<font style="letter-spacing:-0.15pt;"> </font>be<font style="letter-spacing:-0.2pt;"> </font>expected<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>significantly<font style="letter-spacing:-0.15pt;"> </font>alter<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>total<font style="letter-spacing:-0.15pt;"> </font>mix<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>information<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>the marketplace about the Company.<font style="letter-spacing:2pt;"> </font>In simple terms, material information is any type of information that could reasonably be expected to affect the market price of the Company&#8217;s securities.<font style="letter-spacing:2pt;"> </font>Both positive and negative information may be material.<font style="letter-spacing:2pt;"> </font>While it is not possible to identify all information that would be deemed &#8220;material,&#8221; the following items are types of information that should be considered carefully to determine whether they are material:</p><div style="margin-top:12.1pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">projections</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">future</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">earnings</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">losses,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">other</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">earnings</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">guidance;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.84pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">earnings</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">revenue</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">are</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">inconsistent</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">consensus</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">expectations</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the investment community;</font></td><td style="width:21.95pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.94pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">potential</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">restatements</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.3pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company&#8217;s</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">financial</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">statements,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">changes</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">auditors or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">auditor</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">notification</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">may</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">no</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">longer</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">rely</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">on an</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">auditor&#8217;s</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">audit </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">report;</font></td><td style="width:11.7pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.9pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">pending</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.3pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">proposed</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">corporate</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.3pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">mergers,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">acquisitions,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">tender</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.3pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">offers,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">joint</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">ventures or dispositions of significant assets;</font></td><td style="width:12.4pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.09pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">changes</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">management or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Board</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Directors;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.9pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">significant</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">actual</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">threatened</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">litigation</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">governmental</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">investigations</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">major developments in such matters;</font></td><td style="width:12.65pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.09pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">cybersecurity</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> incident;</font></td></tr></table><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="margin-top:3.9pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">significant</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">developments</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">regarding</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">products,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">customers,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">suppliers,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">orders, contracts or financing sources (e.g., the acquisition or loss of a contract);</font></td><td style="width:46.2pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.09pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">announcements</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">regarding</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">collaborations,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">licenses</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">regulatory</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">matters;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.8pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">changes</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">dividend</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">policy,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">declarations</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">stock</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">splits,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">public</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">private</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">sales of additional securities;</font></td><td style="width:15.75pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">potential</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">defaults</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">under</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company&#8217;s</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">credit</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">agreements</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">indentures,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">if</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or the existence of material liquidity deficiencies; and</font></td><td style="width:9.95pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.15pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">bankruptcies</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">receiverships.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.85pt 7.85pt 12pt 0pt;">By<font style="letter-spacing:-0.15pt;"> </font>including<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>list<font style="letter-spacing:-0.15pt;"> </font>above,<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>does<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.15pt;"> </font>mean<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>imply<font style="letter-spacing:-0.15pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>each<font style="letter-spacing:-0.05pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>these<font style="letter-spacing:-0.2pt;"> </font>items above<font style="letter-spacing:-0.05pt;"> </font>is <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">per</u><u style="letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">se</u><font style="letter-spacing:-0.2pt;"> </font>material.<font style="letter-spacing:2pt;"> </font>The<font style="letter-spacing:-0.05pt;"> </font>information and events on this list still require<font style="letter-spacing:-0.05pt;"> </font>determinations as to their materiality (although some determinations will be reached more easily than others). For example, some new products or contracts may clearly be material to an issuer; yet that does not mean<font style="letter-spacing:-0.1pt;"> </font>that<font style="letter-spacing:-0.1pt;"> </font>all<font style="letter-spacing:-0.1pt;"> </font>product<font style="letter-spacing:-0.1pt;"> </font>developments<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font>contracts<font style="letter-spacing:-0.1pt;"> </font>will<font style="letter-spacing:-0.1pt;"> </font>be<font style="letter-spacing:-0.15pt;"> </font>material.<font style="letter-spacing:-0.1pt;"> </font>This<font style="letter-spacing:-0.1pt;"> </font>demonstrates,<font style="letter-spacing:-0.1pt;"> </font>in<font style="letter-spacing:-0.1pt;"> </font>our<font style="letter-spacing:-0.15pt;"> </font>view, why no &#8220;bright-line&#8221; standard or list of items can adequately address the range of situations that may arise. Furthermore, the Company cannot create an exclusive list of events and information that have a higher probability of being considered material.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">The Securities and Exchange Commission (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SEC</u>&#8221;) has stated that there is no fixed quantitative<font style="letter-spacing:-0.2pt;"> </font>threshold<font style="letter-spacing:-0.2pt;"> </font>amount<font style="letter-spacing:-0.2pt;"> </font>for<font style="letter-spacing:-0.2pt;"> </font>determining<font style="letter-spacing:-0.2pt;"> </font>materiality,<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>that<font style="letter-spacing:-0.2pt;"> </font>even<font style="letter-spacing:-0.2pt;"> </font>very<font style="letter-spacing:-0.2pt;"> </font>small<font style="letter-spacing:-0.2pt;"> </font>quantitative changes can be qualitatively material if they would result in a movement in the price of the Company&#8217;s securities.</p><p style="color:#244061;font-family:'Cambria';font-size:12pt;line-height:1.19;margin:2pt 0pt 0pt 6pt;">&#8220;Nonpublic&#8221;<font style="letter-spacing:-0.3pt;"> </font><font style="letter-spacing:-0.1pt;">Information</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 9.05pt 12pt 0pt;">Material<font style="letter-spacing:-0.15pt;"> </font>information<font style="letter-spacing:-0.15pt;"> </font>is<font style="letter-spacing:-0.15pt;"> </font>&#8220;nonpublic&#8221;<font style="letter-spacing:-0.2pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>it<font style="letter-spacing:-0.15pt;"> </font>has<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.15pt;"> </font>been<font style="letter-spacing:-0.15pt;"> </font>disseminated<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>manner<font style="letter-spacing:-0.2pt;"> </font>making<font style="letter-spacing:-0.15pt;"> </font>it available to investors generally.<font style="letter-spacing:2pt;"> </font>To show that information is public, it is necessary to point to some fact that establishes that the information has become publicly available, such as the filing of a report with the SEC, the distribution of a press release through a widely disseminated news or wire service, or by other means that are reasonably designed to provide broad public access.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 9.05pt 12pt 5.95pt;">Before a person who possesses material, nonpublic information can trade, there also must be adequate time for the market as a whole to absorb the information that has been disclosed.<font style="letter-spacing:2pt;"> </font>For the purposes of this Insider Trading Policy, information will be considered public after the close of trading on the second full trading day following the Company&#8217;s public release of the information<font style="letter-spacing:-0.15pt;"> </font>(which<font style="letter-spacing:-0.15pt;"> </font>for<font style="letter-spacing:-0.2pt;"> </font>purposes<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>quarterly<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>annual<font style="letter-spacing:-0.15pt;"> </font>earnings<font style="letter-spacing:-0.15pt;"> </font>will<font style="letter-spacing:-0.15pt;"> </font>be<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>filing<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>quarterly report on Form 10-Q or annual report on Form 10-K, as the case may be).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 7.65pt 12pt 0pt;">For<font style="letter-spacing:-0.2pt;"> </font>example,<font style="letter-spacing:-0.2pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.2pt;"> </font>announces<font style="letter-spacing:-0.2pt;"> </font>material<font style="letter-spacing:-0.1pt;"> </font>nonpublic<font style="letter-spacing:-0.2pt;"> </font>information<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>which<font style="letter-spacing:-0.2pt;"> </font>you<font style="letter-spacing:-0.2pt;"> </font>are aware before trading begins on a Tuesday, the first time you can buy or sell Company securities is the opening of the market on Thursday.<font style="letter-spacing:2pt;"> </font>However, if the Company announces this material information after<font style="letter-spacing:-0.05pt;"> </font>trading begins on that Tuesday, the<font style="letter-spacing:-0.05pt;"> </font>first time<font style="letter-spacing:-0.05pt;"> </font>that you can buy or<font style="letter-spacing:-0.05pt;"> </font>sell Company securities is the opening of the market on Friday.</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:3.95pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#376092;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">D.</td><td style="padding:0pt;"><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">What</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">are</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.2pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">the</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.2pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Penalties</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">for</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Insider</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Trading</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">and</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.3pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Noncompliance</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.2pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">with</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">this</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Insider Trading Policy?</i></td><td style="width:40.95pt;"></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">Both the SEC and the national securities exchanges, through the Financial Industry Regulatory<font style="letter-spacing:-0.2pt;"> </font>Authority<font style="letter-spacing:-0.2pt;"> </font>(&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FINRA</u>&#8221;),<font style="letter-spacing:-0.2pt;"> </font>investigate<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>are<font style="letter-spacing:-0.25pt;"> </font>very<font style="letter-spacing:-0.2pt;"> </font>effective<font style="letter-spacing:-0.25pt;"> </font>at<font style="letter-spacing:-0.2pt;"> </font>detecting<font style="letter-spacing:-0.2pt;"> </font>insider<font style="letter-spacing:-0.25pt;"> </font>trading. The SEC, together with the U.S. Attorneys, pursue insider trading violations vigorously.<font style="letter-spacing:2pt;"> </font>For instance, cases have been successfully prosecuted against trading by employees in foreign accounts,<font style="letter-spacing:-0.05pt;"> </font>trading<font style="letter-spacing:-0.05pt;"> </font>by<font style="letter-spacing:-0.05pt;"> </font>family<font style="letter-spacing:-0.05pt;"> </font>members<font style="letter-spacing:-0.05pt;"> </font>and<font style="letter-spacing:-0.05pt;"> </font>friends,<font style="letter-spacing:-0.05pt;"> </font>and<font style="letter-spacing:-0.05pt;"> </font>trading<font style="letter-spacing:-0.05pt;"> </font>involving<font style="letter-spacing:-0.05pt;"> </font>only<font style="letter-spacing:-0.05pt;"> </font>a<font style="letter-spacing:-0.1pt;"> </font>small<font style="letter-spacing:-0.05pt;"> </font>number<font style="letter-spacing:-0.1pt;"> </font>of <font style="letter-spacing:-0.1pt;">shares.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 42pt;">The<font style="letter-spacing:-0.2pt;"> </font>penalties<font style="letter-spacing:-0.05pt;"> </font>for<font style="letter-spacing:-0.1pt;"> </font>violating<font style="letter-spacing:-0.05pt;"> </font>insider<font style="letter-spacing:-0.1pt;"> </font>trading<font style="letter-spacing:-0.05pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>tipping<font style="letter-spacing:-0.05pt;"> </font>rules<font style="letter-spacing:-0.05pt;"> </font>can<font style="letter-spacing:-0.05pt;"> </font>be<font style="letter-spacing:-0.1pt;"> </font>severe<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:0.1pt;"> </font><font style="letter-spacing:-0.1pt;">include:</font></p><div style="margin-top:12.1pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">disgorgement</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">profit</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">gained or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">loss</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">avoided</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">by</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">trading;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.8pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">payment of the loss suffered by the persons who, contemporaneously with the purchase</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">sale</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">are</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">subject</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">such</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">violation,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">have</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">purchased</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or sold, as applicable, securities of the same class;</font></td><td style="width:29.75pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.09pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">payment</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">criminal</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">penalties of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">up</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">$5.0 </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">million;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:5.9pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">payment</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">civil</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">penalties of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">up</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">three</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">times</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the profit</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">made</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">loss</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">avoided; </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;">and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:6.09pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">imprisonment</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">for</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">up to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">20 </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">years.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.8pt 7.95pt 12pt 0pt;">The<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>and/or<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>supervisors<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>person<font style="letter-spacing:-0.05pt;"> </font>engaged<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>insider<font style="letter-spacing:-0.2pt;"> </font>trading<font style="letter-spacing:-0.15pt;"> </font>may<font style="letter-spacing:-0.15pt;"> </font>also<font style="letter-spacing:-0.15pt;"> </font>be required to pay civil penalties of up to the greater of $2.2 million or three times the profit made or loss avoided, as well as criminal penalties of up to $25.0 million, and could under certain circumstances be subject to private lawsuits.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 7.9pt 12pt 0pt;">Violation of this Insider Trading Policy or any federal or state insider trading laws may subject the person violating such policy or laws to disciplinary action by the Company up to and including termination.<font style="letter-spacing:3.95pt;"> </font>The Company reserves the right to determine, in its own discretion and<font style="letter-spacing:2pt;"> </font>on the basis of the information available to it, whether this Insider Trading Policy has been violated.<font style="letter-spacing:2pt;"> </font>The<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.05pt;"> </font>may<font style="letter-spacing:-0.15pt;"> </font>determine<font style="letter-spacing:-0.2pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>specific<font style="letter-spacing:-0.2pt;"> </font>conduct<font style="letter-spacing:-0.15pt;"> </font>violates<font style="letter-spacing:-0.15pt;"> </font>this<font style="letter-spacing:-0.05pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Policy, whether<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.05pt;"> </font>conduct<font style="letter-spacing:-0.1pt;"> </font>also<font style="letter-spacing:-0.1pt;"> </font>violates<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>law.<font style="letter-spacing:2pt;"> </font>It<font style="letter-spacing:-0.1pt;"> </font>is<font style="letter-spacing:-0.1pt;"> </font>not<font style="letter-spacing:-0.1pt;"> </font>necessary<font style="letter-spacing:-0.1pt;"> </font>for<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.05pt;"> </font>Company<font style="letter-spacing:-0.1pt;"> </font>to<font style="letter-spacing:-0.1pt;"> </font>await<font style="letter-spacing:-0.1pt;"> </font>the filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12.05pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="color:#376092;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">E.</td><td style="padding:0pt;"><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">How</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.2pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Do</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">You</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Report</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">a</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Violation</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">of</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">this</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Insider</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Trading</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Policy?</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">If you have a question about this Insider Trading Policy, including whether certain information<font style="letter-spacing:-0.15pt;"> </font>you<font style="letter-spacing:-0.15pt;"> </font>are<font style="letter-spacing:-0.1pt;"> </font>aware<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>is<font style="letter-spacing:-0.15pt;"> </font>material<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>has<font style="letter-spacing:-0.15pt;"> </font>been<font style="letter-spacing:-0.15pt;"> </font>made<font style="letter-spacing:-0.2pt;"> </font>public,<font style="letter-spacing:-0.15pt;"> </font>you<font style="letter-spacing:-0.15pt;"> </font>are<font style="letter-spacing:-0.1pt;"> </font>encouraged<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>consult with a<font style="letter-spacing:-0.05pt;"> </font>Compliance<font style="letter-spacing:-0.05pt;"> </font>Officer.<font style="letter-spacing:2pt;"> </font>In addition, if<font style="letter-spacing:-0.05pt;"> </font>you violate<font style="letter-spacing:-0.05pt;"> </font>this Insider<font style="letter-spacing:-0.05pt;"> </font>Trading Policy or<font style="letter-spacing:-0.05pt;"> </font>any federal or<font style="letter-spacing:-0.05pt;"> </font>state<font style="letter-spacing:-0.05pt;"> </font>laws governing insider<font style="letter-spacing:-0.05pt;"> </font>trading, or<font style="letter-spacing:-0.05pt;"> </font>know<font style="letter-spacing:-0.05pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font>any such violation by any director, officer<font style="letter-spacing:-0.05pt;"> </font>or employee of the Company, you should report the violation immediately to either Compliance Officer. The Chief Executive Officer may designate one or more individuals who may perform the Compliance Officer&#8217;s duties in the event that either Compliance Officer is unable or unavailable to perform such duties.</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:3.95pt 11.1pt 12pt 0pt;">The<font style="letter-spacing:-0.4pt;"> </font>Company<font style="letter-spacing:-0.35pt;"> </font>has<font style="letter-spacing:-0.3pt;"> </font>designated<font style="letter-spacing:-0.3pt;"> </font>its<font style="letter-spacing:-0.35pt;"> </font>Chief<font style="letter-spacing:-0.4pt;"> </font>Financial<font style="letter-spacing:-0.4pt;"> </font>Officer<font style="letter-spacing:-0.3pt;"> </font>as<font style="letter-spacing:-0.3pt;"> </font>its<font style="letter-spacing:-0.25pt;"> </font>Insider<font style="letter-spacing:-0.3pt;"> </font>Trading Compliance Officer (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance Officer</u>&quot;).</p><div style="height:0.6pt;left:15.42%;max-width:84.58%;position:relative;top:0pt;width:100.35pt;z-index:-9223372036603095040;"><div style="height:0.6pt;left:0pt;padding-bottom:0pt;position:relative;width:100.35pt;"><img src="smlr-20241231xex19d1001.jpg" alt="Graphic" style="height:0.6pt;width:100.35pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.4pt 0pt 12pt 0pt;"><font style="font-size:9.5pt;visibility:hidden;">&#8203;</font></p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:1.19;margin:0pt;">PART<font style="letter-spacing:-0.25pt;"> </font>II.<font style="letter-spacing:2.7pt;"> </font>TRADING<font style="letter-spacing:-0.1pt;"> PROCEDURES</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10.85pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">A.</td><td style="padding:0pt;"><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Special</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Trading</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Restrictions</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">Applicable</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;">to</i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="color:#376092;font-family:'Cambria';font-size:10pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Insiders</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.45pt 12pt 0pt;">In<font style="letter-spacing:-0.1pt;"> </font>addition<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>restrictions<font style="letter-spacing:-0.2pt;"> </font>on<font style="letter-spacing:-0.2pt;"> </font>trading<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.2pt;"> </font>securities<font style="letter-spacing:-0.2pt;"> </font>set<font style="letter-spacing:-0.2pt;"> </font>forth<font style="letter-spacing:-0.1pt;"> </font>above,<font style="letter-spacing:-0.1pt;"> </font>Insiders and their Affiliated Persons are subject to the following special trading restrictions:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:41.95pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">No</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Trading</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Except</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">During</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Trading </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Windows</font><b style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:bold;letter-spacing:-0.1pt;">.</b></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.45pt 12pt 0pt;">The announcement of the Company&#8217;s quarterly financial results almost always has the potential to have a material effect on the market for the Company&#8217;s securities.<font style="letter-spacing:2pt;"> </font>Although an Insider<font style="letter-spacing:-0.2pt;"> </font>may<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.15pt;"> </font>know<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>financial<font style="letter-spacing:-0.15pt;"> </font>results<font style="letter-spacing:-0.15pt;"> </font>prior<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>public<font style="letter-spacing:-0.2pt;"> </font>announcement,<font style="letter-spacing:-0.15pt;"> </font>if<font style="letter-spacing:-0.1pt;"> </font>an<font style="letter-spacing:-0.05pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>engages<font style="letter-spacing:-0.15pt;"> </font>in a trade before the financial results are disclosed to the public, such trades may give an appearance of impropriety that could subject the Insider and the Company to a charge of insider trading.<font style="letter-spacing:2pt;"> </font>Therefore, subject to limited exceptions described herein, Insiders may trade in Company securities only during four quarterly trading windows and then only after obtaining pre-clearance from a Compliance Officer in accordance with the procedures set forth below.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 9.05pt 12pt 5.95pt;">Unless<font style="letter-spacing:-0.15pt;"> </font>otherwise<font style="letter-spacing:-0.2pt;"> </font>advised,<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>four<font style="letter-spacing:-0.2pt;"> </font>trading<font style="letter-spacing:-0.15pt;"> </font>windows<font style="letter-spacing:-0.15pt;"> </font>consist<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>periods<font style="letter-spacing:-0.15pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>begin<font style="letter-spacing:-0.15pt;"> </font>after<font style="letter-spacing:-0.2pt;"> </font>market close on the second full trading day following the Company&#8217;s filing of its quarterly report on Form 10-Q or annual report on Form 10-K, as the case may be, announcing its quarterly or annual earnings and end at the close of business on the 15th day before the end of the then- current quarter (e.g., March 16<sup style="font-size:7.5pt;vertical-align:top;">th</sup>, June 15<sup style="font-size:7.5pt;vertical-align:top;">th</sup>, September 15<sup style="font-size:7.5pt;vertical-align:top;">th</sup> and December 16<sup style="font-size:7.5pt;vertical-align:top;">th</sup>). Insiders may be allowed to trade outside of a trading window only (a) pursuant to a pre-approved Rule 10b5-1 Plan as described below or (b) in accordance with the procedure for waivers as described below.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Prohibited</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Transactions</font></td></tr></table><div style="margin-top:11.94pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:78pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">No Short Sales</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">.</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">No Insider may at any time sell any securities of the Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">are</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">owned</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">by</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">such</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Insider</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">at</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">time</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">sale</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">&#8220;short </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">sale&#8221;).</font></td><td style="width:19.35pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:78pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">No</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Purchases</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Sales</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Derivative</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Hedging</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Transactions</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">.</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.35pt;"> </i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">No Insider may buy or sell puts, calls, other derivative securities of the Company or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">derivative</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">provide</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">economic</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">equivalent</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">ownership of any of the Company&#8217;s securities or an opportunity, direct or indirect, to profit from any change in the value of the Company&#8217;s securities or engage in any other</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">hedging transaction with respect to the Company&#8217;s securities, at any </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">time.</font></td><td style="width:7.15pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:78pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">No</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.3pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Subject</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Margin</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Calls</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">.</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.3pt;"> </i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">No</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Insider</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">may</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">use</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the Company&#8217;s securities as collateral in a margin account.</font></td><td style="width:30.25pt;"></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:78pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">No</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:bold;">Pledges</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">.</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:2.85pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">No Insider may</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">pledge</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">as</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">collateral</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">for </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.5pt;">a</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:3.95pt 0pt 12pt 96pt;">loan<font style="letter-spacing:-0.05pt;"> </font>(or<font style="letter-spacing:-0.1pt;"> </font>modify an<font style="letter-spacing:-0.05pt;"> </font>existing <font style="letter-spacing:-0.1pt;">pledge).</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Gifts</font><b style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:bold;letter-spacing:-0.1pt;">.</b></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">No Insider may give or make any other transfer of Company securities without consideration<font style="letter-spacing:-0.15pt;"> </font>(e.g.,<font style="letter-spacing:-0.05pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>gift)<font style="letter-spacing:-0.2pt;"> </font>during<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>period<font style="letter-spacing:-0.05pt;"> </font>when<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>is<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.15pt;"> </font>permitted<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>trade<font style="letter-spacing:-0.2pt;"> </font>unless<font style="letter-spacing:-0.15pt;"> </font>the donee (recipient) agrees not to sell the shares until such time as the Insider can sell.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.5pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Gill Sans MT';font-size:18pt;line-height:17.5pt;margin-bottom:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">B.</td><td style="padding:0pt;"><i style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Pre-Clearance</i><i style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;font-weight:normal;letter-spacing:-0.35pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </i><i style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Procedures</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.89pt 11.1pt 12pt 0pt;">No Insider may trade in Company securities unless the trade has been approved by a Compliance Officer in accordance with the procedures set forth below.<font style="letter-spacing:2pt;"> </font>A Compliance Officer will<font style="letter-spacing:-0.05pt;"> </font>review<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.05pt;"> </font>either<font style="letter-spacing:-0.1pt;"> </font>approve<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>prohibit<font style="letter-spacing:-0.05pt;"> </font>all<font style="letter-spacing:-0.05pt;"> </font>proposed<font style="letter-spacing:-0.05pt;"> </font>trades<font style="letter-spacing:-0.05pt;"> </font>by Insiders<font style="letter-spacing:-0.05pt;"> </font>in accordance<font style="letter-spacing:-0.1pt;"> </font>with<font style="letter-spacing:-0.05pt;"> </font>the procedures set forth below.<font style="letter-spacing:2pt;"> </font>A Compliance Officer may consult with the Company&#8217;s other officers<font style="letter-spacing:-0.05pt;"> </font>and/or<font style="letter-spacing:-0.2pt;"> </font>outside<font style="letter-spacing:-0.2pt;"> </font>legal<font style="letter-spacing:-0.15pt;"> </font>counsel<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>will<font style="letter-spacing:-0.15pt;"> </font>receive<font style="letter-spacing:-0.2pt;"> </font>approval<font style="letter-spacing:-0.05pt;"> </font>for<font style="letter-spacing:-0.2pt;"> </font>his<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>her<font style="letter-spacing:-0.1pt;"> </font>own<font style="letter-spacing:-0.15pt;"> </font>trades<font style="letter-spacing:-0.15pt;"> </font>from<font style="letter-spacing:-0.15pt;"> </font>the other Compliance Officer or the Chief Executive Officer.</p><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:41.95pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:bold;">Procedures.</b><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:bold;letter-spacing:2.7pt;"> </b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">No Insider</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">may</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trade</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">securities</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">until:</font></td></tr></table><div style="margin-top:11.94pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:77.95pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">The</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Insider</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">has</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">notified</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Compliance</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Officer</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">amount</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">nature</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the proposed trade(s) using the Stock Transaction Request form attached to this Insider Trading Policy.</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">In order to provide adequate time for the preparation of any required reports under Section 16 of the Exchange Act, a Stock Transaction</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Request</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">form</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">should,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">if</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">practicable, be</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">received</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">by</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Compliance Officer at least two (2) business days prior to the intended trade date;</font></td><td style="width:9.9pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:77.95pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">The Insider has certified to a Compliance Officer in writing prior to the proposed</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trade(s)</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Insider</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">is</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">possession</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">material,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">nonpublic information concerning the Company;</font></td><td style="width:21pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:78pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">The Insider has informed a Compliance Officer, using the Stock Transaction Request form attached hereto, whether, to the Insider&#8217;s best knowledge, (a)</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the Insider has (or is deemed to have) engaged in any opposite way transactions</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">within</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">previous</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">six</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">months</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">were</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">exempt</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">from</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 16(b) of the Exchange Act and (b) if the transaction involves a sale by an &#8220;affiliate&#8221; of the Company or of &#8220;restricted securities&#8221; (as such terms are defined under Rule 144 under the Securities Act of 1933, as amended (&#8220;</font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Rule</u><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;"> </font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">144</u><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">&#8221;)), whether the transaction meets all of the applicable conditions of Rule 144; and</font></td><td style="width:7.1pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:78pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">A</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Compliance</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Officer</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">his</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">her</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">designee</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">has</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">approved</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trade(s)</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">has certified such approval in writing.</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Such certification may be made via digitally-signed electronic mail.</font></td><td style="width:8.15pt;"></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.94pt 11.1pt 12pt 5.95pt;">Neither Compliance Officer assumes the responsibility for, and approval from a Compliance<font style="letter-spacing:-0.25pt;"> </font>Officer<font style="letter-spacing:-0.25pt;"> </font>does<font style="letter-spacing:-0.1pt;"> </font>not<font style="letter-spacing:-0.2pt;"> </font>protect<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>Insider<font style="letter-spacing:-0.15pt;"> </font>from,<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>consequences<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>prohibited<font style="letter-spacing:-0.2pt;"> </font>insider trading or any violations of Section 16(b) or Rule 144.</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:3.95pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Additional</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Information.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">Insiders shall provide to a Compliance Officer any documentation reasonably requested by<font style="letter-spacing:-0.15pt;"> </font>him<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>her<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>furtherance<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>foregoing<font style="letter-spacing:-0.15pt;"> </font>procedures.<font style="letter-spacing:2pt;"> </font>Any<font style="letter-spacing:-0.05pt;"> </font>failure<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>provide<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>requested information will be grounds for denial of approval by a Compliance Officer.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">No</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Obligation</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Approve</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Trades.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">The existence of the foregoing approval procedures does not in any way obligate a Compliance<font style="letter-spacing:-0.2pt;"> </font>Officer<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>approve<font style="letter-spacing:-0.2pt;"> </font>any<font style="letter-spacing:-0.15pt;"> </font>trade<font style="letter-spacing:-0.2pt;"> </font>requested<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:-0.15pt;"> </font>an<font style="letter-spacing:-0.05pt;"> </font>Insider.<font style="letter-spacing:2pt;"> </font>A<font style="letter-spacing:-0.2pt;"> </font>Compliance<font style="letter-spacing:-0.2pt;"> </font>Officer<font style="letter-spacing:-0.2pt;"> </font>may reject any trading request at his or her sole discretion.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 7.85pt 12pt 5.95pt;">From time to time, an event may occur that is material to the Company and is known by only a few directors or executives.<font style="letter-spacing:2pt;"> </font>Insiders may not trade in Company securities if they are notified by a Compliance Officer that a proposed trade has not been cleared because of the existence of a material, nonpublic development.<font style="letter-spacing:4pt;"> </font>Even if that particular Insider is not aware of the material, nonpublic development involving the Company, if any Insider engages in a trade before a material, nonpublic development is disclosed to the public or resolved, the Insider and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute<font style="letter-spacing:-0.1pt;"> </font>even<font style="letter-spacing:-0.15pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>Insider<font style="letter-spacing:-0.1pt;"> </font>was<font style="letter-spacing:-0.15pt;"> </font>unaware<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>development.<font style="letter-spacing:2pt;"> </font>So<font style="letter-spacing:-0.15pt;"> </font>long<font style="letter-spacing:-0.15pt;"> </font>as<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>event<font style="letter-spacing:-0.15pt;"> </font>remains<font style="letter-spacing:-0.15pt;"> </font>material and nonpublic, a Compliance Officer may determine not to approve any transactions in the Company&#8217;s securities.<font style="letter-spacing:2pt;"> </font>A Compliance Officer will subsequently notify the Insider once the material, nonpublic development is disclosed to the public or resolved.<font style="letter-spacing:2pt;"> </font>If an Insider requests clearance to trade in the Company&#8217;s securities during the pendency of such an event, the Compliance Officer may reject the trading request without disclosing the reason.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">4.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Completion</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> Trades.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.45pt 12pt 0pt;">After<font style="letter-spacing:-0.2pt;"> </font>receiving<font style="letter-spacing:-0.15pt;"> </font>written<font style="letter-spacing:-0.2pt;"> </font>clearance<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>engage<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>trade<font style="letter-spacing:-0.2pt;"> </font>signed<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>Compliance<font style="letter-spacing:-0.2pt;"> </font>Officer,<font style="letter-spacing:-0.05pt;"> </font>an Insider must complete the proposed trade within two (2) business days or make a new trading <font style="letter-spacing:-0.1pt;">request.</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">5.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Post-Trade</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.4pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Reporting.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.05pt 12pt 0pt;">Any transactions in the Company&#8217;s securities by an Insider (including transactions effected pursuant to a Rule 10b5-1 Plan) must be reported to a Compliance Officer by completing the &#8220;Confirmation of Transaction&#8221; section of the Stock Transaction Request form attached<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>this<font style="letter-spacing:-0.05pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Policy<font style="letter-spacing:-0.15pt;"> </font>on<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>same<font style="letter-spacing:-0.2pt;"> </font>day<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>which<font style="letter-spacing:-0.15pt;"> </font>such<font style="letter-spacing:-0.05pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>transaction<font style="letter-spacing:-0.15pt;"> </font>occurs.<font style="letter-spacing:2pt;"> </font>Each report an Insider makes to a Compliance Officer should include the date of the transaction, quantity of shares, price and broker-dealer through which the transaction was effected.<font style="letter-spacing:2pt;"> </font>This reporting requirement may be satisfied by sending (or having such Insider&#8217;s broker send) duplicate confirmations of trades to a Compliance Officer if such information is received by a Compliance Officer on or before the required date.<font style="letter-spacing:2pt;"> </font>Compliance by directors and executive officers with this provision is imperative given the requirement of Section 16 of the Exchange Act that these<font style="letter-spacing:-0.05pt;"> </font>persons generally must report changes in ownership of<font style="letter-spacing:-0.05pt;"> </font>Company securities within two (2) business days.<font style="letter-spacing:2pt;"> </font>The sanctions for noncompliance with this reporting deadline include mandatory disclosure in the Company&#8217;s proxy statement for the next annual meeting of stockholders, as well as possible civil or criminal sanctions for chronic or egregious violators.</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Gill Sans MT';font-size:18pt;line-height:17.5pt;margin-bottom:0pt;margin-top:3.5pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">C.</td><td style="padding:0pt;"><i style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exemptions</i></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:11.85pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:42pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">1.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Pre-Approved</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Rule</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">10b5-1</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;">Plan.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 7.65pt 12pt 0pt;">Transactions effected pursuant to a Rule 10b5-1 Plan (as defined below) will not be subject to the Company&#8217;s trading windows or pre-clearance procedures, and Insiders are not required<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>complete<font style="letter-spacing:-0.2pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>Stock<font style="letter-spacing:-0.15pt;"> </font>Transaction<font style="letter-spacing:-0.15pt;"> </font>Request<font style="letter-spacing:-0.05pt;"> </font>form<font style="letter-spacing:-0.15pt;"> </font>for<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>transactions.<font style="letter-spacing:2pt;"> </font>Rule<font style="letter-spacing:-0.2pt;"> </font>10b5-1<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the Exchange Act provides an affirmative defense from insider trading liability under the federal securities laws for trading plans, arrangements or instructions that meet certain requirements.<font style="letter-spacing:2pt;"> </font>A trading plan, arrangement or instruction that meets the requirements of Rule 10b5-1 (a &#8220;Rule 10b5-1 Plan&#8221;) enables Insiders to establish arrangements to trade in Company securities outside of<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.05pt;"> </font>trading<font style="letter-spacing:-0.05pt;"> </font>windows,<font style="letter-spacing:-0.05pt;"> </font>even<font style="letter-spacing:-0.05pt;"> </font>when<font style="letter-spacing:-0.05pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>possession<font style="letter-spacing:-0.05pt;"> </font>of<font style="letter-spacing:-0.1pt;"> </font>material,<font style="letter-spacing:-0.05pt;"> </font>nonpublic<font style="letter-spacing:-0.1pt;"> </font>information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12.05pt 11.1pt 12pt 0pt;">If<font style="letter-spacing:-0.2pt;"> </font>an<font style="letter-spacing:-0.05pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>intends<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>trade<font style="letter-spacing:-0.2pt;"> </font>pursuant<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>Rule<font style="letter-spacing:-0.2pt;"> </font>10b5-1<font style="letter-spacing:-0.15pt;"> </font>Plan,<font style="letter-spacing:-0.15pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>plan,<font style="letter-spacing:-0.15pt;"> </font>arrangement<font style="letter-spacing:-0.15pt;"> </font>or instruction must:</p><div style="margin-top:11.94pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:60pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">satisfy</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">requirements</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Rule</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">10b5-1</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">policies</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">related</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Rule 10b5-1 Plans;</font></td><td style="width:8.25pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12.05pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:60pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">be</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">documented</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">writing;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.85pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:60pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">be</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">established</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">during</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">trading</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">window</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">when</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">such</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Insider</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">does</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">possess material, nonpublic information; and</font></td><td style="width:41.45pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12.05pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:60pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:17.95pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">be</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">pre-approved by</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Compliance</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Officer.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.85pt 0pt 12pt 0pt;">Any deviation from, or alteration to, the specifications of an approved Rule 10b5-1 Plan (including,<font style="letter-spacing:-0.1pt;"> </font>without<font style="letter-spacing:-0.15pt;"> </font>limitation,<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>amount,<font style="letter-spacing:-0.1pt;"> </font>price<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font>timing<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.15pt;"> </font>purchase<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>sale)<font style="letter-spacing:-0.15pt;"> </font>must<font style="letter-spacing:-0.1pt;"> </font>be<font style="letter-spacing:-0.15pt;"> </font>reported immediately to a Compliance Officer.<font style="letter-spacing:2pt;"> </font>Any transaction pursuant to a Rule 10b5-1 Plan must be timely reported following the transaction in accordance with the procedures set forth above.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">A Compliance Officer may refuse to approve a Rule 10b5-1 Plan as he or she deems appropriate<font style="letter-spacing:-0.2pt;"> </font>including,<font style="letter-spacing:-0.15pt;"> </font>without<font style="letter-spacing:-0.15pt;"> </font>limitation,<font style="letter-spacing:-0.15pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>he<font style="letter-spacing:-0.2pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>she<font style="letter-spacing:-0.2pt;"> </font>determines<font style="letter-spacing:-0.15pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>plan<font style="letter-spacing:-0.15pt;"> </font>does<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.15pt;"> </font>satisfy the requirements of Rule 10b5-1.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 9.05pt 12pt 5.95pt;">Any modification of an Insider&#8217;s prior Rule 10b5-1 Plan requires pre-approval by a Compliance<font style="letter-spacing:-0.2pt;"> </font>Officer.<font style="letter-spacing:2pt;"> </font>A<font style="letter-spacing:-0.1pt;"> </font>modification<font style="letter-spacing:-0.15pt;"> </font>must<font style="letter-spacing:-0.15pt;"> </font>occur<font style="letter-spacing:-0.1pt;"> </font>during<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>trading<font style="letter-spacing:-0.15pt;"> </font>window<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>while<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.05pt;"> </font>Insider is not aware of material, nonpublic information.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Cambria';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:2pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:41.95pt;"></td><td style="color:#244061;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Employee</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;">Benefit</font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="color:#244061;font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Plans.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;"><font style="font-style:italic;font-weight:bold;">Exercise of Stock Options</font>.<font style="letter-spacing:2pt;"> </font>The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the exercise of an option to purchase securities of the Company when payment of the exercise price is made in cash.<font style="letter-spacing:2pt;"> </font>However, the exercise of an option to purchase securities of the Company is subject to the current reporting requirements of Section 16 of the Exchange Act and, therefore, Insiders must comply with the post-trade reporting requirement described in Section C above for any such transaction.<font style="letter-spacing:2pt;"> </font>In addition, the securities<font style="letter-spacing:-0.15pt;"> </font>acquired<font style="letter-spacing:-0.15pt;"> </font>upon<font style="letter-spacing:-0.05pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>exercise<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>an<font style="letter-spacing:-0.15pt;"> </font>option<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>purchase<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>securities<font style="letter-spacing:-0.15pt;"> </font>are<font style="letter-spacing:-0.2pt;"> </font>subject<font style="letter-spacing:-0.15pt;"> </font>to</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:3.95pt 10.05pt 12pt 0pt;">all of the requirements of this Insider Trading Policy, including the Trading Procedures contained herein.<font style="letter-spacing:2pt;"> </font>Moreover, the Trading Procedures apply to the use of outstanding Company securities to pay part or all of the exercise price of an option, any net option exercise, any exercise of a stock appreciation right, share withholding, any sale of stock as part of a broker- assisted<font style="letter-spacing:-0.15pt;"> </font>cashless<font style="letter-spacing:-0.15pt;"> </font>exercise<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>an<font style="letter-spacing:-0.15pt;"> </font>option,<font style="letter-spacing:-0.15pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>any<font style="letter-spacing:-0.15pt;"> </font>other<font style="letter-spacing:-0.2pt;"> </font>market<font style="letter-spacing:-0.15pt;"> </font>sale<font style="letter-spacing:-0.1pt;"> </font>for<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>purpose<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>generating<font style="letter-spacing:-0.15pt;"> </font>the cash needed to pay the exercise price of an option.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 8.3pt 12pt 0pt;"><font style="font-style:italic;font-weight:bold;">Tax</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-style:italic;font-weight:bold;">Withholding</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-style:italic;font-weight:bold;">on</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.25pt;"> </font><font style="font-style:italic;font-weight:bold;">Restricted</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-style:italic;font-weight:bold;">Stock/Units</font>.<font style="letter-spacing:2pt;"> </font>The<font style="letter-spacing:-0.35pt;"> </font>trading<font style="letter-spacing:-0.15pt;"> </font>prohibitions<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>restrictions<font style="letter-spacing:-0.15pt;"> </font>set forth in the Trading Procedures do not apply to the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable<font style="letter-spacing:2pt;"> </font>plan or award agreement or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Gill Sans MT';font-size:18pt;line-height:17.5pt;margin-bottom:0pt;margin-top:11.55pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:6pt;"></td><td style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;vertical-align:text-top;white-space:nowrap;width:35.95pt;padding:0pt;">D.</td><td style="padding:0pt;"><i style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waivers</i></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.89pt 11.1pt 12pt 0pt;">A waiver of any provision of this Insider Trading Policy, or the Trading Procedures contained<font style="letter-spacing:-0.15pt;"> </font>herein,<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.2pt;"> </font>specific<font style="letter-spacing:-0.2pt;"> </font>instance<font style="letter-spacing:-0.2pt;"> </font>may<font style="letter-spacing:-0.05pt;"> </font>be<font style="letter-spacing:-0.2pt;"> </font>authorized<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>writing<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>Audit<font style="letter-spacing:-0.15pt;"> </font>Committee<font style="letter-spacing:-0.2pt;"> </font>of the Board of Directors, and any such waiver shall be reported to the Company&#8217;s Board of <font style="letter-spacing:-0.1pt;">Directors.</font></p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:1.19;margin:2pt 0pt 0pt 0pt;">PART<font style="letter-spacing:-0.05pt;"> </font>III.<font style="letter-spacing:2.9pt;"> </font><font style="letter-spacing:-0.1pt;">ACKNOWLEDGEMENT</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 5.95pt;">This Insider Trading Policy will be delivered to all current Insiders and to any new directors, officers, employees and designated consultants at the start of their employment or relationship with the<font style="letter-spacing:-0.05pt;"> </font>Company.<font style="letter-spacing:2pt;"> </font>Upon first receiving a<font style="letter-spacing:-0.05pt;"> </font>copy of<font style="letter-spacing:-0.05pt;"> </font>this Insider<font style="letter-spacing:-0.05pt;"> </font>Trading Policy, each individual must acknowledge that he or she has received a copy and agrees to comply with the terms<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>this<font style="letter-spacing:-0.15pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Policy,<font style="letter-spacing:-0.15pt;"> </font>and,<font style="letter-spacing:-0.15pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>applicable,<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Procedures<font style="letter-spacing:-0.15pt;"> </font>contained<font style="letter-spacing:-0.15pt;"> </font>herein. The acknowledgment attached hereto must be returned within ten (10) days of receipt to:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:1.25pt;margin:12pt 176.15pt 0pt 175.3pt;"><b style="font-size:12pt;font-weight:bold;">Chief Financial Officer Semler Scientific, Inc. 2340-2348</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.75pt;"> </b><b style="font-size:12pt;font-weight:bold;">Walsh</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.75pt;"> </b><b style="font-size:12pt;font-weight:bold;">Avenue</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 5.35pt 0pt 4.5pt;"><b style="font-size:12pt;font-weight:bold;">Suite </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;">2344</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 5.35pt 0pt 4.5pt;"><b style="font-size:12pt;font-weight:bold;">Santa</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-size:12pt;font-weight:bold;">Clara,</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-size:12pt;font-weight:bold;">California</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> 95051</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">This<font style="letter-spacing:-0.2pt;"> </font>acknowledgment<font style="letter-spacing:-0.2pt;"> </font>will<font style="letter-spacing:-0.2pt;"> </font>constitute<font style="letter-spacing:-0.25pt;"> </font>consent<font style="letter-spacing:-0.2pt;"> </font>for<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>Company<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>impose<font style="letter-spacing:-0.25pt;"> </font>sanctions<font style="letter-spacing:-0.2pt;"> </font>for violation of the Insider Trading Policy, including the Trading Procedures, and to issue any necessary stop-transfer orders to the Company&#8217;s transfer agent to ensure compliance.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 13.65pt 12pt 0pt;">All directors, officers, and employees and designated consultants will be<font style="letter-spacing:-0.05pt;"> </font>required upon the<font style="letter-spacing:-0.2pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.15pt;"> </font>request<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>re-acknowledge<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>agree<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>comply<font style="letter-spacing:-0.15pt;"> </font>with<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>Insider<font style="letter-spacing:-0.2pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Policy (including<font style="letter-spacing:-0.2pt;"> </font>any<font style="letter-spacing:-0.2pt;"> </font>amendments<font style="letter-spacing:-0.2pt;"> </font>or<font style="letter-spacing:-0.25pt;"> </font>modifications).<font style="letter-spacing:2pt;"> </font>For<font style="letter-spacing:-0.25pt;"> </font>such<font style="letter-spacing:-0.2pt;"> </font>purpose,<font style="letter-spacing:-0.1pt;"> </font>an<font style="letter-spacing:-0.2pt;"> </font>individual<font style="letter-spacing:-0.2pt;"> </font>will<font style="letter-spacing:-0.2pt;"> </font>be<font style="letter-spacing:-0.25pt;"> </font>deemed to<font style="letter-spacing:-0.1pt;"> </font>have<font style="letter-spacing:-0.2pt;"> </font>acknowledged<font style="letter-spacing:-0.05pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>agreed<font style="letter-spacing:-0.1pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>comply<font style="letter-spacing:-0.1pt;"> </font>with<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Insider<font style="letter-spacing:-0.15pt;"> </font>Trading<font style="letter-spacing:-0.1pt;"> </font>Policy,<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.1pt;"> </font>amended<font style="letter-spacing:-0.05pt;"> </font>from time to time, when copies of such items have been delivered by regular or electronic mail (or other delivery option used by the Company) by a Compliance Officer or his or her designee.</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:3.95pt 0.95pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:35.95pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.5pt;">*</font></font><font style="font-size:12pt;letter-spacing:-0.5pt;">*</font><font style="display:inline-block;width:30.5pt;"></font><font style="font-size:12pt;letter-spacing:-0.5pt;">*</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 11.1pt 12pt 0pt;">Questions<font style="letter-spacing:-0.2pt;"> </font>regarding<font style="letter-spacing:-0.2pt;"> </font>this<font style="letter-spacing:-0.1pt;"> </font>Insider<font style="letter-spacing:-0.25pt;"> </font>Trading<font style="letter-spacing:-0.2pt;"> </font>Policy<font style="letter-spacing:-0.2pt;"> </font>are<font style="letter-spacing:-0.25pt;"> </font>encouraged<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>may<font style="letter-spacing:-0.2pt;"> </font>be<font style="letter-spacing:-0.15pt;"> </font>directed<font style="letter-spacing:-0.2pt;"> </font>to the Compliance Officers.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10.19pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:36pt;margin:0pt 0pt 12pt 4.5pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:67.5pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">ADOPTED:</font></font>September<font style="letter-spacing:-0.1pt;"> </font>2, <font style="letter-spacing:-0.2pt;">2021</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:36pt;margin:3.95pt 5.6pt 12pt 4.5pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT</u><u style="letter-spacing:-0.35pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</u></p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:1.19;text-align:center;margin:2pt 5.4pt 0pt 4.5pt;">STOCK<font style="letter-spacing:-0.35pt;"> </font>TRANSACTION<font style="letter-spacing:-0.25pt;"> </font><font style="letter-spacing:-0.1pt;">REQUEST</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:11.94pt 11.1pt 0pt 6pt;">Pursuant<font style="letter-spacing:-0.25pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>Semler<font style="letter-spacing:-0.1pt;"> </font>Scientific,<font style="letter-spacing:-0.15pt;"> </font>Inc.&#8217;s<font style="letter-spacing:-0.15pt;"> </font>Insider<font style="letter-spacing:-0.1pt;"> </font>Trading<font style="letter-spacing:-0.15pt;"> </font>Policy,<font style="letter-spacing:-0.15pt;"> </font>I<font style="letter-spacing:-0.25pt;"> </font>hereby<font style="letter-spacing:-0.15pt;"> </font>notify<font style="letter-spacing:-0.15pt;"> </font>Semler<font style="letter-spacing:-0.1pt;"> </font>Scientific,<font style="letter-spacing:-0.15pt;"> </font>Inc.<font style="letter-spacing:-0.15pt;"> </font>(the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221;) of my intent to trade the securities of the Company as indicated below:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.6pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="padding-left:6.5pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:97.19%;"><tr style="height:39.1pt;"><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:10.8pt;margin:0pt 0pt 0pt 34.85pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">REQUESTER</b><b style="font-weight:bold;letter-spacing:-0.65pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INFORMATION</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:2.75pt 0pt 0pt 34.85pt;">Insider&#8217;s<font style="letter-spacing:-0.4pt;"> </font><font style="letter-spacing:-0.1pt;">Name:</font><font style="display:inline-block;width:187.7pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:3.1pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr><tr style="height:12.4pt;"><td colspan="2" style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:10.8pt;margin:0pt 0pt 0pt 34.85pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INTENT</b><b style="font-weight:bold;letter-spacing:-0.35pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">TO</b><b style="font-weight:bold;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">PURCHASE</b></p></td></tr><tr style="height:14.45pt;"><td colspan="2" style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:1.14pt 0pt 0pt 34.85pt;">Number<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">shares:</font><font style="display:inline-block;width:11.84pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:130.05pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr><tr style="height:13.8pt;"><td colspan="2" style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:11.5pt;margin:1.35pt 0pt 0pt 34.85pt;">Intended<font style="letter-spacing:-0.3pt;"> </font>trade<font style="letter-spacing:-0.3pt;"> </font><font style="letter-spacing:-0.1pt;">date:</font><font style="display:inline-block;width:2.89pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:130.1pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr><tr style="height:10.2pt;"><td colspan="2" style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:8.4pt;margin:0.85pt 0pt 0pt 34.85pt;">Means<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font><font style="letter-spacing:-0.1pt;">acquiring</font><font style="display:inline-block;width:22.51pt;"></font><font style="font-family:'Wingdings';letter-spacing:-0.5pt;">&#168;</font><font style="display:inline-block;width:6.47pt;"></font>Acquisition<font style="letter-spacing:-0.3pt;"> </font>through<font style="letter-spacing:-0.3pt;"> </font>employee<font style="letter-spacing:-0.45pt;"> </font>benefit<font style="letter-spacing:-0.3pt;"> </font>plan<font style="letter-spacing:-0.4pt;"> </font>(please<font style="letter-spacing:-0.3pt;"> </font><font style="letter-spacing:-0.1pt;">specify):</font></p></td></tr><tr style="height:21.05pt;"><td colspan="2" style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:8.95pt;margin:0pt 0pt 0pt 34.85pt;"><font style="letter-spacing:-0.1pt;">shares:</font></p></td></tr><tr style="height:29.15pt;"><td colspan="2" style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1pt;margin:0pt 0pt 0pt 134.15pt;"><div style="display:inline-block;height:1.5pt;width:296.25pt;"><div style="height:0.4pt;left:0.75pt;padding-bottom:0.35pt;position:relative;width:295.05pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.09pt;left:0pt;position:absolute;width:295.05pt;"><img src="smlr-20241231xex19d1002.jpg" alt="Graphic" style="height:0.09pt;width:295.05pt;"></div></div></div></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:11pt 0pt 0pt 106.15pt;"><font style="font-family:'Wingdings';letter-spacing:-0.5pt;">&#168;</font><font style="display:inline-block;width:24.52pt;"></font>Purchase<font style="letter-spacing:-0.2pt;"> </font>through<font style="letter-spacing:-0.2pt;"> </font>a<font style="letter-spacing:-0.25pt;"> </font>broker<font style="letter-spacing:-0.2pt;"> </font>on<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>open<font style="letter-spacing:-0.25pt;"> </font><font style="letter-spacing:-0.1pt;">market</font></p></td></tr><tr style="height:19pt;"><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:5.5pt 0pt 0pt 106.15pt;"><font style="font-family:'Wingdings';letter-spacing:-0.5pt;">&#168;</font><font style="display:inline-block;width:24.52pt;"></font>Other<font style="letter-spacing:-0.05pt;"> </font>(please<font style="letter-spacing:-0.1pt;"> </font>specify):<font style="letter-spacing:-0.25pt;"> </font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:200.35pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr><tr style="height:12.3pt;"><td style="vertical-align:top;width:20.77%;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:10.8pt;margin:0pt 0pt 0pt 34.85pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INTENT</b><b style="font-weight:bold;letter-spacing:-0.35pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">TO</b><b style="font-weight:bold;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> SELL</b></p></td><td style="vertical-align:top;width:79.22%;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:14.4pt;"><td style="vertical-align:top;width:20.77%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:1.1pt 0pt 0pt 34.85pt;">Number<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">shares:</font></p></td><td style="vertical-align:top;width:79.22%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:1.1pt 0pt 0pt 24.1pt;"><font style="font-size:10pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:20.77%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:11.5pt;margin:1.35pt 0pt 0pt 34.85pt;">Intended<font style="letter-spacing:-0.3pt;"> </font>trade<font style="letter-spacing:-0.3pt;"> </font><font style="letter-spacing:-0.1pt;">date:</font></p></td><td style="vertical-align:top;width:79.22%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:11.5pt;margin:1.35pt 0pt 0pt 24.05pt;"><font style="font-size:11.5pt;line-height:1.19;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:10.2pt;"><td style="vertical-align:top;width:20.77%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:8.5pt;margin:0.69pt 0pt 0pt 34.85pt;">Means<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font><font style="letter-spacing:-0.1pt;">selling</font></p></td><td style="vertical-align:top;width:79.22%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:8.4pt;margin:0.85pt 0pt 0pt 8.6pt;"><font style="display:inline-block;text-indent:0pt;width:28.3pt;"><font style="font-family:'Wingdings';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.5pt;">&#168;</font></font>Sale<font style="letter-spacing:-0.3pt;"> </font>through<font style="letter-spacing:-0.3pt;"> </font>employee<font style="letter-spacing:-0.3pt;"> </font>benefit<font style="letter-spacing:-0.25pt;"> </font>plan<font style="letter-spacing:-0.25pt;"> </font>(please<font style="letter-spacing:-0.3pt;"> </font><font style="letter-spacing:-0.1pt;">specify):</font></p></td></tr><tr style="height:21.05pt;"><td style="vertical-align:top;width:20.77%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:8.95pt;margin:0pt 0pt 0pt 34.85pt;"><font style="letter-spacing:-0.1pt;">shares:</font></p></td><td style="vertical-align:top;width:79.22%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:10.14pt 0pt 0.05pt 0pt;"><font style="font-size:10pt;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1pt;margin:0pt 0pt 0pt 36.9pt;"><div style="display:inline-block;height:1.5pt;width:296.25pt;"><div style="height:0.4pt;left:0.75pt;padding-bottom:0.35pt;position:relative;width:295.05pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.09pt;left:0pt;position:absolute;width:295.05pt;"><img src="smlr-20241231xex19d1002.jpg" alt="Graphic" style="height:0.09pt;width:295.05pt;"></div></div></div></div></div></td></tr><tr style="height:27.55pt;"><td style="vertical-align:top;width:20.77%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:79.22%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:10.39pt 0pt 0pt 8.6pt;"><font style="display:inline-block;text-indent:0pt;width:28.3pt;"><font style="font-family:'Wingdings';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.5pt;">&#168;</font></font>Sale<font style="letter-spacing:-0.2pt;"> </font>through<font style="letter-spacing:-0.2pt;"> </font>a<font style="letter-spacing:-0.15pt;"> </font>broker<font style="letter-spacing:-0.25pt;"> </font>on<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>open<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">market</font></p></td></tr><tr style="height:19pt;"><td style="vertical-align:top;width:20.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:79.22%;border-bottom:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:5.5pt 0pt 0pt 8.6pt;"><font style="display:inline-block;text-indent:0pt;width:28.3pt;"><font style="font-family:'Wingdings';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.5pt;">&#168;</font></font>Other<font style="letter-spacing:-0.05pt;"> </font>(please<font style="letter-spacing:-0.1pt;"> </font>specify):<font style="letter-spacing:-0.25pt;"> </font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:200.35pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr><tr style="height:185.85pt;"><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:10.05pt;margin:1.1pt 0pt 0pt 3.95pt;"><b style="font-weight:bold;letter-spacing:-1.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SECTION</b><b style="font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;letter-spacing:-0.25pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">16</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:106.13pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></b><b style="font-weight:bold;letter-spacing:4pt;"> </b><b style="font-weight:bold;">RULE 144 (Not applicable if transaction requested involves a</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:10.05pt;margin:0pt 0pt 0pt 166.4pt;"><b style="font-size:10pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:116.65pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></b><b style="font-size:10pt;font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">purchase)</b><b style="font-size:10pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:140.44pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:13pt;margin:3.84pt 0pt 0pt 34.85pt;"><font style="font-family:'Wingdings';letter-spacing:-0.5pt;vertical-align:sub;">&#168;</font><font style="display:inline-block;width:149.22pt;"></font><font style="vertical-align:sub;">I</font><font style="letter-spacing:-0.15pt;vertical-align:sub;"> </font><font style="vertical-align:sub;">am</font><font style="letter-spacing:-0.15pt;vertical-align:sub;"> </font><font style="vertical-align:sub;">not</font><font style="letter-spacing:-0.2pt;vertical-align:sub;"> </font><font style="vertical-align:sub;">subject</font><font style="letter-spacing:-0.2pt;vertical-align:sub;"> </font><font style="vertical-align:sub;">to</font><font style="letter-spacing:-0.15pt;vertical-align:sub;"> </font><font style="vertical-align:sub;">Section</font><font style="letter-spacing:-0.1pt;vertical-align:sub;"> </font><font style="letter-spacing:-0.25pt;vertical-align:sub;">16.</font><font style="display:inline-block;width:14.84pt;"></font><font style="font-family:'Wingdings';letter-spacing:-0.5pt;">&#168;</font><font style="display:inline-block;width:32.57pt;"></font>I<font style="letter-spacing:-0.2pt;"> </font>am<font style="letter-spacing:-0.15pt;"> </font>not<font style="letter-spacing:-0.2pt;"> </font>an<font style="letter-spacing:-0.15pt;"> </font>&#8220;affiliate&#8221;<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font><font style="letter-spacing:-0.1pt;">transaction</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:10pt;margin:0pt 0pt 0pt 207.35pt;">requested<font style="letter-spacing:-0.2pt;"> </font>above<font style="letter-spacing:-0.25pt;"> </font>does<font style="letter-spacing:-0.25pt;"> </font>not<font style="letter-spacing:-0.2pt;"> </font>involve<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>sale<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">&#8220;restricted</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:9.95pt;margin:0pt 0pt 0pt 207.35pt;">securities&#8221;<font style="letter-spacing:-0.25pt;"> </font>(as<font style="letter-spacing:-0.25pt;"> </font>such<font style="letter-spacing:-0.2pt;"> </font>terms<font style="letter-spacing:-0.3pt;"> </font>are<font style="letter-spacing:-0.2pt;"> </font>defined<font style="letter-spacing:-0.3pt;"> </font>under<font style="letter-spacing:-0.15pt;"> </font>Rule<font style="letter-spacing:-0.25pt;"> </font>144<font style="letter-spacing:-0.25pt;"> </font><font style="letter-spacing:-0.2pt;">under</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:0.91;padding-left:21.15pt;text-indent:-21.15pt;margin:0.5pt 97.3pt 0pt 5.35pt;"><font style="display:inline-block;text-indent:0pt;width:21.15pt;"><font style="font-family:'Wingdings';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.5pt;vertical-align:super;">&#168;</font></font><font style="vertical-align:super;">To the best of my knowledge, I</font><font style="display:inline-block;width:55.74pt;"></font>the<font style="letter-spacing:-0.3pt;"> </font>Securities<font style="letter-spacing:-0.35pt;"> </font>Act<font style="letter-spacing:-0.3pt;"> </font>of<font style="letter-spacing:-0.25pt;"> </font>1933,<font style="letter-spacing:-0.25pt;"> </font>as<font style="letter-spacing:-0.45pt;"> </font>amended). have not (and am not deemed to</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:0.77;margin:3.59pt 11.85pt 0pt 26.5pt;"><font style="vertical-align:super;">have) engaged in an opposite</font><font style="display:inline-block;width:41.55pt;"></font><font style="font-family:'Wingdings';letter-spacing:-0.5pt;vertical-align:super;">&#168;</font><font style="display:inline-block;width:16.37pt;"></font>To<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>best<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.3pt;"> </font>my<font style="letter-spacing:-0.25pt;"> </font>knowledge,<font style="letter-spacing:-0.3pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>transaction<font style="letter-spacing:-0.15pt;"> </font>requested<font style="letter-spacing:-0.2pt;"> </font>above <font style="vertical-align:super;">way transaction within the</font><font style="display:inline-block;width:25.53pt;"></font><font style="display:inline-block;width:19.8pt;"></font>will meet all of the applicable conditions of Rule 144. previous 6 months that was not</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:0.77;margin:2.34pt 28.4pt 0pt 26.5pt;"><font style="vertical-align:super;">exempt from Section 16(b) of</font><font style="display:inline-block;width:41.53pt;"></font><font style="font-family:'Wingdings';letter-spacing:-0.5pt;">&#168;</font><font style="display:inline-block;width:16.37pt;"></font>The transaction requested is being made pursuant to an <font style="vertical-align:super;">the Exchange Act.</font><font style="display:inline-block;width:88.59pt;"></font><font style="display:inline-block;width:19.8pt;"></font>effective<font style="letter-spacing:-0.4pt;"> </font>registration<font style="letter-spacing:-0.35pt;"> </font>statement<font style="letter-spacing:-0.4pt;"> </font>covering<font style="letter-spacing:-0.4pt;"> </font>such<font style="letter-spacing:-0.35pt;"> </font>transaction.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:8.64pt 0pt 0pt 34.85pt;"><font style="font-family:'Wingdings';letter-spacing:-0.5pt;vertical-align:super;">&#168;</font><font style="display:inline-block;width:149.22pt;"></font><font style="vertical-align:super;">None</font><font style="letter-spacing:-0.15pt;vertical-align:super;"> </font><font style="vertical-align:super;">of</font><font style="letter-spacing:-0.05pt;vertical-align:super;"> </font><font style="vertical-align:super;">the</font><font style="letter-spacing:-0.15pt;vertical-align:super;"> </font><font style="letter-spacing:-0.1pt;vertical-align:super;">above.</font><font style="display:inline-block;width:23.47pt;"></font><font style="font-family:'Wingdings';letter-spacing:-0.5pt;vertical-align:super;">&#168;</font><font style="display:inline-block;width:32.57pt;"></font>None<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">above.</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:10.78%;padding-right:10.62%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;min-height:172.7pt;"><div style="height:172.7pt;left:1.25%;max-width:98.75%;position:absolute;top:0pt;width:480pt;z-index:251678720;"><div style="height:172.7pt;left:0pt;padding-bottom:0pt;position:relative;width:479.3pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:172.7pt;left:0pt;position:absolute;width:479.3pt;"><img src="smlr-20241231xex19d1004.jpg" alt="Graphic" style="height:172.7pt;width:479.3pt;"></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:11.05pt;left:255.24pt;position:absolute;top:149.64pt;width:19.85pt;"><div style="height:11.05pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:19.85pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.05pt;width:100%;margin:0pt;"><font style="letter-spacing:-0.2pt;">Date</font></p></div></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:22.55pt;left:17.39pt;position:absolute;top:149.64pt;width:146.75pt;"><div style="height:22.55pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:146.75pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;width:100%;margin:0pt 0.9pt 0pt 0pt;">Signature<font style="letter-spacing:-0.45pt;"> </font>of<font style="letter-spacing:-0.5pt;"> </font>Compliance<font style="letter-spacing:-0.45pt;"> </font>Officer<font style="letter-spacing:-0.4pt;"> </font>(or <font style="letter-spacing:-0.1pt;">designee)</font></p></div></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:11.05pt;left:5.63pt;position:absolute;top:117.6pt;width:127.45pt;"><div style="height:11.05pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:127.45pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.05pt;width:100%;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">AUTHORIZED</b><b style="font-weight:bold;letter-spacing:-0.6pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">APPROVAL</b></p></div></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:11.05pt;left:267.48pt;position:absolute;top:100.44pt;width:19.85pt;"><div style="height:11.05pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:19.85pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.05pt;width:100%;margin:0pt;"><font style="letter-spacing:-0.2pt;">Date</font></p></div></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:11.05pt;left:17.39pt;position:absolute;top:100.44pt;width:76.95pt;"><div style="height:11.05pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:76.95pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.05pt;width:100%;margin:0pt;">Insider&#8217;s<font style="letter-spacing:-0.4pt;"> </font><font style="letter-spacing:-0.1pt;">Signature</font></p></div></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:73.8pt;left:5.63pt;position:absolute;top:0.96pt;width:463.85pt;"><div style="height:73.8pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:463.85pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.05pt;width:100%;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.25;width:100%;margin:2.34pt 0pt 0pt 0pt;">I hereby certify that I am not (1) in possession of any material, nonpublic information concerning the<font style="letter-spacing:-0.05pt;"> </font>Company, as defined in the Company&#8217;s Statement of Company Policy on Insider Trading and Disclosure and (2) purchasing any securities<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>Company<font style="letter-spacing:-0.15pt;"> </font>on<font style="letter-spacing:-0.15pt;"> </font>margin<font style="letter-spacing:-0.05pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>contravention<font style="letter-spacing:-0.15pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.15pt;"> </font>Trading<font style="letter-spacing:-0.05pt;"> </font>Procedures.<font style="letter-spacing:2pt;"> </font>I<font style="letter-spacing:-0.05pt;"> </font>understand<font style="letter-spacing:-0.05pt;"> </font>that,<font style="letter-spacing:-0.05pt;"> </font>if<font style="letter-spacing:-0.2pt;"> </font>I trade while possessing such information or in violation of such trading restrictions, I may be subject to severe civil and/or criminal penalties, and may be subject to discipline by the Company including termination.</p></div></div></div></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:3.2pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0pt 5.6pt;"><i style="font-style:italic;">*NOTE:</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">Multiple</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;">lots</i><i style="font-style:italic;letter-spacing:-0.3pt;"> </i><i style="font-style:italic;">must</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">be</i><i style="font-style:italic;letter-spacing:-0.1pt;"> </i><i style="font-style:italic;">listed</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">on</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">separate</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;">forms</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;">or</i><i style="font-style:italic;letter-spacing:-0.3pt;"> </i><i style="font-style:italic;">broken</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">out</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;letter-spacing:-0.1pt;">herein.</i></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.78%;margin-right:10.62%;margin-top:30pt;page-break-after:always;width:78.59%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:36pt;margin:3.95pt 5.55pt 12pt 4.5pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT</u><u style="letter-spacing:-0.35pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">B</u></p><p style="color:#376092;font-family:'Cambria';font-size:13pt;line-height:1.19;text-align:center;margin:2pt 5.4pt 0pt 4.5pt;"><font style="letter-spacing:-0.1pt;">ACKNOWLEDGMENT</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 10.05pt 12pt 5.95pt;">I<font style="letter-spacing:-0.3pt;"> </font>hereby acknowledge<font style="letter-spacing:-0.15pt;"> </font>that<font style="letter-spacing:-0.1pt;"> </font>I<font style="letter-spacing:-0.3pt;"> </font>have<font style="letter-spacing:-0.05pt;"> </font>read,<font style="letter-spacing:-0.1pt;"> </font>that I<font style="letter-spacing:-0.3pt;"> </font>understand,<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>that I<font style="letter-spacing:-0.3pt;"> </font>agree<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.1pt;"> </font>comply<font style="letter-spacing:-0.1pt;"> </font>with, the Insider Trading Policy of Semler Scientific, Inc. (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221;).<font style="letter-spacing:2pt;"> </font>I further acknowledge and agree that I am responsible for ensuring compliance with the Insider Trading Policy and the Trading Procedures included therein by all of my &#8220;Affiliated Persons&#8221; (including such persons listed below).<font style="letter-spacing:2pt;"> </font>I also understand and agree that I will be subject to sanctions, including termination of employment, that may be imposed by the Company, in its sole discretion, for violation of the Insider Trading Policy, and that the Company may give stop-transfer and other instructions to the Company&#8217;s transfer agent against the transfer of any Company securities in a transaction that the Company considers to be in contravention of the Insider Trading Policy.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:8.39pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 11.4pt;">Date:<font style="letter-spacing:2.65pt;"> </font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:74.22pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="display:inline-block;width:86.25pt;"></font>Signature:<font style="letter-spacing:2.5pt;"> </font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:173.29pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.5pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 237.2pt;"><font style="letter-spacing:-0.1pt;">Name:</font><font style="display:inline-block;width:159.2pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:6.65pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.44pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 237.2pt;"><font style="letter-spacing:-0.1pt;">Title:</font><font style="display:inline-block;width:167.08pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:6.65pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 10.7</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.54pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.5pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">SEMLER</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.25pt;"> </b><b style="font-size:12pt;font-weight:bold;">SCIENTIFIC,</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;">INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 87.4pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">AT-WILL</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.7pt;"> </b><b style="font-size:12pt;font-weight:bold;">EMPLOYMENT,</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.7pt;"> </b><b style="font-size:12pt;font-weight:bold;">CONFIDENTIAL</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.65pt;"> </b><b style="font-size:12pt;font-weight:bold;">INFORMATION, INVENTION ASSIGNMENT,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:14.65pt;text-align:center;margin:0pt 87.45pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">AND</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;"> </b><b style="font-size:12pt;font-weight:bold;">ARBITRATION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.25pt;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;">AGREEMENT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:11.94pt 8.7pt 12pt 38pt;">As a condition of my employment with Semler Scientific, Inc., its subsidiaries, affiliates, successors or assigns (together the &#8220;<b style="font-weight:bold;">Company</b>&#8221;), and in consideration of my employment with the Company<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>my<font style="letter-spacing:-0.35pt;"> </font>receipt<font style="letter-spacing:-0.4pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>compensation<font style="letter-spacing:-0.35pt;"> </font>now<font style="letter-spacing:-0.25pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>hereafter<font style="letter-spacing:-0.3pt;"> </font>paid<font style="letter-spacing:-0.4pt;"> </font>to<font style="letter-spacing:-0.4pt;"> </font>me<font style="letter-spacing:-0.3pt;"> </font>by<font style="letter-spacing:-0.35pt;"> </font>Company,<font style="letter-spacing:-0.35pt;"> </font>I<font style="letter-spacing:-0.35pt;"> </font>agree<font style="letter-spacing:-0.4pt;"> </font>to the<font style="letter-spacing:-0.25pt;"> </font>following<font style="letter-spacing:-0.25pt;"> </font>provisions<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>this<font style="letter-spacing:-0.25pt;"> </font>Semler<font style="letter-spacing:-0.1pt;"> </font>Scientific,<font style="letter-spacing:-0.15pt;"> </font>Inc.<font style="letter-spacing:-0.2pt;"> </font>At-Will<font style="letter-spacing:-0.25pt;"> </font>Employment,<font style="letter-spacing:-0.25pt;"> </font>Confidential<font style="letter-spacing:-0.15pt;"> </font>Information, Invention Assignment, and Arbitration Agreement (this &#8220;<b style="font-weight:bold;">Agreement</b>&#8221;):</p><div style="margin-top:12.1pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">At-Will</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.05pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Employment</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:12pt 8.7pt 0pt 38pt;">I UNDERSTAND AND ACKNOWLEDGE THAT MY EMPLOYMENT WITH THE COMPANY IS FOR NO SPECIFIED TERM AND CONSTITUTES &#8220;AT-WILL&#8221; EMPLOYMENT.<font style="letter-spacing:2pt;"> </font>I ALSO UNDERSTAND THAT ANY REPRESENTATION TO THE CONTRARY IS UNAUTHORIZED AND NOT VALID UNLESS IN WRITING AND SIGNED BY THE PRESIDENT OR CEO OF THE COMPANY.<font style="letter-spacing:2pt;"> </font>ACCORDINGLY, I ACKNOWLEDGE THAT MY EMPLOYMENT<font style="letter-spacing:-0.45pt;"> </font>RELATIONSHIP<font style="letter-spacing:-0.45pt;"> </font>MAY<font style="letter-spacing:-0.45pt;"> </font>BE<font style="letter-spacing:-0.45pt;"> </font>TERMINATED<font style="letter-spacing:-0.45pt;"> </font>AT<font style="letter-spacing:-0.45pt;"> </font>ANY<font style="letter-spacing:-0.45pt;"> </font>TIME,<font style="letter-spacing:-0.45pt;"> </font>WITH<font style="letter-spacing:-0.5pt;"> </font>OR<font style="letter-spacing:-0.55pt;"> </font>WITHOUT<font style="letter-spacing:-0.5pt;"> </font>GOOD<font style="letter-spacing:-0.45pt;"> </font>CAUSE OR FOR ANY OR NO CAUSE, AT MY OPTION OR AT THE OPTION OF THE COMPANY, WITH OR </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 8.7pt 12pt 38pt;">WITHOUT NOTICE.<font style="letter-spacing:2pt;"> </font>I FURTHER ACKNOWLEDGE THAT THE COMPANY MAY MODIFY JOB TITLES, SALARIES, AND BENEFITS FROM TIME TO TIME AS IT DEEMS NECESSARY.</p><div style="margin-top:11.94pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">2.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Confidential</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.4pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Information</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Company Information</i><font style="font-size:12pt;">. I</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">agree that during</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">and after my</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employment with</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the Company, I will hold in the strictest confidence, and will not use (except for the benefit of the Company during my employment) or disclose to any person, firm, or corporation (without written authorization of the President, CEO, or the Board of Directors of the Company) any Company Confidential Information.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that my unauthorized use or disclosure of Company Confidential</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">Information</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">during</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">employment</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">lead</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">disciplinary</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">action, up</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">including immediate</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">termination</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">legal</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">action</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">understand</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Company</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-size:12pt;font-weight:bold;">Confidential Information</b><font style="font-size:12pt;">&#8221; means any non-public information that relates to the actual or anticipated business, research or development of the Company, or to the Company&#8217;s technical data, trade secrets, or know-how,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">including,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">but</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">limited</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">to,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">research,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">product</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">plans,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">other</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">regarding</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">the Company&#8217;s products or services and markets therefor, customer lists and customers (including, but not limited</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">to,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">customers</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">called or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">become</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">acquainted during the term of my employment), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information; provided, however, Company Confidential Information does</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">include</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">foregoing</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">items</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">extent</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">same</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">have</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">become</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">publicly</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">known</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">and made</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">generally</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">available</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">through</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">no</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">wrongful</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">act</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">mine</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">others.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">understand</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">nothing</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">in</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 0pt 12pt 38pt;"><a name="_bookmark0"></a>this<font style="letter-spacing:1.4pt;"> </font>Agreement<font style="letter-spacing:1.7pt;"> </font>is<font style="letter-spacing:1.5pt;"> </font>intended<font style="letter-spacing:1.6pt;"> </font>to<font style="letter-spacing:1.7pt;"> </font>limit<font style="letter-spacing:1.6pt;"> </font>employees&#8217;<font style="letter-spacing:1.5pt;"> </font>rights<font style="letter-spacing:1.55pt;"> </font>to<font style="letter-spacing:1.55pt;"> </font>discuss<font style="letter-spacing:1.5pt;"> </font>the<font style="letter-spacing:1.55pt;"> </font>terms,<font style="letter-spacing:1.65pt;"> </font>wages,<font style="letter-spacing:1.65pt;"> </font>and<font style="letter-spacing:1.5pt;"> </font><font style="letter-spacing:-0.1pt;">working</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">conditions<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>their<font style="letter-spacing:-0.2pt;"> </font>employment,<font style="letter-spacing:-0.2pt;"> </font>as<font style="letter-spacing:-0.25pt;"> </font>protected<font style="letter-spacing:-0.1pt;"> </font>by<font style="letter-spacing:-0.35pt;"> </font>applicable<font style="letter-spacing:-0.05pt;"> </font><font style="letter-spacing:-0.2pt;">law.</font></p><div style="margin-top:11.94pt;"></div><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.85pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Former Employer Information</i><font style="font-size:12pt;">. I agree that during my employment with the Company, I will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former or concurrent employer or other person or entity.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">bring</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">onto</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">premises</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">transfer</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">onto</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Company&#8217;s technology</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">systems</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">unpublished</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">document,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">proprietary</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">information,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">trade</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">secrets</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">belonging to any such employer, person, or entity unless consented to in writing by both the Company and such employer, person, or entity.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.1pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><i style="font-size:12pt;font-style:italic;">Third</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-size:12pt;font-style:italic;">Party</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.1pt;"> </i><i style="font-size:12pt;font-style:italic;">Information</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">recognize</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">have</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">received</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">and in the future may receive from third parties associated with the Company, e.g., the Company&#8217;s customers, suppliers, licensors, licensees, partners, or collaborators (&#8220;</font><b style="font-size:12pt;font-weight:bold;">Associated Third Parties</b><font style="font-size:12pt;">&#8221;), their confidential or proprietary information (&#8220;</font><b style="font-size:12pt;font-weight:bold;">Associated Third Party Confidential Information</b><font style="font-size:12pt;">&#8221;). By way of example, Associated Third Party Confidential Information may include the habits or practices of Associated Third Parties, the technology of Associated Third Parties, requirements of Associated Third Parties,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and information related</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">to the business conducted between</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the Company and</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">such</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Parties.</font><font style="font-size:12pt;letter-spacing:1.85pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">at</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">times</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">during</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">employment</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">and thereafter to hold in the strictest confidence, and not to use or to disclose to any person, firm, or corporation,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">Party</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">Confidential</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Information,</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">except</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">necessary</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">carrying</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">out my work for the Company consistent with the Company&#8217;s agreement with such Associated Third Parties.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further agree to comply with any and all Company policies and guidelines that may be adopted</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">from</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">regarding</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Parties</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Associated</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Third</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Party</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Confidential Information.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that my unauthorized use or disclosure of Associated Third Party Confidential Information or violation of any Company policies during my employment may lead to disciplinary action, up to and including immediate termination and legal action by the Company.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_bookmark1"></a></font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Inventions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.65pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Inventions Retained and Licensed</i><font style="font-size:12pt;">. I have attached hereto as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</u><font style="font-size:12pt;">, a list describing all inventions, discoveries, original works of authorship, developments, improvements, and trade secrets that were conceived in whole or in part by me prior to my employment with the Company and to which I</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">have any right,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">title, or interest,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">which are subject to California Labor Code Section 2870 </font><b style="font-size:12pt;font-weight:bold;">(</b><font style="font-size:12pt;">attached hereto as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u><font style="font-size:12pt;">), and which relate to the Company&#8217;s proposed business, products,</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">research</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">development</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">(&#8220;</font><b style="font-size:12pt;font-weight:bold;">Prior</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.65pt;"> </b><b style="font-size:12pt;font-weight:bold;">Inventions</b><font style="font-size:12pt;">&#8221;);</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">or,</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">if</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">no</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">such</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">list</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">is</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">attached,</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">represent and warrant that there are no such Prior Inventions.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Furthermore, I represent and warrant that if any</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Prior</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Inventions</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">are</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">included</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.45pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</u><font style="font-size:12pt;">,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">they</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">materially</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">affect</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">ability</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">perform</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">all obligations under this Agreement.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">If, in the course of my employment with the Company, I incorporate into or use in connection with any product, process, service, technology, or other work by</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">behalf</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Prior</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Invention,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">hereby</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">grant</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">non-exclusive, royalty-free, fully paid-up, irrevocable, perpetual, transferable, worldwide license, with the right to</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0.05pt 8.9pt 12pt 38pt;"><a name="_bookmark2"></a>grant and authorize sublicenses, to make, have made, modify, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Invention without restriction, including, without limitation, as part of or in connection with such product, process, service, technology, or other work, and to practice any method related thereto.</p><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Assignment of Inventions</i><font style="font-size:12pt;">. I agree that I will promptly make full written disclosure</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">hold</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">trust</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">sole</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">right</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">benefit</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">agree to assign and hereby do irrevocably assign to the Company, or its designee, all my right, title, and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">discoveries, ideas,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">trademarks, or trade secrets, whether or not patentable or registrable under patent, copyright, or similar laws, which I may solely or jointly conceive or develop</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">reduce</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">practice,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">cause</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">conceived</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">developed</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">reduced</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">practice,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">during the period of time I am in the employ of the Company (including during my off-duty hours), or with the use of Company&#8217;s equipment, supplies, facilities, or Company Confidential Information, except as provided in Section </font><font style="font-size:12pt;">3</font><font style="font-size:12pt;">.</font><font style="font-size:12pt;">F</font><font style="font-size:12pt;"> below (collectively referred to as &#8220;</font><b style="font-size:12pt;font-weight:bold;">Inventions</b><font style="font-size:12pt;">&#8221;).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further acknowledge that all original works of authorship that are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Company and that are protectable by copyright are &#8220;works made for hire,&#8221; as that term is defined in the United States Copyright Act.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand and agree that the decision whether or not to commercialize or market any Inventions is within the Company&#8217;s sole discretion and for the Company&#8217;s sole benefit, and that no royalty or other</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">consideration</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">due</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">me</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">result</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">Company&#8217;s</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">efforts</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">commercialize</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">market any such Inventions.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.14pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><a name="_bookmark3"></a><i style="font-size:12pt;font-style:italic;">Moral</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-size:12pt;font-style:italic;">Rights</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Any</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">assignment</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Inventions</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">includes</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">world that may be known as or referred to as &#8220;moral rights,&quot; &#8220;artist&#8217;s rights,&quot; &#8220;droit moral,&quot;</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">like</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">(collectively,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Moral</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.3pt;"> </b><b style="font-size:12pt;font-weight:bold;">Rights</b><font style="font-size:12pt;">&#8221;).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">To</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">extent</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Moral</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Rights</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">cannot</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">assigned under applicable law, I hereby waive and agree not to enforce any and all Moral Rights, including, without</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">limitation,</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">right</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">identification</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">authorship</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">limitation</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">subsequent</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">modification that I may have in the assigned Inventions.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">D.</font><i style="font-size:12pt;font-style:italic;">Maintenance of Records</i><font style="font-size:12pt;">. I agree to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by me (solely or jointly with others) during the term of my employment with the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">The records will be in the form of notes, sketches, drawings, electronic files, reports, or any other format that may be specified by the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">The records are and will be available</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">to and remain</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">sole</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">property of the Company at all times.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">E.</font><i style="font-size:12pt;font-style:italic;">Further Assurances</i><font style="font-size:12pt;">. I agree to assist the Company, or its designee, at the Company&#8217;s expense, in every proper way to secure the Company&#8217;s rights in the Inventions and any rights</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">relating</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">thereto</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">countries,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">including</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">disclosure</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">all</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0.05pt 8.75pt 12pt 38pt;"><a name="_bookmark4"></a>pertinent<font style="letter-spacing:-0.6pt;"> </font>information<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>data<font style="letter-spacing:-0.65pt;"> </font>with<font style="letter-spacing:-0.6pt;"> </font>respect<font style="letter-spacing:-0.6pt;"> </font>thereto,<font style="letter-spacing:-0.6pt;"> </font>the<font style="letter-spacing:-0.5pt;"> </font>execution<font style="letter-spacing:-0.6pt;"> </font>of<font style="letter-spacing:-0.55pt;"> </font>all<font style="letter-spacing:-0.5pt;"> </font>applications,<font style="letter-spacing:-0.55pt;"> </font>specifications, oaths, assignments, and all other instruments that the Company shall deem proper or necessary in order<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>apply<font style="letter-spacing:-0.25pt;"> </font>for,<font style="letter-spacing:-0.05pt;"> </font>register,<font style="letter-spacing:-0.1pt;"> </font>obtain,<font style="letter-spacing:-0.2pt;"> </font>maintain,<font style="letter-spacing:-0.2pt;"> </font>defend,<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>enforce<font style="letter-spacing:-0.2pt;"> </font>such<font style="letter-spacing:-0.15pt;"> </font>rights,<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>order<font style="letter-spacing:-0.3pt;"> </font>to<font style="letter-spacing:-0.15pt;"> </font>assign and<font style="letter-spacing:-0.4pt;"> </font>convey<font style="letter-spacing:-0.45pt;"> </font>to<font style="letter-spacing:-0.55pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>Company,<font style="letter-spacing:-0.45pt;"> </font>its<font style="letter-spacing:-0.45pt;"> </font>successors,<font style="letter-spacing:-0.45pt;"> </font>assigns,<font style="letter-spacing:-0.45pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>nominees<font style="letter-spacing:-0.55pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>sole<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>exclusive<font style="letter-spacing:-0.45pt;"> </font>rights,<font style="letter-spacing:-0.45pt;"> </font>title, and<font style="letter-spacing:-0.4pt;"> </font>interest<font style="letter-spacing:-0.35pt;"> </font>in<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>to<font style="letter-spacing:-0.4pt;"> </font>such<font style="letter-spacing:-0.25pt;"> </font>Inventions<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>any<font style="letter-spacing:-0.45pt;"> </font>rights<font style="letter-spacing:-0.35pt;"> </font>relating<font style="letter-spacing:-0.45pt;"> </font>thereto,<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>testifying<font style="letter-spacing:-0.45pt;"> </font>in<font style="letter-spacing:-0.4pt;"> </font>a<font style="letter-spacing:-0.3pt;"> </font>suit<font style="letter-spacing:-0.4pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>other proceeding relating to such Inventions and any rights relating thereto.<font style="letter-spacing:2pt;"> </font>I further agree that my obligations under this Section 3E shall continue after the termination of this Agreement.<font style="letter-spacing:2pt;"> </font>If the Company<font style="letter-spacing:-0.45pt;"> </font>is<font style="letter-spacing:-0.45pt;"> </font>unable<font style="letter-spacing:-0.55pt;"> </font>because<font style="letter-spacing:-0.4pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>my<font style="letter-spacing:-0.45pt;"> </font>mental<font style="letter-spacing:-0.4pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>physical<font style="letter-spacing:-0.3pt;"> </font>incapacity<font style="letter-spacing:-0.45pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>for<font style="letter-spacing:-0.4pt;"> </font>any<font style="letter-spacing:-0.6pt;"> </font>other<font style="letter-spacing:-0.4pt;"> </font>reason<font style="letter-spacing:-0.4pt;"> </font>to<font style="letter-spacing:-0.4pt;"> </font>secure<font style="letter-spacing:-0.4pt;"> </font>my signature<font style="letter-spacing:-0.05pt;"> </font>with<font style="letter-spacing:-0.05pt;"> </font>respect<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>any<font style="letter-spacing:-0.1pt;"> </font>Inventions,<font style="letter-spacing:-0.1pt;"> </font>including, without<font style="letter-spacing:-0.05pt;"> </font>limitation,<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>apply<font style="letter-spacing:-0.1pt;"> </font>for<font style="letter-spacing:-0.05pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.05pt;"> </font>pursue<font style="letter-spacing:-0.05pt;"> </font>any application for any United States or foreign patents or copyright registrations covering such Inventions, then I hereby irrevocably designate and appoint the Company and its duly authorized officers<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.65pt;"> </font>agents<font style="letter-spacing:-0.55pt;"> </font>as<font style="letter-spacing:-0.55pt;"> </font>my<font style="letter-spacing:-0.7pt;"> </font>agent<font style="letter-spacing:-0.6pt;"> </font>and<font style="letter-spacing:-0.6pt;"> </font>attorney<font style="letter-spacing:-0.55pt;"> </font>in<font style="letter-spacing:-0.65pt;"> </font>fact,<font style="letter-spacing:-0.55pt;"> </font>to<font style="letter-spacing:-0.55pt;"> </font>act<font style="letter-spacing:-0.5pt;"> </font>for<font style="letter-spacing:-0.6pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>in<font style="letter-spacing:-0.5pt;"> </font>my<font style="letter-spacing:-0.7pt;"> </font>behalf<font style="letter-spacing:-0.45pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>stead,<font style="letter-spacing:-0.55pt;"> </font>to<font style="letter-spacing:-0.65pt;"> </font>execute and file any papers and oaths, and to do all other lawfully permitted acts with respect to such Inventions with the same legal force and effect as if executed by me.</p><div style="margin-top:12pt;"></div><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">F.</font><a name="_bookmark5"></a><i style="font-size:12pt;font-style:italic;">Exception to Assignments</i><font style="font-size:12pt;">. I understand</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">that the</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">provisions</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of this</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Agreement requiring</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">assignment</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Inventions</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">do</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">apply</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">invention</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">qualifies</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">fully under the provisions of California Labor Code Section 2870 (attached hereto as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u><font style="font-size:12pt;">).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I will advise</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">promptly</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">writing</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">inventions</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">believe</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">meet</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">criteria</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">California Labor Code Section 2870 and are not otherwise disclosed on </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:12pt;">.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">4.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Conflicting</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.35pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Employment</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Current Obligations. </i><font style="font-size:12pt;">I agree that during the term of my</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employment with the Company, I will not engage in or undertake any other employment, occupation, consulting relationship, or commitment that is directly related to the business in which the Company is now involved or becomes involved or has plans to become involved, nor will I engage in any other activities that conflict with my obligations to the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.05pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;font-style:italic;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Prior Relationships</i><font style="font-size:12pt;">. Without limiting Section 4.A, I represent that I have no other</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">agreements,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">relationships,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">commitments</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">other</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">person</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">entity</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">conflict</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">my obligations to the Company under this Agreement or my ability to become employed and perform the services for which I am being hired by the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I further agree that if I have signed a confidentiality agreement or similar type of agreement with any former employer or other entity, I will comply with the terms of any such agreement to the extent that its terms are lawful under applicable law.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I represent and warrant that after undertaking a careful search (including searches of my computers, cell phones, electronic devices,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and documents), I have returned all</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">property and confidential information belonging to all prior employers.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Moreover, I agree to fully indemnify the Company, its directors, officers, agents, employees, investors, shareholders, administrators, affiliates,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">divisions,</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">subsidiaries,</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">predecessor</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">successor</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">corporations,</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">assigns</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">verdicts, judgments, settlements, and other losses incurred by any of them resulting from my breach of my obligations</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">under any</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">agreement</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">am</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">party</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">obligation</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">am</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">bound,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">well</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;letter-spacing:-0.25pt;">as</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 0pt 12pt 38pt;">any<font style="letter-spacing:1.25pt;"> </font>reasonable<font style="letter-spacing:1.25pt;"> </font>attorneys&#8217;<font style="letter-spacing:1.3pt;"> </font>fees<font style="letter-spacing:1.3pt;"> </font>and<font style="letter-spacing:1.2pt;"> </font>costs<font style="letter-spacing:1.3pt;"> </font>if<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.25pt;"> </font>plaintiff<font style="letter-spacing:1.4pt;"> </font>is<font style="letter-spacing:1.15pt;"> </font>the<font style="letter-spacing:1.25pt;"> </font>prevailing<font style="letter-spacing:1.15pt;"> </font>party<font style="letter-spacing:1.3pt;"> </font>in<font style="letter-spacing:1.35pt;"> </font>such<font style="letter-spacing:1.4pt;"> </font>an<font style="letter-spacing:1.4pt;"> </font><font style="letter-spacing:-0.1pt;">action,</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">except<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.25pt;"> </font>prohibited<font style="letter-spacing:-0.2pt;"> </font>by<font style="letter-spacing:-0.1pt;"> </font><font style="letter-spacing:-0.2pt;">law.</font></p><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">5.</font><i style="font-size:12pt;font-style:italic;">Returning Company Documents</i><font style="font-size:12pt;">. Upon separation from employment with the Company or on demand by the Company during my employment, I will immediately deliver to the Company, and will not keep in my possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Company Confidential Information, Associated Third</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">Party</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Confidential</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">Information,</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">well</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">devices</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">equipment</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">belonging</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">Company (including computers, handheld electronic devices, telephone equipment, and other electronic devices), Company credit cards, records, data, notes, notebooks, reports, files, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, photographs, charts, any other documents and property, and reproductions of any and all of the aforementioned items that were developed by me pursuant to my employment with the Company, obtained by me in connection with my employment with the Company, or otherwise belonging to the Company, its successors,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">assigns,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">including,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">without</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">limitation,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">those</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">records</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">maintained</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">pursuant</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">to Section </font><font style="font-size:12pt;">3.C</font><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I also consent to an exit interview to confirm my compliance with this Section 5.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:12.05pt 9.1pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">6.</font><i style="font-size:12pt;font-style:italic;">Termination Certification. </i><font style="font-size:12pt;">Upon separation from employment with the Company, I agree to immediately sign and deliver to the Company the &#8220;Termination Certification&#8221; attached hereto</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">as</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.15pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">C</u><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">also</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">keep</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">advised</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">home</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">business</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">address</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">for a period of three (3) years after termination of my employment with the Company, so that the Company can contact me regarding my continuing obligations provided by this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 10.95pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">7.</font><i style="font-size:12pt;font-style:italic;">Notification</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-size:12pt;font-style:italic;">of</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.1pt;"> </i><i style="font-size:12pt;font-style:italic;">New</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.15pt;"> </i><i style="font-size:12pt;font-style:italic;">Employer</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">In</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">event</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">leave</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">employ</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">I hereby grant consent to notification by the Company to my new employer about my obligations under this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:12.1pt 8.95pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">8.</font><i style="font-size:12pt;font-style:italic;">Solicitation</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.4pt;"> </i><i style="font-size:12pt;font-style:italic;">of</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.3pt;"> </i><i style="font-size:12pt;font-style:italic;">Employees</i><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">agree</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">period</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">twelve</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">(12)</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">months</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">immediately following the termination of my relationship with the Company for any reason, whether voluntary or involuntary, with or without cause, I shall not either directly or indirectly solicit any of the Company&#8217;s employees</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to leave</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">their</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employment, or attempt to solicit</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">employees of</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">the Company, either for myself or for any other person or entity.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I agree that nothing in this Section 8 shall affect my continuing obligations under this Agreement during and after this twelve (12) month period, including, without limitation, my obligations under Section 2A.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:11.94pt 8.85pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">9.</font><i style="font-size:12pt;font-style:italic;">Conflict of Interest Guidelines</i><font style="font-size:12pt;">. I agree to diligently adhere to all policies of the Company, including the Company&#8217;s insider&#8217;s trading policies and the Company&#8217;s Conflict of Interest Guidelines.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">A copy</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">of the Company&#8217;s current Conflict of Interest Guidelines is attached as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u><u style="font-size:12pt;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">D</u><font style="font-size:12pt;"> hereto,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">but</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">understand</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">these</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Conflict</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Interest</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Guidelines</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">revised</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">from</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">time during my employment.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:0.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:35.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:35.85pt;text-indent:0pt;white-space:nowrap;">10.</font><i style="font-size:12pt;font-style:italic;">Representations</i><font style="font-size:12pt;">. I agree to execute any proper oath or verify any proper document required</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">carry</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">out</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">terms</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">Agreement.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">represent</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">performance</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">terms of</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Agreement</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">not</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">breach</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">agreement</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">keep</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">confidence</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">acquired</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">me in confidence or in trust</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">prior to my employment by the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I hereby represent and warrant that I have not entered into, and I will not enter into, any oral or written agreement in conflict </font><font style="font-size:12pt;letter-spacing:-0.1pt;">herewith.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 12.95pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">11.</font><i style="font-size:12pt;font-style:italic;">Audit. </i><font style="font-size:12pt;">I acknowledge that I have no reasonable expectation of privacy in any computer, technology system, email, handheld device, telephone, or documents that are used to conduct the business of the Company.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">As such, the Company has the right to audit and search all such items and systems, without further notice to me, to ensure that the Company is licensed to use the software on the Company&#8217;s devices in compliance with the Company&#8217;s software licensing policies, to ensure compliance with the Company&#8217;s policies, and for any other business-related purposes in the Company&#8217;s sole discretion.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that I am not permitted to add any unlicensed, unauthorized, or non-compliant applications to the Company&#8217;s technology systems, including, without limitation, open source or free software not authorized by the Company, and that I shall refrain from copying unlicensed software onto the Company&#8217;s technology systems or using non-licensed software or websites.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I understand that it is my responsibility to comply with the Company&#8217;s policies governing use of the Company&#8217;s documents and the internet, email, telephone,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">technology</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">systems</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">which</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">will have</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">access</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">connection</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">my</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">employment.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">12.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Arbitration</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.3pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">and</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.25pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">Equitable</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.15pt;"> </i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;">Relief</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Arbitration</i><font style="font-size:12pt;">. IN CONSIDERATION OF MY EMPLOYMENT WITH THE COMPANY, ITS PROMISE TO ARBITRATE ALL EMPLOYMENT-RELATED DISPUTES, AND MY RECEIPT OF THE COMPENSATION, PAY RAISES, AND OTHER BENEFITS PAID TO ME BY THE COMPANY, AT PRESENT AND IN THE FUTURE, I AGREE THAT ANY AND ALL CONTROVERSIES, CLAIMS, OR DISPUTES WITH ANYONE</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">(INCLUDING</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">THE COMPANY AND ANY EMPLOYEE,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">OFFICER, DIRECTOR, SHAREHOLDER, OR BENEFIT</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">PLAN</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">COMPANY,</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">IN</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">THEIR</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">CAPACITY</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">SUCH</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">OTHERWISE),</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">WHETHER</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">BROUGHT ON</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">AN</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">INDIVIDUAL,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">GROUP,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">CLASS</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">BASIS,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">ARISING</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">OUT</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">OF,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">RELATING</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">TO,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">RESULTING</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">FROM MY EMPLOYMENT WITH THE COMPANY OR THE TERMINATION OF MY EMPLOYMENT WITH THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION UNDER THE ARBITRATION RULES SET FORTH IN CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 1280 THROUGH 1294.2, INCLUDING SECTION 1281.8 (THE &#8220;</font><b style="font-size:12pt;font-weight:bold;">ACT</b><font style="font-size:12pt;">&#8221;), AND PURSUANT</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">CALIFORNIA</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">LAW.</font><font style="font-size:12pt;letter-spacing:1.8pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">FEDERAL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">ARBITRATION</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">ACT</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">SHALL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">CONTINUE</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">APPLY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">WITH FULL</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">FORCE</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">EFFECT</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">NOTWITHSTANDING</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">APPLICATION</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">PROCEDURAL</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">RULES</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">SET</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">FORTH IN</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">ACT.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">DISPUTES</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">THAT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AGREE</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">ARBITRATE,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THEREBY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">AGREE</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">WAIVE</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">RIGHT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">TO A TRIAL BY JURY, INCLUDE ANY STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW, INCLUDING, BUT NOT LIMITED</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">TO, CLAIMS UNDER TITLE VII OF THE CIVIL</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">RIGHTS ACT OF 1964, THE AMERICANS WITH DISABILITIES ACT OF 1990, THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE OLDER WORKERS BENEFIT PROTECTION ACT, THE SARBANES-OXLEY ACT, THE WORKER ADJUSTMENT</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">RETRAINING</font><font style="font-size:12pt;letter-spacing:2pt;"> </font></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:0pt;margin:0pt 8.7pt 0pt 38pt;"><font style="font-size:12pt;">NOTIFICATION</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">ACT,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">CALIFORNIA</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">FAIR</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">EMPLOYMENT</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">AND</font></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0.05pt 8.8pt 12pt 38pt;">HOUSING ACT, THE FAMILY AND MEDICAL LEAVE ACT, THE CALIFORNIA FAMILY RIGHTS ACT, THE CALIFORNIA LABOR CODE, CLAIMS OF HARASSMENT, DISCRIMINATION, AND WRONGFUL TERMINATION, AND ANY STATUTORY OR COMMON LAW CLAIMS.<font style="letter-spacing:2pt;"> </font>I FURTHER UNDERSTAND THAT THIS AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH ME.</p><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.75pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Procedure</i><font style="font-size:12pt;">. I AGREE THAT ANY ARBITRATION WILL BE ADMINISTERED BY JUDICIAL ARBITRATION &amp; MEDIATION SERVICES, INC. (&#8220;</font><b style="font-size:12pt;font-weight:bold;">JAMS</b><font style="font-size:12pt;">&#8221;), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &amp; PROCEDURES (THE &#8220;</font><b style="font-size:12pt;font-weight:bold;">JAMS RULES</b><font style="font-size:12pt;">&#8221;).</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND/OR ADJUDICATION, MOTIONS TO DISMISS </font><font style="font-size:12pt;letter-spacing:-0.1pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">DEMURRERS,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">MOTIONS</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">FOR</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">CLASS</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">CERTIFICATION,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">PRIOR</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">ANY ARBITRATION HEARING. </font><font style="font-size:12pt;">I ALSO AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">APPLICABLE LAW, AND THAT</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">THE ARBITRATOR</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">SHALL</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">AWARD ATTORNEYS&#8217; FEES AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">COSTS</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">PREVAILING</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PARTY,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">EXCEPT</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PROHIBITED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">BY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">LAW.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">AGREE</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THAT</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">DECREE OR</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">AWARD</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">RENDERED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">BY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ARBITRATOR</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">MAY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ENTERED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">A</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">FINAL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">BINDING</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">JUDGMENT IN</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">COURT</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">HAVING</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">JURISDICTION</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THEREOF.</font><font style="font-size:12pt;letter-spacing:1.8pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">UNDERSTAND</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THAT</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">COMPANY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">WILL</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">PAY</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">FOR ANY ADMINISTRATIVE OR HEARING FEES CHARGED BY THE ARBITRATOR OR JAMS EXCEPT THAT I SHALL PAY ANY FILING FEES ASSOCIATED WITH ANY ARBITRATION THAT I INITIATE, BUT ONLY SO MUCH</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">FILING</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FEES</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">WOULD HAVE</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">INSTEAD</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">PAID</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">HAD</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FILED</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">A</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">COMPLAINT</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">IN</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">A</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">COURT OF LAW.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THAT THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO RULES OF CONFLICT OF LAW.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT THE DECISION OF THE ARBITRATOR SHALL BE IN WRITING.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I AGREE THAT</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">ARBITRATION</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">UNDER</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">AGREEMENT</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">SHALL</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">CONDUCTED</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">IN</font><font style="font-size:12pt;letter-spacing:-0.5pt;"> </font><font style="font-size:12pt;">SANTA</font><font style="font-size:12pt;letter-spacing:-0.6pt;"> </font><font style="font-size:12pt;">CLARA</font><font style="font-size:12pt;letter-spacing:-0.55pt;"> </font><font style="font-size:12pt;">COUNTY, </font><font style="font-size:12pt;letter-spacing:-0.1pt;">CALIFORNIA.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.1pt 8.8pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><i style="font-size:12pt;font-style:italic;">Remedy</i><font style="font-size:12pt;">. EXCEPT AS PROVIDED BY THE ACT AND THIS AGREEMENT, ARBITRATION SHALL</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">THE SOLE,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">EXCLUSIVE,</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FINAL</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">REMEDY</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">FOR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">DISPUTE BETWEEN</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">ME AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">COMPANY.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">ACCORDINGLY,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">EXCEPT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AS</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">PROVIDED</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">FOR</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">BY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">ACT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AGREEMENT, NEITHER</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">I</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">NOR</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">COMPANY</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">WILL</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">BE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PERMITTED</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">TO</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">PURSUE</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">COURT</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ACTION</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">REGARDING</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">CLAIMS THAT ARE SUBJECT TO ARBITRATION.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12pt 8.8pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">D.</font><i style="font-size:12pt;font-style:italic;">Administrative Relief</i><font style="font-size:12pt;">. I UNDERSTAND THAT THIS AGREEMENT DOES NOT PROHIBIT ME FROM PURSUING AN ADMINISTRATIVE CLAIM WITH A LOCAL, STATE, OR FEDERAL ADMINISTRATIVE BODY OR GOVERNMENT AGENCY THAT IS AUTHORIZED TO ENFORCE OR ADMINISTER LAWS RELATED TO EMPLOYMENT, </font></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:0pt;margin:12pt 8.8pt 0pt 38pt;"><font style="font-size:12pt;">INCLUDING, BUT NOT LIMITED TO, THE DEPARTMENT OF FAIR EMPLOYMENT AND HOUSING, THE EQUAL EMPLOYMENT OPPORTUNITY COMMISSION,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">NATIONAL</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">LABOR</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">RELATIONS</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">BOARD,</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">WORKERS&#8217;</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">COMPENSATION</font></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 9.8pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.05pt 9.8pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;">BOARD.</font><font style="display:inline-block;width:32.26pt;"></font>THIS<font style="letter-spacing:2pt;"> </font>AGREEMENT<font style="letter-spacing:2pt;"> </font>DOES,<font style="letter-spacing:2pt;"> </font>HOWEVER,<font style="letter-spacing:2pt;"> </font>PRECLUDE<font style="letter-spacing:2pt;"> </font>ME<font style="letter-spacing:2pt;"> </font>FROM<font style="letter-spacing:2pt;"> </font>PURSUING<font style="letter-spacing:2pt;"> </font>COURT<font style="letter-spacing:2pt;"> </font>ACTION REGARDING ANY SUCH CLAIM, EXCEPT AS PERMITTED BY LAW.</p><div style="margin-top:11.94pt;"></div><div style="margin-top:11.94pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">E.</font><i style="font-size:12pt;font-style:italic;">Voluntary Nature of Agreement</i><font style="font-size:12pt;">. I ACKNOWLEDGE AND AGREE THAT I AM EXECUTING</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">AGREEMENT</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">VOLUNTARILY</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">WITHOUT</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">ANY</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">DURESS</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">OR</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">UNDUE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">INFLUENCE</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">BY THE COMPANY OR ANYONE ELSE.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">I FURTHER ACKNOWLEDGE AND AGREE THAT I HAVE CAREFULLY READ THIS AGREEMENT AND THAT I HAVE ASKED ANY QUESTIONS NEEDED FOR ME TO UNDERSTAND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">THE</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">TERMS,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">CONSEQUENCES,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">BINDING</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">EFFECT</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">OF</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">THIS</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">AGREEMENT</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">AND</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">FULLY UNDERSTAND IT, INCLUDING THAT </font><font style="font-size:12pt;font-style:italic;font-weight:bold;">I AM WAIVING MY RIGHT TO A JURY TRIAL</font><font style="font-size:12pt;">.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">FINALLY, I AGREE THAT I HAVE BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF MY CHOICE BEFORE SIGNING THIS AGREEMENT.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12.1pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">13.</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;">General</i><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;font-weight:normal;letter-spacing:-0.1pt;"> Provisions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">.</font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.7pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">A.</font><i style="font-size:12pt;font-style:italic;">Governing Law; Consent to Personal Jurisdiction</i><font style="font-size:12pt;">. This Agreement will be governed by the laws of the State of California without giving effect to any choice-of-law rules or principles that may result in the application of the laws of any jurisdiction other than California.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">To the extent that any lawsuit is permitted under this Agreement, I hereby expressly consent to the personal</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">exclusive</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">jurisdiction</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">venue</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">state</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">federal</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">courts</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">located</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">California</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">for any lawsuit filed against me by the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.9pt;text-indent:0pt;white-space:nowrap;">B.</font><i style="font-size:12pt;font-style:italic;">Entire Agreement</i><font style="font-size:12pt;">. This Agreement,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">together</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">with the Exhibits herein and</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">any executed</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">written</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">offer</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">letter between</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">me</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">Company,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">extent</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">such materials</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">are</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">not in conflict with this Agreement, sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein and supersedes all prior discussions or representations between us, including, but not limited to, any representations made during my interview(s) or relocation negotiations, whether</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">written or oral.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">signed</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">President</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">CEO</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">me.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Any</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">subsequent</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">change</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">changes in my duties, salary, or compensation will not affect the validity or scope of this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12.05pt 9.05pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">C.</font><i style="font-size:12pt;font-style:italic;">Severability</i><font style="font-size:12pt;">. If one or more of the provisions in this Agreement are deemed void by law, then the remaining provisions will continue in full force and effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12pt 8.95pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">D.</font><i style="font-size:12pt;font-style:italic;">Successors and Assigns</i><font style="font-size:12pt;">. This Agreement will be binding upon my heirs, executors,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">assigns,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">administrators,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">other</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">legal</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">representatives,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">and</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">will</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">for</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">benefit</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">the Company, its successors, and its assigns.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">There are no intended third-party beneficiaries to this Agreement,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">except</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">as expressly</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">stated.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">Notwithstanding</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">anything</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">the contrary</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">herein,</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">substantially</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">all</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">Company&#8217;s</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">relevant</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">assets,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">whether</font><font style="font-size:12pt;letter-spacing:-0.45pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">merger,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">consolidation,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">sale</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">assets or stock, or otherwise.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:0.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:0pt 8.9pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">E.</font><i style="font-size:12pt;font-style:italic;">Waiver.</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.7pt;"> </i><font style="font-size:12pt;">Waiver</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">by</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">breach</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">provision</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.65pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.7pt;"> </font><font style="font-size:12pt;">Agreement will not operate as a waiver of any other or subsequent breach.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:11.94pt 9.05pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">F.</font><i style="font-size:12pt;font-style:italic;">Survivorship. </i><font style="font-size:12pt;">The rights and obligations of the parties to this Agreement will survive termination of my employment with the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:71.95pt;margin:12pt 8.95pt 0pt 38pt;"><font style="display:inline-block;font-size:12pt;min-width:35.95pt;text-indent:0pt;white-space:nowrap;">G.</font><i style="font-size:12pt;font-style:italic;">Signatures.</i><i style="font-size:12pt;font-style:italic;letter-spacing:-0.3pt;"> </i><font style="font-size:12pt;">This</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Agreement</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">may</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">signed</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">two</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">counterparts,</font><font style="font-size:12pt;letter-spacing:-0.4pt;"> </font><font style="font-size:12pt;">each</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">which shall be deemed an original, with the same force and effectiveness as though executed in a single </font><font style="font-size:12pt;letter-spacing:-0.1pt;">document.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p><div style="white-space:nowrap;"><div style="display:inline-block;padding-right:0.19%;vertical-align:top;white-space:normal;width:48.13%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:9.25pt 0pt 0pt 38pt;"><font style="font-size:12pt;vertical-align:sub;">Date:</font><font style="font-size:12pt;letter-spacing:-0.1pt;vertical-align:sub;"> </font><font style="letter-spacing:-0.1pt;">05/02/2022</font></p></div><div style="display:inline-block;padding-left:0.19%;vertical-align:top;white-space:normal;width:51.49%;"><p style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;line-height:17.5pt;margin:0pt;"><i style="text-decoration-color:#000000;text-decoration-line:none;"> </i><font style="font-size:17.5pt;text-decoration-color:#000000;text-decoration-line:none;visibility:hidden;">&#8203;</font></p><p style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;line-height:17.5pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:17.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.34pt 0pt 12pt 31.5pt;"><font style="letter-spacing:-0.1pt;">/s/Renae Cormier</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.34pt 0pt 12pt 31.5pt;"><font style="letter-spacing:-0.1pt;">Signature</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:1.89pt 0pt 0pt 33.45pt;"><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Renae</u><u style="font-size:12pt;letter-spacing:1.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u><u style="font-size:12pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cormier</u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:155.18pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:2.15pt 0pt 12pt 31.5pt;">Name<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.1pt;"> </font>Employee<font style="letter-spacing:-0.05pt;"> </font>(typed<font style="letter-spacing:-0.05pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">printed)</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:6.65pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0pt 38pt;"><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</b><font style="font-size:12pt;letter-spacing:-0.1pt;">:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">/S/ Lora Kelly</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;">Signature</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.1pt 278.85pt 12pt 38pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lora Kelly, Human Resources Generalist</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u> Name (typed or printed)</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;min-height:75.05pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.4pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:11.94pt 87.45pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">LIST</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-size:12pt;font-weight:bold;">OF</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-size:12pt;font-weight:bold;">PRIOR</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> INVENTIONS</b></p><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:7.88%;max-width:92.12%;position:absolute;top:74.55pt;width:157.7pt;z-index:251658240;"><div style="height:0.5pt;left:0pt;padding-bottom:0pt;position:relative;width:157.7pt;"><img src="smlr-20241231xex19d1011.jpg" alt="Graphic" style="height:0.5pt;width:157.7pt;"></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 87.65pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;">AND</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-size:12pt;font-weight:bold;">ORIGINAL</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;"> </b><b style="font-size:12pt;font-weight:bold;">WORKS</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.2pt;"> </b><b style="font-size:12pt;font-weight:bold;">OF</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.1pt;">AUTHORSHIP</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:7.65pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><div style="padding-left:73.9pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:85.16%;"><tr style="height:28.3pt;"><td style="vertical-align:top;width:28.56%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:12.19pt 0pt 0pt 36.55pt;"><font style="font-size:12pt;letter-spacing:-0.1pt;">Title</font></p></td><td style="position:relative;vertical-align:top;width:30.47%;margin:0pt;padding:0pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:3.18%;max-width:96.82%;position:absolute;top:27.85pt;width:157.7pt;z-index:251660288;"><div style="height:0.5pt;left:0pt;padding-bottom:0pt;position:relative;width:157.7pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:0pt;position:absolute;width:157.65pt;"><img src="smlr-20241231xex19d1011.jpg" alt="Graphic" style="height:0.5pt;width:157.65pt;"></div></div></div></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:12.19pt 0pt 0pt 71.55pt;"><font style="font-size:12pt;letter-spacing:-0.2pt;">Date</font></p></td><td style="position:relative;vertical-align:top;width:40.96%;margin:0pt;padding:0pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:17.05%;max-width:82.95%;position:absolute;top:27.85pt;width:157.7pt;z-index:251662336;"><div style="height:0.5pt;left:0pt;padding-bottom:0pt;position:relative;width:157.7pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.5pt;left:0pt;position:absolute;width:157.65pt;"><img src="smlr-20241231xex19d1011.jpg" alt="Graphic" style="height:0.5pt;width:157.65pt;"></div></div></div></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:12.2pt;text-align:center;margin:0pt 0.05pt 0pt 34.85pt;"><font style="font-size:12pt;">Identifying</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">Number</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;letter-spacing:-0.1pt;">Brief</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;text-align:center;margin:0pt 0pt 0pt 34.85pt;"><font style="font-size:12pt;letter-spacing:-0.1pt;">Description</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:11.64pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;min-height:24.05pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.1pt;left:7.13%;max-width:92.87%;position:absolute;top:17pt;width:12pt;z-index:251664384;"><div style="height:0.1pt;left:0pt;padding-bottom:0pt;position:relative;width:12pt;"><img src="smlr-20241231xex19d1014.jpg" alt="Graphic" style="height:0.1pt;width:12pt;"></div></div></div><div style="height:0pt;position:relative;width:100%;"><div style="height:12pt;left:7.38%;max-width:92.62%;position:absolute;top:2.1pt;width:12pt;z-index:-9223372036603109376;"><div style="height:10pt;left:0pt;padding-bottom:2pt;position:relative;width:10pt;"><img src="smlr-20241231xex19d1015.jpg" alt="Graphic" style="height:10pt;width:10pt;"></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 39.8pt;"><font style="font-family:'MS Gothic';font-size:10.5pt;vertical-align:super;">&#10004;</font>_<font style="letter-spacing:-0.2pt;"> </font>No<font style="letter-spacing:-0.2pt;"> </font>inventions<font style="letter-spacing:-0.3pt;"> </font>or<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.1pt;">improvements</font></p><div style="height:0pt;position:relative;width:100%;"><div style="height:12pt;left:7.67%;max-width:92.33%;position:absolute;top:12.05pt;width:12pt;z-index:-9223372036603107328;"><div style="height:10pt;left:0pt;padding-bottom:2pt;position:relative;width:10pt;"><img src="smlr-20241231xex19d1015.jpg" alt="Graphic" style="height:10pt;width:10pt;"></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:34pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u>Additional<font style="letter-spacing:-0.35pt;"> </font>Sheets<font style="letter-spacing:-0.35pt;"> </font><font style="letter-spacing:-0.1pt;">Attached</font></p><p style="font-family:'Gill Sans MT';font-size:18pt;font-style:italic;line-height:17.55pt;margin:21.7pt 0pt 0pt 154pt;"><font style="font-size:17.55pt;line-height:17.5pt;margin-left:0pt;text-decoration-color:#000000;text-decoration-line:none;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:11.35pt;margin:0pt 0pt 0pt 38pt;"><font style="font-size:12pt;">Signature</font><font style="font-size:12pt;letter-spacing:0.1pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:0.2pt;"> </font><font style="font-size:12pt;">Employee</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">:</u><u style="font-size:12pt;letter-spacing:0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> /S/ Renae Cormier</u><u style="color:#1372e5;font-size:6.5pt;text-decoration-color:#1372e5;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:63.46pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:1.29pt 0pt 0pt 38pt;"><font style="font-size:12pt;">Print</font><font style="font-size:12pt;letter-spacing:0.1pt;"> </font><font style="font-size:12pt;">Name</font><font style="font-size:12pt;letter-spacing:0.2pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:0.2pt;"> </font><font style="font-size:12pt;">Employee:</font><font style="font-size:12pt;letter-spacing:2.3pt;"> </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;">Renae</u><u style="font-size:12pt;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;"> </u><u style="font-size:12pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;">Cormier</u><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;vertical-align:super;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:72.81pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p><div style="white-space:nowrap;"><div style="display:inline-block;padding-right:0.19%;vertical-align:top;white-space:normal;width:12.08%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12pt 0pt 12pt 38pt;"><font style="letter-spacing:-0.1pt;">DDate:</font></p></div><div style="display:inline-block;padding-left:0.19%;vertical-align:top;white-space:normal;width:87.54%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:7.69pt 0pt 0pt 3pt;"><font style="font-size:12pt;letter-spacing:-0.1pt;">05/02/2002</font></p><div style="height:0.85pt;left:12.58%;max-width:85.63%;position:relative;top:0pt;width:244.65pt;z-index:-9223372036603105280;"><div style="height:0.85pt;left:0pt;padding-bottom:0pt;position:relative;width:244.65pt;"><img src="smlr-20241231xex19d1017.jpg" alt="Graphic" style="height:0.85pt;width:244.65pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.6pt 0pt 12pt 0pt;"><font style="font-size:1.5pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div></div></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.45pt 0pt 116.45pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">B</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:48.5pt;margin:11.94pt 95.45pt 0pt 132.2pt;"><b style="font-size:12pt;font-weight:bold;">CALIFORNIA LABOR CODE SECTION 2870 INVENTION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">ON</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">OWN</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">TIME-EXEMPTION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">FROM</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.4pt;"> </b><b style="font-size:12pt;font-weight:bold;">AGREEMENT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 19pt 12pt 38pt;"><font style="display:inline-block;text-indent:0pt;width:36.05pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;">&#8220;(a)</font></font>Any<font style="letter-spacing:-0.2pt;"> </font>provision<font style="letter-spacing:-0.25pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>an<font style="letter-spacing:-0.25pt;"> </font>employment<font style="letter-spacing:-0.25pt;"> </font>agreement<font style="letter-spacing:-0.25pt;"> </font>which<font style="letter-spacing:-0.15pt;"> </font>provides<font style="letter-spacing:-0.3pt;"> </font>that<font style="letter-spacing:-0.25pt;"> </font>an<font style="letter-spacing:-0.25pt;"> </font>employee<font style="letter-spacing:-0.15pt;"> </font>shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply<font style="letter-spacing:-0.1pt;"> </font>to an invention that the employee developed entirely on his<font style="letter-spacing:-0.05pt;"> </font>or her own time without using the employer&#8217;s equipment, supplies, facilities, or trade secret information except for those inventions that either:</p><div style="margin-top:12.1pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:71.95pt;margin:0pt 18.2pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">(1)</font><font style="font-size:12pt;">Relate</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">at</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">time</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">conception</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">reduction</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">practice</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">invention</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer; or</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:110pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Result</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">from</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">work</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">performed</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">by</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">employee for the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> employer.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 33.7pt 12pt 38pt;"><font style="display:inline-block;text-indent:0pt;width:36.05pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;">(b)</font></font>To the extent a provision in an employment agreement purports to require an employee<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>assign<font style="letter-spacing:-0.2pt;"> </font>an<font style="letter-spacing:-0.15pt;"> </font>invention<font style="letter-spacing:-0.1pt;"> </font>otherwise<font style="letter-spacing:-0.2pt;"> </font>excluded<font style="letter-spacing:-0.15pt;"> </font>from<font style="letter-spacing:-0.15pt;"> </font>being<font style="letter-spacing:-0.2pt;"> </font>required<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>be<font style="letter-spacing:-0.1pt;"> </font>assigned<font style="letter-spacing:-0.15pt;"> </font>under subdivision (a), the provision is against the public policy of this state and is unenforceable.&#8221;</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:13.69pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.4pt 0pt 116.5pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">C</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:2.15;text-indent:14.4pt;margin:11.94pt 176.25pt 0pt 205.55pt;"><b style="font-size:12pt;font-weight:bold;">SEMLER SCIENTIFIC, INC. TERMINATION</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.7pt;"> </b><b style="font-size:12pt;font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 0pt 12pt 38pt;">This<font style="letter-spacing:-0.1pt;"> </font>is<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>certify<font style="letter-spacing:-0.1pt;"> </font>that<font style="letter-spacing:-0.15pt;"> </font>I do<font style="letter-spacing:-0.2pt;"> </font>not<font style="letter-spacing:-0.05pt;"> </font>have<font style="letter-spacing:-0.05pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>my<font style="letter-spacing:-0.2pt;"> </font>possession,<font style="letter-spacing:-0.2pt;"> </font>nor<font style="letter-spacing:-0.15pt;"> </font>have<font style="letter-spacing:-0.05pt;"> </font>I<font style="letter-spacing:-0.25pt;"> </font>failed<font style="letter-spacing:-0.15pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>return,<font style="letter-spacing:-0.1pt;"> </font>any<font style="letter-spacing:-0.1pt;"> </font>devices, records,<font style="letter-spacing:-0.05pt;"> </font>data,<font style="letter-spacing:-0.05pt;"> </font>notes,<font style="letter-spacing:-0.05pt;"> </font>reports,<font style="letter-spacing:-0.05pt;"> </font>proposals, lists, correspondence,<font style="letter-spacing:-0.05pt;"> </font>specifications, drawings,<font style="letter-spacing:-0.1pt;"> </font>blueprints, sketches, materials, equipment, any other documents or property, or reproductions of any and all aforementioned items belonging to Semler Scientific, Inc., its subsidiaries, affiliates, successors or assigns (together, the &#8220;<b style="font-weight:bold;">Company</b>&#8221;).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12.1pt 19pt 12pt 38pt;">I further certify that I have complied with all the terms of the Company&#8217;s At-Will Employment,<font style="letter-spacing:-0.35pt;"> </font>Confidential<font style="letter-spacing:-0.2pt;"> </font>Information,<font style="letter-spacing:-0.35pt;"> </font>Invention<font style="letter-spacing:-0.3pt;"> </font>Assignment,<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.3pt;"> </font>Arbitration<font style="letter-spacing:-0.3pt;"> </font>Agreement<font style="letter-spacing:-0.2pt;"> </font>signed by me, including the reporting of any inventions and original works of authorship (as defined therein) conceived or made by me (solely or jointly with others), as covered by that agreement.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 9.8pt 12pt 38pt;">I<font style="letter-spacing:-0.2pt;"> </font>further<font style="letter-spacing:-0.15pt;"> </font>agree<font style="letter-spacing:-0.25pt;"> </font>that,<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>compliance<font style="letter-spacing:-0.3pt;"> </font>with<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>At-Will<font style="letter-spacing:-0.2pt;"> </font>Employment,<font style="letter-spacing:-0.2pt;"> </font>Confidential<font style="letter-spacing:-0.15pt;"> </font>Information, Invention Assignment, and Arbitration Agreement, I will preserve as confidential all Company Confidential Information and Associated Third Party Confidential Information, including trade secrets, confidential knowledge, data, or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, databases, other original works of authorship, customer lists, business plans, financial information, or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants, or licensees.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 9.8pt 12pt 38pt;">I also agree that for twelve (12) months from this date, I will not either directly or indirectly solicit any of the Company&#8217;s employees to leave their employment, or to enter into an employment, consulting, contractor, or other relationship with any other person, firm, business entity,<font style="letter-spacing:-0.1pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>organization<font style="letter-spacing:-0.15pt;"> </font>(including<font style="letter-spacing:-0.1pt;"> </font>with myself).<font style="letter-spacing:2pt;"> </font>I<font style="letter-spacing:-0.2pt;"> </font>agree<font style="letter-spacing:-0.15pt;"> </font>that<font style="letter-spacing:-0.05pt;"> </font>nothing<font style="letter-spacing:-0.2pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>this<font style="letter-spacing:-0.1pt;"> </font>paragraph<font style="letter-spacing:-0.15pt;"> </font>shall<font style="letter-spacing:-0.2pt;"> </font>affect<font style="letter-spacing:-0.15pt;"> </font>my continuing obligations under the At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement during and after this twelve (12) month period, including, without limitation, my obligations under Section 2A thereof.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12.1pt 0pt 12pt 74pt;">After<font style="letter-spacing:-0.15pt;"> </font>leaving<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Company&#8217;s<font style="letter-spacing:-0.15pt;"> </font>employment,<font style="letter-spacing:-0.1pt;"> </font>I<font style="letter-spacing:-0.2pt;"> </font>will<font style="letter-spacing:-0.2pt;"> </font>be<font style="letter-spacing:-0.05pt;"> </font>employed<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:-0.1pt;"> </font><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:124.28pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 38pt;">in<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>position<font style="letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.25pt;">of:</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:105.54pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</u></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;min-height:25.6pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:4.69pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1pt;text-indent:36pt;margin:0pt 0pt 12pt 254.05pt;"><div style="display:inline-block;height:0.85pt;width:216.05pt;"><div style="height:0.85pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><div style="height:0pt;position:relative;width:100%;"><div style="height:0.85pt;left:0pt;position:absolute;width:216.05pt;"><img src="smlr-20241231xex19d1018.jpg" alt="Graphic" style="height:0.85pt;width:216.05pt;"></div></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.85pt 0pt 0pt 75.1pt;"><i style="font-style:italic;">Signature</i><i style="font-style:italic;letter-spacing:-0.2pt;"> </i><i style="font-style:italic;">of</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;letter-spacing:-0.1pt;">employee</i></p><div style="height:0.75pt;left:47.66%;max-width:52.34%;position:relative;top:0pt;width:216.05pt;z-index:-9223372036603103232;"><div style="height:0.75pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><img src="smlr-20241231xex19d1019.jpg" alt="Graphic" style="height:0.75pt;width:216.05pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10.3pt 0pt 12pt 0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:1.04pt 92.25pt 0pt 116.45pt;"><i style="font-style:italic;">Print</i><i style="font-style:italic;letter-spacing:-0.25pt;"> </i><i style="font-style:italic;letter-spacing:-0.2pt;">name</i></p><div style="height:0.75pt;left:47.66%;max-width:52.34%;position:relative;top:0pt;width:216.05pt;z-index:-9223372036603101184;"><div style="height:0.75pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><img src="smlr-20241231xex19d1019.jpg" alt="Graphic" style="height:0.75pt;width:216.05pt;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10.25pt 0pt 12pt 0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:1.04pt 3.3pt 0pt 0pt;"><i style="font-style:italic;letter-spacing:-0.2pt;">Date</i></p><div style="height:0pt;position:relative;width:100%;"><div style="height:0.85pt;left:47.66%;max-width:52.34%;position:absolute;top:24.75pt;width:216.05pt;z-index:251676672;"><div style="height:0.85pt;left:0pt;padding-bottom:0pt;position:relative;width:216.05pt;"><img src="smlr-20241231xex19d1019.jpg" alt="Graphic" style="height:0.85pt;width:216.05pt;"></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:12pt 0pt 12pt 74pt;">Address<font style="letter-spacing:-0.2pt;"> </font>for<font style="letter-spacing:-0.05pt;"> </font><font style="letter-spacing:-0.1pt;">Notifications:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 87.4pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:5.56%;padding-right:7.35%;position:relative;"><div style="width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0.75pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 87.4pt 0pt 116.5pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.05pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">D</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:2.15;text-indent:27.45pt;margin:11.94pt 143.55pt 0pt 192.45pt;"><b style="font-size:12pt;font-weight:bold;">SEMLER SCIENTIFIC, INC. CONFLICT</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.6pt;"> </b><b style="font-size:12pt;font-weight:bold;">OF</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.65pt;"> </b><b style="font-size:12pt;font-weight:bold;">INTEREST</b><b style="font-size:12pt;font-weight:bold;letter-spacing:-0.6pt;"> </b><b style="font-size:12pt;font-weight:bold;">GUIDELINES</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 19pt 12pt 38pt;">It is the policy of Semler Scientific, Inc. to conduct its affairs in strict compliance with the letter<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>spirit<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>law<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>adhere<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>highest principles<font style="letter-spacing:-0.25pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>business<font style="letter-spacing:-0.15pt;"> </font>ethics.<font style="letter-spacing:2pt;"> </font>Accordingly, all officers, employees, and independent contractors must avoid activities that are in conflict, or give the appearance of being in conflict, with these principles and with the interests of the Company.<font style="letter-spacing:2pt;"> </font>The following are potentially compromising situations that must be avoided:</p><div style="margin-top:12.1pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 10.45pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">1.</font><font style="font-size:12pt;">Revealing</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">confidential</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">outsiders</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">misusing</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">confidential</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">information. Unauthorized divulging of information is a violation of this policy whether or not for personal gain and whether or not harm to the Company is intended.</font><font style="font-size:12pt;letter-spacing:2pt;"> </font><font style="font-size:12pt;">(The At-Will Employment, Confidential Information,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Invention</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">Assignment,</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">and Arbitration Agreement</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">elaborates</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">on</font><font style="font-size:12pt;letter-spacing:-0.05pt;"> </font><font style="font-size:12pt;">this</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">principle</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">and is</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">a binding agreement.)</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:11.94pt 12.75pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">2.</font><font style="font-size:12pt;">Accepting</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">offering</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">substantial</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">gifts,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">excessive</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">entertainment,</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">favors,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">payments that may be deemed to constitute undue influence or otherwise be improper or embarrassing to the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 44.25pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">3.</font><font style="font-size:12pt;">Participating</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">in</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">civic</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">professional</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">organizations</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">might</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">involve</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">divulging confidential information of the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 28.65pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">4.</font><font style="font-size:12pt;">Initiating or approving personnel actions affecting reward or punishment of employees</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">applicants</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">where</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">there</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">is</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">family</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">relationship</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">is</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">appears</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">be</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">a</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">personal</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">or social involvement.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">5.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Initiating</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">approving</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">form</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">personal</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">social</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">harassment</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">employees.</font></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12.1pt 12pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">6.</font><font style="font-size:12pt;">Investing or holding outside directorship in suppliers, customers, or competing companies,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">including</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">financial</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">speculations,</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">where</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">such</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">investment</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">directorship</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">might</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">influence in any manner a decision or course of action of the Company.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">7.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Borrowing</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">from</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">lending</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">employees,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">customers,</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">suppliers.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">8.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Acquiring</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">real</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">estate</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">interest</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Company.</font></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 15.25pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">9.</font><font style="font-size:12pt;">Improperly</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">using</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">disclosing</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">to</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">Company</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">proprietary</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">information</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">trade secrets of any former or concurrent employer or other person or entity with whom obligations of confidentiality exist.</font></div><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.56%;margin-right:7.35%;margin-top:30pt;page-break-after:always;width:87.09%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:1.7pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:0.05pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:0pt 33.1pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">10.</font><font style="font-size:12pt;">Unlawfully</font><font style="font-size:12pt;letter-spacing:-0.35pt;"> </font><font style="font-size:12pt;">discussing</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">prices,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">costs,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">customers,</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">sales,</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">markets</font><font style="font-size:12pt;letter-spacing:-0.3pt;"> </font><font style="font-size:12pt;">with</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">competing companies or their employees.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:11.94pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">11.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Making</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">unlawful</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">agreement</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">distributors</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">respect</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">prices.</font></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 33.45pt 0pt 38pt;"><font style="display:inline-block;font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;min-width:36.05pt;text-indent:0pt;white-space:nowrap;">12.</font><font style="font-size:12pt;">Improperly</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">using</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">or</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">authorizing</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">use</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">of</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">any</font><font style="font-size:12pt;letter-spacing:-0.15pt;"> </font><font style="font-size:12pt;">inventions</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">that</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">are</font><font style="font-size:12pt;letter-spacing:-0.2pt;"> </font><font style="font-size:12pt;">the</font><font style="font-size:12pt;letter-spacing:-0.25pt;"> </font><font style="font-size:12pt;">subject</font><font style="font-size:12pt;letter-spacing:-0.1pt;"> </font><font style="font-size:12pt;">of patent claims of any other person or entity.</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:74pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">13.</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Engaging</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">conduct</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">is</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">best</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">interest</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">Company.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:35.95pt;margin:12pt 19pt 12pt 38pt;">Each<font style="letter-spacing:-0.15pt;"> </font>officer,<font style="letter-spacing:-0.3pt;"> </font>employee,<font style="letter-spacing:-0.3pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>independent<font style="letter-spacing:-0.25pt;"> </font>contractor<font style="letter-spacing:-0.15pt;"> </font>must<font style="letter-spacing:-0.25pt;"> </font>take<font style="letter-spacing:-0.15pt;"> </font>every<font style="letter-spacing:-0.2pt;"> </font>necessary<font style="letter-spacing:-0.2pt;"> </font>action<font style="letter-spacing:-0.25pt;"> </font>to ensure compliance with these guidelines and to bring problem areas to the attention of higher management for review.<font style="letter-spacing:2pt;"> </font>Violations of this conflict of interest policy may result in discharge without warning.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>smlr-20241231xex23d1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:25 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.44pt 0pt;"><b style="color:#231f20;font-weight:bold;">EXHIBIT 23.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="color:#231f20;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;">Semler Scientific, Inc.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="color:#231f20;">Santa Clara, California</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-280013) and Form S-8 (No. 333-198275, No. 333-198891, No. 333-207779, No. 333-263341 and 333-283009) of Semler Scientific, Inc. of our report dated February 28, 2025, relating to the financial statements which appear in this Annual Report on Form 10-K<font style="color:#231f20;">.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;">/s/ BDO USA, P.C.</font></p></td><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;">New York, NY</font></p></td><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#231f20;">February 28, 2025</font></p></td><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>smlr-20241231xex31d1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:25 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 31.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNDER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 302 OF THE SARBANES-OXLEY ACT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I, Douglas Murphy-Chutorian, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">1. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of Semler Scientific, Inc. (the &#8220;registrant&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">2. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">3. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">4. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8211;15(e) and 15d&#8211;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 15d&#8211;15(f)) for the registrant and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">a)&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">b)&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">c)&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">d)&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">5. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">a)&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">b)&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 28, 2025</p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Douglas Murphy-Chutorian, M.D.</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian, M.D.</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer<br>(Principal Executive Officer)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>smlr-20241231xex31d2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:35 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 31.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNDER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 302 OF THE SARBANES-OXLEY ACT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I, Renae Cormier, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of Semler Scientific, Inc. (the &#8220;registrant&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8211;15(e) and 15d&#8211;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 15d&#8211;15(f)) for the registrant and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">a)&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">b)&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">c)&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 0pt 54pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">d)&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 0pt 18pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">a)&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 54pt;">b)&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 28, 2025</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/&#160;Renae Cormier</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier,<br>Chief Financial Officer </p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal Financial Officer and Principal Accounting Officer)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>smlr-20241231xex32d1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:36 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 32.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION PURSUANT TO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">18 U.S.C. SECTION 1350,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AS ADOPTED PURSUANT TO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In connection with the annual report of Semler Scientific, Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Registrant, certifies, in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:<br><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">(1)&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;); and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">(2)&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4</p></div></div></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:48.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Douglas Murphy-Chutorian, M.D.</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:48.05%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Douglas Murphy-Chutorian, M.D. Chief</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Executive Officer</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal Executive Officer)</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 28, 2025&#160;</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not being &#8220;filed&#8221; as part of the Form 10-K or as a separate disclosure document for purposes of Section 18 of the Exchange Act, or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.1 is expressly and specifically incorporated by reference in any such filing.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">A signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.</i></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>smlr-20241231xex32d2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:38 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="color:#231f20;font-weight:bold;">EXHIBIT 32.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 1.1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;"><b style="color:#231f20;font-weight:bold;">CERTIFICATION PURSUANT TO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;"><b style="color:#231f20;font-weight:bold;">18 U.S.C. SECTION 1350,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.44pt 0pt;"><b style="color:#231f20;font-weight:bold;">AS ADOPTED PURSUANT TO</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="color:#231f20;">In connection with the annual report of Semler Scientific, Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Registrant, certifies, in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="color:#231f20;">(1)&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;); and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="color:#231f20;">(2)&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4</p></div></div></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:48.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Renae Cormier</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:48.05%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Renae Cormier</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal Financial Officer and Principal Accounting Officer)</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 28, 2025</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="color:#231f20;font-style:italic;">The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not being &#8220;filed&#8221; as part of the Form 10-K or as a separate disclosure document for purposes of Section 18 of the Exchange Act, or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.2 is expressly and specifically incorporated by reference in any such filing.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="color:#231f20;font-style:italic;">A signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.</i></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>9
<FILENAME>smlr-20241231xex4d2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/28/2025 09:05:42 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 4.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">DESCRIPTION OF CAPITAL STOCK </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;"><font style="white-space:pre-wrap;">The following description of our capital stock is not complete and may not contain all the information you should consider before investing in our capital stock. This description is summarized from, and qualified in its entirety by reference to, our amended and restated certificate of incorporation  and our second amended and restated bylaws, both of which have been publicly filed with the Securities and Exchange Commission.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">General </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;"><font style="white-space:pre-wrap;">Our authorized capital stock consists of 50,000,000 shares of common stock, $0.001 par value.  Our common stock is the only security of our company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">Holders of our common stock are entitled to one vote per share. Except as otherwise provided by statute or by applicable stock exchange rules, or by the certificate of incorporation or our bylaws, in all matters other than the election of directors, the affirmative vote of the holders of a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy duly authorized at the meeting and voting affirmatively or negatively (excluding abstentions and broker non-votes) on such matter is the act of the stockholders. Except as otherwise provided by statute, our certificate of incorporation or bylaws, directors are elected by a plurality of the votes of the shares present in person, by remote communication, if applicable, or represented by proxy duly authorized at the meeting and entitled to vote in the election of directors. Stockholders have no cumulative voting rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">Holders of our common stock are entitled to receive ratably dividends when, as, and if declared by our board of directors out of funds legally available for that purpose and, upon our liquidation, dissolution or winding up, are entitled to share ratably in all assets remaining after payment of liabilities. However, the current policy of our board of directors is to retain earnings, if any, for the operation and expansion of our company. The holders of our common stock have no preemptive rights and have no rights to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. The common stock will not be subject to call or redemption. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">Some provisions of Delaware law, our certificate of incorporation and our bylaws contain provisions that could make the following transactions more difficult: an acquisition of us by means of a tender offer; an acquisition of us by means of a proxy contest or otherwise; or the removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that provide for payment of a premium over the market price for our shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">These provisions, summarized below, are intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of the increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-style:italic;font-weight:bold;">Delaware Anti-Takeover Statute </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">We are subject to the provisions of Section 203 of the Delaware General Corporation Law, or Section 203. Under Section 203, we would generally be prohibited from engaging in any business combination with any interested stockholder for a period of three years following the time that this stockholder became an interested stockholder unless: </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prior to this time, our board of directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding shares owned by persons who are directors and also officers, and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at or subsequent to such time, the business combination is approved by our board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder. </font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Section 203, a &#8220;business combination&#8221; includes: </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any merger or consolidation involving the corporation and the interested stockholder; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any sale, lease, exchange, mortgage, transfer, pledge or other disposition involving the interested stockholder of assets of 10% or more of the aggregate market value of either all of the assets of the corporation or its outstanding stock; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder, subject to limited exceptions; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. </font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">In general, Section 203 defines an interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by such entity or person. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-style:italic;font-weight:bold;">Our Certificate of Incorporation and Bylaws </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">Our certificate of incorporation and bylaws contain provisions that could have the effect of discouraging potential acquisition proposals or making a tender offer or delaying or preventing a change in control, including changes a stockholder might consider favorable. In particular, our certificate of incorporation and bylaws, as applicable, among other things: </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">provide our board of directors with the ability to alter its bylaws without stockholder approval;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">provide that vacancies on our board of directors may be filled by a majority of directors in office, although less than a quorum;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">provide that a special meeting of the stockholders may be called only by our board of directors, the chairman of the board of directors or our chief executive officer; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:12.0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">establish advance notice procedures with respect to stockholder proposals and nomination of candidates for election to our board of directors.&#160;</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt;">Such provisions may have the effect of discouraging a third-party from acquiring our company, even if doing so would be beneficial to our stockholders. These provisions are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and in the policies formulated by them, and to discourage some types of transactions that may involve an actual or threatened change in control of our company. These </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt 0pt 10pt 0pt;">provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal and to discourage some tactics that may be used in proxy fights. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company outweigh the disadvantages of discouraging such proposals because, among other things, negotiation of such proposals could result in an improvement of their terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-style:italic;font-weight:bold;">Amendment of Charter Provisions </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-indent:20pt;margin:0pt 0pt 10pt 0pt;">The provisions of Delaware law, our certificate of incorporation and our bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in the composition of our board and management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-style:italic;font-weight:bold;">Forum Selection Bylaw</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:27pt;margin:0pt;">Unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of Semler Scientific, Inc. (&#8220;Semler&#8221;), (2) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, other employee or stockholder of Semler to Semler or to our stockholders, (3) any action asserting a claim arising pursuant to any provision of the DGCL, the certificate of incorporation, the bylaws, or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, (4) any claim or cause of action seeking to interpret, apply, enforce or determine the validity of the certificate of incorporation or the bylaws, or (5) any action asserting a claim governed by the internal affairs doctrine shall be a state or federal court located within the state of Delaware. However, this provision does not apply to actions arising under the Securities Act of 1933, as amended, or the Securities Act, or the Exchange Act, or any claim for which the federal courts have exclusive jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:27pt;margin:0pt;"><font style="font-size:13.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:27pt;margin:0pt;">Unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:27pt;margin:0pt;"><font style="font-size:13.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:27pt;margin:0pt;">Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of Semler is deemed to have notice of and consented to the forum selection provisions of the bylaws.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>smlr-20241231x10k006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231x10k006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &V [T# 2(  A$! Q$!_\0
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M-_C1_:%U_P _,W_?QO\ &C_6>/\ SZ_$/[4C_)^)^BV1ZBC(]17YT_VA=?\
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MT;QZT68#]U&ZF;QZT;QZT68#]U*'/ [9S[YJ/>/6C>/6BUQ6-?Q#)YUY#<X
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M=LB_7'(['ZBOBJNC^'_C&Z\">+=/UBV=@L+@3(/^6D1(WH1WXY^N*]?*\?+
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M%\$JZ%ONL#V'>N#US0CX?\47>DW<H@-M=&!Y6&_:-V-Q Z\<XKL?@CX9N/\
MA*8?$E_:F'0='4W<]U<J5C; .T*3C+9],UQ'BO77\3^)]3U1U"->7#RX P "
M>/TKAK-O!PE6WN[7WMI^IR3;=&,I[W_#0]?^(?@SP[9> O!R/XQ@@6'3YI+5
MI-/E8W@9M^5 ^X,G W>HKS_PM\/!K&B/K6L:W9^&=%WFWBN[Q6E>XE'WECC3
MEL=S_@:Z7XM)+>^!?ABUM%)<#^R''[M"W(VDC(SR #Q[5LOKS:7\%/!^HV_A
M[1O$MI9FXM+LZE:-.;.0RY7D,,!@1VQTYZ5Z%6E1K8B3G&RC%/KK\/Y>1V2A
M"55\T=E]^B. \4?#N;1#IMSIFH6_B'2M2D\JUO;)64-+D QLIY1AGH>OUK6U
M7X5:7HYN+&Z\>:+%KMLI,MB\4JQAASL\[E=W;&*AUSQUKVMZ+I$-GX7L-!L%
MU);FSDTJQDA2:Z"X &20QZ=.N,9[5T>FG3OB]K]]IVO>$[C1_$7E227&JZ6[
MQXD12<S0N" #@#/K^%81H8:<G&G&\G:U^9+S7?[S)4Z4FU%>F_\ 7WECP'X1
MT*[^#WB.\N?%$5FMR\*7+M9R.MHP;A2!RY/J.*\@UBWM;#4;F&TOTU.VC8[+
MI(S$L@]0K<C\:](\)#=\ _&\2*7F2\MV*(,D#UP.WO7E%S'+ 9$EC:*0 Y5P
M01QZ&N7%N'L:3C'[/GW9E72<*:2MH>KCX$RV<%C?ZMXDTW1-&NH(Y8[Z^X\Q
MV&?+5 V21ZY KGO#_P .O[:?4[JYUNRTKP_8S&!]8N 6CD?G:(T!W.2,'&:Z
M/X^RMY7@A=Q*C18R%SP,DYQZ'WK1\*:L]E\#([BUT/2O$9T_496N[74;5IA
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M1N+MC$R1MF4%LJPQG(Z<]L5O?'S4EA^(<2VDC0WUG9PP3RQ-AA*%&?F!SD<
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M%E)7UXQZ]:Y/>:-YJ_K-?FYN=W]6-5)WOS,V[GQAK=W-I<UQJ$ES+I;%K5Y
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M18!]%,HHL ^BF446 ?13**+ /HIE%%@'T4RBBP#Z*9118!]%,HHL ^BF446
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MMT^[$HZ*/I1;EU+V=Q6N);N]\Z:0RRR2!F=AR23S7Z6>'_\ D!:=_P!>T?\
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M8SIG_?$W_P 32_LW%_\ /L/J>(_D/'=Y]:-Y]:]E'[+VO''_ !.=+_[XF_\
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M_P"AE3_P"/\ \<H_LG&?R!]3Q'\OXGA>\^M&\^M>Z?\ #+DG_0RI_P" 1_\
MCE'_  RY)_T,J?\ @$?_ (Y1_9.,_D#ZEB/Y?Q/"]Y]:-Y]:]W_X99D_Z&9/
M_ $__'*/^&6)/^AF3_P!/_QRC^R<9_('U+$?R_B>$;SZT;SZU[O_ ,,L2?\
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MY'S<US_@'X*:O=W?@R'6;-;.RAEU^VN$MM/8EK=V*P99Q^[#+*YVL&!/3C-
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M!,9)^782145<#]9O*DTGYE8?,)822HU8MKHUJ?*_[('PFU;4/&^F^-]0U]O
M_A+27:>]UQI0C-$F \<8(^?=N ( (^;)X'/(^(9?M7B#591J$NK(UW*5OY@P
M:Y7>0)#NYRPP>?6N[^*_Q>U+QGIMAX5LWMK+P=HK/%866GVQM8YP'.V>6/<W
M[Q@03R,GDC(S7FBXYQZY-;X/"/#W<GJSU:M95;6V(9$(4U/X4 'BK1_47<7_
M *$*5AO0\4OAE=OBW2?^ON/_ -"%;XI+V,_1G.]G<^W2<DTE1E\,<'O1O/K7
MX XZL\26YZ]^RNW_ !>_0Q_TRN/_ $6:^J/A3X<T_P 3?"^QMM2LX+V!;J\8
M).N0I-S.N1W!VLPX[$CO7RG^RL__ !>[12><0W!_\AFOJ#P</''@71VT:+1O
M#>H107-PT=P_B*2!G1YG=2T?V1MIPXR-QY'6OL<G5J#]?T1])EW\#YL[(?#3
M2!"B?9H0RRF1G$2C>"Q)4@# ],@ \9SG-<MXAT!_#OVV\GT30+?0H<2275WJ
M,BF&$;M[!5MSS@*<%B.OISICQAXZ)P/#?AC/_8TR?_(55=3UOQCJUE/:7GA7
MPO+;W"&.1#XKE7<I&",BR![]J]T],H?VK\,X=872#K.C/JEM")I[,2+YK(R%
ME=E'W<@;@!C/0>E3:'X[^&/B/PV/LOB?P_J.B7DC>7'/<PHI8<E0&(.5P3S\
MP[UQ-]\*8=0UM-9G^'_AF76([9K2&\D\:7,DD410IM7?:D<#IP<=11I_PAAL
M;>V0?#GPI+)#&$,S^+IU>;"[<R;+0!S@GDCZ4 =1K/B3X4>'-+$M_P")_#UG
M'/\ ):R_:X6;'\*(%)\S Z @D^]:^I>$9KH"?P]H.AW]M) #%)>W\D"RL5)#
M,$@<@9VCANC$XR #YM'\#]/LKJYNM/\ AGX0TR]GM19"YM_%4K&*,)L&Q'LV
MC5MI^\%R>I.:](TO7?&6C:?;6-MX9\,)!;QK%&I\52$A0,#_ )<J -ZV^&NF
MK:VXDMH([A&#LT: C_<' X[;@ >_!)KFOB%X9M/#T?A]K-%ABG\2Z9^Z1% 7
M$O7.,G.>YX[8K2'C#QT3@>&_"Y/I_P )3)_\A5SOC*?QWXJATE%T3PM;FQU.
MVU EO$\C!Q"^XI_QY<$],T =[/\ #S1;R[:Z?3[423-ON"(A^_[C=[[@K9&#
ME1SU%4=7^'EI%:74FGZ7975T5'DPSOY*(>^'".??E6Z517Q?XZ  _P"$:\,<
M#_H:9/\ Y"H/B_QR1@^&_"Y!_P"IID_^0J ,!CX=\/W^I?\ "6?\(YH,%C;+
M=,J7Q<^5G:992\480!MN-I(R3G&!4$?C?X4VUUIT">*M%6YOI\6<ZR(5F8$'
M8K#Y<\C!ZGL34GB33M;\7%VU7P?X;N-\!M7*>,KF(/$6#%&"6@R"0#S7'Q_!
M.RCO!+#\-_"<=M^\\VT_X2N5H)6<@DL&LR>"HP 0!R,<T >EW^H?#SQ'JQB.
MK^'9M:E102+RWDN'13Q\I;D=1R..V#5#2M8^&_B/7IM)T'4]#US53:^<NG6M
MPL@"@XWLZ;BH.0!G/ R >:\^N_@+H6H1:A'<?"CP9.;]&6YD?QA=&1PV,G?]
MEW*?E W @C& :V/!_P .Y_AZ-"B\-^!O"VD6FC6\EM9VD'BJ1@ ^W)9WLC([
M +@;G/4\4 =UH'@"\GO8QK&@Z+:6429$MK>/<2S-E@0ZF"-5!!5LK@@KCE37
M0+\.=&"7"FS@/F-E"8Q^Z^4# ]><GYLGYB.F ,-?&'C@  >&_"_X>*7_ /D*
ME/C#QS_T+?A<?]S3)_\ (5 'SU^T[!]F^'OBR(N9&3Q?;H6( SC3[?G X'X5
M\L6?WJ^K/VH--U:R^$>J:AK,=A;W6J^)XKQ8-/NVNHXT%M'$ 9#''DYB)^[Q
MD5\GV3'<.:^,S97Q'R/G<?\ QOD;D/W:?4$3D+UI^\^M>'RH\DU_#R9U19FP
MD=JC7!;=C[HR/UQ6?+(TLC.V-[G<>/7G\:O6ZK;^'[F=C^\N9!"G /RKRWTY
M*UDAL=#5M))%O1$M7='U$Z7J$<Y4/'RLJ'HZ$89?Q_H*SMY]:-Y]:E*Q&VIJ
M:EIXTS6'@5@\6Y7A<?QQG!4_E^HK]-?#O_( TW_KVC_] %?F?:/_ &II"@_\
M?%BX;/4M"2,_D?YFOTP\._\ ( TW/!^S1_\ H KZC)U:51KR/>RY:R:\C1HH
MHKZ8]H**** /G7]MO_DG.E?]A%?_ $$U\5CI7VG^VX0/ASI6?^@BO_H)KXK+
MBOC<T5\2_1?J?,Y@_P!_\A:*3>*-XKR>4\T6K>D'&K6.>/\ 2(O_ $,53WBK
M&FR8U&TP,GSX^/\ @0JH+WEZC3LT?>^MWUO+9W:+/$6.< 2 D\^E<O:<R'/&
M#W%4=0U2Y8F-K(Q;Y I8\\;JNV3 RG'/%?IU&[6JL?28B47;E9>II.1BG9Q3
M*ZSE$(PM1$XJ1F&"*B;K56N)[#HAN7/O5A.3]>*ABZ>U3QJ>#7"]V>I!WBB6
M9W:6Q"W<=O"JM+.CA&\Q!CCYN1SCYEZ>M/TMY\WRSWUK,?,W1)'L'E1'H"5X
MYZYJK>V<%PD'F1(SR0M!NE5V38Q&Y2%]0/7M2Z=IUO;33SPVEO'YD:1X99,[
M4X"\G' QT ]ZTVB6O(T8VP ?T-3+US5=#N.<'GVJ<':VULHWHW%<CW*L3H<"
MITZ56#J!C<*E5PPR,X& >*AH=BU&<DU*#593SP:F!XJ03L25'?7MK964L]Y-
M#;6B+^\FN'58U'N6( _&N3^*_P 2]-^$?@'5O%&J;G@LH_W<2?>FD) 2,<'E
MF('3O7Y8_&3X^>+?BIJ<UUK^I2&-CF/38Y"EM:KG(&P<9']X@DUZ6&PDL2NR
M[D3K<GJ>]_&K]L)/"FMZEI?@>&VNS%*8_P"TYD\V)\'G8IP&'^T<^PKY,\;_
M !/\3_$+4#<Z[K=YJ4F3M6>4E4'HJYPH]@*Y.YNF>1E/RGJ1WIL)Q+@]>M>]
MAL!A\,OW4;>?4PK8RM6^*1H6<)[\"NX^'GC35?AYXGT_7M$NWM-3LI1)'("<
M$=U(SRK#(([@FN0LG5T&*TH@#VKV5",HV:.&Y^O7[/7Q\TGX^>#EU.T5;+5K
M;$6HZ89%8P.>CKW,;$\'ZCM7<:UXOLM O;"WNUG5KMWC#I$76+:A<E\=!@8S
MSR1TK\??AU\0-:^&WBNQU[0KU['4;5\JP&4E7^*.0?Q(PX(/Z'!K[V\6^.=7
M^-OPV\*>(_ $#M?-=307UJ(5F-L_V6421L"K?*',>&Q\P(/?%?*8O+_85%;X
M7^!W4JO,K/<^BU\<:,+F*WDU.U$\A&V*23:_)P..WMFO-/VMP$^'5LF03]N3
M. <=#WQ7R7\.O$_Q5T.\\.Z5KGP2O]2EM7@CFUPV$LDCC=DS;Y(R<KN]0!M[
M5]9?M:SQGX<V<?G^=(+Z/YF92S#!YXKR,WPL</AVHR3NNAS2JU*M*ISP<;;7
MZGR$1NR!U]JR1XWO?#.JW!BG;8%W;2I"J .01G#9_2M,NI!R<#U-<'XEN0FK
M2EVDD564^3*/DP/3V/\ 3I7@\.U8X>O4JRV47^AY>#HRKUE3CU/0?#GQY\<Z
M%9.?#UC+-8%C,R6]HK!1W.SN/]T#\:^AO@'^T7I_Q=A.G74:V6O(ID:)0521
M1P<*?F5NY4]N]>._"KQ-8"SB>%XO.'+)Q\I_*O5M-&F7FJ0:F]G -1CY@O1&
MHE4^S8S75+/(UVXUJ2\FM'\S]'_L-4HITJCOU['N@.*=7$Z;XY"@)=[) #MR
MA^=>V<=ZZZSU"UOTW6]Q'*/9JVIUJ=7X6>;6PU2@[21:5\#&*<K;JCR-VW(S
MZ45N<374E&0<YIXYJ+.[@=:D!%!(M%&<44 %%%% "CJ*DZ-FHJ<K8ZTT[ .)
M4D8J2F8IRG&<T@%HHHH <K8&,4^HJ4'!H DKEOB)?"VT/RB2#,X  .,@<FNH
M+ \=?I7E_P 1M7$^L1VS?ZNT7IG@D^]<V*G[.DW<[L%2=2LEV.'UF]$> Q(!
M&.*\ ^,7BH1V\L(8*X!& ?6O6O%FL+;03&1BN\$J7QC\,5\C?%OQ8)[F4M(B
ML<#KC@=Z^<I0YYI(^TF_9QNSS&^U W?BG3&!W'[9".O_ $T6OJ]_]8W^\:^2
M_#'AO7?%'B"QFTC0]1U>".[CD>:QM))D558,Q+*"  ,DY(XKZR:12[$'())S
M59C3<.3T/S'/)J=2#3Z'VO\  /58+;X3>'X6WF01R<(N>LK>E>C+J<!'(=?]
MZ-A_2O'?V=M6L[KPEH5G'<(]S$CJ\.<-]]CT/7J.E>W;><<5]-AH-4H771?D
M=-"2=*-NR,N+Q'IDSLJ:C:,5)5EWC((ZBK4=[:7&=D\+GT6121^55H;.!EFW
M0JP,K9! /-,;0K&7[]K$1Z%!74X(VYC0,2.!@8]"1P:8;=,\K68?#.GKGRX&
MA)Z^7(R _@#2'P\B#,=Y?0GT2Y;'ZDTO9]@YC3$*$D#@5DZ_"A2%,"1E</L9
M<AA[TZ6TFL82YU2[Q_M%&S_XX*IB:27,DLA=R.2W7]*ZL/1;GS=CS\542@X]
MRE>20VZDA6W8Z+UK@?$_B*UACD2X2XBPI*2,A*'ZL.E=7KSF,,5(+$'[U>;A
M+S7M5CTFWC5GN"4R)-ZJ.Y.1Q^1%?2QC!Q;EJCY6=24:D4M'?0Z7X2^$8?$=
M^/$UYB6W@.VRCDY4MW<^N.@KV&2(%2!S7)>%;!O!7A^ST>PT.Y^QVJE5)O(Y
M'8DY)).WJ:V/^$A< >9I6HQ_\ 20?FK5\;*E",GR+0^\]K*HDZFYI00%$Q@#
MZTXP _PBLU_$%FBAG6XC]0]O(<?D#47_  EVDC[UZ(_^NL;I_P"A**CD%=&D
M]LK'&T@^HX-?E)^WCX+;PG\>]2N(XA%:ZK:P7D8  7=M\M\ =MR9^I-?J;'X
MGTFX^6/5+-SZ"X4'^=?''_!23P+'XB\.>$?%.G 7=[;7ITN46_[PNLPS'@+G
M^-<?5^.37HX"7LZUWU,JUN0Q/V"/"Y\(_#G7?%MQ^X.HW MHG<X!BB!9C_WT
M1^5?8?AC68M=T:*_@D$L,ZY5QT/.*^<[C29?!GPZ\%^ -&4Q:A,D5M)CDI*Z
M[I6/T)8GZ5[_ *+>V&BZ9:::)T;[/$D*G.,[0!G\>OXU[U5;/J?,JJYSEV-U
MFVYR:0S1+U#&HX76[.5.X4DJLOW02*QW&0W+(RL,G![&OSI_X*#:H+GXOZ)I
MP?*V.CHQ3)^5I)7;U] OY5^@VIW<=G;3W-Q*L,,*EY)'.%0 9))^E?D?\:_B
M8WQ;^,.O^(O,9K.:00V2G^&VC^6,>_ S_P "->C05G<5'6I=]#B+B,9)JKY8
M'3KZ5HL ]LPSSGKBJL>U@23G'?&*[&>@G<B090T_PT@;Q;I0]+J,_P#CPIRH
M,N >/>K/A:)/^$MTXGM<1]!_M"N/%+]S+T8I;,^PR<EC[T4A<;C1O%?@LEJ>
M'U/7OV4O^2X:)_UQN/\ T6:^F?A!\+O!VN>"(K[4/">A7][/=WCRW%UID$LD
MC?:I>69D))]S7S+^RBP/QRT0?],;C_T6:^B_AA\0=4\-^ EW>#-2N;""[NU&
MH)J&GQ0N#=R@$>;<JP!) ^8 ^U?693I0?K_D?2Y=_!^;.+\80ZKX5UW7(U^!
M/P]?1(;ZWM--U35+VRT];E9'VGAHVR0NTC[I+OL ^4LW(S:YK\CZE<6_PF^#
M*A \=GITFK6!<L 0LTDH& C2CR]@7/JPZ5]!^+[B?Q_HS:3XC^#NJ:UIK2QS
M&TO;G3)(RZ,&1B#==0P!'N*\['P/^'MW');_ /#-MM+#&["2V']E-'O++(2Z
M?:MI?.TY(S@^AKVCU#B;?6=<M8%@D^#OP<UO4)((966PUNQMDA+;5?*O&Y<!
MR^#E1\N,L>:]<^%'P^.O0Z@GCSX.^"?#5Q!+LMI-.CMKM;I,GYL"/*8&."3G
MGI7'-\-_A?I,EO(WP TVT>V3$.;C1T6-%DSE0;L ;7/7L37LT7Q"\0O"DB?#
M?76B(R'6_P!,((]0?M5 'DWQ-^'GA[2_B%)9:)X%M&GDTFWE5],\,V=W''MN
MF+AT<*!O4%,CD9SVKF-(\"ZLEAK<>J^#H9I[G*V$MA\/+&/[)SD,0\I#'L1\
MPQ@@@UZBOCCQ _Q:N91\.];,G]B1+Y)O].W >?)\V?M.,=NN:XF?X=:AK=QK
M-QID7Q9L5OKD231:9XXLA'!("25C'VEO+!SRHP.!P* .%U/P9>:/8ZG=^)/!
M,6H:?-J&G_9+2Q\#6=K]FS?P;AYN_<^4^0 CG=@\#+;DOP]UA]5BE3PO'!8I
M=RRM:)\.+!Q- 9E:.)F,H*[8PR[AU+@\;?F[GQGKVK:5\+HM.M_!'B.X@CU*
MPQ>7^KZ?<NS?VA"<,_VHDDM\OMQG %5?B-X.U#Q;J>LZY=:1\2_#:7NG)9W:
M:/XOL;&V2*)S)Y@47.$?&X,XQE2P- '':M\/=;O-5,]EX6AL;'[?YWV4?#FQ
MD/V7 'DAFEX;.3NYZD=\C!;P7J'B#1[T>#O!D.@R"_OHWEOO UG?<F8;<9?C
M8H88.1DC@@5Z%\-?#=SI7B-?%>C0?$GQ(AC%O-!>^-=/O["=UB$>]XQ<E2X&
M"2".0#C-;?@3XDWVB>%-<DU#P5JEM:-J]ZKW<FJ:9 J%I2-NY[I<'^M 'GU[
MX!UW^P[*WT_PC:Q:G$\IFO+KX<6128'.P;%F'W>.1C..E9L_A.X@U'2=/N?
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M=Z+K]S;PZ5JUK>NV'=(I/F52 5)'8'->*J5522G%H]!UH*+DG<[?4];BN;H
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MJ,XKAM4_9P\&6K%A8:YHTV,+(-0N#@^FV0D?G7+3_";Q?X50_P!@ZI;^(+
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M&ZCE F@;]]'D_P :_P Z_5;P[_R --_Z]HO_ $ 5^4UN<SQ?[P_G7ZL^'?\
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M?*[R9W-DY&WCKGK7:_$7PKH_A'X*^,;#0]*L](L?[-NY?LUC L,>]D9F;:H
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M/]H6G)_UR?\ H0IQCJAK='V,URZLWSL.3WI\=_*"!NW#WJ@9/WC<YY-*),G
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MMY'959]HFQPI'^R,?CVKL/A'XATK6]#AN-!TBVTRRN;&.=B3ON[@,%\MY#P
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MH]B'M#T*/6HIXLB0EAR,D\>_-:MIXACC#&.8;B,*6/0=Z\SCU,M!Y,A"J "
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M]ER0':181@KZ$YQD8/(QU]J^8_ G_!0;2_'_ (TM/#EAX'OK>6?<1<37\7R
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M_I7*Z'K)A$MO<$/(&X=5W<=!D5:N]16!F9!))M/SY_=Y]@*Y)4KLW4T6-?\
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M_%%L^,[?LZ #\2PKR8-.*/L,+/VE&+70^J?[ C/1XS^%+_PC>1D>6:^5[?\
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M='D?J*^!G =0K<YKT*:O!$7UN02.=M56C+G-6?+(. .!3'..*F5[ZFFY7<;
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M[A24 >(37W[12V>H"+3OA?+='R?L,KW^I(@X_?>8@A)//W<,/?%1_P#"3_M
MKHMI/_PB'@*;4X;J:*^LTUZZ"30CR?*FMY#;\$@W&Z.4*1L3#')%>Z4E  ,X
MYI:3-&: %HI,T9H 6BDS1F@!:*3-&: /F7]O[_DCNG_]A:#^35\$6?6OO?\
M;_\ ^2.V'_86A_DU? MF<\5Y>)5Y'S68?QOD:T9PM.W5%&V%J2N/E/,%W4;J
M2BCE 7=1NI**.4":V/\ I,7^^/YBOUF\-'/A[3#_ -.L7_H K\EH?]=%_OK_
M #K]:/#/_(NZ7_UZQ?\ H KOP:LF>WEB^(TZ***]$]T**** /F;]O$X^&FC?
M]A-?_0&KX6WGUK[I_;Q_Y)GH_P#V$U_] :OA*O/KQO.Y\SF'\?Y$F\^M&\^M
M1T5S<AYI)O/K1YA]:CHHY -_P=XNN_!VIBZM2'B;Y9;=C\LJ^GUZX->]>&?'
MVD>)X@;6X2*?'S6TS;'7Z _>_"OF:C !!P">N2 :[L/B9T--T;0J.!]>AF89
M ./857U#5K+2;<S7UY!9Q 9+S.%Q^!.?RKY8BUW4X45$U*\5 ,!1<. /H :J
MWD[ZA()+MFNI1TDF8NP_$UV2S!V]V.IM&O&_O+0^I/#OC;P]XK69])UJSO1"
MVQ_+9@0WT*CBMY4$@'ERQ-]'!KXZM7>QE:6V=H)6^])&=K'\1S5W^W-2R"=1
MNR1_TW;_ !KG6.K(Z7B*#TY7]Y]9PP&$,SLH49)P<G\/>H);V*=2K1,R=MP(
M-?*8US4ATU"[!]1</_C0-=U,#C4KS_P(?_&N6I6J5-&;PQ]*/V&?2U[-]DCD
M=0QB"D[<=*Y_3[^YU33+*\&AV,T$EN))'AU.7SY#W"1&%P#_ ,#P?05X0^N:
MDZE6U&[(_P"OA_\ &FV^KWUFH6VO;FW5?NB.9EQ^1%8JZ1NLUBOL'<>-O@UX
M:\;>*GN+V+QU#JUO''+-IT<=B\$"$<(SH^02.H^]@]*\?U[]F(PRM'>:QHTL
M!D*E)8-3M+B*(GY<(8)4DP.I#@<5U,>LZA"\K17]TC2MOD(G8;SZGGD^YR:D
M7Q%JZC U:_V]P+J09_\ 'NGM6RJ2!YI3:^!F)X8^&L/P2\0:W>^'O%V@VFHQ
MVC6]VDZW:LN00C;O((RK-N 4DG KPS7?"VH6MT;QO-UV,\DV-G.R@DY. \:[
M@3D],Y-?1,>KW\/W+ZYCR2Q\N9ER3U/7K[U*?$6K$8.JWY'I]JD_^*JO:)2Y
MK%?VO'V?LU'0\B\#Z=-J<]M_Q2GBY5B)<7-IIXC&[IEA(021V(88ZUTFL^!_
M$MO;ZO<VMEKL5QJ$AE\V[TRS+H2BQY603%@=H(Y'0XKMCK6H-]Z^NC_VW?\
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M6G]NZ_P_Q_X!+L>G1:FEDNY2NS.64'C'UIFJ^/[.Q@*60\V<_P ((8)[[O\
M)KS,\C'4>A)H_3Z5RU\ZJ5(VIP4?G<5V6]0OYM3NY+BX?S)7ZD]*@WGUJ.BO
MFY)R;<GJ]1%FTO[C3KF*YM9G@N(G#I+$<,I!R"#7TE\/_P!H_3-9MXK'Q4L5
MC>?=^V&-6@E/]Y^#L)[\8]Z^9**2O%G50Q%3#OW&?>=M'H'B" 2Q6>CZI"0/
MG2"&5?SP:KS>!/"DY_>^$M#DSQSIT/\ \37PLDC1@A&9 3SL8C/U]:=Y\O\
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M66V]ZQIT445VGMA1110!\R?MZG'PRT?_ +":_P#H#5\*#H*^Z_V]O^28Z/\
M]A-?_0&KX0WFN.JO>/F<P_C_ ")**9O-&\UCRH\T?13-YHWFCE0#Z*9O-&\T
M<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0
M#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?1
M3-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O
M-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHW
MFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<
MJ ?13-YI-YHY4!)13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J
M?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*9O-&\T<J ?13-YHWFCE0#Z*
M9O-&\T<J ?13-YHWFCE0#ZT-$L%O;MFG)6T@7S9W S\@[?4GBLS>WH3]!G%;
M.JN-)LH]*4D7#8FNV5LY;^%,?[(Z^YHY45%=7L4]3OGU*]DN'"@MPJ@8"J.
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MRHS'D9Z\T= 1V-,WFC>:.5 /HIF\T;S1RH":#_71?[Z_SK]</#'_ "+FE_\
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M/X^,'PZUGP;%XQ?P#J'V^/5=/U0W,T$,K;/+E@F>/E5*A&7MN'/2O%B2>O-
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MC_I$?^\/YBOV$\,?\BYI?_7K%_Z *_'BWXN(C_M#^8K]AO"__(MZ5_UZQ?\
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M>FV:"2[NY5AB1F"@LQP 6/ Y/4U)X@T&\\,:W?:3J$:17UE,T$R1R+(H<'!
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M+"&R0/O!,X[9ZTU!]2)SA)6BNQ[EXA\.?#_0_C78^"5\%K-9:G%9PR7DFI7
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M(1-&U]'+,KQF1?+0[FW =L#OQ7ZT)]P8Z5Q5M&D>]ED?=E(=1117.>T%%%%
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M6BS DHJ/>/6C>/6BS DHJ/>/6C>/6BS DHJ/>/6C>/6BS DHJ/>/6C>/6BS
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M,?%C0'TKQ-IR7UODM%(/DFMV.,M'(.4/KCJ.#D5\0_%W]@[Q1X5\_4/!<_\
MPE&FJ2WV"4K'?H.O X27 ],,?[I->S2Q<)Z3T9\Y7R^=-WIZH^6Z*NZ[H6J>
M&-0>PUC3;K2KU#@P7D+1-W' 8#/0\CBJ&\^E=RL]4>4TT[-#J*9YGM1YGM3L
M(?13/,]J/,]J+ /HIGF>U'F>U%@'T4SS/:CS/:BP#Z*9YGM1YGM18!]%,\SV
MH\SVHL ^BF>9[4>9[46 ?13/,]J/,]J+ /HIGF>U'F>U%@'T4SS/:CS/:BP#
MZ*9YGM1YGM18!]%,\SVH\SVHL ^BF>9[4>9[46 ?13/,]J/,]J+ /HIGF>U'
MF>U%@'T4SS/:CS/:BP#Z*9YGM1YGM18!]%,\SVH\SVHL ^BF>9[4>9[46 ?1
M3/,]J/,]J+ /HIGF>U'F>U%@'T4SS/:CS/:BP#Z*9YGM1YGM18!]%,\SVH\S
MVHL ^BF>9[4>9[46 ?13/,]J/,]J+ /HIGF>U'F>U%@'T4SS/:CS/:BP#Z*9
MYGM1YGM18!]%,\SVH\SVHL ^BF>9[4>9[46 ?13/,]J/,]J+ /HIGF>U'F>U
M%@'T4SS/:CS/:BP#Z*9YGM1YGM18!]%,\SVH\SVHL ^BF>9[4>9[46 ?13/,
M]J/,]J+ /HIGF>U'F>U%@'T4SS/:CS/:BP#ZW-"O(;NW;1K^3R[.=]\,[, +
M:;'#$X)VMPK?@>U8'F>U(QW=N<$9%%AIM;%BXMY;2>2">-HIHSM=&ZJ:CK<&
M/%&FEU+2:S8I\XY8W%N .<]WC';NN.XKGQ+NYQQ]<T6')=B2BF>9[4>9[46)
M'T4SS/:CS/:BP#Z*9YGM1YGM18!]%,\SVH\SVHL ^CK3/,]J/,]J+ /(!)R
M<]>.M:MMXDNHK=+:Z"ZE9+Q]GNAOVC_9;(=<>Q_"L?S/:CS/:BPU)HWC8:5J
M[*-/N9+&X/'V;4)!L8_[,H&/P8 >]9^IZ7=Z/.(;VW>VD;.W=@AQZ@C@_@35
M$MN!!'ZUH:7XAO-*C,*,D]HQR]K<KYD3?\!/0^ZX-'*S1M/1E*BMB./1=5)(
MD.B71_A<-);.?9AED_'(JIJ6C7NDJKSP@P-]VXB8/$WT<9'X9S[46(Y>J)-
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M?_BJ^SJ6CZS7_F#ZG0_E/C#_ (=L:1_T/>I_^ $/_P 51_P[8TC_ *'O4_\
MP A_^*K[/I*/K-?^8/J=#^4^,?\ AVQI'_0]ZG_X 0__ !5'_#MC2/\ H>]3
M_P# "'_XJOL^DH^LU_Y@^IT/Y3XQ_P"';&D?]#WJ?_@!#_\ %4?\.V-(_P"A
M[U/_ , (?_BJ^SZ2CZS7_F#ZG0_E/C'_ (=L:1_T/>I_^ $/_P 51_P[8TC_
M *'O4_\ P A_^*K[/HH^LU_Y@^IT/Y3XP_X=L:1_T/>I_P#@!#_\51_P[8TC
M_H>]3_\  "'_ .*K[/HH^LU_Y@^IT/Y3XP_X=L:1_P!#WJ?_ ( 0_P#Q5'_#
MMC2/^A[U/_P A_\ BJ^SJ6CZS7_F#ZG0_E/C#_AVQI'_ $/>I_\ @!#_ /%4
M?\.V-(_Z'O4__ "'_P"*K[.HH^LU_P"8/J=#^4^,?^';&D?]#WJ?_@!#_P#%
M4?\ #MC2/^A[U/\ \ (?_BJ^SZ*/K-?^8/J=#^4^,/\ AVQI'_0]ZG_X 0__
M !5'_#MC2/\ H>]3_P# "'_XJOL^DQ1]9K_S!]3H?RGQC_P[8TC_ *'O4_\
MP A_^*H_X=L:1_T/>I_^ $/_ ,57V?24?6:_\P?4Z'\I\8_\.V-(_P"A[U/_
M , (?_BJ/^';&D?]#WJ?_@!#_P#%5]G4M'UFO_,'U.A_*?&'_#MC2/\ H>]3
M_P# "'_XJC_AVQI'_0]ZG_X 0_\ Q5?9]%'UFO\ S!]3H?RGQA_P[8TC_H>]
M3_\  "'_ .*H_P"';&D?]#WJ?_@!#_\ %5]G8I:/K-?^8/J=#^4^,/\ AVQI
M'_0]ZG_X 0__ !5'_#MC2/\ H>]3_P# "'_XJOLZBCZS7_F#ZG0_E/C'_AVQ
MI'_0]ZG_ . $/_Q5'_#MC2/^A[U/_P  (?\ XJOL^BCZS7_F#ZG0_E/C#_AV
MQI'_ $/>I_\ @!#_ /%4?\.V-(_Z'O4__ "'_P"*K[/I,4?6:_\ ,'U.A_*?
M&/\ P[8TC_H>]3_\ (?_ (JC_AVQI'_0]ZG_ . $/_Q5?9]%'UFO_,'U.A_*
M?&'_  [8TC_H>]3_ / "'_XJC_AVQI'_ $/>I_\ @!#_ /%5]GTE'UFO_,'U
M.A_*?&/_  [8TC_H>]3_ / "'_XJC_AVQI'_ $/>I_\ @!#_ /%5]GT4?6:_
M\P?4Z'\I\8?\.V-(_P"A[U/_ , (?_BJ/^';&D?]#WJ?_@!#_P#%5]G8I:/K
M-?\ F#ZG0_E/C#_AVQI'_0]ZG_X 0_\ Q5'_  [8TC_H>]3_ / "'_XJOL^B
MCZS7_F#ZG0_E/C#_ (=L:1_T/>I_^ $/_P 51_P[8TC_ *'O4_\ P A_^*K[
M.I:/K-?^8/J=#^4^,/\ AVQI'_0]ZG_X 0__ !5'_#MC2/\ H>]3_P# "'_X
MJOL^DQ1]9K_S!]3H?RGQC_P[8TC_ *'O4_\ P A_^*H_X=L:1_T/>I_^ $/_
M ,57V?11]9K_ ,P?4Z'\I\8?\.V-(_Z'O4__   A_P#BJ/\ AVQI'_0]ZG_X
M 0__ !5?9])1]9K_ ,P?4Z'\I\8_\.V-(_Z'O4__   A_P#BJ/\ AVQI'_0]
MZG_X 0__ !5?9U+1]9K_ ,P?4Z'\I\8?\.V-(_Z'O4__   A_P#BJ/\ AVQI
M'_0]ZG_X 0__ !5?9V*6CZS7_F#ZG0_E/C#_ (=L:1_T/>I_^ $/_P 51_P[
M8TC_ *'O4_\ P A_^*K[/HH^LU_Y@^IT/Y3XP_X=L:1_T/>I_P#@!#_\51_P
M[8TC_H>]3_\  "'_ .*K[.I:/K-?^8/J=#^4^,/^';&D?]#WJ?\ X 0__%4?
M\.V-(_Z'O4__   A_P#BJ^SZ2CZS7_F#ZG0_E/C'_AVQI'_0]ZG_ . $/_Q5
M'_#MC2/^A[U/_P  (?\ XJOL^BCZS7_F#ZG0_E/C#_AVQI'_ $/>I_\ @!#_
M /%4?\.V-(_Z'O4__ "'_P"*K[/I*/K-?^8/J=#^4^,?^';&D?\ 0]ZG_P"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>smlr-20241231xex10d7001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex10d7001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ! 3P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\JJ*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>smlr-20241231xex10d7004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex10d7004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " !@# 2(  A$! Q$!_\0
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%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>smlr-20241231xex10d7005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex10d7005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  6 !8# 2(  A$! Q$!_\0
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I]ON^\&6EIX,A\%2>%X[Z4F;5S>BY%P;8=K>/85\D>N=W;')110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>smlr-20241231xex10d7007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex10d7007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " >H# 2(  A$! Q$!_\0
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? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>smlr-20241231xex10d7008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex10d7008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  $ ;(# 2(  A$! Q$!_\0
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>smlr-20241231xex10d7009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex10d7009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " ;$# 2(  A$! Q$!_\0
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3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>smlr-20241231xex19d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " ,D# 2(  A$! Q$!_\0
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$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>smlr-20241231xex19d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ! D\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>smlr-20241231xex19d1004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %: [\# 2(  A$! Q$!_\0
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MP_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\
M_"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L
M?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5
M>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4
M >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?
M\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?
M!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_H
MC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P_
M_P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"
M7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_
M (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1
M_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,
MG?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#
M_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?
MP_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\
M_"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L
M?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5
M>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4
M >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?
M\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?
M!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_H
MC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P_
M_P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"
M7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_
M (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1
M_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,
MG?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#
M_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?
MP_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\
M_"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L
M?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5
M>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4
M >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?
M\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?
M!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_H
MC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P_
M_P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"
M7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_
M (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1
M_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,
MG?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#
M_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?
MP_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\
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MK_P?_P"Q.T?_ -(H:]2KRW]E7_DU_P"#_P#V)VC_ /I%#7J5 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MY;XV_P"3@/A?_P!@_6__ $&TKU*O+?&W_)P'PO\ ^P?K?_H-I0 ?LJ_\FO\
MP?\ ^Q.T?_TBAKU*O+?V5?\ DU_X/_\ 8G:/_P"D4->I4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7EOC
M;_DX#X7_ /8/UO\ ]!M*]2KRWQM_R<!\+_\ L'ZW_P"@VE !^RK_ ,FO_!__
M +$[1_\ TBAKU*O+?V5?^37_ (/_ /8G:/\ ^D4->I4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7EOC;_
M ). ^%__ &#];_\ 0;2O4J\M\;?\G ?"_P#[!^M_^@VE !^RK_R:_P#!_P#[
M$[1__2*&O4J\M_95_P"37_@__P!B=H__ *10UZE0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>6^-O^3@/
MA?\ ]@_6_P#T&TKU*O+?&W_)P'PO_P"P?K?_ *#:4 '[*O\ R:_\'_\ L3M'
M_P#2*&O4J\M_95_Y-?\ @_\ ]B=H_P#Z10UZE0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>6^-O\ DX#X
M7_\ 8/UO_P!!M*]2KRWQM_R<!\+_ /L'ZW_Z#:4 '[*O_)K_ ,'_ /L3M'_]
M(H:]2KRW]E7_ )-?^#__ &)VC_\ I%#7J5 !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y;XV_Y. ^%_P#V
M#];_ /0;2O4J\M\;?\G ?"__ +!^M_\ H-I0 ?LJ_P#)K_P?_P"Q.T?_ -(H
M:]2KRW]E7_DU_P"#_P#V)VC_ /I%#7J5 !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y;XV_P"3@/A?_P!@
M_6__ $&TKU*O+?&W_)P'PO\ ^P?K?_H-I0 ?LJ_\FO\ P?\ ^Q.T?_TBAKU*
MO+?V5?\ DU_X/_\ 8G:/_P"D4->I4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7EOC;_DX#X7_ /8/UO\
M]!M*]2KRWQM_R<!\+_\ L'ZW_P"@VE !^RK_ ,FO_!__ +$[1_\ TBAKU*O+
M?V5?^37_ (/_ /8G:/\ ^D4->I4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7EOC;_ ). ^%__ &#];_\
M0;2O4J\M\;?\G ?"_P#[!^M_^@VE !^RK_R:_P#!_P#[$[1__2*&O4J\M_95
M_P"37_@__P!B=H__ *10UZE0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %>6^-O^3@/A?\ ]@_6_P#T&TKU
M*O+?&W_)P'PO_P"P?K?_ *#:4 '[*O\ R:_\'_\ L3M'_P#2*&O4J\M_95_Y
M-?\ @_\ ]B=H_P#Z10UZE0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT_\ \!4_PH P/^%W?#K_ *'[PO\ ^#FV_P#BZ/\ A=WPZ_Z'[PO_ .#FV_\
MBZW_ /A$]#_Z VG_ /@*G^%'_")Z'_T!M/\ _ 5/\* ,#_A=WPZ_Z'[PO_X.
M;;_XNC_A=WPZ_P"A^\+_ /@YMO\ XNM__A$]#_Z VG_^ J?X4?\ ")Z'_P!
M;3__  %3_"@# _X7=\.O^A^\+_\ @YMO_BZ/^%W?#K_H?O"__@YMO_BZW_\
MA$]#_P"@-I__ ("I_A1_PB>A_P#0&T__ ,!4_P * ,#_ (7=\.O^A^\+_P#@
MYMO_ (NC_A=WPZ_Z'[PO_P"#FV_^+K?_ .$3T/\ Z VG_P#@*G^%'_")Z'_T
M!M/_ / 5/\* ,#_A=WPZ_P"A^\+_ /@YMO\ XNC_ (7=\.O^A^\+_P#@YMO_
M (NM_P#X1/0_^@-I_P#X"I_A1_PB>A_] ;3_ /P%3_"@# _X7=\.O^A^\+_^
M#FV_^+H_X7=\.O\ H?O"_P#X.;;_ .+K?_X1/0_^@-I__@*G^%'_  B>A_\
M0&T__P !4_PH P/^%W?#K_H?O"__ (.;;_XNC_A=WPZ_Z'[PO_X.;;_XNM__
M (1/0_\ H#:?_P" J?X4?\(GH?\ T!M/_P# 5/\ "@# _P"%W?#K_H?O"_\
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MB>A_] ;3_P#P%3_"@# _X7=\.O\ H?O"_P#X.;;_ .+H_P"%W?#K_H?O"_\
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M5L55OM+LM45%O+2"[5#E1/$KA3[9% '*?\+N^'7_ $/WA?\ \'-M_P#%T?\
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M - ;3_\ P%3_  H_X1/0_P#H#:?_ . J?X4 8'_"[OAU_P!#]X7_ /!S;?\
MQ='_  N[X=?]#]X7_P#!S;?_ !=;_P#PB>A_] ;3_P#P%3_"C_A$]#_Z VG_
M /@*G^% &!_PN[X=?]#]X7_\'-M_\71_PN[X=?\ 0_>%_P#P<VW_ ,76_P#\
M(GH?_0&T_P#\!4_PH_X1/0_^@-I__@*G^% &!_PN[X=?]#]X7_\ !S;?_%T?
M\+N^'7_0_>%__!S;?_%UO_\ ")Z'_P! ;3__  %3_"C_ (1/0_\ H#:?_P"
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M ("I_A0!@?\ "[OAU_T/WA?_ ,'-M_\ %T?\+N^'7_0_>%__  <VW_Q=;_\
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M ,76_P#\(GH?_0&T_P#\!4_PH_X1/0_^@-I__@*G^% &!_PN[X=?]#]X7_\
M!S;?_%T?\+N^'7_0_>%__!S;?_%UO_\ ")Z'_P! ;3__  %3_"C_ (1/0_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?XX_\";/_P"1:/\ A3>H_P#13_''_@39_P#R+0!Z717FG_"F]1_Z*?XX_P#
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MBG^./_ FS_\ D6C_ (4WJ/\ T4_QQ_X$V?\ \BT >ET5YI_PIO4?^BG^./\
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MQ_X$V?\ \BT >ET5YI_PIO4?^BG^./\ P)L__D6C_A3>H_\ 13_''_@39_\
MR+0!Z717FG_"F]1_Z*?XX_\  FS_ /D6C_A3>H_]%/\ ''_@39__ "+0!Z71
M7FG_  IO4?\ HI_CC_P)L_\ Y%H_X4WJ/_13_''_ ($V?_R+0!Z717FG_"F]
M1_Z*?XX_\";/_P"1:/\ A3>H_P#13_''_@39_P#R+0!Z717FG_"F]1_Z*?XX
M_P# FS_^1:/^%-ZC_P!%/\<?^!-G_P#(M 'I=%>:?\*;U'_HI_CC_P ";/\
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M/^%-ZC_T4_QQ_P"!-G_\BT >ET5YI_PIO4?^BG^./_ FS_\ D6C_ (4WJ/\
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MB#?R^//%6LQQ?V?FRU&>V:"3.HVR_,$@5N,Y&&'('TH ^BOV5?\ DU_X/_\
M8G:/_P"D4->I5Y;^RK_R:_\ !_\ [$[1_P#TBAKU*@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OEO\ X*=?
M\F._$K_N&_\ ISM:^I*^6_\ @IU_R8[\2O\ N&_^G.UH ]2_95_Y-?\ @_\
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M $6KX@?]\:-_\KJ /5:*\J_X4KXB_P"BU?$#_OC1O_E=1_PI7Q%_T6KX@?\
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M_P KJ /5:*\J_P"%*^(O^BU?$#_OC1O_ )74?\*5\1?]%J^('_?&C?\ RNH
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M*** "BBB@ HHHH **** "BN3\<^"=2\8-9'3_&WB'P>+</O&A+9$7&[;C?\
M:;:;[N#C;M^\<YXQRW_"E?$7_1:OB!_WQHW_ ,KJ /5:*\J_X4KXB_Z+5\0/
M^^-&_P#E=1_PI7Q%_P!%J^('_?&C?_*Z@#U6BO*O^%*^(O\ HM7Q _[XT;_Y
M74?\*5\1?]%J^('_ 'QHW_RNH ]5HKRK_A2OB+_HM7Q _P"^-&_^5U'_  I7
MQ%_T6KX@?]\:-_\ *Z@#U6BO*O\ A2OB+_HM7Q _[XT;_P"5U'_"E?$7_1:O
MB!_WQHW_ ,KJ /5:*\J_X4KXB_Z+5\0/^^-&_P#E=1_PI7Q%_P!%J^('_?&C
M?_*Z@#U6BO*O^%*^(O\ HM7Q _[XT;_Y74?\*5\1?]%J^('_ 'QHW_RNH ]5
MHKRK_A2OB+_HM7Q _P"^-&_^5U'_  I7Q%_T6KX@?]\:-_\ *Z@#U6BO*O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\
M"HOO_CM ']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^
M_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO
M_CM ']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#C
MM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM
M']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']
M*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=
M%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?
MS6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6
M?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\
M-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8
M_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&
M_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__
M *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z
M+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)
M\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0
M/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)\0/_
M  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"H
MOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)\0/_  J+
M[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\
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M /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\
MHLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HL
MGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ
M _\ "HOO_CM ']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _
M\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\
M"HOO_CM ']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^
M_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO
M_CM ']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#C
MM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM
M']*=%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']
M*=%?S6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=
M%?S6?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?
MS6?\-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6
M?\-8_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\
M-8_&_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8
M_&__ *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&
M_P#Z+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__
M *+)\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z
M+)\0/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)
M\0/_  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0
M/_"HOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)\0/_
M  J+[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"H
MOO\ X[1_PUC\;_\ HLGQ _\ "HOO_CM ']*=%?S6?\-8_&__ *+)\0/_  J+
M[_X[1_PUC\;_ /HLGQ _\*B^_P#CM ']*=%?S6?\-8_&_P#Z+)\0/_"HOO\
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-%6PRJPR."H/44 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>smlr-20241231xex19d1011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ! 3P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\JJ*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>smlr-20241231xex19d1014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " !@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\JJ*** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>smlr-20241231xex19d1015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  6 !8# 2(  A$! Q$!_\0
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I]ON^\&6EIX,A\%2>%X[Z4F;5S>BY%P;8=K>/85\D>N=W;')110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>smlr-20241231xex19d1017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " >H# 2(  A$! Q$!_\0
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? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>smlr-20241231xex19d1018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  $ ;(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZY\0_L.?\
M)#K^IZI_PT!\=--^W74MS]BT[QGY5M;[W+>7$GDG:BYPJY.  *S_ /A@7_JX
MW]H#_P +G_[1110 ?\,"_P#5QO[0'_A<_P#VBC_A@7_JXW]H#_PN?_M%%% !
M_P ,"_\ 5QO[0'_A<_\ VBC_ (8%_P"KC?V@/_"Y_P#M%%% !_PP+_U<;^T!
M_P"%S_\ :*/^&!?^KC?V@/\ PN?_ +1110 ?\,"_]7&_M ?^%S_]HH_X8%_Z
MN-_: _\ "Y_^T444 '_# O\ U<;^T!_X7/\ ]HH_X8%_ZN-_: _\+G_[1110
M ?\ # O_ %<;^T!_X7/_ -HH_P"&!?\ JXW]H#_PN?\ [1110 ?\,"_]7&_M
M ?\ A<__ &BC_A@7_JXW]H#_ ,+G_P"T444 '_# O_5QO[0'_A<__:*/^&!?
M^KC?V@/_  N?_M%%% !_PP+_ -7&_M ?^%S_ /:*/^&!?^KC?V@/_"Y_^T44
M4 '_  P+_P!7&_M ?^%S_P#:*/\ A@7_ *N-_: _\+G_ .T444 '_# O_5QO
M[0'_ (7/_P!HH_X8%_ZN-_: _P#"Y_\ M%%% !_PP+_U<;^T!_X7/_VBC_A@
M7_JXW]H#_P +G_[1110 ?\,"_P#5QO[0'_A<_P#VBC_A@7_JXW]H#_PN?_M%
M%% !_P ,"_\ 5QO[0'_A<_\ VBC_ (8%_P"KC?V@/_"Y_P#M%%% !_PP+_U<
M;^T!_P"%S_\ :*/^&!?^KC?V@/\ PN?_ +1110 ?\,"_]7&_M ?^%S_]HH_X
M8%_ZN-_: _\ "Y_^T444 '_# O\ U<;^T!_X7/\ ]HH_X8%_ZN-_: _\+G_[
M1110 ?\ # O_ %<;^T!_X7/_ -HH_P"&!?\ JXW]H#_PN?\ [1110 ?\,"_]
M7&_M ?\ A<__ &BC_A@7_JXW]H#_ ,+G_P"T444 '_# O_5QO[0'_A<__:*/
M^&!?^KC?V@/_  N?_M%%% !_PP+_ -7&_M ?^%S_ /:*/^&!?^KC?V@/_"Y_
M^T444 '_  P+_P!7&_M ?^%S_P#:*/\ A@7_ *N-_: _\+G_ .T444 '_# O
M_5QO[0'_ (7/_P!HH_X8%_ZN-_: _P#"Y_\ M%%% !_PP+_U<;^T!_X7/_VB
MC_A@7_JXW]H#_P +G_[1110 ?\,"_P#5QO[0'_A<_P#VBC_A@7_JXW]H#_PN
M?_M%%% !_P ,"_\ 5QO[0'_A<_\ VBC_ (8%_P"KC?V@/_"Y_P#M%%% 'M_A
M[X4_\(]H&F:7_P )CXLU+[#:Q6WVW4=4\VYN-B!?,E?:-SMC+-@9))HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>smlr-20241231xex19d1019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smlr-20241231xex19d1019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  " ;$# 2(  A$! Q$!_\0
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3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>26
<FILENAME>smlr-20241231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/28/2025 9:05:53 PM-->
<!--Modified on: 2/28/2025 9:05:53 PM-->
<xsd:schema xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" targetNamespace="http://semlerscientific.com/20241231" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:smlr="http://semlerscientific.com/20241231" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/StatementBalanceSheets" id="StatementBalanceSheets">
        <link:definition>995200100 - Statement - Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/StatementStatementsOfIncome" id="StatementStatementsOfIncome">
        <link:definition>995200200 - Statement - Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/StatementStatementsOfCashFlows" id="StatementStatementsOfCashFlows">
        <link:definition>995200400 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails" id="DisclosureAssetsForLeaseNetDetails">
        <link:definition>99940301 - Disclosure - Assets for Lease, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails" id="DisclosurePropertyAndEquipmentNetDetails">
        <link:definition>99940501 - Disclosure - Property and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" id="DisclosureFairValueMeasurementsDetails">
        <link:definition>99940701 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAccruedExpensesDetails" id="DisclosureAccruedExpensesDetails">
        <link:definition>99941101 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails" id="DisclosureLeasesFutureMinimumRentalPaymentsDetails">
        <link:definition>99941301 - Disclosure - Leases - Future minimum rental payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLesseeArrangementsFutureMinimumRentalPaymentsDetailsCalc2" id="DisclosureLesseeArrangementsFutureMinimumRentalPaymentsDetailsCalc2">
        <link:definition>41301 - Disclosure - Lessee Arrangements - Future minimum rental payments (Details) - Calc2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" id="DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails">
        <link:definition>99941701 - Disclosure - Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" id="DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails">
        <link:definition>99941702 - Disclosure - Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" id="DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails">
        <link:definition>99941703 - Disclosure - Income Taxes - Summary of Deferred tax (liabilities) assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails" id="DisclosureNetIncomePerShareBasicAndDilutedDetails">
        <link:definition>99941801 - Disclosure - Net Income Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" id="DisclosureSegmentInformationReportableSegmentInformationDetails">
        <link:definition>99941902 - Disclosure - Segment Information - Reportable Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity" id="StatementStatementsOfStockholdersEquity">
        <link:definition>995200300 - Statement - Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails">
        <link:definition>99940202 - Disclosure - Summary of Significant Accounting Policies and Estimates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureInventoryDetails" id="DisclosureInventoryDetails">
        <link:definition>99940401 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails" id="DisclosureLongTermInvestmentsDetails">
        <link:definition>99940601 - Disclosure - Long-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails" id="DisclosureLongTermInvestmentsAdditionalInformationDetails">
        <link:definition>99940602 - Disclosure - Long-Term Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" id="DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>99940702 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails" id="DisclosureFairValueMeasurementsValuationModelDetails">
        <link:definition>99940703 - Disclosure - Fair Value Measurements - Valuation model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" id="DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails">
        <link:definition>99940704 - Disclosure - Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails" id="DisclosureNotesHeldForInvestmentDetails">
        <link:definition>99940801 - Disclosure - Notes held for investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails" id="DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails">
        <link:definition>99940901 - Disclosure - Intangible Digital Assets- Intangible Assets Cost Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails" id="DisclosureOtherNonCurrentAssetsDetails">
        <link:definition>99941001 - Disclosure - Other non-current assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails" id="DisclosureConcentrationOfCreditRiskDetails">
        <link:definition>99941201 - Disclosure - Concentration of Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails" id="DisclosureLeasesLesseeArrangementsDetails">
        <link:definition>99941302 - Disclosure - Leases - Lessee Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureCommitmentsAndContingenciesDetails" id="DisclosureCommitmentsAndContingenciesDetails">
        <link:definition>99941401 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>99941501 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails" id="DisclosureStockOptionPlanAdditionalInformationDetails">
        <link:definition>99941601 - Disclosure - Stock Option Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" id="DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails">
        <link:definition>99941603 - Disclosure - Stock Option Plan - Weighted average assumptions used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" id="DisclosureStockOptionPlanStockBasedCompensationExpenseDetails">
        <link:definition>99941604 - Disclosure - Stock Option Plan - Stock-based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>99941705 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>99942001 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>995200090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/StatementBalanceSheetsParenthetical" id="StatementBalanceSheetsParenthetical">
        <link:definition>995200105 - Statement - Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureCompany" id="DisclosureCompany">
        <link:definition>995210101 - Disclosure - The Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates" id="DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates">
        <link:definition>995210201 - Disclosure - Summary of Significant Accounting Policies and Estimates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNet" id="DisclosureAssetsForLeaseNet">
        <link:definition>995210301 - Disclosure - Assets for Lease, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureInventory" id="DisclosureInventory">
        <link:definition>995210401 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet" id="DisclosurePropertyAndEquipmentNet">
        <link:definition>995210501 - Disclosure - Property and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestments" id="DisclosureLongTermInvestments">
        <link:definition>995210601 - Disclosure - Long-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>995210701 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestment" id="DisclosureNotesHeldForInvestment">
        <link:definition>995210801 - Disclosure - Notes held for investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets" id="DisclosureIntangibleDigitalAssets">
        <link:definition>995210901 - Disclosure - Intangible Digital Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets" id="DisclosureOtherNonCurrentAssets">
        <link:definition>995211001 - Disclosure - Other non-current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAccruedExpenses" id="DisclosureAccruedExpenses">
        <link:definition>995211101 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk" id="DisclosureConcentrationOfCreditRisk">
        <link:definition>995211201 - Disclosure - Concentration of Credit Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLeases" id="DisclosureLeases">
        <link:definition>995211301 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>995211401 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
        <link:definition>995211501 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlan" id="DisclosureStockOptionPlan">
        <link:definition>995211601 - Disclosure - Stock Option Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>995211701 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted" id="DisclosureNetIncomePerShareBasicAndDiluted">
        <link:definition>995211801 - Disclosure - Net Income Per Share, Basic and Diluted</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSegmentInformation" id="DisclosureSegmentInformation">
        <link:definition>995211901 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>995212001 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies">
        <link:definition>99920102 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables">
        <link:definition>99930203 - Disclosure - Summary of Significant Accounting Policies and Estimates (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables" id="DisclosureAssetsForLeaseNetTables">
        <link:definition>99930303 - Disclosure - Assets for Lease, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables" id="DisclosurePropertyAndEquipmentNetTables">
        <link:definition>99930503 - Disclosure - Property and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables" id="DisclosureLongTermInvestmentsTables">
        <link:definition>99930603 - Disclosure - Long-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>99930703 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables" id="DisclosureNotesHeldForInvestmentTables">
        <link:definition>99930803 - Disclosure - Notes held for investment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables" id="DisclosureIntangibleDigitalAssetsTables">
        <link:definition>99930903 - Disclosure - Intangible Digital Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAccruedExpensesTables" id="DisclosureAccruedExpensesTables">
        <link:definition>99931103 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>99931303 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanTables" id="DisclosureStockOptionPlanTables">
        <link:definition>99931603 - Disclosure - Stock Option Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>99931703 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables" id="DisclosureNetIncomePerShareBasicAndDilutedTables">
        <link:definition>99931803 - Disclosure - Net Income Per Share, Basic and Diluted (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationTables" id="DisclosureSegmentInformationTables">
        <link:definition>99931903 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails">
        <link:definition>99940201 - Disclosure - Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails" id="DisclosureAssetsForLeaseNetAdditionalInformationDetails">
        <link:definition>99940302 - Disclosure - Assets for Lease, net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" id="DisclosurePropertyAndEquipmentNetAdditionalInformationDetails">
        <link:definition>99940502 - Disclosure - Property and Equipment, net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails" id="DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails">
        <link:definition>99940902 - Disclosure - Intangible Digital Assets- Reconciliation of fair value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails" id="DisclosureLeasesLessorArrangementsDetails">
        <link:definition>99941303 - Disclosure - Leases - Lessor Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails" id="DisclosureLeasesVariableFeeRevenueDetails">
        <link:definition>99941304 - Disclosure - Leases - Variable-fee Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails" id="DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails">
        <link:definition>99941602 - Disclosure - Stock Option Plan - Summary of the Company's stock option activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails">
        <link:definition>99941704 - Disclosure - Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationDetails" id="DisclosureSegmentInformationDetails">
        <link:definition>99941901 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="smlr-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="smlr-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="smlr-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="smlr-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="https://xbrl.org/2023/calculation-1.1" schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd" />
  <xsd:element name="CustomerOneConcentrationRiskMember" id="smlr_CustomerOneConcentrationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="CustomerTwoConcentrationRiskMember" id="smlr_CustomerTwoConcentrationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="VendorOneMember" id="smlr_VendorOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="VendorTwoMember" id="smlr_VendorTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="VendorThreeMember" id="smlr_VendorThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="ConcentrationRiskNumberOfCustomers" id="smlr_ConcentrationRiskNumberOfCustomers" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="ConcentrationRiskNumberOfVendors" id="smlr_ConcentrationRiskNumberOfVendors" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="KeyPersonStockOptionPlan2007Member" id="smlr_KeyPersonStockOptionPlan2007Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="StockIncentivePlan2014Member" id="smlr_StockIncentivePlan2014Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element name="PercentageOfSharesReserveIncrease" id="smlr_PercentageOfSharesReserveIncrease" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
  <xsd:element id="smlr_CompanyAbstract" name="CompanyAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_StockholdersEquityDeficitTable" name="StockholdersEquityDeficitTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_CommonStockWarrantsMember" name="CommonStockWarrantsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_StockholdersEquityDeficitLineItems" name="StockholdersEquityDeficitLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_ExaminationOfCompanyTaxYears" name="ExaminationOfCompanyTaxYears" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="smlr_CustomerThreeConcentrationRiskMember" name="CustomerThreeConcentrationRiskMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_LeaseDisclosureTextBlock" name="LeaseDisclosureTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="smlr_AssetsForLeaseNetAbstract" name="AssetsForLeaseNetAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_AssetsForLeaseNetTextBlock" name="AssetsForLeaseNetTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock" name="ScheduleOfAssetsForLeaseNetTableTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" />
  <xsd:element id="smlr_AssetsForLeaseCustomerLocation" name="AssetsForLeaseCustomerLocation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="smlr_InvestmentInPrivateCompanyTwoMember" name="InvestmentInPrivateCompanyTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_InvestmentInPrivateCompanyThreeMember" name="InvestmentInPrivateCompanyThreeMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_PromissoryNoteFromPrivateCompanyTwoMember" name="PromissoryNoteFromPrivateCompanyTwoMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
  <xsd:element id="smlr_OperatingLeaseExpensesInExcessOfCashPayments" name="OperatingLeaseExpensesInExcessOfCashPayments" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="smlr_DeferredTaxAssetsLeaseLiabilities" name="DeferredTaxAssetsLeaseLiabilities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" />
  <xsd:element id="smlr_DeferredTaxAssetsRightOfUseAssets" name="DeferredTaxAssetsRightOfUseAssets" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" />
  <xsd:element name="ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" id="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" id="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="NumberOfVotesForEachShare" id="smlr_NumberOfVotesForEachShare" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="SeniorSecuredPromissoryNotesMember" id="smlr_SeniorSecuredPromissoryNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" id="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TaxesPaidRelatedToNetShareSettlementOfEquityAwards" id="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OtherNoncurrentAssetsTextBlock" id="smlr_OtherNoncurrentAssetsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="SecuredConvertiblePromissoryNoteMember" id="smlr_SecuredConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NotesReceivableInterestBearingInterestRate" id="smlr_NotesReceivableInterestBearingInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NotesReceivableTerm" id="smlr_NotesReceivableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfNotesReceivable" id="smlr_NumberOfNotesReceivable" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="AssetsForLeaseReductionToAccumulatedDepreciation" id="smlr_AssetsForLeaseReductionToAccumulatedDepreciation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DebtSecurityMaximumAmountOfAvailableFunding" id="smlr_DebtSecurityMaximumAmountOfAvailableFunding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DebtSecuritiesTransactionFee" id="smlr_DebtSecuritiesTransactionFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="NumberOfConsecutiveTermsOptionToExtendMaturityDate" id="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ExtensionPeriodOptionToExtendMaturityDate" id="smlr_ExtensionPeriodOptionToExtendMaturityDate" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtSecurityInterestIncome" id="smlr_DebtSecurityInterestIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtSecurityChangesInFairValue" id="smlr_DebtSecurityChangesInFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="MonarchMedicalTechnologyLlcMember" id="smlr_MonarchMedicalTechnologyLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DebtSecurityInterestRate" id="smlr_DebtSecurityInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MiscellaneousReceivables" id="smlr_MiscellaneousReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="LongTermDeposits" id="smlr_LongTermDeposits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="PercentageOfProbabilityOfEquityFinancing" id="smlr_PercentageOfProbabilityOfEquityFinancing" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfProbabilityOfChangeOfControl" id="smlr_PercentageOfProbabilityOfChangeOfControl" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" id="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="FairValueAdjustmentOfNotesHeldForInvestment" id="smlr_FairValueAdjustmentOfNotesHeldForInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" id="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="PrepaidLicensePurchasesWriteoff" id="smlr_PrepaidLicensePurchasesWriteoff" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ResearchAndExperimentalExpendituresCapitalized" id="smlr_ResearchAndExperimentalExpendituresCapitalized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ClassOfWarrantOrRightValueRepurchased" id="smlr_ClassOfWarrantOrRightValueRepurchased" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DebtSecurityFaceValue" id="smlr_DebtSecurityFaceValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="BitcoinMember" id="smlr_BitcoinMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IntangibleDigitalAssetsAbstract" id="smlr_IntangibleDigitalAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IntangibleDigitalAssetsPolicyPolicyTextBlock" id="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="AccountsReceivableAllowanceForCreditLossAdditionalReserve" id="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ContractWithCustomerAccountsReceivableNet" id="smlr_ContractWithCustomerAccountsReceivableNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="SaleOfStockValueAuthorized" id="smlr_SaleOfStockValueAuthorized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ImpairmentLossesInvestments" id="smlr_ImpairmentLossesInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="CryptoAssetNumberOfUnitsPurchased" id="smlr_CryptoAssetNumberOfUnitsPurchased" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="CryptoAssetAveragePurchasePrice" id="smlr_CryptoAssetAveragePurchasePrice" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" id="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ProceedsFromTransactionFeeOfDebtSecurities" id="smlr_ProceedsFromTransactionFeeOfDebtSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ProceedsRelatingToAccruedInterestOfDebtSecurities" id="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="AtMarketOfferingMember" id="smlr_AtMarketOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" id="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OtherCorporateIncomeExpense" id="smlr_OtherCorporateIncomeExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ConvertibleSeniorNote4.25Member" id="smlr_ConvertibleSeniorNote4.25Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" id="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" id="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" id="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ProceedsFromPaymentsForEquipmentForLeases" id="smlr_ProceedsFromPaymentsForEquipmentForLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="RevenuePerformanceObligationPaymentTermsNumberOfDays" id="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DefectiveProductReplacementCost" id="smlr_DefectiveProductReplacementCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ConcentrationRiskCryptoAssetNumberOfProviders" id="smlr_ConcentrationRiskCryptoAssetNumberOfProviders" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IntangibleDigitalAssetBenchmarkMember" id="smlr_IntangibleDigitalAssetBenchmarkMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="InvestmentHoldingConcentrationRiskMember" id="smlr_InvestmentHoldingConcentrationRiskMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CryptoAssetProviderOneMember" id="smlr_CryptoAssetProviderOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CryptoAssetProviderTwoMember" id="smlr_CryptoAssetProviderTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" id="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtInstrumentConvertibleThresholdBusinessDays" id="smlr_DebtInstrumentConvertibleThresholdBusinessDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" id="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" id="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" id="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="DebtInstrumentFundamentalChangeRepurchasePricePercentage" id="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IncomeTaxExaminationsMaximumEstimatedLiability" id="smlr_IncomeTaxExaminationsMaximumEstimatedLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultInterestPeriod" id="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" id="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" id="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" id="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" id="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" id="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" id="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="CryptoAssetMarketPricePerCryptoAsset" id="smlr_CryptoAssetMarketPricePerCryptoAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" id="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="SingleReportableSegmentMember" id="smlr_SingleReportableSegmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EngineeringAndProductDevelopmentMember" id="smlr_EngineeringAndProductDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" id="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" id="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>27
<FILENAME>smlr-20241231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/28/2025 9:05:53 PM-->
<!--Modified on: 2/28/2025 9:05:53 PM-->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementBalanceSheets" roleURI="http://semlerscientific.com/role/StatementBalanceSheets" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementStatementsOfIncome" roleURI="http://semlerscientific.com/role/StatementStatementsOfIncome" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementStatementsOfCashFlows" roleURI="http://semlerscientific.com/role/StatementStatementsOfCashFlows" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAssetsForLeaseNetDetails" roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosurePropertyAndEquipmentNetDetails" roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAccruedExpensesDetails" roleURI="http://semlerscientific.com/role/DisclosureAccruedExpensesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeasesFutureMinimumRentalPaymentsDetails" roleURI="http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLesseeArrangementsFutureMinimumRentalPaymentsDetailsCalc2" roleURI="http://semlerscientific.com/role/DisclosureLesseeArrangementsFutureMinimumRentalPaymentsDetailsCalc2" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNetIncomePerShareBasicAndDilutedDetails" roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSegmentInformationReportableSegmentInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" />
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" />
  <link:calculationLink xlink:role="http://semlerscientific.com/role/StatementBalanceSheets" xlink:type="extended" xlink:title="995200100 - Statement - Balance Sheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_638763735487620527" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638763735487620527" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638763735487620527" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638763735487620527" xlink:to="us-gaap_RestrictedCashCurrent_638763735487620527" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638763735487620527" xlink:to="us-gaap_AccountsReceivableNetCurrent_638763735487620527" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638763735487620527" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_638763735487620527" order="4" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638763735487620527" xlink:to="us-gaap_InventoryNet_638763735487620527" order="5" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638763735487620527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638763735487620527" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638763735487620527" order="6" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_638763735487630532" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent_638763735487630532" order="2" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValueNoncurrent" xlink:label="us-gaap_CryptoAssetFairValueNoncurrent_638763735487630532" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_CryptoAssetFairValueNoncurrent_638763735487630532" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments_638763735487630532" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_LongTermInvestments_638763735487630532" order="4" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_638763735487630532" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent_638763735487630532" order="5" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_638763735487630532" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_638763735487630532" order="6" use="optional" weight="1" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_638763735487630532" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_638763735487630532" order="7" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_638763735487640529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_638763735487640529" order="8" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_637044010124671620" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638763735487640529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_637044010124671620" xlink:to="us-gaap_LiabilitiesCurrent_638763735487640529" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_638763735487640529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638763735487640529" xlink:to="us-gaap_AccountsPayableCurrent_638763735487640529" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638763735487640529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638763735487640529" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638763735487640529" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_638763735487640529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638763735487640529" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_638763735487640529" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_638763735487650529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638763735487640529" xlink:to="us-gaap_OtherLiabilitiesCurrent_638763735487650529" order="4" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent_638763735487650529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_637044010124671620" xlink:to="us-gaap_LiabilitiesNoncurrent_638763735487650529" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638763735487650529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent_638763735487650529" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638763735487650529" order="1" use="optional" weight="1" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_638763735487650529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent_638763735487650529" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_638763735487650529" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638763735487650529" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent_638763735487650529" xlink:to="us-gaap_CommitmentsAndContingencies_638763735487650529" order="3" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638763735487660531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_637044010124671620" xlink:to="us-gaap_StockholdersEquity_638763735487660531" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638763735487660531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638763735487660531" xlink:to="us-gaap_CommonStockValue_638763735487660531" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638763735487660531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638763735487660531" xlink:to="us-gaap_AdditionalPaidInCapital_638763735487660531" order="2" use="optional" weight="1" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638763735487660531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638763735487660531" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638763735487660531" order="3" use="optional" weight="1" priority="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/StatementStatementsOfIncome" xlink:type="extended" xlink:title="995200200 - Statement - Statements of Income">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637044010124671620" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735487670520" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_637044010124671620" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735487670520" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638763735487670520" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735487670520" xlink:to="us-gaap_OperatingIncomeLoss_638763735487670520" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638763735487670520" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487670520" xlink:to="us-gaap_Revenues_638763735487670520" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses_638763735487670520" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487670520" xlink:to="us-gaap_CostsAndExpenses_638763735487670520" order="2" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue_638763735487670520" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_638763735487670520" xlink:to="us-gaap_CostOfRevenue_638763735487670520" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_638763735487670520" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_638763735487670520" xlink:to="us-gaap_ResearchAndDevelopmentExpense_638763735487670520" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_638763735487670520" xlink:to="us-gaap_SellingAndMarketingExpense_638763735487680527" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_638763735487670520" xlink:to="us-gaap_GeneralAndAdministrativeExpense_638763735487680527" order="4" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_638763735487670520" xlink:to="us-gaap_RestructuringCharges_638763735487680527" order="5" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735487670520" xlink:to="us-gaap_NonoperatingIncomeExpense_638763735487680527" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638763735487680527" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735487680527" order="1" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638763735487680527" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735487680527" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_638763735487680527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638763735487680527" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_638763735487680527" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments_638763735487690527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638763735487680527" xlink:to="smlr_ImpairmentLossesInvestments_638763735487690527" order="4" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638763735487690527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638763735487680527" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638763735487690527" order="5" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638763735487690527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_637044010124671620" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638763735487690527" order="2" use="optional" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/StatementStatementsOfCashFlows" xlink:type="extended" xlink:title="995200400 - Statement - Statements of Cash Flows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" order="1" use="optional" weight="1" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_ProfitLoss_638763735487700533" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_DepreciationAndAmortization_638763735487700533" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735487700533" order="3" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_638763735487700533" order="4" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_638763735487700533" order="5" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PrepaidLicensePurchasesWriteoff" xlink:label="smlr_PrepaidLicensePurchasesWriteoff_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="smlr_PrepaidLicensePurchasesWriteoff_638763735487700533" order="6" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesTradingRealizedGain" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain_638763735487700533" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_DebtSecuritiesTradingRealizedGain_638763735487700533" order="7" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638763735487710531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_ShareBasedCompensation_638763735487710531" order="8" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_638763735487710531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_638763735487710531" order="9" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_638763735487710531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInInventories_638763735487710531" order="10" use="optional" weight="-1" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638763735487710531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638763735487710531" order="11" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_638763735487710531" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_638763735487710531" order="12" use="optional" weight="-1" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_638763735487720542" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_638763735487720542" order="13" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638763735487720542" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638763735487720542" order="14" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638763735487720542" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638763735487720542" order="15" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735487720542" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735487720542" order="16" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735487720542" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735487720542" order="17" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments_638763735487720542" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735487690527" xlink:to="smlr_ImpairmentLossesInvestments_638763735487720542" order="18" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" order="2" use="optional" weight="1" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638763735487730528" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638763735487730528" order="1" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_638763735487730528" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_638763735487730528" order="2" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_638763735487730528" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset_638763735487730528" order="3" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_638763735487730528" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_638763735487730528" order="4" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromPaymentsForEquipmentForLeases" xlink:label="smlr_ProceedsFromPaymentsForEquipmentForLeases_638763735487740522" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" xlink:to="smlr_ProceedsFromPaymentsForEquipmentForLeases_638763735487740522" order="5" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_638763735487740522" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735487730528" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_638763735487740522" order="6" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" order="3" use="optional" weight="1" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_638763735487740522" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_638763735487740522" order="1" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638763735487740522" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638763735487740522" order="2" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_638763735487750524" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_638763735487750524" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants_638763735487750524" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants_638763735487750524" order="4" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638763735487750524" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735487740522" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638763735487750524" order="5" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails" xlink:type="extended" xlink:title="99940301 - Disclosure - Assets for Lease, net (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_638763735487760523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_638763735487760523" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_638763735487760523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_638763735487760523" order="2" use="optional" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="99940501 - Disclosure - Property and Equipment, net (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_638763735487760523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_1" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_638763735487760523" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_638763735487760523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_1" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_638763735487760523" order="2" use="optional" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="99940701 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt" xlink:label="us-gaap_TradingSecuritiesDebt_638763735487770521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_TradingSecuritiesDebt_638763735487770521" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HeldToMaturitySecuritiesFairValue" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_638763735487770521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_638763735487770521" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_638763735487770521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_638763735487770521" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue_638763735487770521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CryptoAssetFairValue_638763735487770521" order="4" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureAccruedExpensesDetails" xlink:type="extended" xlink:title="99941101 - Disclosure - Accrued Expenses (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_638763735487770521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_638763735487770521" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638763735487770521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638763735487770521" order="2" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_638763735487780521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_638763735487780521" order="3" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails" xlink:type="extended" xlink:title="99941301 - Disclosure - Leases - Future minimum rental payments (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638763735487780521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638763735487780521" order="1" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureLesseeArrangementsFutureMinimumRentalPaymentsDetailsCalc2" xlink:type="extended" xlink:title="41301 - Disclosure - Lessee Arrangements - Future minimum rental payments (Details) - Calc2">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638763735487780521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638763735487780521" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_638763735487780521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2" xlink:to="us-gaap_OperatingLeaseLiability_638763735487780521" order="2" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" xlink:type="extended" xlink:title="99941701 - Disclosure - Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735487790521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735487790521" order="1" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638763735487790521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735487790521" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638763735487790521" order="1" use="optional" weight="1" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638763735487790521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735487790521" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638763735487790521" order="2" use="optional" weight="1" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_638763735487790521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_638763735487790521" order="2" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638763735487790521" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit_638763735487790521" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638763735487790521" order="1" use="optional" weight="1" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_638763735487800523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit_638763735487790521" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_638763735487800523" order="2" use="optional" weight="1" priority="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" xlink:type="extended" xlink:title="99941702 - Disclosure - Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638763735487800523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638763735487800523" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_638763735487800523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_638763735487800523" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_638763735487800523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_638763735487800523" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_638763735487800523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_638763735487800523" order="4" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_638763735487810523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_638763735487810523" order="5" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" xlink:type="extended" xlink:title="99941703 - Disclosure - Income Taxes - Summary of Deferred tax (liabilities) assets (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_638763735487810523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_638763735487810523" order="1" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet_638763735487810523" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet_638763735487810523" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet_638763735487830557" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsNet_638763735487830557" order="1" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_638763735487840544" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet_638763735487830557" xlink:to="us-gaap_DeferredTaxAssetsGross_638763735487840544" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638763735487840544" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638763735487840544" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_638763735487840544" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_638763735487840544" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638763735487840544" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638763735487840544" order="3" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_638763735487840544" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_638763735487840544" order="4" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_638763735487850573" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_638763735487850573" order="5" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther_638763735487850573" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsOther_638763735487850573" order="6" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_638763735487850573" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_638763735487850573" order="7" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxAssetsLeaseLiabilities" xlink:label="smlr_DeferredTaxAssetsLeaseLiabilities_638763735487850573" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_638763735487840544" xlink:to="smlr_DeferredTaxAssetsLeaseLiabilities_638763735487850573" order="8" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_638763735487850573" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet_638763735487830557" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_638763735487850573" order="2" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_638763735487860559" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_638763735487860559" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxAssetsRightOfUseAssets" xlink:label="smlr_DeferredTaxAssetsRightOfUseAssets_638763735487860559" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities_638763735487860559" xlink:to="smlr_DeferredTaxAssetsRightOfUseAssets_638763735487860559" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" xlink:label="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_638763735487860559" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities_638763735487860559" xlink:to="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_638763735487860559" order="2" use="optional" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails" xlink:type="extended" xlink:title="99941801 - Disclosure - Net Income Per Share, Basic and Diluted (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_638763735487880537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_638763735487880537" order="1" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" xlink:label="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_638763735487880537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_638763735487880537" order="2" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638763735487880537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638763735487880537" order="1" use="optional" weight="1" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638763735487880537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638763735487880537" order="2" use="optional" weight="1" priority="2" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" xlink:type="extended" xlink:title="99941902 - Disclosure - Segment Information - Reportable Segment Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638763735487890536" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss_638763735487890536" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638763735487890536" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_Revenues_638763735487890536" order="1" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue_638763735487890536" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_CostOfRevenue_638763735487890536" order="2" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_638763735487890536" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_ResearchAndDevelopmentExpense_638763735487890536" order="3" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDevelopment" xlink:label="us-gaap_BusinessDevelopment_638763735487890536" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_BusinessDevelopment_638763735487890536" order="4" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_638763735487900537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_GeneralAndAdministrativeExpense_638763735487900537" order="5" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount_638763735487900537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_SegmentReportingOtherItemAmount_638763735487900537" order="6" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense_638763735487900537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_SellingExpense_638763735487900537" order="7" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_638763735487900537" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638763735487890536" xlink:to="us-gaap_DepreciationDepletionAndAmortization_638763735487900537" order="8" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_638763735487910535" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_638763735487910535" order="2" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments_638763735487910535" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="smlr_ImpairmentLossesInvestments_638763735487910535" order="3" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735487910535" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735487910535" order="4" use="optional" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735487910535" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735487910535" order="5" use="optional" weight="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OtherCorporateIncomeExpense" xlink:label="smlr_OtherCorporateIncomeExpense_638763735487910535" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="smlr_OtherCorporateIncomeExpense_638763735487910535" order="6" use="optional" weight="1" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>28
<FILENAME>smlr-20241231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/28/2025 9:05:53 PM-->
<!--Modified on: 2/28/2025 9:05:53 PM-->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementStatementsOfStockholdersEquity" roleURI="http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLongTermInvestmentsDetails" roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLongTermInvestmentsAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsValuationModelDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNotesHeldForInvestmentDetails" roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureConcentrationOfCreditRiskDetails" roleURI="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSegmentInformationReportableSegmentInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSubsequentEventsDetails" roleURI="http://semlerscientific.com/role/DisclosureSubsequentEventsDetails" />
  <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:roleRef roleURI="http://semlerscientific.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="smlr-20241231.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended" xlink:title="Extensible Enumeration Domain Members">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="us-gaap_AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:title="us-gaap_OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_AssetsAbstract To us-gaap_OtherAssetsNoncurrent" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_AssetsAbstract To us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:title="us-gaap_OtherLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_LiabilitiesCurrentAbstract To us-gaap_OtherLiabilitiesCurrent" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:title="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_LiabilitiesNoncurrentAbstract To us-gaap_OtherLiabilitiesNoncurrent" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" xlink:title="us-gaap_LiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_1" xlink:title="us-gaap_OtherLiabilitiesCurrent_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_LiabilitiesAbstract To us-gaap_OtherLiabilitiesCurrent_1" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_1" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_LiabilitiesAbstract To us-gaap_OtherLiabilitiesNoncurrent_1" order="2" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_IncomeStatementAbstract To us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralDomain" xlink:label="us-gaap_CollateralDomain" xlink:title="us-gaap_CollateralDomain" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember_2" xlink:title="smlr_InvestmentInPrivateCompanyThreeMember_2" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_CollateralDomain" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember_2" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_CollateralDomain To smlr_InvestmentInPrivateCompanyThreeMember_2" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" xlink:title="us-gaap_InvestmentTypeCategorizationMember_2" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember_3" xlink:title="smlr_InvestmentInPrivateCompanyThreeMember_3" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_InvestmentTypeCategorizationMember_2" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember_3" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_InvestmentTypeCategorizationMember_2 To smlr_InvestmentInPrivateCompanyThreeMember_3" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_BitcoinMember" xlink:label="smlr_BitcoinMember_1" xlink:title="smlr_BitcoinMember_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetDomain" xlink:label="srt_CryptoAssetDomain_3" xlink:title="srt_CryptoAssetDomain_3" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_BitcoinMember" xlink:label="smlr_BitcoinMember_3" xlink:title="smlr_BitcoinMember_3" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CryptoAssetDomain_3" xlink:to="smlr_BitcoinMember_3" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:srt_CryptoAssetDomain_2 To smlr_BitcoinMember_2" order="1" priority="0" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_1" xlink:title="us-gaap_StatementEquityComponentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1" xlink:title="us-gaap_EquityComponentDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementEquityComponentsAxis_1" xlink:to="us-gaap_EquityComponentDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementEquityComponentsAxis_1 To us-gaap_EquityComponentDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_1" xlink:title="srt_CounterpartyNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_1" xlink:title="srt_RepurchaseAgreementCounterpartyNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CounterpartyNameAxis_1" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_CounterpartyNameAxis_1 To srt_RepurchaseAgreementCounterpartyNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_1" xlink:title="srt_RangeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_1" xlink:title="srt_RangeMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_RangeAxis_1" xlink:to="srt_RangeMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_RangeAxis_1 To srt_RangeMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis_1" xlink:title="us-gaap_InvestmentTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_1" xlink:title="us-gaap_InvestmentTypeCategorizationMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_InvestmentTypeAxis_1" xlink:to="us-gaap_InvestmentTypeCategorizationMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_InvestmentTypeAxis_1 To us-gaap_InvestmentTypeCategorizationMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_1" xlink:title="us-gaap_DebtInstrumentAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_1" xlink:title="us-gaap_DebtInstrumentNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_DebtInstrumentAxis_1" xlink:to="us-gaap_DebtInstrumentNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_DebtInstrumentAxis_1 To us-gaap_DebtInstrumentNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis_1" xlink:title="us-gaap_BalanceSheetLocationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_1" xlink:title="us-gaap_BalanceSheetLocationDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_BalanceSheetLocationAxis_1" xlink:to="us-gaap_BalanceSheetLocationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_BalanceSheetLocationAxis_1 To us-gaap_BalanceSheetLocationDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_1" xlink:title="us-gaap_ConcentrationRiskByTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_1" xlink:title="us-gaap_ConcentrationRiskTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_1" xlink:to="us-gaap_ConcentrationRiskTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ConcentrationRiskByTypeAxis_1 To us-gaap_ConcentrationRiskTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:title="us-gaap_ConcentrationRiskByBenchmarkAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_1" xlink:title="us-gaap_ConcentrationRiskBenchmarkDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ConcentrationRiskByBenchmarkAxis_1 To us-gaap_ConcentrationRiskBenchmarkDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis_1" xlink:title="srt_MajorCustomersAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_1" xlink:title="srt_NameOfMajorCustomerDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_MajorCustomersAxis_1" xlink:to="srt_NameOfMajorCustomerDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_MajorCustomersAxis_1 To srt_NameOfMajorCustomerDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis_1" xlink:title="us-gaap_LeaseContractualTermAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_1" xlink:title="us-gaap_LeaseContractualTermDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LeaseContractualTermAxis_1" xlink:to="us-gaap_LeaseContractualTermDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_LeaseContractualTermAxis_1 To us-gaap_LeaseContractualTermDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_1" xlink:title="us-gaap_IncomeStatementLocationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_1" xlink:title="us-gaap_IncomeStatementLocationDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeStatementLocationAxis_1" xlink:to="us-gaap_IncomeStatementLocationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_IncomeStatementLocationAxis_1 To us-gaap_IncomeStatementLocationDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_1" xlink:title="us-gaap_PlanNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_1" xlink:title="us-gaap_PlanNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_PlanNameAxis_1" xlink:to="us-gaap_PlanNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_PlanNameAxis_1 To us-gaap_PlanNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_1" xlink:title="us-gaap_AwardTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AwardTypeAxis_1" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AwardTypeAxis_1 To us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_1" xlink:title="srt_TitleOfIndividualAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_TitleOfIndividualAxis_1" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_TitleOfIndividualAxis_1 To srt_TitleOfIndividualWithRelationshipToEntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1 To us-gaap_AntidilutiveSecuritiesNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_PropertyPlantAndEquipmentByTypeAxis_1 To us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis_1" xlink:title="us-gaap_LineOfCreditFacilityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_1" xlink:title="us-gaap_LineOfCreditFacilityLenderDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LineOfCreditFacilityAxis_1" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_LineOfCreditFacilityAxis_1 To us-gaap_LineOfCreditFacilityLenderDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_1" xlink:title="us-gaap_MeasurementInputTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_1" xlink:title="us-gaap_MeasurementInputTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_MeasurementInputTypeAxis_1" xlink:to="us-gaap_MeasurementInputTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_MeasurementInputTypeAxis_1 To us-gaap_MeasurementInputTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_1" xlink:title="us-gaap_LongtermDebtTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_1" xlink:title="us-gaap_LongtermDebtTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LongtermDebtTypeAxis_1" xlink:to="us-gaap_LongtermDebtTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_LongtermDebtTypeAxis_1 To us-gaap_LongtermDebtTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="us-gaap_RelatedPartyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1 To us-gaap_RelatedPartyDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_1" xlink:title="dei_LegalEntityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_1" xlink:title="dei_EntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_LegalEntityAxis_1" xlink:to="dei_EntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_LegalEntityAxis_1 To dei_EntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis_1" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain_1" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis_1" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_DebtInstrumentRedemptionPeriodAxis_1 To us-gaap_DebtInstrumentRedemptionPeriodDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_1" xlink:title="us-gaap_FinancialInstrumentAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:title="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FinancialInstrumentAxis_1" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FinancialInstrumentAxis_1 To us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis_1" xlink:title="us-gaap_GranteeStatusAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain_1" xlink:title="us-gaap_GranteeStatusDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_GranteeStatusAxis_1" xlink:to="us-gaap_GranteeStatusDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_GranteeStatusAxis_1 To us-gaap_GranteeStatusDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_1" xlink:title="us-gaap_TypeOfArrangementAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_TypeOfArrangementAxis_1" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_TypeOfArrangementAxis_1 To us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_1" xlink:title="us-gaap_SubsequentEventTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_1" xlink:title="us-gaap_SubsequentEventTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_SubsequentEventTypeAxis_1" xlink:to="us-gaap_SubsequentEventTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_SubsequentEventTypeAxis_1 To us-gaap_SubsequentEventTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis_1" xlink:title="us-gaap_TaxCreditCarryforwardAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_1" xlink:title="us-gaap_TaxCreditCarryforwardNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_TaxCreditCarryforwardAxis_1" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_TaxCreditCarryforwardAxis_1 To us-gaap_TaxCreditCarryforwardNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_1" xlink:title="us-gaap_RelatedPartyTransactionAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_1" xlink:title="us-gaap_RelatedPartyTransactionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionAxis_1" xlink:to="us-gaap_RelatedPartyTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionAxis_1 To us-gaap_RelatedPartyTransactionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_1" xlink:title="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain_1" xlink:title="us-gaap_ReceivableTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_1" xlink:to="us-gaap_ReceivableTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_1 To us-gaap_ReceivableTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis_1" xlink:title="srt_ProductOrServiceAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_1" xlink:title="srt_ProductsAndServicesDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_ProductOrServiceAxis_1" xlink:to="srt_ProductsAndServicesDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_ProductOrServiceAxis_1 To srt_ProductsAndServicesDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1" xlink:title="us-gaap_StatementClassOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementClassOfStockAxis_1" xlink:to="us-gaap_ClassOfStockDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementClassOfStockAxis_1 To us-gaap_ClassOfStockDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis_1" xlink:title="us-gaap_CashAndCashEquivalentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_CashAndCashEquivalentsAxis_1" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_CashAndCashEquivalentsAxis_1 To us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByFairValueHierarchyLevelAxis_1 To us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:title="us-gaap_FairValueByMeasurementFrequencyAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_1" xlink:title="us-gaap_FairValueMeasurementFrequencyDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByMeasurementFrequencyAxis_1 To us-gaap_FairValueMeasurementFrequencyDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis_1" xlink:title="us-gaap_FairValueByAssetClassAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:title="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByAssetClassAxis_1" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByAssetClassAxis_1 To us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_1" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ClassOfWarrantOrRightAxis_1 To us-gaap_ClassOfWarrantOrRightDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_1" xlink:title="srt_StatementScenarioAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_1" xlink:title="srt_ScenarioUnspecifiedDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_StatementScenarioAxis_1" xlink:to="srt_ScenarioUnspecifiedDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_StatementScenarioAxis_1 To srt_ScenarioUnspecifiedDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis_1" xlink:title="us-gaap_VestingAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_1" xlink:title="us-gaap_VestingDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_VestingAxis_1" xlink:to="us-gaap_VestingDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_VestingAxis_1 To us-gaap_VestingDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_1" xlink:title="srt_EquityMethodInvesteeNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1" xlink:to="srt_EquityMethodInvesteeNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1 To srt_EquityMethodInvesteeNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetAxis" xlink:label="srt_CryptoAssetAxis_1" xlink:title="srt_CryptoAssetAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetDomain" xlink:label="srt_CryptoAssetDomain_1" xlink:title="srt_CryptoAssetDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CryptoAssetAxis_1" xlink:to="srt_CryptoAssetDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_CryptoAssetAxis_1 To srt_CryptoAssetDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:title="us-gaap_SubsidiarySaleOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:title="us-gaap_SaleOfStockNameOfTransactionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_SubsidiarySaleOfStockAxis_1 To us-gaap_SaleOfStockNameOfTransactionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_1" xlink:title="srt_CumulativeEffectPeriodOfAdoptionAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_1" xlink:title="srt_CumulativeEffectPeriodOfAdoptionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis_1" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_CumulativeEffectPeriodOfAdoptionAxis_1 To srt_CumulativeEffectPeriodOfAdoptionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1" xlink:title="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_1" xlink:title="us-gaap_TypeOfAdoptionMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1" xlink:to="us-gaap_TypeOfAdoptionMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1 To us-gaap_TypeOfAdoptionMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis_1" xlink:title="us-gaap_StatementBusinessSegmentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_1" xlink:title="us-gaap_SegmentDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementBusinessSegmentsAxis_1" xlink:to="us-gaap_SegmentDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementBusinessSegmentsAxis_1 To us-gaap_SegmentDomain_1" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:type="extended" xlink:title="SRT Extensible Enumeration Domain Members">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetDomain" xlink:label="srt_CryptoAssetDomain_2" xlink:title="srt_CryptoAssetDomain_2" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_BitcoinMember" xlink:label="smlr_BitcoinMember_2" xlink:title="smlr_BitcoinMember_2" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CryptoAssetDomain_2" xlink:to="smlr_BitcoinMember_2" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:srt_CryptoAssetDomain_2 To smlr_BitcoinMember_2" order="1" priority="0" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="995200300 - Statement - Statements of Stockholders' Equity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockCommonMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesIssued" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TreasuryStockCommonShares" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" xlink:label="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:to="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" xlink:type="extended" xlink:title="99940202 - Disclosure - Summary of Significant Accounting Policies and Estimates (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" xlink:label="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202308Member" xlink:label="us-gaap_AccountingStandardsUpdate202308Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202308Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SeniorSecuredPromissoryNotesMember" xlink:label="smlr_SeniorSecuredPromissoryNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="smlr_SeniorSecuredPromissoryNotesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="smlr_MonarchMedicalTechnologyLlcMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityFaceValue" xlink:label="smlr_DebtSecurityFaceValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="smlr_DebtSecurityFaceValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromTransactionFeeOfDebtSecurities" xlink:label="smlr_ProceedsFromTransactionFeeOfDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="smlr_ProceedsFromTransactionFeeOfDebtSecurities" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" xlink:label="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_NotesReceivableNet" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecurities" xlink:label="us-gaap_DebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DebtSecurities" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AdvertisingExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" xlink:label="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DefectiveProductReplacementCost" xlink:label="smlr_DefectiveProductReplacementCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="smlr_DefectiveProductReplacementCost" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails" xlink:type="extended" xlink:title="99940601 - Disclosure - Long-Term Investments (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:to="us-gaap_InvestmentTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyTwoMember" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="smlr_InvestmentInPrivateCompanyTwoMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_LongTermInvestments" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails" xlink:type="extended" xlink:title="99940602 - Disclosure - Long-Term Investments - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PromissoryNoteFromPrivateCompanyTwoMember" xlink:label="smlr_PromissoryNoteFromPrivateCompanyTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="smlr_PromissoryNoteFromPrivateCompanyTwoMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="99940701 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CryptoAssetFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt" xlink:label="us-gaap_TradingSecuritiesDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_TradingSecuritiesDebt" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HeldToMaturitySecuritiesFairValue" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentInterestRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesTradingRealizedGain" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtSecuritiesTradingRealizedGain" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails" xlink:type="extended" xlink:title="99940703 - Disclosure - Fair Value Measurements - Valuation model (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputDiscountRateMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_RangeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" xlink:type="extended" xlink:title="99940704 - Disclosure - Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_FairValueByAssetClassAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesMember" xlink:label="us-gaap_DebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_DebtSecuritiesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails" xlink:type="extended" xlink:title="99940801 - Disclosure - Notes held for investment (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SeniorSecuredPromissoryNotesMember" xlink:label="smlr_SeniorSecuredPromissoryNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="smlr_SeniorSecuredPromissoryNotesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="smlr_MonarchMedicalTechnologyLlcMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_InvestmentTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyTwoMember" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="smlr_InvestmentInPrivateCompanyTwoMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_NotesReceivableNet" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NotesReceivableInterestBearingInterestRate" xlink:label="smlr_NotesReceivableInterestBearingInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_NotesReceivableInterestBearingInterestRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfNotesReceivable" xlink:label="smlr_NumberOfNotesReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_NumberOfNotesReceivable" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NotesReceivableTerm" xlink:label="smlr_NotesReceivableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_NotesReceivableTerm" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityMaximumAmountOfAvailableFunding" xlink:label="smlr_DebtSecurityMaximumAmountOfAvailableFunding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_DebtSecurityMaximumAmountOfAvailableFunding" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecuritiesTransactionFee" xlink:label="smlr_DebtSecuritiesTransactionFee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_DebtSecuritiesTransactionFee" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" xlink:label="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ExtensionPeriodOptionToExtendMaturityDate" xlink:label="smlr_ExtensionPeriodOptionToExtendMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_ExtensionPeriodOptionToExtendMaturityDate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestIncome" xlink:label="smlr_DebtSecurityInterestIncome" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_DebtSecurityInterestIncome" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HeldToMaturitySecuritiesFairValue" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityChangesInFairValue" xlink:label="smlr_DebtSecurityChangesInFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_DebtSecurityChangesInFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestRate" xlink:label="smlr_DebtSecurityInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="smlr_DebtSecurityInterestRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_LongTermInvestments" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails" xlink:type="extended" xlink:title="99941201 - Disclosure - Concentration of Credit Risk (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_SupplierConcentrationRiskMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentHoldingConcentrationRiskMember" xlink:label="smlr_InvestmentHoldingConcentrationRiskMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="smlr_InvestmentHoldingConcentrationRiskMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_RevenueFromContractWithCustomerMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsPayableMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetBenchmarkMember" xlink:label="smlr_IntangibleDigitalAssetBenchmarkMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="smlr_IntangibleDigitalAssetBenchmarkMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_MajorCustomersAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerOneConcentrationRiskMember" xlink:label="smlr_CustomerOneConcentrationRiskMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="smlr_CustomerOneConcentrationRiskMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerTwoConcentrationRiskMember" xlink:label="smlr_CustomerTwoConcentrationRiskMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="smlr_CustomerTwoConcentrationRiskMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerThreeConcentrationRiskMember" xlink:label="smlr_CustomerThreeConcentrationRiskMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="smlr_CustomerThreeConcentrationRiskMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorOneMember" xlink:label="smlr_VendorOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="smlr_VendorOneMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorTwoMember" xlink:label="smlr_VendorTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="smlr_VendorTwoMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorThreeMember" xlink:label="smlr_VendorThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="smlr_VendorThreeMember" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetProviderOneMember" xlink:label="smlr_CryptoAssetProviderOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="smlr_CryptoAssetProviderOneMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetProviderTwoMember" xlink:label="smlr_CryptoAssetProviderTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="smlr_CryptoAssetProviderTwoMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="us-gaap_TimeDepositsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_TimeDepositsAtCarryingValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_CryptoAssetNumberOfUnits" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskCryptoAssetNumberOfProviders" xlink:label="smlr_ConcentrationRiskCryptoAssetNumberOfProviders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="smlr_ConcentrationRiskCryptoAssetNumberOfProviders" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskNumberOfCustomers" xlink:label="smlr_ConcentrationRiskNumberOfCustomers" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="smlr_ConcentrationRiskNumberOfCustomers" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskNumberOfVendors" xlink:label="smlr_ConcentrationRiskNumberOfVendors" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="smlr_ConcentrationRiskNumberOfVendors" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_CryptoAssetFairValue" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="extended" xlink:title="99941501 - Disclosure - Stockholders' Equity - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockholdersEquityDeficitTable" xlink:label="smlr_StockholdersEquityDeficitTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="smlr_StockholdersEquityDeficitTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AtMarketOfferingMember" xlink:label="smlr_AtMarketOfferingMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="smlr_AtMarketOfferingMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="smlr_StockholdersEquityDeficitTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CommonStockWarrantsMember" xlink:label="smlr_CommonStockWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="smlr_CommonStockWarrantsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="smlr_StockholdersEquityDeficitTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_ChiefExecutiveOfficerMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockholdersEquityDeficitLineItems" xlink:label="smlr_StockholdersEquityDeficitLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="smlr_StockholdersEquityDeficitTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfVotesForEachShare" xlink:label="smlr_NumberOfVotesForEachShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="smlr_NumberOfVotesForEachShare" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SaleOfStockValueAuthorized" xlink:label="smlr_SaleOfStockValueAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="smlr_SaleOfStockValueAuthorized" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="srt_StockRepurchaseProgramAuthorizedAmount1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ClassOfWarrantOrRightValueRepurchased" xlink:label="smlr_ClassOfWarrantOrRightValueRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="smlr_ClassOfWarrantOrRightValueRepurchased" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails" xlink:type="extended" xlink:title="99941601 - Disclosure - Stock Option Plan - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockIncentivePlan2014Member" xlink:label="smlr_StockIncentivePlan2014Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PlanNameDomain" xlink:to="smlr_StockIncentivePlan2014Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_KeyPersonStockOptionPlan2007Member" xlink:label="smlr_KeyPersonStockOptionPlan2007Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PlanNameDomain" xlink:to="smlr_KeyPersonStockOptionPlan2007Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_GranteeStatusAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfSharesReserveIncrease" xlink:label="smlr_PercentageOfSharesReserveIncrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="smlr_PercentageOfSharesReserveIncrease" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" xlink:type="extended" xlink:title="99941603 - Disclosure - Stock Option Plan - Weighted average assumptions used (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" xlink:type="extended" xlink:title="99941604 - Disclosure - Stock Option Plan - Stock-based compensation expense (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_EngineeringAndProductDevelopmentMember" xlink:label="smlr_EngineeringAndProductDevelopmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="smlr_EngineeringAndProductDevelopmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="extended" xlink:title="99941705 - Disclosure - Income Taxes - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_DomesticCountryMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ExaminationOfCompanyTaxYears" xlink:label="smlr_ExaminationOfCompanyTaxYears" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="smlr_ExaminationOfCompanyTaxYears" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ResearchAndExperimentalExpendituresCapitalized" xlink:label="smlr_ResearchAndExperimentalExpendituresCapitalized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="smlr_ResearchAndExperimentalExpendituresCapitalized" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" xlink:type="extended" xlink:title="99941902 - Disclosure - Segment Information - Reportable Segment Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SingleReportableSegmentMember" xlink:label="smlr_SingleReportableSegmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SegmentDomain" xlink:to="smlr_SingleReportableSegmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_Revenues" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostOfRevenue" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDevelopment" xlink:label="us-gaap_BusinessDevelopment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_BusinessDevelopment" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SegmentReportingOtherItemAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemCompositionDescription" xlink:label="us-gaap_SegmentReportingOtherItemCompositionDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_SegmentReportingOtherItemCompositionDescription" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="smlr_ImpairmentLossesInvestments" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OtherCorporateIncomeExpense" xlink:label="smlr_OtherCorporateIncomeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="smlr_OtherCorporateIncomeExpense" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://semlerscientific.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="99942001 - Disclosure - Subsequent Events (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="smlr_MonarchMedicalTechnologyLlcMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConvertibleSeniorNote4.25Member" xlink:label="smlr_ConvertibleSeniorNote4.25Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="smlr_ConvertibleSeniorNote4.25Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" xlink:label="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleThresholdBusinessDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleThresholdBusinessDays" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" xlink:label="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" xlink:label="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" xlink:label="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" xlink:label="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" xlink:label="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" xlink:label="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" xlink:label="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="28" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NotesReceivableNet" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestRate" xlink:label="smlr_DebtSecurityInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="29" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_DebtSecurityInterestRate" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetNumberOfUnitsPurchased" xlink:label="smlr_CryptoAssetNumberOfUnitsPurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="30" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_CryptoAssetNumberOfUnitsPurchased" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="31" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="us-gaap_CryptoAssetCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="32" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CryptoAssetCost" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetAveragePurchasePrice" xlink:label="smlr_CryptoAssetAveragePurchasePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="33" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_CryptoAssetAveragePurchasePrice" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="34" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CryptoAssetNumberOfUnits" priority="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetMarketPricePerCryptoAsset" xlink:label="smlr_CryptoAssetMarketPricePerCryptoAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="35" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="smlr_CryptoAssetMarketPricePerCryptoAsset" priority="1" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>29
<FILENAME>smlr-20241231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/28/2025 9:05:53 PM-->
<!--Modified on: 2/28/2025 9:05:53 PM-->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Document and Entity Information</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Securities Act File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Balance Sheets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade accounts receivable, net of allowance for credit losses of $199 and $287, respectively</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xml:lang="en-US">Short-term notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Assets, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_lbl" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_lbl" xml:lang="en-US">Assets for lease, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_lbl" xml:lang="en-US">Assets for lease, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_lbl" xml:lang="en-US">Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, after Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_lbl" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_lbl" xml:lang="en-US">Property and equipment, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestments" xlink:to="us-gaap_LongTermInvestments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestments_lbl" xml:lang="en-US">Long-Term Investments.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermInvestments_lbl" xml:lang="en-US">Long-term investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermInvestments_lbl" xml:lang="en-US">Total long-term investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl" xml:lang="en-US">Notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValueNoncurrent" xlink:label="us-gaap_CryptoAssetFairValueNoncurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetFairValueNoncurrent" xlink:to="us-gaap_CryptoAssetFairValueNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetFairValueNoncurrent_lbl" xml:lang="en-US">Crypto Asset, Fair Value, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetFairValueNoncurrent_lbl" xml:lang="en-US">Intangible digital assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other short-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-term liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liability</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 14)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value; 50,000,000 shares authorized; 9,770,908 and 7,099,441 shares issued, and 9,556,486 and 6,885,019 shares outstanding (treasury shares of 214,422 and 214,422), respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock shares (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Statements of Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Engineering and product development</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administration</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US">Strategic streamlining</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Costs and Expenses</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income from operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest and dividend income, net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest income, net</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ImpairmentLossesInvestments" xlink:to="smlr_ImpairmentLossesInvestments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ImpairmentLossesInvestments_lbl" xml:lang="en-US">The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earning or other comprehensive income.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ImpairmentLossesInvestments_lbl" xml:lang="en-US">Impairment Losses Investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_ImpairmentLossesInvestments_lbl" xml:lang="en-US">Impairment of investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ImpairmentLossesInvestments_lbl" xml:lang="en-US">Impairment of long-term investments</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_lbl" xml:lang="en-US">The fair adjustments in notes held for investment.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_lbl" xml:lang="en-US">Fair Value Adjustment of Notes Held for Investment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_lbl" xml:lang="en-US">Change in fair value of notes held for investment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_lbl" xml:lang="en-US">Change in fair value of notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_lbl" xml:lang="en-US">Crypto Asset, Unrealized Gain (Loss), Nonoperating</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_lbl" xml:lang="en-US">Change in fair value of digital assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_lbl" xml:lang="en-US">Change in fair value of digital assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Pre-tax income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax provision</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total income tax provision</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net income per share, basic</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic EPS (in dollars per share)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares used in computing basic net income per share</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net income per share, diluted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted EPS (in dollars per share)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of shares used in computing diluted net income per share</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statements of Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares, Issued</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" xlink:label="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" xlink:to="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants_lbl" xml:lang="en-US">Amount of decrease in additional paid in capital (APIC) resulting from the repurchase of warrants.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Repurchase Of Warrants</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants_lbl" xml:lang="en-US">Common stock warrants acquired</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Employee/Directors stock grants</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Employee/Directors stock grants (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Stock issuance expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:to="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_lbl" xml:lang="en-US">Equity impact from taxes paid related to net share settlement of equity awards.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_lbl" xml:lang="en-US">Taxes Paid related to Net Share Settlement of Equity Awards</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_lbl" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" xlink:to="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares_lbl" xml:lang="en-US">Number of shares impact from taxes paid related to net share settlement of equity awards.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares_lbl" xml:lang="en-US">Taxes Paid related to Net Share Settlement of Equity Awards, Shares</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares_lbl" xml:lang="en-US">Taxes paid related to net share settlement of equity awards (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock option exercises</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Options exercised</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock option exercises (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statements of Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Reconciliation of Net Income to Net Cash Provided by Operating Activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax expense (income)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total deferred tax provision</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:to="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_lbl" xml:lang="en-US">Gain (Loss) on Sale of Leased Assets, Net, Operating Leases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_lbl" xml:lang="en-US">Loss on disposal of assets for lease</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_lbl" xml:lang="en-US">Loss on disposal of assets for lease</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PrepaidLicensePurchasesWriteoff" xlink:label="smlr_PrepaidLicensePurchasesWriteoff" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PrepaidLicensePurchasesWriteoff" xlink:to="smlr_PrepaidLicensePurchasesWriteoff_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PrepaidLicensePurchasesWriteoff_lbl" xml:lang="en-US">Write-off of amounts previously capitalized as prepaid license purchases.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PrepaidLicensePurchasesWriteoff_lbl" xml:lang="en-US">Prepaid License Purchases, Writeoff</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_PrepaidLicensePurchasesWriteoff_lbl" xml:lang="en-US">Write off of prepaid software licenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesTradingRealizedGain" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesTradingRealizedGain" xlink:to="us-gaap_DebtSecuritiesTradingRealizedGain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain_lbl" xml:lang="en-US">Debt Securities, Trading, Realized Gain</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain_lbl" xml:lang="en-US">Gain on short-term investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain_lbl" xml:lang="en-US">Interest income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in Operating Assets and Liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US">Other current and non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xml:lang="en-US">Purchase of notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForAcquisitionCryptoAsset" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_lbl" xml:lang="en-US">Payment for Acquisition, Crypto Asset</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_lbl" xml:lang="en-US">Purchase of digital assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_lbl" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xml:lang="en-US">Proceeds from maturities of short-term investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchase cost</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromPaymentsForEquipmentForLeases" xlink:label="smlr_ProceedsFromPaymentsForEquipmentForLeases" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ProceedsFromPaymentsForEquipmentForLeases" xlink:to="smlr_ProceedsFromPaymentsForEquipmentForLeases_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ProceedsFromPaymentsForEquipmentForLeases_lbl" xml:lang="en-US">The cash inflow (outflow) for sale or purchase of rented equipment which is recorded as an asset.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ProceedsFromPaymentsForEquipmentForLeases_lbl" xml:lang="en-US">Proceeds From (Payments For) Equipment For Leases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_ProceedsFromPaymentsForEquipmentForLeases_lbl" xml:lang="en-US">Proceeds from sale (purchase) of assets for lease</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net Cash (Used in) Provided by Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US">Taxes paid related to net settlement of equity awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfWarrants" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants_lbl" xml:lang="en-US">Payments for Repurchase of Warrants</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants_lbl" xml:lang="en-US">Common stock warrants acquired</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Stock issuance expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CompanyAbstract" xlink:label="smlr_CompanyAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CompanyAbstract" xlink:to="smlr_CompanyAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CompanyAbstract_lbl" xml:lang="en-US">No definition available.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CompanyAbstract_lbl" xml:lang="en-US">The Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">The Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Summary of Significant Accounting Policies and Estimates</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies and Estimates</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetAbstract" xlink:label="smlr_AssetsForLeaseNetAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AssetsForLeaseNetAbstract" xlink:to="smlr_AssetsForLeaseNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AssetsForLeaseNetAbstract_lbl" xml:lang="en-US">No definition available.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AssetsForLeaseNetAbstract_lbl" xml:lang="en-US">Assets for Lease, net</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetTextBlock" xlink:label="smlr_AssetsForLeaseNetTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AssetsForLeaseNetTextBlock" xlink:to="smlr_AssetsForLeaseNetTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AssetsForLeaseNetTextBlock_lbl" xml:lang="en-US">The entire disclosure on assets for lease.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AssetsForLeaseNetTextBlock_lbl" xml:lang="en-US">Assets for Lease, Net [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_AssetsForLeaseNetTextBlock_lbl" xml:lang="en-US">Assets for Lease, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesTextBlock" xlink:label="us-gaap_FinancingReceivablesTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesTextBlock" xlink:to="us-gaap_FinancingReceivablesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivablesTextBlock_lbl" xml:lang="en-US">Financing Receivables [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancingReceivablesTextBlock_lbl" xml:lang="en-US">Notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsAbstract" xlink:label="smlr_IntangibleDigitalAssetsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_IntangibleDigitalAssetsAbstract" xlink:to="smlr_IntangibleDigitalAssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_IntangibleDigitalAssetsAbstract_lbl" xml:lang="en-US">No definition available.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_IntangibleDigitalAssetsAbstract_lbl" xml:lang="en-US">Intangible Digital Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetTextBlock" xlink:label="us-gaap_CryptoAssetTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetTextBlock" xlink:to="us-gaap_CryptoAssetTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetTextBlock_lbl" xml:lang="en-US">Crypto Asset [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetTextBlock_lbl" xml:lang="en-US">Intangible Digital Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrentDisclosureAbstract" xlink:label="us-gaap_OtherAssetsNoncurrentDisclosureAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrentDisclosureAbstract" xlink:to="us-gaap_OtherAssetsNoncurrentDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrentDisclosureAbstract_lbl" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OtherNoncurrentAssetsTextBlock" xlink:label="smlr_OtherNoncurrentAssetsTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_OtherNoncurrentAssetsTextBlock" xlink:to="smlr_OtherNoncurrentAssetsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_OtherNoncurrentAssetsTextBlock_lbl" xml:lang="en-US">The entire disclosure for other noncurrent assets.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_OtherNoncurrentAssetsTextBlock_lbl" xml:lang="en-US">Other Noncurrent Assets [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_OtherNoncurrentAssetsTextBlock_lbl" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_LeaseDisclosureTextBlock" xlink:label="smlr_LeaseDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_LeaseDisclosureTextBlock" xlink:to="smlr_LeaseDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_LeaseDisclosureTextBlock_lbl" xml:lang="en-US">The entire disclosure of information about leases.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_LeaseDisclosureTextBlock_lbl" xml:lang="en-US">Lease Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_LeaseDisclosureTextBlock_lbl" xml:lang="en-US">Leases</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Stock Option Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Option Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net Income Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Income Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Information</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segment Information</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis for Presentation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy" xlink:label="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy" xlink:to="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy_lbl" xml:lang="en-US">Financing Receivable, Held-for-Investment [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy_lbl" xml:lang="en-US">Short-Term Notes Held for Investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="us-gaap_LessorLeasesPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorLeasesPolicyTextBlock" xlink:to="us-gaap_LessorLeasesPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LessorLeasesPolicyTextBlock_lbl" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LessorLeasesPolicyTextBlock_lbl" xml:lang="en-US">Assets for Lease</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock" xlink:label="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock" xlink:to="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Disclosure of accounting policy for intangible digital assets.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Intangible Digital Assets, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Intangible Digital Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment Valuation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Schedule of Property Plant And Equipment Useful Life [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives of property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ScheduleOfAssetsForLeaseNetTableTextBlock" xlink:label="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock" xlink:to="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock_lbl" xml:lang="en-US">The tabular disclosure on assets for lease.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets for Lease, Net [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock_lbl" xml:lang="en-US">Summary of assets for lease, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_lbl" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of carrying value of non-marketable equity investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of financial assets measured at fair value on a recurring basis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of key inputs for the valuation model</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of changes in the notes held for the investments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">Schedule of notes receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTableTextBlock" xlink:label="us-gaap_CryptoAssetHoldingTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetHoldingTableTextBlock" xlink:to="us-gaap_CryptoAssetHoldingTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetHoldingTableTextBlock_lbl" xml:lang="en-US">Crypto Asset, Holding [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetHoldingTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets cost basis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetActivityTableTextBlock" xlink:label="us-gaap_CryptoAssetActivityTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetActivityTableTextBlock" xlink:to="us-gaap_CryptoAssetActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetActivityTableTextBlock_lbl" xml:lang="en-US">Crypto Asset, Activity [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of the fair values</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum rental payments required under operating leases</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions used to determining the fair value of stock options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xml:lang="en-US">Schedule of stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of components of the (benefit) provision for income taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of differences between the Company's effective income tax rate and the federal statutory income tax rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax (liabilities) assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of activity related to unrecognized tax benefits</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of basic and diluted net EPS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of reportable segment information</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ContractWithCustomerAccountsReceivableNet" xlink:label="smlr_ContractWithCustomerAccountsReceivableNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ContractWithCustomerAccountsReceivableNet" xlink:to="smlr_ContractWithCustomerAccountsReceivableNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ContractWithCustomerAccountsReceivableNet_lbl" xml:lang="en-US">Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is unconditional.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ContractWithCustomerAccountsReceivableNet_lbl" xml:lang="en-US">Contract with Customer, Accounts Receivable, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ContractWithCustomerAccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable, net, related to revenue recognized under ASC 606</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve" xlink:label="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve" xlink:to="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve_lbl" xml:lang="en-US">Amount of expense related to additional reserve for credit losses.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve_lbl" xml:lang="en-US">Accounts Receivable, Allowance For Credit Loss, Additional Reserve</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve_lbl" xml:lang="en-US">Allowance for credit loss, additional reserve</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_lbl" xml:lang="en-US">Allowance for credit loss, recovery</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" xlink:label="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" xlink:to="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent_lbl" xml:lang="en-US">Amount of allowance for credit loss on accounts receivable from exchange for good or service transferred, classified as current.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent_lbl" xml:lang="en-US">Contract with Customer, Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent_lbl" xml:lang="en-US">Credit losses related to ASC 606 receivables</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" xlink:label="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" xlink:to="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_lbl" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_lbl" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_lbl" xml:lang="en-US">Assets for Lease</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery &amp; Equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment &amp; Software</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture &amp; Fixtures</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xml:lang="en-US">Cumulative-adjustment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202308Member" xlink:label="us-gaap_AccountingStandardsUpdate202308Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202308Member" xlink:to="us-gaap_AccountingStandardsUpdate202308Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate202308Member_lbl" xml:lang="en-US">Accounting Standards Update 2023-08 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountingStandardsUpdate202308Member_lbl" xml:lang="en-US">ASU 2023-08</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="us-gaap_ReceivableTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivableTypeDomain_lbl" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SeniorSecuredPromissoryNotesMember" xlink:label="smlr_SeniorSecuredPromissoryNotesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_SeniorSecuredPromissoryNotesMember" xlink:to="smlr_SeniorSecuredPromissoryNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_SeniorSecuredPromissoryNotesMember_lbl" xml:lang="en-US">Represents information pertaining to senior secured promissory notes.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_SeniorSecuredPromissoryNotesMember_lbl" xml:lang="en-US">Senior secured promissory notes</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_SecuredConvertiblePromissoryNoteMember" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Secured convertible promissory note.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Secured convertible promissory note</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Senior secured convertible promissory note</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_MonarchMedicalTechnologyLlcMember" xlink:to="smlr_MonarchMedicalTechnologyLlcMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_MonarchMedicalTechnologyLlcMember_lbl" xml:lang="en-US">Represents the information pertaining to Monarch Medical Technology, LLC.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_MonarchMedicalTechnologyLlcMember_lbl" xml:lang="en-US">Monarch</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_MonarchMedicalTechnologyLlcMember_lbl" xml:lang="en-US">Monarch</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">PPE useful life</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityFaceValue" xlink:label="smlr_DebtSecurityFaceValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtSecurityFaceValue" xlink:to="smlr_DebtSecurityFaceValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtSecurityFaceValue_lbl" xml:lang="en-US">Face (par) value of the debt security at the time of issuance or purchase.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtSecurityFaceValue_lbl" xml:lang="en-US">Debt Security, Face Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtSecurityFaceValue_lbl" xml:lang="en-US">Debt security at face value</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" xlink:to="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_lbl" xml:lang="en-US">The cash inflow associated with the maturity of debt securities, partial amount.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_lbl" xml:lang="en-US">Proceeds From Maturities Of Debt Securities, Partial Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_lbl" xml:lang="en-US">Repaid amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_lbl" xml:lang="en-US">Debt securities, partial amount</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromTransactionFeeOfDebtSecurities" xlink:label="smlr_ProceedsFromTransactionFeeOfDebtSecurities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ProceedsFromTransactionFeeOfDebtSecurities" xlink:to="smlr_ProceedsFromTransactionFeeOfDebtSecurities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ProceedsFromTransactionFeeOfDebtSecurities_lbl" xml:lang="en-US">The cash inflow associated with the transaction fees of debt securities.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ProceedsFromTransactionFeeOfDebtSecurities_lbl" xml:lang="en-US">Proceeds From Transaction Fee Of Debt Securities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ProceedsFromTransactionFeeOfDebtSecurities_lbl" xml:lang="en-US">Transaction fee</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" xlink:label="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" xlink:to="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities_lbl" xml:lang="en-US">The cash inflow associated with the accrued interest of debt securities.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities_lbl" xml:lang="en-US">Proceeds Relating to Accrued Interest of Debt Securities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities_lbl" xml:lang="en-US">Accrued interest</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableNet" xlink:to="us-gaap_NotesReceivableNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableNet_lbl" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesReceivableNet_lbl" xml:lang="en-US">Total notes held for investment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesReceivableNet_lbl" xml:lang="en-US">Restated secured convertible note</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecurities" xlink:label="us-gaap_DebtSecurities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecurities" xlink:to="us-gaap_DebtSecurities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecurities_lbl" xml:lang="en-US">Debt Securities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtSecurities_lbl" xml:lang="en-US">Debt securities measured at fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_lbl" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_lbl" xml:lang="en-US">Impairment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_lbl" xml:lang="en-US">Impairment charges</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Deferred revenue recognized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US">Employer matching contribution</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xml:lang="en-US">Maximum contribution of percentage of employee's eligible earnings</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl" xml:lang="en-US">Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" xlink:label="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" xlink:to="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays_lbl" xml:lang="en-US">The payments terms in contract with customer specifying the timing of payment as net number of days.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays_lbl" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms, Number Of Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays_lbl" xml:lang="en-US">Payment terms</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DefectiveProductReplacementCost" xlink:label="smlr_DefectiveProductReplacementCost" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DefectiveProductReplacementCost" xlink:to="smlr_DefectiveProductReplacementCost_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DefectiveProductReplacementCost_lbl" xml:lang="en-US">The amount of  cost incurred for replacing the defective products.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DefectiveProductReplacementCost_lbl" xml:lang="en-US">Defective Product Replacement Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DefectiveProductReplacementCost_lbl" xml:lang="en-US">Defective sensors charges</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_lbl" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease, before Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_lbl" xml:lang="en-US">Assets for lease</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_lbl" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease, Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_lbl" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease" xlink:label="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease" xlink:to="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_lbl" xml:lang="en-US">Depreciation, Lessor Asset under Operating Lease</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_lbl" xml:lang="en-US">Depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseReductionToAccumulatedDepreciation" xlink:label="smlr_AssetsForLeaseReductionToAccumulatedDepreciation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AssetsForLeaseReductionToAccumulatedDepreciation" xlink:to="smlr_AssetsForLeaseReductionToAccumulatedDepreciation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AssetsForLeaseReductionToAccumulatedDepreciation_lbl" xml:lang="en-US">Reduction to accumulated depreciation of assets for lease.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AssetsForLeaseReductionToAccumulatedDepreciation_lbl" xml:lang="en-US">Assets for Lease, Reduction to Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_AssetsForLeaseReductionToAccumulatedDepreciation_lbl" xml:lang="en-US">Reduction to accumulated depreciation for returned and retired items</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseCustomerLocation" xlink:label="smlr_AssetsForLeaseCustomerLocation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AssetsForLeaseCustomerLocation" xlink:to="smlr_AssetsForLeaseCustomerLocation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AssetsForLeaseCustomerLocation_lbl" xml:lang="en-US">Represents the total assets for lease in use at customer locations.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AssetsForLeaseCustomerLocation_lbl" xml:lang="en-US">Assets For Lease, Customer Location</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_AssetsForLeaseCustomerLocation_lbl" xml:lang="en-US">Total assets for lease, net, in use at customer locations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryCurrentTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryCurrentTable_lbl" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_lbl" xml:lang="en-US">Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, before Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_lbl" xml:lang="en-US">Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, Accumulated Depreciation</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_lbl" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:to="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_lbl" xml:lang="en-US">Depreciation, Excluding Lessor Asset under Operating Lease</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_lbl" xml:lang="en-US">Depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_lbl" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyTwoMember" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_InvestmentInPrivateCompanyTwoMember" xlink:to="smlr_InvestmentInPrivateCompanyTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember_lbl" xml:lang="en-US">Represents information pertaining to investment in private company two.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember_lbl" xml:lang="en-US">Investments in SYNAPS Dx</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_InvestmentInPrivateCompanyThreeMember" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember_lbl" xml:lang="en-US">Represents information pertaining to investment in private company three.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember_lbl" xml:lang="en-US">Investments in Mellitus Health, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_lbl" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PromissoryNoteFromPrivateCompanyTwoMember" xlink:label="smlr_PromissoryNoteFromPrivateCompanyTwoMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PromissoryNoteFromPrivateCompanyTwoMember" xlink:to="smlr_PromissoryNoteFromPrivateCompanyTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PromissoryNoteFromPrivateCompanyTwoMember_lbl" xml:lang="en-US">Represents the information pertaining to promissory note from private company two.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PromissoryNoteFromPrivateCompanyTwoMember_lbl" xml:lang="en-US">Promissory note from SYNAPS Dx</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Aggregate principal amount of offering price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Conversion value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_lbl" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_lbl" xml:lang="en-US">Cumulative recorded impairment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Recurring</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Level 3</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">U.S. Treasury bill</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" xml:lang="en-US">U.S. Government money market fund accounts</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetFairValue" xlink:to="us-gaap_CryptoAssetFairValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetFairValue_lbl" xml:lang="en-US">Crypto Asset, Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CryptoAssetFairValue_lbl" xml:lang="en-US">Ending balance at Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CryptoAssetFairValue_lbl" xml:lang="en-US">Beginning balance at Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetFairValue_lbl" xml:lang="en-US">Bitcoin investments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CryptoAssetFairValue_lbl" xml:lang="en-US">Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt" xlink:label="us-gaap_TradingSecuritiesDebt" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesDebt" xlink:to="us-gaap_TradingSecuritiesDebt_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingSecuritiesDebt_lbl" xml:lang="en-US">Debt Securities, Trading</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradingSecuritiesDebt_lbl" xml:lang="en-US">U.S. Treasury bill</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HeldToMaturitySecuritiesFairValue" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_lbl" xml:lang="en-US">Investment in debt securities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Investment Interest Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfProbabilityOfEquityFinancing" xlink:label="smlr_PercentageOfProbabilityOfEquityFinancing" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PercentageOfProbabilityOfEquityFinancing" xlink:to="smlr_PercentageOfProbabilityOfEquityFinancing_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PercentageOfProbabilityOfEquityFinancing_lbl" xml:lang="en-US">The Percentage of probability of equity financing.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PercentageOfProbabilityOfEquityFinancing_lbl" xml:lang="en-US">Percentage Of Probability Of Equity Financing</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_PercentageOfProbabilityOfEquityFinancing_lbl" xml:lang="en-US">Percentage of probability of equity financing</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfProbabilityOfChangeOfControl" xlink:label="smlr_PercentageOfProbabilityOfChangeOfControl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PercentageOfProbabilityOfChangeOfControl" xlink:to="smlr_PercentageOfProbabilityOfChangeOfControl_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PercentageOfProbabilityOfChangeOfControl_lbl" xml:lang="en-US">The Percentage of probability of change of control.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PercentageOfProbabilityOfChangeOfControl_lbl" xml:lang="en-US">Percentage Of Probability Of Change Of Control</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_PercentageOfProbabilityOfChangeOfControl_lbl" xml:lang="en-US">Percentage of probability of change of control</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" xlink:label="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" xlink:to="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent_lbl" xml:lang="en-US">The Percentage of probability of payment at maturity or an insolvency event.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent_lbl" xml:lang="en-US">Percentage Of Probability Of Payment At Maturity Or An Insolvency Event</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent_lbl" xml:lang="en-US">Percentage of probability of payment at maturity or an insolvency event</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Cashflow discount rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Expected term in years</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Expected volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US">Debt Instrument, Measurement Input</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US">Measurement input</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesMember" xlink:label="us-gaap_DebtSecuritiesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesMember" xlink:to="us-gaap_DebtSecuritiesMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesMember_lbl" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtSecuritiesMember_lbl" xml:lang="en-US">Notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_lbl" xml:lang="en-US">Ending balance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_lbl" xml:lang="en-US">Beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_lbl" xml:lang="en-US">Purchased</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_lbl" xml:lang="en-US">Change in fair value of the notes held for investment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NotesReceivableInterestBearingInterestRate" xlink:label="smlr_NotesReceivableInterestBearingInterestRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_NotesReceivableInterestBearingInterestRate" xlink:to="smlr_NotesReceivableInterestBearingInterestRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_NotesReceivableInterestBearingInterestRate_lbl" xml:lang="en-US">Interest rate on notes receivable.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_NotesReceivableInterestBearingInterestRate_lbl" xml:lang="en-US">Notes Receivable, Interest-Bearing, Interest Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_NotesReceivableInterestBearingInterestRate_lbl" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfNotesReceivable" xlink:label="smlr_NumberOfNotesReceivable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_NumberOfNotesReceivable" xlink:to="smlr_NumberOfNotesReceivable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_NumberOfNotesReceivable_lbl" xml:lang="en-US">Represents the number of notes receivable.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_NumberOfNotesReceivable_lbl" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_NumberOfNotesReceivable_lbl" xml:lang="en-US">Number of notes receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NotesReceivableTerm" xlink:label="smlr_NotesReceivableTerm" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_NotesReceivableTerm" xlink:to="smlr_NotesReceivableTerm_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_NotesReceivableTerm_lbl" xml:lang="en-US">Term of notes receivable.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_NotesReceivableTerm_lbl" xml:lang="en-US">Notes receivable, Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_NotesReceivableTerm_lbl" xml:lang="en-US">Term (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityMaximumAmountOfAvailableFunding" xlink:label="smlr_DebtSecurityMaximumAmountOfAvailableFunding" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtSecurityMaximumAmountOfAvailableFunding" xlink:to="smlr_DebtSecurityMaximumAmountOfAvailableFunding_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtSecurityMaximumAmountOfAvailableFunding_lbl" xml:lang="en-US">Maximum amount of available funding.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtSecurityMaximumAmountOfAvailableFunding_lbl" xml:lang="en-US">Debt Security, Maximum Amount of Available Funding</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtSecurityMaximumAmountOfAvailableFunding_lbl" xml:lang="en-US">Maximum amount of available funding</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecuritiesTransactionFee" xlink:label="smlr_DebtSecuritiesTransactionFee" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtSecuritiesTransactionFee" xlink:to="smlr_DebtSecuritiesTransactionFee_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtSecuritiesTransactionFee_lbl" xml:lang="en-US">Amount of transaction fee paid for debt security.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtSecuritiesTransactionFee_lbl" xml:lang="en-US">Debt Securities, Transaction Fee</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtSecuritiesTransactionFee_lbl" xml:lang="en-US">Transaction fee</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" xlink:label="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" xlink:to="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate_lbl" xml:lang="en-US">Option to extend the maturity date.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate_lbl" xml:lang="en-US">Number of Consecutive Terms, Option to Extend the Maturity Date</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate_lbl" xml:lang="en-US">Option to extend the maturity date</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ExtensionPeriodOptionToExtendMaturityDate" xlink:label="smlr_ExtensionPeriodOptionToExtendMaturityDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ExtensionPeriodOptionToExtendMaturityDate" xlink:to="smlr_ExtensionPeriodOptionToExtendMaturityDate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ExtensionPeriodOptionToExtendMaturityDate_lbl" xml:lang="en-US">Option to extend the maturity date.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ExtensionPeriodOptionToExtendMaturityDate_lbl" xml:lang="en-US">Extension Period, Option to Extend the Maturity Date</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ExtensionPeriodOptionToExtendMaturityDate_lbl" xml:lang="en-US">Period to extend the maturity date</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestIncome" xlink:label="smlr_DebtSecurityInterestIncome" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtSecurityInterestIncome" xlink:to="smlr_DebtSecurityInterestIncome_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtSecurityInterestIncome_lbl" xml:lang="en-US">Amount of interest income on debt security recognized.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtSecurityInterestIncome_lbl" xml:lang="en-US">Debt Security, Interest Income</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtSecurityInterestIncome_lbl" xml:lang="en-US">Interest income from promissory notes</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityChangesInFairValue" xlink:label="smlr_DebtSecurityChangesInFairValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtSecurityChangesInFairValue" xlink:to="smlr_DebtSecurityChangesInFairValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtSecurityChangesInFairValue_lbl" xml:lang="en-US">Amount of changes in fair value of debt security.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtSecurityChangesInFairValue_lbl" xml:lang="en-US">Debt Security, Changes in Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtSecurityChangesInFairValue_lbl" xml:lang="en-US">Changes in fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestRate" xlink:label="smlr_DebtSecurityInterestRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtSecurityInterestRate" xlink:to="smlr_DebtSecurityInterestRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtSecurityInterestRate_lbl" xml:lang="en-US">Percentage of interest rate.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtSecurityInterestRate_lbl" xml:lang="en-US">Debt Security, Interest Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtSecurityInterestRate_lbl" xml:lang="en-US">Interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTable" xlink:label="us-gaap_CryptoAssetHoldingTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetHoldingTable" xlink:to="us-gaap_CryptoAssetHoldingTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetHoldingTable_lbl" xml:lang="en-US">Crypto Asset, Holding [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingLineItems" xlink:label="us-gaap_CryptoAssetHoldingLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetHoldingLineItems" xlink:to="us-gaap_CryptoAssetHoldingLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetHoldingLineItems_lbl" xml:lang="en-US">Crypto Asset, Holding [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetHoldingLineItems_lbl" xml:lang="en-US">Intangible Digital Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetNumberOfUnits" xlink:to="us-gaap_CryptoAssetNumberOfUnits_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetNumberOfUnits_lbl" xml:lang="en-US">Units Held</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetNumberOfUnits_lbl" xml:lang="en-US">Crypto Asset, Number of Units</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CryptoAssetNumberOfUnits_lbl" xml:lang="en-US">Crypto assets number of assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="us-gaap_CryptoAssetCost" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetCost" xlink:to="us-gaap_CryptoAssetCost_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetCost_lbl" xml:lang="en-US">Crypto Asset, Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetCost_lbl" xml:lang="en-US">Crypto Asset, Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CryptoAssetCost_lbl" xml:lang="en-US">Cost Basis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNameExtensibleEnumeration" xlink:label="us-gaap_CryptoAssetNameExtensibleEnumeration" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetNameExtensibleEnumeration" xlink:to="us-gaap_CryptoAssetNameExtensibleEnumeration_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetNameExtensibleEnumeration_lbl" xml:lang="en-US">Crypto Asset, Name [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRollForward" xlink:label="us-gaap_CryptoAssetRollForward" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetRollForward" xlink:to="us-gaap_CryptoAssetRollForward_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetRollForward_lbl" xml:lang="en-US">Crypto Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetAddition" xlink:label="us-gaap_CryptoAssetAddition" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetAddition" xlink:to="us-gaap_CryptoAssetAddition_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetAddition_lbl" xml:lang="en-US">Crypto Asset, Addition</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetAddition_lbl" xml:lang="en-US">Additions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainNonoperating" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetUnrealizedGainNonoperating" xlink:to="us-gaap_CryptoAssetUnrealizedGainNonoperating_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetUnrealizedGainNonoperating_lbl" xml:lang="en-US">Crypto Asset, Unrealized Gain, Nonoperating</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CryptoAssetUnrealizedGainNonoperating_lbl" xml:lang="en-US">Unrealized gain, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedLossNonoperating" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetUnrealizedLossNonoperating" xlink:to="us-gaap_CryptoAssetUnrealizedLossNonoperating_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetUnrealizedLossNonoperating_lbl" xml:lang="en-US">Crypto Asset, Unrealized Loss, Nonoperating</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CryptoAssetUnrealizedLossNonoperating_lbl" xml:lang="en-US">Unrealized loss, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Total ROU asset</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">ROU asset</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MiscellaneousReceivables" xlink:label="smlr_MiscellaneousReceivables" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_MiscellaneousReceivables" xlink:to="smlr_MiscellaneousReceivables_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_MiscellaneousReceivables_lbl" xml:lang="en-US">Amount of miscellaneous receivables.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_MiscellaneousReceivables_lbl" xml:lang="en-US">Miscellaneous Receivables</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_MiscellaneousReceivables_lbl" xml:lang="en-US">Miscellaneous receivables</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_LongTermDeposits" xlink:label="smlr_LongTermDeposits" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_LongTermDeposits" xlink:to="smlr_LongTermDeposits_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_LongTermDeposits_lbl" xml:lang="en-US">Amount of long-term deposits.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_LongTermDeposits_lbl" xml:lang="en-US">Long-term Deposits</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_LongTermDeposits_lbl" xml:lang="en-US">Long-term deposits</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Accrued Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Miscellaneous Accruals</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer concentration risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentHoldingConcentrationRiskMember" xlink:label="smlr_InvestmentHoldingConcentrationRiskMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_InvestmentHoldingConcentrationRiskMember" xlink:to="smlr_InvestmentHoldingConcentrationRiskMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_InvestmentHoldingConcentrationRiskMember_lbl" xml:lang="en-US">Represents information pertaining to percentage that arises from holding of investments. Risk is materially adverse effects of loss on investment holdings which could occur upon sale of or decrease in value of investments.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_InvestmentHoldingConcentrationRiskMember_lbl" xml:lang="en-US">Investment Holding, Concentration Risk [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_InvestmentHoldingConcentrationRiskMember_lbl" xml:lang="en-US">Investment Holding Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetBenchmarkMember" xlink:label="smlr_IntangibleDigitalAssetBenchmarkMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_IntangibleDigitalAssetBenchmarkMember" xlink:to="smlr_IntangibleDigitalAssetBenchmarkMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_IntangibleDigitalAssetBenchmarkMember_lbl" xml:lang="en-US">Represents information pertaining to intangible digital assets, when it serves as benchmark in concentration of risk calculation.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_IntangibleDigitalAssetBenchmarkMember_lbl" xml:lang="en-US">Intangible Digital Asset, Benchmark [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_IntangibleDigitalAssetBenchmarkMember_lbl" xml:lang="en-US">Intangible digital assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerOneConcentrationRiskMember" xlink:label="smlr_CustomerOneConcentrationRiskMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CustomerOneConcentrationRiskMember" xlink:to="smlr_CustomerOneConcentrationRiskMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CustomerOneConcentrationRiskMember_lbl" xml:lang="en-US">Customer One.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CustomerOneConcentrationRiskMember_lbl" xml:lang="en-US">Customer one</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerTwoConcentrationRiskMember" xlink:label="smlr_CustomerTwoConcentrationRiskMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CustomerTwoConcentrationRiskMember" xlink:to="smlr_CustomerTwoConcentrationRiskMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CustomerTwoConcentrationRiskMember_lbl" xml:lang="en-US">Customer Two.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CustomerTwoConcentrationRiskMember_lbl" xml:lang="en-US">Customer two</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerThreeConcentrationRiskMember" xlink:label="smlr_CustomerThreeConcentrationRiskMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CustomerThreeConcentrationRiskMember" xlink:to="smlr_CustomerThreeConcentrationRiskMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CustomerThreeConcentrationRiskMember_lbl" xml:lang="en-US">This member stands for customer three.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CustomerThreeConcentrationRiskMember_lbl" xml:lang="en-US">Customer three</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorOneMember" xlink:label="smlr_VendorOneMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_VendorOneMember" xlink:to="smlr_VendorOneMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_VendorOneMember_lbl" xml:lang="en-US">Vendor one</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_VendorOneMember_lbl" xml:lang="en-US">Vendor one</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorTwoMember" xlink:label="smlr_VendorTwoMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_VendorTwoMember" xlink:to="smlr_VendorTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_VendorTwoMember_lbl" xml:lang="en-US">Vendor two</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_VendorTwoMember_lbl" xml:lang="en-US">Vendor two</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorThreeMember" xlink:label="smlr_VendorThreeMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_VendorThreeMember" xlink:to="smlr_VendorThreeMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_VendorThreeMember_lbl" xml:lang="en-US">Vendor three.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_VendorThreeMember_lbl" xml:lang="en-US">Vendor three</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetProviderOneMember" xlink:label="smlr_CryptoAssetProviderOneMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CryptoAssetProviderOneMember" xlink:to="smlr_CryptoAssetProviderOneMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CryptoAssetProviderOneMember_lbl" xml:lang="en-US">Represents information pertaining to crypto asset provider one.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CryptoAssetProviderOneMember_lbl" xml:lang="en-US">Crypto Asset, Provider One [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_CryptoAssetProviderOneMember_lbl" xml:lang="en-US">Provider One</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetProviderTwoMember" xlink:label="smlr_CryptoAssetProviderTwoMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CryptoAssetProviderTwoMember" xlink:to="smlr_CryptoAssetProviderTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CryptoAssetProviderTwoMember_lbl" xml:lang="en-US">Represents information pertaining to crypto asset provider two.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CryptoAssetProviderTwoMember_lbl" xml:lang="en-US">Crypto Asset, Provider Two [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_CryptoAssetProviderTwoMember_lbl" xml:lang="en-US">Provider Two</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="us-gaap_TimeDepositsAtCarryingValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimeDepositsAtCarryingValue" xlink:to="us-gaap_TimeDepositsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimeDepositsAtCarryingValue_lbl" xml:lang="en-US">Time Deposits, at Carrying Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TimeDepositsAtCarryingValue_lbl" xml:lang="en-US">Deposits</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskCryptoAssetNumberOfProviders" xlink:label="smlr_ConcentrationRiskCryptoAssetNumberOfProviders" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ConcentrationRiskCryptoAssetNumberOfProviders" xlink:to="smlr_ConcentrationRiskCryptoAssetNumberOfProviders_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ConcentrationRiskCryptoAssetNumberOfProviders_lbl" xml:lang="en-US">Number of major providers of crypto asset holdings in concentration risk.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ConcentrationRiskCryptoAssetNumberOfProviders_lbl" xml:lang="en-US">Concentration Risk, Crypto Asset, Number Of Providers</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ConcentrationRiskCryptoAssetNumberOfProviders_lbl" xml:lang="en-US">Number Of Providers</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskNumberOfCustomers" xlink:label="smlr_ConcentrationRiskNumberOfCustomers" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ConcentrationRiskNumberOfCustomers" xlink:to="smlr_ConcentrationRiskNumberOfCustomers_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ConcentrationRiskNumberOfCustomers_lbl" xml:lang="en-US">Represents number of major customers in concentration risk.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ConcentrationRiskNumberOfCustomers_lbl" xml:lang="en-US">Concentration Risk Number Of Customers</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_ConcentrationRiskNumberOfCustomers_lbl" xml:lang="en-US">Number of customers</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskNumberOfVendors" xlink:label="smlr_ConcentrationRiskNumberOfVendors" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ConcentrationRiskNumberOfVendors" xlink:to="smlr_ConcentrationRiskNumberOfVendors_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ConcentrationRiskNumberOfVendors_lbl" xml:lang="en-US">Represents number of major vendors in concentration risk.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ConcentrationRiskNumberOfVendors_lbl" xml:lang="en-US">Concentration Risk Number Of Vendors</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ConcentrationRiskNumberOfVendors_lbl" xml:lang="en-US">Number of vendors</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US">Future minimum rental payments required under operating leases</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total undiscounted future minimum lease payments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: present value discount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OperatingLeaseExpensesInExcessOfCashPayments" xlink:label="smlr_OperatingLeaseExpensesInExcessOfCashPayments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_OperatingLeaseExpensesInExcessOfCashPayments" xlink:to="smlr_OperatingLeaseExpensesInExcessOfCashPayments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_OperatingLeaseExpensesInExcessOfCashPayments_lbl" xml:lang="en-US">Represents the amount of lease expense in excess of cash payments during the period.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_OperatingLeaseExpensesInExcessOfCashPayments_lbl" xml:lang="en-US">Operating Lease Expenses in Excess of Cash Payments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_OperatingLeaseExpensesInExcessOfCashPayments_lbl" xml:lang="en-US">Lease expense in excess cash payment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lease agreement term</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US">Discount rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Remaining lease term</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xml:lang="en-US">Lessee, Operating Lease, Existence of Option to Extend [true false]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xml:lang="en-US">Options to renew</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Lease expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome" xlink:label="us-gaap_OperatingLeaseLeaseIncome" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLeaseIncome" xlink:to="us-gaap_OperatingLeaseLeaseIncome_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLeaseIncome_lbl" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLeaseIncome_lbl" xml:lang="en-US">Lease revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent" xlink:label="us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent" xlink:to="us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent_lbl" xml:lang="en-US">Lease, Practical Expedient, Lessor Single Lease Component [true false]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:label="us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:to="us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_lbl" xml:lang="en-US">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseIncome" xlink:label="us-gaap_VariableLeaseIncome" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseIncome" xlink:to="us-gaap_VariableLeaseIncome_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeaseIncome_lbl" xml:lang="en-US">Variable Lease, Income</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableLeaseIncome_lbl" xml:lang="en-US">Revenue from variable-fee licenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesTypeLeaseRevenue" xlink:label="us-gaap_SalesTypeLeaseRevenue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesTypeLeaseRevenue" xlink:to="us-gaap_SalesTypeLeaseRevenue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesTypeLeaseRevenue_lbl" xml:lang="en-US">Sales-type Lease, Revenue</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesTypeLeaseRevenue_lbl" xml:lang="en-US">Revenues from sales of hardware and equipment accessories</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IncomeTaxExaminationsMaximumEstimatedLiability" xlink:label="smlr_IncomeTaxExaminationsMaximumEstimatedLiability" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_IncomeTaxExaminationsMaximumEstimatedLiability" xlink:to="smlr_IncomeTaxExaminationsMaximumEstimatedLiability_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_IncomeTaxExaminationsMaximumEstimatedLiability_lbl" xml:lang="en-US">Maximum amount of estimated liability on income tax examinations.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_IncomeTaxExaminationsMaximumEstimatedLiability_lbl" xml:lang="en-US">Income Tax Examinations, Maximum Estimated Liability</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_IncomeTaxExaminationsMaximumEstimatedLiability_lbl" xml:lang="en-US">Estimated liability</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockholdersEquityDeficitTable" xlink:label="smlr_StockholdersEquityDeficitTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_StockholdersEquityDeficitTable" xlink:to="smlr_StockholdersEquityDeficitTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_StockholdersEquityDeficitTable_lbl" xml:lang="en-US">Disclosure of information about the stockholders' equity (deficit).</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_StockholdersEquityDeficitTable_lbl" xml:lang="en-US">Stockholders Equity Deficit [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AtMarketOfferingMember" xlink:label="smlr_AtMarketOfferingMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_AtMarketOfferingMember" xlink:to="smlr_AtMarketOfferingMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_AtMarketOfferingMember_lbl" xml:lang="en-US">Represents information pertaining to at-the-market (ATM) offering.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_AtMarketOfferingMember_lbl" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_AtMarketOfferingMember_lbl" xml:lang="en-US">At The Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CommonStockWarrantsMember" xlink:label="smlr_CommonStockWarrantsMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CommonStockWarrantsMember" xlink:to="smlr_CommonStockWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CommonStockWarrantsMember_lbl" xml:lang="en-US">Common stock warrants</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">CEO</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockholdersEquityDeficitLineItems" xlink:label="smlr_StockholdersEquityDeficitLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_StockholdersEquityDeficitLineItems" xlink:to="smlr_StockholdersEquityDeficitLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_StockholdersEquityDeficitLineItems_lbl" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_StockholdersEquityDeficitLineItems_lbl" xml:lang="en-US">Stockholders Equity Deficit [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfVotesForEachShare" xlink:label="smlr_NumberOfVotesForEachShare" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_NumberOfVotesForEachShare" xlink:to="smlr_NumberOfVotesForEachShare_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_NumberOfVotesForEachShare_lbl" xml:lang="en-US">Represents the number of votes for each share held by shareholders.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_NumberOfVotesForEachShare_lbl" xml:lang="en-US">Number of Votes for Each Share</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_NumberOfVotesForEachShare_lbl" xml:lang="en-US">Number of votes for each share</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SaleOfStockValueAuthorized" xlink:label="smlr_SaleOfStockValueAuthorized" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_SaleOfStockValueAuthorized" xlink:to="smlr_SaleOfStockValueAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_SaleOfStockValueAuthorized_lbl" xml:lang="en-US">The maximum value of authorized shares permitted to be issued under the respective stock transaction.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_SaleOfStockValueAuthorized_lbl" xml:lang="en-US">Sale of Stock, Value Authorized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_SaleOfStockValueAuthorized_lbl" xml:lang="en-US">Sale of stock, value authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="srt_StockRepurchaseProgramAuthorizedAmount1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Shares authorized under Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Number of warrant issued to purchase common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Treasury stock acquired (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ClassOfWarrantOrRightValueRepurchased" xlink:label="smlr_ClassOfWarrantOrRightValueRepurchased" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ClassOfWarrantOrRightValueRepurchased" xlink:to="smlr_ClassOfWarrantOrRightValueRepurchased_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ClassOfWarrantOrRightValueRepurchased_lbl" xml:lang="en-US">The value of warrants or rights repurchased.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ClassOfWarrantOrRightValueRepurchased_lbl" xml:lang="en-US">Class Of Warrant Or Right, Value Repurchased</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ClassOfWarrantOrRightValueRepurchased_lbl" xml:lang="en-US">Warrants repurchased</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockIncentivePlan2014Member" xlink:label="smlr_StockIncentivePlan2014Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_StockIncentivePlan2014Member" xlink:to="smlr_StockIncentivePlan2014Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_StockIncentivePlan2014Member_lbl" xml:lang="en-US">Represents information related to 2014 Stock Incentive Plan ("2014 Plan").</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_StockIncentivePlan2014Member_lbl" xml:lang="en-US">2014 Stock Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_KeyPersonStockOptionPlan2007Member" xlink:label="smlr_KeyPersonStockOptionPlan2007Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_KeyPersonStockOptionPlan2007Member" xlink:to="smlr_KeyPersonStockOptionPlan2007Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_KeyPersonStockOptionPlan2007Member_lbl" xml:lang="en-US">Represents information related to 2007 Key Person Stock Option Plan ("2007 Plan").</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_KeyPersonStockOptionPlan2007Member_lbl" xml:lang="en-US">2007 Key Person Stock Option Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingDomain_lbl" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Vested one year after the grant date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Each month thereafter contingent upon the participant's continued service beginning on the initial vesting date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GranteeStatusAxis_lbl" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_GranteeStatusDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GranteeStatusDomain_lbl" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xml:lang="en-US">Employee</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_lbl" xml:lang="en-US">Non-employee directors</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Stock Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Maximum number of shares issued pursuant to awards granted under plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Maximum term of stock option grants</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfSharesReserveIncrease" xlink:label="smlr_PercentageOfSharesReserveIncrease" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_PercentageOfSharesReserveIncrease" xlink:to="smlr_PercentageOfSharesReserveIncrease_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_PercentageOfSharesReserveIncrease_lbl" xml:lang="en-US">Represents percentage of shares reserve to total number of shares of common stock outstanding.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_PercentageOfSharesReserveIncrease_lbl" xml:lang="en-US">Percentage Of Shares Reserve Increase</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_PercentageOfSharesReserveIncrease_lbl" xml:lang="en-US">Percentage of shares reserve increased</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available for future stock-based compensation grants</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Total unrecognized compensation cost related to non-vested awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted average period of unvested stock awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Fair value of options granted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant date fair value of options granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Fully vested stock granted</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" xlink:to="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue_lbl" xml:lang="en-US">Grant date fair value of non-option equity instruments.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue_lbl" xml:lang="en-US">Grant date fair value of stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Vesting percentage (in percent)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:to="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xml:lang="en-US">Amount of grant date fair value of options granted during the reporting period.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xml:lang="en-US">Grant date fair value of options granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_lbl" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Number of Stock Options Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Balance, Ending</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Balance, Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options forfeited/cancelled</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable, Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Balance, Ending</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Balance, Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable, Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Options Outstanding (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Options Exercisable (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Options Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Options Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term (in years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Revenues</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_EngineeringAndProductDevelopmentMember" xlink:label="smlr_EngineeringAndProductDevelopmentMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_EngineeringAndProductDevelopmentMember" xlink:to="smlr_EngineeringAndProductDevelopmentMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_EngineeringAndProductDevelopmentMember_lbl" xml:lang="en-US">This is related to Engineering and product development.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_EngineeringAndProductDevelopmentMember_lbl" xml:lang="en-US">Engineering And Product Development [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_EngineeringAndProductDevelopmentMember_lbl" xml:lang="en-US">Engineering and Product Development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Sales and Marketing</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_lbl" xml:lang="en-US">Total tax benefit from the exercise of stock options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Current tax provision:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current tax provision</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Deferred tax provision:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income tax rate, net of federal benefit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Permanent items</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accrual and reserves</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Research and development credits</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxAssetsLeaseLiabilities" xlink:label="smlr_DeferredTaxAssetsLeaseLiabilities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DeferredTaxAssetsLeaseLiabilities" xlink:to="smlr_DeferredTaxAssetsLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DeferredTaxAssetsLeaseLiabilities_lbl" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DeferredTaxAssetsLeaseLiabilities_lbl" xml:lang="en-US">Deferred Tax Assets, Lease Liabilities</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DeferredTaxAssetsLeaseLiabilities_lbl" xml:lang="en-US">Lease liability</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less valuation allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxAssetsRightOfUseAssets" xlink:label="smlr_DeferredTaxAssetsRightOfUseAssets" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DeferredTaxAssetsRightOfUseAssets" xlink:to="smlr_DeferredTaxAssetsRightOfUseAssets_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DeferredTaxAssetsRightOfUseAssets_lbl" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax liabilities attributable to deductible temporary differences from right of use assets.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DeferredTaxAssetsRightOfUseAssets_lbl" xml:lang="en-US">Deferred Tax Assets, Right of Use Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_DeferredTaxAssetsRightOfUseAssets_lbl" xml:lang="en-US">Right of use assets</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" xlink:label="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" xlink:to="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_lbl" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from change in fair value of digital assets.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_lbl" xml:lang="en-US">Deferred Tax Liabilities, Change In Fair Value Of Digital Assets</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_lbl" xml:lang="en-US">Change in fair value of digital assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Net deferred tax (liabilities)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xml:lang="en-US">Unrecognized tax benefits:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits - December 31</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits - January 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Gross increases related to prior tax positions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Gross decreases related to prior tax positions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Gross increases related to current tax positions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Federal</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">NOL carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Net operating loss carryforwards for California</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xml:lang="en-US">Unrecognized tax benefits, if recognized, would affect the effective tax rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Interest and penalty expenses related to uncertain tax positions</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ExaminationOfCompanyTaxYears" xlink:label="smlr_ExaminationOfCompanyTaxYears" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ExaminationOfCompanyTaxYears" xlink:to="smlr_ExaminationOfCompanyTaxYears_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ExaminationOfCompanyTaxYears_lbl" xml:lang="en-US">Period as income tax examination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ExaminationOfCompanyTaxYears_lbl" xml:lang="en-US">Examination Of Company Tax Years</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_ExaminationOfCompanyTaxYears_lbl" xml:lang="en-US">Company's tax years beginning for examination</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ResearchAndExperimentalExpendituresCapitalized" xlink:label="smlr_ResearchAndExperimentalExpendituresCapitalized" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ResearchAndExperimentalExpendituresCapitalized" xlink:to="smlr_ResearchAndExperimentalExpendituresCapitalized_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ResearchAndExperimentalExpendituresCapitalized_lbl" xml:lang="en-US">Amount of research or experimental expenditures capitalized during the period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ResearchAndExperimentalExpendituresCapitalized_lbl" xml:lang="en-US">Research And Experimental Expenditures, Capitalized</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_ResearchAndExperimentalExpendituresCapitalized_lbl" xml:lang="en-US">Research and experimental expenditures, capitalized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US">Common stock options (in shares)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income - Basic EPS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" xlink:label="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" xlink:to="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_lbl" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_lbl" xml:lang="en-US">Net Income - Common stock options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net Income - Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of reportable segments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SingleReportableSegmentMember" xlink:label="smlr_SingleReportableSegmentMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_SingleReportableSegmentMember" xlink:to="smlr_SingleReportableSegmentMember_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_SingleReportableSegmentMember_lbl" xml:lang="en-US">Represents information pertaining to the Company's single reportable segment.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_SingleReportableSegmentMember_lbl" xml:lang="en-US">Single Reportable Segment [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_SingleReportableSegmentMember_lbl" xml:lang="en-US">Single reportable operating segment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Information</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xml:lang="en-US">Less:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingExpense_lbl" xml:lang="en-US">Selling Expense</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingExpense_lbl" xml:lang="en-US">Sales</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDevelopment" xlink:label="us-gaap_BusinessDevelopment" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDevelopment" xlink:to="us-gaap_BusinessDevelopment_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDevelopment_lbl" xml:lang="en-US">Business Development</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessDevelopment_lbl" xml:lang="en-US">Sales operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_SegmentReportingOtherItemAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xml:lang="en-US">Other Segment expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemCompositionDescription" xlink:label="us-gaap_SegmentReportingOtherItemCompositionDescription" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingOtherItemCompositionDescription" xlink:to="us-gaap_SegmentReportingOtherItemCompositionDescription_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingOtherItemCompositionDescription_lbl" xml:lang="en-US">Segment Reporting, Other Segment Item, Composition, Description</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OtherCorporateIncomeExpense" xlink:label="smlr_OtherCorporateIncomeExpense" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_OtherCorporateIncomeExpense" xlink:to="smlr_OtherCorporateIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_OtherCorporateIncomeExpense_lbl" xml:lang="en-US">Amount of other corporate income (expense).</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_OtherCorporateIncomeExpense_lbl" xml:lang="en-US">Other Corporate Income (Expense)</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_OtherCorporateIncomeExpense_lbl" xml:lang="en-US">Other corporate income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConvertibleSeniorNote4.25Member" xlink:label="smlr_ConvertibleSeniorNote4.25Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_ConvertibleSeniorNote4.25Member" xlink:to="smlr_ConvertibleSeniorNote4.25Member_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_ConvertibleSeniorNote4.25Member_lbl" xml:lang="en-US">Represents information pertaining to 4.25% Convertible Senior Notes.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_ConvertibleSeniorNote4.25Member_lbl" xml:lang="en-US">Convertible Senior Note 4.25% [Member]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="smlr_ConvertibleSeniorNote4.25Member_lbl" xml:lang="en-US">4.25% Convertible Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" xlink:label="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" xlink:to="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised_lbl" xml:lang="en-US">Maximum additional face amount of debt instrument at issuance upon exercise in full of the initial purchaser option.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised_lbl" xml:lang="en-US">Debt Instrument, Maximum Additional Face Amount On option, Exercised</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised_lbl" xml:lang="en-US">Additional principal amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xml:lang="en-US">Trading days</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xml:lang="en-US">Consecutive trading days</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xml:lang="en-US">Conversion price trading day</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleThresholdBusinessDays" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleThresholdBusinessDays" xlink:to="smlr_DebtInstrumentConvertibleThresholdBusinessDays_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleThresholdBusinessDays_lbl" xml:lang="en-US">Threshold number of specified business days that trading price per base principal amount must be below the threshold percentage within a specified consecutive trading period or measurement period to trigger conversion feature.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleThresholdBusinessDays_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Business Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleThresholdBusinessDays_lbl" xml:lang="en-US">Business days</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" xlink:label="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" xlink:to="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod_lbl" xml:lang="en-US">Threshold number of consecutive trading days or measurement period in which the trading price per base principal amount must be below the threshold percentage for specified number of business days to trigger conversion feature.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod_lbl" xml:lang="en-US">After consecutive trading day</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays_lbl" xml:lang="en-US">Threshold number of business days over which the default on conversion of debt instrument upon exercise by the holder continues.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default On Conversion Upon Exercise, Threshold Business Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays_lbl" xml:lang="en-US">Failure business days</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays_lbl" xml:lang="en-US">Threshold number of business days over which the fundamental notice of default has not been issued by the company.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default, Fundamental Change Notice, Threshold Business Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays_lbl" xml:lang="en-US">fundamental notice of default business days</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays_lbl" xml:lang="en-US">Threshold number of business days over which the fundamental notice of default has not been issued by the company.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default, Specified Corporate Action Notice, Threshold Business Days</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays_lbl" xml:lang="en-US">Notice of a specified corporate transaction</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Percentage of convertible senior notes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Redemption price (In percentage)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" xlink:label="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" xlink:to="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage_lbl" xml:lang="en-US">Percentage price of original principal amount of debt at which debt can be redeemed by the issuer that has undergone fundamental change.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage_lbl" xml:lang="en-US">Debt Instrument, Fundamental Change, Repurchase Price, Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage_lbl" xml:lang="en-US">Fundamental change repurchase price (In Percentage)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage_lbl" xml:lang="en-US">Minimum percentage of outstanding debt holders sending written notice of default of compliance with agreements in indenture to company in pursuant to the convertible debt instrument.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default, Post Written Notice From Holders Of Outstanding Debt, Minimum Percentage</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage_lbl" xml:lang="en-US">Minimum aggregate principal amount (In percentage)</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod_lbl" xml:lang="en-US">Period over which the default of interest payment continues for a convertible debt instrument, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default Interest, Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod_lbl" xml:lang="en-US">Default period</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees_lbl" xml:lang="en-US">Period over which the company fails to comply with other agreements in the indenture after written notice from the trustees.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default On Compliance Of Other Agreements In Indenture, Post Written Notice From Trustees</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees_lbl" xml:lang="en-US">Post Written Notice</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod_lbl" xml:lang="en-US">Period over which the company is in default of payments of principal and interest when due and payable or failure to comply with the acceleration clause that is a part of the debt instrument, expressed in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default, Indebtedness, Acceleration Clause, Period</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod_lbl" xml:lang="en-US">Default not cured indebtedness not paid after written notice</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" xlink:label="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" xlink:to="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts_lbl" xml:lang="en-US">The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity per base principal amount.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts_lbl" xml:lang="en-US">Debt Instrument, Number of Equity Instruments Convertible Per Base Principal Amounts</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts_lbl" xml:lang="en-US">Conversion rate for common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" xlink:label="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" xlink:to="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion_lbl" xml:lang="en-US">Maximum number of shares issuable upon conversion of convertible debt instrument.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion_lbl" xml:lang="en-US">Debt Instrument, Convertible, Maximum Shares Issuable Upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" xlink:label="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" xlink:to="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate_lbl" xml:lang="en-US">Base principal amount used for computing the conversion rate of debt instrument.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate_lbl" xml:lang="en-US">Debt Instrument, Base Principal Amount On Computation Of Conversion Rate</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate_lbl" xml:lang="en-US">Principal amount on conversion rate</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" xlink:label="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" xlink:to="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger_lbl" xml:lang="en-US">Maximum percentage of trading price on the product of stock price and conversion price of convertible debt instrument to determine the eligibility of conversion.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage Of Product Of Stock Price And Conversion Price, Stock Price Trigger</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger_lbl" xml:lang="en-US">Trading day of the measurement period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Initial conversion price per share</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" xlink:label="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" xlink:to="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice_lbl" xml:lang="en-US">Percentage of premium on computation of conversion price over the last reported sale price.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice_lbl" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price, Premium Percentage Over Last Reported Sale Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice_lbl" xml:lang="en-US">Premium conversion price over the last reported sale price</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount_lbl" xml:lang="en-US">Minimum amount of principal amount of convertible debt which has been in default with principal, interest, covenants that existed and against which the indebtedness exists or shall be created.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount_lbl" xml:lang="en-US">Debt Instrument, Convertible, Debt Default, Indebtedness, Minimum Principal Amount</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount_lbl" xml:lang="en-US">Minimum Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetNumberOfUnitsPurchased" xlink:label="smlr_CryptoAssetNumberOfUnitsPurchased" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CryptoAssetNumberOfUnitsPurchased" xlink:to="smlr_CryptoAssetNumberOfUnitsPurchased_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CryptoAssetNumberOfUnitsPurchased_lbl" xml:lang="en-US">Number of crypto asset units purchased during the period.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CryptoAssetNumberOfUnitsPurchased_lbl" xml:lang="en-US">Crypto Asset, Number of Units Purchased</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_CryptoAssetNumberOfUnitsPurchased_lbl" xml:lang="en-US">Number of crypto asset units purchased</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetAveragePurchasePrice" xlink:label="smlr_CryptoAssetAveragePurchasePrice" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CryptoAssetAveragePurchasePrice" xlink:to="smlr_CryptoAssetAveragePurchasePrice_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CryptoAssetAveragePurchasePrice_lbl" xml:lang="en-US">Average purchase price per bitcoin.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CryptoAssetAveragePurchasePrice_lbl" xml:lang="en-US">Crypto Asset, Average Purchase Price</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_CryptoAssetAveragePurchasePrice_lbl" xml:lang="en-US">Average purchase price per bitcoin</link:label>
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetMarketPricePerCryptoAsset" xlink:label="smlr_CryptoAssetMarketPricePerCryptoAsset" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="smlr_CryptoAssetMarketPricePerCryptoAsset" xlink:to="smlr_CryptoAssetMarketPricePerCryptoAsset_lbl" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="smlr_CryptoAssetMarketPricePerCryptoAsset_lbl" xml:lang="en-US">Market price per crypto asset.</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="smlr_CryptoAssetMarketPricePerCryptoAsset_lbl" xml:lang="en-US">Crypto Asset, Market Price Per Crypto Asset</link:label>
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="smlr_CryptoAssetMarketPricePerCryptoAsset_lbl" xml:lang="en-US">Market price</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>30
<FILENAME>smlr-20241231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/28/2025 9:05:53 PM-->
<!--Modified on: 2/28/2025 9:05:53 PM-->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://semlerscientific.com/role/DocumentDocumentAndEntityInformation" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementBalanceSheets" roleURI="http://semlerscientific.com/role/StatementBalanceSheets" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementBalanceSheetsParenthetical" roleURI="http://semlerscientific.com/role/StatementBalanceSheetsParenthetical" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementStatementsOfIncome" roleURI="http://semlerscientific.com/role/StatementStatementsOfIncome" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementStatementsOfStockholdersEquity" roleURI="http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#StatementStatementsOfCashFlows" roleURI="http://semlerscientific.com/role/StatementStatementsOfCashFlows" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureCompany" roleURI="http://semlerscientific.com/role/DisclosureCompany" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates" roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAssetsForLeaseNet" roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNet" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureInventory" roleURI="http://semlerscientific.com/role/DisclosureInventory" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosurePropertyAndEquipmentNet" roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLongTermInvestments" roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestments" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurements" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurements" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNotesHeldForInvestment" roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestment" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIntangibleDigitalAssets" roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureOtherNonCurrentAssets" roleURI="http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAccruedExpenses" roleURI="http://semlerscientific.com/role/DisclosureAccruedExpenses" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureConcentrationOfCreditRisk" roleURI="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeases" roleURI="http://semlerscientific.com/role/DisclosureLeases" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockholdersEquity" roleURI="http://semlerscientific.com/role/DisclosureStockholdersEquity" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlan" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlan" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxes" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxes" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNetIncomePerShareBasicAndDiluted" roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSegmentInformation" roleURI="http://semlerscientific.com/role/DisclosureSegmentInformation" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSubsequentEvents" roleURI="http://semlerscientific.com/role/DisclosureSubsequentEvents" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies" roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables" roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAssetsForLeaseNetTables" roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosurePropertyAndEquipmentNetTables" roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLongTermInvestmentsTables" roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsTables" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNotesHeldForInvestmentTables" roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIntangibleDigitalAssetsTables" roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAccruedExpensesTables" roleURI="http://semlerscientific.com/role/DisclosureAccruedExpensesTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeasesTables" roleURI="http://semlerscientific.com/role/DisclosureLeasesTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanTables" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesTables" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNetIncomePerShareBasicAndDilutedTables" roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSegmentInformationTables" roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationTables" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails" roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" roleURI="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAssetsForLeaseNetDetails" roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAssetsForLeaseNetAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureInventoryDetails" roleURI="http://semlerscientific.com/role/DisclosureInventoryDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosurePropertyAndEquipmentNetDetails" roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLongTermInvestmentsDetails" roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLongTermInvestmentsAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsValuationModelDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" roleURI="http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNotesHeldForInvestmentDetails" roleURI="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails" roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails" roleURI="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureOtherNonCurrentAssetsDetails" roleURI="http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureAccruedExpensesDetails" roleURI="http://semlerscientific.com/role/DisclosureAccruedExpensesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureConcentrationOfCreditRiskDetails" roleURI="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeasesFutureMinimumRentalPaymentsDetails" roleURI="http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeasesLesseeArrangementsDetails" roleURI="http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeasesLessorArrangementsDetails" roleURI="http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureLeasesVariableFeeRevenueDetails" roleURI="http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://semlerscientific.com/role/DisclosureCommitmentsAndContingenciesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" roleURI="http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureNetIncomePerShareBasicAndDilutedDetails" roleURI="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSegmentInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSegmentInformationReportableSegmentInformationDetails" roleURI="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="smlr-20241231.xsd#DisclosureSubsequentEventsDetails" roleURI="http://semlerscientific.com/role/DisclosureSubsequentEventsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
  <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
  <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
  <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="995200090 - Document - Document and Entity Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638763735488860585" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_638763735488860585" order="1" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_638763735488860585" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport_638763735488860585" order="2" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638763735488860585" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638763735488860585" order="3" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_638763735488860585" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport_638763735488860585" order="4" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638763735488860585" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_638763735488860585" order="5" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_638763735488870586" order="6" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638763735488870586" order="7" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638763735488870586" order="8" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638763735488870586" order="9" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638763735488870586" order="10" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638763735488870586" order="11" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638763735488870586" order="12" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638763735488870586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_638763735488870586" order="13" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_638763735488880586" order="14" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_638763735488880586" order="15" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_638763735488880586" order="16" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_638763735488880586" order="17" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer_638763735488880586" order="18" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers_638763735488880586" order="19" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_638763735488880586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus_638763735488880586" order="20" use="optional" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_638763735488890586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent_638763735488890586" order="21" use="optional" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638763735488890586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory_638763735488890586" order="22" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_638763735488890586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness_638763735488890586" order="23" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638763735488890586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638763735488890586" order="24" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_638763735488890586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag_638763735488890586" order="25" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_638763735488890586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_638763735488890586" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_638763735488900586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany_638763735488900586" order="27" use="optional" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat_638763735488900586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat_638763735488900586" order="28" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_638763735488900586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_638763735488900586" order="29" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName_638763735488900586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName_638763735488900586" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_638763735488900586" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId_638763735488900586" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_638763735488910589" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation_638763735488910589" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638763735488910589" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638763735488910589" order="33" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638763735488910589" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_638763735488910589" order="34" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_638763735488910589" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus_638763735488910589" order="35" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_638763735488910589" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_638763735488910589" order="36" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638763735488920587" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_638763735488920587" order="37" use="optional" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/StatementBalanceSheets" xlink:type="extended" xlink:title="995200100 - Statement - Balance Sheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637044010124570191" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_638763735488920587" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124570191" xlink:to="us-gaap_AssetsAbstract_638763735488920587" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638763735488920587" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_AssetsCurrentAbstract_638763735488920587" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638763735489020593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638763735489020593" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_638763735489020593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_RestrictedCashCurrent_638763735489020593" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent_638763735489020593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_AccountsReceivableNetCurrent_638763735489020593" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_638763735489020593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_638763735489020593" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638763735489020593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_InventoryNet_638763735489020593" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638763735489030594" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638763735488920587" xlink:to="us-gaap_AssetsCurrent_638763735489030594" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_638763735489030594" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_638763735489030594" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_LongTermInvestments_638763735489030594" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent_638763735489030594" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValueNoncurrent" xlink:label="us-gaap_CryptoAssetFairValueNoncurrent_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_CryptoAssetFairValueNoncurrent_638763735489030594" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_638763735489030594" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_OtherAssetsNoncurrent_638763735489030594" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_638763735489040595" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638763735488920587" xlink:to="us-gaap_Assets_638763735489040595" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124570191" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638763735489040595" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638763735489040595" xlink:to="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" xlink:to="us-gaap_AccountsPayableCurrent_638763735489040595" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638763735489040595" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_638763735489040595" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_638763735489040595" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" xlink:to="us-gaap_OtherLiabilitiesCurrent_638763735489050596" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638763735489040595" xlink:to="us-gaap_LiabilitiesCurrent_638763735489050596" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638763735489040595" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_638763735489050596" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract_638763735489050596" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_638763735489050596" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract_638763735489050596" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638763735489050596" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract_638763735489050596" xlink:to="us-gaap_LiabilitiesNoncurrent_638763735489050596" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638763735489050596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract_638763735489050596" xlink:to="us-gaap_CommitmentsAndContingencies_638763735489050596" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_638763735489060596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638763735489040595" xlink:to="us-gaap_StockholdersEquityAbstract_638763735489060596" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638763735489060596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638763735489060596" xlink:to="us-gaap_CommonStockValue_638763735489060596" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638763735489060596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638763735489060596" xlink:to="us-gaap_AdditionalPaidInCapital_638763735489060596" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638763735489060596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638763735489060596" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638763735489060596" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638763735489060596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638763735489060596" xlink:to="us-gaap_StockholdersEquity_638763735489060596" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_638763735489060596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638763735489040595" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_638763735489060596" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/StatementBalanceSheetsParenthetical" xlink:type="extended" xlink:title="995200105 - Statement - Balance Sheets (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638763735489070596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638763735489070596" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638763735489070596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638763735489070596" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638763735489070596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" xlink:to="us-gaap_CommonStockSharesAuthorized_638763735489070596" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638763735489070596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" xlink:to="us-gaap_CommonStockSharesIssued_638763735489070596" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638763735489070596" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" xlink:to="us-gaap_CommonStockSharesOutstanding_638763735489070596" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_637044010124671620" xlink:to="us-gaap_TreasuryStockCommonShares_638763735489080597" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/StatementStatementsOfIncome" xlink:type="extended" xlink:title="995200200 - Statement - Statements of Income">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues_638763735489080597" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_638763735489080597" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638763735489080597" xlink:to="us-gaap_CostOfRevenue_638763735489080597" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638763735489080597" xlink:to="us-gaap_ResearchAndDevelopmentExpense_638763735489080597" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638763735489080597" xlink:to="us-gaap_SellingAndMarketingExpense_638763735489080597" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638763735489080597" xlink:to="us-gaap_GeneralAndAdministrativeExpense_638763735489080597" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges_638763735489080597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638763735489080597" xlink:to="us-gaap_RestructuringCharges_638763735489080597" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638763735489080597" xlink:to="us-gaap_CostsAndExpenses_638763735489090597" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_638763735489090597" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_638763735489090597" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="smlr_ImpairmentLossesInvestments_638763735489090597" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735489090597" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735489090597" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638763735489090597" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638763735489090597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense_638763735489090597" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735489100601" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638763735489100601" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_638763735489100601" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic_638763735489100601" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638763735489100601" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted_638763735489100601" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638763735489100601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638763735489100601" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="995200300 - Statement - Statements of Stockholders' Equity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_637044010124671620" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract_637044010124671620" xlink:to="us-gaap_StatementTable_638763735489110601" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638763735489110601" xlink:to="us-gaap_StatementEquityComponentsAxis_638763735489110601" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638763735489110601" xlink:to="us-gaap_CommonStockMember_638763735489110601" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638763735489110601" xlink:to="us-gaap_TreasuryStockCommonMember_638763735489110601" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638763735489110601" xlink:to="us-gaap_AdditionalPaidInCapitalMember_638763735489110601" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638763735489110601" xlink:to="us-gaap_RetainedEarningsMember_638763735489110601" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638763735489110601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638763735489110601" xlink:to="us-gaap_EquityComponentDomain_638763735489110601" order="5" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638763735489110601" xlink:to="us-gaap_StatementLineItems_638763735489120602" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638763735489120602" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_StockholdersEquity_638763735489120602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_SharesIssued_638763735489120602" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_TreasuryStockCommonShares_638763735489120602" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" priority="3" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants" xlink:label="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants_638763735489120602" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_638763735489120602" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_638763735489120602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_638763735489120602" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_638763735489120602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638763735489130603" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues_638763735489130603" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638763735489130603" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_638763735489130603" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_638763735489130603" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares" xlink:label="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards_638763735489130603" xlink:to="smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares_638763735489130603" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638763735489130603" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638763735489130603" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638763735489130603" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_638763735489130603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_638763735489130603" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638763735489140601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_NetIncomeLoss_638763735489140601" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638763735489140601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_StockholdersEquity_638763735489140601" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638763735489140601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_SharesIssued_638763735489140601" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares_638763735489140601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638763735489120602" xlink:to="us-gaap_TreasuryStockCommonShares_638763735489140601" order="14" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/StatementStatementsOfCashFlows" xlink:type="extended" xlink:title="995200400 - Statement - Statements of Cash Flows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_ProfitLoss_638763735489150601" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_DepreciationAndAmortization_638763735489150601" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735489150601" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_638763735489150601" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PrepaidLicensePurchasesWriteoff" xlink:label="smlr_PrepaidLicensePurchasesWriteoff_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="smlr_PrepaidLicensePurchasesWriteoff_638763735489150601" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesTradingRealizedGain" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_DebtSecuritiesTradingRealizedGain_638763735489150601" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_638763735489150601" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_638763735489150601" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735489160605" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735489160605" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_ShareBasedCompensation_638763735489160605" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="smlr_ImpairmentLossesInvestments_638763735489160605" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_638763735489160605" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInInventories_638763735489160605" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638763735489160605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638763735489160605" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_638763735489170603" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_638763735489170603" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638763735489170603" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638763735489160605" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638763735489170603" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638763735489150601" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638763735489170603" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638763735489170603" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638763735489170603" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_638763735489180602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_638763735489180602" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_638763735489180602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset_638763735489180602" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_638763735489180602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_638763735489180602" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_638763735489180602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_638763735489180602" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromPaymentsForEquipmentForLeases" xlink:label="smlr_ProceedsFromPaymentsForEquipmentForLeases_638763735489180602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="smlr_ProceedsFromPaymentsForEquipmentForLeases_638763735489180602" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735489180602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638763735489170603" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638763735489180602" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638763735489190604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638763735489190604" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_638763735489190604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_638763735489190604" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants_638763735489190604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants_638763735489190604" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638763735489190604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638763735489190604" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_638763735489190604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_638763735489190604" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735489200604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638763735489190604" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638763735489200604" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638763735489200604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638763735489200604" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638763735489200604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638763735489200604" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6387637354892006041" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6387637354892006041" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638763735489200604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638763735489200604" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid_638763735489210605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638763735489200604" xlink:to="us-gaap_IncomeTaxesPaid_638763735489210605" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureCompany" xlink:type="extended" xlink:title="995210101 - Disclosure - The Company">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CompanyAbstract" xlink:label="smlr_CompanyAbstract_637044010124773047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations_638763735489210605" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_CompanyAbstract_637044010124773047" xlink:to="us-gaap_NatureOfOperations_638763735489210605" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates" xlink:type="extended" xlink:title="995210201 - Disclosure - Summary of Significant Accounting Policies and Estimates">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_637044010124773047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_638763735489220606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_637044010124773047" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_638763735489220606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAssetsForLeaseNet" xlink:type="extended" xlink:title="995210301 - Disclosure - Assets for Lease, net">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetAbstract" xlink:label="smlr_AssetsForLeaseNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetTextBlock" xlink:label="smlr_AssetsForLeaseNetTextBlock_638763735489220606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract" xlink:to="smlr_AssetsForLeaseNetTextBlock_638763735489220606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureInventory" xlink:type="extended" xlink:title="995210401 - Disclosure - Inventory">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock_638763735489220606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock_638763735489220606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet" xlink:type="extended" xlink:title="995210501 - Disclosure - Property and Equipment, net">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_638763735489220606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_638763735489220606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLongTermInvestments" xlink:type="extended" xlink:title="995210601 - Disclosure - Long-Term Investments">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_638763735489230606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_638763735489230606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurements" xlink:type="extended" xlink:title="995210701 - Disclosure - Fair Value Measurements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_638763735489230606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_638763735489230606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureNotesHeldForInvestment" xlink:type="extended" xlink:title="995210801 - Disclosure - Notes held for investment">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesTextBlock" xlink:label="us-gaap_FinancingReceivablesTextBlock_638763735489240606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_FinancingReceivablesTextBlock_638763735489240606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets" xlink:type="extended" xlink:title="995210901 - Disclosure - Intangible Digital Assets">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsAbstract" xlink:label="smlr_IntangibleDigitalAssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetTextBlock" xlink:label="us-gaap_CryptoAssetTextBlock_638763735489240606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract" xlink:to="us-gaap_CryptoAssetTextBlock_638763735489240606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets" xlink:type="extended" xlink:title="995211001 - Disclosure - Other non-current assets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrentDisclosureAbstract" xlink:label="us-gaap_OtherAssetsNoncurrentDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OtherNoncurrentAssetsTextBlock" xlink:label="smlr_OtherNoncurrentAssetsTextBlock_638763735489240606" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentDisclosureAbstract" xlink:to="smlr_OtherNoncurrentAssetsTextBlock_638763735489240606" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAccruedExpenses" xlink:type="extended" xlink:title="995211101 - Disclosure - Accrued Expenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_638763735489250608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_638763735489250608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk" xlink:type="extended" xlink:title="995211201 - Disclosure - Concentration of Credit Risk">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_638763735489250608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_0" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_638763735489250608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLeases" xlink:type="extended" xlink:title="995211301 - Disclosure - Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_LeaseDisclosureTextBlock" xlink:label="smlr_LeaseDisclosureTextBlock_638763735489250608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="smlr_LeaseDisclosureTextBlock_638763735489250608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="995211401 - Disclosure - Commitments and Contingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638763735489260607" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638763735489260607" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockholdersEquity" xlink:type="extended" xlink:title="995211501 - Disclosure - Stockholders' Equity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract_637044010124773047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638763735489260607" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract_637044010124773047" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638763735489260607" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlan" xlink:type="extended" xlink:title="995211601 - Disclosure - Stock Option Plan">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_638763735489260607" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_638763735489260607" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="995211701 - Disclosure - Income Taxes">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_638763735489270608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_638763735489270608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted" xlink:type="extended" xlink:title="995211801 - Disclosure - Net Income Per Share, Basic and Diluted">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock_638763735489270608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="us-gaap_EarningsPerShareTextBlock_638763735489270608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSegmentInformation" xlink:type="extended" xlink:title="995211901 - Disclosure - Segment Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_638763735489270608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_638763735489270608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSubsequentEvents" xlink:type="extended" xlink:title="995212001 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_638763735489280608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock_638763735489280608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies" xlink:type="extended" xlink:title="99920102 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_638763735489280608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_638763735489280608" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_638763735489280608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates_638763735489280608" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_638763735489280608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk_638763735489280608" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_638763735489290610" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638763735489290610" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy" xlink:label="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy_638763735489290610" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_638763735489290610" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock_638763735489290610" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="us-gaap_LessorLeasesPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LessorLeasesPolicyTextBlock_638763735489290610" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock" xlink:label="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock_638763735489290610" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638763735489290610" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_638763735489290610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_638763735489290610" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_638763735489300610" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock_638763735489300610" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_638763735489300610" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_638763735489300610" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_638763735489300610" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_638763735489300610" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_638763735489300610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_638763735489300610" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_638763735489310609" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_638763735489310609" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638763735489310609" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638763735489310609" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables" xlink:type="extended" xlink:title="99930203 - Disclosure - Summary of Significant Accounting Policies and Estimates (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_637044010124773047_1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_638763735489310609" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_637044010124773047_1" xlink:to="smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_638763735489310609" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables" xlink:type="extended" xlink:title="99930303 - Disclosure - Assets for Lease, net (Tables)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetAbstract" xlink:label="smlr_AssetsForLeaseNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ScheduleOfAssetsForLeaseNetTableTextBlock" xlink:label="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock_638763735489320610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract" xlink:to="smlr_ScheduleOfAssetsForLeaseNetTableTextBlock_638763735489320610" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables" xlink:type="extended" xlink:title="99930503 - Disclosure - Property and Equipment, net (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_638763735489320610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_638763735489320610" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables" xlink:type="extended" xlink:title="99930603 - Disclosure - Long-Term Investments (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_638763735489320610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_638763735489320610" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables" xlink:type="extended" xlink:title="99930703 - Disclosure - Fair Value Measurements (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_638763735489330610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_2" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_638763735489330610" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638763735489330610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_2" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638763735489330610" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638763735489330610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_2" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638763735489330610" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables" xlink:type="extended" xlink:title="99930803 - Disclosure - Notes held for investment (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_638763735489330610" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract_1" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_638763735489330610" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables" xlink:type="extended" xlink:title="99930903 - Disclosure - Intangible Digital Assets (Tables)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsAbstract" xlink:label="smlr_IntangibleDigitalAssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTableTextBlock" xlink:label="us-gaap_CryptoAssetHoldingTableTextBlock_638763735489340611" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract" xlink:to="us-gaap_CryptoAssetHoldingTableTextBlock_638763735489340611" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetActivityTableTextBlock" xlink:label="us-gaap_CryptoAssetActivityTableTextBlock_638763735489340611" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract" xlink:to="us-gaap_CryptoAssetActivityTableTextBlock_638763735489340611" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAccruedExpensesTables" xlink:type="extended" xlink:title="99931103 - Disclosure - Accrued Expenses (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_638763735489340611" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_638763735489340611" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLeasesTables" xlink:type="extended" xlink:title="99931303 - Disclosure - Leases (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_638763735489350612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_638763735489350612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanTables" xlink:type="extended" xlink:title="99931603 - Disclosure - Stock Option Plan (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010124773047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_638763735489350612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_638763735489350612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_638763735489350612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_638763735489350612" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_638763735489350612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_638763735489350612" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="99931703 - Disclosure - Income Taxes (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_638763735489360612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_638763735489360612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638763735489360612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638763735489360612" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638763735489360612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638763735489360612" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_638763735489360612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010124773047" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_638763735489360612" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables" xlink:type="extended" xlink:title="99931803 - Disclosure - Net Income Per Share, Basic and Diluted (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638763735489360612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638763735489360612" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSegmentInformationTables" xlink:type="extended" xlink:title="99931903 - Disclosure - Segment Information (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_638763735489370615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_1" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_638763735489370615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails" xlink:type="extended" xlink:title="99940201 - Disclosure - Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent_638763735489370615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_3" xlink:to="us-gaap_AccountsReceivableNetCurrent_638763735489370615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ContractWithCustomerAccountsReceivableNet" xlink:label="smlr_ContractWithCustomerAccountsReceivableNet_638763735489370615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_3" xlink:to="smlr_ContractWithCustomerAccountsReceivableNet_638763735489370615" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_3" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638763735489380615" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve" xlink:label="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_3" xlink:to="smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve_638763735489380615" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_3" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_638763735489380615" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent" xlink:label="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_3" xlink:to="smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent_638763735489380615" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails" xlink:type="extended" xlink:title="99940202 - Disclosure - Summary of Significant Accounting Policies and Estimates (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638763735489380615" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638763735489380615" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638763735489380615" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember" xlink:label="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_638763735489380615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638763735489380615" xlink:to="smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_638763735489380615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638763735489380615" xlink:to="us-gaap_MachineryAndEquipmentMember_638763735489390614" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638763735489380615" xlink:to="us-gaap_ComputerEquipmentMember_638763735489390614" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638763735489380615" xlink:to="us-gaap_FurnitureAndFixturesMember_638763735489390614" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_638763735489390614" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis_638763735489390614" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_638763735489390614" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain_638763735489390614" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_638763735489390614" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638763735489390614" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638763735489390614" xlink:to="us-gaap_TypeOfAdoptionMember_638763735489390614" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202308Member" xlink:label="us-gaap_AccountingStandardsUpdate202308Member_638763735489390614" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember_638763735489390614" xlink:to="us-gaap_AccountingStandardsUpdate202308Member_638763735489390614" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="us-gaap_SubsequentEventTypeAxis_638763735489400615" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis_638763735489400615" xlink:to="us-gaap_SubsequentEventTypeDomain_638763735489400615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain_638763735489400615" xlink:to="us-gaap_SubsequentEventMember_638763735489400615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735489400615" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735489400615" xlink:to="us-gaap_ReceivableTypeDomain_638763735489400615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SeniorSecuredPromissoryNotesMember" xlink:label="smlr_SeniorSecuredPromissoryNotesMember_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivableTypeDomain_638763735489400615" xlink:to="smlr_SeniorSecuredPromissoryNotesMember_638763735489400615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember_638763735489400615" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivableTypeDomain_638763735489400615" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember_638763735489400615" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="srt_CounterpartyNameAxis_638763735489410618" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638763735489410618" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489410618" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489410618" xlink:to="smlr_MonarchMedicalTechnologyLlcMember_638763735489410618" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638763735489380615" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_638763735489410618" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityFaceValue" xlink:label="smlr_DebtSecurityFaceValue_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="smlr_DebtSecurityFaceValue_638763735489410618" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_638763735489410618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_638763735489410618" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromTransactionFeeOfDebtSecurities" xlink:label="smlr_ProceedsFromTransactionFeeOfDebtSecurities_638763735489420619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="smlr_ProceedsFromTransactionFeeOfDebtSecurities_638763735489420619" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities" xlink:label="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities_638763735489420619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities_638763735489420619" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet_638763735489420619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_NotesReceivableNet_638763735489420619" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecurities" xlink:label="us-gaap_DebtSecurities_638763735489420619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_DebtSecurities_638763735489420619" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_638763735489420619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_638763735489420619" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638763735489420619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638763735489420619" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense_638763735489430619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_AdvertisingExpense_638763735489430619" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_638763735489430619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_ResearchAndDevelopmentExpense_638763735489430619" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_638763735489430619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_638763735489430619" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_638763735489430619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_638763735489430619" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_638763735489430619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_638763735489430619" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_638763735489430619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList_638763735489430619" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638763735489440618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638763735489440618" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays" xlink:label="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays_638763735489440618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays_638763735489440618" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DefectiveProductReplacementCost" xlink:label="smlr_DefectiveProductReplacementCost_638763735489440618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638763735489410618" xlink:to="smlr_DefectiveProductReplacementCost_638763735489440618" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails" xlink:type="extended" xlink:title="99940301 - Disclosure - Assets for Lease, net (Details)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetAbstract" xlink:label="smlr_AssetsForLeaseNetAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_1" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross_638763735489450618" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_1" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation_638763735489450618" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_1" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_638763735489450618" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails" xlink:type="extended" xlink:title="99940302 - Disclosure - Assets for Lease, net - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseNetAbstract" xlink:label="smlr_AssetsForLeaseNetAbstract_4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease" xlink:label="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_4" xlink:to="us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_638763735489450618" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseReductionToAccumulatedDepreciation" xlink:label="smlr_AssetsForLeaseReductionToAccumulatedDepreciation_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_4" xlink:to="smlr_AssetsForLeaseReductionToAccumulatedDepreciation_638763735489450618" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:label="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_4" xlink:to="us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_638763735489450618" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AssetsForLeaseCustomerLocation" xlink:label="smlr_AssetsForLeaseCustomerLocation_638763735489450618" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_AssetsForLeaseNetAbstract_4" xlink:to="smlr_AssetsForLeaseCustomerLocation_638763735489450618" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureInventoryDetails" xlink:type="extended" xlink:title="99940401 - Disclosure - Inventory (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638763735489460620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet_638763735489460620" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="99940501 - Disclosure - Property and Equipment, net (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_638763735489460620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation_638763735489460620" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_638763735489460620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation_638763735489460620" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation" xlink:label="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_638763735489460620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation_638763735489460620" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" xlink:type="extended" xlink:title="99940502 - Disclosure - Property and Equipment, net - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_638763735489470619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease_638763735489470619" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails" xlink:type="extended" xlink:title="99940601 - Disclosure - Long-Term Investments (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489470619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489470619" order="1" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis_638763735489470619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489470619" xlink:to="us-gaap_InvestmentTypeAxis_638763735489470619" order="1" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_638763735489470619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis_638763735489470619" xlink:to="us-gaap_InvestmentTypeCategorizationMember_638763735489470619" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyTwoMember" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember_638763735489470619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember_638763735489470619" xlink:to="smlr_InvestmentInPrivateCompanyTwoMember_638763735489470619" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember_638763735489470619" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember_638763735489470619" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember_638763735489470619" order="2" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489470619" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" order="2" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" xlink:to="us-gaap_LongTermInvestments_638763735489480620" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails" xlink:type="extended" xlink:title="99940602 - Disclosure - Long-Term Investments - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489480620" order="1" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489480620" xlink:to="us-gaap_DebtInstrumentAxis_638763735489480620" order="1" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_638763735489480620" xlink:to="us-gaap_DebtInstrumentNameDomain_638763735489480620" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PromissoryNoteFromPrivateCompanyTwoMember" xlink:label="smlr_PromissoryNoteFromPrivateCompanyTwoMember_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_638763735489480620" xlink:to="smlr_PromissoryNoteFromPrivateCompanyTwoMember_638763735489480620" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_638763735489480620" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" order="2" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_638763735489480620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" xlink:to="us-gaap_DebtInstrumentFaceAmount_638763735489480620" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_638763735489490622" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_638763735489490622" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_638763735489480620" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_638763735489490622" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="99940701 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_1" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638763735489490622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638763735489490622" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_638763735489490622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_638763735489490622" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_638763735489490622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_638763735489490622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_638763735489490622" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_638763735489490622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638763735489490622" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638763735489500622" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638763735489500622" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638763735489500622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638763735489500622" xlink:to="us-gaap_FairValueInputsLevel1Member_638763735489500622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638763735489500622" xlink:to="us-gaap_FairValueInputsLevel2Member_638763735489500622" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638763735489500622" xlink:to="us-gaap_FairValueInputsLevel3Member_638763735489500622" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638763735489490622" xlink:to="us-gaap_FinancialInstrumentAxis_638763735489500622" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis_638763735489500622" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638763735489500622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638763735489500622" xlink:to="us-gaap_USTreasurySecuritiesMember_638763735489500622" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638763735489490622" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_638763735489510623" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_CryptoAssetFairValue_638763735489510623" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt" xlink:label="us-gaap_TradingSecuritiesDebt_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_TradingSecuritiesDebt_638763735489510623" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HeldToMaturitySecuritiesFairValue" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_638763735489510623" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_AssetsFairValueDisclosure_638763735489510623" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_InvestmentInterestRate_638763735489510623" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesTradingRealizedGain" xlink:label="us-gaap_DebtSecuritiesTradingRealizedGain_638763735489510623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_DebtSecuritiesTradingRealizedGain_638763735489510623" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_638763735489520624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638763735489500622" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_638763735489520624" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" xlink:title="99940702 - Disclosure - Fair Value Measurements - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_3" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfProbabilityOfEquityFinancing" xlink:label="smlr_PercentageOfProbabilityOfEquityFinancing_638763735489520624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_3" xlink:to="smlr_PercentageOfProbabilityOfEquityFinancing_638763735489520624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfProbabilityOfChangeOfControl" xlink:label="smlr_PercentageOfProbabilityOfChangeOfControl_638763735489520624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_3" xlink:to="smlr_PercentageOfProbabilityOfChangeOfControl_638763735489520624" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent" xlink:label="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent_638763735489520624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_3" xlink:to="smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent_638763735489520624" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityFaceValue" xlink:label="smlr_DebtSecurityFaceValue_638763735489520624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_3" xlink:to="smlr_DebtSecurityFaceValue_638763735489520624" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecurities" xlink:label="us-gaap_DebtSecurities_638763735489520624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_3" xlink:to="us-gaap_DebtSecurities_638763735489520624" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails" xlink:type="extended" xlink:title="99940703 - Disclosure - Fair Value Measurements - Valuation model (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_4" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638763735489530624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638763735489530624" xlink:to="us-gaap_MeasurementInputTypeAxis_638763735489530624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis_638763735489530624" xlink:to="us-gaap_MeasurementInputTypeDomain_638763735489530624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638763735489530624" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_638763735489530624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638763735489530624" xlink:to="us-gaap_MeasurementInputDiscountRateMember_638763735489530624" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638763735489530624" xlink:to="us-gaap_MeasurementInputExpectedTermMember_638763735489530624" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638763735489530624" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_638763735489530624" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638763735489530624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638763735489530624" xlink:to="srt_RangeAxis_638763735489530624" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638763735489530624" xlink:to="srt_RangeMember_638763735489540624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638763735489540624" xlink:to="srt_MinimumMember_638763735489540624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638763735489540624" xlink:to="srt_MaximumMember_638763735489540624" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638763735489530624" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638763735489540624" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638763735489540624" xlink:to="us-gaap_DebtInstrumentMeasurementInput_638763735489540624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails" xlink:type="extended" xlink:title="99940704 - Disclosure - Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_5" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_638763735489540624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis_638763735489540624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_638763735489540624" xlink:to="us-gaap_FairValueByAssetClassAxis_638763735489540624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_638763735489550624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis_638763735489540624" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_638763735489550624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesMember" xlink:label="us-gaap_DebtSecuritiesMember_638763735489550624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_638763735489550624" xlink:to="us-gaap_DebtSecuritiesMember_638763735489550624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_638763735489550624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_638763735489540624" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_638763735489550624" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_638763735489550624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems_638763735489550624" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_638763735489550624" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_638763735489550624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems_638763735489550624" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_638763735489550624" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_638763735489550624" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems_638763735489550624" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_638763735489550624" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6387637354895506241" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems_638763735489550624" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6387637354895506241" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails" xlink:type="extended" xlink:title="99940801 - Disclosure - Notes held for investment (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract_2" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_638763735489560625" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_638763735489560625" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735489560625" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735489560625" xlink:to="us-gaap_ReceivableTypeDomain_638763735489560625" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SeniorSecuredPromissoryNotesMember" xlink:label="smlr_SeniorSecuredPromissoryNotesMember_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivableTypeDomain_638763735489560625" xlink:to="smlr_SeniorSecuredPromissoryNotesMember_638763735489560625" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivableTypeDomain_638763735489560625" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember_638763735489560625" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_638763735489560625" xlink:to="srt_CounterpartyNameAxis_638763735489560625" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638763735489560625" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489560625" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489560625" xlink:to="smlr_MonarchMedicalTechnologyLlcMember_638763735489560625" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis_638763735489560625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_638763735489560625" xlink:to="us-gaap_InvestmentTypeAxis_638763735489560625" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis_638763735489560625" xlink:to="us-gaap_InvestmentTypeCategorizationMember_638763735489570626" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyTwoMember" xlink:label="smlr_InvestmentInPrivateCompanyTwoMember_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember_638763735489570626" xlink:to="smlr_InvestmentInPrivateCompanyTwoMember_638763735489570626" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentInPrivateCompanyThreeMember" xlink:label="smlr_InvestmentInPrivateCompanyThreeMember_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember_638763735489570626" xlink:to="smlr_InvestmentInPrivateCompanyThreeMember_638763735489570626" order="2" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_638763735489560625" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="us-gaap_NotesReceivableNet_638763735489570626" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NotesReceivableInterestBearingInterestRate" xlink:label="smlr_NotesReceivableInterestBearingInterestRate_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_NotesReceivableInterestBearingInterestRate_638763735489570626" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfNotesReceivable" xlink:label="smlr_NumberOfNotesReceivable_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_NumberOfNotesReceivable_638763735489570626" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NotesReceivableTerm" xlink:label="smlr_NotesReceivableTerm_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_NotesReceivableTerm_638763735489570626" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_638763735489570626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_638763735489570626" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityMaximumAmountOfAvailableFunding" xlink:label="smlr_DebtSecurityMaximumAmountOfAvailableFunding_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_DebtSecurityMaximumAmountOfAvailableFunding_638763735489580625" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecuritiesTransactionFee" xlink:label="smlr_DebtSecuritiesTransactionFee_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_DebtSecuritiesTransactionFee_638763735489580625" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate" xlink:label="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate_638763735489580625" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ExtensionPeriodOptionToExtendMaturityDate" xlink:label="smlr_ExtensionPeriodOptionToExtendMaturityDate_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_ExtensionPeriodOptionToExtendMaturityDate_638763735489580625" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestIncome" xlink:label="smlr_DebtSecurityInterestIncome_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_DebtSecurityInterestIncome_638763735489580625" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HeldToMaturitySecuritiesFairValue" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_638763735489580625" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityChangesInFairValue" xlink:label="smlr_DebtSecurityChangesInFairValue_638763735489580625" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_DebtSecurityChangesInFairValue_638763735489580625" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestRate" xlink:label="smlr_DebtSecurityInterestRate_638763735489590627" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="smlr_DebtSecurityInterestRate_638763735489590627" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments_638763735489590627" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems_638763735489570626" xlink:to="us-gaap_LongTermInvestments_638763735489590627" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails" xlink:type="extended" xlink:title="99940901 - Disclosure - Intangible Digital Assets- Intangible Assets Cost Basis (Details)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsAbstract" xlink:label="smlr_IntangibleDigitalAssetsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits_638763735489590627" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract_1" xlink:to="us-gaap_CryptoAssetNumberOfUnits_638763735489590627" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="us-gaap_CryptoAssetCost_638763735489590627" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract_1" xlink:to="us-gaap_CryptoAssetCost_638763735489590627" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue_638763735489590627" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract_1" xlink:to="us-gaap_CryptoAssetFairValue_638763735489590627" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNameExtensibleEnumeration" xlink:label="us-gaap_CryptoAssetNameExtensibleEnumeration_638763735489600626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract_1" xlink:to="us-gaap_CryptoAssetNameExtensibleEnumeration_638763735489600626" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails" xlink:type="extended" xlink:title="99940902 - Disclosure - Intangible Digital Assets- Reconciliation of fair value (Details)">
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetsAbstract" xlink:label="smlr_IntangibleDigitalAssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRollForward" xlink:label="us-gaap_CryptoAssetRollForward_638763735489650629" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_IntangibleDigitalAssetsAbstract" xlink:to="us-gaap_CryptoAssetRollForward_638763735489650629" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue_638763735489650629" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CryptoAssetRollForward_638763735489650629" xlink:to="us-gaap_CryptoAssetFairValue_638763735489650629" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetAddition" xlink:label="us-gaap_CryptoAssetAddition_638763735489650629" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CryptoAssetRollForward_638763735489650629" xlink:to="us-gaap_CryptoAssetAddition_638763735489650629" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainNonoperating_638763735489650629" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CryptoAssetRollForward_638763735489650629" xlink:to="us-gaap_CryptoAssetUnrealizedGainNonoperating_638763735489650629" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedLossNonoperating_638763735489650629" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CryptoAssetRollForward_638763735489650629" xlink:to="us-gaap_CryptoAssetUnrealizedLossNonoperating_638763735489650629" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue_6387637354896506291" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CryptoAssetRollForward_638763735489650629" xlink:to="us-gaap_CryptoAssetFairValue_6387637354896506291" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails" xlink:type="extended" xlink:title="99941001 - Disclosure - Other non-current assets (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrentDisclosureAbstract" xlink:label="us-gaap_OtherAssetsNoncurrentDisclosureAbstract_3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638763735489660632" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentDisclosureAbstract_3" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638763735489660632" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MiscellaneousReceivables" xlink:label="smlr_MiscellaneousReceivables_638763735489660632" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentDisclosureAbstract_3" xlink:to="smlr_MiscellaneousReceivables_638763735489660632" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_LongTermDeposits" xlink:label="smlr_LongTermDeposits_638763735489660632" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentDisclosureAbstract_3" xlink:to="smlr_LongTermDeposits_638763735489660632" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureAccruedExpensesDetails" xlink:type="extended" xlink:title="99941101 - Disclosure - Accrued Expenses (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_638763735489660632" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_638763735489660632" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638763735489660632" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638763735489660632" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_638763735489660632" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_638763735489660632" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_0" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638763735489670638" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails" xlink:type="extended" xlink:title="99941201 - Disclosure - Concentration of Credit Risk (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_0" xlink:to="us-gaap_ConcentrationRiskTable_638763735489670638" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_638763735489670638" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_638763735489670638" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_638763735489670638" xlink:to="us-gaap_ConcentrationRiskTypeDomain_638763735489670638" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_638763735489670638" xlink:to="us-gaap_CustomerConcentrationRiskMember_638763735489670638" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_638763735489670638" xlink:to="us-gaap_SupplierConcentrationRiskMember_638763735489670638" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_InvestmentHoldingConcentrationRiskMember" xlink:label="smlr_InvestmentHoldingConcentrationRiskMember_638763735489670638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_638763735489670638" xlink:to="smlr_InvestmentHoldingConcentrationRiskMember_638763735489670638" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_638763735489670638" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_638763735489680633" order="2" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis_638763735489680633" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_638763735489680633" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638763735489680633" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_638763735489680633" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638763735489680633" xlink:to="us-gaap_AccountsReceivableMember_638763735489680633" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638763735489680633" xlink:to="us-gaap_AccountsPayableMember_638763735489680633" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IntangibleDigitalAssetBenchmarkMember" xlink:label="smlr_IntangibleDigitalAssetBenchmarkMember_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638763735489680633" xlink:to="smlr_IntangibleDigitalAssetBenchmarkMember_638763735489680633" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_638763735489670638" xlink:to="srt_MajorCustomersAxis_638763735489680633" order="3" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis_638763735489680633" xlink:to="srt_NameOfMajorCustomerDomain_638763735489680633" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerOneConcentrationRiskMember" xlink:label="smlr_CustomerOneConcentrationRiskMember_638763735489680633" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638763735489680633" xlink:to="smlr_CustomerOneConcentrationRiskMember_638763735489680633" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerTwoConcentrationRiskMember" xlink:label="smlr_CustomerTwoConcentrationRiskMember_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638763735489680633" xlink:to="smlr_CustomerTwoConcentrationRiskMember_638763735489690636" order="2" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CustomerThreeConcentrationRiskMember" xlink:label="smlr_CustomerThreeConcentrationRiskMember_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638763735489680633" xlink:to="smlr_CustomerThreeConcentrationRiskMember_638763735489690636" order="3" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorOneMember" xlink:label="smlr_VendorOneMember_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638763735489680633" xlink:to="smlr_VendorOneMember_638763735489690636" order="4" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorTwoMember" xlink:label="smlr_VendorTwoMember_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638763735489680633" xlink:to="smlr_VendorTwoMember_638763735489690636" order="5" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_VendorThreeMember" xlink:label="smlr_VendorThreeMember_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638763735489680633" xlink:to="smlr_VendorThreeMember_638763735489690636" order="6" use="optional" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_638763735489670638" xlink:to="srt_CounterpartyNameAxis_638763735489690636" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638763735489690636" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489690636" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetProviderOneMember" xlink:label="smlr_CryptoAssetProviderOneMember_638763735489690636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489690636" xlink:to="smlr_CryptoAssetProviderOneMember_638763735489690636" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetProviderTwoMember" xlink:label="smlr_CryptoAssetProviderTwoMember_638763735489700636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638763735489690636" xlink:to="smlr_CryptoAssetProviderTwoMember_638763735489700636" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems_638763735489700636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_638763735489670638" xlink:to="us-gaap_ConcentrationRiskLineItems_638763735489700636" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="us-gaap_TimeDepositsAtCarryingValue_638763735489700636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="us-gaap_TimeDepositsAtCarryingValue_638763735489700636" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_638763735489700636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_638763735489700636" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits_638763735489700636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="us-gaap_CryptoAssetNumberOfUnits_638763735489700636" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskCryptoAssetNumberOfProviders" xlink:label="smlr_ConcentrationRiskCryptoAssetNumberOfProviders_638763735489700636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="smlr_ConcentrationRiskCryptoAssetNumberOfProviders_638763735489700636" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskNumberOfCustomers" xlink:label="smlr_ConcentrationRiskNumberOfCustomers_638763735489710636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="smlr_ConcentrationRiskNumberOfCustomers_638763735489710636" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConcentrationRiskNumberOfVendors" xlink:label="smlr_ConcentrationRiskNumberOfVendors_638763735489710636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="smlr_ConcentrationRiskNumberOfVendors_638763735489710636" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1_638763735489710636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="us-gaap_ConcentrationRiskPercentage1_638763735489710636" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue_638763735489710636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_638763735489700636" xlink:to="us-gaap_CryptoAssetFairValue_638763735489710636" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails" xlink:type="extended" xlink:title="99941301 - Disclosure - Leases - Future minimum rental payments (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638763735489720636" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_638763735489720636" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638763735489720636" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" xlink:to="us-gaap_OperatingLeaseLiability_638763735489720636" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OperatingLeaseExpensesInExcessOfCashPayments" xlink:label="smlr_OperatingLeaseExpensesInExcessOfCashPayments_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" xlink:to="smlr_OperatingLeaseExpensesInExcessOfCashPayments_638763735489720636" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638763735489720636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638763735489720636" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638763735489720636" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails" xlink:type="extended" xlink:title="99941302 - Disclosure - Leases - Lessee Arrangements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_638763735489730638" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_638763735489730638" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_638763735489730638" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_638763735489730638" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseCost_638763735489730638" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638763735489730638" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_638763735489730638" order="7" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638763735489730638" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_638763735489730638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_638763735489730638" order="9" use="optional" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails" xlink:type="extended" xlink:title="99941303 - Disclosure - Leases - Lessor Arrangements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome" xlink:label="us-gaap_OperatingLeaseLeaseIncome_638763735489740637" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLeaseIncome_638763735489740637" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent" xlink:label="us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent_638763735489740637" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent_638763735489740637" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:label="us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_638763735489740637" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_638763735489740637" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails" xlink:type="extended" xlink:title="99941304 - Disclosure - Leases - Variable-fee Revenue (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseIncome" xlink:label="us-gaap_VariableLeaseIncome_638763735489750644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_VariableLeaseIncome_638763735489750644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesTypeLeaseRevenue" xlink:label="us-gaap_SalesTypeLeaseRevenue_638763735489750644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_SalesTypeLeaseRevenue_638763735489750644" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="99941401 - Disclosure - Commitments and Contingencies (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_IncomeTaxExaminationsMaximumEstimatedLiability" xlink:label="smlr_IncomeTaxExaminationsMaximumEstimatedLiability_638763735489750644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1" xlink:to="smlr_IncomeTaxExaminationsMaximumEstimatedLiability_638763735489750644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="extended" xlink:title="99941501 - Disclosure - Stockholders' Equity - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract_637044010125080146" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockholdersEquityDeficitTable" xlink:label="smlr_StockholdersEquityDeficitTable_638763735489750644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract_637044010125080146" xlink:to="smlr_StockholdersEquityDeficitTable_638763735489750644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638763735489750644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitTable_638763735489750644" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638763735489750644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638763735489750644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638763735489750644" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638763735489750644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_AtMarketOfferingMember" xlink:label="smlr_AtMarketOfferingMember_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638763735489750644" xlink:to="smlr_AtMarketOfferingMember_638763735489760640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitTable_638763735489750644" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638763735489760640" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638763735489760640" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638763735489760640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CommonStockWarrantsMember" xlink:label="smlr_CommonStockWarrantsMember_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638763735489760640" xlink:to="smlr_CommonStockWarrantsMember_638763735489760640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitTable_638763735489750644" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638763735489760640" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638763735489760640" xlink:to="us-gaap_RelatedPartyDomain_638763735489760640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638763735489760640" xlink:to="srt_ChiefExecutiveOfficerMember_638763735489760640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockholdersEquityDeficitLineItems" xlink:label="smlr_StockholdersEquityDeficitLineItems_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitTable_638763735489750644" xlink:to="smlr_StockholdersEquityDeficitLineItems_638763735489760640" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_CommonStockSharesAuthorized_638763735489760640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638763735489760640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638763735489760640" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_NumberOfVotesForEachShare" xlink:label="smlr_NumberOfVotesForEachShare_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="smlr_NumberOfVotesForEachShare_638763735489770641" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SaleOfStockValueAuthorized" xlink:label="smlr_SaleOfStockValueAuthorized_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="smlr_SaleOfStockValueAuthorized_638763735489770641" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638763735489770641" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="srt_StockRepurchaseProgramAuthorizedAmount1_638763735489770641" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638763735489770641" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638763735489770641" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_TreasuryStockSharesAcquired_638763735489770641" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ClassOfWarrantOrRightValueRepurchased" xlink:label="smlr_ClassOfWarrantOrRightValueRepurchased_638763735489770641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="smlr_ClassOfWarrantOrRightValueRepurchased_638763735489770641" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638763735489780640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="smlr_StockholdersEquityDeficitLineItems_638763735489760640" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638763735489780640" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails" xlink:type="extended" xlink:title="99941601 - Disclosure - Stock Option Plan - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010125283555" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010125283555" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_638763735489780640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" xlink:to="us-gaap_PlanNameAxis_638763735489780640" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_638763735489780640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_638763735489780640" xlink:to="us-gaap_PlanNameDomain_638763735489780640" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_StockIncentivePlan2014Member" xlink:label="smlr_StockIncentivePlan2014Member_638763735489780640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638763735489780640" xlink:to="smlr_StockIncentivePlan2014Member_638763735489780640" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_KeyPersonStockOptionPlan2007Member" xlink:label="smlr_KeyPersonStockOptionPlan2007Member_638763735489780640" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638763735489780640" xlink:to="smlr_KeyPersonStockOptionPlan2007Member_638763735489780640" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" xlink:to="us-gaap_AwardTypeAxis_638763735489790641" order="2" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638763735489790641" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638763735489790641" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638763735489790641" xlink:to="us-gaap_EmployeeStockOptionMember_638763735489790641" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" xlink:to="us-gaap_VestingAxis_638763735489790641" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis_638763735489790641" xlink:to="us-gaap_VestingDomain_638763735489790641" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain_638763735489790641" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_638763735489790641" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain_638763735489790641" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_638763735489790641" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" xlink:to="us-gaap_GranteeStatusAxis_638763735489790641" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain_638763735489790641" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis_638763735489790641" xlink:to="us-gaap_GranteeStatusDomain_638763735489790641" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusDomain_638763735489790641" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember_638763735489800642" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusDomain_638763735489790641" xlink:to="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_638763735489800642" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489780640" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_638763735489800642" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638763735489800642" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_PercentageOfSharesReserveIncrease" xlink:label="smlr_PercentageOfSharesReserveIncrease_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="smlr_PercentageOfSharesReserveIncrease_638763735489800642" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_638763735489800642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_638763735489800642" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_638763735489810643" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638763735489810643" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638763735489810643" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_638763735489810643" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue_638763735489810643" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638763735489810643" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_638763735489810643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_638763735489810643" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638763735489820642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638763735489820642" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:label="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_638763735489820642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_638763735489820642" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_638763735489820642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489800642" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_638763735489820642" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails" xlink:type="extended" xlink:title="99941602 - Disclosure - Stock Option Plan - Summary of the Company's stock option activity (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638763735489830643" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638763735489830643" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_638763735489830643" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638763735489830643" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6387637354898306431" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6387637354898306431" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_638763735489830643" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638763735489840642" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_638763735489840642" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_638763735489840642" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6387637354898406421" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6387637354898406421" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638763735489830643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_638763735489840642" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_638763735489840642" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_638763735489840642" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638763735489840642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638763735489840642" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_638763735489850643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_638763735489850643" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails" xlink:type="extended" xlink:title="99941603 - Disclosure - Stock Option Plan - Weighted average assumptions used (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489850643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489850643" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638763735489850643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489850643" xlink:to="us-gaap_AwardTypeAxis_638763735489850643" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638763735489850643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638763735489850643" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638763735489850643" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638763735489850643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638763735489850643" xlink:to="us-gaap_EmployeeStockOptionMember_638763735489850643" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638763735489850643" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489850643" xlink:to="srt_RangeAxis_638763735489850643" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638763735489850643" xlink:to="srt_RangeMember_638763735489860644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638763735489860644" xlink:to="srt_MinimumMember_638763735489860644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638763735489860644" xlink:to="srt_MaximumMember_638763735489860644" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489850643" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638763735489860644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_638763735489860644" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_638763735489860644" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_638763735489860644" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_638763735489860644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_638763735489860644" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638763735489870644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638763735489870644" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638763735489870644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489860644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638763735489870644" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails" xlink:type="extended" xlink:title="99941604 - Disclosure - Stock Option Plan - Stock-based compensation expense (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010125283555" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489870644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_637044010125283555" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489870644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638763735489870644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489870644" xlink:to="us-gaap_IncomeStatementLocationAxis_638763735489870644" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638763735489870644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638763735489870644" xlink:to="us-gaap_IncomeStatementLocationDomain_638763735489870644" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember_638763735489870644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638763735489870644" xlink:to="us-gaap_CostOfSalesMember_638763735489870644" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_EngineeringAndProductDevelopmentMember" xlink:label="smlr_EngineeringAndProductDevelopmentMember_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638763735489870644" xlink:to="smlr_EngineeringAndProductDevelopmentMember_638763735489880646" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638763735489870644" xlink:to="us-gaap_SellingAndMarketingExpenseMember_638763735489880646" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638763735489870644" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_638763735489880646" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638763735489870644" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489880646" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489880646" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638763735489880646" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638763735489880646" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_638763735489880646" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails" xlink:type="extended" xlink:title="99941701 - Disclosure - Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489880646" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489880646" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489880646" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_638763735489890647" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489880646" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638763735489890647" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489880646" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_638763735489890647" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489890647" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489890647" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638763735489890647" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489890647" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638763735489890647" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638763735489890647" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638763735489890647" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638763735489890647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638763735489890647" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails" xlink:type="extended" xlink:title="99941702 - Disclosure - Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638763735489900647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638763735489900647" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_638763735489900647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_638763735489900647" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_638763735489900647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_638763735489900647" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_638763735489900647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_638763735489900647" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_638763735489900647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_638763735489900647" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_638763735489900647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_638763735489900647" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails" xlink:type="extended" xlink:title="99941703 - Disclosure - Income Taxes - Summary of Deferred tax (liabilities) assets (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638763735489910649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_638763735489910649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638763735489910649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_638763735489910649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_638763735489910649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsOther_638763735489910649" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_638763735489910649" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxAssetsLeaseLiabilities" xlink:label="smlr_DeferredTaxAssetsLeaseLiabilities_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="smlr_DeferredTaxAssetsLeaseLiabilities_638763735489910649" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_638763735489910649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsGross_638763735489910649" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_638763735489920649" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_638763735489910649" xlink:to="us-gaap_DeferredTaxAssetsNet_638763735489920649" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_638763735489920649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxAssetsRightOfUseAssets" xlink:label="smlr_DeferredTaxAssetsRightOfUseAssets_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638763735489920649" xlink:to="smlr_DeferredTaxAssetsRightOfUseAssets_638763735489920649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets" xlink:label="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638763735489920649" xlink:to="smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets_638763735489920649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638763735489920649" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_638763735489920649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities_638763735489920649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_638763735489920649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_638763735489920649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended" xlink:title="99941704 - Disclosure - Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_638763735489930649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" xlink:to="us-gaap_UnrecognizedTaxBenefits_638763735489930649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_638763735489930649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_638763735489930649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_638763735489930649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_638763735489930649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_638763735489930649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_638763735489930649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638763735489930649" xlink:to="us-gaap_UnrecognizedTaxBenefits_638763735489940649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="extended" xlink:title="99941705 - Disclosure - Income Taxes - Additional Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract_637044010125384353" xlink:to="us-gaap_TaxCreditCarryforwardTable_638763735489940649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable_638763735489940649" xlink:to="us-gaap_TaxCreditCarryforwardAxis_638763735489940649" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis_638763735489940649" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_638763735489940649" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain_638763735489940649" xlink:to="us-gaap_DomesticCountryMember_638763735489940649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain_638763735489940649" xlink:to="us-gaap_StateAndLocalJurisdictionMember_638763735489940649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable_638763735489940649" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards_638763735489950649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" xlink:to="us-gaap_OperatingLossCarryforwards_638763735489950649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_638763735489950649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_638763735489950649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_638763735489950649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_638763735489950649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_638763735489950649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_638763735489950649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ExaminationOfCompanyTaxYears" xlink:label="smlr_ExaminationOfCompanyTaxYears_638763735489950649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" xlink:to="smlr_ExaminationOfCompanyTaxYears_638763735489950649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ResearchAndExperimentalExpendituresCapitalized" xlink:label="smlr_ResearchAndExperimentalExpendituresCapitalized_638763735489950649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems_638763735489940649" xlink:to="smlr_ResearchAndExperimentalExpendituresCapitalized_638763735489950649" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails" xlink:type="extended" xlink:title="99941801 - Disclosure - Net Income Per Share, Basic and Diluted (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_637557367570085107" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638763735489960651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638763735489960651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638763735489960651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_638763735489960651" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits" xlink:label="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits_638763735489960651" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_638763735489960651" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_EarningsPerShareBasic_638763735489960651" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638763735489960651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_637557367570085107" xlink:to="us-gaap_EarningsPerShareDiluted_638763735489960651" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSegmentInformationDetails" xlink:type="extended" xlink:title="99941901 - Disclosure - Segment Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments_638763735489970652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_2" xlink:to="us-gaap_NumberOfReportableSegments_638763735489970652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails" xlink:type="extended" xlink:title="99941902 - Disclosure - Segment Information - Reportable Segment Information (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638763735489970652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_3" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638763735489970652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis_638763735489970652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638763735489970652" xlink:to="us-gaap_StatementBusinessSegmentsAxis_638763735489970652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_638763735489970652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis_638763735489970652" xlink:to="us-gaap_SegmentDomain_638763735489970652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SingleReportableSegmentMember" xlink:label="smlr_SingleReportableSegmentMember_638763735489970652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638763735489970652" xlink:to="smlr_SingleReportableSegmentMember_638763735489970652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638763735489970652" xlink:to="us-gaap_SegmentReportingInformationLineItems_638763735489980654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_Revenues_638763735489980654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_CostOfRevenue_638763735489980654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_ResearchAndDevelopmentExpense_638763735489980654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_SellingExpense_638763735489980654" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDevelopment" xlink:label="us-gaap_BusinessDevelopment_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_BusinessDevelopment_638763735489980654" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_GeneralAndAdministrativeExpense_638763735489980654" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_638763735489980654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_DepreciationDepletionAndAmortization_638763735489980654" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract_638763735489980654" xlink:to="us-gaap_SegmentReportingOtherItemAmount_638763735489990652" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemCompositionDescription" xlink:label="us-gaap_SegmentReportingOtherItemCompositionDescription_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingOtherItemAmount_638763735489990652" xlink:to="us-gaap_SegmentReportingOtherItemCompositionDescription_638763735489990652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_OperatingIncomeLoss_638763735489990652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_638763735489990652" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ImpairmentLossesInvestments" xlink:label="smlr_ImpairmentLossesInvestments_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="smlr_ImpairmentLossesInvestments_638763735489990652" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_FairValueAdjustmentOfNotesHeldForInvestment" xlink:label="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="smlr_FairValueAdjustmentOfNotesHeldForInvestment_638763735489990652" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735489990652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_CryptoAssetUnrealizedGainLossNonoperating_638763735489990652" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_OtherCorporateIncomeExpense" xlink:label="smlr_OtherCorporateIncomeExpense_638763735490000653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="smlr_OtherCorporateIncomeExpense_638763735490000653" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735490000653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638763735490000653" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638763735490000653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638763735490000653" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638763735490000653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638763735489980654" xlink:to="us-gaap_NetIncomeLoss_638763735490000653" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://semlerscientific.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="99942001 - Disclosure - Subsequent Events (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable_638763735490010652" order="1" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638763735490010652" xlink:to="us-gaap_SubsequentEventTypeAxis_638763735490010652" order="1" use="optional" priority="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis_638763735490010652" xlink:to="us-gaap_SubsequentEventTypeDomain_638763735490010652" order="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain_638763735490010652" xlink:to="us-gaap_SubsequentEventMember_638763735490010652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638763735490010652" xlink:to="srt_CounterpartyNameAxis_638763735490010652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638763735490010652" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638763735490010652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_MonarchMedicalTechnologyLlcMember" xlink:label="smlr_MonarchMedicalTechnologyLlcMember_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638763735490010652" xlink:to="smlr_MonarchMedicalTechnologyLlcMember_638763735490010652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638763735490010652" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735490010652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_638763735490010652" xlink:to="us-gaap_ReceivableTypeDomain_638763735490010652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_SecuredConvertiblePromissoryNoteMember" xlink:label="smlr_SecuredConvertiblePromissoryNoteMember_638763735490010652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivableTypeDomain_638763735490010652" xlink:to="smlr_SecuredConvertiblePromissoryNoteMember_638763735490010652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638763735490010652" xlink:to="srt_RangeAxis_638763735490020655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638763735490020655" xlink:to="srt_RangeMember_638763735490020655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638763735490020655" xlink:to="srt_MaximumMember_638763735490020655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638763735490010652" xlink:to="us-gaap_DebtInstrumentAxis_638763735490020655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_638763735490020655" xlink:to="us-gaap_DebtInstrumentNameDomain_638763735490020655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ConvertibleSeniorNote4.25Member" xlink:label="smlr_ConvertibleSeniorNote4.25Member_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_638763735490020655" xlink:to="smlr_ConvertibleSeniorNote4.25Member_638763735490020655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_638763735490010652" xlink:to="us-gaap_SubsequentEventLineItems_638763735490020655" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised" xlink:label="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised_638763735490020655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised_638763735490020655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638763735490030653" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_638763735490030653" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_638763735490030653" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_638763735490030653" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleThresholdBusinessDays_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleThresholdBusinessDays_638763735490030653" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod" xlink:label="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod_638763735490030653" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays_638763735490030653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays_638763735490030653" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays_638763735490040655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays_638763735490040655" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays_638763735490040655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays_638763735490040655" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_638763735490040655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_638763735490040655" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_638763735490040655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentFaceAmount_638763735490040655" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_638763735490040655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_638763735490040655" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage" xlink:label="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage_638763735490040655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage_638763735490040655" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage_638763735490050655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage_638763735490050655" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod_638763735490050655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod_638763735490050655" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees_638763735490050655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees_638763735490050655" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod_638763735490050655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod_638763735490050655" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts" xlink:label="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts_638763735490050655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts_638763735490050655" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion" xlink:label="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion_638763735490050655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion_638763735490050655" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate" xlink:label="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate_638763735490060656" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate_638763735490060656" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger" xlink:label="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger_638763735490060656" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger_638763735490060656" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_638763735490060656" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_638763735490060656" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice" xlink:label="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice_638763735490060656" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice_638763735490060656" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount" xlink:label="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount_638763735490060656" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount_638763735490060656" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount" xlink:label="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_638763735490070658" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount_638763735490070658" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet_638763735490070658" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_NotesReceivableNet_638763735490070658" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_DebtSecurityInterestRate" xlink:label="smlr_DebtSecurityInterestRate_638763735490070658" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_DebtSecurityInterestRate_638763735490070658" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetNumberOfUnitsPurchased" xlink:label="smlr_CryptoAssetNumberOfUnitsPurchased_638763735490070658" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_CryptoAssetNumberOfUnitsPurchased_638763735490070658" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_638763735490070658" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset_638763735490070658" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="us-gaap_CryptoAssetCost_638763735490080659" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_CryptoAssetCost_638763735490080659" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetAveragePurchasePrice" xlink:label="smlr_CryptoAssetAveragePurchasePrice_638763735490080659" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_CryptoAssetAveragePurchasePrice_638763735490080659" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits_638763735490080659" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="us-gaap_CryptoAssetNumberOfUnits_638763735490080659" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <link:loc xlink:type="locator" xlink:href="smlr-20241231.xsd#smlr_CryptoAssetMarketPricePerCryptoAsset" xlink:label="smlr_CryptoAssetMarketPricePerCryptoAsset_638763735490080659" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_638763735490020655" xlink:to="smlr_CryptoAssetMarketPricePerCryptoAsset_638763735490080659" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended" xlink:title="995443 - Disclosure - Award Timing Disclosure" />
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended" xlink:title="995445 - Disclosure - Insider Trading Arrangements" />
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures" />
  <link:presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended" xlink:title="995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767584944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 21, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-36305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SEMLER SCIENTIFIC, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1367393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2340-2348 Walsh Avenue, Suite 2344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Clara<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">774-4211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMLR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,913,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,596,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO USA, P.C.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001554859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766277904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,819<span></span>
</td>
<td class="nump">$ 57,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowance for credit losses of $199 and $287, respectively</a></td>
<td class="nump">4,378<span></span>
</td>
<td class="nump">6,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Short-term notes held for investment</a></td>
<td class="nump">6,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">22,688<span></span>
</td>
<td class="nump">65,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet', window );">Assets for lease, net</a></td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">2,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation', window );">Property and equipment, net</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValueNoncurrent', window );">Intangible digital assets</a></td>
<td class="nump">214,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,962<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">239,828<span></span>
</td>
<td class="nump">78,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">5,173<span></span>
</td>
<td class="nump">4,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">774<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other short-term liabilities</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">2,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">2,765<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 50,000,000 shares authorized; 9,770,908 and 7,099,441 shares issued, and 9,556,486 and 6,885,019 shares outstanding (treasury shares of 214,422 and 214,422), respectively</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">130,039<span></span>
</td>
<td class="nump">11,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">100,702<span></span>
</td>
<td class="nump">59,803<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">230,750<span></span>
</td>
<td class="nump">71,795<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 239,828<span></span>
</td>
<td class="nump">$ 78,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset classified as noncurrent. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289870696768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Balance Sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">9,770,908<span></span>
</td>
<td class="nump">7,099,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">9,556,486<span></span>
</td>
<td class="nump">6,885,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock shares (in shares)</a></td>
<td class="nump">214,422<span></span>
</td>
<td class="nump">214,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766613120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Statements of Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 56,294<span></span>
</td>
<td class="nump">$ 68,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">4,759<span></span>
</td>
<td class="nump">6,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Engineering and product development</a></td>
<td class="nump">4,792<span></span>
</td>
<td class="nump">5,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">13,078<span></span>
</td>
<td class="nump">18,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">12,732<span></span>
</td>
<td class="nump">14,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Strategic streamlining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">35,361<span></span>
</td>
<td class="nump">45,928<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">20,933<span></span>
</td>
<td class="nump">22,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividend income, net</a></td>
<td class="nump">1,877<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ImpairmentLossesInvestments', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment', window );">Change in fair value of notes held for investment</a></td>
<td class="nump">128<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating', window );">Change in fair value of digital assets</a></td>
<td class="nump">24,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">26,951<span></span>
</td>
<td class="nump">1,844<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax income</a></td>
<td class="nump">47,884<span></span>
</td>
<td class="nump">24,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">6,985<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 40,899<span></span>
</td>
<td class="nump">$ 20,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share, basic</a></td>
<td class="nump">$ 5.66<span></span>
</td>
<td class="nump">$ 3.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares used in computing basic net income per share</a></td>
<td class="nump">7,228,961<span></span>
</td>
<td class="nump">6,732,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share, diluted</a></td>
<td class="nump">$ 5.13<span></span>
</td>
<td class="nump">$ 2.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares used in computing diluted net income per share</a></td>
<td class="nump">7,980,118<span></span>
</td>
<td class="nump">7,819,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair adjustments in notes held for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_FairValueAdjustmentOfNotesHeldForInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ImpairmentLossesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earning or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ImpairmentLossesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetUnrealizedGainLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771565936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,449<span></span>
</td>
<td class="nump">$ 39,220<span></span>
</td>
<td class="nump">$ 55,676<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">6,906,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,422)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants', window );">Common stock warrants acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee/Directors stock grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Employee/Directors stock grants (in shares)</a></td>
<td class="nump">24,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,510)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares', window );">Taxes paid related to net share settlement of equity awards (in shares)</a></td>
<td class="num">(114,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises (in shares)</a></td>
<td class="nump">283,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,583<span></span>
</td>
<td class="nump">20,583<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,985<span></span>
</td>
<td class="nump">59,803<span></span>
</td>
<td class="nump">$ 71,795<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">7,099,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,422)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,422)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee/Directors stock grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Employee/Directors stock grants (in shares)</a></td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">2,197,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(874)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(874)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares', window );">Taxes paid related to net share settlement of equity awards (in shares)</a></td>
<td class="num">(34,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises (in shares)</a></td>
<td class="nump">497,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,899<span></span>
</td>
<td class="nump">40,899<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130,039<span></span>
</td>
<td class="nump">$ 100,702<span></span>
</td>
<td class="nump">$ 230,750<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">9,770,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,422)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214,422)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from the repurchase of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact from taxes paid related to net share settlement of equity awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares impact from taxes paid related to net share settlement of equity awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766412592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 40,899<span></span>
</td>
<td class="nump">$ 20,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Reconciliation of Net Income to Net Cash Provided by Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense (income)</a></td>
<td class="nump">5,727<span></span>
</td>
<td class="num">(664)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases', window );">Loss on disposal of assets for lease</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_PrepaidLicensePurchasesWriteoff', window );">Write off of prepaid software licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRealizedGain', window );">Gain on short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="num">(88)<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment', window );">Change in fair value of notes held for investment</a></td>
<td class="num">(128)<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating', window );">Change in fair value of digital assets</a></td>
<td class="num">(24,933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ImpairmentLossesInvestments', window );">Impairment of long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in Operating Assets and Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="nump">1,844<span></span>
</td>
<td class="num">(2,508)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(865)<span></span>
</td>
<td class="num">(603)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(262)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">671<span></span>
</td>
<td class="num">(246)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other current and non-current liabilities</a></td>
<td class="num">(367)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">24,410<span></span>
</td>
<td class="nump">21,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of notes held for investment</a></td>
<td class="num">(500)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForAcquisitionCryptoAsset', window );">Purchase of digital assets</a></td>
<td class="num">(189,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturities of short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,869)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ProceedsFromPaymentsForEquipmentForLeases', window );">Proceeds from sale (purchase) of assets for lease</a></td>
<td class="nump">269<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash (Used in) Provided by Investing Activities</a></td>
<td class="num">(189,982)<span></span>
</td>
<td class="nump">18,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">119,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net settlement of equity awards</a></td>
<td class="num">(874)<span></span>
</td>
<td class="num">(3,510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Common stock warrants acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance expenses</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,464<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used in) Financing Activities</a></td>
<td class="nump">117,192<span></span>
</td>
<td class="num">(5,408)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(48,380)<span></span>
</td>
<td class="nump">34,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD</a></td>
<td class="nump">57,332<span></span>
</td>
<td class="nump">23,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD</a></td>
<td class="nump">8,952<span></span>
</td>
<td class="nump">57,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="nump">$ 4,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair adjustments in notes held for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_FairValueAdjustmentOfNotesHeldForInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ImpairmentLossesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earning or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ImpairmentLossesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_PrepaidLicensePurchasesWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as prepaid license purchases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_PrepaidLicensePurchasesWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ProceedsFromPaymentsForEquipmentForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) for sale or purchase of rented equipment which is recorded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ProceedsFromPaymentsForEquipmentForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetUnrealizedGainLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) arising from the lessor's sale of assets held- or available-for-lease under contractual arrangements classified as operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481222/840-30-40-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482161/360-10-40-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForAcquisitionCryptoAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForAcquisitionCryptoAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770543232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_CompanyAbstract', window );"><strong>The Company</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">The Company</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">1.&#160;&#160;&#160;&#160;The Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Semler Scientific Inc. (the &#8220;Company&#8221;) is a company developing and marketing technology products and services that assist its customers in evaluating and treating chronic diseases. The Company&#8217;s patented and FDA cleared product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of PAD. The Company also invests in bitcoin and have adopted bitcoin as its primary treasury reserve asset. As an operating business, the Company uses cash flows as well as proceeds from equity and debt financings to accumulate bitcoin. The Company&#8217;s healthcare technology solutions business is its predominant operational focus, providing cash flows and enabling it to pursue its bitcoin strategy.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_CompanyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_CompanyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771698656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Estimates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies and Estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies and Estimates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies and Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis for Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">The preparation of the accompanying financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses, and related disclosures during the reporting period. Significant items subject to such estimates include allowance for credit losses, valuation of equipment on lease, recognition and measurement of current and deferred income taxes, valuation and recognition of investments and intangible assets and valuation of inventory. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, bitcoin, accounts receivable and trade payables. The Company maintains its cash and bitcoins with major financial institutions and reputed bitcoin traders. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The cash and cash equivalents also include U.S. government money market fund accounts. Our bitcoins are held offline in cold storage with multiple third-party providers. The Company manages its accounts receivable credit risk through ongoing credit evaluation of its customers&#8217; financial conditions. The Company generally does not require collateral from its customers.&#160;For information regarding the Company&#8217;s significant customers and vendors, see Note 12 to financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue Recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company generates revenues primarily from the rental or license of its vascular testing product. The Company recognizes revenues from the licensing of its product primarily pursuant to agreements that automatically renew each&#160;month with revenue recognized on a daily convention basis or when the test is performed. The Company&#8217;s arrangements with customers for its vascular testing product are normally on a&#160;month-to-month basis with fees billed at the rates established in the customer agreement, either on a fixed or variable (e.g. fee per test) basis, as earned. The </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company also recognizes revenue for hardware and supplies sales as of the date of shipment. Shipping and handling costs are included in cost of revenues in the statement of income. Payment terms of the customers are net 30 days. Semler replaces the defective sensors with no charge. Other than replacing the defective sensors there are no other obligations to the customers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Cash and cash equivalents are comprised of highly liquid investments purchased with an initial maturity date of three&#160;months or less. Funds held as investments in money market funds are included within cash and cash equivalents.</span>&#160;Restricted cash represents amounts pledged as cash security related to the use of credit cards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Short-Term Notes Held for Investments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#111111;background:#ffffff;">Short-term notes held for investments are</span><b style="color:#111111;font-weight:bold;background:#ffffff;">&#160;</b><span style="color:#111111;background:#ffffff;">those</span><span style="color:#111111;background:#ffffff;"> investment instruments that will mature within one year or which are expected to be liquidated within one year.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Accounts Receivable and Allowance for Credit Losses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Accounts receivables are recorded at the invoiced amount, net of allowances for credit losses. T<span style="background:#ffffff;">he allowance for credit losses is based on management&#8217;s assessment of the collectability of accounts. The Company regularly reviews the adequacy of this allowance for credit losses by considering historical experience, the age of the accounts receivable balances, the credit quality of the customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect customers&#8217; ability to pay to determine whether a specific reserve is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for credit losses when identified. Accounts receivable, net as of December 31, 2024, December 31, 2023 and December 31, 2022 was </span><span style="background:#ffffff;">$4,378</span><span style="background:#ffffff;">, </span><span style="background:#ffffff;">$6,125</span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$3,884</span><span style="background:#ffffff;">, respectively, include </span><span style="background:#ffffff;">$2,067</span><span style="background:#ffffff;">, </span><span style="background:#ffffff;">$5,966</span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$1,735</span><span style="background:#ffffff;">, respectively, related to revenue recognized under ASC 606.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2024, the allowance for credit losses was $199. During t<span style="color:#212529;background:#ffffff;">he year the Company provided an additional reserve of&#160;</span><span style="color:#212529;background:#ffffff;">$135</span><span style="color:#212529;background:#ffffff;">&#160;and recovered&#160;or expensed credit losses of </span><span style="color:#212529;background:#ffffff;">$223</span><span style="color:#212529;background:#ffffff;">&#160;from customers. The allowance for credit losses as of December 31, 2023 was&#160;</span><span style="color:#212529;background:#ffffff;">$287</span><span style="color:#212529;background:#ffffff;">. </span>Credit losses related to ASC 606 receivables were $113 and $6 as of December 31, 2024 and December 31, 2023, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Inventory</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inventory, which is made up of finished goods, is recorded at the lower of cost or net realizable value. Cost is determined on the first-in, first-out method. The Company periodically analyzes its inventory levels to identify inventory that has a cost basis in excess of its estimated realizable value and writes down such inventory as appropriate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Assets for Lease</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Assets for lease are recorded at cost. At December&#160;31, 2024 and 2023, assets for lease consisted of vascular testing devices, which are primarily leased to customers. The cost of such assets for lease is depreciated on a straight-line basis over 36 months for the units outstanding and recorded as cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of assets may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected undiscounted net cash flows associated with the related assets over their estimated remaining lives against their respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its assets for lease in this analysis. Impairment, if any, is </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Intangible Digital Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 350, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other</i>. The Company has ownership of and control over its bitcoin and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoin. The Company&#8217;s digital assets are initially recorded at cost and subsequently remeasured to fair value at the end of each reporting period, with changes recognized in other income, net.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company purchases bitcoins for long term investment. It intends to hold its digital assets for long term gains and treats them as long term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. A valuation allowance is recorded for unrealized capital losses. Bitcoins are stored in cold wallets. Average cost of wallet is used for calculating the unrealized gains or losses. See Note 9 to Financial Statements for additional information regarding the Company&#8217;s purchases and sales of digital assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Capital assets are recorded at cost. The cost of such capital assets is depreciated on a straight-line basis over a term depending on the assigned category (described below) and recorded as depreciation for capital assets recorded in engineering and product development, sales and marketing and general and administrative expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are classified into one of the following categories:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;">Category Name</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:48.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;">Description</p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Manufacturing, R&amp;D, or other non-office equipment</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Software, computers, monitors, printers and other related equipment.</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Office equipment and furniture owned by the company</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Account Name</b></p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Useful Life </b></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Five years</p></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Three years</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Five years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of capital assets, may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected fair value of the related asset over the estimated remaining life against the respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its capital assets in this analysis. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Impairment of Long-Lived Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-15, &#8220;Impairment or Disposal of Long-Lived Assets.&#8221; ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of the fair value hierarchy under Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, Fair Value Measurement, are described as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 1 </i>&#8212; Unadjusted quoted prices in active markets for identical assets or liabilities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 2 </i>&#8212; Inputs other than quoted prices included in Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 3 </i>&#8212; Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own models.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The financial instruments of the Company consist primarily of cash, U.S. government money market fund accounts, trade receivables, trade payables, bitcoins, and debt securities. Because carrying values of cash, trade receivables, and payables are equal to or approximate their fair value, the Company excluded them from the leveling requirements. U.S. government money market fund accounts are classified as Level 1&#160;due to their short-term nature, their market interest rates and also based on the fact that they are publicly traded. Bitcoins purchased for investments, which are included in Intangible digital assets are classified as Level 1 as the unadjusted quoted prices in active markets are used for the fair valuation. The Company also invests in non-convertible promissory notes and equity securities in a privately held company, which were recorded on cost basis. See Notes 7 and 8 to Financial Statements for more information.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="background:#ffffff;">The Company's privately held debt security is recorded at fair value on a recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company deems these assets as Level 3 within the fair value measurement framework. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">As of December 31, 2024, the Company valued the debt security at face value of </span><span style="background:#ffffff;">$5,000</span><span style="background:#ffffff;">. The original maturity date of December 6, 2024 was extended to January 17, 2025 and a partial amount of </span><span style="background:#ffffff;">$3.5</span><span style="background:#ffffff;"> million along with transaction fee of </span><span style="background:#ffffff;">$100</span><span style="background:#ffffff;"> and accrued interest of </span><span style="background:#ffffff;">$47</span><span style="background:#ffffff;"> was collected on January 15, 2025. A new amended and restated secured convertible note for the balance of </span><span style="background:#ffffff;">$1.5</span><span style="background:#ffffff;"> million was signed on January 15, 2025 with new terms (see note 20 for the details). The fair value of the Company&#8217;s privately held debt security was estimated at&#160;</span><span style="background:#ffffff;">$</span>5,000 as of December 31, 2024, in view of partial payment and a new note for the balance was signed<span style="background:#ffffff;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Investment Valuation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s investments in equity in privately held companies without readily determinable fair values, which are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. As part of its assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If its qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgment and subjectivity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> The Company did not record any impairment during the year December 31, 2024. The Company recorded an impairment of </span>$309 for the preferred stock investment in Mellitus Health, Inc (&#8220;Mellitus&#8221;) during the year ended December 31, 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Deferred Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;">Deferred revenue represents amounts billed to or collected from customers for which the related revenues have not been recognized because one or more of the revenue recognition criteria have not been met. The full amount is expected to be recognized as revenues within one&#160;year from the balance sheet date and, therefore, such deferred amounts have been classified as current liabilities in the balance sheets presented. The Company generally invoices its clients in advance of a rental period with payment due upon receipt of the invoice. Revenue recognized for the year ended December&#160;31, 2024 from amounts included in deferred revenue as of December 31, 2023 was $1,120. Revenue recognized for the year ended December&#160;31, 2023 from amounts included in deferred revenue as of December 31, 2022 was $1,160.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Advertising Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company expenses advertising costs as incurred. Advertising expense incurred during the years ended December 31, 2024 and 2023 was $167 and $319, respectively. These costs are included in sales and marketing expenses in the statements of income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company expenses costs related to the research and development associated with the design, development, testing and enhancement of its products and services. Such expenses include salaries and related employee benefits, and fees paid to external service providers. The Company incurred Research and development expenses of $4,792 and $5,773 for the year ended December 31, 2024 and 2023, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock-Based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock-based compensation expense is measured based on the grant-date fair value of the stock-based awards. The Company recognizes stock-based compensation expense for the portion of each option grant or stock award that is expected to vest over the estimated period of service and vesting. The Company uses the Black-Scholes option pricing model as the method for determining the estimated grant-date fair value of stock options. The Black-Scholes option pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected volatility. Forfeitures are recognized as incurred. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the grant. See Note 16 to financial statements for the details.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Employee Benefit Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company has a savings plan that qualifies under Section&#160;401(k)&#160;of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Effective January 1, 2022, the Company started to match&#160;50% of employee&#8217;s 401(k) deferral up to a maximum of&#160;6% of the employee&#8217;s eligible earnings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the expected tax consequences attributable to the differences between financial reporting and the tax bases of existing assets and liabilities and net operating loss (&#8220;NOL&#8221;) carryforwards, and they are measured using enacted tax rates expected to be in effect when differences are expected to reverse. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recently Issued Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Accounting Pronouncements Recently Adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In November 2023, the FASB issued <span style="background:#ffffff;">Accounting Standards Update</span> (&#8220;ASU&#8221;)&#160;2023-07&#160;&#8220;Segment Reporting: Improvements to Reportable Segment Disclosures&#8221;. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an entity&#8217;s financial statements. The Company adopted the new accounting standard for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s financial statements related disclosure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-08, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets</i> (&#8220;ASU 2023-08&#8221;). ASU 2023-08 requires in-scope crypto assets to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning after December 15, 2024, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company early adopted <span style="-sec-ix-hidden:Hidden_J8wOH7bw2UqoKIsy6ORpDQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ASU 2023-08</span></span> in the second quarter ended June 30, 2024, effective retroactively as of January 1, 2024 with no cumulative-adjustment to the retained earnings as of the beginning of the annual period of adoption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements not yet adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:6pt;text-indent:18pt;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-09,<i style="font-style:italic;"> Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning after December 15, 2024 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. Adoption of this update is not expected to have a significant impact on the Company&#8217;s financial statements and related disclosures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">In November 2024, the FASB issued ASU 2024-03,</span><i style="font-style:italic;background:#ffffff;">&#160;"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.</i><span style="background:#ffffff;">" This standard requires entities to disaggregate operating expenses into specific categories such as employee compensation, depreciation, and intangible asset amortization, by relevant expense caption on the statement of operations. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, which means that it will be effective for the Company&#8217;s annual and interim reporting for the fiscal year ending December 31, 2028. Early adoption is permitted on either a prospective or retrospective basis. The Company is currently evaluating the impact of adopting ASU 2024-03 on its financial statements and related disclosures.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289768103632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets for Lease, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseNetAbstract', window );"><strong>Assets for Lease, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseNetTextBlock', window );">Assets for Lease, net</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">3.&#160;&#160;&#160;&#160;Assets fo<span style="font-weight:normal;">r</span> Lease, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company provides financing of certain equipment through operating leases (see Note 13 to the financial statements). Assets for lease consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,522</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,375</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,099)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,090)</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease, net </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,285</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Depreciation expense amounted to $296 and $307 for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Reduction to accumulated depreciation for returned items was $279 and $441 for the&#160;years ended December&#160;31, 2024 and December&#160;31, 2023, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $298 and $369 for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, total assets for lease, net, in use at customer locations were $295 and $489, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on assets for lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289865497184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">4.&#160;&#160;&#160;&#160;Inventory</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">As of December 31, 2024 and 2023, the inventory balance was </span><span style="font-weight:normal;">$358</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$445</span><span style="font-weight:normal;">, respectively. Inventory includes finished goods of sensors, light blocking bags and heel warmers.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770869280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, net</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">5.&#160;&#160;&#160;&#160;Property and Equipment, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Capital assets consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, gross</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,467</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,544</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (980)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (824)</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 487</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 720</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Depreciation expense amounted to $283 and $292 for the years ended December 31, 2024 and 2023, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289865339616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Long-Term Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Long-Term Investments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">6.&#160;&#160;&#160;&#160;Long-Term Investments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Carrying value of non-marketable securities is measured as the total initial cost plus the cumulative net gain (loss). Carrying value of non-marketable equity investments consist of the following for the periods presented:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in SYNAPS Dx</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total long-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September 2020, the Company acquired a promissory note from NeuroDiagnostics Inc., which is doing business as SYNAPS Dx, in the principal amount of $500. Subsequently, in December 2020, the Company agreed to convert the promissory note, together with all accrued interest thereon, into shares of preferred stock of SYNAPS Dx as repayment in full of the promissory note. The value of the note exchanged for the shares of preferred stock of SYNAPS Dx held by the Company as of December 31, 2024 and 2023 was approximately $512. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The investments in SYNAPS Dx as of December 31, 2024 were recorded in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 321, <i style="font-style:italic;">Investments &#8211; equity securities,</i> which provides that investments in equity securities in privately-held companies without readily determinable fair values are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. The Company elected the practical expedient permitted by ASC 321 and recorded the above investments on a cost basis. As a part of the assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgement and subjectivity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company assessed the investment for impairment in accordance with ASC 321. As of December 31, 2024, the Company determined that there was no impairment. A<span style="color:#212529;background:#ffffff;">s of December 31, 2023, the Company determined that there was an impairment to the preferred stock investment in Mellitus and recorded an impairment of </span><span style="color:#212529;background:#ffffff;">$309</span><span style="color:#212529;background:#ffffff;">&#160;due to the following factors: 1) due to continued operating losses; 2) due to lack of revenue growth; and 3) delayed capital raise. The cumulative recorded impairment as of December 31, 2024, was </span><span style="color:#212529;background:#ffffff;">$309</span><span style="color:#212529;background:#ffffff;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770537232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">7.    Fair Value Measurements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The following table presents fair value hierarchy of the Company&#8217;s financial assets measured at fair value on a recurring basis:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:46.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value Hierarchy</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Government money market fund accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 3,638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 3,638</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bitcoin investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 214,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 214,633</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in intangible digital assets)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 218,271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 218,271</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18pt;"></span> <span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.12%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.24%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Government money market fund accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 41,373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 41,373</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Treasury bill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 10,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 10,494</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment in debt securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,372</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in notes held for investment)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 41,373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 10,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 56,239</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Treasury bill was purchased on October 10, 2023, at a cost of&#160;$10,414, and fair value accretes to maturity date at an interest rate of&#160;5.35%. The treasury bill was classified as Level 2 as it is considered &#8220;off the run&#8221; because similar treasury bills were issued before the most recent issue and were outstanding as of December 31, 2023 and therefore not considered as liquid as other treasury bills with the same maturity date. As of December 31, 2023, the interest income recorded on these bills was&#160;$80.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company valued the debt securities at face value as of December 31, 2024 because the debt was to be repaid in January 2025. As of December 31, 2023, the Company valued the debt securities using a bond plus call option model reflecting the cash flow from the debt securities and assuming a&#160;5%&#160;probability of an equity financing, a&#160;75%&#160;probability of a change of control, and a&#160;20%&#160;probability of payment at maturity or an insolvency event. As of December 31, 2023, the fair value of the Company&#8217;s privately held debt securities was estimated at $4,372.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The key inputs for the valuation model are:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.94%-5.26%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cashflow discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">27.8</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.25-2.92</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">120%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:69pt;"></span><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The following table represents changes in the notes held for the investments with significant unobservable inputs:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.11%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Convertible Notes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchased </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of the notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767293152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes held for investment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Notes held for investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablesTextBlock', window );">Notes held for investment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">8.    Notes held for investment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">Notes receivable consist of the following for the periods presented:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior secured promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;">In June 2022, the Company loaned Mellitus an aggregate of $1,000&#160;through the purchase of&#160;two&#160;senior secured promissory notes that bear interest at a rate of&#160;5% per annum, and mature in&#160;three years&#160;<span style="white-space:pre-wrap;">unless accelerated due to an event of default as provided in the notes. Repayment of notes is secured by a first priority interest in all of Mellitus&#8217; assets.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="background:#ffffff;">In December 2022, the Company entered into a senior convertible promissory note (also referred as debt security) arrangement with Monarch, providing Monarch with up to </span><span style="background:#ffffff;">$5,000&#160;</span><span style="background:#ffffff;">in available funding, of which </span><span style="background:#ffffff;">$5,000</span><span style="background:#ffffff;">, in principal was drawn as of December 31, 2024. The Monarch debt security accrues interest at&#160;</span><span style="background:#ffffff;">10%</span><span style="background:#ffffff;"> per annum, payable monthly, and the principal balance was originally due December 6, 2024, with such due date extended to January 17, 2025 (refer to note 20 for additional information). The note along with up to </span><span style="background:#ffffff;">$100</span><span style="background:#ffffff;">&#160;of transaction expenses is due and payable on the occurrence of an event of default or change of control unless accelerated due to the conversion into preferred stock prior thereto at the option of the Company. The Company has the option to extend the maturity date for&#160;</span><span style="background:#ffffff;">two</span><span style="background:#ffffff;">&#160;consecutive&#160;</span><span style="background:#ffffff;">one-year</span><span style="background:#ffffff;"> terms. The Monarch debt security can be converted into Monarch&#8217;s shares at the Company&#8217;s option upon (a) an equity financing at Monarch, (b) upon a change of control at Monarch, or (c) at the Company&#8217;s option at any time prior to the maturity date. If converted upon a change of control, the Company has the right to receive a cash payment equal to the balance of the Monarch debt security or the amount payable upon conversion into Monarch&#8217;s shares. The Monarch debt security is redeemable at any time at Monarch&#8217;s option or automatically upon an event of default (as defined in the note)</span>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The Company made an irrevocable election to account for the Debt Securities using the fair value option under ASC 825 &#8211; <i style="font-style:italic;">Financial Instruments</i> (&#8220;ASC 825&#8221;) and will measure the fair value of the Debt Securities in accordance with ASC 820. The Company made the fair value option election to present the Debt Securities in its entirety at fair value, which it </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">believes to be preferable to recognizing the host instrument at fair value under ASC 320 and potentially separately recognizing certain embedded features as bifurcated derivatives under ASC 815. As of December 31, 2024, the Company assessed and estimated the fair value of the Debt Security of Monarch to be $5,000 and Mellitus senior secured promissory notes to be $1,000. A<span style="background:#ffffff;">s of December 31, 2023, the Company estimated the fair value of the Monarch debt security to be </span><span style="background:#ffffff;">$4,372</span><span style="background:#ffffff;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The Company recognizes interest income on the Monarch debt security, which is included in interest and dividend income in the statements of income. Accrued interest on the Monarch convertible promissory note was included in prepaid and other current assets. For the year ended December 31, 2024 and 2023, the Company recognized </span><span style="background:#ffffff;">$483</span><span style="background:#ffffff;">&#160;and </span><span style="background:#ffffff;">$449</span><span style="background:#ffffff;">, respectively, of interest income from Monarch debt security. The Company recognizes changes in fair value of the notes in the statements of income separately from the interest income. For the year ended December 31, 2024 and 2023, the Company recorded&#160;a change in fair value of </span><span style="background:#ffffff;">$128</span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$307</span><span style="background:#ffffff;">, respectively, for the Monarch debt security</span>.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481933/310-10-55-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 44<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-44<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767277232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Digital Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_IntangibleDigitalAssetsAbstract', window );"><strong>Intangible Digital Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetTextBlock', window );">Intangible Digital Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span><b style="font-weight:bold;">Intangible Digital Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In May 2024, the Company announced that its board of directors adopted bitcoin as its primary treasury reserve asset. Under this new treasury strategy, the Company purchases and holds bitcoins for long term investment purposes. The Company accounts for its bitcoin as an indefinite-lived intangible asset in accordance with ASC 350, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other</i> and has ownership of and control over its bitcoin, which are included in Intangible digital assets in the Balance Sheets. As of December 31, 2024, there were no contractual restrictions on the sale of bitcoins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Bitcoin Investment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Company early adopted ASU No. 2024-08 in the second quarter of 2024 effective retroactively as of January 1, 2024. See <i style="font-style:italic;">Recently Adopted</i> <i style="font-style:italic;">Accounting Pronouncement</i> in Note 2 to Financial Statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s bitcoin purchased for investment purpose are initially recorded at cost, inclusive of transaction costs and fees. Subsequently, <span style="-sec-ix-hidden:Hidden_EtskwuOt8E-UAPDIhjG0PQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company remeasures its bitcoin investment</span></span> at fair value at the end of each reporting period with changes recognized in net income through &#8220;Other income, net&#8221; in the Company&#8217;s Statements of Income. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Intangible Assets Cost Basis</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The Company uses average cost for computing capital gains or losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth the units held, cost basis, and fair value of crypto assets held, as shown on the balance sheet as of December 31, 2024:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Units Held</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets held:</p></td><td style="vertical-align:bottom;width:13.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Third party bitcoin custodians</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">2,298 </p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">189,700 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 214,633</p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,298</p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 189,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 214,633</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reconciliation of fair value</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>The following table represents a reconciliation of the fair values of the Company&#8217;s Intangible digital assets held for the year ended December 31, 2024:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For The Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets held:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Beginning balance at fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 189,700</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrealized gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 29,766</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrealized loss, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,833)</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 214,633</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:6pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_IntangibleDigitalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_IntangibleDigitalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771251008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other non-current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentDisclosureAbstract', window );"><strong>Other non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_OtherNoncurrentAssetsTextBlock', window );">Other non-current assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;background:#ffffff;">10.</b></span><b style="font-weight:bold;">Other non-current assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Other non-current includes right-of-use asset (&#8220;ROU&#8221;) of&#160;</span><span style="background:#ffffff;">$65</span><span style="background:#ffffff;"> and long-term deposits of&#160;</span><span style="background:#ffffff;">$20</span><span style="background:#ffffff;">&#160;as of December 31, 2024. As of December 31, 2023, </span><span style="-sec-ix-hidden:Hidden_xVAitRPWgkWwaTzZPw38ow;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ROU asset</span></span><span style="background:#ffffff;"> of </span><span style="background:#ffffff;">$150</span><span style="background:#ffffff;"> and miscellaneous receivable of </span><span style="background:#ffffff;">$100</span><span style="background:#ffffff;"> and long term deposits balances of&#160;</span><span style="background:#ffffff;">$20</span><span style="background:#ffffff;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_OtherNoncurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_OtherNoncurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767277232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">11.&#160;&#160;&#160;&#160;Accrued Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 3,743</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 2,008</p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued Taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 1,991</p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Miscellaneous Accruals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 521</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 503</p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Accrued Expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 5,173</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,502</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289855806912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">12.&#160;&#160;&#160;&#160;Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash, bitcoins and accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company maintains cash with major financial institutions. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. <span style="background:#ffffff;">The cash and cash equivalents also includes U.S. government money market fund accounts. As of December 31, 2024, the Company held deposits of </span><span style="background:#ffffff;">$5,314</span><span style="background:#ffffff;">, which exceeded federal deposit corporation limits. The Company also invested in U.S. government money market accounts of </span><span style="background:#ffffff;">$3,638</span>. The Company holds 2,298 bitcoins as of December 31, 2024, valued at $214,633. As of December 31, 2024, two providers accounted for 60% and 40% of the Company&#8217;s total bitcoin holdings. <span style="background:#ffffff;">Our bitcoins are held offline in cold storage with </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="background:#ffffff;">multiple third-party providers. </span>The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the&#160;year ended December&#160;31, 2024, two customers (including affiliates) accounted for 43.1% and 27.6% of the Company&#8217;s revenue. For the year ended December 31, 2023, two customers accounted for 36.0%, and 34.9% of the Company&#8217;s revenue. As of December 31, 2024, three customers accounted for 33.9%, 28.7% and 14% of the Company&#8217;s accounts receivable. As of December 31, 2023, three customers accounted for 27.5%, 27.5% and 23.6% of the Company&#8217;s accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of December 31, 2024, three vendors accounted for 29.4%, 16.7 and $15.6% of the Company&#8217;s accounts payable. As of December 31, 2023, two vendors accounted for 24.0% and 10.1% of the Company&#8217;s accounts payable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766924576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_LeaseDisclosureTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">13.&#160;&#160;&#160;&#160;Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Lessee Arrangements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On July 31, 2020, the Company entered into a 61-month lease agreement for office space to use, as necessary, for office administration, lab space and assembly and storage purposes, located in Santa Clara, California. The Company took possession of the leased office space in September 2020, and the lease is effective through September 30, 2025. The discount rate determined for this lease was 2.5%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024, the remaining lease term is nine months with no options to renew. The Company recognized facilities lease expenses of $88 and $88 for the years ended December 31, 2024 and 2023, respectively. The following table summarizes the future minimum rental payments required under operating leases that had initial or remaining non-cancelable lease terms greater than one year as of December 31, 2024:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total undiscounted future minimum lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: present value discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 70</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease expense in excess cash payment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5)</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total ROU asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 65</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024, the Company&#8217;s <span style="-sec-ix-hidden:Hidden_ZCznBrDkRkiZHIq0TZrasQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ROU asset</span></span> was $65, which is recorded on the Company&#8217;s balance sheet as other non-current assets, and the Company&#8217;s <span style="-sec-ix-hidden:Hidden_2GncPSotZkeJ6j2K3RM9Gw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">current</span></span> lease liabilities were $70, which were recorded on the Company&#8217;s balance sheet as other short-term liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Lessor Arrangements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company enters into contracts with customers for the Company&#8217;s QuantaFlo<sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> product. The Company has determined these contracts meet the definition of a lease under Topic 842. The lease portfolio primarily consists of operating leases that are short-term in nature (monthly, quarterly or one year, all of which have renewal options). The Company made an accounting policy election to apply the practical expedient to not separate lease and eligible non-lease components. The lease component is the predominant component and consists of fees charged for use of the equipment over the period of the arrangement. The nature of the eligible non-lease component is primarily software support. The assets associated with these leasing arrangements are separately identified in the Balance Sheet as Assets for Lease and separately disclosed in Note 3 to the financial statements. During the year ended December 31, 2024 and 2023, the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company recognized approximately $27,488 and $37,262, respectively, in lease revenue related to these arrangements, which is included in revenues on the Statements of Income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Variable-fee Revenue</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company recognizes revenues from variable-fee licenses (e.g., fee per test) and sales of hardware equipment and accessories in accordance with Topic 606. Total revenues from variable-fee licenses were approximately $25,955 and $28,992 for the years ended December 31, 2024 and 2023, respectively. Total revenues from sales of hardware and equipment accessories were approximately $2,851 and $1,930 for the years ended December 31, 2024 and 2023, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_LeaseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of information about leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_LeaseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772478832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">14.&#160;&#160;Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Indemnification Obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company&#8217;s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company&#8217;s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Other</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company is subject to various state sales and use tax audits and believes its current exposure could result in an estimated liability of up to $500. The Company did not record such estimated liability as of December 31, 2024, as it was not determined to be probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;background:#ffffff;">Legal Matters</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">From time to time, the Company may be subject to legal proceedings and claims in the ordinary course of business. The Company is not currently a party to any litigation the outcome of which, if determined adversely to it, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business, operating results, cash flows or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In July 2017, the Company received an initial civil investigative demand (&#8220;CID&#8221;) from the U.S. Department of Justice (&#8220;DOJ&#8221;) pursuant to the federal False Claims Act investigating whether the Company and others may have violated the False Claims Act by marketing tests on devices that use photoplethysmography technology as reimbursable by Medicare in alleged contravention of applicable laws and regulations.&#160;The Company cooperated with the investigation, along with subsequent CIDs received in February 2019, December 2021, April 2022 and April 2023 addressed to the Company or individual current or former employees related to the same investigation. In September </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024, DOJ shared certain information to which the Company responded in January and February 2025. On February 6, 2025, DOJ asked if the Company wished to engage in settlement discussions to resolve any potential claims by February 11, 2025 and if so that the Company make a settlement offer by such deadline.&#160;Prior to February 6, 2025, DOJ had not stated an intention to pursue a claim of wrongdoing against the Company.&#160;On February 11, 2025, the Company began initial settlement discussions with DOJ, but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.&#160;The Company does not believe the amount of loss can be reasonably estimated. The Company intends to vigorously defend itself in any such action.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770544240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">15.&#160;&#160;Stockholders&#8217; Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has 50,000,000 authorized shares of capital stock, all of which are designated as common stock with par value of $0.001 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">Each holder of shares of common stock is entitled to one vote for each share held.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">At-the-Market Offering</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 24, 2024, the Company&#8217;s registration statement on Form S-3 became effective, which allowed it to offer and sell securities from time to time in one or more offerings, up to an aggregate value of $150.0 million, including under its June 2024 Controlled Equity Offering<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">SM</sup> Sales Agreement with Cantor Fitzgerald &amp; Co., pursuant to which the Company may offer and sell from time to time its common stock in an at-the-market (&#8220;ATM&#8221;) offering. <span style="background:#ffffff;">Pursuant to this agreement, the Company agreed to pay the sales agent commissions for their services in acting as agent with respect to the sale of shares through the ATM offering program.</span> <span style="background:#ffffff;">The sales commission and expenses related to each of the ATM equity offering program are considered direct and incremental costs and are charged against &#8220;Additional paid-in capital&#8221; on the Balance Sheet in the period in which the corresponding shares are issued and sold.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">Through December 31, 2024, the Company had issued and sold a total of 2,197,988 shares of its common stock for aggregate gross proceeds of approximately $119.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Treasury Stock Acquired</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;">On March 14, 2022, the Company&#8217;s Board of Directors authorized a share repurchase program under which it may repurchase up to&#160;$20.0&#160;million of its outstanding common stock. Under this program the Company&#160;may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans or through the use of other techniques such as accelerated share repurchases. The timing and amount of any transactions will be subject to the discretion of the Company based upon market conditions and other opportunities that it may have for the use or investment of its cash balances. The repurchase program has no expiration date, does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. No purchases were made during the years ended December 31, 2024 and 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Warrants Acquired- Related Party Transaction</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">On May 17, 2023, the Company repurchased outstanding warrants to acquire 76,875 shares of common stock from its chief executive officer at a cost of $1,949. The warrants, which were originally issued on June 7, 2012 (16,875&#160;shares) with an exercise price of $4.00&#160;per share and on July 31, 2013 (60,000&#160;shares), with an exercise price of $4.50&#160;per share, were amended in September 2015 and, as amended, had an expiration date of July 31, 2023. The $1,949&#160;aggregate cash purchase price reflects the difference between the aggregate exercise price of the warrants and the aggregate fair market value of the shares of common stock underlying the warrants, based on the closing price of a share </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">of the Company&#8217;s common stock on May 16, 2023, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrants were cancelled and are no longer issued and outstanding.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767257264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock Option Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Option Plan</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">16.&#160;&#160;Stock Option Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company&#8217;s stock-based compensation program is designed to attract and retain certain key employees while also aligning employees&#8217; interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2014 Stock Incentive Plan (&#8220;2014 Plan&#8221;). Our board of directors adopted the 2024 Stock Option and Incentive Plan (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">2024 Plan</span>&#8221;) on August 14, 2024 and stockholder approval of the 2024 Plan became effective in October&#160;2024. In connection with expiration of the 2014 Plan in July 2024, the available share reserve (including any awards outstanding under the 2014 Plan that lapsed prior to stockholder approval of the new 2024 Plan) were transferred to the 2024 Plan upon stockholder approval thereof. The 2024 Plan provided that the aggregate number of shares of common stock that initially may be issued pursuant to awards granted under the 2024 Plan may not exceed 1,916,011 shares (the &#8220;Share Reserve&#8221;), along with any awards that transfer over from the 2014 Plan. In addition, the Share Reserve automatically increases on January 1st of each&#160;year, for a period of not more than 10&#160;years, beginning on January 1st of the&#160;year following the&#160;year in which the 2024 Plan became effective and ending on (and including) January 1, 2034, in an amount equal to 4% of the total number of shares of common stock outstanding on December&#160;31st of the preceding calendar&#160;year. The Company&#8217;s board of directors may act prior to January 1st of a given&#160;year to provide that there will be no January 1st increase in the Share Reserve for such&#160;year or that the increase in the Share Reserve for such&#160;year will be a lesser number of shares of common stock than would otherwise occur. The Share Reserve is currently 3,172,399 shares as of December&#160;31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In light of stockholder approval of the 2024 Plan, the Company no longer grants equity awards under the 2014 Plan. As of December&#160;31, 2024, there were no shares available for future stock-based compensation grants under the 2014 plan. 2,155,895 shares of an aggregate total of 3,172,399 shares, are available for future stock-based compensation grants under the 2024 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Aggregate intrinsic value represents the difference between the closing market value as of December&#160;31, 2024 of the underlying common stock and the exercise price of outstanding options. A summary of the Company&#8217;s stock option activity and related information for 2024 and 2023 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:60.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options&#160;Outstanding</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic&#160;Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;(In&#160;Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In&#160;Thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance, December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,021,785</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 3.84</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> 3.76</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 41,333</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 173,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 23.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options forfeited/cancelled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,650)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (497,385)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3.42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance, December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 691,450</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 8.86</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 3.21</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 31,209</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Exercisable as of December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 528,867</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 4.43</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 1.88</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 26,214</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">As of December 31, 2024,&#160;the fair value of unvested stock options was approximately&#160;$2,315. This unrecognized stock-based compensation expense is expected to be recorded over a weighted average period of&#160;3.35&#160;years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;background:#ffffff;margin:0pt;"><span style="font-family:'inherit';">&#160;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="color:#231f20;">During the year ended December 31, 2024</span><span style="color:#231f20;">, the Company awarded&#160;stock options of&#160;</span><span style="color:#231f20;">173,700</span><span style="color:#231f20;">&#160;to&#160;employees&#160;as compensation pursuant to the 2014 Plan. Of these </span><span style="color:#231f20;">119,700</span><span style="color:#231f20;"> options,&#160;</span><span style="-sec-ix-hidden:Hidden_Tzy6P97uHUaeUF-cBrMSEA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">1/4</span></span>th vest&#160;one&#160;year after the grant date and&#160;<span style="-sec-ix-hidden:Hidden_V32SFWmW3EWJ45UKw92nEg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">1/48</span></span>th for each month thereafter contingent upon the participant&#8217;s continued service beginning on the initial vesting date and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;">ending when the Vested Ratio equals 1/1. Grant date fair value of options granted to the employees for the year ended December 31, 2024 and 2023 was $1,792 and $316, respectively. Also during the year ended December 31, 2024, the Company awarded stock options of 54,000 to members of the board of directors pursuant to the 2014 Plan (the &#8220;Director Options&#8221;). Of these options, 1/<span style="-sec-ix-hidden:Hidden_8RoI3HM5VE6VepajHbnVVQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">24</span></span> vested immediately on the date of grant and 1/<span style="-sec-ix-hidden:Hidden_r6U7ShkGaEyl2_KE4RIe3w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">24</span></span> for each month thereafter contingent upon participant&#8217;s continued service beginning on the initial vesting date and ending when the vested ratio equals 1/1. The Director Options will be cancelled if not exercised by May 23, 2026. Grant date fair value of options granted to the non-employee directors for the year ended December 31, 2024 and 2023 was $559 and zero, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="color:#212529;">&#160;</span><span style="color:#212529;">No</span><span style="color:#212529;">&#160;stock-based compensation was capitalized or included in inventories for the years ended&#160;</span><span style="color:#212529;">December 31</span><i style="color:#212529;font-style:italic;">, </i><span style="color:#212529;">2024</span><i style="color:#212529;font-style:italic;">&#160;</i><span style="color:#212529;">and</span><i style="color:#212529;font-style:italic;">&#160;</i><span style="color:#212529;">2023</span><i style="color:#212529;font-style:italic;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><span style="color:#231f20;">The fair value of each option grant is estimated using the Black-Scholes option pricing model. The weighted-average assumptions used, and the calculated weighted average fair values of options are as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2-7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4.5%-4.9%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4.14%-4.41%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">62.3%-77.2%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">69.0%-79.5%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividend rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value of options granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$10.35-$14.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$17.54-$19.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Total tax benefit from the exercise of stock options was $4,428 and $2,133 for the years ended December 31, 2024 and 2023, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> Stock grants</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company granted 10,500 and 18,048 shares of fully vested stock to employees and board of directors in the year ended December 31, 2024 and 2023, respectively. Grant date fair value of the stock was $300 and $860 for the year ended December 31, 2024 and 2023, respectively. <span style="display:inline-block;width:13.29pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has recorded an expense of $862 and $944 as it relates to stock-based compensation for the&#160;years ended December&#160;31, 2024 and 2023, respectively, which was allocated as follows based on the role and responsibility of the recipient in the Company:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 8</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Engineering and Product Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 53</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales and Marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 135</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 317</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General and Administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 642</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 566</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 862</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 944</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767277232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">17.&#160;&#160;<b style="font-weight:bold;white-space:pre-wrap;">  Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The components of the provision for income taxes are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current tax provision:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Federal </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,576</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 605</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total current tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,181</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax provision:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Federal </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,015</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (680)</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">State </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 16</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total deferred tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,727</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (664)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,517</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of the differences between the Company&#8217;s effective income tax rate and the federal statutory income tax rate for the&#160;years ended December&#160;31, 2024 and 2023 are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal statutory rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income tax rate, net of federal benefit </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8.32)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7.98)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Permanent items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.03)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.71)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.07)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 0.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Effective income tax rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 14.54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 14.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax (liabilities) assets are comprised of the following at December&#160;31:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 188</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 268</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 385</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrual and reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 180</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 251</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 262</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 156</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,450</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 38</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">     Total gross deferred tax assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,998</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">     Less valuation allowance</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,998</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Right of use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (36)</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,974)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (36)</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 24pt;"><b style="font-weight:bold;">Net deferred tax (liabilities) assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,765)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,962</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Federal and California tax laws imposes significant restrictions on the utilization of net operating loss (&#8220;NOL&#8221;) carryforwards in the event of a change in ownership of the Company, as defined by Section 382 of the Code (&#8220;Section 382&#8221;). The Company completed a formal 382 study for the period from January 1, 2012 through June 30, 2019 and concluded that a change in ownership has likely occurred. The Company has no NOL carryforwards for Federal income </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">tax purposes and approximately $2,580 for California income tax purposes as of December 31, 2024. The state NOL carryforwards, if not utilized, will expire beginning in 2035 and extended to 2038. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2024 and 2023, the Company had $487 and $470, respectively, of unrecognized tax benefits (excluding interest and penalties) that, if recognized, would affect the effective tax rate. The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Unrecognized Tax Benefits 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Unrecognized Tax Benefits 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits &#8211; January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 470</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 401</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross increases related to prior tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross decreases related to prior tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross increases related to current tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 65</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits &#8211; December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 487</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 470</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s policy is to recognize interest and penalty expenses related to uncertain tax positions in income tax expense, which was $155 and $87 for the years ended December 31, 2024 and 2023, respectively. The Company files income tax returns in the U.S. federal and various state tax jurisdictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company&#8217;s tax years beginning in 2020 remain open for examination by the state tax authorities for four years. The Company&#8217;s tax years beginning in 2021 remain open for examination by the federal tax authorities for three years. Tax years beginning in 2018 will remain open for examination from the date of utilization of any NOL or credits. The Company does not have any tax positions for which it is reasonably possible the total amount of gross unrecognized tax benefits will increase or decrease within 12 months of the year-ended December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Before January 1, 2022, IRC &#167;174 provided a taxpayer may treat research or experimental expenditures which are paid or incurred by the taxpayer during the taxable year in connection with the taxpayer&#8217;s trade or business as expenses.  As amended by TCJA, IRC &#167;174 provides that in a case of a taxpayer's specified research or experimental expenditures for any taxable year beginning after December 31, 2021, no deduction is allowed for such expenditures.  The expenditures must be charged to capital account and allowed an amortization deduction of such expenditures ratably over the 5-year period (15-year period in the case of any specified research expenditures which are attributable to foreign research). The Company capitalized </span>$4,153 and $4,610 specified research or experimental expenditures for the year ended December 31, 2024 and 2023, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767953984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share, Basic and Diluted<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Income Per Share, Basic and Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share, Basic and Diluted</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">18.&#160;&#160;<b style="font-weight:bold;white-space:pre-wrap;">  Net Income Per Share, Basic and Diluted</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Basic earnings per share (&#8220;EPS&#8221;) represent net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.<span style="background:#ffffff;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Basic and diluted net EPS is calculated as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:72.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:33.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EPS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EPS</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,228,961</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 40,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,732,806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Common stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 751,157</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,086,353</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,980,118</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 40,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,819,159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2.63</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766825840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.</b></span><b style="font-weight:bold;">Segment Information</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">ASU No. 2023-07 topic 280, &#8220;Segment Reporting&#8221; establishes standards for reporting information about operating segments on a basis consistent with the Company&#8217;s internal organization structure as well as information about services categories, business segments and major customers in financial statement. </span><span style="background:#ffffff;">The Company manages its business in </span><span style="background:#ffffff;">one</span><span style="background:#ffffff;"> reportable operating segment, which is engaged in the manufacturing, marketing, and sales of its</span><span style="color:#212529;background:#ffffff;">&#160;patented and FDA cleared product, QuantaFlo.</span><span style="background:#ffffff;"> </span><span style="color:#212529;">In accordance with the &#8220;Segment Reporting&#8221; Topic 280, the Chief Executive Officer and President has been identified as the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;), who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. The </span>CODM uses segment operating profit to allocate resources including employees, property and investments. The CODM also uses month-over-month expense variance analysis for cost control and for making decisions about allocating capital and personnel to the segment<span style="font-size:12pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">The following table breaks out the operations of the Company&#8217;s single reportable segment information.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 56,294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 68,184</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Less:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cost of revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,685</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,923</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,709</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,674</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,895</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,777</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,702</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 12,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 14,208</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 283</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 292</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other segment expenses <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,192</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,352</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Segment operating profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 22,256</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest income, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,877</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,471</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Impairment of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (337)</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (307)</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 24,933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other corporate income <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 17</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income before taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><span style="font-size:11pt;"> 47,884</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><span style="font-size:11pt;"> 24,100</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,517</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 40,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,583</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Research and development include clinical affairs and HITRUST.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other segment expenses include marketing, customer education, business development, and strategic streamlining.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other corporate income represents unallocated income.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">See note 12 to the financial statements for the customers accounted for 10% or more of the revenues and receivables.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;">As of December 31, 2024 and 2023, all assets of the Company were located in United States of America.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766884752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">20.</b></span><b style="color:#212529;font-weight:bold;">Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Offering of </b><b style="font-weight:bold;">4.25%</b><b style="font-weight:bold;"> Convertible Senior Notes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">On January 28, 2025, the Company completed its previously announced private offering of </span><span style="background:#ffffff;">$100.0</span><span style="background:#ffffff;"> million aggregate principal amount of its </span><span style="background:#ffffff;">4.25%</span><span style="background:#ffffff;"> Convertible Senior Notes due 2030, or the Notes, including the exercise in full of the initial purchasers&#8217; option to purchase up to an additional </span><span style="background:#ffffff;">$15.0</span><span style="background:#ffffff;"> million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated January 28, 2025, or the Indenture, between the Company and U.S. Bank Trust Company, National Association, as trustee.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">The Notes are general senior, unsecured obligations of the Company and will mature on August 1, 2030, unless earlier converted, redeemed or repurchased. The Notes bear interest at a rate of </span><span style="background:#ffffff;">4.25%</span><span style="background:#ffffff;"> per year, payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2025. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 1, 2030, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2025 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock, par value </span><span style="background:#ffffff;">$0.001</span><span style="background:#ffffff;"> per share, or the Common Stock, for at least </span><span style="background:#ffffff;">20</span><span style="background:#ffffff;"> trading days (whether or not consecutive) during a period of </span><span style="background:#ffffff;">30</span><span style="background:#ffffff;"> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to </span><span style="background:#ffffff;">130%</span><span style="background:#ffffff;"> of the conversion price for the Notes on each applicable trading day; (2) during the </span><span style="background:#ffffff;">five</span><span style="background:#ffffff;"> business day period after any </span><span style="background:#ffffff;">10</span><span style="background:#ffffff;"> consecutive trading day period, or the measurement period, in which the trading price (as defined in the Indenture) per </span><span style="background:#ffffff;">$1,000</span><span style="background:#ffffff;"> principal amount of the Notes for each trading day of the measurement period was less than </span><span style="background:#ffffff;">98%</span><span style="background:#ffffff;"> of the product of the last reported sale price of Common Stock and the conversion rate for the Notes on each such trading day; (3) if Semler calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after May 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company may satisfy its conversion obligation by paying and/or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company&#8217;s election, in the manner and subject to the terms and conditions provided in the Indenture</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">The conversion rate for the Notes will initially be </span><span style="background:#ffffff;">13.0826</span><span style="background:#ffffff;"> shares of Common Stock per </span><span style="background:#ffffff;">$1,000</span><span style="background:#ffffff;"> principal amount of Notes, which is equivalent to an initial conversion price of approximately </span><span style="background:#ffffff;">$76.44</span><span style="background:#ffffff;"> per share of Common Stock. The initial conversion price of the Notes represents a premium of approximately </span><span style="background:#ffffff;">25.0%</span><span style="background:#ffffff;"> over the last reported sale price of the Common Stock on the Nasdaq Capital Market on January 23, 2025. The conversion rate for the Notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, it will, in certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes in connection with such a corporate event or convert its notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be. Initially, a maximum of </span><span style="background:#ffffff;">1,635,320</span><span style="background:#ffffff;"> shares of Common Stock may be issued upon conversion of the Notes, based on the initial maximum conversion rate of </span><span style="background:#ffffff;">16.3532</span><span style="background:#ffffff;"> shares of common stock per </span><span style="background:#ffffff;">$1,000</span><span style="background:#ffffff;"> principal amount of Notes</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The Company may not redeem the Notes prior to August 4, 2028. The Company may redeem for cash all or any portion of the Notes (subject to the partial redemption limitation described in the Indenture), at its option, on or after August 4, 2028 and prior to the 21st scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Common Stock has been at least </span><span style="background:#ffffff;">130%</span><span style="background:#ffffff;"> of the conversion price for the Notes then in effect for at least </span><span style="background:#ffffff;">20</span><span style="background:#ffffff;"> trading days (whether or not consecutive) during any </span><span style="background:#ffffff;">30</span><span style="background:#ffffff;"> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to </span><span style="background:#ffffff;">100%</span><span style="background:#ffffff;"> of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as set forth in the Indenture, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The following events are considered &#8220;events of default&#8221; under the Indenture:</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">default in any payment of interest on any Note when due and payable and the default continues for a period of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">default in the payment of principal of any Note when due and payable at its stated maturity, upon optional redemption, upon any required repurchase, upon declaration of acceleration or otherwise;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to comply with its obligation to convert the Notes in accordance with the Indenture upon exercise of a holder&#8217;s conversion right, and such failure continues for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">three</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> business days;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to give (i) a fundamental change notice or notice of a make-whole fundamental change, in either case when due and such failure continues for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">five</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> business days, or (ii) notice of a specified corporate transaction when due and such failure continues for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">one</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> business day;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to comply with its obligations in respect of any consolidation, merger or sale of assets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">failure by the Company to comply with any of its other agreements in the Notes or the Indenture for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">60 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> after written notice of such failure from the trustee or the holders of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">25%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> in principal amount of the Notes then outstanding;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">default by the Company or any of its significant subsidiaries (as defined in the Indenture) with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed with a principal amount in excess of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">$15.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> million (or its foreign currency equivalent), in the aggregate of the Company and/or any such significant subsidiary, whether such indebtedness now exists or shall hereafter be created, (i) resulting in such indebtedness becoming or being declared due and payable prior to its stated maturity date or (ii) constituting a failure to pay the principal of any such indebtedness when due and payable (after the expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, and in the cases of clauses (i) and (ii), such acceleration shall not have been rescinded or annulled or such failure to pay or default shall not have been cured or waived, or such </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">indebtedness is not paid or discharged, as the case may be, within </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> after written notice to the Company by the trustee or to the Company and the trustee by holders of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">25%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> in aggregate principal amount of the Notes then outstanding in accordance with the Indenture; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">certain events of bankruptcy, insolvency or reorganization of the Company or any of its significant subsidiaries&#8217;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Neither the notes, nor any shares of the Company&#8217;s common stock issuable upon conversion of the notes, have been registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons, absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Repayment of Senior Convertible Senior Note</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On January 15, 2025, Monarch repaid $3,500, along with the transaction fees and accrued interest. At the same time, the Company entered into an Amended and Restated Secured Convertible Promissory Note (&#8220;New Note&#8221;) and related subordination agreement for the outstanding balance of $1,500 (&#8220;Principal Amount&#8221;). The New Note carries an interest rate of 15% payable monthly on 5<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> day of each month. Unless earlier repaid or converted, the New Note will mature and the outstanding Principal Amount, together with accrued and unpaid interest thereon and the transaction expenses (the &#8220;Balance&#8221;), shall be due and payable on the first to occur of (i) the occurrence of an Event of Default (as defined in the New Note), (ii) a Change of Control (as defined in the New Note) unless converted as set forth in the New Note or (iii) February 15, 2028 (the &#8220;Maturity Date&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-family:'TimesNewRomanPSMT';visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#212529;font-weight:bold;">Bitcoin Purchase Update</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the period January 1, 2025 and February 14, 2025, the Company purchased a total of approximately 894 bitcoins at an aggregate purchase price of approximately $90.7 million for an average purchase price of approximately $101,532 per bitcoin. See Note 9 to Financial Statements &#8220;Intangible Digital Assets&#8221; for further details.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">As of February 14, 2025, The Company held approximately 3,192 bitcoins that were acquired at an aggregate purchase price of $280.4 million and an average purchase price of approximately $87,854 per bitcoin, inclusive of fees and expenses. As of February 14, 2025, at 4 p.m. Eastern Time, the market price of one bitcoin reported on the Coinbase exchange (the Company&#8217; principal market) was $97,505.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771159792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 40,899<span></span>
</td>
<td class="nump">$ 20,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771505888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Equity Grant Policies and Procedures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From time to time, we award stock options to our employees, including our named executive officers, and have in the past also granted stock awards to consultants and our non-employee directors. We routinely re-evaluate the use of our equity incentive plans, including the administrative costs of such programs, when deciding the amount and types of equity awards to grant employees, consultants and our non-employee directors. Our current practice is to award certain key employees option grants on an annual basis, which are typically approved at a meeting of our compensation committee around the beginning of our fiscal year in connection with general compensation review. Non-employee directors receive annual grants as part of compensation under our non-employee director compensation policy. We do not routinely provide new hire grants to employees when they first join our Company, nor initial equity grants to non-employee directors when they first join our board, although we may choose to do so in the future. For additional information on our non-employee director compensation policy see above under the heading, &#8220;&#8212;Non-Employee Director Compensation Policy.&#8221; Other than our non-employee director compensation policy, we do not otherwise maintain any policies on the timing of awards of stock options, stock awards, stock appreciation rights, or similar instruments with option-like features. Our compensation committee considers whether there is any material nonpublic information, or MNPI, about our company when determining the timing and terms of stock option awards and, where appropriate, has provided for grants to be effective after our public disclosure of MNPI (such as our 2024 non-employee director grants, which were bifurcated due to the expiration of the 2014 Plan prior to stockholder approval of the 2024 Plan, and thus timed to be effective after publication of our quarterly report on Form 10-Q for the quarter ended September 30, 2024). Our company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">Our compensation committee considers whether there is any material nonpublic information, or MNPI, about our company when determining the timing and terms of stock option awards and, where appropriate, has provided for grants to be effective after our public disclosure of MNPI (such as our 2024 non-employee director grants, which were bifurcated due to the expiration of the 2014 Plan prior to stockholder approval of the 2024 Plan, and thus timed to be effective after publication of our quarterly report on Form 10-Q for the quarter ended September 30, 2024).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771666688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770879616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772686720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">We regularly assess risks from cybersecurity threats; monitor our information systems for potential vulnerabilities; and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program. To protect our information systems from cybersecurity threats, we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner. Our Information Technology or IT, department assesses risks based on probability and potential impact to key business systems and processes. Risks that are considered high are incorporated into our overall risk management program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">All employees receive cybersecurity training with job-specific topic considerations. Our IT team engages third-party vendors to assist with providing timely cybersecurity threat alerts in addition to monitoring cybersecurity threats and our defenses against cyberattacks. This monitoring includes the proactive identification of vulnerabilities in our systems with threat intelligence. The employees within our broader IT team who specialize in cybersecurity operations are responsible for coordinating and overseeing the activities of these third-party vendors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Cybersecurity threats, including those resulting from any previous cybersecurity incidents, have not materially affected our company, including our business strategy, results of operations, or financial condition. We do not believe that cybersecurity threats resulting from any previous cybersecurity incidents of which we are aware are reasonably likely to materially affect our company. Refer to the risk factor captioned &#8220;<i style="font-style:italic;">An information security incident, including a cybersecurity breach, could have a negative impact on our business or reputation&#8221;</i> in Part I, Item 1A. &#8220;General Risk Factors&#8221; for additional description of cybersecurity risks and potential related impacts on our company.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">We regularly assess risks from cybersecurity threats; monitor our information systems for potential vulnerabilities; and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program. To protect our information systems from cybersecurity threats, we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner. Our Information Technology or IT, department assesses risks based on probability and potential impact to key business systems and processes. Risks that are considered high are incorporated into our overall risk management program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">All employees receive cybersecurity training with job-specific topic considerations. Our IT team engages third-party vendors to assist with providing timely cybersecurity threat alerts in addition to monitoring cybersecurity threats and our defenses against cyberattacks. This monitoring includes the proactive identification of vulnerabilities in our systems with threat intelligence. The employees within our broader IT team who specialize in cybersecurity operations are responsible for coordinating and overseeing the activities of these third-party vendors.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our board of directors oversees our risk management process, including as it pertains to cybersecurity risks, directly and through its committees. The audit committee of the board oversees our risk management program, which focuses on the most significant risks we face in the short, intermediate, and long-term timeframe. Audit committee meetings include discussions of specific risk areas throughout the year, including, among others, those relating to cybersecurity threats, and reports from the chief technology officer or CTO on our enterprise risk profile on an annual basis. The audit committee reviews our cybersecurity risk profile with management on a periodic basis using key performance and/or risk indicators. These key performance indicators are metrics and measurements designed to assess the effectiveness of our cybersecurity program in the prevention, detection, mitigation, and remediation of cybersecurity incidents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents. Our CTO is responsible for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The audit committee <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Audit committee meetings include discussions of specific risk areas throughout the year, including, among others, those relating to cybersecurity threats, and reports from the chief technology officer or CTO on our enterprise risk profile on an annual basis. The audit committee reviews our cybersecurity risk profile with management on a periodic basis using key performance and/or risk indicators. These key performance indicators are metrics and measurements designed to assess the effectiveness of our cybersecurity program in the prevention, detection, mitigation, and remediation of cybersecurity incidents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents. Our CTO is responsible for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">chief technology officer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our CTO is responsible for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289768031440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Estimates (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies and Estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis for Presentation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis for Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;">The preparation of the accompanying financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses, and related disclosures during the reporting period. Significant items subject to such estimates include allowance for credit losses, valuation of equipment on lease, recognition and measurement of current and deferred income taxes, valuation and recognition of investments and intangible assets and valuation of inventory. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, bitcoin, accounts receivable and trade payables. The Company maintains its cash and bitcoins with major financial institutions and reputed bitcoin traders. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The cash and cash equivalents also include U.S. government money market fund accounts. Our bitcoins are held offline in cold storage with multiple third-party providers. The Company manages its accounts receivable credit risk through ongoing credit evaluation of its customers&#8217; financial conditions. The Company generally does not require collateral from its customers.&#160;For information regarding the Company&#8217;s significant customers and vendors, see Note 12 to financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue Recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company generates revenues primarily from the rental or license of its vascular testing product. The Company recognizes revenues from the licensing of its product primarily pursuant to agreements that automatically renew each&#160;month with revenue recognized on a daily convention basis or when the test is performed. The Company&#8217;s arrangements with customers for its vascular testing product are normally on a&#160;month-to-month basis with fees billed at the rates established in the customer agreement, either on a fixed or variable (e.g. fee per test) basis, as earned. The </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company also recognizes revenue for hardware and supplies sales as of the date of shipment. Shipping and handling costs are included in cost of revenues in the statement of income. Payment terms of the customers are net 30 days. Semler replaces the defective sensors with no charge. Other than replacing the defective sensors there are no other obligations to the customers. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Cash and cash equivalents are comprised of highly liquid investments purchased with an initial maturity date of three&#160;months or less. Funds held as investments in money market funds are included within cash and cash equivalents.</span>&#160;Restricted cash represents amounts pledged as cash security related to the use of credit cards.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy', window );">Short-Term Notes Held for Investments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Short-Term Notes Held for Investments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#111111;background:#ffffff;">Short-term notes held for investments are</span><b style="color:#111111;font-weight:bold;background:#ffffff;">&#160;</b><span style="color:#111111;background:#ffffff;">those</span><span style="color:#111111;background:#ffffff;"> investment instruments that will mature within one year or which are expected to be liquidated within one year.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Accounts Receivable and Allowance for Credit Losses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Accounts receivables are recorded at the invoiced amount, net of allowances for credit losses. T<span style="background:#ffffff;">he allowance for credit losses is based on management&#8217;s assessment of the collectability of accounts. The Company regularly reviews the adequacy of this allowance for credit losses by considering historical experience, the age of the accounts receivable balances, the credit quality of the customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect customers&#8217; ability to pay to determine whether a specific reserve is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for credit losses when identified. Accounts receivable, net as of December 31, 2024, December 31, 2023 and December 31, 2022 was </span><span style="background:#ffffff;">$4,378</span><span style="background:#ffffff;">, </span><span style="background:#ffffff;">$6,125</span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$3,884</span><span style="background:#ffffff;">, respectively, include </span><span style="background:#ffffff;">$2,067</span><span style="background:#ffffff;">, </span><span style="background:#ffffff;">$5,966</span><span style="background:#ffffff;"> and </span><span style="background:#ffffff;">$1,735</span><span style="background:#ffffff;">, respectively, related to revenue recognized under ASC 606.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2024, the allowance for credit losses was $199. During t<span style="color:#212529;background:#ffffff;">he year the Company provided an additional reserve of&#160;</span><span style="color:#212529;background:#ffffff;">$135</span><span style="color:#212529;background:#ffffff;">&#160;and recovered&#160;or expensed credit losses of </span><span style="color:#212529;background:#ffffff;">$223</span><span style="color:#212529;background:#ffffff;">&#160;from customers. The allowance for credit losses as of December 31, 2023 was&#160;</span><span style="color:#212529;background:#ffffff;">$287</span><span style="color:#212529;background:#ffffff;">. </span>Credit losses related to ASC 606 receivables were $113 and $6 as of December 31, 2024 and December 31, 2023, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Inventory</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inventory, which is made up of finished goods, is recorded at the lower of cost or net realizable value. Cost is determined on the first-in, first-out method. The Company periodically analyzes its inventory levels to identify inventory that has a cost basis in excess of its estimated realizable value and writes down such inventory as appropriate.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Assets for Lease</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Assets for Lease</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Assets for lease are recorded at cost. At December&#160;31, 2024 and 2023, assets for lease consisted of vascular testing devices, which are primarily leased to customers. The cost of such assets for lease is depreciated on a straight-line basis over 36 months for the units outstanding and recorded as cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of assets may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected undiscounted net cash flows associated with the related assets over their estimated remaining lives against their respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its assets for lease in this analysis. Impairment, if any, is </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock', window );">Intangible Digital Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Intangible Digital Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 350, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other</i>. The Company has ownership of and control over its bitcoin and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoin. The Company&#8217;s digital assets are initially recorded at cost and subsequently remeasured to fair value at the end of each reporting period, with changes recognized in other income, net.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company purchases bitcoins for long term investment. It intends to hold its digital assets for long term gains and treats them as long term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. A valuation allowance is recorded for unrealized capital losses. Bitcoins are stored in cold wallets. Average cost of wallet is used for calculating the unrealized gains or losses. See Note 9 to Financial Statements for additional information regarding the Company&#8217;s purchases and sales of digital assets. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Capital assets are recorded at cost. The cost of such capital assets is depreciated on a straight-line basis over a term depending on the assigned category (described below) and recorded as depreciation for capital assets recorded in engineering and product development, sales and marketing and general and administrative expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are classified into one of the following categories:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;">Category Name</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:48.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;">Description</p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Manufacturing, R&amp;D, or other non-office equipment</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Software, computers, monitors, printers and other related equipment.</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Office equipment and furniture owned by the company</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Account Name</b></p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Useful Life </b></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Five years</p></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Three years</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Five years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of capital assets, may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected fair value of the related asset over the estimated remaining life against the respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its capital assets in this analysis. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Impairment of Long-Lived Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-15, &#8220;Impairment or Disposal of Long-Lived Assets.&#8221; ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of the fair value hierarchy under Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, Fair Value Measurement, are described as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 1 </i>&#8212; Unadjusted quoted prices in active markets for identical assets or liabilities;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 2 </i>&#8212; Inputs other than quoted prices included in Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Level 3 </i>&#8212; Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own models.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">The financial instruments of the Company consist primarily of cash, U.S. government money market fund accounts, trade receivables, trade payables, bitcoins, and debt securities. Because carrying values of cash, trade receivables, and payables are equal to or approximate their fair value, the Company excluded them from the leveling requirements. U.S. government money market fund accounts are classified as Level 1&#160;due to their short-term nature, their market interest rates and also based on the fact that they are publicly traded. Bitcoins purchased for investments, which are included in Intangible digital assets are classified as Level 1 as the unadjusted quoted prices in active markets are used for the fair valuation. The Company also invests in non-convertible promissory notes and equity securities in a privately held company, which were recorded on cost basis. See Notes 7 and 8 to Financial Statements for more information.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="background:#ffffff;">The Company's privately held debt security is recorded at fair value on a recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company deems these assets as Level 3 within the fair value measurement framework. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">As of December 31, 2024, the Company valued the debt security at face value of </span><span style="background:#ffffff;">$5,000</span><span style="background:#ffffff;">. The original maturity date of December 6, 2024 was extended to January 17, 2025 and a partial amount of </span><span style="background:#ffffff;">$3.5</span><span style="background:#ffffff;"> million along with transaction fee of </span><span style="background:#ffffff;">$100</span><span style="background:#ffffff;"> and accrued interest of </span><span style="background:#ffffff;">$47</span><span style="background:#ffffff;"> was collected on January 15, 2025. A new amended and restated secured convertible note for the balance of </span><span style="background:#ffffff;">$1.5</span><span style="background:#ffffff;"> million was signed on January 15, 2025 with new terms (see note 20 for the details). The fair value of the Company&#8217;s privately held debt security was estimated at&#160;</span><span style="background:#ffffff;">$</span>5,000 as of December 31, 2024, in view of partial payment and a new note for the balance was signed<span style="background:#ffffff;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment Valuation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Investment Valuation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s investments in equity in privately held companies without readily determinable fair values, which are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. As part of its assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If its qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgment and subjectivity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> The Company did not record any impairment during the year December 31, 2024. The Company recorded an impairment of </span>$309 for the preferred stock investment in Mellitus Health, Inc (&#8220;Mellitus&#8221;) during the year ended December 31, 2023. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Deferred Revenue</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Deferred Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;">Deferred revenue represents amounts billed to or collected from customers for which the related revenues have not been recognized because one or more of the revenue recognition criteria have not been met. The full amount is expected to be recognized as revenues within one&#160;year from the balance sheet date and, therefore, such deferred amounts have been classified as current liabilities in the balance sheets presented. The Company generally invoices its clients in advance of a rental period with payment due upon receipt of the invoice. Revenue recognized for the year ended December&#160;31, 2024 from amounts included in deferred revenue as of December 31, 2023 was $1,120. Revenue recognized for the year ended December&#160;31, 2023 from amounts included in deferred revenue as of December 31, 2022 was $1,160.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Advertising Costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company expenses advertising costs as incurred. Advertising expense incurred during the years ended December 31, 2024 and 2023 was $167 and $319, respectively. These costs are included in sales and marketing expenses in the statements of income.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company expenses costs related to the research and development associated with the design, development, testing and enhancement of its products and services. Such expenses include salaries and related employee benefits, and fees paid to external service providers. The Company incurred Research and development expenses of $4,792 and $5,773 for the year ended December 31, 2024 and 2023, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock-Based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock-based compensation expense is measured based on the grant-date fair value of the stock-based awards. The Company recognizes stock-based compensation expense for the portion of each option grant or stock award that is expected to vest over the estimated period of service and vesting. The Company uses the Black-Scholes option pricing model as the method for determining the estimated grant-date fair value of stock options. The Black-Scholes option pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected volatility. Forfeitures are recognized as incurred. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the grant. See Note 16 to financial statements for the details.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPPolicy', window );">Employee Benefit Plan</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Employee Benefit Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">The Company has a savings plan that qualifies under Section&#160;401(k)&#160;of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Effective January 1, 2022, the Company started to match&#160;50% of employee&#8217;s 401(k) deferral up to a maximum of&#160;6% of the employee&#8217;s eligible earnings.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the expected tax consequences attributable to the differences between financial reporting and the tax bases of existing assets and liabilities and net operating loss (&#8220;NOL&#8221;) carryforwards, and they are measured using enacted tax rates expected to be in effect when differences are expected to reverse. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recently Issued Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Accounting Pronouncements Recently Adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">In November 2023, the FASB issued <span style="background:#ffffff;">Accounting Standards Update</span> (&#8220;ASU&#8221;)&#160;2023-07&#160;&#8220;Segment Reporting: Improvements to Reportable Segment Disclosures&#8221;. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an entity&#8217;s financial statements. The Company adopted the new accounting standard for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s financial statements related disclosure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-08, <i style="font-style:italic;">Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets</i> (&#8220;ASU 2023-08&#8221;). ASU 2023-08 requires in-scope crypto assets to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning after December 15, 2024, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company early adopted <span style="-sec-ix-hidden:Hidden_J8wOH7bw2UqoKIsy6ORpDQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ASU 2023-08</span></span> in the second quarter ended June 30, 2024, effective retroactively as of January 1, 2024 with no cumulative-adjustment to the retained earnings as of the beginning of the annual period of adoption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements not yet adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:6pt;text-indent:18pt;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-09,<i style="font-style:italic;"> Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning after December 15, 2024 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. Adoption of this update is not expected to have a significant impact on the Company&#8217;s financial statements and related disclosures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="background:#ffffff;">In November 2024, the FASB issued ASU 2024-03,</span><i style="font-style:italic;background:#ffffff;">&#160;"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.</i><span style="background:#ffffff;">" This standard requires entities to disaggregate operating expenses into specific categories such as employee compensation, depreciation, and intangible asset amortization, by relevant expense caption on the statement of operations. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, which means that it will be effective for the Company&#8217;s annual and interim reporting for the fiscal year ending December 31, 2028. Early adoption is permitted on either a prospective or retrospective basis. The Company is currently evaluating the impact of adopting ASU 2024-03 on its financial statements and related disclosures.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible digital assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for financing receivable classified as held-for-investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289870696768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Estimates (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies and Estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule of estimated useful lives of property and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Account Name</b></p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Useful Life </b></p></td></tr><tr><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Machinery &amp; Equipment</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Five years</p></td></tr><tr><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Computer Equipment&#160;&amp; Software</p></td><td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Three years</p></td></tr><tr><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Furniture&#160;&amp; Fixtures</p></td><td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Five years</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772643744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets for Lease, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseNetAbstract', window );"><strong>Assets for Lease, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ScheduleOfAssetsForLeaseNetTableTextBlock', window );">Summary of assets for lease, net</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,522</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,375</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,099)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,090)</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets for lease, net </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,285</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ScheduleOfAssetsForLeaseNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure on assets for lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ScheduleOfAssetsForLeaseNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289855808176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, net</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, gross</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,467</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,544</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (980)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (824)</p></td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 487</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 720</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772642368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Long-Term Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock', window );">Schedule of carrying value of non-marketable equity investments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in SYNAPS Dx</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total long-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772646112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of financial assets measured at fair value on a recurring basis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:46.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value Hierarchy</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Government money market fund accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 3,638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 3,638</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Bitcoin investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 214,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 214,633</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in intangible digital assets)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 218,271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 218,271</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18pt;"></span> <span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.12%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.24%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Government money market fund accounts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 41,373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 41,373</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">U.S. Treasury bill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 10,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 10,494</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in cash and cash equivalents)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment in debt securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,372</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">(Included in notes held for investment)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 41,373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 10,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 56,239</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of key inputs for the valuation model</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.94%-5.26%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cashflow discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">27.8</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected term in years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.25-2.92</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">120%</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of changes in the notes held for the investments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.11%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Convertible Notes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Purchased </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of the notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of December 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770533536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes held for investment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Notes held for investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of notes receivable</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior secured promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured convertible promissory notes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289867382256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Digital Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_IntangibleDigitalAssetsAbstract', window );"><strong>Intangible Digital Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetHoldingTableTextBlock', window );">Schedule of intangible assets cost basis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table sets forth the units held, cost basis, and fair value of crypto assets held, as shown on the balance sheet as of December 31, 2024:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Units Held</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets held:</p></td><td style="vertical-align:bottom;width:13.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Third party bitcoin custodians</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">2,298 </p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">189,700 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 214,633</p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,298</p></td><td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 189,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 214,633</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetActivityTableTextBlock', window );">Schedule of reconciliation of the fair values</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For The Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible digital assets held:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Beginning balance at fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 189,700</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrealized gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 29,766</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrealized loss, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,833)</p></td></tr><tr><td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 214,633</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:6pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_IntangibleDigitalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_IntangibleDigitalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about activity for crypto asset. Excludes information about crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetHoldingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetHoldingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771705152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 3,743</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 2,008</p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued Taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 1,991</p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Miscellaneous Accruals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 521</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 503</p></td></tr><tr><td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Accrued Expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 5,173</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 4,502</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772679136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future minimum rental payments required under operating leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total undiscounted future minimum lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: present value discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 70</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lease expense in excess cash payment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5)</p></td></tr><tr><td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total ROU asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"> 65</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289768114176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock Option Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:60.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options&#160;Outstanding</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic&#160;Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;(In&#160;Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In&#160;Thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance, December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 1,021,785</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 3.84</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> 3.76</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 41,333</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 173,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 23.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options forfeited/cancelled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,650)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="color:#231f20;font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (497,385)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3.42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance, December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 691,450</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 8.86</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 3.21</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 31,209</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Exercisable as of December&#160;31,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 528,867</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 4.43</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 1.88</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><b style="font-weight:bold;"> 26,214</b></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to determining the fair value of stock options</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2-7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4.5%-4.9%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4.14%-4.41%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">62.3%-77.2%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">69.0%-79.5%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividend rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value of options granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$10.35-$14.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$17.54-$19.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 8</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Engineering and Product Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 53</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sales and Marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 135</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 317</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General and Administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 642</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 566</p></td></tr><tr><td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 862</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 944</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771159792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of the (benefit) provision for income taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current tax provision:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Federal </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,576</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 605</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total current tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,181</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax provision:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Federal </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,015</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (680)</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">State </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 16</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total deferred tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,727</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (664)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax provision</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,517</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of differences between the Company's effective income tax rate and the federal statutory income tax rate</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal statutory rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 21.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income tax rate, net of federal benefit </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8.32)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7.98)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Permanent items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.03)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.71)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.07)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 0.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Effective income tax rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 14.54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 14.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax (liabilities) assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 188</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 268</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 385</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrual and reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 180</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 251</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 262</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 156</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,450</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 38</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">     Total gross deferred tax assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,998</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">     Less valuation allowance</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,998</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Right of use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (36)</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,974)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (36)</p></td></tr><tr><td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 24pt;"><b style="font-weight:bold;">Net deferred tax (liabilities) assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,765)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,962</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of activity related to unrecognized tax benefits</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Unrecognized Tax Benefits 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Unrecognized Tax Benefits 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits &#8211; January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 470</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 401</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross increases related to prior tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross decreases related to prior tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross increases related to current tax positions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 65</p></td></tr><tr><td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits &#8211; December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 487</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 470</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767342672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share, Basic and Diluted (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Income Per Share, Basic and Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net EPS</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:72.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:33.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EPS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EPS</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,228,961</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 40,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,732,806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Common stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 751,157</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,086,353</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,980,118</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 40,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,819,159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2.63</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289865497184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of reportable segment information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 56,294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 68,184</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Less:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cost of revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,685</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,923</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,709</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,674</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 5,895</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,777</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sales operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,702</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 12,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 14,208</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 283</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 292</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other segment expenses <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 4,192</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 7,352</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Segment operating profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 22,256</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest income, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 1,877</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 2,471</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Impairment of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (337)</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of notes held for investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (307)</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in fair value of digital assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 24,933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other corporate income <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 17</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income before taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><span style="font-size:11pt;"> 47,884</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><span style="font-size:11pt;"> 24,100</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 3,517</p></td></tr><tr><td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 40,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"> 20,583</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="color:#212529;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Research and development include clinical affairs and HITRUST.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other segment expenses include marketing, customer education, business development, and strategic streamlining.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other corporate income represents unallocated income.</span></td></tr></table><div style="margin-top:12pt;"></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766245664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies and Estimates</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 4,378<span></span>
</td>
<td class="nump">$ 6,125<span></span>
</td>
<td class="nump">$ 3,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ContractWithCustomerAccountsReceivableNet', window );">Accounts receivable, net, related to revenue recognized under ASC 606</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="nump">5,966<span></span>
</td>
<td class="nump">$ 1,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve', window );">Allowance for credit loss, additional reserve</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Allowance for credit loss, recovery</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent', window );">Credit losses related to ASC 606 receivables</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to additional reserve for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable from exchange for good or service transferred, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ContractWithCustomerAccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ContractWithCustomerAccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766338448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Estimates (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 15, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>D</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityFaceValue', window );">Debt security at face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Restated secured convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
<td class="nump">$ 5,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">$ 1,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,792<span></span>
</td>
<td class="nump">5,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Maximum contribution of percentage of employee's eligible earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption', window );">Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ASU 2023-08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,702<span></span>
</td>
<td class="nump">59,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays', window );">Payment terms | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DefectiveProductReplacementCost', window );">Defective sensors charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember', window );">Senior secured promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Restated secured convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember', window );">Senior secured convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Restated secured convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Senior secured convertible promissory note | Monarch</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount', window );">Debt securities, partial amount</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ProceedsFromTransactionFeeOfDebtSecurities', window );">Transaction fee</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities', window );">Accrued interest</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Restated secured convertible note</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative-adjustment | ASU 2023-08</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember', window );">Assets for Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment &amp; Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture &amp; Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) value of the debt security at the time of issuance or purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DefectiveProductReplacementCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of  cost incurred for replacing the defective products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DefectiveProductReplacementCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity of debt securities, partial amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ProceedsFromTransactionFeeOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the transaction fees of debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ProceedsFromTransactionFeeOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the accrued interest of debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The payments terms in contract with customer specifying the timing of payment as net number of days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 80: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was early adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-5<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202308Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202308Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770901376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets for Lease, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseNetAbstract', window );"><strong>Assets for Lease, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross', window );">Assets for lease</a></td>
<td class="nump">$ 2,522<span></span>
</td>
<td class="nump">$ 3,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,099)<span></span>
</td>
<td class="num">(1,090)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet', window );">Assets for lease, net</a></td>
<td class="nump">$ 1,423<span></span>
</td>
<td class="nump">$ 2,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 20<br> -Topic 840<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481532/840-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 20<br> -Topic 840<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481532/840-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772678640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets for Lease, net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseNetAbstract', window );"><strong>Assets for Lease, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease', window );">Depreciation expense</a></td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseReductionToAccumulatedDepreciation', window );">Reduction to accumulated depreciation for returned and retired items</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases', window );">Loss on disposal of assets for lease</a></td>
<td class="num">(298)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_AssetsForLeaseCustomerLocation', window );">Total assets for lease, net, in use at customer locations</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseCustomerLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total assets for lease in use at customer locations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseCustomerLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_AssetsForLeaseReductionToAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction to accumulated depreciation of assets for lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_AssetsForLeaseReductionToAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) arising from the lessor's sale of assets held- or available-for-lease under contractual arrangements classified as operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481222/840-30-40-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482161/360-10-40-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation expense for lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766358688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory balance</a></td>
<td class="nump">$ 358<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289772545488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation', window );">Property and equipment, gross</a></td>
<td class="nump">$ 1,467<span></span>
</td>
<td class="nump">$ 1,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation', window );">Less: accumulated depreciation</a></td>
<td class="num">(980)<span></span>
</td>
<td class="num">(824)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation', window );">Property and equipment, net</a></td>
<td class="nump">$ 487<span></span>
</td>
<td class="nump">$ 720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of accumulated amortization, depreciation, depletion for physical asset used in normal conduct of business to create and distribute product and service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770642800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease', window );">Depreciation expense</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767944192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems', window );"><strong>Equity Securities without Readily Determinable Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Total long-term investments</a></td>
<td class="nump">$ 512<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyTwoMember', window );">Investments in SYNAPS Dx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems', window );"><strong>Equity Securities without Readily Determinable Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Total long-term investments</a></td>
<td class="nump">$ 512<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771311968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Investments - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems', window );"><strong>Equity Securities without Readily Determinable Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount', window );">Cumulative recorded impairment</a></td>
<td class="nump">309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=smlr_PromissoryNoteFromPrivateCompanyTwoMember', window );">Promissory note from SYNAPS Dx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems', window );"><strong>Equity Securities without Readily Determinable Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion value</a></td>
<td class="nump">$ 512<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=smlr_PromissoryNoteFromPrivateCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=smlr_PromissoryNoteFromPrivateCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766634208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 10, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">U.S. Government money market fund accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Bitcoin investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRealizedGain', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="nump">5.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRealizedGain', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase cost</a></td>
<td class="nump">$ 10,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">U.S. Government money market fund accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,373<span></span>
</td>
<td class="nump">3,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Bitcoin investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">U.S. Treasury bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Investment in debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,239<span></span>
</td>
<td class="nump">218,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">U.S. Government money market fund accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,373<span></span>
</td>
<td class="nump">3,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Bitcoin investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,633<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,373<span></span>
</td>
<td class="nump">$ 218,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">U.S. Treasury bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Investment in debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771695840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_PercentageOfProbabilityOfEquityFinancing', window );">Percentage of probability of equity financing</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_PercentageOfProbabilityOfChangeOfControl', window );">Percentage of probability of change of control</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent', window );">Percentage of probability of payment at maturity or an insolvency event</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityFaceValue', window );">Debt security at face value</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities measured at fair value</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 4,372<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) value of the debt security at the time of issuance or purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_PercentageOfProbabilityOfChangeOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Percentage of probability of change of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_PercentageOfProbabilityOfChangeOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_PercentageOfProbabilityOfEquityFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Percentage of probability of equity financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_PercentageOfProbabilityOfEquityFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Percentage of probability of payment at maturity or an insolvency event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766415296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Valuation model (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.0394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.0526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Cashflow discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="nump">27.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term in years | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term in years | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="nump">2.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="nump">120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771161344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details) - Notes held for investment<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">$ 4,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchased</a></td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Change in fair value of the notes held for investment</a></td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767683376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes held for investment (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="nump">$ 5,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityInterestIncome', window );">Interest income from promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyTwoMember', window );">Investments in SYNAPS Dx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember', window );">Monarch</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityChangesInFairValue', window );">Changes in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember', window );">Senior secured promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_NotesReceivableInterestBearingInterestRate', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_NumberOfNotesReceivable', window );">Number of notes receivable | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_NotesReceivableTerm', window );">Term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember', window );">Senior secured promissory notes | Investments in Mellitus Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember', window );">Secured convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember', window );">Secured convertible promissory note | Monarch</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityMaximumAmountOfAvailableFunding', window );">Maximum amount of available funding</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecuritiesTransactionFee', window );">Transaction fee</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate', window );">Option to extend the maturity date | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ExtensionPeriodOptionToExtendMaturityDate', window );">Period to extend the maturity date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Investment in debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 4,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityInterestRate', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecuritiesTransactionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction fee paid for debt security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecuritiesTransactionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityChangesInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of changes in fair value of debt security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityChangesInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income on debt security recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityMaximumAmountOfAvailableFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of available funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityMaximumAmountOfAvailableFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ExtensionPeriodOptionToExtendMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option to extend the maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ExtensionPeriodOptionToExtendMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_NotesReceivableInterestBearingInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate on notes receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_NotesReceivableInterestBearingInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_NotesReceivableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of notes receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_NotesReceivableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option to extend the maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_NumberOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of notes receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_NumberOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-5<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SeniorSecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=smlr_InvestmentInPrivateCompanyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767346960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Digital Assets- Intangible Assets Cost Basis (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>item</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_IntangibleDigitalAssetsAbstract', window );"><strong>Intangible Digital Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetNumberOfUnits', window );">Units Held</a></td>
<td class="nump">2,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetCost', window );">Cost Basis</a></td>
<td class="nump">$ 189,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Fair Value</a></td>
<td class="nump">$ 214,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetNameExtensibleEnumeration', window );">Crypto Asset, Name [Extensible Enumeration]</a></td>
<td class="text">smlr:BitcoinMember<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_IntangibleDigitalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_IntangibleDigitalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates name of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-6<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetNumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetNumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289762677984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Digital Assets- Reconciliation of fair value (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetRollForward', window );"><strong>Crypto Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetAddition', window );">Additions</a></td>
<td class="nump">$ 189,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedGainNonoperating', window );">Unrealized gain, net</a></td>
<td class="nump">29,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedLossNonoperating', window );">Unrealized loss, net</a></td>
<td class="num">(4,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Ending balance at Fair Value</a></td>
<td class="nump">$ 214,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetAddition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in crypto asset from addition. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetAddition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetUnrealizedGainNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetUnrealizedGainNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetUnrealizedLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetUnrealizedLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767944480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other non-current assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentDisclosureAbstract', window );"><strong>Other non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU asset</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_MiscellaneousReceivables', window );">Miscellaneous receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_LongTermDeposits', window );">Long-term deposits</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_LongTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_LongTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_MiscellaneousReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of miscellaneous receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_MiscellaneousReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766650848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 3,743<span></span>
</td>
<td class="nump">$ 2,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued Taxes</a></td>
<td class="nump">909<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Miscellaneous Accruals</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total Accrued Expenses</a></td>
<td class="nump">$ 5,173<span></span>
</td>
<td class="nump">$ 4,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289762670000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>customer </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>customer </div>
<div>item</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimeDepositsAtCarryingValue', window );">Deposits</a></td>
<td class="nump">$ 5,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">U.S. Government money market fund accounts</a></td>
<td class="nump">$ 3,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetNumberOfUnits', window );">Crypto Asset, Number of Units</a></td>
<td class="nump">2,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Fair Value</a></td>
<td class="nump">$ 214,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Revenue from Contract with Customer Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ConcentrationRiskNumberOfCustomers', window );">Number of customers | customer</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Revenue from Contract with Customer Benchmark | Customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">43.10%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Revenue from Contract with Customer Benchmark | Customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">27.60%<span></span>
</td>
<td class="nump">34.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ConcentrationRiskNumberOfCustomers', window );">Number of customers | customer</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Accounts receivable | Customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">33.90%<span></span>
</td>
<td class="nump">27.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Accounts receivable | Customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">28.70%<span></span>
</td>
<td class="nump">27.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Accounts receivable | Customer three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">23.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Accounts payable | Vendor two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">16.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk | Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ConcentrationRiskNumberOfVendors', window );">Number of vendors | item</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk | Accounts payable | Vendor one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">29.40%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk | Accounts payable | Vendor two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk | Accounts payable | Vendor three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">15.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=smlr_InvestmentHoldingConcentrationRiskMember', window );">Investment Holding Concentration Risk | Intangible digital assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ConcentrationRiskCryptoAssetNumberOfProviders', window );">Number Of Providers | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=smlr_InvestmentHoldingConcentrationRiskMember', window );">Investment Holding Concentration Risk | Intangible digital assets | Provider One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=smlr_InvestmentHoldingConcentrationRiskMember', window );">Investment Holding Concentration Risk | Intangible digital assets | Provider Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ConcentrationRiskCryptoAssetNumberOfProviders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of major providers of crypto asset holdings in concentration risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ConcentrationRiskCryptoAssetNumberOfProviders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ConcentrationRiskNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of major customers in concentration risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ConcentrationRiskNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ConcentrationRiskNumberOfVendors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of major vendors in concentration risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ConcentrationRiskNumberOfVendors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetNumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetNumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimeDepositsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Any certificate of deposit or savings account held by a bank or other financial institution for a short-term specified period of time. Because of their short-term, time deposits are considered highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimeDepositsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=smlr_CustomerOneConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=smlr_CustomerOneConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=smlr_CustomerTwoConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=smlr_CustomerTwoConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=smlr_CustomerThreeConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=smlr_CustomerThreeConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=smlr_VendorTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=smlr_VendorTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=smlr_VendorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=smlr_VendorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=smlr_VendorThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=smlr_VendorThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=smlr_InvestmentHoldingConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=smlr_InvestmentHoldingConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=smlr_IntangibleDigitalAssetBenchmarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=smlr_IntangibleDigitalAssetBenchmarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=smlr_CryptoAssetProviderOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=smlr_CryptoAssetProviderOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=smlr_CryptoAssetProviderTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=smlr_CryptoAssetProviderTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766416960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future minimum rental payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Future minimum rental payments required under operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted future minimum lease payments</a></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: present value discount</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_OperatingLeaseExpensesInExcessOfCashPayments', window );">Lease expense in excess cash payment</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total ROU asset</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_OperatingLeaseExpensesInExcessOfCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of lease expense in excess of cash payments during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_OperatingLeaseExpensesInExcessOfCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766581248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lessee Arrangements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">61 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Options to renew</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Lease expenses</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU asset</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether lessee has option to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289773561024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lessor Arrangements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Lease revenue</a></td>
<td class="nump">$ 27,488<span></span>
</td>
<td class="nump">$ 37,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent', window );">Lease, Practical Expedient, Lessor Single Lease Component [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList', window );">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Revenues<span></span>
</td>
<td class="text">Revenues<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether practical expedient is elected to account for lease component and nonlease component as single lease component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes operating lease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770862224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Variable-fee Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseIncome', window );">Revenue from variable-fee licenses</a></td>
<td class="nump">$ 25,955<span></span>
</td>
<td class="nump">$ 28,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Revenues from sales of hardware and equipment accessories</a></td>
<td class="nump">$ 2,851<span></span>
</td>
<td class="nump">$ 1,930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766547968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_IncomeTaxExaminationsMaximumEstimatedLiability', window );">Estimated liability</a></td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_IncomeTaxExaminationsMaximumEstimatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of estimated liability on income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_IncomeTaxExaminationsMaximumEstimatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766311840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 17, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 24, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2013 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 07, 2012 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_StockholdersEquityDeficitLineItems', window );"><strong>Stockholders Equity Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_NumberOfVotesForEachShare', window );">Number of votes for each share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_SaleOfStockValueAuthorized', window );">Sale of stock, value authorized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Shares authorized under Share Repurchase Program | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock acquired (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=smlr_CommonStockWarrantsMember', window );">Common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_StockholdersEquityDeficitLineItems', window );"><strong>Stockholders Equity Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant issued to purchase common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">16,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=smlr_CommonStockWarrantsMember', window );">Common stock warrants | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_StockholdersEquityDeficitLineItems', window );"><strong>Stockholders Equity Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant issued to purchase common stock | shares</a></td>
<td class="nump">76,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ClassOfWarrantOrRightValueRepurchased', window );">Warrants repurchased | $</a></td>
<td class="nump">$ 1,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smlr_AtMarketOfferingMember', window );">At The Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_StockholdersEquityDeficitLineItems', window );"><strong>Stockholders Equity Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ClassOfWarrantOrRightValueRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of warrants or rights repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ClassOfWarrantOrRightValueRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_NumberOfVotesForEachShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of votes for each share held by shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_NumberOfVotesForEachShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_SaleOfStockValueAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum value of authorized shares permitted to be issued under the respective stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_SaleOfStockValueAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_StockholdersEquityDeficitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_StockholdersEquityDeficitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=smlr_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=smlr_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smlr_AtMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smlr_AtMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289773603488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Fully vested stock granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="nump">18,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue', window );">Grant date fair value of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue', window );">Grant date fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember', window );">Non-employee directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue', window );">Grant date fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member', window );">2014 Stock Incentive Plan | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares issued pursuant to awards granted under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,172,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,916,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Maximum term of stock option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_PercentageOfSharesReserveIncrease', window );">Percentage of shares reserve increased</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future stock-based compensation grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,155,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to non-vested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unvested stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 4 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member', window );">2014 Stock Incentive Plan | Employee Stock Option | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member', window );">2014 Stock Incentive Plan | Employee Stock Option | Non-employee directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member', window );">2014 Stock Incentive Plan | Employee Stock Option | Vested one year after the grant date | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member', window );">2014 Stock Incentive Plan | Employee Stock Option | Vested one year after the grant date | Non-employee directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member', window );">2014 Stock Incentive Plan | Employee Stock Option | Each month thereafter contingent upon the participant's continued service beginning on the initial vesting date | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smlr_KeyPersonStockOptionPlan2007Member', window );">2007 Key Person Stock Option Plan | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future stock-based compensation grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_PercentageOfSharesReserveIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of shares reserve to total number of shares of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_PercentageOfSharesReserveIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant date fair value of non-option equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of grant date fair value of options granted during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=smlr_StockIncentivePlan2014Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=smlr_KeyPersonStockOptionPlan2007Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=smlr_KeyPersonStockOptionPlan2007Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770862608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Summary of the Company's stock option activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, Beginning</a></td>
<td class="nump">1,021,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">173,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited/cancelled</a></td>
<td class="num">(6,650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
<td class="num">(497,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance, Ending</a></td>
<td class="nump">691,450<span></span>
</td>
<td class="nump">1,021,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Ending</a></td>
<td class="nump">528,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance, Beginning</a></td>
<td class="nump">$ 3.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted</a></td>
<td class="nump">23.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised</a></td>
<td class="nump">3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance, Ending</a></td>
<td class="nump">8.86<span></span>
</td>
<td class="nump">$ 3.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Ending</a></td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Options Outstanding (in years)</a></td>
<td class="text">3 years 2 months 15 days<span></span>
</td>
<td class="text">3 years 9 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Options Exercisable (in years)</a></td>
<td class="text">1 year 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Options Outstanding</a></td>
<td class="nump">$ 31,209<span></span>
</td>
<td class="nump">$ 41,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Options Exercisable</a></td>
<td class="nump">$ 26,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767598752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Weighted average assumptions used (Details) - Employee Stock Option [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, Minimum</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.14%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, Maximum</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">4.41%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, Minimum</a></td>
<td class="nump">62.30%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, Maximum</a></td>
<td class="nump">77.20%<span></span>
</td>
<td class="nump">79.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options granted</a></td>
<td class="nump">$ 10.35<span></span>
</td>
<td class="nump">$ 17.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options granted</a></td>
<td class="nump">$ 14.97<span></span>
</td>
<td class="nump">$ 19.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767187840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan - Stock-based compensation expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 862<span></span>
</td>
<td class="nump">$ 944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Total tax benefit from the exercise of stock options</a></td>
<td class="nump">4,428<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=smlr_EngineeringAndProductDevelopmentMember', window );">Engineering and Product Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">$ 566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=smlr_EngineeringAndProductDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=smlr_EngineeringAndProductDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289770914784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of components of the (benefit) provision for income taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 948<span></span>
</td>
<td class="nump">$ 3,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">605<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax provision</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">4,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">5,015<span></span>
</td>
<td class="num">(680)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred tax provision</a></td>
<td class="nump">5,727<span></span>
</td>
<td class="num">(664)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 6,985<span></span>
</td>
<td class="nump">$ 3,517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289773266352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax rate, net of federal benefit</a></td>
<td class="nump">1.96%<span></span>
</td>
<td class="nump">2.04%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(8.32%)<span></span>
</td>
<td class="num">(7.98%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Permanent items</a></td>
<td class="num">(0.03%)<span></span>
</td>
<td class="num">(0.71%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.07%)<span></span>
</td>
<td class="nump">0.24%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">14.54%<span></span>
</td>
<td class="nump">14.59%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289771343264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Deferred tax (liabilities) assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrual and reserves</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="nump">2,004<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DeferredTaxAssetsLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="nump">2,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="nump">2,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DeferredTaxAssetsRightOfUseAssets', window );">Right of use assets</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets', window );">Change in fair value of digital assets</a></td>
<td class="num">(5,958)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(5,974)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax (liabilities)</a></td>
<td class="num">$ (2,765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,962<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DeferredTaxAssetsRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax liabilities attributable to deductible temporary differences from right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DeferredTaxAssetsRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from change in fair value of digital assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289766575728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits - January 1</a></td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases related to prior tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases related to prior tax positions</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases related to current tax positions</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits - December 31</a></td>
<td class="nump">$ 487<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289864632400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Net operating loss carryforwards for California</a></td>
<td class="nump">$ 2,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits, if recognized, would affect the effective tax rate</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalty expenses related to uncertain tax positions</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ResearchAndExperimentalExpendituresCapitalized', window );">Research and experimental expenditures, capitalized</a></td>
<td class="nump">4,153<span></span>
</td>
<td class="nump">$ 4,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ExaminationOfCompanyTaxYears', window );">Company's tax years beginning for examination</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ExaminationOfCompanyTaxYears', window );">Company's tax years beginning for examination</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ExaminationOfCompanyTaxYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period as income tax examination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ExaminationOfCompanyTaxYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ResearchAndExperimentalExpendituresCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of research or experimental expenditures capitalized during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ResearchAndExperimentalExpendituresCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767038288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Income Per Share, Basic and Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">7,228,961<span></span>
</td>
<td class="nump">6,732,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Common stock options (in shares)</a></td>
<td class="nump">751,157<span></span>
</td>
<td class="nump">1,086,353<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">7,980,118<span></span>
</td>
<td class="nump">7,819,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income - Basic EPS</a></td>
<td class="nump">$ 40,899<span></span>
</td>
<td class="nump">$ 20,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits', window );">Net Income - Common stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net Income - Diluted EPS</a></td>
<td class="nump">$ 40,899<span></span>
</td>
<td class="nump">$ 20,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic EPS (in dollars per share)</a></td>
<td class="nump">$ 5.66<span></span>
</td>
<td class="nump">$ 3.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted EPS (in dollars per share)</a></td>
<td class="nump">$ 5.13<span></span>
</td>
<td class="nump">$ 2.63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of stock options or restrictive stock units (RSUs).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289856046624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289767423056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Reportable Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 56,294<span></span>
</td>
<td class="nump">$ 68,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">4,759<span></span>
</td>
<td class="nump">6,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,792<span></span>
</td>
<td class="nump">5,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="nump">12,732<span></span>
</td>
<td class="nump">14,290<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">20,933<span></span>
</td>
<td class="nump">22,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest income, net</a></td>
<td class="nump">1,877<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ImpairmentLossesInvestments', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(337)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment', window );">Change in fair value of notes held for investment</a></td>
<td class="nump">128<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating', window );">Change in fair value of digital assets</a></td>
<td class="nump">24,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax income</a></td>
<td class="nump">47,884<span></span>
</td>
<td class="nump">24,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">6,985<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">40,899<span></span>
</td>
<td class="nump">20,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=smlr_SingleReportableSegmentMember', window );">Single reportable operating segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">56,294<span></span>
</td>
<td class="nump">68,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">4,685<span></span>
</td>
<td class="nump">6,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,709<span></span>
</td>
<td class="nump">5,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Sales</a></td>
<td class="nump">5,895<span></span>
</td>
<td class="nump">7,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDevelopment', window );">Sales operations</a></td>
<td class="nump">2,946<span></span>
</td>
<td class="nump">3,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="nump">12,651<span></span>
</td>
<td class="nump">14,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other Segment expenses</a></td>
<td class="nump">$ 4,192<span></span>
</td>
<td class="nump">$ 7,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemCompositionDescription', window );">Segment Reporting, Other Segment Item, Composition, Description</a></td>
<td class="text">Other segment expenses include marketing, customer education, business development, and strategic streamlining.<span></span>
</td>
<td class="text">Other segment expenses include marketing, customer education, business development, and strategic streamlining.<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 20,933<span></span>
</td>
<td class="nump">$ 22,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest income, net</a></td>
<td class="nump">1,877<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ImpairmentLossesInvestments', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(337)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment', window );">Change in fair value of notes held for investment</a></td>
<td class="nump">128<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating', window );">Change in fair value of digital assets</a></td>
<td class="nump">24,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_OtherCorporateIncomeExpense', window );">Other corporate income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax income</a></td>
<td class="nump">47,884<span></span>
</td>
<td class="nump">24,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">6,985<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 40,899<span></span>
</td>
<td class="nump">$ 20,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_FairValueAdjustmentOfNotesHeldForInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair adjustments in notes held for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_FairValueAdjustmentOfNotesHeldForInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ImpairmentLossesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earning or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ImpairmentLossesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_OtherCorporateIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other corporate income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_OtherCorporateIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetUnrealizedGainLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetUnrealizedGainLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemCompositionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of composition of other segment item not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemCompositionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=smlr_SingleReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=smlr_SingleReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46289754991424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 14, 2025 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jan. 28, 2025 </div>
<div>USD ($) </div>
<div>D </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 15, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 14, 2025 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Feb. 14, 2025 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 5,372,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForAcquisitionCryptoAsset', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetCost', window );">Crypto Asset, Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetNumberOfUnits', window );">Crypto assets number of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember', window );">Secured convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="nump">$ 4,372,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember', window );">Monarch | Secured convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_CryptoAssetNumberOfUnitsPurchased', window );">Number of crypto asset units purchased | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForAcquisitionCryptoAsset', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetCost', window );">Crypto Asset, Cost</a></td>
<td class="nump">$ 280,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_CryptoAssetAveragePurchasePrice', window );">Average purchase price per bitcoin</a></td>
<td class="nump">87,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,532<span></span>
</td>
<td class="nump">101,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetNumberOfUnits', window );">Crypto assets number of assets | item</a></td>
<td class="nump">3,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_CryptoAssetMarketPricePerCryptoAsset', window );">Market price</a></td>
<td class="nump">$ 97,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 4.25% Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised', window );">Additional principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Trading days | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion price trading day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleThresholdBusinessDays', window );">Business days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod', window );">After consecutive trading day | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays', window );">Failure business days | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays', window );">fundamental notice of default business days | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays', window );">Notice of a specified corporate transaction | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (In percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage', window );">Fundamental change repurchase price (In Percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage', window );">Minimum aggregate principal amount (In percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod', window );">Default period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees', window );">Post Written Notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod', window );">Default not cured indebtedness not paid after written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts', window );">Conversion rate for common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.0826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion', window );">Debt Instrument, Convertible, Maximum Shares Issuable Upon Conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,635,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate', window );">Principal amount on conversion rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger', window );">Trading day of the measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice', window );">Premium conversion price over the last reported sale price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount', window );">Minimum Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Maximum | 4.25% Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts', window );">Conversion rate for common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.3532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Monarch | Secured convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount', window );">Repaid amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total notes held for investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smlr_DebtSecurityInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_CryptoAssetAveragePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average purchase price per bitcoin.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_CryptoAssetAveragePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_CryptoAssetMarketPricePerCryptoAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market price per crypto asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_CryptoAssetMarketPricePerCryptoAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_CryptoAssetNumberOfUnitsPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of crypto asset units purchased during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_CryptoAssetNumberOfUnitsPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Base principal amount used for computing the conversion rate of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of premium on computation of conversion price over the last reported sale price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of business days over which the fundamental notice of default has not been issued by the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which the company is in default of payments of principal and interest when due and payable or failure to comply with the acceleration clause that is a part of the debt instrument, expressed in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of principal amount of convertible debt which has been in default with principal, interest, covenants that existed and against which the indebtedness exists or shall be created.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which the default of interest payment continues for a convertible debt instrument, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which the company fails to comply with other agreements in the indenture after written notice from the trustees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of business days over which the default on conversion of debt instrument upon exercise by the holder continues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of outstanding debt holders sending written notice of default of compliance with agreements in indenture to company in pursuant to the convertible debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of business days over which the fundamental notice of default has not been issued by the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares issuable upon conversion of convertible debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleThresholdBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified business days that trading price per base principal amount must be below the threshold percentage within a specified consecutive trading period or measurement period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleThresholdBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of consecutive trading days or measurement period in which the trading price per base principal amount must be below the threshold percentage for specified number of business days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of trading price on the product of stock price and conversion price of convertible debt instrument to determine the eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer that has undergone fundamental change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum additional face amount of debt instrument at issuance upon exercise in full of the initial purchaser option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity per base principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_DebtSecurityInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_DebtSecurityInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity of debt securities, partial amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smlr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetNumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetNumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-5<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForAcquisitionCryptoAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForAcquisitionCryptoAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=smlr_SecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=smlr_MonarchMedicalTechnologyLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=smlr_ConvertibleSeniorNote4.25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=smlr_ConvertibleSeniorNote4.25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>115
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MF+U=,>HQD7X!/G_B7.XVT@/L?PER^1]02P,$%     @ !81<6B/#!41F!@
M5AP  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX;6RU66EOXS80_2N$&[2[
M@!*+U)UU#&0=%%V@1Y#LMI\9B;:)E467I'/TUY>4%,D6*<9)TP^)=<P,W^,Q
M;TC-'AC_+M:$2/"X*2MQ,5E+N3V?3D6^)ALLSMB65.K-DO$-ENJ6KZ9BRPDN
M:J=-.46^'T\WF%:3^:Q^=LWG,[:3):W(-0=BM]E@_O29E.SA8@(GSP]NZ&HM
M]8/I?+;%*W)+Y+?M-5=WTRY*03>D$I15@)/EQ>02GB^"4#O4%G]2\B#VKH&F
M<L?8=WWSI;B8^!H1*4DN=0BL?N[)@I2ECJ1P_-T&G71M:L?]Z^?H/]?D%9D[
M+,B"E7_10JXO)ND$%&2)=Z6\80^_D)90I./EK!3U?_#0VOH3D.^$9)O662'8
MT*KYQ8]M1^PYP'#$ ;4.Z%B'H'4(:J(-LIK6%99X/N/L 7!MK:+IB[IO:F_%
MAE9Z&&\E5V^I\I/SS[C$54[ K8X@P"GX=GL%/IQ\!"> 5N#KFNT$K@HQFTK5
MF':9YFW@STU@-!+XBN1G(( >0#X*+>Z+X]V#0_>IHMCQ1!U/5,<+1N(M=IR3
M2H)+(13/<QN?)D!H#Z"7T[G8XIQ<3-1Z$83?D\G\QQ]@['^RL7NG8 =<@XYK
MX(H^7V"Q!FK40*XOR-\[>H]+1=XZBDVHJ ZEU_S]/$UA-IO>[[,QC:)$)8K.
MZ@!FV,$,G3!OB)"<YI(T0&W@F@#Q7KLP" ;8;#;(CBSJD$5.9%\Y+HC*,#G;
MJ5Y3V2HGJ@OO2N*!2F56M@2X5/FO7C@JDX*<DX)*4#(UN81^?0*SK!Z!$Y0F
MG@H@MJ3.5^63C69D4 B#)!WP-(UBB"([T;@C&CN)WJX9EZ>2\ VHF%38UZ0L
M:DJTNE?#H_*UM &.+5CVID,#V-GT&Y= TA%+G,2^*/B59/RI'C$;A<2@$$3#
M+C=MPG"DQ],.6.H$=LW)%M,"D$<EQ'JVZ%G"Y)JH6=2F*%RG*!OFU,"#,J/;
M+49^.+(@L@YUYEX03.+R"("9V3:*TV&WFE9QE(6A'2+T>R7SG2";U%[/WI(H
M91\=^C;.0<H(T3"O6*P02D>&'^[I+7QA J@2C,NG>N!U;M[J13:.%9IS,$V&
M4$TCE9Y'D/:*"9TB-?^55:LF-_3)P%X((*/Y"*(A1K?1(<9>Z:!;ZGY_3=9R
MQWJMPK?1#@@%R1BC7A2A6Q6_5!)7*ZK$!A1T1?6Z&U]OT!0_!,/8T$AWFV_,
MQ;"74^C6TS_J_%:QZO3E% )-G=M;="T=TP8E8_.]UT+H%L,KLB0*70$D?G0!
M?"==:ZF84HJR>&P6]?('W?K7)&P'"5/:4)"E:)BJ+79)ZL=C6;!709@>58Z7
M%-_1DDI*[#4Y=*KIJSO[G:(=DNY%%+I5]/*YH-SB)UU-6@F;X@C#H<1;C$)_
M9,Z@7C_1"_J9YWQ'^M+$ND<R13&"R3#=6*S":!1@+YW(+9W= N5$57<[:_\A
MBQ0FX1"?:03AF&"BO2VF6S";-"?ZFGIO=ENQFI*HRJ4A5M,()O$(U%XWD5LW
M#PNZEW":2A<'T!ATB]7H'A'U>HA"9Z;HJY"7<@5Z)Y%KZ?P?DHEZR41NR3P0
MHV?FULTCLHEA/)1,=W-OI=-K*W)K:[,T2MM86CF]J\8B4V/'J@74*RPZ1F&/
M9V017,LH6>1V#&FOM<B]Y5RPS88VU7MS*L0J2:L5J7*%%7S0)32 X4<KZC<(
M)K .P7\/=,B^%UV4.?/'K63Y]S4K"\+%3_6&2S[9TX=3O%\]Y]XIVN$!8*_E
M@5O+]9BS"@A-W@,G_IGO0U5V<'"/RQWY!"+?\_WZ3^D5YOH<8B>5<-%_2/$)
M9%Z2^%[FI_5\23P_R[PPA,^F5 A5)WCUR\R+HM@+T[B^B[TTC3P?9L^F;">%
MVL\4:KZ!#Y*K;?F./W4OET#M5KP0H=JYO?[X\GE98-87QHFE:9+8%U+0UQ^!
MN_ZX+ JJOSVH=:_/<$YI!7*\U5LT*TA+D1'X?F @M14CV=A!0]!7(X&[&KDA
M$JM'JI[#O%+];S_]M507OI_XP]V[Q2[*4C\8 ;EW4GU,'2(L:]2*UBPQ4. G
MT; ^MM@E,,G&NK2O10+WWKS-^7VFK^?MT>A#XQ3=NN>RV-GV7-.]CS[ZB]MO
MF*]H)4!)ELK//TM4 -Y\Q&IN)-O6WX'NF)1L4U^N"5:HM8%ZOV1*"=H;_6FI
M^Y0X_Q=02P,$%     @ !81<6ELXY/79 @  G0@  !@   !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6RMEEMOVC 8AO^*E553*W7D0$YT$*FEFK:+2:BTV[6;
M?!"K3IS9#K3[];.=$'$(A4KC FSG>U\_;[#CC->,OX@<0*+7@I9B8N525C>V
M+=(<"BP&K()275DP7F"INGQIBXH#SHRHH+;G.*%=8%):R=B,S7@R9K6DI(09
M1Z(N"LS?[H"R]<1RK<W  UGF4@_8R;C"2YB#?*IF7/7LSB4C!92"L!)Q6$RL
M6_=F&NMZ4_"+P%ILM9%.\LS8B^[\R":6HX& 0BJU U8_*Y@"I=I(8?QI/:UN
M2BW<;F_<OYGL*LLS%C!E]#?)9#ZQ8@MEL, UE0]L_1W:/('V2QD5YANMF]H@
MM%!:"\F*5JP("E(VO_BUO0]; M<_(O!:@7>N8-@*AB9H0V9BW6.)DS%G:\1U
MM7+3#7-OC%JE(:7^%^>2JZM$Z61RARDN4T!S[2#0Y0QS*&4.DJ287J$OZ&E^
MCRXOKM %(B5ZS%DM<)F)L2W5Y-K"3MN)[IJ)O",3W4,Z0$/W&GF.Y_?(I^?+
MA[MR6T7N<GM=;L_X#<_*W1>GT?O]>KVY;D2%4YA8:O<(X"NPDL^?W-#YVA?N
M/YGM1!UV48?ON2>W5&U5$U9M>I1RR(A$E D!O;D;L\"8Z6? *G%'H[&]VHYS
M6./%45>S0^EWE/Z[E%-6%&I;JP6?OERC"G.TPK0&=*F67<8HQ5R@"M3S)U<K
M]*H/O/&/MJ"<@>.X>^BGJG;@@PX^^ "\010(US)GG/R%S(1H1GO)&_-PBREP
MFL\>_!F%._QAQQ]^G)\(49]F#P^01E'DC)QX#_VP3E6-?/_(G8\Z\NCCY.JT
M$E(]IDBY/(4?'>('0>C'X1[^85T8QX'CCOKQXPX_?A?_49V\HN9O38 -_PGF
M^(#%<WW?\_:03Y8UQ/;6X:$/[I^8+TDI$(6%$CJ#2"TZWAR&34>RRIPGSTRJ
MT\DT<_7^ %P7J.L+QN2FHX^H[HTD^0=02P,$%     @ !81<6@R<Q@(L!0
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MUQN6E[22M%<\2%]B#HJVP+KK$SC=607JJY@953E:OP2;#9,_Y<J5YE((UBL
MJ"\"BK8 18NP;MH0RPWLCN]XLIDJ0^MY8&-1/63;VKVBN"=]6S/;Z$R[VDEC
M' 9N=[3KS=PPL+04]G0?^T?EAYK"UCC 9N?@#.NO/YUZS>Q;8>@XN)M44',
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MW6Q_(/BF?CWJ,Q>"K^N/*T835E0-Y._WG(N7@^J-J\-+?[/_ %!+ P04
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M#139Q!K783IL^@V* AGJ16]0[VME;LA+4UDB!]\B:Y]T686X:18-XR(_XRJ
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M X6E: U]=<<_L??S(?))9T+ZA6-7.U]D(-M KN[!K*#6MGN*ESZ',\#5[!>
MH@<427>W45)Y+TAL5MX=P<=J9HLOR6I"LSAMXZ$\D>=5S3C:?*L0[ES="'M:
MY<2$<3J7/?BV Q>_ ,\+^.(L50'^L K5:X*<E8QRBD'.;7&1\1[E%!;S"12S
M8GF!;S':6R2^Q?^SUX&7;X/C]W =&B%QG?&%#^@/F&W>OYM_G-U<D+8<I2TO
ML?^7M,O@^13.\/"$M4$/3U*C)5UJ"9\M!_D;<<W[=U=%,;OI2]-H?O,[Z  "
M9(]7>.#/L]%V#\(JOE_^&2F."&5EG7'[$S3>J5922!4Q#"TQ %6"0(2@ X'F
MQ>[*H@^@+>!!F%;00$O<-=) 5MY9%JET0/ZBPBLS4>'\TTV 1A"[096P#_=;
MD :%YW&O9 )_M<*2>#!N C43M7Q((#RAU\+ SCBGH.2N$Z7$)/"%%=2:=-3M
M0&@UK"@M]M:Q"7 E/&[O7Z<K3'!<><! R=9.DW3\C+HJ<4 0RC51Z+@04A:-
MU['1)=\L[@3])8IY(4UA&[,$[J^^BV77!C[F$"9)T[![RP&!%*%*7D(D/W(3
MBT\.0B*J *5W->"/5M,IJ5*X(RBU%58R<>=6RK9N#6<ZR'P[]0J%H4IRT.>'
M'YQI8Q<-H\AX@3J3J%P=MZ+!BK,<?^GX*DRBQ(-6Z=#/++!$M&)GXKRF**]I
M?6@Q,0XI!F(RW)^F;WUL^5G+X^NV3XV=<W*MI:[[C;/C?\>V:YG_EG=_/%^$
MWVMV9K!DZ&SZZ4,&OFOFW8!<DQKHSA'?[?3**2GTL8#72^=H&,0-QG_4S4]0
M2P,$%     @ !81<6E07M$B2&   "$L  !@   !X;"]W;W)K<VAE971S+W-H
M965T."YX;6S57/MOV\:R_E<(GYS>!*!EV8[MI$D#.*]S<I&T09ST_KPB5](V
M%*ER23_ZU]]O9O9%BG+2WHL"!PAB6R1W9N?YS>Q0SV^:]JM=:]UEMYNJMC\=
MK+MN^^/1D2W6>J/LK-GJ&E>63;M1'?YL5T=VVVI5\D.;ZNAD/C\_VBA3'[QX
MSI]];%\\;_JN,K7^V&:VWVQ4>_=25\W-3P?'!_Z#3V:U[NB#HQ?/MVJEKW3W
M9?NQQ5]'8972;'1M35-GK5[^='!Y_./+QW0_W_"KT3<V^3VCG2R:YBO]\:[\
MZ6!.#.E*%QVMH/#C6K_2544+@8W?W9H'@20]F/[N5W_+>\=>%LKJ5TWU/Z;L
MUC\=/#G(2KU4?=5]:F[^K=U^SFB]HJDL_Y_=R+UG%P=9T=NNV;B'P<'&U/)3
MW3HY) \\F>]YX,0]<,)\"R'F\K7JU(OG;7.3M70W5J-?>*O\-)@S-2GEJFMQ
MU>"Y[L65*"-KEMF56=5F:0I5=]EE431]W9EZE7UL*E,8;3-5E]D;VQF(0MOG
M1QVHTQI'A:/T4BB=[*%T?))]:.IN;;,W=:G+X0)'8#OP?N)Y?WER[XJO=3'+
M3H_S[&1^\OB>]4Z#+$YYO=._019"Z?$T)?*T'^U6%?JG [B2U>VU/GCQPS^.
MS^?/[MG'X["/Q_>M_O^ZC_LIG<RROTHL>ZFLL1G"2O:11%!WBMWT\UIGKYK-
M5M5W/_SCR<GQQ3/<9&I5%T95F<5=&C&AD]44J/"M1*=N:%G5Z@PRW>)GF9F:
M;VE+/*[A6=V:_W:,;5N#5;<5GEKI6K>JJN[HNMYV\FP'7K[4AOZZZIAI[/)R
MHUOL,7M([)W,GWV97<VR?UU>?N2_CY\]FF5?K*8[XUYI4\*4;!(7:>T!^Y.;
M!!-%4U/L-=V=;"#00TS\O3>0'>)!C0!*3V1=@[^^ZJS0;8>0G.G  \O+(OAN
MB04+!E27J>42X5&8V9!<>(NX33L)5T8M3&4ZTA\VT+001IZ5QA958WLBKA:(
M]<0ER918V/.T$C(EF/'[G]IRS@]Z4BE7K;[6=>]VHF^1EJP.MU>*[D[Y*ON6
MQ$IT9#56.737E+.!J4*_&XNLM/B-1='@UV*=" Y&4O4E!%0A@[$AD=$6L"_3
M9:#&7%RKJ@^Z);UL61WXN])(&CEX*!K0E%0$EC?X&'S*74N$^K9EX>$2DHIN
MQ7QA'SKKU.V0A&PYKH?G37T-CJ-G&/A3O3*+2J?Z&'!)C]1=T][-R#YALOMM
MA9R*<E])&XK6%AQT@4='C__6ERNZ9Y9]B-;9ZE5?J19NIH45$B]XVT^YMZ2V
MM4$B)*^K6/&MT:0&NK>!?MMLB>3>M/99MFYN8"5M3MF^Q]TP!*1G"_/L*S(/
MF#L0250^.%FVS8:L)!7 #"$(%.HN^NLKT?<G8[]FM._YZ;/L;;!?4]NN[47\
M[%A;!"-X!(>48%HQM)&9%2D)MG!G4RW10'!"7#5X'/<A4HJ5*+O.^7^V,<A0
M7 ;;[" ><@&Y96&ZHC%U[L,=.6^A\0 ;!.0&LC#IK;JC3^PL#;L983D*'J(;
MID:/N#6MA*&-^@U>L!Q(P'2]LQ=QX9X8<H\)Q79(*A@0$W$;95$L5/T5CK!M
M+/&PUM >DZ7/1<0Y1Q0 1.Q?WQ8:I):Z=%$<W/3D095!X'0TPT;&\H-GVR:X
M.<?750,KJMEF-TVM22;M5T#D9>^R#LETEOW2MU$LY"3,:+-<4J*4X(V_R7;A
M 4YNL$?*.=B#:<M#I 0$]FW;7)L=Z3A/$S5,*3*UEV[=-OUJ#0==->0R[IH>
MNCSIDT$E:#GA)SJ$ DJ.*",^8G8L&["#1.MS#VV00B^NBB,-*,PR(&>(06H'
M@?$KU98^+H^M('',N(@$+EV7</ \LUIG/\.W,L!)^-!4!ID%__PD&0,_8ZS<
MW5?'J<WEENAV/BYD%)=! #L!CJ&DXR5YK6Q!X2SK*' PH&C*ONB&PG.!^H^4
M2EA;5J1GW9INB82/;=_:7DEJ5ZM6ZR3*J!XR@F0+5@X8116D%;+7AI"V&)PC
M&OG@(*Z0B%UPH2Q DEDP(,,V;]9:L _M*\-GB+BD0EU..Z]J6^0:QQ?3C,JC
M5'F?K-AK:K(/V@$SQKP?=LVA;$+8XF67&K(#H*@(&$@\%?5A33B$01D4<)MG
M(<H,8<)PMF J2W-+DFC!66O8FQ[JV6I&-&B_S.<C(8Y( Q*JK4<"D+BQJU_>
M]!IV?D.;(_.U_79;$0BRBM"FLAX!>31DUP(8@$SPVY8$1,^M\5_%WMQ07*3E
M7)@J);I(6@AVY?8>?$'2/(&(6?91W0E"U.TFT$^\C/2 "'<Z!U-W<*(KO:D@
M!X3Q"H6*%78UP464T?##VL(A12\UDAGVNP*57UC",,[:/>E]??=1NE,[_;L\
MWD")*Y</8>X##I&3?0#G7]XD ?S5_M#.,6H#=V+TL@246*UA:97!3>4 -L'1
ML NZ30J%&E<-I7#$X0Y@$G$Z@E?8E!@J>PR42L$.R<'E*F4'2T,O.VEDI$ZB
M22K=MQ.R#(#8P\]0'T= F_V;*)&MO4M(R5VD9%<0K?U= XC84@)JK$X^W04Q
M-W UV;SV_&$7V1U\0>*$0:BAI0B4,?J TA;:"9<1^>BQF2\,+07E%)!<#M"U
M0UOO&5W'9V+NDRV0[[5EC ;83(.(ZLN&G"V:"AJ_N-W%[G#I;'TONJ<0>!_Z
M)8!MK?<W-EID10A$BA^NC2-F&.8&CX?APM1PDDJLA-Y5<2>K&7LO;PL'$($>
M]B+E7)9=Z;3P'(.)A:I80G*S(P(^_ X&SIB'@@4:J)N-*1+P0'A4V:8.NJ7P
M!ZODO[$##=L6E+?LV;8FU]A!]V*3&W7GJ]8=)./E#2L$LJ4?I29/(#"&I,:+
MJ<S"5@EE9*[S0NI56^0C! G8[&S*W+ 0=%YF?1U46TGLDL 'BUL18G:E]#WZ
MXN0*;2'G+@TEE EJ8K>2)5[CT\T"C/M&5[[ST2G+:OSI27:#%1X\SD\OGF1Y
M]N \/SXYXSL?G.9/GCS.N&S82E"N[O( @!^<Y//S"WKD+']Z?BZ/'.<7IV<[
MC_BZNVNF8 :"'-BYO'J5G<_/(RJ[W+>O;XJ.]G/\].DL>^UJ>W)<CD9I:>7
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M7<HJG8\R_6B;$N*$YI5OF3TET<>>]54\9J(E$ZCT_1V[: .,\[F[ 8Z':HU
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M!E$9,,ATW%:FH^#.-YN%H$^_@1HU>%H\0!6K4'EK;CL^:_14?ADS2,LMPU/
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MO "=;S3-BV[A#?2_'.L?4$L#!!0    (  6$7%H0DX&$1@(  "0%   9
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M(5$R5RM+*^F)X^$D6NP+:YI5$8.AL5F!DAC"96- XW$V?2&]6)!D"SPA@KS
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M&6WW:%F OJ^,\;L7-M#\OS#]"U!+ P04    "  &A%Q:@+XAVW0"  #"!0
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MA8,E ?Q>&.S&;D,&^G?]_!]02P,$%     @ !H1<6GTJPLSX!   %PP  !D
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M'0^/Y@.P\1H:%][4X>JW-IZZ*;R6='-'RP?H>V&,[Q8<8/>_P.H_4$L#!!0
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M\@.$[!E_$)6MS:[NK'-JRZCD-F)4U_J,UD:G#CED[2!5/8@^YGD&7@*2\+3
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MP_>V^_R9Z;@]?ZS[HD/)XYFC#8XN9J^O)BKD#V#Y!G53/CJM?4J^ELL*0*7
M&_!\X\&+_H85#%\A[_X+4$L#!!0    (  :$7%J]H!$** <  ,,0   9
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MNT,+K5GY85A;!SI%\D=B@YX%-'2JNY"A]^)!Z%0:@824V Y<Z*;&XC6Q-(D
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M+7@F-!'@_5(IVS[0!MV7_XO_ 5!+ P04    "  &A%Q:1-:.*KX(  !M&0
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MJ(HVX/NUE*9Z( 'U/RRW?P)02P,$%     @ !H1<6@G7S9]R P  LPD  !D
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M=$5ER4"@\7>-V6I4LN#V\QK]?3@[SC*6CJY,^:<J_.R\-6R)@B9R6?I;L_I
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M:Q1@J:<4>A-PQ9,L$>Y UL;#>C,JBU"X-HJ..'NX1T=\1$>AILIS1*%>'CE
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MP(,&V2V2 6YI4E;4Q&1?\BB=DVMBEZ9&8@0Y39GQS7M33CS+GD'K0W,&(+V
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MP&6P.]7@D7$HQ/<$'$&W%\JM.B5WO<?&Q#N;QGK9=%02EQ[&?.[BT<M.LN?
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MV=#'M<*W6>$-<'UI !V[+T@@O!3VU?\"4$L#!!0    (  :$7%IS5QI%O@(
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M1^T<Z#U7RNX-%Z#_UTA^ U!+ P04    "  &A%Q:M"?*$5T"  "\!0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6RM5&UOVC 0_BN6.U5%0B1QH*44
M(D&[J9-6";5[^6R2@T3U2V8[I?OW.SN0TJU%FK0OL<^^>^XY7YZ;;K5YM"6
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MT+A[-:#$-).D,9RN@GH7VN$L"-L2AR\8[X#W2ZW=UO )VG&>_0%02P,$%
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MH<F-@K"MW.Q%XP/<^5)KVAG^@FZ:9[\!4$L#!!0    (  :$7%JM(Y-I. 0
M !80   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;,58ZV_:.A3_5ZRL
MG3:)0AY :0=(I7M5NIVJMMO];)(38M6QF>U ^>_OL0,I4,AZU<>^$+_.[[R/
M?>C/I;K3&8 A]SD7>N!EQDQ/6RT=9Y!3W913$+B32I53@U,U:>FI IHXHIRW
M0M_OMG+*A#?LN[4K->S+PG FX$H17>0Y58L1<#D?>(&W6KAFD\S8A=:P/Z43
MN 'S<WJE<-:J4!*6@]!,"J(@'7AGP>FH:\^[ [\8S/7:F%A-QE+>V<E%,O!\
M*Q!PB(U%H/B9P3EP;H%0C-]+3*]B:0G7QROTKTYWU&5,-9Q+_B]+3#;P>AY)
M(*4%-]=R_AV6^G0L7BRY=K]D7IX]CCP2%]K(?$F,$N1,E%]ZO[3#&D'/WT,0
M+@E")W?)R$GYF1HZ["LY)\J>1C0[<*HZ:A2.">N4&Z-PER&=&7ZE3)%?E!=
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M$*+ 0672JYPG1XEW4)R3-!Z1)$K&1WCID'7J>>EGL]Z7;(L:[T>Y1W-E:EK
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MT<$1I9VN'P+UP*K*7[YS9>DJ]]V"WDZHG0/-+Y2RZX%;H'V-37\"4$L#!!0
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M4LG%:(B1;E=)JUA5A_%=*>N601!+MWU!^P#G7RME.\5?T._S[#=02P,$%
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M970T,RYX;6RM6-MRVS80_16,<JDTHTJ\B!?YHIG83MITFM83.^TS1*XD3$A
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MJU8;R3%N%N5.2_S*4$\O/O)$Y$#NZ3=09'A/EQFHT<54([01F"85S%4)XYV
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M    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;,U5WV^;,!#^5RPZ59N$ IA
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MX)0'90/P_5I*\[2Q@Z3_;J3_ %!+ P04    "  &A%Q:+5'@MND"  #X!P
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MY2;GNNA&>U0N_.'5#M\.HR :=A,>M(0'1PD_"8TL=RG:9W%NBDFE@%#=E#_
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M+!7,KBVN^E;J R,;?QJWTMBS[8>5O7U N02[OI/2' -WP,?[+'\!4$L#!!0
M   (  :$7%I,<6?_6P(  %X&   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;*U5:V^;,!3]*Q:KIE9J"P'R6$:0UF35)FU2U*S;9P=N@E6#J6V2]M_O
MVA"6I*3JIGT!/^XY/N?:OHZV0CZH#$"3IYP7:N)D6I=CUU5)!CE5UZ*$ F=6
M0N948U>N755*H*D%Y=SU/6_@YI053AS9L;F,(U%IS@J82Z*J/*?R^0:XV$Z<
MGK,;N&/K3)L!-XY*NH8%Z/MR+K'GMBPIRZ%03!1$PFKB?.J-IWT3;P-^,MBJ
MO38Q3I9"/)C.UW3B>$80<$BT8:#XV\ 4.#=$*..QX73:)0UPO[UCO[7>T<N2
M*I@*_HNE.ILX(X>DL*(5UW=B^P4:/U9@(KBR7[*M8P>!0Y)*:9$W8%20LZ+^
MTZ<F#WN 7G@"X#< _ZV H $$UFBMS-J:44WC2(HMD28:V4S#YL:BT0TKS"XN
MM,19AC@=SR4>"*F?"2U2\OFQ8B5ND;XD!1Z@\QEHRKBZ(%?D?C$CYV<7Y(RP
M@OS(1*40H")7HP;#Y";->C?U>OZ)]6:07).@=TE\SP\[X-.WPX-#N(O.6_M^
M:]^W?,'?V^_R5I.%W63FPHU521.8.'BC%,@-./'[=[V!]['+Z7\B._ =M+Z#
MU]@/?<,?WVLI5.>NUG1]2V<JPR;NA8-AY&[V'74$]<.P#3I0&K9*PU>5?@.E
MQGC;DRJO.-60XB7%A"2,FC+0);7F&^RIN/HP\HZD=@2-_!-2^ZW4_C\E]<1A
MZK_(5C@ZSNC+F*'O':ET]VZ_J;S?J5RS0A$.*T1YUT.$R[J:U1TM2EL0ED)C
M>;'-#!\ D"8 YU="Z%W'U)CV28E_ U!+ P04    "  &A%Q:!8O(XU<"  #
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M;N?!64!R6-.2VVNU_P/J>,:.+U/<^$^RKVVC@&2EL4K48/1 ,%E]T]M:AP/
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M!*X%DAEC1#R=0<Q7$PM;SP<W=!$I<V#[XY0LX!;4]_1:Z)U=HH2402(I3Y"
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M*RD-8KA6TI8&/LH,L^< (=6G*U+\6*1%?!!QB>DI# ?O(([B$=S=+N'XZ.0
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MK2S--K\LZ6."VCG0>:ZHIJWA"+K/4_(74$L#!!0    (  :$7%K_AO.IM 8
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MCLO4O:R>D"ZJ_K'0Y+I1-<Q=^T?C ]S^4FO:3;Q \X>2_ %02P,$%     @
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M]$Y8T H++@H[[L(*'_JWH(9'G:0C9W0B[#S&'8W<?F%A*RR\*.R9B$25%5R
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M+,^Q.D4TA!'8+4("2EE0:N9-%YJRZ)$5K[9!=NNU=5^JU;&EY]D#3S5 43=
MG1SXIHM$=WNM?9\#PZC&, J[;4A!H0M*S32OH8L";QM2Z[:AY]>W4]SMGNKK
MX 8J-T]]3C<LD\7]1Y]X'$;IPA[^S\IHNHCRV(?1(I)!C(+\SA[[K5>@"UY0
M:N8(:9RCL+N(%)37H-1,\YK7J'OMK,3MKW-T)_@F"ID3N*GE%JYZW,^!8%0C
M&'4CV"_'77VW'PGTU0[L[BZT#L Y%L>H9D *NP5)02$/2LTTKR&/'EEI:SWI
MCRP@_FK&/P>\^1K>?#>\@9X"W^RH[^Y"VQ1 J9D#IJG0A]V^]$&A#TK--*^A
MSP?>OBSUS%.@?L'J;K2MJ>[!4PH)$XOBX8T,%;2^N^^_^K1Z0.2Z>"RB]OF-
M=SG=/>:A979/G7P)Q")*,Q2SN9+L70S4S[+8/<BQ>R/YJG@6XHE+R9/BY9(%
MZA3)"ZCOYYS+_9N\@>IQFLE_4$L#!!0    (  :$7%JLI4.#T@(  #4)   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;*V6;V_:,!#&OXJ555,KK0T$
M HA!I!54;5*G5?VSO3;)0:PZ=FH[0+_]S@YD%-(4H;TA=N+G[G[WX#BCE53/
M.@4P9)UQH<=>:DP^]'T=IY!1?25S$/AD+E5&#4[5PM>Y IHX4<;]H-7J^1EE
MPHM&[MZ=BD:R,)P)N%-$%UE&U>LU<+D:>VUO>^.>+5)C;_C1**<+> #SE-\I
MG/E5E(1E(#23@BB8C[UO[>%D8->[!;\9K/3.F%B2F93/=O(C&7LM6Q!PB(V-
M0/&RA EP;@-A&2^;F%Z5T@IWQ]OH-XX=6694PT3R/RPQZ=@;>"2!.2VXN9>K
M[[#A"6V\6'+M?LFJ7-L//1(7VLAL(\8*,B;**UUO^K C:'??$00;07"LH+,1
M=!QH69G#FE)#HY&2*Z+L:HQF!ZXW3HTT3%@7'XS"IPQU)KH%[($FE^2F,(4"
MFX)E188&"4,YR>DK6F8T.9^"H8SK"USZ]# EYV<7Y(PP01Y366@J$CWR#=9C
MH_KQ)O=UF3MX)_<4XBO2:7\A02OHUL@GQ\L[;^4^=J%J15"U(G#Q.N_$^Z #
M"EX*IB AA4A $=Q'BAHF%H2[%M;AE_FZ]?GL_ASJG,8P]G #:E!+\*+/G]J]
MUM>Z9ORG8&]:TZE:TVF*'F&'PSK 4A4ZE7U?+*-^>^0O=\MN#'QBV=VJ[&YC
MV8_2.HA^,1W+0A@T;_[69.==Y7$=8IFAUX386,2)B&&%&#8BWH+60^(""T.6
ME!= MKAU..$!SN4^3F/"$W%Z%4[O",=*5SBC,\:98?6;JW=H3&N/I#'7B23]
MBJ3_@3&6 =9XW.(57Y2PCM$K$E.=;O]P=5C]0X/"/:S&Q"=B#2JLP1$&W?]Z
M(E1KJ"48'+P4>OL$ATO:X3_SRL+\G4/-?E#\I&K!A,8_QQQ5K2M[!*ORD"XG
M1N;NG)M)@Z>F&Z;X70/*+L#G<RG-=F*/SNI+*?H+4$L#!!0    (  :$7%I5
M!($6R0,  #$0   9    >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;*U8VV[;
M.!#]%4);+%K B2Z^)FL;2*P&W47:!DG3?5CL RV/+:(4Z9)4G/Y]>5$4VY69
M.M!++%(\AS-G1N1,QALNOLD<0*''@C(Y"7*EUN=A*+,<"BQ/^1J8?K/DHL!*
M#\4JE&L!>&%!!0V3*!J$!28LF([MW(V8CGFI*&%P(Y LBP*+'Y= ^682Q,'3
MQ"U9Y<I,A-/Q&J_@#M3]^D;H45BS+$@!3!+.D(#E)+B(S],X,0"[XBN!C=QZ
M1L:5.>??S.#OQ22(C$5 (5.& NN?!Y@!I89)V_&](@WJ/0UP^_F)_<HZKYV9
M8PDS3O\E"Y5/@E& %K#$)56W?/,!*H?ZAB_C5-J_:%.MC0*4E5+QH@)K"PK"
MW"]^K(38 B3# X"D B3[@/X!0+<"=/< <>\ H%<!>E89YXK5(<4*3\>";Y P
MJS6;>;!B6K1VGS 3]SLE]%NB<6IZ#5HTB4[0-4@)@"Z$P&P%.K)*HK<I*$RH
M?*??W]^EZ.V;=^@-(@Q]R7DI,5O(<:BT$88JS*H-+]V&R8$-XP1]Y$SE$KUG
M"UCL$H3:^MJ%Y,F%R\3+F$)VBKIQ!R51TFLP:/;[\&X#//7#_REI#8\\WG3K
M@'0M7]<;D"9=':[7C#/GP[E<XPPF@3X )(@'"*9__A$/HK^:-&F3+&V);$>O
M7JU7S\?N]$)X)< F+5(@BB;UO"S'JM<F6>KW;Q"CPGXO'JWZM59]+U=*9,9+
M+9+ "II$\L*/%:E-LM21Q9%E,Y?9PS0ZC9+^.'QH$&10"S+P"G(+YFHD;(6H
M3:-#R>-G.6N,D!/!BSQ6A);(=J0:UE(-O4Y^7IM[6B+%]77/8-,DDY]AB:EL
MRKJ9%W:L1BV1[6@TJC4:_<99!(^Z*#MPACM\?RN+1Z,ZA9T:+R])O5:\TL>S
MVL<S_R?S^1YA72JH)O?.?K%]T-]S[]<E<3_:\\]KP2O]BZ/GBBAZ(=-!GX_F
M4+#Q["!;#)_PY<F]CNZ%\;V#[I0^0NV%PY?HBC#,,H(INN&2V'KVO_>/RE3'
M<PJZT"D+2\G9_XT%TPOVJ!R$VU=VT"?.LE+H3[ I +/VJ%(_U6NCL%67QEY3
M9\ZRZF"F!,\)U=(V?U85UW96#?>2:N;?[]ACIBVV77629W62XW+TNA+H1P=5
MRK6<HR_88Q/K^CE*M1F-6>HE.SH4+;&Y4(1;O9169&5[4HELW>1ZDGJV[GLO
M;+>W-W\9G\]<]_I,XYKICUBLB+Y**2PU970ZU'DK7'_J!HJO;<<VYTKW?_8Q
MUST]"+- OU]RKIX&9H/ZOP33GU!+ P04    "  &A%Q:HNZ.!M,"  "V!P
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M7@'X%<"W1DMEUM:4:18,I=B"--'$9@8V-Q9-;A)N;G&A)>TFA-/!+5(.%'R
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MCQYN^Y;L'31M;(.M0=]4T6S\%(,- ?Y\9PR>G-!9XW^A? %02P,$%     @
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M-,XW X+E2)X5D)^O*!6[G:R"ZM6WY7]02P,$%     @ !H1<6JKG1#4+"
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M'R57=V-E)Z>/DH4OZ/LZS^E]0BCZC!Z+*45L@>0*T)RE:T+?_A!(Y(/9NIZ
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M M<!ZOF<,;F=Z VJ/C/Z!U!+ P04    "  &A%Q:SVLWTQ(#  "("0  &0
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MH@T7-*N<)4%&\O*)WJI$-!R@=\+!KASLML/PA(-3.3@ZT)),AS5' H5C1G>
M*6NII@8Z-]I;1D-R]3<N!9-OB?03X5>Y4Q[RB&88+# #RP0Q? VFB),(H#P&
M<Y)N!([!Y1P+1%)^!6[ \W(.+B^NP 4P 5<.') </.=$\&NY*,??$KKATIV/
M32$AU:?,J *:ED#V"2!H@T>:BX2#^SS&\:& *:.K0[3W(4[M7L4YC@; @=?
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ME'55'*:M>S9 >P>W7RME3X8_8'J(BA=02P,$%     @ !H1<6M(!6GD&!@
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M,(A9F@!4YP?4GA\<U@2@QFYQ/R$T2(TW :A."Z@]+; W :@A%3 T 0QBIB;
M=.>J39+4LKZ!Y'*/;0K17$UU7[M;SH_UW5[O^PV^G#=WE5I-<W7ZB57+M. H
M@X54Z5P$$E/5W$8V+Z)<UQ=Z3Z603%D_KH E4"D!^?NBE &H?5$3='?"LW\
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M8'=)%"6)&P',[2"*, 3N1AS!'( '#(DB\Q[<>1\%Z_=4T/Z'=O074$L#!!0
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M[TR@=T:],X'>>?*QDD#OC'IG KTSZIT)],ZH=R;0.Z/>F4!O1[V=0&]'O9U
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M              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ !81<6O0!!W"G!P  %3(  !@              ("!# @  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  6$7%HCPP5$9@8  %8<   8
M              " @>D/  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    "  %A%Q:6SCD]=D"  "="   &               @(&%%@  >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ !81<6@R<Q@(L!0
MG!0  !@              ("!E!D  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    (  6$7%KFCE@['@<    X   8              " @?8>
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  %A%Q:/&%3
ML#$(   @)0  &               @(%*)@  >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ !81<6AU=@^]> P  70<  !@
M ("!L2X  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  6$
M7%I4%[1(DA@   A+   8              " @44R  !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    "  %A%Q:-CM$FU\#  !^"   &
M        @($-2P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ !81<6A"3@81& @  ) 4  !D              ("!HDX  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  %A%Q::1?X2:4"  ""!@
M&0              @($?40  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    (  6$7%KY)R!DE00  (8+   9              " @?M3  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ !81<6G \_-#%
M!0  R!,  !D              ("!QU@  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    "  &A%Q:B=]1F*H&  !H$@  &0
M@('#7@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (  :$
M7%K4>.V'D00  #L,   9              " @:1E  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ !H1<6H"^(=MT @  P@4  !D
M         ("!;&H  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    "  &A%Q:/-$">&L"   &!@  &0              @($7;0  >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  :$7%K"T1^TK 0  .,+
M   9              " @;EO  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ !H1<6GTJPLSX!   %PP  !D              ("!G'0
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  &A%Q:0;@[
MIDX(  "1%   &0              @('+>0  >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    (  :$7%J]H!$** <  ,,0   9
M  " @5""  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
M!H1<6AH/2!83"   !1@  !D              ("!KXD  'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    "  &A%Q:1-:.*KX(  !M&0  &0
M            @('YD0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    (  :$7%H)U\V?<@,  +,)   9              " @>Z:  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ !H1<6G0,^PC]!0
M7!   !D              ("!EYX  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    "  &A%Q:[A[$R\@.  #]+   &0              @('+
MI   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  :$7%H%
M2=8>2@(  *(%   9              " @<JS  !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ !H1<6OL9G<F;!0  P \  !D
M     ("!2[8  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  :$7%IS5QI%O@(  $$&   9              "
M@6_D  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ !H1<
M6K0GRA%= @  O 4  !D              ("!9.<  'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    "  &A%Q:R#:/7&0"  #:!0  &0
M        @('XZ0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   (  :$7%H#'3#17@(  -D%   9              " @9/L  !X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ !H1<6JTCDVDX!   %A
M !D              ("!*.\  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    "  &A%Q:F:X9UFX"  !*!@  &0              @(&7\P
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  :$7%K:PX;Y
M4 ,  )D)   9              " @3SV  !X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ !H1<6I^K!(]K @  VP4  !D
M ("!P_D  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  &
MA%Q:,0CA0WX"  #)!0  &0              @(%E_   >&PO=V]R:W-H965T
M<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (  :$7%I:UF Q>P0  /0-   9
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M970T-BYX;6Q02P$"% ,4    "  &A%Q:QE+D2?L(   ?40  &0
M    @('J$P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (
M  :$7%I46<Z65 (  $,&   9              " @1P= 0!X;"]W;W)K<VAE
M971S+W-H965T-#@N>&UL4$L! A0#%     @ !H1<6BU1X+;I @  ^ <  !D
M             ("!IQ\! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"
M% ,4    "  &A%Q:G/XW# ,"  #;!   &0              @(''(@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (  :$7%I,<6?_6P(
M %X&   9              " @0$E 0!X;"]W;W)K<VAE971S+W-H965T-3$N
M>&UL4$L! A0#%     @ !H1<6@6+R.-7 @  P 4  !D              ("!
MDR<! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  &A%Q:
MO8<QH(0"  #L!P  &0              @($A*@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;%!+ 0(4 Q0    (  :$7%I.1ME<40,  +,,   9
M      " @=PL 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%
M  @ !H1<6I_1I8"!!0  12@  !D              ("!9# ! 'AL+W=O<FMS
M:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  &A%Q:G%$0Q.X"  !$"0
M&0              @($<-@$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+
M 0(4 Q0    (  :$7%KNQQJR-@,   X/   9              " @4$Y 0!X
M;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ !H1<6F*K\;/%
M @  J@8  !D              ("!KCP! 'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6Q02P$"% ,4    "  &A%Q:_X;SJ;0&   Q-0  &0
M@(&J/P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (  :$
M7%JKLG)8E (  %P&   9              " @95& 0!X;"]W;W)K<VAE971S
M+W-H965T-C N>&UL4$L! A0#%     @ !H1<6MU$]8.> @  0 8  !D
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M=#8U+GAM;%!+ 0(4 Q0    (  :$7%I5!($6R0,  #$0   9
M  " @4E; 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @
M!H1<6J+NC@;3 @  M@<  !D              ("!25\! 'AL+W=O<FMS:&5E
M=',O<VAE970V-RYX;6Q02P$"% ,4    "  &A%Q:9)X!3(8"  !L!@  &0
M            @(%38@$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4
M Q0    (  :$7%I6R?60^P$  ",$   9              " @1!E 0!X;"]W
M;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ !H1<6LG/G11K!@
M!C<  !D              ("!0F<! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX
M;6Q02P$"% ,4    "  &A%Q:JN=$-0L(  #<0P  &0              @('D
M;0$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (  :$7%I^
MJD;77@0  +,2   9              " @29V 0!X;"]W;W)K<VAE971S+W-H
M965T-S(N>&UL4$L! A0#%     @ !H1<6NVSK'?# P  71   !D
M     ("!NWH! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  :$7%IVK5UX\0(  ,T(   9              "
M@;V- 0!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ !H1<
M6DV-!W/D P  [0X  !D              ("!Y9 ! 'AL+W=O<FMS:&5E=',O
M<VAE970W.2YX;6Q02P$"% ,4    "  &A%Q:;@=S*#L#  "8"@  &0
M        @($ E0$ >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0
M   (  :$7%JRMT!X#@(  )0$   9              " @7*8 0!X;"]W;W)K
M<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ !H1<6M(!6GD&!@  'QX
M !D              ("!MYH! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q0
M2P$"% ,4    "  &A%Q:K+IH)JH-  "<K   &0              @('TH $
M>&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (  :$7%H'7_FM
M50,  *X5   -              "  =6N 0!X;"]S='EL97,N>&UL4$L! A0#
M%     @ !H1<6I>*NQS     $P(   L              ( !5;(! %]R96QS
M+RYR96QS4$L! A0#%     @ !H1<6F@,4&U1!@  :#8   \
M ( !/K,! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  :$7%HT3CM]>@(
M   Q   :              "  ;RY 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    (  :$7%H@< [9) (  *DO   3              "
M 6Z\ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !; %L ]!@  ,.^ 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>149</ContextCount>
  <ElementCount>426</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>62</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995200090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995200100 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/StatementBalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995200105 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/StatementBalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995200200 - Statement - Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/StatementStatementsOfIncome</Role>
      <ShortName>Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995200300 - Statement - Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity</Role>
      <ShortName>Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995200400 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/StatementStatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995210101 - Disclosure - The Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureCompany</Role>
      <ShortName>The Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995210201 - Disclosure - Summary of Significant Accounting Policies and Estimates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates</Role>
      <ShortName>Summary of Significant Accounting Policies and Estimates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995210301 - Disclosure - Assets for Lease, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAssetsForLeaseNet</Role>
      <ShortName>Assets for Lease, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995210401 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureInventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995210501 - Disclosure - Property and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995210601 - Disclosure - Long-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLongTermInvestments</Role>
      <ShortName>Long-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995210701 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995210801 - Disclosure - Notes held for investment</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureNotesHeldForInvestment</Role>
      <ShortName>Notes held for investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995210901 - Disclosure - Intangible Digital Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets</Role>
      <ShortName>Intangible Digital Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995211001 - Disclosure - Other non-current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets</Role>
      <ShortName>Other non-current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995211101 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995211201 - Disclosure - Concentration of Credit Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk</Role>
      <ShortName>Concentration of Credit Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995211301 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995211401 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995211501 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995211601 - Disclosure - Stock Option Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockOptionPlan</Role>
      <ShortName>Stock Option Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995211701 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995211801 - Disclosure - Net Income Per Share, Basic and Diluted</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted</Role>
      <ShortName>Net Income Per Share, Basic and Diluted</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995211901 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995212001 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>99920102 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies and Estimates (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>99930203 - Disclosure - Summary of Significant Accounting Policies and Estimates (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables</Role>
      <ShortName>Summary of Significant Accounting Policies and Estimates (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>99930303 - Disclosure - Assets for Lease, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables</Role>
      <ShortName>Assets for Lease, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureAssetsForLeaseNet</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>99930503 - Disclosure - Property and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>99930603 - Disclosure - Long-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables</Role>
      <ShortName>Long-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureLongTermInvestments</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>99930703 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>99930803 - Disclosure - Notes held for investment (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables</Role>
      <ShortName>Notes held for investment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureNotesHeldForInvestment</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>99930903 - Disclosure - Intangible Digital Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables</Role>
      <ShortName>Intangible Digital Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>99931103 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureAccruedExpenses</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>99931303 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureLeases</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>99931603 - Disclosure - Stock Option Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockOptionPlanTables</Role>
      <ShortName>Stock Option Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureStockOptionPlan</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>99931703 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>99931803 - Disclosure - Net Income Per Share, Basic and Diluted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables</Role>
      <ShortName>Net Income Per Share, Basic and Diluted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>99931903 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureSegmentInformation</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>99940201 - Disclosure - Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>99940202 - Disclosure - Summary of Significant Accounting Policies and Estimates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies and Estimates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>99940301 - Disclosure - Assets for Lease, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails</Role>
      <ShortName>Assets for Lease, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>99940302 - Disclosure - Assets for Lease, net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails</Role>
      <ShortName>Assets for Lease, net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>99940401 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureInventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureInventory</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>99940501 - Disclosure - Property and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>99940502 - Disclosure - Property and Equipment, net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment, net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>99940601 - Disclosure - Long-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails</Role>
      <ShortName>Long-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>99940602 - Disclosure - Long-Term Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Long-Term Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>99940701 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>99940702 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>99940703 - Disclosure - Fair Value Measurements - Valuation model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails</Role>
      <ShortName>Fair Value Measurements - Valuation model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>99940704 - Disclosure - Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails</Role>
      <ShortName>Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>99940801 - Disclosure - Notes held for investment (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails</Role>
      <ShortName>Notes held for investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>99940901 - Disclosure - Intangible Digital Assets- Intangible Assets Cost Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails</Role>
      <ShortName>Intangible Digital Assets- Intangible Assets Cost Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>99940902 - Disclosure - Intangible Digital Assets- Reconciliation of fair value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails</Role>
      <ShortName>Intangible Digital Assets- Reconciliation of fair value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>99941001 - Disclosure - Other non-current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails</Role>
      <ShortName>Other non-current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>99941101 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureAccruedExpensesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>99941201 - Disclosure - Concentration of Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails</Role>
      <ShortName>Concentration of Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>99941301 - Disclosure - Leases - Future minimum rental payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails</Role>
      <ShortName>Leases - Future minimum rental payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>99941302 - Disclosure - Leases - Lessee Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails</Role>
      <ShortName>Leases - Lessee Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>99941303 - Disclosure - Leases - Lessor Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails</Role>
      <ShortName>Leases - Lessor Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>99941304 - Disclosure - Leases - Variable-fee Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails</Role>
      <ShortName>Leases - Variable-fee Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>99941401 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureCommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>99941501 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>99941601 - Disclosure - Stock Option Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails</Role>
      <ShortName>Stock Option Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>99941602 - Disclosure - Stock Option Plan - Summary of the Company's stock option activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails</Role>
      <ShortName>Stock Option Plan - Summary of the Company's stock option activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>99941603 - Disclosure - Stock Option Plan - Weighted average assumptions used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails</Role>
      <ShortName>Stock Option Plan - Weighted average assumptions used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>99941604 - Disclosure - Stock Option Plan - Stock-based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock Option Plan - Stock-based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>99941701 - Disclosure - Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>99941702 - Disclosure - Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails</Role>
      <ShortName>Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>99941703 - Disclosure - Income Taxes - Summary of Deferred tax (liabilities) assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails</Role>
      <ShortName>Income Taxes - Summary of Deferred tax (liabilities) assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>99941704 - Disclosure - Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>99941705 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>99941801 - Disclosure - Net Income Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails</Role>
      <ShortName>Net Income Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>99941901 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureSegmentInformationTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>99941902 - Disclosure - Segment Information - Reportable Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails</Role>
      <ShortName>Segment Information - Reportable Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="smlr-20241231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>99942001 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://semlerscientific.com/role/DisclosureSubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://semlerscientific.com/role/DisclosureSubsequentEvents</ParentRole>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>smlr-20241231.xsd</File>
    <File>smlr-20241231_cal.xml</File>
    <File>smlr-20241231_def.xml</File>
    <File>smlr-20241231_lab.xml</File>
    <File>smlr-20241231_pre.xml</File>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="smlr-20241231x10k.htm">smlr-20241231x10k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>smlr-20241231x10k006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="635">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>122
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "smlr-20241231x10k.htm": {
   "nsprefix": "smlr",
   "nsuri": "http://semlerscientific.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "smlr-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "smlr-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "smlr-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "smlr-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smlr-20241231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "smlr-20241231x10k.htm"
     ]
    }
   },
   "keyStandard": 350,
   "keyCustom": 76,
   "axisStandard": 28,
   "axisCustom": 0,
   "memberStandard": 38,
   "memberCustom": 24,
   "hidden": {
    "total": 16,
    "http://fasb.org/us-gaap/2024": 13,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 149,
   "entityCount": 1,
   "segmentCount": 62,
   "elementCount": 721,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 635,
    "http://xbrl.sec.gov/dei/2024": 37,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 7,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation",
     "longName": "995200090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://semlerscientific.com/role/StatementBalanceSheets",
     "longName": "995200100 - Statement - Balance Sheets",
     "shortName": "Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical",
     "longName": "995200105 - Statement - Balance Sheets (Parenthetical)",
     "shortName": "Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://semlerscientific.com/role/StatementStatementsOfIncome",
     "longName": "995200200 - Statement - Statements of Income",
     "shortName": "Statements of Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:Revenues",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:SellingAndMarketingExpense",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity",
     "longName": "995200300 - Statement - Statements of Stockholders' Equity",
     "shortName": "Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://semlerscientific.com/role/StatementStatementsOfCashFlows",
     "longName": "995200400 - Statement - Statements of Cash Flows",
     "shortName": "Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://semlerscientific.com/role/DisclosureCompany",
     "longName": "995210101 - Disclosure - The Company",
     "shortName": "The Company",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates",
     "longName": "995210201 - Disclosure - Summary of Significant Accounting Policies and Estimates",
     "shortName": "Summary of Significant Accounting Policies and Estimates",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://semlerscientific.com/role/DisclosureAssetsForLeaseNet",
     "longName": "995210301 - Disclosure - Assets for Lease, net",
     "shortName": "Assets for Lease, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:AssetsForLeaseNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:AssetsForLeaseNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://semlerscientific.com/role/DisclosureInventory",
     "longName": "995210401 - Disclosure - Inventory",
     "shortName": "Inventory",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet",
     "longName": "995210501 - Disclosure - Property and Equipment, net",
     "shortName": "Property and Equipment, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://semlerscientific.com/role/DisclosureLongTermInvestments",
     "longName": "995210601 - Disclosure - Long-Term Investments",
     "shortName": "Long-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://semlerscientific.com/role/DisclosureFairValueMeasurements",
     "longName": "995210701 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://semlerscientific.com/role/DisclosureNotesHeldForInvestment",
     "longName": "995210801 - Disclosure - Notes held for investment",
     "shortName": "Notes held for investment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets",
     "longName": "995210901 - Disclosure - Intangible Digital Assets",
     "shortName": "Intangible Digital Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CryptoAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CryptoAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets",
     "longName": "995211001 - Disclosure - Other non-current assets",
     "shortName": "Other non-current assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:OtherNoncurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:OtherNoncurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://semlerscientific.com/role/DisclosureAccruedExpenses",
     "longName": "995211101 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk",
     "longName": "995211201 - Disclosure - Concentration of Credit Risk",
     "shortName": "Concentration of Credit Risk",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://semlerscientific.com/role/DisclosureLeases",
     "longName": "995211301 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:LeaseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:LeaseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies",
     "longName": "995211401 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://semlerscientific.com/role/DisclosureStockholdersEquity",
     "longName": "995211501 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://semlerscientific.com/role/DisclosureStockOptionPlan",
     "longName": "995211601 - Disclosure - Stock Option Plan",
     "shortName": "Stock Option Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxes",
     "longName": "995211701 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted",
     "longName": "995211801 - Disclosure - Net Income Per Share, Basic and Diluted",
     "shortName": "Net Income Per Share, Basic and Diluted",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://semlerscientific.com/role/DisclosureSegmentInformation",
     "longName": "995211901 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://semlerscientific.com/role/DisclosureSubsequentEvents",
     "longName": "995212001 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R28": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies",
     "longName": "99920102 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies)",
     "shortName": "Summary of Significant Accounting Policies and Estimates (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "32",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables",
     "longName": "99930203 - Disclosure - Summary of Significant Accounting Policies and Estimates (Tables)",
     "shortName": "Summary of Significant Accounting Policies and Estimates (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables",
     "longName": "99930303 - Disclosure - Assets for Lease, net (Tables)",
     "shortName": "Assets for Lease, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:ScheduleOfAssetsForLeaseNetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "smlr:AssetsForLeaseNetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:ScheduleOfAssetsForLeaseNetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "smlr:AssetsForLeaseNetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables",
     "longName": "99930503 - Disclosure - Property and Equipment, net (Tables)",
     "shortName": "Property and Equipment, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables",
     "longName": "99930603 - Disclosure - Long-Term Investments (Tables)",
     "shortName": "Long-Term Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables",
     "longName": "99930703 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables",
     "longName": "99930803 - Disclosure - Notes held for investment (Tables)",
     "shortName": "Notes held for investment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinancingReceivablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinancingReceivablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables",
     "longName": "99930903 - Disclosure - Intangible Digital Assets (Tables)",
     "shortName": "Intangible Digital Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CryptoAssetHoldingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CryptoAssetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CryptoAssetHoldingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CryptoAssetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://semlerscientific.com/role/DisclosureAccruedExpensesTables",
     "longName": "99931103 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://semlerscientific.com/role/DisclosureLeasesTables",
     "longName": "99931303 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "smlr:LeaseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "smlr:LeaseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://semlerscientific.com/role/DisclosureStockOptionPlanTables",
     "longName": "99931603 - Disclosure - Stock Option Plan (Tables)",
     "shortName": "Stock Option Plan (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxesTables",
     "longName": "99931703 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables",
     "longName": "99931803 - Disclosure - Net Income Per Share, Basic and Diluted (Tables)",
     "shortName": "Net Income Per Share, Basic and Diluted (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://semlerscientific.com/role/DisclosureSegmentInformationTables",
     "longName": "99931903 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails",
     "longName": "99940201 - Disclosure - Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details)",
     "shortName": "Summary of Significant Accounting Policies and Estimates - Accounts Receivable and Allowance for Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails",
     "longName": "99940202 - Disclosure - Summary of Significant Accounting Policies and Estimates (Details)",
     "shortName": "Summary of Significant Accounting Policies and Estimates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "smlr:DebtSecurityFaceValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails",
     "longName": "99940301 - Disclosure - Assets for Lease, net (Details)",
     "shortName": "Assets for Lease, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "smlr:ScheduleOfAssetsForLeaseNetTableTextBlock",
       "smlr:AssetsForLeaseNetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "smlr:ScheduleOfAssetsForLeaseNetTableTextBlock",
       "smlr:AssetsForLeaseNetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails",
     "longName": "99940302 - Disclosure - Assets for Lease, net - Additional Information (Details)",
     "shortName": "Assets for Lease, net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "smlr:AssetsForLeaseNetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "smlr:AssetsForLeaseNetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://semlerscientific.com/role/DisclosureInventoryDetails",
     "longName": "99940401 - Disclosure - Inventory (Details)",
     "shortName": "Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:InventoryNet",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R51": {
     "role": "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails",
     "longName": "99940501 - Disclosure - Property and Equipment, net (Details)",
     "shortName": "Property and Equipment, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails",
     "longName": "99940502 - Disclosure - Property and Equipment, net - Additional Information (Details)",
     "shortName": "Property and Equipment, net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails",
     "longName": "99940601 - Disclosure - Long-Term Investments (Details)",
     "shortName": "Long-Term Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:LongTermInvestments",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R54": {
     "role": "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
     "longName": "99940602 - Disclosure - Long-Term Investments - Additional Information (Details)",
     "shortName": "Long-Term Investments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails",
     "longName": "99940701 - Disclosure - Fair Value Measurements (Details)",
     "shortName": "Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_G3Anxea5Bk2Jp-whqZzF4Q",
      "name": "us-gaap:InvestmentInterestRate",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "longName": "99940702 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:PercentageOfProbabilityOfEquityFinancing",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:PercentageOfProbabilityOfEquityFinancing",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails",
     "longName": "99940703 - Disclosure - Fair Value Measurements - Valuation model (Details)",
     "shortName": "Fair Value Measurements - Valuation model (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_PxnEcaDrekmg5pbwORI6uA",
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_PxnEcaDrekmg5pbwORI6uA",
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails",
     "longName": "99940704 - Disclosure - Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)",
     "shortName": "Fair Value Measurements - Changes in the notes held for the investments with significant unobservable inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_x1XWviIRvEuBTZOXDrOPnA",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_x1XWviIRvEuBTZOXDrOPnA",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
     "longName": "99940801 - Disclosure - Notes held for investment (Details)",
     "shortName": "Notes held for investment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:NotesReceivableNet",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:FinancingReceivablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "smlr:DebtSecurityInterestIncome",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails",
     "longName": "99940901 - Disclosure - Intangible Digital Assets- Intangible Assets Cost Basis (Details)",
     "shortName": "Intangible Digital Assets- Intangible Assets Cost Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:CryptoAssetNumberOfUnits",
      "unitRef": "Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetHoldingTableTextBlock",
       "us-gaap:CryptoAssetTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R61": {
     "role": "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails",
     "longName": "99940902 - Disclosure - Intangible Digital Assets- Reconciliation of fair value (Details)",
     "shortName": "Intangible Digital Assets- Reconciliation of fair value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CryptoAssetAddition",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CryptoAssetAddition",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails",
     "longName": "99941001 - Disclosure - Other non-current assets (Details)",
     "shortName": "Other non-current assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "smlr:OtherNoncurrentAssetsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw",
      "name": "smlr:MiscellaneousReceivables",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "smlr:OtherNoncurrentAssetsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://semlerscientific.com/role/DisclosureAccruedExpensesDetails",
     "longName": "99941101 - Disclosure - Accrued Expenses (Details)",
     "shortName": "Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails",
     "longName": "99941201 - Disclosure - Concentration of Credit Risk (Details)",
     "shortName": "Concentration of Credit Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:TimeDepositsAtCarryingValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:TimeDepositsAtCarryingValue",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails",
     "longName": "99941301 - Disclosure - Leases - Future minimum rental payments (Details)",
     "shortName": "Leases - Future minimum rental payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "smlr:LeaseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "smlr:LeaseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails",
     "longName": "99941302 - Disclosure - Leases - Lessee Arrangements (Details)",
     "shortName": "Leases - Lessee Arrangements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "smlr:LeaseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "smlr:LeaseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails",
     "longName": "99941303 - Disclosure - Leases - Lessor Arrangements (Details)",
     "shortName": "Leases - Lessor Arrangements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails",
     "longName": "99941304 - Disclosure - Leases - Variable-fee Revenue (Details)",
     "shortName": "Leases - Variable-fee Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:VariableLeaseIncome",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:VariableLeaseIncome",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://semlerscientific.com/role/DisclosureCommitmentsAndContingenciesDetails",
     "longName": "99941401 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "smlr:IncomeTaxExaminationsMaximumEstimatedLiability",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "smlr:IncomeTaxExaminationsMaximumEstimatedLiability",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
     "longName": "99941501 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "smlr:NumberOfVotesForEachShare",
      "unitRef": "Unit_Standard_Vote_fmvi7R5wJUe0Kn3AIo8T4g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
     "longName": "99941601 - Disclosure - Stock Option Plan - Additional Information (Details)",
     "shortName": "Stock Option Plan - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails",
     "longName": "99941602 - Disclosure - Stock Option Plan - Summary of the Company's stock option activity (Details)",
     "shortName": "Stock Option Plan - Summary of the Company's stock option activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
     "longName": "99941603 - Disclosure - Stock Option Plan - Weighted average assumptions used (Details)",
     "shortName": "Stock Option Plan - Weighted average assumptions used (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails",
     "longName": "99941604 - Disclosure - Stock Option Plan - Stock-based compensation expense (Details)",
     "shortName": "Stock Option Plan - Stock-based compensation expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails",
     "longName": "99941701 - Disclosure - Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)",
     "shortName": "Income Taxes - Summary of components of the (benefit) provision for income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails",
     "longName": "99941702 - Disclosure - Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)",
     "shortName": "Income Taxes - Summary of differences between the Company's effective income tax rate and the federal statutory income tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails",
     "longName": "99941703 - Disclosure - Income Taxes - Summary of Deferred tax (liabilities) assets (Details)",
     "shortName": "Income Taxes - Summary of Deferred tax (liabilities) assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails",
     "longName": "99941704 - Disclosure - Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details)",
     "shortName": "Income Taxes - Summary of activity related to the Company's gross unrecognized tax benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "99941705 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails",
     "longName": "99941801 - Disclosure - Net Income Per Share, Basic and Diluted (Details)",
     "shortName": "Net Income Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://semlerscientific.com/role/DisclosureSegmentInformationDetails",
     "longName": "99941901 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "Unit_Standard_segment_Ijr0hkbG8kGjCrFIHbBeqw",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "Unit_Standard_segment_Ijr0hkbG8kGjCrFIHbBeqw",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
     "longName": "99941902 - Disclosure - Segment Information - Reportable Segment Information (Details)",
     "shortName": "Segment Information - Reportable Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A",
      "name": "us-gaap:Revenues",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw",
      "name": "us-gaap:Revenues",
      "unitRef": "Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
     "longName": "99942001 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA",
      "name": "smlr:CryptoAssetNumberOfUnitsPurchased",
      "unitRef": "Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smlr-20241231x10k.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies and Estimates"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202308Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202308Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update 2023-08 [Member]",
        "terseLabel": "ASU 2023-08",
        "documentation": "Accounting Standards Update 2023-08 Intangibles - Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r368"
     ]
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdateExtensibleList",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "documentation": "Indicates amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r204",
      "r205",
      "r206",
      "r275",
      "r276",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r367",
      "r368",
      "r376",
      "r525",
      "r526",
      "r527",
      "r528",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r559",
      "r560",
      "r561",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r608",
      "r609",
      "r621",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r1052"
     ]
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r1065"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r68"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "verboseLabel": "Accrued Expenses",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r51",
      "r55",
      "r1126"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r897"
     ]
    },
    "us-gaap_AccountsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable [Member]",
        "terseLabel": "Accounts payable",
        "documentation": "Obligations incurred and payable to vendors for goods and services received."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "smlr_AccountsReceivableAllowanceForCreditLossAdditionalReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AccountsReceivableAllowanceForCreditLossAdditionalReserve",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to additional reserve for credit losses.",
        "label": "Accounts Receivable, Allowance For Credit Loss, Additional Reserve",
        "terseLabel": "Allowance for credit loss, additional reserve"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "verboseLabel": "Accounts receivable",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, net of allowance for credit losses of $199 and $287, respectively",
        "verboseLabel": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Accrued Taxes",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r105"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAccruedExpensesDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total Accrued Expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r897",
      "r1197"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "verboseLabel": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r751",
      "r1049",
      "r1050",
      "r1051",
      "r1053",
      "r1137",
      "r1198"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r204",
      "r205",
      "r206",
      "r207",
      "r217",
      "r275",
      "r276",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r367",
      "r368",
      "r376",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r608",
      "r609",
      "r620",
      "r621",
      "r622",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r685",
      "r686",
      "r687",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739"
     ]
    },
    "smlr_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from the repurchase of warrants.",
        "label": "Adjustments to Additional Paid in Capital, Repurchase Of Warrants",
        "negatedLabel": "Common stock warrants acquired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r453"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Stock issuance expenses",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r96"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Reconciliation of Net Income to Net Cash Provided by Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Cost [Policy Text Block]",
        "verboseLabel": "Advertising Costs",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Expense",
        "verboseLabel": "Advertising expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r879"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r936",
      "r947",
      "r957",
      "r990"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r993"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r985",
      "r994",
      "r998",
      "r1006"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "verboseLabel": "Stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r489"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails",
      "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Allowance for credit losses",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r280",
      "r331"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "terseLabel": "Allowance for credit loss, recovery",
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units",
        "verboseLabel": "Net Income - Common stock options",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of stock options or restrictive stock units (RSUs)."
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r119",
      "r173",
      "r194",
      "r239",
      "r246",
      "r264",
      "r268",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r553",
      "r557",
      "r610",
      "r696",
      "r780",
      "r857",
      "r858",
      "r897",
      "r915",
      "r1095",
      "r1096",
      "r1154"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r178",
      "r194",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r553",
      "r557",
      "r610",
      "r897",
      "r1095",
      "r1096",
      "r1154"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total Assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r884"
     ]
    },
    "smlr_AssetsForLeaseCustomerLocation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AssetsForLeaseCustomerLocation",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total assets for lease in use at customer locations.",
        "label": "Assets For Lease, Customer Location",
        "terseLabel": "Total assets for lease, net, in use at customer locations"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_AssetsForLeaseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AssetsForLeaseNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Assets for Lease, net"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_AssetsForLeaseNetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AssetsForLeaseNetTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on assets for lease.",
        "label": "Assets for Lease, Net [Text Block]",
        "terseLabel": "Assets for Lease, net"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_AssetsForLeaseReductionToAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AssetsForLeaseReductionToAccumulatedDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction to accumulated depreciation of assets for lease.",
        "label": "Assets for Lease, Reduction to Accumulated Depreciation",
        "terseLabel": "Reduction to accumulated depreciation for returned and retired items"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_AtMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "AtMarketOfferingMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to at-the-market (ATM) offering.",
        "label": "At The Market Offering [Member]",
        "terseLabel": "At The Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r943"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r943"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r943"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis for Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimates"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Summary of Significant Accounting Policies and Estimates",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_BusinessDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDevelopment",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development",
        "verboseLabel": "Sales operations",
        "documentation": "Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r170",
      "r842"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD",
        "periodStartLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r82",
      "r192"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r82"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "verboseLabel": "Supplemental Disclosure of Cash Flow Information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was early adopted."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r203",
      "r275",
      "r320",
      "r323",
      "r329",
      "r367",
      "r376",
      "r527",
      "r537",
      "r546",
      "r548",
      "r561",
      "r574",
      "r577",
      "r608",
      "r609",
      "r687",
      "r728",
      "r729"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "verboseLabel": "CEO",
        "documentation": "Person with designation of chief executive officer."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Number of warrant issued to purchase common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "smlr_ClassOfWarrantOrRightValueRepurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ClassOfWarrantOrRightValueRepurchased",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of warrants or rights repurchased.",
        "label": "Class Of Warrant Or Right, Value Repurchased",
        "terseLabel": "Warrants repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 14)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r108",
      "r699",
      "r766"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r382",
      "r383",
      "r837",
      "r1088",
      "r1094"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "verboseLabel": "Common Stock",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r905",
      "r906",
      "r907",
      "r909",
      "r910",
      "r911",
      "r912",
      "r1049",
      "r1050",
      "r1053",
      "r1137",
      "r1196",
      "r1198"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized (in shares)",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r767"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued (in shares)",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r61",
      "r767",
      "r786",
      "r1198",
      "r1199"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 50,000,000 shares authorized; 9,770,908 and 7,099,441 shares issued, and 9,556,486 and 6,885,019 shares outstanding (treasury shares of 214,422 and 214,422), respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r700",
      "r897"
     ]
    },
    "smlr_CommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CommonStockWarrantsMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "smlr_CompanyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CompanyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "The Company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "verboseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r99"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "verboseLabel": "Computer Equipment &amp; Software",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r46",
      "r47",
      "r274",
      "r836"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r46",
      "r47",
      "r274",
      "r741",
      "r836"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r46",
      "r47",
      "r274",
      "r836",
      "r1029"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r133"
     ]
    },
    "smlr_ConcentrationRiskCryptoAssetNumberOfProviders": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ConcentrationRiskCryptoAssetNumberOfProviders",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of major providers of crypto asset holdings in concentration risk.",
        "label": "Concentration Risk, Crypto Asset, Number Of Providers",
        "terseLabel": "Number Of Providers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRisk"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentration of Credit Risk",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration of Credit Risk",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "smlr_ConcentrationRiskNumberOfCustomers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ConcentrationRiskNumberOfCustomers",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of major customers in concentration risk.",
        "label": "Concentration Risk Number Of Customers",
        "verboseLabel": "Number of customers"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_ConcentrationRiskNumberOfVendors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ConcentrationRiskNumberOfVendors",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of major vendors in concentration risk.",
        "label": "Concentration Risk Number Of Vendors",
        "terseLabel": "Number of vendors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Concentration risk percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r46",
      "r47",
      "r274"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r25",
      "r46",
      "r102",
      "r836"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r46",
      "r47",
      "r274",
      "r836"
     ]
    },
    "smlr_ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable from exchange for good or service transferred, classified as current.",
        "label": "Contract with Customer, Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Credit losses related to ASC 606 receivables"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_ContractWithCustomerAccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ContractWithCustomerAccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesAccountsReceivableAndAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is unconditional.",
        "label": "Contract with Customer, Accounts Receivable, Net",
        "terseLabel": "Accounts receivable, net, related to revenue recognized under ASC 606"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Deferred revenue",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r431",
      "r440"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Deferred revenue recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "smlr_ConvertibleSeniorNote4.25Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ConvertibleSeniorNote4.25Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 4.25% Convertible Senior Notes.",
        "label": "Convertible Senior Note 4.25% [Member]",
        "verboseLabel": "4.25% Convertible Senior Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenues",
        "verboseLabel": "Cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r194",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r610",
      "r857",
      "r1095"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Sales [Member]",
        "verboseLabel": "Cost of Revenues",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r196",
      "r197",
      "r400",
      "r416",
      "r646",
      "r666",
      "r693",
      "r845",
      "r847"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CryptoAssetActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetActivityTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Activity [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the fair values",
        "documentation": "Tabular disclosure of information about activity for crypto asset. Excludes information about crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "us-gaap_CryptoAssetAddition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetAddition",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Addition",
        "terseLabel": "Additions",
        "documentation": "Amount of increase in crypto asset from addition. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "smlr_CryptoAssetAveragePurchasePrice": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CryptoAssetAveragePurchasePrice",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average purchase price per bitcoin.",
        "label": "Crypto Asset, Average Purchase Price",
        "terseLabel": "Average purchase price per bitcoin"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CryptoAssetCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetCost",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Cost",
        "terseLabel": "Crypto Asset, Cost",
        "verboseLabel": "Cost Basis",
        "documentation": "Cost of crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r359"
     ]
    },
    "us-gaap_CryptoAssetFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetFairValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails",
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails",
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails",
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Fair Value",
        "periodEndLabel": "Ending balance at Fair Value",
        "periodStartLabel": "Beginning balance at Fair Value",
        "terseLabel": "Bitcoin investments",
        "verboseLabel": "Fair Value",
        "documentation": "Fair value of crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r360",
      "r362"
     ]
    },
    "us-gaap_CryptoAssetFairValueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetFairValueNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Fair Value, Noncurrent",
        "terseLabel": "Intangible digital assets",
        "documentation": "Fair value of crypto asset classified as noncurrent. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r360",
      "r362"
     ]
    },
    "us-gaap_CryptoAssetHoldingTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetHoldingTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Holding [Table Text Block]",
        "terseLabel": "Schedule of intangible assets cost basis",
        "documentation": "Tabular disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "smlr_CryptoAssetMarketPricePerCryptoAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CryptoAssetMarketPricePerCryptoAsset",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market price per crypto asset.",
        "label": "Crypto Asset, Market Price Per Crypto Asset",
        "terseLabel": "Market price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CryptoAssetNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetNameExtensibleEnumeration",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Name [Extensible Enumeration]",
        "documentation": "Indicates name of crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r1076",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_CryptoAssetNumberOfUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetNumberOfUnits",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails",
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsIntangibleAssetsCostBasisDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units Held",
        "terseLabel": "Crypto Asset, Number of Units",
        "verboseLabel": "Crypto assets number of assets",
        "documentation": "Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "smlr_CryptoAssetNumberOfUnitsPurchased": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CryptoAssetNumberOfUnitsPurchased",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of crypto asset units purchased during the period.",
        "label": "Crypto Asset, Number of Units Purchased",
        "terseLabel": "Number of crypto asset units purchased"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_CryptoAssetProviderOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CryptoAssetProviderOneMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to crypto asset provider one.",
        "label": "Crypto Asset, Provider One [Member]",
        "terseLabel": "Provider One"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_CryptoAssetProviderTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CryptoAssetProviderTwoMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to crypto asset provider two.",
        "label": "Crypto Asset, Provider Two [Member]",
        "terseLabel": "Provider Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CryptoAssetRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetRollForward",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CryptoAssetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset [Text Block]",
        "terseLabel": "Intangible Digital Assets",
        "documentation": "The entire disclosure for crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365",
      "r366"
     ]
    },
    "us-gaap_CryptoAssetUnrealizedGainLossNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetUnrealizedGainLossNonoperating",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Unrealized Gain (Loss), Nonoperating",
        "negatedLabel": "Change in fair value of digital assets",
        "terseLabel": "Change in fair value of digital assets",
        "documentation": "Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "us-gaap_CryptoAssetUnrealizedGainNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetUnrealizedGainNonoperating",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Unrealized Gain, Nonoperating",
        "terseLabel": "Unrealized gain, net",
        "documentation": "Amount of unrealized gain from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "us-gaap_CryptoAssetUnrealizedLossNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetUnrealizedLossNonoperating",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIntangibleDigitalAssetsReconciliationOfFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Unrealized Loss, Nonoperating",
        "negatedLabel": "Unrealized loss, net",
        "documentation": "Amount of unrealized loss from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative-adjustment",
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r161",
      "r202",
      "r210",
      "r217",
      "r324",
      "r330",
      "r368",
      "r524",
      "r525",
      "r538",
      "r540",
      "r562",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r575",
      "r578",
      "r580",
      "r581",
      "r641"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r161",
      "r202",
      "r210",
      "r217",
      "r324",
      "r330",
      "r368",
      "r524",
      "r525",
      "r538",
      "r540",
      "r562",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r575",
      "r578",
      "r580",
      "r581",
      "r641"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r161",
      "r202",
      "r210",
      "r217",
      "r324",
      "r330",
      "r368",
      "r524",
      "r525",
      "r538",
      "r540",
      "r562",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r575",
      "r578",
      "r580",
      "r581",
      "r641"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "verboseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1030",
      "r1047",
      "r1136"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current tax provision",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r1047"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Current tax provision:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1030",
      "r1047",
      "r1136"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "verboseLabel": "Customer concentration risk",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r274"
     ]
    },
    "smlr_CustomerOneConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CustomerOneConcentrationRiskMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One.",
        "label": "Customer one"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_CustomerThreeConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CustomerThreeConcentrationRiskMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for customer three.",
        "label": "Customer three"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_CustomerTwoConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "CustomerTwoConcentrationRiskMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two.",
        "label": "Customer two"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r928",
      "r1017"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r928",
      "r1017"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r930",
      "r1019"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r930",
      "r1019"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1021"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r930",
      "r1019"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1012"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r924",
      "r1013"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r924",
      "r1013"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r922",
      "r1011"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r922",
      "r1011"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r922",
      "r1011"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r925",
      "r1014"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r1016"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r1016"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r928",
      "r1017"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r931",
      "r1020"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r929",
      "r1018"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r926",
      "r1015"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Conversion value",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r50",
      "r51",
      "r104",
      "r107",
      "r198",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r894",
      "r1045",
      "r1089",
      "r1090",
      "r1091",
      "r1147",
      "r1148"
     ]
    },
    "smlr_DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Base principal amount used for computing the conversion rate of debt instrument.",
        "label": "Debt Instrument, Base Principal Amount On Computation Of Conversion Rate",
        "terseLabel": "Principal amount on conversion rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Conversion Price",
        "verboseLabel": "Initial conversion price per share",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r399"
     ]
    },
    "smlr_DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of premium on computation of conversion price over the last reported sale price.",
        "label": "Debt Instrument, Convertible, Conversion Price, Premium Percentage Over Last Reported Sale Price",
        "terseLabel": "Premium conversion price over the last reported sale price"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of business days over which the fundamental notice of default has not been issued by the company.",
        "label": "Debt Instrument, Convertible, Debt Default, Fundamental Change Notice, Threshold Business Days",
        "terseLabel": "fundamental notice of default business days"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which the company is in default of payments of principal and interest when due and payable or failure to comply with the acceleration clause that is a part of the debt instrument, expressed in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Debt Default, Indebtedness, Acceleration Clause, Period",
        "terseLabel": "Default not cured indebtedness not paid after written notice"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of principal amount of convertible debt which has been in default with principal, interest, covenants that existed and against which the indebtedness exists or shall be created.",
        "label": "Debt Instrument, Convertible, Debt Default, Indebtedness, Minimum Principal Amount",
        "terseLabel": "Minimum Principal Amount"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultInterestPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultInterestPeriod",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which the default of interest payment continues for a convertible debt instrument, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Debt Default Interest, Period",
        "terseLabel": "Default period"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees": {
     "xbrltype": "durationItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which the company fails to comply with other agreements in the indenture after written notice from the trustees.",
        "label": "Debt Instrument, Convertible, Debt Default On Compliance Of Other Agreements In Indenture, Post Written Notice From Trustees",
        "terseLabel": "Post Written Notice"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of business days over which the default on conversion of debt instrument upon exercise by the holder continues.",
        "label": "Debt Instrument, Convertible, Debt Default On Conversion Upon Exercise, Threshold Business Days",
        "terseLabel": "Failure business days"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of outstanding debt holders sending written notice of default of compliance with agreements in indenture to company in pursuant to the convertible debt instrument.",
        "label": "Debt Instrument, Convertible, Debt Default, Post Written Notice From Holders Of Outstanding Debt, Minimum Percentage",
        "terseLabel": "Minimum aggregate principal amount (In percentage)"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of business days over which the fundamental notice of default has not been issued by the company.",
        "label": "Debt Instrument, Convertible, Debt Default, Specified Corporate Action Notice, Threshold Business Days",
        "terseLabel": "Notice of a specified corporate transaction"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleMaximumSharesIssuableUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleMaximumSharesIssuableUponConversion",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares issuable upon conversion of convertible debt instrument.",
        "label": "Debt Instrument, Convertible, Maximum Shares Issuable Upon Conversion"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleThresholdBusinessDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleThresholdBusinessDays",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified business days that trading price per base principal amount must be below the threshold percentage within a specified consecutive trading period or measurement period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Business Days",
        "terseLabel": "Business days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days",
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of consecutive trading days or measurement period in which the trading price per base principal amount must be below the threshold percentage for specified number of business days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days Period",
        "terseLabel": "After consecutive trading day"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of trading price on the product of stock price and conversion price of convertible debt instrument to determine the eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage Of Product Of Stock Price And Conversion Price, Stock Price Trigger",
        "terseLabel": "Trading day of the measurement period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion price trading day",
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Trading days",
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount",
        "verboseLabel": "Aggregate principal amount of offering price",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r618",
      "r619",
      "r866",
      "r867",
      "r894"
     ]
    },
    "smlr_DebtInstrumentFundamentalChangeRepurchasePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentFundamentalChangeRepurchasePricePercentage",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer that has undergone fundamental change.",
        "label": "Debt Instrument, Fundamental Change, Repurchase Price, Percentage",
        "terseLabel": "Fundamental change repurchase price (In Percentage)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Percentage of convertible senior notes",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r398"
     ]
    },
    "smlr_DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum additional face amount of debt instrument at issuance upon exercise in full of the initial purchaser option.",
        "label": "Debt Instrument, Maximum Additional Face Amount On option, Exercised",
        "terseLabel": "Additional principal amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMeasurementInput",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Measurement Input",
        "terseLabel": "Measurement input",
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt."
       }
      }
     },
     "auth_ref": [
      "r1141",
      "r1142",
      "r1143"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r198",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r894",
      "r1045",
      "r1089",
      "r1090",
      "r1091",
      "r1147",
      "r1148"
     ]
    },
    "smlr_DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity per base principal amount.",
        "label": "Debt Instrument, Number of Equity Instruments Convertible Per Base Principal Amounts",
        "terseLabel": "Conversion rate for common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (In percentage)",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_DebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities",
        "terseLabel": "Debt securities measured at fair value",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r693",
      "r694",
      "r903",
      "r904"
     ]
    },
    "us-gaap_DebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities [Member]",
        "terseLabel": "Notes held for investment",
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r907",
      "r1200"
     ]
    },
    "us-gaap_DebtSecuritiesTradingRealizedGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesTradingRealizedGain",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Trading, Realized Gain",
        "negatedLabel": "Gain on short-term investments",
        "terseLabel": "Interest income",
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "smlr_DebtSecuritiesTransactionFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtSecuritiesTransactionFee",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction fee paid for debt security.",
        "label": "Debt Securities, Transaction Fee",
        "terseLabel": "Transaction fee"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtSecurityChangesInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtSecurityChangesInFairValue",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of changes in fair value of debt security.",
        "label": "Debt Security, Changes in Fair Value",
        "terseLabel": "Changes in fair value"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtSecurityFaceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtSecurityFaceValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) value of the debt security at the time of issuance or purchase.",
        "label": "Debt Security, Face Value",
        "terseLabel": "Debt security at face value"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtSecurityInterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtSecurityInterestIncome",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income on debt security recognized.",
        "label": "Debt Security, Interest Income",
        "terseLabel": "Interest income from promissory notes"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtSecurityInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtSecurityInterestRate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of interest rate.",
        "label": "Debt Security, Interest Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DebtSecurityMaximumAmountOfAvailableFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DebtSecurityMaximumAmountOfAvailableFunding",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of available funding.",
        "label": "Debt Security, Maximum Amount of Available Funding",
        "terseLabel": "Maximum amount of available funding"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DefectiveProductReplacementCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DefectiveProductReplacementCost",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of  cost incurred for replacing the defective products.",
        "label": "Defective Product Replacement Cost",
        "terseLabel": "Defective sensors charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1047",
      "r1135",
      "r1136"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r499"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax expense (income)",
        "totalLabel": "Total deferred tax provision",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r143",
      "r1047"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Deferred tax provision:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r106",
      "r516"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r499",
      "r697"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1047",
      "r1135",
      "r1136"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Deferred Income",
        "verboseLabel": "Deferred revenue",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "smlr_DeferredTaxAssetsLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.",
        "label": "Deferred Tax Assets, Lease Liabilities",
        "terseLabel": "Lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "verboseLabel": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "verboseLabel": "Net operating loss carryforwards for California",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "verboseLabel": "Depreciation and amortization",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "smlr_DeferredTaxAssetsRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DeferredTaxAssetsRightOfUseAssets",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax liabilities attributable to deductible temporary differences from right of use assets.",
        "label": "Deferred Tax Assets, Right of Use Assets",
        "negatedLabel": "Right of use assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "verboseLabel": "Research and development credits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "verboseLabel": "Stock based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "verboseLabel": "Accrual and reserves",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax (liabilities)",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDeferredTaxLiabilitiesAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from change in fair value of digital assets.",
        "label": "Deferred Tax Liabilities, Change In Fair Value Of Digital Assets",
        "negatedLabel": "Change in fair value of digital assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Maximum contribution of percentage of employee's eligible earnings",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r33"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r239",
      "r251",
      "r268",
      "r857",
      "r858"
     ]
    },
    "us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationExcludingLessorAssetUnderOperatingLease",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Excluding Lessor Asset under Operating Lease",
        "terseLabel": "Depreciation expense",
        "documentation": "Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r634"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Option Plan",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r456",
      "r485",
      "r486",
      "r488",
      "r876"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r943"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r943",
      "r986"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "verboseLabel": "Federal",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Per Share, Basic and Diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share, basic",
        "verboseLabel": "Basic EPS (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r219",
      "r222",
      "r232",
      "r233",
      "r234",
      "r238",
      "r542",
      "r551",
      "r581",
      "r582",
      "r691",
      "r710",
      "r851"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share, diluted",
        "verboseLabel": "Diluted EPS (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r222",
      "r232",
      "r233",
      "r234",
      "r238",
      "r542",
      "r551",
      "r581",
      "r582",
      "r691",
      "r710",
      "r851"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDiluted"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income Per Share, Basic and Diluted",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r235",
      "r236",
      "r237"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r881"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "verboseLabel": "Federal statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r501",
      "r529",
      "r881"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "verboseLabel": "Permanent items",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r505",
      "r1048",
      "r1127"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r881",
      "r1048",
      "r1127",
      "r1129"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r881",
      "r1048",
      "r1127",
      "r1128"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfDifferencesBetweenCompanySEffectiveIncomeTaxRateAndFederalStatutoryIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income tax rate, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r881",
      "r1048",
      "r1127"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "verboseLabel": "Stock-based compensation",
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Total unrecognized compensation cost related to non-vested awards",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Weighted average period of unvested stock awards",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "verboseLabel": "Total tax benefit from the exercise of stock options",
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOwnershipPlanESOPPolicy",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block]",
        "verboseLabel": "Employee Benefit Plan",
        "documentation": "Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "smlr_EngineeringAndProductDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "EngineeringAndProductDevelopmentMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is related to Engineering and product development.",
        "label": "Engineering And Product Development [Member]",
        "terseLabel": "Engineering and Product Development"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1026"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r161",
      "r182",
      "r183",
      "r184",
      "r199",
      "r200",
      "r201",
      "r205",
      "r212",
      "r214",
      "r216",
      "r241",
      "r324",
      "r330",
      "r368",
      "r429",
      "r524",
      "r525",
      "r538",
      "r539",
      "r540",
      "r543",
      "r550",
      "r551",
      "r562",
      "r564",
      "r565",
      "r566",
      "r567",
      "r569",
      "r580",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r621",
      "r623",
      "r643",
      "r708",
      "r730",
      "r731",
      "r732",
      "r751",
      "r806"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Impairment",
        "verboseLabel": "Impairment charges",
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount",
        "terseLabel": "Cumulative recorded impairment",
        "documentation": "Amount of cumulative impairment loss on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value [Table]",
        "documentation": "Disclosure of information about investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value [Table Text Block]",
        "terseLabel": "Schedule of carrying value of non-marketable equity investments",
        "documentation": "Tabular disclosure of investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r936",
      "r947",
      "r957",
      "r990"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r944",
      "r954",
      "r987"
     ]
    },
    "smlr_ExaminationOfCompanyTaxYears": {
     "xbrltype": "durationItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ExaminationOfCompanyTaxYears",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as income tax examination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Examination Of Company Tax Years",
        "verboseLabel": "Company's tax years beginning for examination"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "smlr_ExtensionPeriodOptionToExtendMaturityDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ExtensionPeriodOptionToExtendMaturityDate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to extend the maturity date.",
        "label": "Extension Period, Option to Extend the Maturity Date",
        "terseLabel": "Period to extend the maturity date"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_FairValueAdjustmentOfNotesHeldForInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "FairValueAdjustmentOfNotesHeldForInvestment",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair adjustments in notes held for investment.",
        "label": "Fair Value Adjustment of Notes Held for Investment",
        "negatedLabel": "Change in fair value of notes held for investment",
        "terseLabel": "Change in fair value of notes held for investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r598",
      "r884"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r598",
      "r884"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587",
      "r588",
      "r887"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587",
      "r588",
      "r887"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "verboseLabel": "Schedule of key inputs for the valuation model",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587",
      "r887"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of financial assets measured at fair value on a recurring basis",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1139",
      "r1140"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r599",
      "r885"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of changes in the notes held for the investments",
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r594",
      "r599",
      "r885"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r599",
      "r885"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r583",
      "r585",
      "r586",
      "r587",
      "r588",
      "r597",
      "r598",
      "r600",
      "r653",
      "r654",
      "r655",
      "r866",
      "r867",
      "r872",
      "r873",
      "r874",
      "r884",
      "r887"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r586",
      "r588",
      "r884",
      "r1142",
      "r1145"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r595",
      "r596",
      "r597",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r688",
      "r884",
      "r888"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r443",
      "r448",
      "r585",
      "r598",
      "r653",
      "r872",
      "r873",
      "r874",
      "r884"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r443",
      "r448",
      "r585",
      "r586",
      "r598",
      "r654",
      "r866",
      "r867",
      "r872",
      "r873",
      "r874",
      "r884"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r585",
      "r586",
      "r587",
      "r588",
      "r598",
      "r655",
      "r866",
      "r867",
      "r872",
      "r873",
      "r874",
      "r884",
      "r887"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r586",
      "r588",
      "r884",
      "r1142",
      "r1145"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value of the notes held for investment",
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r591",
      "r599",
      "r885"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchased",
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r599",
      "r885"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r599",
      "r885"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r583",
      "r585",
      "r586",
      "r587",
      "r588",
      "r597",
      "r598",
      "r600",
      "r653",
      "r654",
      "r655",
      "r866",
      "r867",
      "r872",
      "r873",
      "r874",
      "r884",
      "r887"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1145"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "verboseLabel": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, Held-for-Investment [Policy Text Block]",
        "terseLabel": "Short-Term Notes Held for Investments",
        "documentation": "Disclosure of accounting policy for financing receivable classified as held-for-investment."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r123",
      "r1063",
      "r1064"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r332",
      "r333",
      "r336",
      "r337",
      "r338",
      "r340",
      "r341",
      "r342",
      "r413",
      "r426",
      "r570",
      "r605",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r709",
      "r863",
      "r884",
      "r885",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r898",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1138",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_FinancingReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablesTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivables [Text Block]",
        "terseLabel": "Notes held for investment",
        "documentation": "The entire disclosure for financing receivable."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r281",
      "r282",
      "r283",
      "r862"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r994"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r994"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r994"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r994"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r994"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture &amp; Fixtures",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfLeasedAssetsNetOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Sale of Leased Assets, Net, Operating Leases",
        "negatedLabel": "Loss on disposal of assets for lease",
        "verboseLabel": "Loss on disposal of assets for lease",
        "documentation": "The net gain (loss) arising from the lessor's sale of assets held- or available-for-lease under contractual arrangements classified as operating leases."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r369"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administration",
        "verboseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r790"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "General and Administrative",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HeldToMaturitySecuritiesFairValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "terseLabel": "Investment in debt securities",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r310",
      "r585",
      "r597",
      "r689",
      "r695"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r943"
     ]
    },
    "smlr_ImpairmentLossesInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ImpairmentLossesInvestments",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earning or other comprehensive income.",
        "label": "Impairment Losses Investments",
        "negatedLabel": "Impairment of investments",
        "terseLabel": "Impairment of long-term investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r92"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Pre-tax income",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r110",
      "r118",
      "r692",
      "r705",
      "r852",
      "r857",
      "r1055",
      "r1057",
      "r1058",
      "r1059",
      "r1060"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statements of Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r375",
      "r377",
      "r590",
      "r594",
      "r599",
      "r725",
      "r727",
      "r791",
      "r840",
      "r886",
      "r1167"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r377",
      "r590",
      "r594",
      "r599",
      "r725",
      "r727",
      "r791",
      "r840",
      "r886",
      "r1167"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r494",
      "r501",
      "r506",
      "r507",
      "r508",
      "r514",
      "r520",
      "r530",
      "r532",
      "r533",
      "r534",
      "r749",
      "r881"
     ]
    },
    "smlr_IncomeTaxExaminationsMaximumEstimatedLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "IncomeTaxExaminationsMaximumEstimatedLiability",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of estimated liability on income tax examinations.",
        "label": "Income Tax Examinations, Maximum Estimated Liability",
        "terseLabel": "Estimated liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfComponentsOfBenefitProvisionForIncomeTaxesDetails",
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision",
        "totalLabel": "Total income tax provision",
        "verboseLabel": "Income tax expense",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r145",
      "r215",
      "r216",
      "r239",
      "r254",
      "r268",
      "r500",
      "r501",
      "r531",
      "r712",
      "r881"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r496",
      "r497",
      "r514",
      "r515",
      "r519",
      "r522",
      "r746"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for taxes",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r84",
      "r1043",
      "r1131",
      "r1132"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Trade accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in Operating Assets and Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other non-current assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "verboseLabel": "Other current and non-current liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "verboseLabel": "Common stock options (in shares)",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r234",
      "r455"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r985",
      "r994",
      "r998",
      "r1006"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r921",
      "r1010"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r921",
      "r1010"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r921",
      "r1010"
     ]
    },
    "smlr_IntangibleDigitalAssetBenchmarkMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "IntangibleDigitalAssetBenchmarkMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to intangible digital assets, when it serves as benchmark in concentration of risk calculation.",
        "label": "Intangible Digital Asset, Benchmark [Member]",
        "terseLabel": "Intangible digital assets"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_IntangibleDigitalAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "IntangibleDigitalAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Intangible Digital Assets"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_IntangibleDigitalAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "IntangibleDigitalAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible digital assets.",
        "label": "Intangible Digital Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Digital Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureInventory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventory",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureInventoryDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "verboseLabel": "Inventory balance",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r843",
      "r897"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r169",
      "r176",
      "r343",
      "r344",
      "r345",
      "r683",
      "r848"
     ]
    },
    "smlr_InvestmentHoldingConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "InvestmentHoldingConcentrationRiskMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to percentage that arises from holding of investments. Risk is materially adverse effects of loss on investment holdings which could occur upon sale of or decrease in value of investments.",
        "label": "Investment Holding, Concentration Risk [Member]",
        "terseLabel": "Investment Holding Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_InvestmentInPrivateCompanyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "InvestmentInPrivateCompanyThreeMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to investment in private company three.",
        "label": "Investments in Mellitus Health, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_InvestmentInPrivateCompanyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "InvestmentInPrivateCompanyTwoMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to investment in private company two.",
        "label": "Investments in SYNAPS Dx"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterestAndDividend",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Interest and dividend income, net",
        "verboseLabel": "Interest income, net",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Interest Rate",
        "terseLabel": "Interest rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r813",
      "r814",
      "r818",
      "r819",
      "r821",
      "r822",
      "r827",
      "r828",
      "r907",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment Valuation",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r711",
      "r742",
      "r743",
      "r744",
      "r745",
      "r816",
      "r817"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r812",
      "r815",
      "r820",
      "r824",
      "r825",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r907"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r812",
      "r815",
      "r820",
      "r824",
      "r825",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r907"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Long-Term Investments",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r148",
      "r284",
      "r287",
      "r606",
      "r607",
      "r1163"
     ]
    },
    "smlr_KeyPersonStockOptionPlan2007Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "KeyPersonStockOptionPlan2007Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to 2007 Key Person Stock Option Plan (\"2007 Plan\").",
        "label": "2007 Key Person Stock Option Plan"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_LeaseDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "LeaseDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of information about leases.",
        "label": "Lease Disclosure [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasePracticalExpedientLessorSingleLeaseComponent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasePracticalExpedientLessorSingleLeaseComponent",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Practical Expedient, Lessor Single Lease Component [true false]",
        "documentation": "Indicates (true false) whether practical expedient is elected to account for lease component and nonlease component as single lease component."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDiscountRate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Discount rate",
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]",
        "terseLabel": "Options to renew",
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease."
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "verboseLabel": "Schedule of future minimum rental payments required under operating leases",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted future minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: present value discount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r631",
      "r1149"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease agreement term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1150"
     ]
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorLeasesPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessor, Leases [Policy Text Block]",
        "verboseLabel": "Assets for Lease",
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r139",
      "r140",
      "r633"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r109",
      "r702",
      "r897",
      "r1046",
      "r1075",
      "r1146"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r168",
      "r194",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r554",
      "r557",
      "r558",
      "r610",
      "r897",
      "r1095",
      "r1154",
      "r1155"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total long-term liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r54",
      "r55",
      "r56",
      "r59",
      "r194",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r554",
      "r557",
      "r558",
      "r610",
      "r1095",
      "r1154",
      "r1155"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_LongTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "LongTermDeposits",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term deposits.",
        "label": "Long-term Deposits",
        "terseLabel": "Long-term deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Investments.",
        "terseLabel": "Long-term investments",
        "verboseLabel": "Total long-term investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "verboseLabel": "Machinery &amp; Equipment",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r871",
      "r899",
      "r902",
      "r1099",
      "r1166",
      "r1168",
      "r1169",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r384",
      "r385",
      "r386",
      "r387",
      "r450",
      "r490",
      "r588",
      "r682",
      "r724",
      "r726",
      "r740",
      "r758",
      "r759",
      "r813",
      "r818",
      "r822",
      "r823",
      "r827",
      "r838",
      "r839",
      "r862",
      "r870",
      "r875",
      "r887",
      "r888",
      "r892",
      "r893",
      "r900",
      "r1097",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Cashflow discount rate",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1141",
      "r1142",
      "r1143"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "verboseLabel": "Expected term in years",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r1141",
      "r1142",
      "r1143"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "verboseLabel": "Expected volatility",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r1141",
      "r1142",
      "r1143"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r1141",
      "r1142",
      "r1143"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587",
      "r588",
      "r887"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587",
      "r588",
      "r887"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r384",
      "r385",
      "r386",
      "r387",
      "r450",
      "r490",
      "r588",
      "r682",
      "r724",
      "r726",
      "r740",
      "r758",
      "r759",
      "r813",
      "r818",
      "r822",
      "r823",
      "r827",
      "r838",
      "r839",
      "r862",
      "r870",
      "r875",
      "r887",
      "r888",
      "r892",
      "r900",
      "r1097",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "smlr_MiscellaneousReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "MiscellaneousReceivables",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of miscellaneous receivables.",
        "label": "Miscellaneous Receivables",
        "terseLabel": "Miscellaneous receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "smlr_MonarchMedicalTechnologyLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "MonarchMedicalTechnologyLlcMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Monarch Medical Technology, LLC.",
        "label": "Monarch",
        "terseLabel": "Monarch"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails",
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "U.S. Government money market fund accounts",
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r871",
      "r899",
      "r902",
      "r1099",
      "r1166",
      "r1168",
      "r1169",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureCompany"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "The Company",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r146"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash (Used in) Provided by Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r85"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome",
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r85",
      "r111",
      "r166",
      "r179",
      "r180",
      "r184",
      "r194",
      "r204",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r230",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r542",
      "r551",
      "r582",
      "r610",
      "r707",
      "r788",
      "r804",
      "r805",
      "r913",
      "r1095"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net Income - Basic EPS",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r208",
      "r209",
      "r210",
      "r211",
      "r219",
      "r220",
      "r231",
      "r234",
      "r551"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net Income - Diluted EPS",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r221",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r234"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r985",
      "r994"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Other income, net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Short-term notes held for investment",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r1062"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "verboseLabel": "Notes held for investment",
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_NotesReceivableInterestBearingInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "NotesReceivableInterestBearingInterestRate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate on notes receivable.",
        "label": "Notes Receivable, Interest-Bearing, Interest Rate",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Total notes held for investment",
        "verboseLabel": "Restated secured convertible note",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r775",
      "r1062",
      "r1165"
     ]
    },
    "smlr_NotesReceivableTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "NotesReceivableTerm",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of notes receivable.",
        "label": "Notes receivable, Term",
        "terseLabel": "Term (in years)"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_NumberOfConsecutiveTermsOptionToExtendMaturityDate": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "NumberOfConsecutiveTermsOptionToExtendMaturityDate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to extend the maturity date.",
        "label": "Number of Consecutive Terms, Option to Extend the Maturity Date",
        "terseLabel": "Option to extend the maturity date"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_NumberOfNotesReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "NumberOfNotesReceivable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of notes receivable.",
        "label": "Number of Notes Receivable",
        "terseLabel": "Number of notes receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r853",
      "r861",
      "r1056"
     ]
    },
    "smlr_NumberOfVotesForEachShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "NumberOfVotesForEachShare",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of votes for each share held by shareholders.",
        "label": "Number of Votes for Each Share",
        "terseLabel": "Number of votes for each share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpensesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Less:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r852",
      "r1055",
      "r1057",
      "r1058",
      "r1059",
      "r1060"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Lease expenses",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r628",
      "r896"
     ]
    },
    "smlr_OperatingLeaseExpensesInExcessOfCashPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "OperatingLeaseExpensesInExcessOfCashPayments",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of lease expense in excess of cash payments during the period.",
        "label": "Operating Lease Expenses in Excess of Cash Payments",
        "negatedLabel": "Lease expense in excess cash payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseIncomeComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes operating lease income."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLeaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLessorArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Lease revenue",
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r632",
      "r635"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "verboseLabel": "Future minimum rental payments required under operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesFutureMinimumRentalPaymentsDetails",
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails",
      "http://semlerscientific.com/role/DisclosureOtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Total ROU asset",
        "verboseLabel": "ROU asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesLesseeArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Lessor Asset under Operating Lease",
        "terseLabel": "Depreciation expense",
        "documentation": "Amount of depreciation expense for lessor's underlying asset for which right to use has been conveyed to lessee under operating lease."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r634"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "terseLabel": "NOL carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Miscellaneous Accruals",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other non-current assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_OtherAssetsNoncurrentDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrentDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_OtherCorporateIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "OtherCorporateIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other corporate income (expense).",
        "label": "Other Corporate Income (Expense)",
        "verboseLabel": "Other corporate income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current",
        "terseLabel": "Other short-term liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r897"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "smlr_OtherNoncurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "OtherNoncurrentAssetsTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureOtherNonCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other noncurrent assets.",
        "label": "Other Noncurrent Assets [Text Block]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r938",
      "r949",
      "r959",
      "r992"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r941",
      "r952",
      "r962",
      "r995"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r941",
      "r952",
      "r962",
      "r995"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_PaymentForAcquisitionCryptoAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForAcquisitionCryptoAsset",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for Acquisition, Crypto Asset",
        "negatedLabel": "Purchase of digital assets",
        "terseLabel": "Aggregate purchase price",
        "documentation": "Amount of cash outflow to acquire crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Repurchase of Warrants",
        "negatedLabel": "Common stock warrants acquired",
        "documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Stock issuance expenses",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net settlement of equity awards",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "negatedLabel": "Purchase of notes held for investment",
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r286"
     ]
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireNotesReceivable",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Notes Receivable",
        "terseLabel": "Aggregate principal amount",
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchase of short-term investments",
        "terseLabel": "Purchase cost",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "smlr_PercentageOfProbabilityOfChangeOfControl": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PercentageOfProbabilityOfChangeOfControl",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Percentage of probability of change of control.",
        "label": "Percentage Of Probability Of Change Of Control",
        "terseLabel": "Percentage of probability of change of control"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_PercentageOfProbabilityOfEquityFinancing": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PercentageOfProbabilityOfEquityFinancing",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Percentage of probability of equity financing.",
        "label": "Percentage Of Probability Of Equity Financing",
        "terseLabel": "Percentage of probability of equity financing"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Percentage of probability of payment at maturity or an insolvency event.",
        "label": "Percentage Of Probability Of Payment At Maturity Or An Insolvency Event",
        "terseLabel": "Percentage of probability of payment at maturity or an insolvency event"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_PercentageOfSharesReserveIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PercentageOfSharesReserveIncrease",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of shares reserve to total number of shares of common stock outstanding.",
        "label": "Percentage Of Shares Reserve Increase",
        "verboseLabel": "Percentage of shares reserve increased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "smlr_PrepaidLicensePurchasesWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PrepaidLicensePurchasesWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as prepaid license purchases.",
        "label": "Prepaid License Purchases, Writeoff",
        "terseLabel": "Write off of prepaid software licenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "smlr_ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the maturity of debt securities, partial amount.",
        "label": "Proceeds From Maturities Of Debt Securities, Partial Amount",
        "terseLabel": "Repaid amount",
        "verboseLabel": "Debt securities, partial amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Proceeds from maturities of short-term investments",
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r79"
     ]
    },
    "smlr_ProceedsFromPaymentsForEquipmentForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ProceedsFromPaymentsForEquipmentForLeases",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow (outflow) for sale or purchase of rented equipment which is recorded as an asset.",
        "label": "Proceeds From (Payments For) Equipment For Leases",
        "negatedLabel": "Proceeds from sale (purchase) of assets for lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "verboseLabel": "Proceeds from exercise of stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r12"
     ]
    },
    "smlr_ProceedsFromTransactionFeeOfDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ProceedsFromTransactionFeeOfDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the transaction fees of debt securities.",
        "label": "Proceeds From Transaction Fee Of Debt Securities",
        "terseLabel": "Transaction fee"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_ProceedsRelatingToAccruedInterestOfDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ProceedsRelatingToAccruedInterestOfDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the accrued interest of debt securities.",
        "label": "Proceeds Relating to Accrued Interest of Debt Securities",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r179",
      "r180",
      "r190",
      "r194",
      "r204",
      "r212",
      "r215",
      "r216",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r542",
      "r551",
      "r552",
      "r555",
      "r556",
      "r582",
      "r610",
      "r692",
      "r706",
      "r750",
      "r788",
      "r804",
      "r805",
      "r882",
      "r883",
      "r914",
      "r1040",
      "r1095"
     ]
    },
    "smlr_PromissoryNoteFromPrivateCompanyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PromissoryNoteFromPrivateCompanyTwoMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLongTermInvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to promissory note from private company two.",
        "label": "Promissory note from SYNAPS Dx"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r630"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property and Equipment, net",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r134",
      "r141",
      "r142"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, Accumulated Depreciation",
        "negatedLabel": "Less: accumulated depreciation",
        "documentation": "Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of accumulated amortization, depreciation, depletion for physical asset used in normal conduct of business to create and distribute product and service."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r634"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, after Accumulated Depreciation",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount, after accumulated depreciation and excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service."
       }
      }
     },
     "auth_ref": [
      "r1087",
      "r1152"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, before Accumulated Depreciation",
        "terseLabel": "Property and equipment, gross",
        "documentation": "Amount, before accumulated depreciation and excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r634"
     ]
    },
    "smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant, and Equipment, Lessor Asset under Operating Lease.",
        "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease [Member]",
        "terseLabel": "Assets for Lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r134",
      "r141",
      "r704"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosurePropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Schedule of property and equipment, net",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r630"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PPE useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, Accumulated Depreciation",
        "negatedLabel": "Less: accumulated depreciation",
        "documentation": "Amount of accumulated depreciation of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r125",
      "r372",
      "r634"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseGross",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, before Accumulated Depreciation",
        "verboseLabel": "Assets for lease",
        "documentation": "Amount, before accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r125",
      "r371",
      "r634"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation",
        "totalLabel": "Assets for lease, net",
        "verboseLabel": "Assets for lease, net",
        "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r1087",
      "r1152"
     ]
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "verboseLabel": "Allowance for credit losses",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r334"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r384",
      "r385",
      "r386",
      "r387",
      "r442",
      "r450",
      "r479",
      "r480",
      "r481",
      "r490",
      "r588",
      "r656",
      "r665",
      "r682",
      "r724",
      "r726",
      "r740",
      "r758",
      "r759",
      "r813",
      "r818",
      "r822",
      "r823",
      "r827",
      "r838",
      "r839",
      "r862",
      "r870",
      "r875",
      "r887",
      "r888",
      "r892",
      "r893",
      "r900",
      "r907",
      "r1092",
      "r1097",
      "r1142",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsValuationModelDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r384",
      "r385",
      "r386",
      "r387",
      "r442",
      "r450",
      "r479",
      "r480",
      "r481",
      "r490",
      "r588",
      "r656",
      "r665",
      "r682",
      "r724",
      "r726",
      "r740",
      "r758",
      "r759",
      "r813",
      "r818",
      "r822",
      "r823",
      "r827",
      "r838",
      "r839",
      "r862",
      "r870",
      "r875",
      "r887",
      "r888",
      "r892",
      "r893",
      "r900",
      "r907",
      "r1092",
      "r1097",
      "r1142",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r68"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes held for investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "verboseLabel": "Unrecognized tax benefits:",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r944",
      "r954",
      "r987"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r449",
      "r644",
      "r645",
      "r698",
      "r703",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r785",
      "r787",
      "r811"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r449",
      "r644",
      "r645",
      "r698",
      "r703",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r785",
      "r787",
      "r811",
      "r1153"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails",
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r196",
      "r197",
      "r400",
      "r416",
      "r646",
      "r666",
      "r693",
      "r846",
      "r847"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Engineering and product development",
        "verboseLabel": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r840",
      "r857",
      "r1162"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "verboseLabel": "Research and Development",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "smlr_ResearchAndExperimentalExpendituresCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ResearchAndExperimentalExpendituresCapitalized",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of research or experimental expenditures capitalized during the period",
        "label": "Research And Experimental Expenditures, Capitalized",
        "terseLabel": "Research and experimental expenditures, capitalized"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r934",
      "r945",
      "r955",
      "r988"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r935",
      "r946",
      "r956",
      "r989"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r953",
      "r963",
      "r996"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1044"
     ]
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges",
        "terseLabel": "Strategic streamlining",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r379",
      "r380",
      "r1093"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails",
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r96",
      "r701",
      "r734",
      "r739",
      "r748",
      "r768",
      "r897"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r199",
      "r200",
      "r201",
      "r205",
      "r212",
      "r214",
      "r216",
      "r324",
      "r330",
      "r368",
      "r524",
      "r525",
      "r538",
      "r539",
      "r540",
      "r543",
      "r550",
      "r551",
      "r562",
      "r565",
      "r566",
      "r569",
      "r580",
      "r621",
      "r623",
      "r730",
      "r732",
      "r751",
      "r1198"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r1028"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Deferred Revenue",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r841"
     ]
    },
    "smlr_RevenuePerformanceObligationPaymentTermsNumberOfDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "RevenuePerformanceObligationPaymentTermsNumberOfDays",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payments terms in contract with customer specifying the timing of payment as net number of days.",
        "label": "Revenue, Performance Obligation, Payment Terms, Number Of Days",
        "terseLabel": "Payment terms"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "verboseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r789",
      "r841",
      "r849"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "terseLabel": "Revenues",
        "verboseLabel": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r185",
      "r194",
      "r239",
      "r247",
      "r248",
      "r262",
      "r268",
      "r271",
      "r273",
      "r274",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r610",
      "r692",
      "r857",
      "r1095"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_SaleOfStockValueAuthorized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "SaleOfStockValueAuthorized",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum value of authorized shares permitted to be issued under the respective stock transaction.",
        "label": "Sale of Stock, Value Authorized",
        "terseLabel": "Sale of stock, value authorized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesTypeLeaseRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesTypeLeaseRevenue",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales-type Lease, Revenue",
        "terseLabel": "Revenues from sales of hardware and equipment accessories",
        "documentation": "Amount of sales-type lease revenue."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r636"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r68",
      "r279",
      "r1065"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of notes receivable",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r68"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of accrued expenses",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_ScheduleOfAssetsForLeaseNetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ScheduleOfAssetsForLeaseNetTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureAssetsForLeaseNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure on assets for lease.",
        "label": "Schedule of Assets for Lease, Net [Table Text Block]",
        "terseLabel": "Summary of assets for lease, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "verboseLabel": "Schedule of stock-based compensation expense",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "verboseLabel": "Schedule of components of the (benefit) provision for income taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1134"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of deferred tax (liabilities) assets",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsChangesInNotesHeldForInvestmentsWithSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r37",
      "r38"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted net EPS",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "verboseLabel": "Schedule of differences between the Company's effective income tax rate and the federal statutory income tax rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r881",
      "r1127"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r630"
     ]
    },
    "smlr_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Schedule of Property Plant And Equipment Useful Life [Table Text Block]",
        "terseLabel": "Schedule of estimated useful lives of property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of reportable segment information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of stock option activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r98"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of assumptions used to determining the fair value of stock options",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of activity related to unrecognized tax benefits",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r880"
     ]
    },
    "smlr_SecuredConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "SecuredConvertiblePromissoryNoteMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured convertible promissory note.",
        "label": "Secured convertible promissory note",
        "terseLabel": "Senior secured convertible promissory note"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r239",
      "r243",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r274",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r378",
      "r381",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r854",
      "r857",
      "r858",
      "r864",
      "r901",
      "r1166",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r258",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r853",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Information",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Segment Item, Amount",
        "terseLabel": "Other Segment expenses",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r260",
      "r261",
      "r268",
      "r857"
     ]
    },
    "us-gaap_SegmentReportingOtherItemCompositionDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemCompositionDescription",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Segment Item, Composition, Description",
        "documentation": "Description of composition of other segment item not separately disclosed."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r260",
      "r261",
      "r268",
      "r857"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense",
        "verboseLabel": "Sales and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense [Member]",
        "verboseLabel": "Sales and Marketing",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_SellingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling Expense",
        "terseLabel": "Sales",
        "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "smlr_SeniorSecuredPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "SeniorSecuredPromissoryNotesMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNotesHeldForInvestmentDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to senior secured promissory notes.",
        "label": "Senior secured promissory notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Vesting period (in years)",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Expected dividend rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanStockBasedCompensationExpenseDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Stock Incentive Plan",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant date fair value of non-option equity instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grant Date Fair Value",
        "terseLabel": "Grant date fair value of stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Fully vested stock granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Maximum number of shares issued pursuant to awards granted under plan",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "verboseLabel": "Number of shares available for future stock-based compensation grants",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Exercisable, Ending",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Exercisable, Ending",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options forfeited/cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "smlr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of grant date fair value of options granted during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value",
        "terseLabel": "Grant date fair value of options granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Options granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value of options granted",
        "verboseLabel": "Weighted average grant date fair value of options granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Aggregate Intrinsic Value, Options Outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance, Ending",
        "periodStartLabel": "Balance, Beginning",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Number of Stock Options Outstanding",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance, Ending",
        "periodStartLabel": "Balance, Beginning",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails",
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Vested one year after the grant date",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Each month thereafter contingent upon the participant's continued service beginning on the initial vesting date",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Employee",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Non-employee directors",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage (in percent)",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "verboseLabel": "Maximum term of stock option grants",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected term (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Aggregate Intrinsic Value, Options Exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted Average Remaining Contractual Term, Options Exercisable (in years)",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted Average Remaining Contractual Term, Options Outstanding (in years)",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "smlr_SingleReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "SingleReportableSegmentMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the Company's single reportable segment.",
        "label": "Single Reportable Segment [Member]",
        "terseLabel": "Single reportable operating segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "verboseLabel": "State",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSegmentInformationReportableSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r165",
      "r239",
      "r243",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r274",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r374",
      "r378",
      "r381",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r854",
      "r857",
      "r858",
      "r864",
      "r901",
      "r1166",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r61",
      "r65",
      "r66",
      "r161",
      "r182",
      "r183",
      "r184",
      "r199",
      "r200",
      "r201",
      "r205",
      "r212",
      "r214",
      "r216",
      "r241",
      "r324",
      "r330",
      "r368",
      "r429",
      "r524",
      "r525",
      "r538",
      "r539",
      "r540",
      "r543",
      "r550",
      "r551",
      "r562",
      "r564",
      "r565",
      "r566",
      "r567",
      "r569",
      "r580",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r621",
      "r623",
      "r643",
      "r708",
      "r730",
      "r731",
      "r732",
      "r751",
      "r806"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r241",
      "r623",
      "r684",
      "r742",
      "r752",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r767",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r787",
      "r789",
      "r790",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r806",
      "r908"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statements of Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statements of Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r241",
      "r278",
      "r623",
      "r684",
      "r742",
      "r752",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r767",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r787",
      "r789",
      "r790",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r806",
      "r908"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r937",
      "r948",
      "r958",
      "r991"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "smlr_StockIncentivePlan2014Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "StockIncentivePlan2014Member",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to 2014 Stock Incentive Plan (\"2014 Plan\").",
        "label": "2014 Stock Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock (in shares)",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r61",
      "r96",
      "r747",
      "r806",
      "r834"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Employee/Directors stock grants (in shares)",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r61",
      "r96"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanSummaryOfCompanySStockOptionActivityDetails",
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised",
        "verboseLabel": "Stock option exercises (in shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r61",
      "r96",
      "r465"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r61",
      "r96",
      "r751",
      "r806",
      "r834",
      "r914"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Employee/Directors stock grants",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r60",
      "r61",
      "r96"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option exercises",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r61",
      "r65",
      "r66",
      "r96"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program, Authorized, Amount",
        "terseLabel": "Shares authorized under Share Repurchase Program",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1098"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets",
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r65",
      "r66",
      "r89",
      "r769",
      "r786",
      "r807",
      "r808",
      "r897",
      "r915",
      "r1046",
      "r1075",
      "r1146",
      "r1198"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_StockholdersEquityDeficitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "StockholdersEquityDeficitLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Stockholders Equity Deficit [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_StockholdersEquityDeficitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "StockholdersEquityDeficitTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the stockholders' equity (deficit).",
        "label": "Stockholders Equity Deficit [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "verboseLabel": "Stockholders' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r193",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r429",
      "r571",
      "r809",
      "r810",
      "r835"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Events",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r648"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "verboseLabel": "Subsequent Event",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r648"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r648"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r648"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEventsDetails",
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r648"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r649"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierConcentrationRiskMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk",
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardLineItems",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardTable",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Table]",
        "documentation": "Disclosure of information about tax credit carryforward available to reduce future taxable income. Includes, but is not limited to, description, amount, expiration date, limitation on use, and related deferred tax asset and valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "TaxesPaidRelatedToNetShareSettlementOfEquityAwards",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact from taxes paid related to net share settlement of equity awards.",
        "label": "Taxes Paid related to Net Share Settlement of Equity Awards",
        "verboseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares impact from taxes paid related to net share settlement of equity awards.",
        "label": "Taxes Paid related to Net Share Settlement of Equity Awards, Shares",
        "terseLabel": "Taxes paid related to net share settlement of equity awards (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TimeDepositsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TimeDepositsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Time Deposits, at Carrying Value",
        "terseLabel": "Deposits",
        "documentation": "Any certificate of deposit or savings account held by a bank or other financial institution for a short-term specified period of time. Because of their short-term, time deposits are considered highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Policy Text Block]",
        "verboseLabel": "Accounts Receivable and Allowance for Credit Losses",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r123",
      "r1063",
      "r1064",
      "r1066"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_TradingSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradingSecuritiesDebt",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Trading",
        "terseLabel": "U.S. Treasury bill",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r584",
      "r844",
      "r1067",
      "r1141",
      "r1142",
      "r1143"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://semlerscientific.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r413",
      "r426",
      "r570",
      "r605",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r709",
      "r884",
      "r885",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r898",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1138",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "verboseLabel": "Treasury Stock",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://semlerscientific.com/role/StatementBalanceSheetsParenthetical",
      "http://semlerscientific.com/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Balance (in shares)",
        "negatedPeriodStartLabel": "Balance (in shares)",
        "terseLabel": "Treasury stock shares (in shares)",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury stock acquired (in shares)",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r61",
      "r96"
     ]
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r204",
      "r205",
      "r206",
      "r207",
      "r217",
      "r275",
      "r276",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r367",
      "r368",
      "r376",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r608",
      "r609",
      "r620",
      "r621",
      "r622",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r685",
      "r686",
      "r687",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "verboseLabel": "U.S. Treasury bill",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r850",
      "r872",
      "r874",
      "r884",
      "r1164"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits - December 31",
        "periodStartLabel": "Unrecognized tax benefits - January 1",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r510",
      "r880"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Gross decreases related to prior tax positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r880"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest and penalty expenses related to uncertain tax positions",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r880"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "verboseLabel": "Gross increases related to current tax positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r880"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesSummaryOfActivityRelatedToCompanySGrossUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "verboseLabel": "Gross increases related to prior tax positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r880"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits, if recognized, would affect the effective tax rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r880"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r131",
      "r132",
      "r135",
      "r136"
     ]
    },
    "us-gaap_VariableLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureLeasesVariableFeeRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Lease, Income",
        "terseLabel": "Revenue from variable-fee licenses",
        "documentation": "Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "smlr_VendorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "VendorOneMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor one",
        "label": "Vendor one"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_VendorThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "VendorThreeMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor three.",
        "label": "Vendor three"
       }
      }
     },
     "auth_ref": []
    },
    "smlr_VendorTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://semlerscientific.com/20241231",
     "localname": "VendorTwoMember",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureConcentrationOfCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor two",
        "label": "Vendor two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureStockOptionPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of shares used in computing diluted net income per share",
        "totalLabel": "Diluted shares (in shares)",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r234"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://semlerscientific.com/role/DisclosureNetIncomePerShareBasicAndDilutedDetails",
      "http://semlerscientific.com/role/StatementStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average number of shares used in computing basic net income per share",
        "verboseLabel": "Basic shares (in shares)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r234"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "20",
   "Topic": "840",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481532/840-20-45-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "840",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481532/840-20-45-3"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-4"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481222/840-30-40-8"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-14"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3A"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3A"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-6A"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "44",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-44"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-20/tableOfContent"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-4"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482161/360-10-40-3A"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479016/842-30-45-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-13"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-14"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-2"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-4"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-13"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>123
<FILENAME>0001554859-25-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001554859-25-000011-xbrl.zip
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M:\,"L?4.DFBOL\B*9OKS/2 AGA'1*-[VG=EK>L_(,Q+9QVIRAUXMHQMI+U?
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M1Z$D%TM/M#:1_!X^1Y6(-JVPA$BV'GUP1%SDSK[%7)1]<=$5J\)6RSJT9L7
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M7UHF)ZWN:>VAL+=HD.0)(58,TZX29*)9B)191AL6LNZM0NC((=8)TRX=* ;
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M[>$_D?O5QD2(%61#XVE5M8NFFW]_]6<]HMK,O2;%L")7+5>4P2+&YA'^[&5
M4?+]I;V29+0O.JG.5*/OQ3^OMH]^_2]02P,$%     @ !H1<6O'%% +>-@
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MJQ>>8'294C:(< %I5B\RPN]W]2)#ZW\&KW*E/&EF)@>T4E$KH%H>+DZ454^
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M'6($; 3I1XC 7D')NABEPZ1^0/\YZ97F95SC%*VN _(591=Y&M'C[#0@9,7
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M<QV0KRC;I FIYY46Y=Q+I&^TP@Y7U^NMUU_S?YZ8/?[]_P-02P,$%     @
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M795\ R&-<?%QN.4#X8ITLFP1C< 5)&EW+K+2 #.Z_.8I>?YV14/P=W^$/YS
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M/(N+"\>I+RM-#Z:Q@[2,,DW?G,:K<\9/E!1= +D34"ZG6AS,<,Y"F':,IT%
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M(.RN/$TNM*UXR"<!BE\UN@_WWO74T>JU!MZKGCIJ/5<"^])31ZLY\IXZ_EC
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M":?):\651+%CMJH$UUF0;2ZCY"6SKY0F0?'@?:!&%$5=M X\=CDT!4.&*FB
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M!ZH>UC20O'*K/82:QEX4-RZNXIR-'3*^SD4?,Q&%Z^X2&5&0[EY8BE)=P##
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MKIP9=7?G9GM<7])V?649J0/@:'9P&QRLC> (%M\"I,S+U+\%B*K[$D[4RE(
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M'4$=:]%VDO(T)P\L_! 8I$3QHM'5"'(@UQ2. GA%_UN0,L^3WZ3\AIHFSM#
M(U83-@G1*B6L L:I(ZSGIGNK">#!\Q<8<.[ <;R(.:32:(,-+89G&J4.+S3@
M_FB5-J#0Z-6$P<59LMTF,0]BBG$S39]--3!:?P,#^XW&!@K(6=7#AA5)D6^
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M[*-F/*=1/:$2CSY410(F'.<5NA33I(WB852#O"Z'HY=B?/_3>MLH'@?/53;
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M7H[5X:(L:7-4_X6M"\I[>=W;F-#J013K^79?==H'W(<H(C[A[B=:O^Y7^Y@
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MGE&5M[#&"0<YVE((M"ZWJI'22/S5I,@W>1I(&/4;#-\NHR#TEP!).?8%!S$
M-PH(3L'45:7T\V$RWSAX/B$,,!_IVP\Q_-3T,@ P32A,$=+6 \M"R% *)P"8
MR^36XPJO(M>GYX D 1771A'H:0!2FE*9HF7T[E?6,S+!BT.QW@8 I0VE*5C:
M.FL'!\OU<N7Z:Y \]/WA8<OJ#:Z(F^'Z>?;(52<B70V 26,R4XP,[;U5]\A/
M]+Q3W3S/)%)3I&AB:8\%*=+2 +:V'MO!Y?\ ?F38A'P/_VB#S'E?#!>RPQB
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MD =#$LE'4FQ]D)\"+C38'0Q'AR3ABGRPW0 D0&$&'/A?6V#@?WR[C):1:Y%
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ML\C]63A#-*B!5Z>6U5XK4*C;&.3H5>O=UP4._'*V[!Y:0:*90 4!P:%7TSV
MG)I]CRZ1A)2 DPZ;U7@\$N9(J+ %R!$[M'A;K_@GX!('QR-)%9[9,H.+=?8O
MG!U!? "MT*)NBVC) +4W> ,CB+M5E!MJA0A%\N0#1..=HAH(=95SWB"87W\
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M)LB7Z&D@<-I2WTN:K $"@,CB <Y51&X#L9T%?2<VW1_ #_HG9@2%4&<#@:2
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MAWG)\VR_ 2=RP6Q>G%B&OQ?KY(^\)SX-1AJ7=JA\YZ.*ZM$_ *+QSX3&BRB
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M.,91T+56Z)5GWKD>+E=U]HL\[8H"KD8!'/((-DEN>P4"&\$51Q=)CJ(EL)H
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ML9;'T/'Q7I&PW*<FY%N3[<<H=>GGB@A+%@KYSRO>Y?_C_P-02P,$%     @
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MO/NASI#<QN<!(!$^D;&P7N)1/0O&+@X7I<K-'9?J@8&N=\>S82)T_BL)F>\
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MBMK3X&U=H7Y#IG ,3Q+^_%0NF8\@*1[88)4_F;^H$5(3F#]$"BB*SR1![AE
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M^0'AEXB$7^B%WPEP7Y-5W#E(@M:2*LJFH&BF;<!(#'Y;,?AZGM0:T4<9K>=
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M2V*(RXAJH"1ACL9D1QZP363[FN;*7MV*%D2$]5L1%J8*+&>Q\$)NL#8@&?$
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M)KXWX">3T+TH2SADCKT[0P:*@N!O:!/727?](V=7 -NL+MB)3Q7P_;_&<7Y
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MZ SY#'AYW=;7TNW&PE3$N'>Z+"$DTV3F"$KR"9761>7>Y&LA(M:G+2++$29
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M7&L) \^$YD/7PA>GYS_9C[^T<DU7.F<R!I"$:Q*9*Z4IFU9WV  ::4L]]VF
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M;YEH9TSNWFYU7<T1?ZN#?N/&$W"8BW5C2#)Y!,\=Y&^I,^-V7R?T$SQZ8_I
MO7+,M.W9W02.)G0;!)3@^1>2?O1G]IO)B25,R+EH GX2+B, <8A2=-.+/A72
M:F7N_3"^Z**6)=Q,'^&.T@5_JF[+%9ZQL4R\4MP^UI3]OF(WAOOPG"7)/_VQ
MNJ-]_T,$';/&=NUV<^NHG151:GR\<<.^MQ4B,$];&\3$]KV566X82&"CZI]L
MTZ1[IFIV[,/#[+^G=UDA0%[9$#H2_LROTC1K@KVX0<'4#1=5)UF?"E&U01.^
MIC+G4\.4-I_9NBNG]O%A]E(NYZNDI5O(U76I2,P>_K+W,VV&F#7J?1X_(')Q
M@?7@M=J<!\Q<'WDYM8_J9S#)7)7(KX'DH*@O@3>^6IH]9/['Q>D:FLD5^<"\
MFON&-X-^N[<M0=I\()O*-RTQ"FY?7J.0Z69-N3G<7]>"))[1Y$+53N; 9Z8F
M%Y$M#+L2IJ)?D[M_L48D[.>_D,7@I?42T+N+"]UW UC[5R[(O6-;O9EZTKJR
M'BS-*H="C6<8-O3D11D]BR]MIY 'IO(LF!G75G5']VL)E'5VY7C!A#/J4L**
M;>QW#ZAVPT/+9KWJM7L-!]-?W*<!5%UU/8C#T/4ZS[,'1^$J3$SRYTR,7K(P
MKYA0C$)X&#$T]S"((71SGAP?$<0GVYC#7M(E^&)J*R\0R1%I^:4N,MY2;W%5
MU->:!&6JYVU9KF!Z\7?VA[JU7&__+ Q=@"Y]=C2^N[.+[%@[.;Y_]*6><O$E
MBNE,*Z;RWN&Q^\=XDOP8G7.#P)0O_/CPP<.)[ZZ0'=)G^"0/P)?MW,L;>,4F
M.P5?ZZ:XNY,O]GA3O]4<(P\_;=I,?<U,-7Y \=(C_T$_R;V4OA5W9MU4"LBG
M*_NV5$*9(%G5+@:R+(G-7S=]XLF$] :2D:6='QVKW^N5.+YLI?7&TAQFM;WS
MTK=T;%F@"* $/?!VW8<ZM0OZZ43; '-3>]CPP9#]0/_!UN-PRGA;*1G77+?6
M@J'.G79P"2A#KH"L7@V V!(+.9T603O9G*L3Z&WC:MU?^>L"/-^36RK!I$Q&
M#57CVV*]U^R]8#"SHSS!ABZTCCAKHU:SU= BQ[Y$QVS4Q[)>7:*PG[Y;[0(H
M5X.^W)OPU*<<GN3%"V-$S 'NBO:+MSDQ\??6ZR0R1O*_]G[F_@5Q'!R#>'#Q
M Z81EPM0S*'FNU 7R#L'481TA8XH'$JY!3!^X;Y81 >*>_UX>TC#Z> Y@6YY
M_-TT1G2<7.A-<"$3ZFBW?WJ-EP@O2Q[!K02CI406&(K-XFV/MIE;P#<@#P!_
MV/JN'(+;3>5S]] XY[OLM.KF[DVND(=G]/VZ=5^YPP#A+V64UT5D>MG [UO(
MB+G0PY ]H7<#[@WD4B663+CG6<0WY;]JJ;2+]485S+I)4E%<9]X5-VZA+/QD
M17?VX8+S%ZMN6)>),V/-85=L9Y@:TG/IS\>U15F9(FI2P-THK)"L"V^Y\$S(
M![F2'@3ZNO1T-X2&U:11/Z*[V+CI6<+00(W*JP2I+%4N1'?1?Y,N0+\4<U%B
M</#0A6W,#<R*[39 -,BU7='9[ H50-%8 <GRX+[!EF_P4]TD2X[W5$3W3@F;
M'!*WX@=+H[C'^0L3(?T=>A@ATQ&]>IQM(O>]KFI<*I+J+HDC]N>ZH(0#72+.
M]2OWZ$9-(>?I$O/#L[P02E\VAG98E78RZ''1)=&T]S0*(S1O-AH7AC,S#=KL
ML-S6]/&1A*S8P^P<V/"%O3+5250T2:J5&,01)75E:;,VDL(@Y)J<Q9F7;DO.
MGSRC+Z&'R(/CS^U['OO7>1QMV51%?= N#DST<?S59O*X_8TV1>J:ND.SNFP$
M['Y16J:MEEQ_(S&(P(UA$/I6HLE6N\ 58*L9OK>EI&ZC/-X7_9=;:GS(^G"Q
MN.L[_\=G@^7M!"<JGB,W4@!D#IU?'ZGQL4L[*/$%B+5F-04"./R.6[(>[NMI
M^WK:OI[VOBU9-T#$ ,S?*^)?/4CXZ9N5-NP3:<?\3#>G"_]%<&^<"5Q=;7K]
MIEG#D*(6KF">=*@=4>$W4X7?-:L?"%+,[_L27[RNBA M*%N%GBZI/#"35*\:
M.=7H-U'<5U)(D^=983:3SB18JNI:(.PN KRJ^BO^4X[&&X;[]'KY!Y TBR!3
MKZU8+EQ;*A->4ZW61GM0+H51 .P<&L95(T%AS0=4W=B6!TEA0,!%53XXK(>*
MB#(A*#MY<?JSTT*4\RQC;^YDJF6LBI%5$SGS,D.28! N<]Q9?Y]K'J,#^ -,
M$B&#[+R*LLQ>$'YZ>FCG^8^0;'DNOH_BNGZD3,:/04_P5CHDCL/@W'J%?P'!
M6G5G[@A*N^V*F7L5HJL;B?Q]9LN2U -=R= ^\$#:!R8\49_NMNJ-Y"N8.W,6
MP', &N]97*G<*KW2-;),6;+/0G98?>?3=SF3WI>4G<\GK4NW^:2O4:I@L#CK
MQOK_]/7'$:,/$^>E\LGY]V^C=KN$*3A1CM'U:941H9Y)XP.0';7S4055B8.Z
M J%&E!'WF;,^&JAN3(J@=T5_916T\80:$%7I1\1\C_00HA!BIU^>1_%M9')\
M9.O.%.<F958L5'9N15/K_2;+TK^9-8EKO[I]8XB%><+799WTJ+'4'R8H)AMW
M:ZD@<F*Y+#O@4_-85I56%R$G4XP1,?G=&H7;X_LM:,SK*-UW=U'\&V'>()^9
M#W=LB$E&TJI4%,YAOY0)[+#W2W1W8F2-X>,3TDBO499T;(5<59Y==.U;?KPJ
M-DOEGIPQ^,-6D9/=7\086A3%_&MU67V\JA$G$*^;-70\ 7D^E>3+5RN&JW5?
M%2@T"S_FHF0_'C+J<A2,B=PDDI9>WW55HX4;%%&#I/GQBV4QNP)<6[(-.%\E
M_DM>A#]HVCI@:JP\TT>GF'3CSX".<192,NU2_%]>(*PV/RW-M5M!-,4_]&*K
MU$1]"++$(R#03OM)OO 7R4YY(SM%WK_/@TQM)I],"L6<7BU^U $:_?;FJC7A
M*TDVXX?R7[GOM,DCJK.$.2Q0UQP(DMR- 7X<''2$!:&]["CFUSE_=F; .509
M.U+GL5.4N.22Q&9&%":KU:IW->B6/$NU<$]!.4Y8^/"O51LZL9^]><W73L6*
MQJ B$9F@-S9&96'# Z<J!%C@(F"-<G20-)SJ7(WB%+97U!LA#^8IQAJ_1P6L
M!Q-E'%#M8J6']!&8@ZY<@0BK43R$0 @$XN"'U8>QW#(??'#=;/2EY15NOT%[
MV8?R$_5'+H!@TC:+5@+/0G1G0OL24XN\I4TK/M=#VKAYHX4FR53-SI:%.&*7
M&BN" +%=.B^+RG[$#[41_D,05?'-Q-RCE*;-$9^FX4XZ?WRK= ]JW,I_.#[W
M;/+L?2H/+[: ;P94CK ZA4%&K=7290@J@! =)>Y5L"3ZTNV7\_!3[>VO2E*1
M2JI@, 48Z<-FAUS'L-L-Q-_=" XE"Z&-<NZZQ&T&E(P](O@*F1>/3P]D0=5_
M*[W/VA=+%,J:!C:C3Q?@Y+Y^D?)P2QM2=#_@B,C5J6KD.E@]\((]\W^/"+LD
MXB=EBGC[GGW#MW.Y95\EG"/,7]ODX!"EOY1;LB:0N\C]E\;+$+UC]OUKM[K^
M52Z>VTV$#7-D.]E8LLUS4HPH*L1&!Q@6?.FKHAF\06$)/[F )7_4]_(H"5 "
MK84B.L$>I&R.Q1*4GK)&%Q)D"&=<8=07.NAIH<\=[F,.GL[?)I)Y&H+,T/BS
M;L+:-2J<!MSR$5@/!'&@SG!W8$;< M#(3<,+B/NY4Z.0[_@[\PE8!)V0ZUP2
MPNJFMRO6\SPJKA55S0.)XF$^5 J88F..=U'NLI?$PX198E8"*NL7[CRZLIIW
M-JL+J<@&.;00JA8^-^9L_P+*@;,R5G,8W8:AWU@-.R&\^632/+<?">?CB$;<
MNJT_"ULP4A4@?AK@U%$BU_CQ6]TQ2;0UP@E;2#85--7!;PSLG1%)?XBB%<,T
M0/QY%%VY"^;N/>(T%]POS;W=/A"QYJ.(2^DR-OY^ I6)#-14,LKH=7LACQ8Y
M$?;8"3!0V+<]&[;"9K<F5O>&V:BP98MK]XA,Z$AT%<^W?!OV+U)4P-2S-Z"N
ME<>6)ESOV)>26AH!SQ)\_N^RP/=H7^#;%_CV!;Y?Z8"0^E+*&7!WF3XAQB /
MP?N10@:7Y$:C!39N],/(40MA0<HBMX7V92C@O,B.V?J::L:LC8W3Q5*=V @T
MEC%+=.HY7PJTC\4MJ;]<.P'ZDB2%&E5+"(O_"E4%UA:M9(6P#.X\W50<@ 'A
MY,,,5KS2X4K^3=K%UV0S:=L%$OT")I*X6(+LJ5::A%/9?<"*S,G1R8FX[X3B
MENMEP&W#W^0VT+I:TM'" @.0I;X>5<*-KOHECR_M-ME25DA;=%(JSQIUFW%'
M#1W(J2>ULNHM[U>[ZM UI%3R44AD4*L;*7I($DR?D'YI2="CI]L(468,)O*H
M<6"E+V6:2$=)YU1X7B[*6:&Z4I*M9"9+HXE';/!:5M*DP)0+J"</_N$V"_SM
MNG)SY2&A7UA,'<73H.6&O=((_\HMV@.J'? [@?W<Q[I?0BM#&!5#$XUWBJ-G
MYS15'62J9)^=1Y\17@HNN<;Y/JMJ#F](Q*^B%Q+E9'87;4C)6<ZK]3))"/!I
M1G&FN*Z0S4+$VXQ;;,>Y 6/I^2!CY%:_AS\3ZCEIC?J=YHAK)'YJVUEW1<?D
MW4]D:*T;@*1U>,$]$(;,9'3P3/E:M0E)^M$&:5?RC^_1B"R>911%ZT;FY<P9
MPR(T447W])<Q%D@68\^^>7I&$3H6Z6Z([40KA'>OI>C<KTU^,.(7/)%0X1)I
MF4;HN5( P4\->6[/!]]!@;\^6W<N8G7KU7U,F,QU*7P_ED$PVC//0#J+"@;H
M1<"@;\T[C/$.I1O])0V#UX)+U]2[,Q#91TM!O$D'U'$OB_;+]-#&$AHBZA$5
M4^/C3:"2&L_ OV?<)X(;HKCHIO!2C(0).S>*LU5NK(24?AS'(W0/9[*72M'
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M@'4DNXN8L>3+@CSHV:0+T9,9$1@L:.L9&"C,J\:.7?'-:"='33ZQ"QEP8B1
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M1-:VAUAUUFF2,LY]K!W R>O+>G$@L93EAG8$_'>5!,J>EQ>=2:R<1 L-:^S
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MG'.:GD3U)(+5L\9HI27Z3*.SSRUA)%VUEI":_I[HOCRCFOG1UT_+ )KV_4^
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M&%)OFU6Y9>SZ[;6=@W[*>77!(0VWPO""HYU<JBE+7?&>M[#99,9C%;)1&IR
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MA3;;6;@V^>$VYBQN$TZ(^2H3$&'XXM0S3Z=SR COJT3J0[CM\)TXZJH+*L"
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ML5[>DU_8RUN0\&RF2@?]7JLT0!%$OL7N#+O5T">60NCE(5"2,'E'1HG4]2Y
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M[3BDJC%^G4'B(UM53'IO3#;(M5"HQEIJ:02^S_P"JEN:G+"+/;FG= =,K1Q
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MD05B)<BT8 65R+@+^.S?_RC3O1=JPU'<QP[T2D!DJL*^(M;[$E9,9)>XUI+
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MN3$&FPP]#Y=0_OH%O!CA;S_$*_( _B*^C%O+/:E*I?6@[UGE,K2MR)<5Q/[
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M+/)WV=!!YF[NE1VE7MQDV3O,*&IT_A5%KY^L94TN<F13T3'2]\6N,G'Z,NI
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M9!'NWJ.B?EY&_9/]DLNN"?G7"'<ME9?6=ZTU%U6]W"(GF1X G ,#.FM2O*^
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M'[A@R+W@-/S@'.2GFC A(5_D:[7!$P,4:'@"XKJ9"T[G3,Y?*4<T51HI6]2
M#5E8QJG5F?IIW/QRS$DA*7UGQOC/=UG<@^;N_:P/)*?$'&%>"VE?9"^%UN(\
MP1:85.D*E6HAF8:N] J3;OMF  .9(GK%TG5/Z>8O47WAH?&,\<A,@=L87"@?
M>SI =Z+0HZ,4VID,X7:^W;W0[(M2G[;/4= NR1(BYT=_N2<D1MD_S';IK^YI
M>K.5)_?T0[*WH=TZG(19NSN[TC0-'9Y)T5TN*(Q,V8]G5K<RXJX;]U)(FJ&F
M,)C@LMJ7)2P1.?KY"P+S.K.>-A[TZS_MS)Z]?O=Z)*]$>M1\570"1R35W4R>
M&L"Q3TB-E8=R&J>A%,>L%+SR<A.WA^L2<_N 2J2WD@1D6D1_N+!TDC;7D(DR
M?3?0D!?1]!PB8)3. PLFS?!SG$$M]_#[?QRC.6?J39T<B.YU_JTM5BHIOON8
MG#JWLE5D$"91.3Z-F!YGOLC#T/,*Z[/.(.@W)>UTV:B5)":]2I^RQ(NU3JN6
M1#J;!9=(/$.6&\0Y%0G"SN>>%Y)',\^ETE5>LKTC'<]/1 M8VV!L&QU3!&M!
M+?(&_'V]#'MG9EC7C%'0@[(DT7D!$LCX /&3XE]%5^%]]RE%,8)(TYR?I:KT
M"P8\]I0UI&EQ3]9EM"^H@QG>FJXCTU^$^W.!<\8S044)"*!<46<[*P>&0U(.
M"6*22YH\D\:#F'"2/6QFJ!D]"E1MT97QLV097+NE4(W+'>+85XYR9T\JN(75
M;,O]!S.(*G_3-M16E"M/*5[3F 7,S-O"^^GNBP=F3CBW]YL[LUST>C./#./<
M& 0G4G_>IM(IDM>IB[$6*)!;]B%:21Q*1)5]S]5!H58^GV=ISA7L"H4-*>IT
M' 6Z3EHG5Q(J<';:W-E3!*]&EWF]; ?(4D2?8GA(+[@:PM8SR X*S(#E,(YX
MKUC;2I2[#46NWAT4^ZAB!%;6T5.WKE3S9SPHS=KTK6AE5 FOLN0=96JX?7IE
M@%9)\$YT@%$B"7IT(9MDY>J]> +[% ]Y/?_.Y!N%"63=4K?VSA%_H@21 FL<
M*8RVX36'1JH M*N<M8)@<6;//H;_HNJFK5!2&8H.2%5I<:<S_<#=D)WH+RP]
M]VOF<7XXFAM_(M.L$J7 U@2]I?T);I38@BTZ.[MQ3ZM%*@;>,78:_2N-WI.!
M9]LB.!<3.^\"+BY#AX-(IQ<C':T3(S5D6NR>>CJM ?(A4Z(?9&R05NYN"QV7
MKXSBM>G"4JDVY+JZ$@L(4>#6I^35.)N'*U,8MQIK29.+LJGO*PV4V^NVC2YW
MI>!)8&I;/E38W,MLLS\4B:5,DE2T=T=!A0EQK^_LK"!A2;O.A7L9;!V^RNJY
M3<2#(&\Q"->LY6WIJBHD92B51YL5DEP)8X[,Z-E$R"VTJ9]/+G=IP,*R]"Y-
M[?5[[6.$"1YF37)O4Y/<U"0W-<GXM?1<G<Y[VMWS[^DUX&&O \"%@-8G)?44
M92D=57^(]]$=Q<?AP7,S3&D-"Z+;PCKB84H(I6=%=:6 I8)Y,6-AS;'"D *7
M0L1>^N&<7.LIN?A$GR]<:-/KE7"?:&8L>M9OOJZ$@Q YG;J5AFO)ZE#>9PZW
M]@_P'Z\Y=;JO] A/^RR;(D\QVM\=NWVS=X"C.,U31(1<K0#^*KQ))#G_EI0M
M13+N*X_P%0&"_MEME.T=Y\45!>;V_+S.SEFS-B\IHUD8O3$A#T;NN^9HW]VU
MRR#)G(X&=A8M*W(9LVRI$+H :Z,.'A%_C+Y@8$J#51A3-&S\ O0!'T6M6N.,
ME]8'\38Z?R1JZ"$_U7DLWV I,)V*GI XSK8 TELTV3?ZEV_O8*>KIV!^0D<4
M%A*-8<O%O56[_&:6O\]2:PCUC&7;L*S=?U,=L'R,%M^?_F)_\;L&C 7B;+SX
M'5CG;JS?NF@;4O+)E,ZJJSI9?&L&( ;>QU.'CY\<.I]JF=IQQ1_J6[K?9>1O
M/D6E'U4!>Y=M0<#E8&H\@,XMGFJ>3R7.$ !IZ$(+OB(]WE_HI?P%;W&SH/ZS
M%A2.U($>%Z%P,H8T&,LA)J>*4VY%L5E9FY6%E<5\[@HG25TX'@@Z8U!0APD_
M^'9<; KG(WBE.2U3=4YJ3VU/*1!#PAW\!R['Q-XB5UB$^&^S<C<KMV\39T7V
M/@]V<5$D %V,F?D+Y>UJ+&@[))&LH[=94ILEA265YD6[5%L8&$+$XGER7[0L
M^*@A%BBDF F?(<7B('YH>AU&[0*\HJ7@[+3VBC#I6W(%-\MQLQQI.5)O)ZVE
M%K(,20 94!DCHQ+)90:@5GJ9L(*%)QBEW_J,OM>%+S)NM$H9]-O"(12-RR5H
M\GT?WY2;*;?7K\6[SVX,Y*N0X7S<G_YXE5(*),H^8EU\)MK W23-*ROQHG5Z
MSZ'2M)!<HHJ:4"8:28S0*C:QXO&^9\Y\&7Z4LT#.$:-"-IV)R4K\+*:O#7FM
M7D[/^W=(N,042Y^ #/;W9RH- F(([5 GN9!%,65-D,> [THMRL9 -Y&%'BE$
MB#$T1.]"<.0F,Q^!A4]P\03 T4)<C[&?7LEM(:7(BN_\"JU:O336F8'3.\3-
M>V=(;4=BQWN_&<D?Y)3TYV!("TJFD&<, 8%_54C>1\*Z =VHN1$AL0&FB'GF
MN^)49D+ Q,"P11/&<'W8O#(@XAB)),#XH9?(QGC@Y^:&C)K,2$N)AH(B1I!\
M[F5-P]+A5MEPI73LG%F MJ9U*XB@MEPD>>H=%+1RH#.=?%P"UD.;B5M2=9&O
M'RH)379 KM=Y*&-JZR5#047Y0EY/FA7$,#!JJH+R]-<X/V&#">^TO\E7FC4E
M(M0$W.:J:E3D60OB:[Z-LB+-:JX0$_T[W?'KP/6$.626.;:0[Z0:X:[LI=J4
M B1Z ;Y?F!9JU#!SU3$J6<G81A^LJEDP"CR2H#%:1%P9(<235NI[ PTOIV%^
M8QI7@U7I6YCK#*%Q'4Q"E]5DS>-$+[IC7@:-&=NY=9:G8QRE&@\KQBB>(KD:
MTY]6 :%=7DA_48UN\  T9V$+']6QD8PK%71^$MBAK;/.F'D(V)T\OPJZ-9_)
MFS#?TCO-EDQX1/2@+%=^O7!)M-31K'WVY+I+7RFQ?- U2+-90E%#8/?U'R<P
MW#6_-M,4OZ?AS2YBQU)-H_J+P==%=_FP-W$RT]GE3:73H:W[D5^AU$&T.9R7
M6<#=<<.9P>]TTVVP..Z!<J:O/W=;'!28>94V_2W8]99D021A]B._9MWZ'C /
MO66./5?-/E>/YU@.2 "A&I6;N7G5T'2"D(!A,PR5<_>VKF:9L0HHN@CH&@2<
M)"U [@^\7P_C]SPXWGN^9("RIUP08HRLA# UHZ<MYLPHW[5-A\']YON*B:"N
MU(_R< 96,*0FO6V^K1-#+5&V#R6OI^V<^Q7X7A&KJCFHF>L1T\))$"W6XXR!
MMKIQE3O0^P23OG7EOCEDJ\CP^57&8AYH7W$>X;E809G N2<JN\J&I\4]X5_0
MA+'^,6*:^V@YD-I&L9+G# H:\N89/\]J\*JAH>/>'IVBZ=*2JE :B;M[Q,4-
M'9K8?:+.+AN0Z9DZ\\#/BH%&<:#=GY5(W'F9H(<),-O? ,PV +,-P.R/\Q;.
MV!0: ^7-XBSS?94FYB,U;+;!%)$"QS.$REJ'Q1KB4+U'G^$D)KO\H+D MW>8
MBHN0X#"9C(DTY19>SHR.QBCA8%I?E*J)0C?NYA>'5Z)%PJHMF*'B)*9.U;O[
M0'S@3H,!NP6[V4#?X]XH@C'A]LV!_9V%[TI28,-B21DD(7M36Q;@X2?05@<D
M74*$0J.ZA>BG[XCHA,R9\(_IU(L ]_5OP+*=^N>2D"N$/=1FT/+I#^8!:0D3
ML3>?Q.JDL(BLB]PVY:J6Y%(W-"6:LQK=AVXG^C=%E,Z@XPOZ8;'\O)7^\01@
MJ-Q;,$"9D6M2<UN@KQQ\GH'2<%J+ R&J_[%_%DAC-<VFSQI5_WH<;FGF?+BF
M(^0Y0'=VC];O+/:#M:LT;*D/F)1F:%:V1V^N32"J3A$NR;U]DG9!IP>,!#I#
M!4.L?21CV;OKK1 WI]./)BK@Z#$E1$2Z]HO:.1,,)%N<]=:%O/[UUO CA\$=
MATU2!$;F1>ON.54&O:%[4<D9]@/A7S>MNL;$4:21,$6K)>=;-SG6 BY[[#'1
M>G$_=1>@P ADGT'L?N7O9*D05')MV5N5X;+>=K;2%Z7'%]]!_:]&N GXXF!#
M7'-!\.)>\_KXAK?=RY^EG<,N3]"\.Z5]'754P8$+DIT1^X4/GC\SLW4RW,=/
M+T::XV,38U70Z%.7W 5=9N?5DCE,UTX/E]&OIY#^BNXF+ EBQ&+) Z%*^)H9
MF=;>:\H2IC83!+(3JD8F*37=AK;"4=D"V$\F^YH2"]BPB"0$:@EP,YP+9DJ"
MUX](>A"93Y1J&+,942Y@LGT>A*$R(B1K60_*56?7!?B_]'!J)^1H<-HT;</^
MDV'0<NO5V:O$Y^Z8&\Y]LBVO<B;(<E^XR-+S+%@$LCI8"$(=584OT$]43L_-
M$*V/_#+K3 6/19)+DJ11@S9D])4^W(L1\PN"-6\([IW2>Q4[V*?L0#1 ;>7T
MIV=" S,#12)"R19VZ5>J1!V(=M%82N4*$&MY$OP4C+_";[/FS:OG!VF>J9O)
M5N(7;M8WA++5A( %?+)QK!(QS/<7@4FWL_..M/]+]Q[1H[*_(ZN6">(&\X9N
M+U/.F>M6M2$R!S:KD ^C)Y_EF[.!>N_Z53]TSW)E,HOC: 39>\FC4O8WJ8NU
M#XS]GX-U([\,TLRB,^IFXK+*4V8'D3PE?(<N1<A-#+I:_M&:_V=Y)OV:=66?
M;A;+O.ZEW;\?O<:$A:ZESK'AX3R=>?"=\=SL':NCK+>57+WA"EZDR=31@1UK
MH.+M@9YN(HEAM\U8<PZ#"J1KWP4*L^CDD\KLDKG<G-L8FO[7/HGL?-7\$([P
MP&.^/;J?E_PSL1:=L\" ;]<Q-1H$,ET&NR!7',3[M&1=V2R9KSG)43%'7F1P
MY2!"H<)<;_I4AR?JP[]&=T4R5&A9)!1@7V@%CU$U6=2B+V9X6B3Y/"!;*OO2
M+;B!5PP71L(RZ:P2ID+(B%V*#@9^?"$CF+3+L:K!%!"6B$!H5>\Z$V'@\VVU
MG6_TS*BP.\ ##NI>-P=  N_2C8>U.O1>?+V:RM24ZE$)PN1]W)((=E6N08I7
MA>0,!+"0LZ&XS8<U@WK"\7!_9>TZ8<6(1.TLA5Y8:<W22&5?>BGYZ[;L0RXP
M'6P*3)L"TZ; =+<,!L=L@D[)!-WA87T+S_)ZL#4S(%%L5]%I"VJC-">FUDJZ
MOFW3N$UD<MT+_?T75<7BL=Q+=)Z1JS4>1!?'8H5Y.2N8KEIR]5-AFR4':DY
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M.1G%*6H00&V8*5VTR-$1*0K>X(.L%3_>V=2*-[7B3:WX0W!T9P-6BDRJ<F3
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M?< A:[5+X^ZK+MIG[?9]L]LU:*WAOH+<LW:WU+#^Z-U03<%CK(<:ES?5O:0
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MA7:%$D&./.2P6RY_DT<*RRU %5?M"B="BJ&7X8T(V&3Q*<!G>3QC/8Y>ZTB
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M%X25AY8:Z8J;!VJW -.;!Y<V'[1+00VH;2 (^ :-2L>2P9<D; W#;\H8X2-
M&>]_"[Z+T@#X*B07)W%%8'I@+T@>NFV*31:NRP HZ"Z^0%8NGTWX=X/7@I&)
M>BD(!PD:#_FKM ]A1(0CNQ,^WB<V]7/I#B([<@3,.I)N4.4>\H);&$Y^)<<T
MKR2O'*Y+>@$CC[S [-AQ0(DF1O(U]-$_H0( (!Y'Z%C='D1YOK1QMC2PVX Z
M@*Q2GRSEV(F\OG3YGH=@836TT37PT +RD!(3V >=?Y4=QW#^L>.'L?F.]!P
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M4-,+FA@\-@@SBY'!(67(?*>BI/E/VB6E0GPZ @(&21Z<P,B!_!GF(A&8>)H
MXW"44:!/0:,D)]&"Z8+#DLC#F 0/ M"LI/N+2&^'8P8=&S.P,0,;,UB0Z_T(
M;7F"'QEJ\TS>D<L/K9*; ?@-JLR+Q<93DMTWDIMJJ'S_\F80AU)37_VDE'N
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MP>6:YH+KQ6.?WQ]Y 5[Z..C[H?-MRJHV;_#^I,V&4MC\#PB%C_*6R ,TU\1
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MJ;V(>B=\3!K'A8AEF93M^OUY/*S0ORF?!W0C6= "D]4CC^Z'TX]DV@Y!;3]
M#;^0?HZ@,!.*>/*P:]1,59KQ/-@C1*44#=3IE+['R<+R5'3B</$84]EI1G+:
MK"G)1)]5,%LBM/!=60N0];W$"5'C)#\K\+7\)FY1OWS=J+<,#(5)Z9ZM"T_*
MM#@UDG&:F!"*-Z-YG$;2\VD,"9^H+("TGY#D<"A5&$6%[HS<)!C8()AD"$SV
M9JA-*E.5K^!SRIK2=[YFV&23&72P\PDE?($.GFU*C_F0*KX4@RC8?EE"^,1
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M/N'YK,Q2O*9\FUJUG-3(*H8WE&BO\!9=VI,<"P]F4LNOY9'?BF1&%!_ 1QV
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MU(M9^5=:)/:VA<,&- D<F#8AMOE?+-^<#_+N@_!]<9L*]EGMZX0,'HEF,.1
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M]AGTTA<WJ')ZF8HB.3>:B]1B;ISV@5OIKA6(ZC#P1U OL#?!C/$ 4Z@;&OO
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M&(1D1.VHB*M*B85R#9D5REW2=F(PH\401(7DY>]"S;LE?Y?F;QIA,S1@?"0
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MY*JH3Q;(ME[%W+WV5MQY ^PPQ9W[3&H:7B;5">N"@]T )_&)8Z?BT'70"3G
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MNY'S;H+U5 H">W(D<KR8DLH5L1-Y?9G,0-&'W.YYH.LAJOKX*+RKU(<3&4$
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M#JNWOV3J6(4?I+9>2GFN'^0+=0M:D0_$XL/#7*.U7NODN?APB5TQ=LHEMCO
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M]4,D@#"%Q:0NX(]KA.#B!+8UHJTJDG29\&-Q!_0AX"O8B >;"X(4'H[$.(R
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M1&$,NJ0/PWS+(%>JVE(@UQ;+(4&]O134&QKJ7\:9ECL7 1H/(T"[6^VU2H4
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MKCBR%#Y5=CX[+2:_D%(("\2 7U&B\E3RP60$<=G@NKQ4C+BE5(@<Q51"#PN
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M)HQHC+X3I-2C\#:ZQC%,6M#K:8MJZ'Z:D+7^C.'H.@%YA^2857;ZW1%@I"!
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MJQ;EQ)]3:;9__J-^6'L?#N1_I?-:_IWEPUM463.J/"2=MXXJ7S-?_ ;09;&
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MSJ<^,I(W I';/'=>YJ[+$=IHRA,C-Y9'&#=$3_4?1):GG%+.!SRM3UM/TSG
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MH)U].7\F"Z#V?B1FA/(3GN#^E_!T>//7JT-X=9HS WQZEO#5BN$W=2P?C-4
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M2([>J\XL[X72/!!+E\O-^4VFJ7'+.O5]C4KVJ^+(HOW]%H3R&'/UR0"OJ7F
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M0(,2 'ZE3N^D7K_2#9<5G"$,Q9,YOD+Y,,T7][)/9O,#&D>FF.6=)GQW<"D
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M(X5P<H&P[]\._)6(@TXO;\^14AM@A;QH4 X'_3YH5RLEI*%_C+<"A9"/,P,
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M@5OZWV>"UM5?Y<MDSY6_C*B0ED14,+Y\C'QY/^G9,QAEL!<E>6HPR@)1K,9
MU-N[@8'$U1 1,,N!2; CQ_@:[D,WYIJB@>AJ:TH$Q%B,H\TLYR082))7$F[;
MID006Y+RFFTR@<4$UGZ2K[A%@24S@<4$UO?!^,#NFHFB.2DULZ>\^DN><-F&
MC!.9C&,R[AO).&F+,B[.9!R3<=\'XP,95S2-:,4EQ]G6B"!9(>>@RA\1(0.H
MA9?K#W1S$A1*S)J&[>H.@L()VY:&$I.&3!I^(VDH;U$:)I@T9-+P^V#\IZ4A
M/!A(0NY,L[!":]QN6P3*3 1N500&A80.LR*LQ"K"LHJPJW'UT"K"LHI5K&(5
MJUC%*E9]TXI5^Z-2[<*XT,;_GVHJ__E(*8XW[8Q4;XM6=9)9U<RJ_G:('QC7
M4 # TA1G:EDW#*(79$;(4O?>UQS?C*$=X@<Q9F@S7_.WY1&$Q%),.#+A^.T0
M__/"<4]<SPGF>F82\6 DXF<J=,6E4(6NA,1O/Q8IO2@*68XCDX5'B_(U/$!^
M?:&9K/-JQND8V7B:9^[5</-*N(%PHJV/^J;162GTX(DST^WHR.9N7&O0G42S
M79=(3.WKH49?SX?T$^4%F56A8])NGTE_F[%& L\L/R;MO@_*>\:;)^.FTLX3
M<#=HPHGQ[<LW>4/RC?DWF7S;<62AP,^('>K#><2>W*9\$YA\.VCYQM#\KV4:
ME0?BQT5:%1L(A(O5U\@C'Y9CR==R[(M>R1M$0._5J&4^R2U)L=3VX2#NN1B;
M5O^3).@A ]7_I'1JRU6H0(*)6Y%@N\6 W8NP]>^?X?O?9/^KN&]X%=7G/),1
MZ#AMF4._KP7%*^QW5F]A9P1]J]^ZAZ,O(2)?:-MUS&F.S:G3>SSZZYA(*7HG
M9[;)>QB^MN'Q2U<GPE1^M\RFNIGB.-[TZ24U-C=1NOTPV0$3C%MC%$NZ,!!&
MD=JF8%Q2RFT3-W6'20I,,AX7PM>P-83:HO^-^H,_7,T=#(@XF%W8!;+O+;E7
M[IK8T,;<&;XE/[H6MOT?/5O1DW+>-9](0T($X</&7^KHFYD<)AM@$G&[UQM+
M.LQMN<"IL)V"<8=)#DPJ'B'29TUS@'VI@F:&XES8BM]Z,/)Q+RBU#@T" 6H9
M;KL4ZG8[)AXF,3/9MGDR]UMI2WQ"2(D2M-*6A 0O2ZJX T_H=LK$'28Q,,EV
M="A_ARS:5:**!RY9,[+Q)PT^$#<+<2EYNDJN;D&P2./WV>^Z+RDOD>$B:\()
M1$H*Z70R$KI#%!)^7,RVY2"=/,FD().">\ 29#Z1%N04L 192,B2SQ*BVRP'
M+FRG.MQAT@(3@L>&\5!2R3)UD!RY9Y<@ 5=J$X%#SBLX_(TO@2";G.+_;'$^
M*$%30SH9+?/:G+UT#1S$QDR-V8_H EFB29A$&FO.2X<8R[KJ>Y*SYD=E^JL*
MZ+4HT08D28J**1[\KU^]U9SMA\EW)M]WRNWB/)](\G'@=G$YD4BK6^XM#^)]
M.V5J#I,4F'@_,H2',!]Z$QF9NX,,+%'O%A)R,CXAZ!JQ6HP[14;/-W']>C81
MKD@]Q$CG,K9M*AK]%($9Z7,8?U .RFL+Z'FU2R;^F/C;##?X1&6.U8QAJ_5H
MA.T4I#E,DF!B\$@1/XA^/=?-%I%31=,A@M'" PO;(.=67U@"I@C)/S813F+\
MOZ!8&\4,*-%;PX9&"]<X9(FJBXFHD?@/B[HU-;UBHHZ)NOU7?+=]G;FDT@R3
M<4S&'2G&!\*-"*>V1KZCX3JTX"@:## X*'6=F&+(L G,R&_;C[E9D%(;SJ _
M3,ID4NIS-#LK;NAG!J>W& Z:CH7SW_^'B1<F7O8455>Y] J&K4%Q32(9 /A<
MV=0U9<+LATUQ9BE(B>>$'23'SZ @2C'A?]:4SK4O>]H-N]KH[O>'68G2-B/.
M#?#(@-IY>E;B&K5,A"O'LAM(03IXU#TR=5&4"5MB:M2!JU%^Q[>R.<)6TVPW
MD>.8EH$GRWC'^]R #D-S)_UAJ.6JNRHQ04VO'(%-@(+@HI.#UGT<F0\I7?)S
ME]BSCLG<H=^ <TC"^A2:_=G5MV,=VU5J)&&+2@V<P[3B"F%G98NP,6V ="XW
MK8E2\FJB< /7LEU(3G!,KNI"J*(@H:@@4_^:$%?)GS_1+QI>@51S  Z\\"LU
M3'U\G,2+0266&K):R,!VM#36"0O-*%2]$GE>9)G=WX,]BHP],O;X6?:XO4CT
MU>PQKQF(_$G^8NQQ7PCH"%J&RZQE.&L9OAI7-]HR/ 1D@7J>7AT+:R+.FHBS
M)N*LB3AK(GX4QA=9RO_\_-]?S/YB]M>G["]Q3]U36TO6G5IM6YN1F(="BF8Y
M96,<2)KD'V)<QOEWC<DTGV#&)/.U>>Q>!';/N/U!<?L=<?B=>=BVQE(_YLH[
M0@[/&/QQ,OATDD6I'"!WAU1U;-@>_ZMBQ23KG?@1KTN\C'00D;X9,*>/I4P
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M.Z:&NQ?0IH UU9Y:4Q@IW2 ,S;.JR%^&9UIY+X2G-*B:_!.NQ#&-MM?]HBI
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MQ^_OHL'*,43[TR8CXCJX/S/O]PP/=@T7%A2_#PI$%1,YZ"J."_?WV2[9Z=(
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M.E?\-O605(?W@I,[OXFFU/I$/*U6B9&2]"I!,=?!\215[$Y",PZPQ:C$SW*
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MM+*<%C.KM)H?\3U6ELO36K+?7R*7$87,/:T</WG8_((Q<DPG0MU&RL$*Y1/
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ME,;$59XX"WO>@:'J9DR)LC+B^5*/B0_L6*PY7W,"=8119EJK]>2*K60']&J
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MB(P "T4:$*0?O,'W_O*04=3GZFRDCT1+WIH)+UEA3T_L1;&P'@6&;*(8MPT
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MK8YIOM=+LN$X6VOF4U-:8-KQZN96M#HM\8T5_[0,=EJ[NLH$5H%>C4-50!_
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M('<3RKA ?[6LBB6WL_OS</B^7;G/ 5E>80B=YI/>=8CNT7N2*CPS?&H>2&N
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MJV*JVLC64@VW\O!>5YX,U<)D/Z]EAK55(%21=FS2K3P\/'D*@+1:W\UKN_U
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M_AFQ!(;^1QF/*1T^2C5D_$GP'VH$>,[0 *6)D"=PZO%;-&H#OPZ?I1GP(2,
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MH*-T5N-E;C".5.2^@"9TAT]7,I)0CF<7\HI>0'I7A?4\J563P_#Y,Z="?Y\
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M[$XXI$.(!JD>%8QQL@X)6QG!C:[Q8TEV_5TRZ%URYG&2?,>Q/^(&!W O/+Q
M,W7^-%>^,F\DDEGF*<?V MOJ?+^9%YB-GRM_W5SY&R;+^ZG!7LA(91[I9T?@
M^A?Q<1?A9P9[X2*@7AYZ-C/2OXF/(PE?2'@N6?[KNQ]>DHD>.^154D3#9YV1
M/U6*:%J1\9F1%HT[4)PETKZ'!=U["M5+D+E1H<'5^,6]HV8I3N)D_E(GP-#5
M6,:]S_G9&K(3G??>4+M&AW53:;QOE/124_6[=E3'7I\TZM-[Y.T];JAF.G>W
MP7YO+1:::]9(M9]J_8Q:J\O)=[1M<^O6WA/UZ9FS23OV-AV[IO 1+DV:+_+<
M3%CLIF4ZJK77_':SR,WW&]+EYF:S'TRQ]#W9S>=48^MVW_<OH*%^&MGR:93X
M&_DJ/K^,>2D(\4Z1H^Q'05V9UOMT*\!4RD_5=B\@O:=3Z!5%CL4RSOJ-(K$3
M[XRV;3U9G!O</C&8@X@BIE C-"AV(O1Y&/)J0N<[,)TO8_B0QLXH9'C>Q/<D
M@'@('OKFD-?,H7O['[PAY3P(&%\PWD4PHI$;9473"C(O&0(0"G(-34E!;<E5
M, 6R)J[AH]!\$[3*17JV.N-.<%HN[.?,4ND!+:XWQ!EJ#AI"23S/%4;X)MOW
M,=F>=QN&?3ON X7BO6<7WLQC>.^#><A_^&Z9-0@-9JFZWM'97C*K9KN=5)^)
M>]Q_*/:K7&LYRA3I$I.?%W/+U;A+HV[)R)![H'U3[@J2Q\LYMV\+[9\TQK[]
M:,[3$0!G1[C.F$Z[-7AI5UE5:J/.<"[2@5)**5>?AGW7MNA:H#A8S0VMUF'R
M:FPU3M#B .IRP6'T=.53:3V-=3J# <N(+:V@:Z-X2'9MBRZ,DNFUD5)$-M"H
MY_5P=AM.EU"K];-GALO\L# TV#*]6@:$17:QJ84GK@W4!W)![$XWFD"G Q6Y
M4X_L=>$)K3Q[>UV*=).@"X)L6BK)J7[J:6!$43O\R.E*78EN4ENVR=,!5N*'
M75G/];L-MZ;LPU6@IO42?+\3;<A;(:<KW76JX=:4O1NC%\%5.Y2C:YGRN%B)
MLY%9ON%HRFZOG,4RR\QB*J5I)M]5:T*0S3(\:M]N[?/FJ<76?"[(;X&(N;%V
MGBB\$I?I@ 0,J<-,V%EUOV$@QDR(),*C*)+Z,^O,KO*W22M^@=Y>-R'$R>6A
M_8/SG. WXH\4_%_ULI=G=--L]\L<SS4-G^Q3M>^1S,/$8W#)$"H[,=[*=E_"
M?2@"&CZ%$^2!\-O)2&Z->BU^"@1# K5QDL>%_QH^05F!8BLI"RZ8>8Z8-7U<
MDYG=*#4O!=2:K);7&4WR,]BOF<%^F_3U:/0QZ/=Z]T:*:-#/U?7"100?$SY%
M>.(B@H\1QK\)+]R$3Q)>N8BX7UKCB8M@'B-^18<G;L(G"8^5UKQH4WR)4/Y+
M^KK'#GF%TIK08SCV^><LW$P)^M0%,C=CO]\4*B^I!U^>5KXP5O@2TI>0STG(
M3UQ\2I*!?'%Y8W'IH63/SP$U(DX_-V&%?-GZ@;+UWNFI+2"+BDII*'T*"-12
M51:BIBGJCE0K7$V\WON<]VBIF?# _5XE<9($.+YWJ?4A5?*UZ0>IG2,5P>J]
MJ2TD=4B(KD5HKFZ3''Z@F5@YB3?504(Q:O.H4MBG>IETE$E-WI%8B1]^V% 5
MZ"ZID9M!O$>+G4Z;#13VTZ+82^69S(34N 5OE1KI#4*Y2\_=K]*+P=1[OC6#
M"'TP@RC$6N597(C-C3&M%F(YMI]F;\X@EE*37@QG.6;./2V&+8FK+B9]E%(9
MO2F#\ *AO)E!?$X_C(E\"./M/D\WTPX_QT6^5\)]\YI24XOTCD_AWA+CNBHE
M)E='5[9CL6%*#;D\K84'U>9DGMX R=@/IRNV\YX:TU=)C>&RU)S *ZBQ@7XK
MS[722<8H-4CQ9^0A>$NU\JL3E2?\=/<&PMW=;E[C+-?515_%67AUEDF&&YW>
M?#%;ZLL4F,RRTGLJ 5_%61KL,+!L,/G*' 1[PE-\OF"%&AJX%[UA+["/\6QZ
M3/F\M_K=5G1.NG$+%=]1^4ROCR]1 G[1DWGWLWI(>H2':K;VI.W'*\"F(^/E
M(MS,*;7US9EY91[;2'QR79N+8751'G%=-6^8A=G1VZJ)WY'J+SA5[DX)'^B>
MO/M9/43UH:&:$O:CAIR-S1D]5I:98-%(+&YN'/:B[' 2C:?K;"#87(1*LA:0
M]HCJH\@XO*D*]VFI_@-Z++Q[H_=H]4!JN \D4Y"IHB$#U#R(>< US*AC%2?O
M* F:0D"@*D""!S$T"AZ/FTQ4,.%TW*_OOV_5.RQ*:J 95 ,='89H\LN'A@X2
M['A>+.X7QCR:68V-:G$&*?H]H8,ZM\,ST-I*DE\9H@I."/^4ZO'\U8#8K"<;
MZ^B<CE;224,KZF,I/;D41B!IG_H4WOQD2JK1S5Z=\+;,G-#7W1CD"(OA)C9_
MJJ<4EF9K3+XM=/GP)A5RY8]WNJ/R4*>!U&NV:;#KC5?9@=IO3XYX<:&:/;JD
M@ 9X=%&H'$0#LG5'Z(6_(6^ #ZV-+]V+<RYN7"J4MT80/'5VD\!"!ZV26.TE
M?_S1-\J%6]&>SR&!M\7IU APR%[3@0HM-@I^P%$JH;6_NKU7C\7\7 3WNFG'
MY"Z/[[!@@C0%X0MW;/W:A+"UKS? ..YW*:R;S9Q:U.:[77Z0;D8FQEIL0%E[
M/D@3=7R G!'NY@'^1Z#@_N AX2T>7=FS+1\\#/U3VA$,U95VCN&-AE@[H!F>
ML,-M(,=(<S%0&S>VN\U8R2!JF:H 4#MX*=JI@#:!YQ2I%QJ*&+($-"B;H&XB
M 40M B48@-(5)*[ &K)<)*H$,.8,24=-\R#IK44!+G..K'RDFF!).#1:3FA2
MU&QZ'>T@+8Y%%9+E4H7 A(+]0*CP09PDH>]9HA*)^F#L'_@Z-%SRD:(^<L3H
M7\Q+Q=H":HNCG<U+=>V' G4%N^'@N;Z <PLQ8!'T*9/E/1,<I7Y"PE8H%8R!
MBKX(;T< (YU '8+X%P71!_4*QO>"AX=6%)F#,NW!O$;4>L7\B/S=6**K?_6!
MKJW"G-@+#!X1GT;T"]0EI^J[*B2: V6:6Z\  >GE;<!/9452)KNRQ)\,E/\P
M'_5RHD8&J7PE-0^P%2FVF>^54?(M;@W,&!P-\785;BLNC$5R@0Y2&R?7G"BA
M;6;AE< SN"I 0C MR>OA8DN7LBF^T)V6=\':YE(/.JONY967C^C6V@0U)KMX
M0&0,60W$I[LAT4N]@#X=3BV,S&2;+10;;+3'C9;+SGP]";_'5?8F9;JJ):K<
M*EW3V4 HJ^R9BO@4D2[BTJMO_P'Q?R@4(-"6G$1M$!-3N8U\J4'K(X5&*EM,
MZXC?(2FF&GB:LJT#_B5.WTQ%A/AWT%(^,X-3I\V*/%2&)=HP IG(H%T;:NWD
M&Q5-)W][6:UL1&/#8*3&]CNU7F# %3J1)Z:&S#G7 >VOO'&G @I5&,S,%O &
MI]*.:*38$+3Q<V2V#T9X"O48J$- W66'=28;5:,$4Q_,>=T&PE/X=P'9(A Q
M@(S4)RAFBYQL<%"6!V/X"Q'J)Q;EZ$]8O#,TCD A'Q$Z%'R[*!/(PM]^$4+
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M\B5^K-_/,PKQY+SK<M[C313VL-Z;-=2 __++A;Y:Q+)JE\^FZNWUB,T68TO
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M'10^4V\6/N]! Z;]9@R>$ZT !,QMBJ"=#1A@ P'11'7/Z&>P-]@F-S Q-"7
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ML 4A-$IL\&J@C=T38K)VBEVG#-2M(JI?!?O=B3QPE"#+ /:3T:MW$M , %L
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MCVP&Q8)^F*!RB>,]_DO..I+ $2M)HO*L6LO$"[S$PW$1T9=DU!^6_1DBZJ/
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MZ'N)B5ZRS2* 'WH3,+P<>RA-$)6YO+$CM+W%X<)(I/IE';+W(9<XEI=[)<8
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M#!Q>P<@:A _\*Q Q)K"Z(18 JLP=FL&F<OS8L*$\ =20?-EI,J#%@"Y+Z09
M/OB90IO:_AH&W,H9L(.">PNZW1H2 JY0V!HMD#V!W@<+[_SQ_6M48 DI!X=
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M*^]S0B],M7-]I1^F^Z5(M%M>)BF5%NZ'$Q(^5@"8"O ,.PTH8)4I/+O!8S!
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M'*V$ OE#QS=BW7A[*N49>BU3HS(=:17Y\/)>C__Q".6YHY.'9I&#",-G%G7
M'P^)-+ 491EF96Q;G@?$24#5K%T'PL!X':@RZP 51D(W]GG["G!<T!5,'K;Z
M<<:67_[V>AQ1Y5M4KIO7>M-DN$9DS>%7,NUNI\N3D8RPXDEJ(#$;:PD.,;"K
M:2A1H_[*-QPMOVMCRX^C<6)IE49ILTK8ZK!7Z8C322%V:OX<NBL">#JX*[H=
MBM1^O5.=C:5-MTPTXYEL<5.@R\M?_VQX0WO/WCICP/&83W>>W!F2BE))7X;/
MJ2?/3(1?'9SZ61KZ5"I82I8U%OU4GQPF>\$T,#/#Z*+%R/#3E ) ;AVEGOBT
M-DAJJVR:Z.N;1$:;ZIK87UX<A)]OGGB_()2T]B(66R86-%^ADW+5&BHC<@E#
M_T=2'#Z1\[!/]V_F6D+5R.XV&@!Z5519V88:553!_RT ^VF&>!#@,+'2_3A3
M>;2S^[AX_%F/885VQ:)L-7#VTR_P)KY]8F7W!.^L#@CV<HM#,?"%U4-HX5OE
M*N);-T]9PJG$FXXO]QO9N]CF<XQ[F.T+S%.8\LT%;-/UX=,RV$6PS4XU&9S&
M^89N "L8/*!H'"]CZ]1-!0ZZJ<",:=J*8U3:@.Y?D(4!EX2W/+:,WN-+(-[M
MTO1:I>CV"K( 8/JE^=M[P7G^TJL#]Y>=\IPM\_7)<>WO;;\,]3P63KO#HYO=
M#MA3&E[5_G)#M9UYTTZOQ]J2F/.#PC)=Y+FL %[. QFE@]=;!K 8SG9UO;LA
M]U[2O9FAB[X)__C!@@=4CK'-0T!) S '069TD__M_N#=%+RV=S8$KP99?.F]
M=Y_(V):V?YF(/MF[ /3?_^TR-1)$B RCZS[+<+?FO)+$Q_Y85X=8-!0[66[H
MN9WTK \SY"> 6%VXN;\'87'3;YQW =7?N_D.CDFV=Z_)C$U-MJW#>\V+Y#D
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MH_>N?74G:^DZZI=NLJM]Y.KWV9C[VLN[9A\&&^%=G0)?GLEJ RK?W8<]W.&
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M6NK))C49QAB(GHO923HW7VE%I[!$+$12%^JN%!RU?V/Q0P+W\]8]Q'=+'*0
M?+B'Z-4ZI2$O%@91"? -:SW8@&YMB40/1:23I\=0OV[:8_0\<3^?N;\V$/61
MMWCMXZC@].W^<<;!\=O[T4933NB10;+8(NE2SZBM*ES9[*-Z=!!M)*@+5>CV
M@WH(3MX#V;\7Q/./LJ]V2J Y+D0W3+@R2\<+@\5"BZ)29A#N4.=)+_3?^3OO
M&22_31?J:A#'3SKM:G=Z DWW]2CG_<JM45 9?=5ME\AU<\/VA\\S=2:AZHLX
MC)*@7^M;&^B 0 ?<N@ZXJY#./\1RDI.\P.GTLB[-++:Q6:\;,TX7H/RC6$[\
MM#O)/\5RWH WU_9Q;,2SKRIY ;QS[27Z-LIS#^V8WNGE??,.31<'/^\'/15R
M,NN5^R5! CK-E>.%\"*R:J)"TA#UQ$.IY 4/CZZM":X3T G$_+N(^<7!SOO%
M/#VGR2(7R\GDO)CJL=WY"A1IW,7#OAM*O>;<'#1?.VYRYA,+_>75N=.$8<W@
MU^MM86Y>'$/H"10.OG$$S"4 "OX<U<5FE36:,Y7X8Q!03 "'*O6Y89:.#M)0
M_R'TB[&31V.8K&F9*GS%\4A4^AN.M%77&K Z?"R<-4_D (=[2=O?1*@0@0P,
M?C)BP2N7"&>V2]\Q;@NNI@7@.SFXQ?A=+]0(KRK<8L6V\W.2SK4?T_U9@YXE
MED&-<,%?-<+IA\BKG9.#:I=?5HB7C <;X8.-2 55\_VQ$9&':"38"!]L!$4^
M4(&1\,-.T ]4+-B(\VW$1U/ZWD)+=UF;^G5<XM>BQ)\Q_K=2A]CIFDU'J#%-
MGK;<.FMQZK>L\7WQ@6/R[HD1(F>K4OZZ#;JT#O18ZXY@)RN_Y.TMVQA<.R:>
M/XD]Z6?+\4::_]KK.V,^XY7.:R\1X=8L'0S[CX.&M>A'GYE9AEXM%PU5X0KI
M<Y]D13\4X7Y/Q#"]K9'8WO+LP>!=-#Q,[\+A[60TK#;%1*H[T]=5-I6+SMIM
MP6Y<2U,/Y$7JA]DF[]H"\#_G/O5R3-LW%X2/G_7X0A"L>6;*/">22RD^>Q16
MI"87M2$2A.@%!<$V^5<7A,^:ZB^=K7W5ZN@<*$0HP$3G3]L3HY%] '@^<WW+
MMOE;Z1\_&&+O2P7 \%(\DA&/,05M$6':@Z=.:A,UY_H0M7F'%IAZ2+UVE\"_
M/N>76=MOQ=I^,*T?8>UN6"TEPM2ZTPTGI4(M')F'U_P2LC:RJ0_D:2+I;7K1
M_V0_7TQ_]8?WVS953@J/6 /PN/4Z4 R\_7?C_EXC[=U_?O)',MUOVB+75)05
M9,%A(QDX26+M":N##&+QK(O#LZKAD1Q_X#(/LN-\-9_J%M)%4VU2R?1::PZC
MR& G'R*G]WY_!2[S+;G,7R(3?C#E9Y0)E4\U#*$7&9%U5AASJUDSRPFH"#VT
M](F'U&G)UW/(1. ]?WRV#0!92$%%M"%19T;@'E_7/?[6]O=5C3+(ILC)Y%G(
M,S1#-P:15*VA;U )6FAER0<R<D$K>P\F]=YYVJ_V\U6>II.I(66(4U::#TOY
M%#U26"Z>ACP=13R=.*VJ?#XK>5LF\=HVO6Y.@!X<];[?A;V3R]PW;6(QTZ;Y
MJ668,PCPC%=54:X:S3VV::;;[6FKQZ01W916_>8P[IC7TTM0@1/[<2?6QU+Q
M/8/7'B)R(AGD9&B90SH^8>)BBZ]T*YS5I990,K"1IB\8M+ZZ8-R.)WM<?Y-Y
M\2IAX.&>Y-W>R67D&S/663@C4;$@:>L:L"?DJ7_T%3F.E$EAW17)>MM*\;PY
MFRR'"7P>''V(740!W8_C&[#Z]8WN>UD]'#;&X5ZDE)0*\2)XE)16L==)0U:/
MVJR>NM,#XLM6$'CEZOZME!0XZ,;T$X(W/$D1&+\(UC" :>#K^^A<6A?1";53
M>,"^S _WDF#-DP( 7WW%?[L&*!-I/&>4-+%?R0NW^W.E4B\?X^<L6=>65KE#
MK<9L)[C=[[?;_=$'D@[N"_KBXF;DU?8/P49\U5WF!SJXRNR'C4@]T(%$^&$C
MH&H*[I3[82.HAVB@FORP$5 U!1)QQHWX:)3V+=1ZEU467L>'?KU=#[TC1(+_
M^X/^\>_QL%CD=F[:7[;(PENV^*[9(''=:NMG8(.C$@O_IO>N?;Q60S<4[7BH
M(A"R:A@$Q^KZ>JSJ2U;GSY.+&;E.W]_+'%[9/N6UEW.>,L&T[QHR7[P*<-H8
MUL?N$*J>KP^,S7@.F&QLK,VBK8):7YRCM<DNQEK?RE<%BE?6+5T>I8!3HW6'
M+HG3IE1/#)DI7^*+R>5R2*."W]2ERGU'?'#0?_9RW]'[$=/K;(^/Q#0RU#/\
M9M14\@F)-A,5A:9*5FIVCE8D_R:F*VW<7$8FVB.SSE'Q$A@P4TY!E1E0J[7D
MZ=62S^*$+^7:W4F7#A9 L< MN#P7M_AW?Q'T]0CMW:F4K[#\A^V./-1(IM,L
M:0,Z7Y!$/9V-U8Q\99!'E]$O;>UOW[3?OSQ^P3;Y2!Z_PL2_*8_91K59[4>'
M%<FJSG*# A,3Y3JJ>P+-.AT_OUF_-C[%%16("U54"-S^^]!#09#@"Z "_&/[
MF7-KSWW7/:WP3O<@X]7+\,?Z+%*5"L_5?K(JT:TNOS2?-ZQ90F4A(BB$^9H^
M"Z()_HLF7 N%?&_I_PI@<AGIMZI:0NATR3R953=I(]YB5DL.23_J*O:J=W$#
M08HTQ^D6*^/F63J /UB \YU6W#)&N7^5% 0J+H\^6HY(0=WC2)I7&+3QG%W/
MAYNTU&T7$APGU)_R9!,5#\#QBPN5IPWB%[<AID'\XO(PX7UB*J5S)!F/, NR
MSDXMM:YU^T]4$XHI"FO$3DM\W'I8 U&%U;D)!@<\6 !9U=#=:H*#E(,H*@AO
M!.&-(+SQQ0 CBV7OX&!U*Z<>*JNX:,7TR+Q98N(SE>0WW'+(-E'%@\A;*BN(
M7 21BR!R\860Y&."K1=KBEF/#P;=\HC1J@UUWN\#5.0''[&<%JJ]J: $KN5R
MFU&(KQ?1(%QQCTKG2S(JD9AY@8;$@GF*/O4V7;912IMB;&PVVL(P@<,1B0M5
M;OCR<,0U)#6(6-R?I'Y)4N4+DFJIG<8XD4X_=GO1>$5A4V:!B2-)1?F3L=?Z
MR]QF1"('-!V2#)_6X*@$.U/AI#?WE6UQ+0SQ_=8=Q"V^!FDT='0[REPW9%8Q
MTPK/S"T1AQ(]=%K4FCX;D;3Y3++ET:9+M@6R+#2'21RR")&7:BWDAZ#%M2#)
M]UMW$-?X&N#R$<'OC,?]N6B-(\Q:6_<C1BJF3_@T%'P$9D+1V&OGH#<0U*@
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M8F>(Z.B];Q3(L1>V/?9!L]MFQ,!OS E<+443,\@?$V-;YQ>1*/R"ROPZ[74
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M]4GV!2PYF]"?H5UPXH&^;0N+CK-NA3E\VR,8L<%U <49V"!R#MU_[<N.+;
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M#K'SHB":J#06='F"^&H07_4-B8+@T>W%5[\]M-XU\M/7FJFFD4[M*CJ ]-L
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M4PA3)?*BPBJ<"!'3SG@8Q$_.SI$!_*_KS?]G42',B6H94),:B(&Z#^T'(H?
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M.SY\(#K;/VVG5#0,"YDU2S<L%@ZV&<JVN% !A5 \%'Y_:C<=[B[N1XZ N01
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MB?.K%S7_?_XK%4^D_GR@L/GE2YE["N:>?VWSRZYQLA,J%[A5G:K]%>)=R,I
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MD\0_/,*=5,#'JYL<KM U:>+^4)[V["'', #="[I76@,J]U4H+,#U!.BE(6<
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M'P/)GY"1/"$B(27Y,PD&YMT8+.R'V-@/2?!P\4C^'[?;7P#"!QBUF"V8&,\
M]P@Q, DQ;CL!='=V8F/\U0#_T3#NW=EX'^?!PT>X=PHU!(![&)B8][ P_UA]
MU^M_UP_ (L0F>LHM=9]8XQW.,V<2GD^Q60\8I"M^DVJ.'3+ROG<)?/B(C/P)
M!273<V:6%ZQ\_ *"0L(B,J]EY>05%)6TM'5T]?0-#,TM+#]868-L7-W</3R]
MO'V"/@>'A'X)"X^+_Y:0F/0].24[)S<OOZ"PJ+BRJKJFMJZ^H;&]H[.KNZ>W
MKW]\ CH)@T]-SRPC5E;7UC<VM[:/CD].S\XOD)=7?W!A # Q_M'^+W$1WN&Z
MAX6%B87S!Q?&/<\_"H18V$^Y[Q-):>"\<R9^QO/I 8ET;%;%[X<,O)J'I.]=
MQAZ1,?(M,QW]@?87LO\Y8('_+63_">R_<,T 'F-BW 4/DQ @";C1R@YG ?SG
M_7T<&RON)5OJ46@G#?#7*/O,< %>QO+QZP 0XRW '< .QM 0[D[SSM]M[G/1
MT+-2>>.ILY/AM64FB(P_KW\[0O8I)PS B)LN5;M_\:!Y91L,5..!24@@=_1=
M5)N84ASF*X<9(^K>?%2DT[3=8#NZCQ]?315_;+9A/E+T73W4Z(K.X?Z<"%W_
MQVWPC<XEVL\?X3+8T^E3J[]Z"RA0'D&+&VC:>,;UCC"M=49W)GHFAS%OJW@?
MA/W(;%*YV6 88AB7#+MBB]UFZ3TCO9RXR7*_!4CR@A>[;P&4DM6<;1OKCM?(
MQ14M=%4/VC_@&1H:<QS O%DK7YC# -7;4#L/AJ-00[< ,!7*&CW:> O(3&X[
M6 %'T>V(@3?@"+J96+1:YPU9[QF)A4\X:NM?5&;(S4Y.!&]0CD<Y-U8QJ"N4
MS+6F9!\R,WN:-CLR1L,L7?*?-*ZE=] !'VX!;5%H/G#IT=TL9E_ -O*7DL2G
M1@Q0C=AMMI."?]&Q-@&/#"Y>'+5UQYQE2)[L' 'W%&X!S(B B#M+>,1E ]QN
M ?^DLX<+N;Q,1:,%D6-_0WUZ4T2WBE(;LXO1D),OA QG_I/&OWH)YG4+&(%T
M2M8PH#+#KCC^1ZZ4OQJANSQ#AI[G@N./)&4KQ64I:+/;1,#_I/'/7KT%&*S<
M B3:"/[M^G^[_M^N_[?K_^WZ_W5<7P]4^C.]/\CSPM:JJ&]#^5DI!OX6U1K[
M-@;UM:[G/WD,= LHW3*XYNITY%7>_9_Q*M??2,C_WXL:&>8M8/)?(E'B(U'A
M;%L\HW RN,EHTF_Q_M%&+'QTPEB-;/S<[ O,BOP<3'S*]1\A:3_W;5(>^(+7
M6?P^-CY,/Q"CITSJ7YQGMB/F<3>L[;]-6VRH>>Q(38!;E/2&V-Q(#(@*92MG
M>[G'Y\4@2!S&:7%B=E'6SBD=W3(,*G^N(KA;>T)WGE+SAS4DA-'0/YS<)+]X
MA7&>'#JN^\><_PKR^#^\1_@?-#/0)^[V\5&WP$T+ZEDVRTBD98:Y_4 ,Z+55
M :/:<8L(J/WQ0 9^;XX\,E_$ 8FVBU?-.=Q&>L;"2&W#BB3#4U&/#')%NFXV
M%L.E* KT>BAQ]L17Q)EM%A1M2SJ%;@&*0;;@1<48J%ZIE_)YX>%^726-Z<-J
MMD#N5K6%5VK72Q; 0H@9,'VI D]6::1J HTQJT8C71XV"SV_8LU(+YJU\7 V
MGIGK<L4*8F/GI-#W)=1-"'(3AKCS38XMMG849H>_)=&0!?S7K:#* A!G+3O/
MP4^W9^KJR%67RUN-G6(MI%%\GER\?>XC&SPTO]=N./LJ>#51JT;;9[V5#SEP
ME'&"(,LZ5Q9FK#M$L?M]=PV2=.11VZQ97:>($L.6 -DR5Z(;J;]'OG$Z:IK;
M;V5!3SB*P2D=/Y^7&N=LES_\(%'!I2K9W+')]LOQC*I,\UBY9"#,89]1V-O*
M?W>A,T-%9P$('M1H]H&O"S7;^UE<EDC*CEX:3H4GK'ES7Q?.OUD0MUX0MQV9
M3%NYT&A,;O89:_89K\+XSQ[K?\O_'Y$QE:9VQR!IBG5^L;)5=%Y^@VJ;K"';
MU8-%6>7:^[YQOZ_?TC]!S10YTM:43L;)*O^X@3KD.])6WSU/2&;X3VZ,?<#\
M%UDS5 Q_>J351GP%%K4"BS#6Y4?),*=[XPT#KG6:78E$B"/I)A51MESNUB8\
M<]8"FF0FA\J,6%9?"_#;R@^&JP3#8=D7Y8U)3&4]^SGNO%YG.5YGI3>*[(;M
M#N59GP)0Y22^OIFPTAW!P.V;\Z_O(PAE8_99?N4H2EJ%'%_<67+IO-%41_=C
MR,J!U&,M*E-S(;PWX,!&4$LPQO#NBN#]0_&]OST ,H@,V,9\N^I^]C>L:H-/
MDTC,GI210/>(#^,'4;E UM*?PL_O8WU4?NZ,A$^:X:)%MF@E8D\O7_L$U'Z.
MJ6R*5(E!R"P6J&:W<H2HQ\M-=S^A@Y5OD\N-&&7XRL=-YWRO?A.I\S7H-Y:+
MY*,+%]1P*^:PX.Q [ZD3LO&;SSQ==O'LQP*]0+][R&,QU:>'MX OY?=V'C79
ME\\MF7Q",:-3 ))+)O+"I =/.QZ'WPCBAA5$Y!=K^@28%DR,EU!6; 2-NI-H
MF'S(DB51Q_AS:PQV$3/018G!8P/&)(G RX\/?:<-%;2TH:XDLE3W^=',Z,PH
M5SB$6EQ8)Z-W.'=22+CWJ&V&#;&:P0JS.$2GLZ#[*^.)%$+#UFA\5ZQO5+PJ
MWOJD96Q0IX 8*Y@;AA6'F )DPCI'R'5@J8N'\MVZ):P3KAF[ 7H+D9 6GO U
M;KJ$BQRV@S?9'_\(# N9()#X3;N4+58=;T-[%Y;EW V)BZV9X2'7EV9!ZR21
M\C#_@E\]UG$(HI),B-*85FI$2D3ESFC-0_'8B+\GVI+]\ H%::$P\[$D ?PM
MU)EG;8ODE<T/)01WS9&!UHT5'ULF,IV9S^9IK%1@^41_VQW7M)6O4.5@7-2X
M-//A:3TS5QZ'\#<A2^TX\IJ:DB2,7Y:O._XHY*2/@WF_2Q$(U_^>DQ-)^@Y*
MR;[G:\TF:O8C^<^HT_X7#_[&Q?<XZ+<0A1 %(NAWCFFA/9\HVX&<WD*R[+U_
M 7LG,&*D:)8*STS1$R@P"&_!HDQ[\\C.:/Y#*= TZ+CUU-)_ZYLZYO]8L+B'
M(98IE8+I_!>"T\C(W!#-7(]GJ7(E<GA&<I)_6V""'W5XT;GPK,)HGDNJ%<H^
ME4 \V]7P$ ?+:FJR/6U;5,KL !RK$5F0JS-(_9?K1F$H[E(O!^T(W?']TVFJ
M!*/"2-\6)S4<S P\7ME1?B["^503SFY_Z:6G7[L<4K^S;#MOR5<5#?7U'TSY
M14GHUKRP]-_LO<B-$PB1D]>,SBUYL?U B!ZN6.#'<^0 ,2==BPGEIVI2U'-S
M[7K(N@+U&7ODSBHJS8'*W!2:^):>'>WZE]G5[FVXMA)4%B9ZBLT3$3>+U>WJ
M@C_%>?<,S%,T(Y?VF-X;&YND0/]VO2 60(&>,/:K'(A5$53VY/_$!&L<K*4E
M=R$AU!8+U)Y/\O\N+/\0]+CX..35*JJ;&RHR%L9WB;'&GY.IB^R);X=AW]O'
M]G3KO9NHOE\TNX&Q3J;R[S!H,OZ#VA@V?\]?NF4HCF[P2_1Q3[N J^8E4KEQ
M=F+T_=IE+9';W"^/+O\<HEG *O5[I(#?N+*./V(59&S\-VMS-WU"6ES.K^R_
MP2>R*2B%R!E9M@,"BP@#I7H9HN5>N#2],))322^'!?WUUMOSK:&%\UM)(I%D
MO$/O[%YEK!%\1S#GKXRZ%TN6X7,8[CC75R=<Q?1?CR5<Y&L6)[TMQB7^!?B0
MF*UTC?_7BR64IO&^Y6:RE@6& [Z>7'.!3 -U 0E8AXKV8E_[HZ@K*N3EG[!V
M!.))Z#G86E.7PVL#[V+;?SW!DOOT;\KUSXRB2"'(9(K3*+);@&:8:S)'V?0W
MCYV)PY+/3!K'OTTN;;3?KN_&QO[E6]VS*&+UP[/IFDEV![Z=-*O^AL@LL97(
M,Q1KU)L<%@F#YYG?4VS=_A&BI\ _-N9K98=M) KE:!Z+8NO0].VIL$6QI>@U
MY8Q53S*["*:R%NXESH[<'-O>K3<38!B*US=G=FM=(2;QYV>/R!",8\5A$?=R
MA^JBAU(S2C.4VA$157_GG&0C'[I ,2F$+XB3+XKL0BM0\'AZ+V>!M"*-KCW_
MY;?Y[/+>S\;S<=Q_K;2=K$D)*F2)3$7BA<;A?HXYB&!@1$Q4(Z" /[YXTR<Z
MY# _QY(_?NA)(G^Z1Z+,6&B-\>9D0>D2O"]:>X,NC)3G;YH@W\:MZT0_63!X
MLL1H8Q"SQ,8F'E;ET'O7:^$[63)/=JT:\J+<WB*:XJ'VMW<Y[X497.)X]V!%
MZBLL38H&02H.4?X<K6-Y-K7!+F(U]5(QS>JGMX!6Q=+VCLA5:K>2!9KOLB72
M9>UO*,FNA-AN;"44!GGX[%[V*F46[JALQZI9<-YQ-.868,)3MJ6;:=\:SN-,
MZRE\JM%75'/*Q-9$SG\OL=$_[\=[XQ@)V=,/FY(8!MYF/ID:C;8[T^5/J$73
MG)S$JTZ[=(H3#M[GU?_'$B-E!/[-+8U7_R6P \3.R^@(WCR?9$QZ%V6AX]3:
M)?OAT2@L?=U7V)";LJ54ZM76QR9PGN8DSQ5/+N^3Y]$*T^.OWVYO.O5+#2_O
MBZ!)S\&_8B)R$ (?.2"TW.73V.1/R7%9XSQZVXQ=1.D*(>$E.4CP"A7DGE>=
M&HPC/;!]Z4T0VO"UPL)GSY7,<C9X_]'Q+[@>DJD!'E2^J6VX>2$IO5DZCZM;
M W<;L+U^\1H&YRZMJ-\'OKF&?8%,OH<FP'K@^1F%ABS9A??"67X\6'N;4T@!
M"4:+(CO01'=[[4SDEUU8K?VY_OU#.?(# O&18TBEQ%-;\&$T4E(/ZFE_+5Y2
MOY6V$FD!W_B<!'398ZOP_)KT0;QO%=[M3..1]8BMO" B&5IMKN+.."=N/2=N
MPP%U@'R6<$IR.LMQ.BNLTVC\R/2?'?D,)8?@&$XQPOOY,WX/N Z>'A-=>S#6
M&1]K11? G[40_U8L\S+[O<#4<A36%"/35LD],[NM6465/,(Z5D*DRIMV9.J\
M/((Q[Y738=A:\,ZIR@349'"Z&I:A%WGFWE.0SU:%E"VRN3"4#^<X$RY_?MB_
M-1[6.LOPQ/P;,![D@&F%>:]ECK@PCU0T=V)M[T3<3BPW17-F>+[5*LE@5M'7
M%:^:L+IJ$"%T![:*^"/@"N[O>Y@]\291G.>@J]&8ENE]\8P6P[)Q[#$%>LG!
MAQ9)[60+7*:!.ODI'4+C>BNZN0C( P"]] &Y.D/@#LK)Q2[?H9>&QJ;;*D7D
MOSY]JS_!6(S^Y.3:E(_O8IL*5$K-VV/"_[!F?[[CS_^RX,'Q"Z'Y.D>I\\7'
M'U(1*HN?\7]$\->G"H8\T]Z-;)L;]F^$ 8/$Q!:XCR12L_/Z9\1/,]23O];+
M!/H\_M#B\%L)#?7)-7[(:%N?H(CI2O4>0+L*ISADZYC)@W?9$P_\3+L%6,TY
M-DL8W .0?F)7P\S@AIZ7QQ3]G@R,=&B8"4C2O5&A>>#:)6N].IJ!/UY3?6@5
M[7"ZYZ$B,MS.'WT\2>S4I#G8VL8E<S!BF+7L&,ICFT(SW%!D<]Y*,_H#S+8'
M=Z[.-Y!LC(4,SLO9EAYRT3UNY<#<S+SB4<I!*!NUZ"TY!I?;S>_;G<XFKS2%
M\\VO-@GH?#_#Q*%-F]#W\A524DX9<X O+M2MM41HK[!T]0GF3&S<V%G[<1ZN
M10<?^;8/%>PDIMQ$#30QP@K'&I?>AA'^U#LJ]Z##&D#< LB\,G2;(]Y,L#]/
M,4J]#F:/C=IX=%]._YRB!'SO-/6:*YR6O+&^JKZNNB$!5;3Z);LO6/SA]23,
MJW<6)7^87V*Y7,\XX7AJU%?0,O;N:>*>,H$5%JJK?M,U');^!-IQ/5:3.Q/C
M3P9G)5D1T8NK29UH_7)T_\V@YC/+RUK(0.#<DI.(5?@IV\CGJP]Q Y;%R!WY
M\;,J@J_3QK+,280,3TW?'1?U:(2?6#>/\&.]#?/$^X$O8Q4-](-7@?02,TG$
M3*Q^>%7]AI.EH 96!TI T8=SSTD^,5805G_J5FMQ6BK2*AJBD!4&V2XLAO0(
MT!*D0Q-;N,"CX';P0VMX*\91U]I(V-L:JY_7'..X(!I[XB$F2W9AI]]>N$CX
M0\LE<P20K.\NGVC73=K'BL&A"\_K0EA^#?"&K&)O,+<YU$RBA()V;P'X:$Y#
MN3>5/5:4G]$\I*M8>]LO C H&";]]"PX./9KV-(I6OO,"U]W<0:\G55:M7AY
ML4I]6GY@KEJ9I:116=4$S[%2^ORA2#8/WI#@?EC>O]U^KH:/K.SH3()I)!=4
MU04JI'5+G,@WA7'O(=V+SS-Q9]0>;Z+IF^'LU4//D;V,*6OX[UF=2%CCQKEW
M 2LM=B S$G=K+BYB!23XAX$-MRRC2Y]Y?G^5=/W38QFBER+KN4<FN54!(P&X
MZ4\]H]GZ.J._*!@G=JN]57E=^"[E6PY5?<FL=IW)6=OIYZUQ4'V/=O-UVD6X
M!,5(MC[()SJY\#>"AD'#^;%@8N$8PGCEG>X YED9GORR:E).F!W$SS/'<*>B
M9UW1G%US5R;R&Z__Z'Q%.+12^0#HAQ<M7+8:H0YU_[(V0:: =M'#<2DQQY1,
MUY^P_(FL0BA60PB0TO9LG7B88E?E&2.X):PW6UF.WS"C>UHT.]Y=QJE?Y,97
MM20<Y,%&H 'MZ:>&39XWDEK][/1U]6WA5"70BEJK6:8QN5ASLP-[4WU_MJE6
M02\UF8FRTQ!'DLZZ<T-VPMFIEK00Y1^\(?@2.O,'$Z0(<N75YE[A&0/74XC^
M3=9RXH[):'XT<QQPEX6ZO_"-KY1=6G0'P\F5G@!YPKOB!7)/L[OC%<,C0\T4
MF_.*H&P4?X@C_NR.S]TV8"_&7;"0:$16_VD];@/KOF64\"->Z-D5H;8?:$DY
MYD%>.L)TQF9&_/R@8EN HU%8>H4^NGBA9Q2N>.2#FWH+P$5BZGY*65%$=T6/
MO7&.^SF<II![AI7F!&[J!KG7,XY)6MT\&]&HBQ,=V'NO7,*7[K3UX!7%1R'6
MAR-PI[.2#,JD-K6XN0JUE&MTRFF%2PX5_T!ERYD0Y+&7MY^B+R./36- #!:+
M9>*&>M+[8)J/%.S^'X<<O(*6!\DDJ.--Q\3D+1'BG ]?"_+(XOYF9_>QI$NC
M,XQ?S@RL;O%4.;K?4BKO[ODN^U<5%17S-..^XJ_YH$^_AX7++]ZT3-1P!4D(
M9RH?)J$8$MM9QCY<OZFB2J/=G;, 5^VH 3\7B @6QC7&&RVJ_6(9U2HX8(*W
MH007G%+4.A[< I9I:V#-\@@J-=SI!7!/]A#NG+(0C='[M\$7_)DX'0-#>MV$
M7F"YEFH88\+K,$^[59FUV+B]>DLG(/V)"7EWJG+)+-W#G9<?#A23E,,?/%<X
MCGAVLWHV[$NMG7G_-$JIPQ3NUO<^26G2G8-,XT-5NXR20B^ 5I@"M=7,+VBB
MOCJAYFOB-OOSYAN-++X1!_^^N6T&8*QZENVB\J@UN6AQ*@14.KZ@7_<V^)F@
M8T(O\T<1&',XBHWK,UR>9ZZL#UJ]68,]$RSV\[*=.CZ^Q\QG4 U_.U[-TZ'1
M[ECQ0R2<Y2?Q:N&PYV._EEL ZWXKQ^R(J^426V[PPL-J7&OS6/REXQ=/OYK7
MSPE=E"M*DX*@18_\R@P']."#[>J:GUMF^1T'.Y-^Q76+T41,2A[&L5C<+*)\
MT=?]&YF9\$@]18@?*2UAA ;E17AU&>LV(</,C/+@A77NQV49OT\5W8H2-7FE
M6W4I_(N_2\2EI_<X$6&"'?0=SQTQ*&BB'R :8J('C_V,CR0V.-!?BQLVZ)J,
MW4<@XTVLHUG21)E,,\Z* E?=^^<G(E:JZ?S, _YZJZ'6;?AN P.XPF=JE"!*
ML8MB2EP5B--.!D[*0#OU54I\1^L]]" RQ_Z';4J:H<68&I4\HT9RHOE7[:>F
MJ4W$$RV..[04AR,=ME'$;Y+:DTPY8 =[SQH\,]9?!W'%Q/%%N4Q="*-3)4DH
MZ)&7R]+F9,5/JP95>A(EFT;$W-9KKO)89)4TE#2<U?3@;6KU >T$2BIL^4UH
MR4-\JQ6K4+=Z/]MBE8*=(QN?LJZ#I.=)-#FEL?$?[Y\<UPEM[:C+'P9V+R!H
M1+6/:N/SD(&OR*^Y$7%25)F-,:RHXIY\UI$O81.W &N# P?S.%RALP0.L=BO
M/ZC-TW3K.KF>F'@Y=E^<$Z,D#[M6#[B]F).48Q?6]->,"3:<):!K2I\W-'-7
MSLOL35,75<!2C>HN:;F-EQG*95ODIC23Y=4#R$'!Q&'S6" ]X:9OC+1(^.F\
MLGJJRDU:LR!'#30Q>F9UJ9GG>Q]"E>?!D/=!=$VZLLF1:99OR32>J$9"3[H-
MX5<YZ8_W88S1@&U;J%VSD>\R<'JV Z[+;:#,GC+9:6$ZP[B-<P#$J,>A=S6N
M5[.BK"F="8\XFW^BH:B4K=H_<LKJ):G1? 3\[4A5WB16-V.:2<T#JIQOO05P
MKL9_HDK+"-" TW&?\7-U^*NCV)'NWHAU*L<:Y>J*ZA6GESD.WV)GLS9N4I9J
M1FB]4A$,^B!!/9M1ON+$<]VO><VX3T6E9G[@NT;[6%S!"U J;8?/,]S #VQQ
M3!>7=]PCT$SW%OM %%(NGL=&XEXTML7?5@;V<MA<.'5>@$IVFJ9-9]*YXQS3
M)8,-!*'+:,'-KUL2@BG'77K7@KI1CGL&+ABZ= *2=!M&MP"B&K86T>6DCLS*
M^3G#@ZIXYY /*HO<.T%#)D<_QL1<#WT6=CHJMHGH'BNN-MF(8J%E?+X)L0)7
MNBS\= ?\N)'VP<PW1%(9BUYCFID,$!%'1<;)YIF6-D(E3MIQC>WX40E\9.N)
M$1QQ&%WC=I416E+R"G81QQ=(_IMUTVC_IWBHS]+9T ,DN(O<1V4N&]/>[:VW
MON.,H+DS)H0:T407*$%1?POXG$]'9#;SW8V&1F7N0H]55^"7J'1\9*T_K[%\
M^!G\2#+L3%P#RF!J+%:/";CG=<,64N6(\U!W81^^,!-0P#CK9O[B -PA T<_
M1?)VU)K>.W21C'S[Z=W$>MSD79EM[D51M_;J.H@9T[,0(GE8U_&[U#JFS)9R
M/C/$S61]@:VI"V2*T+A(%)I(['%%WV\TBU#D./@4\*2F6M,8N!M*UR0]%Y4;
M&7D,$//5'=@9RD.1' ;D."[O4776)GY C.]NZT8)5WT=2%A]^>NMO)W;1IX/
M*4BC[$M\FET.R=7.(=I4WB+KH8[?V+3_%</'(_F.AFJ9_+FME."V+VYE2FJL
ML/,^ QGEKX_M"KZ]RPB%P&IJS((-3:,=V!V:O;.[RF=?\$PU:Y:^"Q45V]?S
MM'N?!1=SA]CZ<,;B90;O\E%A0Q/7AU58NQ4T;7_4 RR^]A2HUG?[ZLGGIXLB
MSMO\"VP7B.O'4+)KBDS=)7E-/6&$BH.C]?28'WEWD+J$62%I::#N8X^:R[@3
M$_0)D^JW5 W3NZW4S-O\5P#A:#D:Z!5]O-%%:% VT)[$"7,1F7GI0/)I('Y;
M"$(/X]BSXZ?Z;L\UH54;%3V0&]E9"50OZT79CHLQ"OIA'C4KY*TK#WBP!#$"
MC?$7SM;(N0<P8IFBLK]B)CA)4?M0KG75^U*J<E]+^$\GN*6]R"W+VEY9>E/K
MI+^XO< XX:9"N?U@+?KJ.H9[RFI &R].OOQ5N6_'79W85INIU=@ VZV& *<&
MW_J_7R*+EM^PCL*86XVD_M H&5-9E[ 4/*<41<9#+O8X/LV'SF?L,+_TW R3
MH;YF]!1"F"ZID5"^YTZE^_U5I(0!X/%+4>(1TRG^Z3,_01B3?&+_HXLFSS&0
MXS%T<CQOCUK8XTPHDQ0EJ0*4#34:=R\Q([*&,'^]T(UMMB>I'^Z16W,1QCG9
M9GM_L,P4\E6SQ_ N1>;L0(@&W;:ROGWQ9+%49*)C%2R7\[XH-J4_6B\H]Q+8
M'@<^V#)\'L4_R,&_D&#.R#J>Q412\?[ASJ5Y^#;?C1)7V )G]5V)%-G\U)G\
M2SZN/6=% >_L7.$CZ3[V-X\J/PW0O9MZG\_G-)$:R> M:HCJ,T&+EXTRJ$;F
M0LTO9U'HDQ'ZP]2A914SXVMC.7&1?3:91W@(S=6H;91?L\5C+;X87 '(<IFG
MGE%>F%M-5,JS9!Y'N[?41Y>4.WQ[S_71),C][FG*E5V1L@;S[@,."K@W78AB
M(8HY;]$017M4AH)5RE@YU6Z1'-\K>4KD6L>0IL?3(:T9TU3  .8'(^\KA:\;
MNH$#\MLZG[Q-70[M4-A(YW@7]^)U?"79 T'JVK&^GCP;E,%AR"?SY4S<'*]&
ME@RXTO,9878+<R\>!?IH8O&7MIB(B!BD=B:^\$IO9EU#D83@;Z;U^"6K</(4
MR5UU9;F\),!)G!"B:4<H3_>H:2TTH(B&N*9@?U$A67<1UX[#;4_$']Q-"0XM
M/WOP>=1@!"NN,NLZ7\Z46.*LPT8@1ZTU8\K$:*&44V^/+*I5V!FEX-4K9LZ_
M)0+^$F\6+WUX$2E&P7'3I[]7QH\KY^N[R+)B"\ P . (GY*V(U>D0]L7N"9/
MOS#&6=OM4S)Z?UGX1?NPRQO9R+>BHOI-I_K O_D6P.>J\YE$^T?UY>+5*9?7
MRF\>+_[J).5)*(>[*$E+H)M*2="DJII&C\QBC;7?&Z01^+#K-*9VKL>M,;@M
M_?L**X-SU-@&(Q&F^\&6R6)'"[8$$Y*NX_[6RK$?6W%]L]7O=Q9ZPR/E@L\7
M>.=.23((%5M%]&W4!W7*V6M.)TF$Z<MR!W5UMH4PM ]=H8_UK* OM"-6=5WK
MN.:]P4F]B]N':6:L,*. ?/G/$K0V5W31;DUXO)UA^387E$8V>/S-5,W!%B.)
M4F)QO'T W:1V,R H)>ES,ZC(%!G[MBEQ6 %"I&P%K@J\/-&/:545X1*#A7:T
MD0#) T938+FA L>&\[+X^/+?ONCX>RUEU*\W0()5VG[3$2',4N0J^G^LQM:O
M(AJMVR,MR;&]%CPF3\V*<AFPF2QS7 Y6K?V X[OV$DS; CX.A2F3;>?&"-%"
MA+5.GVFJ66R,EO%>9OMW_GK'G D_O7RS'=A1\TB>+'5:<>9W]H*U]^*5;#+G
M7B$*8HX!3%$(U]RYET0OM +3"(#F.SJ25J5T$8F E7VUD65]3>WMB1Q5)]/3
MW,:M"CXHTQ.ILMD7FX8.=73M8$(;LIG5Q!0ETQY'U_S/C&]ZGKQW/5Z)3G=6
M-#]LR#WL#D-0[;GT*(\[HGZS7["X$K.MV!3'C?,"% !O 2ZV.1-HLT^T0AJC
MMK%+ 3K*W3)6NS>'%P4H?Y/SN]((YM(QH7W -#2 -3F[F-+9Z%RSJ( N$%R1
M!,0\VDI1+;$J-;*=X<RE>-=:)Q=!Q+4@':G\@O;&>]/GS*PJ(]B\!'E,%59C
M6=U4;< 8/M+'/@%)_!V-#B>7U)K);@$$#(J8>THPQ+== ]710Y6L?AJU<]+[
MU?52\9'Q%$N:>4KI8I9D.;FE>^5)K^4(HY^1&4VGM#UV,V%00G8M;YY""&0A
M['%O+*W+,@@I?O\2O;K8VM)^CC2P1W 1VR0Z>U6]B>DD,E8=W9(PCJG?9WSZ
M[:X\GK(B55OR+QU%F8VEZ&>\M$ICXR%XB%$5Z+/2EB>U9"HAJK^!0SEP#%ZT
M@4GT:R]3?IM,FZE92*4LEW_2K;&@\F2![)#FX,L!)#MQ>U:I<N*RM:W93MXQ
M*-*Y[[T/!JS:?3&4[+P1K[OJ!S)ZI+.6K)1LIS=0@2F(&2-<4D<BNX7W35LB
M&UU8A<%6HLC>66LQ9ZI*ZY=!",%2ZZB<\UYFGA.OGP+TC O/-O'*,=#-A*??
M^K5>78IIYC,>SJ57'/6?1@J+$HF!<ND9907EY4.FLZ"+Y.$H(3;E$1/P<J1C
M< !)1/>"Q+A;ZD?#<0/!X:;:-1('2Y0\78PIFPQ"K=-?QO0(;Z@E>+66DO1;
ME*.Y)8A!AL0Y:P9_LH?Q[6KT387!+0 'I6&_U/:E4:#$O8*#P2-$3U( ZER=
M=NW./$IIU07$GO=BZR+7^%ZWY8D_,37?<R+/AQ57'R!%_]9<N%SH!3OI%NC
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M\JJ0PB^LJH;?E]*!8-:L0MN4D-**LK55^ LZENA%%N:B7RMB9SN&K1B39U'
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M=<$.U0\W\"2^S_[0NHC$0^/%(L,OODH!HA,.%W>7$0*C 2] O<:E@K_+C"T
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M/K\4NP[?= -'20@<HI/M"T!7NU\-C J22-X_^,YZ9?DU<Q ._&-%1:=N:(=
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MP.KW]>NX+(?SQ+%;1ZAA 0S_&>YWPJ-P=,,9\"\1#Z&H/F?H\" <@PO%K(M
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M;,K 2I8[?@'7L%5R6V,2_;S]-AO<Q'TXKO6(QTTJE;W*D%(C0$E.N 1O*R=
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M<D:6G:'7>??7MJ7=PP)5)K&'%$/%YEW.2JT,IR69QCC"ETU.4^=33^UG/CT
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MQ4OO$WLY=\7!ZUUGK[0S=.%INQJQK5=\PK*'7<EOC1]80-6&VG/.MLV/*?C
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M@U*4+(SDTNL;SJS^U ]Q:O=WFLF6V[_B=V\^.)HQDS38/?M]6)08:;:)9UU
M##I,? :X04Z >UIU_C+$\C1Y;G>U'GA]HBSZL:&\DNLD&YI>E5'U!,"?5&"4
M^K[8'=2M6(&,+[;,2E5P9UV,;-A^SBOM('PTBNL[Y Y^?DE^>N^T)7:H_.>D
MR<;*H(M8O@C& @FS(_E\D'G/)X>X4Q6\K4"?',&DDS(0(.SJR!Q\@*;9=E C
MY$!ABEY<IZ+Y$+8XP[;Y OT[(YA_R9K <*8YSS%'IYJ0Q,]G_CE>3X!3/G9_
M1!D'[)<ZFW5B<Z_SAS[H+YY7[^79+YQ$I],+SJQS_9K^@G$N-</[1,VDW)_5
MBOF<>4(!J[)G4&T$![QOJ^,#_&5^@GSP=\HYQG!!>H7Q2]E?:JG9%OGCU6PL
MKQ5J[X8F64^\!SX=2-4LC![.MD*;[&5P9T?I0JG\P4\  T6F?'HY"HQ\QV<W
M.FN'O2"EA^/3KBC15%F76MHW5CI?Y0/CM"$9!Q_$'^G3) P6IG+&_N%A#H(Z
M??/)<A> =J*?#DUF0 AGWQC-40:2OS8P?7D$W;4"5R*</MZ(=OHT/,),RR0;
ME_QAWH@'%15C,RN&@T1C4IIM0S^RB<PV_!:^DYA@NL<D2$%Q._=N?N7;E.A'
M5!];X@C4>T:EUD?J'V$/R>)YP_&LDK9#GVBJ1;>!.<*NQX-!]V=L$.XVZ.V$
MUXE6)07V+"]H[?5I['K>@-I4N<B',/R? ZQ?"G=!$86_PQLE7DM8LVR/)J11
MQR2/] A46FV3P[%-,^P97FM?T!S_@L^/2^Z,?BP#!&R:SN6#8H6M%\>H_2 =
M@5LA7AIL4ZK!4_*37_4X-"Q*= U2>;L&C]]@[*!/^K)6M>^>+DQSNI>)?4R\
MUFP-K+E)Y&/'_.G;P_4]/TT\>4JD6H)!5?N'%YB>(.VLETW'AXJXPMK[7>A9
M=4^V&W.Z?4YZT' ]5Z=:NG/R3VF*0<L<GLL:,G6DQ,)I'PMWW!K:<BC?K1N=
MK@'5:$]B#?3;9UOU!$?9[!-6OZJTJF[WI8,LG/L60*-/H=2X_)FQ[)&TD#9R
M1U"^=HG%:^S-Y&_A6VS8JVK4UI^ QJ8(*0OR?TR$"M)Z*3#>7,A9Z4^26CN>
M:]XV,DZ)!_4NVVH?#=>\HPVV*!_;IOF:G\U&P>'$1BM\JD<&I&_.-F_J1@17
M$N2F[K>'1QC-N&Z<K %Y9\J79[OY6)CW0#G6*'OA="6;<K0636$,;@KFX%RK
M=CJKY%/<U!J2S"^\R;DAW_U,\M,>;72$7K"CW41APX2<JMB36M*<,<=3CE%^
MU+<:!7YVIUJN1F&F88E.&<C#W\B/Q1:NG#ZY.DC8ENLZVTR3SYT7G2K?R!Z_
M8B"_&>YW-[#DS6+X24/I;Y3>IEM(O-O.F!/;A/.O5RI]=8V)TP%B6OY69:+Z
M-,6,Z@$J"+^F<<^6WL47VWNWPS^9,&Z2I:BMN7UJT?_BZ9X4\A?-3XHK,HM:
M\Z]U)*VC8'>FZFG:&5XOW66#Y[T7=T.WVA1[<^Y-CPW=J%;T2+Y&]&=0IQ[Y
M5I;-NH4V*SG/[%-?#FGH.OG@9N_*T:Z5>IY8KY,LN*[)+0B\-79D<.G]_C*;
M^6%3!+B M/4_^I\NM=I$\WGU$)9=!'[?NV]$<Y5KT_\UIW+*&(S^7?7K/FE[
M%JSRE/@? 'QD0KP;NEPYHE0\PRIORUK</,5$I]!$GW85^#D,6R3" 5ZMCOAI
MX]=T"E-_)^BCDP(K>]IL[8;U;'6PE9\JR+$FF<FR*O^2=2C^NMAC8<>F&S#P
M;K$86Q9%WS9ZGT%@\/M+?_%+&=X%VI]]_<7"/\66:.G*K&[C&C8G!/8:V[M;
MXN"G+9H'2XE!S0S2WWJ-.YAMJ#<]2FTVB"'*VUBRM4#JI%WRY]Q'[D[TU*Z[
MV3=:L][@@8P+WV?C<C)I/CZJ >>G[",+M=Q*P)0DB%!=CON8;8BW+7F-[3=Z
M@7W71@EL"2YS6DU(SQ8.U6!63NULS4EC-98"KD%^;8N.O39MX62"8-_CYBV!
M8:H38D,Z75G[A"'Y8[MT_^K*Y&GKU3DZ4:LOCV&I!:*F?ZD! ZAR(4-?K8C8
M]Z353WI[.B5_7I*25G9AK*;J\06!A1>YSH&0N,]2A/<Q2(<^<_QL?O)U/\$&
M_/^H^^ZHJ)YGST$0%!$D2D8EJ23)>09$LH" Y# @2!00D!R&H" (##D,.8,D
MR3F'(>><&7*>(8=A6/R^M^_]WNZ^<_:?_6//N>?<GIJN[KJWJZKK<[IO]7O4
M]Z<$)(A):Z=HSR7S\+H#<:0U!$'4PD!L74TQ)6*6;<D4$8EO& !]M-?]$-WY
M2?KO9@!#W&J/4$>EB,),84%GV_(,HC.?RQ@OU&D)1>4KL'3Z2?P7?58&MYUO
MB_2E58L$H2\-9G!*&;*=[.=U+<M"0R);-C=('"3.BA\IQ6FB: NLT[>U!'G"
M@28,<=10M8$PMHD&UFM1_9V_4(R(Q#7L6YT/216UU?X'[JYM2M)+K-/"[16K
M">=@_H+03'E#E0-J3Y6,6;U84C=VW&6'-Z"KB?Z=5(JF$:KJD<S8TSJJMY@]
M+VV4P6'[X0\@987_![>*CO'/H5I?ZGR/>Z]#YXEZ:^AL9TSJ8X@U&'5HK/(
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M3#(-;5137RF/(6E_G+]8+HCFV%>=<7DSW6)#-5L[+YID%'S5WY6UEL=*N:U
MAN4#N/J !P=7#'W/'O7&VJXZS"J&_E[:C5!QL[O)Y<R\1F0+WF2H-W9U*-?,
MXHJ:HF,\/&@H"VU4KLB+-1[< F)#O(]32X[(SV7W5UW/&/"*WDO@QJD%\RRT
MO)Z!'Z&ME]EXA.BX9QN^Z#8<>&X8C18<\2.N*ZY^T+"UYMXYE.72=1+U%9B>
M9:S%9PLSP[!  F!@7AZ/EQ(5,.<75NU-I4V>?8'>^A#NV11QK_B,J]8-4:.
M"J$*NYU TG;^7%Z/*V\CWK7E>>".^.Y3^U.^K9S(18W85]3"6@=UW&H@8N7.
M!?$>HR\J#)!X;]J3DDDN0DAW<PYDJO!O?K$^2J=N)ZI, S5L1Y:57]T ^:L0
M6\S36X O45>S>H,H=.^Q(!5\)J-+AFB>?'O9Q-9DML_F4'LD(YAM7/Q/1O!+
M[ WH7,/J2C'T%F#,?PL8IFZBFK<^ ,\U8^2+0_^35L)*4J*:RAT/85CCW!%4
M4]5OR$WBW$GI4J7;KR]M*\SKN *T\QOZ#X\I#"*.@2V$5+]>$>2&R]KO*A-(
MDL,]!5$\KE%M9V6\#!4M.*3I7_:-WMP%OPUOO+.NM-0;PH3(S\8W<LF9W/-S
MHJ2WLO%GQ+Q>3\UB;6M?#\@W7$WZ\RMU:B8KAO9,IH4MY\W!W(?"3D.V97Y7
M1'Q-RJ_OC/FI@R6[4L<#0S1HK3#7:%I\PM*+%+>NC8;;4WX693)$E.?610J\
M0+R1-:-[[#EA!1Q4GF.04BCA>7_)AA!LZP%.<69G,WW=4>!^+0=R<F)P7:,/
MG*JTGYQM;$BA;4*6\UI$Z N[Q9KW?"=4($[ZPX259!3B0GY:'>0I!(MV4,2/
M^4(*=T<>,J!%*B:?]+SV@EV]<5;^CHN6 1J?%J,)/[-SU7)\ZNXP-C%PE)*Q
MPW0"6>+:ETA.+)CTK),%D .9S UA6N>16.RV??[1O;2T) ]+AB,R=YW=8SH[
M<^+2V=4!C_@7X( KSGXN-![YI>CR+:#*$S1>."OW#M;A6(0FE7$F/TH2,L4K
M_BCT;%.<[4!<'8,OC^P='10H'T%+>1[)X$?8X8A[>(Y^0[.]5_^A4XV7.3[X
M)-HH&JJ,Q-N#Y[B*=K$AS%!$/XLK'WR.U"[:G,A.F9'RCWZ)Y@E!I<1LE\ZG
M314_"SW3#Z?+TI;!OR)-,C4ZXIZ:;3)!LJ+):!11MX!0#C%AXV6/73?S>>F.
M*92G#X%?[]-F ,&1'#E7!]'L>4L3 4P:A5MOA]M,PM-GG%LN_\0[BY=0:%5X
M<U=?HZ"&O]=9+5VD#FXBJ*D(]FEBFT3 D$-90P1EEB/996VZ*YLP.S97&GT<
MTW<TOJKT;UQ,/2V70S5!-)Y**+P@)S?;%#T=>XNWN"K"OAS520>J(2;0Q$:E
M:PG,Z"P<+E=QS4 DE")JB7Q>)@/AD:%\!W#0#N@2O]EED_=260D,\11?QFT8
M)>W2]9,]&_LJ)96C])QS5QC/NCO?SSZ$!$^WD%]7-;%#0[<HSK&L$G^QYT/.
M1/94&2=F3/?S127RVX"U&UUZ8T3[0@?Q5\:6EGGY+A5^!*P=)X"?E=ZT'Q<8
ML[]$V>#D@FA\VGXF*%D2]?X^)[_3>RG^5:+%=R%"-OXXJU.C#7KZE8_$ZTII
M/MBBE;RJ[I5WK-Q4Q!1[+K)\_UHI'F(P*J2D/%)^1+I1$#N@]2>^GN06X"4Y
M8#!)E3F9+ 4(<4Q5&*P__D3"6]=TL,.MUT@WZ)TM7VVX2"(,F%(U/I*(&9JQ
M">@F/18U9SHKNI;'F\DT<DQIFO@86TU;629HW#^K/^(?U=I:2$2XD @BB6;R
MT:;']9A<3-J0VS!LKN<?G/]1C7KF]+405^<A-M _Y71$/#J"&^34P&W]63#P
M))4C8^%,Z&&WD>-Z25X)\TTQQ2)1H$!P-3%?S@W(.=+/G=X9NJV[A-LDJ'L!
M74D-X-1G,MU&9KJE%>M\>,6(1]E=0G>3U\2B=]&L.W9B+1[ (<07Q4/KST9@
M(D3KB]X]_B+U8YUFQWG53I'P,O::GE8O5[ER&T->;RGVZM-/WP07-H8OQX8&
M%]A[UG47CM[E07RQSB1R+BWW>"F$U@@('UM&?PRE56F<8.!Z3%A\<*;]3DWN
MA9'_=TTQU/Y[P;&B0HNJ,FG&\':3L^UYE"ZWJ[?<P?URG<&Q)I4A;!(MAA_:
M7B3;3@*614ST%M-8HC+N1T3WFLYAXLIA6O-POPV-($^XN?ESAT9<1Q]A<=_?
M03;L99=EN?$)(#:;(5"HDXO(1^<_O/,=I:P+X).?72J?1*XG[4>^#]L%:..P
MKTA8QY\3F-,2NA]YY_P02K/G!@XQY:WPDM"F0:&)4[0CD-R%[?JW_4:+@H?F
M+>!/HI.[%E63Q5W6\8AW %SYG[L]J^3,\("*[8:"@D8=:H*#CD@![H,'!9MO
MRX6%LVHLQ@:=-$VZQH[I7=<XI=]_MGCVX1;PRL'D%>M S;6I>?!BG-+P8=/@
MR*)>!,4JE+L&+CS8K\Y>8<.J^_T!YW*X3#_3<>X\S>[11MBWV'2S3Y5K/4\B
M1AE)G\W5D #VAS=9\K+;LUL>4JK-=-C'4F+G,P5O%YY</.YW=EC2K:MRWD "
M[&\!6*O;RC5C'%\<M+=_]$8;G%\^=QS"\K(\ECDS-OO4,K8@SQJ-%?/3H80+
M*["8R"KL6$OQP>CS*@V\@X!'J<KNJ>"N.CHVF;(:HGL&TF=^V;'2M8/]U^3T
M*1/*AU+EE2%#S -^(?MN3#5!?I"R-T+["B@58WY&_,4=">"8&["3XTAGS4\V
M7VC[8OQ\MO,@BWRM)E*HM6TU#;N*T/["5RMELL=F9/%@GO$-^ U0BG[ZF<:O
M0]S964NP;=R'8#9Y0OR;M -T][9F-LY$1Y0YD8M;WJ+^37!G>53@5QG V;-E
MC,;8MB5+H"U'>JUK,0N3:-*]>2_)(CT&7.WYV:Y)P=A/W*WA2R\7X,(#AJ5(
MIZ8"ARI-W0HV;BK+^VT]%>9)!*,Q<DR'PYZ%;:-?UB8K?:+*E:SQ!MC6(NJ'
MD59#/]$*3/8X$EG/+CW&V-:/PSX22COGRHZ=",5)E29GU1QU"][[V"/4TX94
MV9RL*5_QJ*?1RX=]K(EQ:'OA68M:"$Z!Q*\6O50FF6=*^J8;_\1JBF)1)TA"
MJ88S:RWDZ!;0_94MKW82,V,1<:_@^7V_<AL"+V$ZZ]"G)GL;SM'OL/>IPM>A
M6])6"[/,_<2#S:^632[<3XM,H\;[$C(+D.A%4\ZRW_#G]_6H:.#510:":CKS
M01GZ\+& 5DI,3.^6>\]W1;NO4MTT@1H+<,D(S>)3<M^$<'F6L>/-<[>S>[7,
M"GL+2A1WH07!].Y@M:8:Q-Q0L+\O!,Y] D=&W>P@./D?)8NX<91P9%5%*.,W
MTZ[F >/AJ@8_JK+B&'B$)<=#UII+Z7[H-E973;YX[,40G^GS$8/"RQ.'7_,W
M"@M9<OR,5%D19DN6-RFMU4BNBG8R"7O0>L,VV-I"/N$ZVCLG]_!QT5A_E#\F
M9$832O?SY(2_5ZMC<\)8K<&8H2PD^2I5S?-956G#A6.6X"SC,;F!/L.*T:;_
M9?#^4YD*^Z,A>N^8([- 5/#ARF*D391D$PJ'2V"%/*@_PM3!>9_9%U[UH,#!
M>]K=(.S^DC]:]<O%X%)Y&C:*G:W'7_GE-0'[339EY?!5[O4]WI%5T \N-*,;
M%;U.2<S^+<!F"1=Z<5$ZM0?U0K*9'+EOG8!F;P$MN@V_R'0G3AN*1D5_4A$=
MORB)X2TPA ^G(L-X4FMRMUX1!LM^!/<V*(-GVUNH/3%*4R'[^TP]E,FF7;)?
M]N&[!D/?O8$7(-VJR(VE3IARNLVYRV5+2(H_?6UVW[R+5UCKB9$R/GXFQ)C
MZ.W; \<*7*J-\B+@*TO=T_'86?U1*PZ:F(C]96,2^E4W (,RKP%]1&YBG$>0
MKR5WC/JP:A^Q<!D':_L?2\U;0/T'%9RD(VO=*84::N=LU^M,WZ(9<@/GR\!Q
M#_P19'$2[/LAT^H:-#PY]!O]<R@U,Y+AN+/F!%%GV=7?J]84&.6J(%ZE&P98
MEW9=K+2K._.\!=Q=(F=#^)R[XA*0<D.I0LE?/0&@D#OBHJ(Z?VGJRK3 SDN\
M(H_)<!_+82^VCI,']GGI</=S<6;[W/8]-I8Z/R;&O+P99T2N=T[&YX7@J'>%
MWEZ05L4]71"%*POR9H;]X,70=7'@%>RB3#),1>'Z&(,/SJY(H4-J7/Q:#SYR
MI9:<^^;&D%?BFX3WH6C0>CBG!$?ZM!8GS'E",Z1V0.>H6PC;][UCV.O/'CN6
MM09=+=R3Q3J#+"'^Y[X;^7)9L%"J]&B1U1?1YKWH[Q,#?N(B$W-D3-=C?!U*
M"CRD<:HA#+K-Y$E59>2F8NY:)0H/BRWV' ;E+2QTV61FGFEIK+R=$L' \A*3
M!N,U#@<<*>:JS7,\7$K4+]A6QG[OFJN[PF>^R..KH.3<O0VLW2=,9$*R>0=_
MCW^:$U]U5B'+='Q"KLC]#" 2:5E9FA$]9K,QR8+O&3!C3>O_>@SB07<6YEU3
M,NBFNI+M1M]S_::;KSFTB6&443CB>6WDUF9 =/NY=[ 0O-AZA\,)PU]5"R$,
MQ/,!2_4763M".)"UAG)APL_?S;K.ZG3XYV-Q#W@&73/%QJT.!NC\*I=RBC7I
MN1G9:&I"X>V5(C<[%E_3,S6.V,J4<2IMP<9TFBM5Q,JYP^%D.S^"S.Y7K>7/
MNB(:WW.U> D8CF7F.E1FG\/):AP]LCU%]=2_9!MR:*(%4TM=TA?L,"7>1[2T
M$17DM+!OYZDT*382NEO-1)%<%3;E-39Z'QR,YB4MR?0 M)Q B0YS1A>JO KP
M#/:*2V")66TI\F:4#^[8R5F;ITCAD$5,,]C]8#K^N<P]'R%$I4VS&11+YR+V
ML?N27%W5N'&#B)\8]<")_>6&3'AID!GQ'_8]A9C7KMTME'OB+PJU(#32I],>
M1 !I*X"B9>?I<3><MC[].]80$A=TZ)RCOX1V5HPG65*^<+$'E+)8?A[G0IBX
M# JD^?K\M)_X1>^N]6=$@I[_<P':5>1=LS7R%M!^N*^:G*)9Z75F?ETC?/W*
M'JU#X[J*LX;(WBBZ?BM)GS2\M41H[D8A=S#AQ+9<*O>IW^&5172T#I8FY?Q'
MOS>2Y =DT5@(4K#WB*)YWH.*PQ]'"PRL>SR-F*R?0C?G\7XD*B 7 G&4ZBV@
M3>5:HOB7)0C]@OY>HGK CD5)X9AAW4,^QIZCG.KP.:2<($UF]"L:4@(':8]L
M9@"VT$9L%)^9#T7P^Q$80/<5KXP%ED76 %4:40+$[O"2L0YR\R,-HP3&T3DM
M:;P%V-T"+AFK&,XH B_Y/1^9.7:ZN<:X,?#'0VC6K&6^5NQ/D-G\R&>#1A_?
M7Y#947BYCN6B6A<9+"P!F[X%9'5B+C"?FG4:^!Q7]M_< L;^ ;<]%I I:<S5
MWP]T+)!#Z%]UX!OWSK\;&@Y;"U@\W#Y=A(J\S&@D7?@GI[;938,RD-IBZ8P4
M?(-5L&*S.=FT?=, 64O8N@7\.^WU\6[7<>T_.;7?)0X5T0P5R4H[.M!;LASO
MRL9[68F\7,.&M"YRUB.=<SB+Y%P3UV,7H'VOK[S<EZ<:7<WAL[)!"-S)E1>I
M#/P5 Z536T2+:+8-JS=8>("4VF?4!^T(<RFED8K70@R& 694@-5I#2\IS;)1
MF_ZIJ7"=#ES%_A7["]+4WB;M7P;C*]+OQDO( 2VJ7Y>)TG!_+RI???=3K++.
MEY5G^;0'(C6([*=KG-ZQH48U-U0 LY"'H0WBB,J$DV2KP9.W<PQ]9CB"PWF(
MZA@<'S>'CB59W":12I?2F.PJ9S_-ZU$9YU*T++_+M:-:-ZMJ/1-DS/D60+VI
MO=.][1I,I*QUGJK3CO6=5_2E:N17!PB1NY_>=*Y:$2F/\_P#_J/X*?[G8Q_J
M\<;U01?#_ OO"?G9AM /(*ABW9C?'T<2VQD40,:IBH8#9W)K3@2?\)7GOQ5#
M5)IK)_CZV%K3IP=P8A'R]'3*8*#4/)/,4\#=Y(7TNN\JM0N+RM<<M^V^!90$
MWLEBTU3B999N4V)K,^&]%6:F[_U.\_4V3>$DVQX=/+3IL:MUU^)KCU_3#4Z$
M17:T#@.YLG2_6N\1M_%FKI&(0!O]1QL@AC?Q(3P5+K"N4';<M]G,_NH5-<$O
MO/6?^WV,PLXGQ",?AQ?N/&DH(K\S^J*FMZS&#5<I;L!-EBPPL=7.&W[KF\:6
MNG#S6P#]]K[>ZT@\F+KULAEK )"Z':G80;UP&-A@D#9KQ3W+WSBK7&W5%_Y6
MX/!92(' ,EGD5[9V_J5'5A35,JB&!6?>'@$!QS(_967LKGI?87'>*/ [>,%2
M^SE7L4D/NV=M@H.*^E1)HX*G= &Q_^^EB.VS?-#%[Q*+Z-I"K;,&K]1RU>$C
M+NSM,2O'.4CG*\2Z=I"]HV7NSZZ#!./G.!'3 92[!BSERQ"2N;F=<X$JW3TM
MZN\!8('#]^6<WS/@,>'OM>G2PF2E@O?#*O,$%YOJ0&<+MX#\O-0/=5'/#W*_
MN@>&1ZB_#C/ HUV1S*5L%!OB^3.,UBC4MJ16Z@JT,[',Z63ZT#P;;;=X/3.C
MR#WHM9MTD9NI?X%_, ]N/XO@>V'',^'_V\?^V#2$H:TQ6TX]IAND&W T^E@*
M9.7'EA2:I>Q[<;+1^)[%7/WQ??D2E]).,!W^Z*:]"U TU<#?L"E242CW"XFW
M40W&27/G%M ?('UDRIF[064(TKTFY'J\A0QAB?KD?Y.H#<?T22(/HAUO 23U
M].ZW@ SXT+8!9':_:S2L29/'M08LETK7FO<0\8+R$2I,7[,XE7G:OX];K_@@
M(4ZHI, $.1A*?,GG)8YW+9"?NJX&,;(TR4DPQ;OQ8+W0:!=2=&UN4'GZ]$PE
MUK2FOLK?N$;:DBCN^@]9R!4M[ IR)IHJ-?:%OZ]O5]%&0>=S*(6XQ+MEGX:(
M!GHKR!X=U[-DGO[E-;,%4%NA[HR>=I=)=:4?#BNS2=!'<V2GPZHC5]&'&,J<
MQ%U'?: (F=7OR!^C6QY:(4#V;?MMAIDKCF@VY\P^@C]I?O=O 48$][RX6W8'
MW+#[C[H'#PRF8\U,(N5WK'@<Y<&\RGZYI6&B#'IT0"NH=-E6D&"JKJ<@SUQ_
M9">C]&O:@O16O-T/JGHOYSZZY5JF7TQD3U)LJM<D,OMR?GY&P,GM(U[@P';)
M3Z=SF.E$L?/(9BG"?T_)S6?97Y+IE#6EYA L+268K_R:_UF6;I2XWH?Q=Q3!
MD4S";R7=E"56J5HHUZ['(7,JYC9D;$S&P4DA.+OSQT,*1X@]R9X><4<Y[4UA
M1I1P<?-^338:!,< +DMJMW1CUKO2-/EA%/ZNMK@("4J:WUVY]B]F6^X/?Y9&
M/*?.N!'?'7 \4!F'/:(UHG_=7*U1M'<+8+C H0^R%*^HBK2M?;W!D_-2BQ%D
M^-J+<X=-D2[H:>0@T'@];]YQ]\9ZX&'O*A/TK6NFN'B=.F9!$\.P>@L 6*:$
M&O709[;TW,DM]RSU@Y6!$F?)H:0*([[ \U?UV'1NJ\(E? 22W:S VDS[>65E
M[\8=3?<2B/E%R1'QMJ[!_N993#M7;( T9=]O^N0W(A-T)DHU#=RM#S]DEQT\
M"5T8E.'6OYL#_$2(6S/=3D')>D,QA_\(?4^<UM*HE;*&@_8)IQL.+K"K\"+@
MV_C)^/ORMT%MYL^]&Z;B^7ZT$&C[SO$%R##FHP>84]F69C @)& OX+?1F+I*
MF72LL_X] #,T_:RX>N4@=I&LNJ:QP=5D(A=JV])B(R[K?@38(W2A'=-[/&X6
M?7SPV<Z\.16--7^B+:8DUB04-JN71$:B+Z?X1,[0QQW:5>FD\M1 <7-^B%21
MUC=#4JC5$/3]E&K?WU"IMDP90<C=NK^MH!^.)0Q_?Y9UW+&$;&:X &1-J4^<
MOMQ#RY(7+"1'93PQ?_?H60N^("NZ8K6 :P#3LZNEG/(MVXE!/$VBR4K@8NYF
M#+W;-3-3&NEZRI<8SSG<__0Z#:5.BRHIO;CSYYS;!^[K%3*(67GCD#\</_;L
MEV#Y',UG7Z4J9_"81"D8?KC9F\WY].,9IX!>8Q,O(?=U(;:[?W4'BQ.>*YV?
M'7F@5L\;^\$5/IGP^P(SV'4O5FH@Z1;PX+F?Q\$M@*6A_XA[W)W$X@88TP<6
MR5<3R+W/D-SIK#?.M3%^L%93 ^'1VE%1\'<[S=LJ28QTL.G9.24V&\6L*M<&
M;TR:^R%8"2,[OO9*=C^;&@43W0(L;GAUJH/AG8KDH9L+U\:AN@]5SE/]_Z2@
M31:;3#,B&W0FI(C5"6^ZO#9MZ'T1#W!*=;:NLIB(DI\%:*"15@V+.,BLS?,F
MDN&U(=KMX5L BA]9)C?B1YR );;WB??T--?M#DD/Z8 .R_6.+^E3SS)W2?<]
MFOV;B9P TG#?"M:>GEO 6VG,V\1L3RJD;6)>(4PKL,*+5B[[4;OE]3 \79,5
MGSM<AC?EI@!14J%X"Q WO04T#3!8Q#_QG!(Z-9&*!L\0[2MZ11WN@K%FMXUD
M[7#L?W_%SR/_8IDQ*,@18E+D[4$3)#\4?_D/4@K%1:A/ZH#P0*ORR@OW;W(A
M?[P#7>40.BTK]BU%(&+3[:<^#)>?9DH&#BL&9G6PSAQ 1;AN*CKZUT^%,$YE
M);9^F%%PKU?FBNDKRSQ(K:%2 :?M9Z93$T.BS6X1T3#'/IBEL[C!+>#PMQVQ
M2REH%K0@OBM).4X*K-R':=\")*##6NVBTQ!2+P='Y>,UQAL3HDQJ8.F:6G_<
M$8.3G/A]J8">;E",)_\FZ'P)<\7G5G)S?O>TH?0SS@QGD1CULEN 7YBVDCW2
M6K%6^F:AJHA406Z+RD!V1]K[2RRMT<EY24,6BVJ@*#S3$;T#>@&ZW$@];RDR
M^;6NN?[T+!@CM<)B7.W'J[$.-P2)7$]U0S%NN3?(5^^XB2X_,]P<O4[A370-
M-9/WBCJ^F5Y;S7XW<?7 ^&?JJ2IDZ9XO#OBX%W2]K G1,?"_EH>\0CI_[X]T
M^SFG4+UM$-J4R7'B)_3";4V<A(ES*9S\#.!WU[?_5IIZ# 5OM(;Z#J!X5B>N
M#/HZ* 35ZWZ4*N:JLGS0C!!6,Y 3",HUWR#D%O.?$?52!L8<S@(CS-,L43K:
M;55GR)#78?+GK+7\5B&K4:,->\HLQ:_G#Z6'E_-U-?@^+XB,&B@<L5DX'T:4
MQF[A.5XX%>@>I-.>$\_IW6/?QPKCZ*!;6K3K.+[\&)PI,^+9[NOA2=A&-$#+
M6#)<K9+]2>LIQ\]FSL *[VYS#->D#R\\ZFYZS0CU#@M&K]R$*P/%+60Q\?.W
M@*U,<*9O8\%P>X'$%4'S!4@ &&QV"S"YI!8;V6'+.L4;>7^L==T6-0 ^Q =$
M!IO#FA?)4JQN :X?<&)"$:'4JX:EBM9>>JHC\4*.]CD5UL^[O-5,92F%-T-0
MDY4-$QADYC^<R[> %:T=\,D'3YU; &0?=$D-O="XBKLA8Z"X!2Q=JV!DB@__
M5@3S0QI>8OO? GZ \R$CDBB[FUM Q2U@S:H/!6I?(K6L>[P_&(18(MT5*;2/
MK?Z3JEI1);]T7<0U0V-T/FL]+G;789J0.*%W--8Q\SR8^E.311KR,)BU^@%X
MZ!;PO5U!/[D6GVQFD[EF,\0Q95P"R"N?)3;JZM(9OB-Q+Q:*6'@5$0A+]XVP
M :JOQQIW/33(I1KP$JX+G3\!Q0 \AYQ,4-E?6".7%*?6&W^P0\,Q+_]\3%CC
MN<EBO(G*DC2>U:/IS\V9S<R=]1Y^"L5*E&PLU0K]5=C$7^X K3,JB!D;HM&D
M8,+&E/H,+GKG+.Q9<.Q??<#K E428)CBSC[?.9<5CC^U8TZ=$PC2=B</NE7L
M #%%:IGB6J9[3[ZRK?YB'/"Z!5Q[S"IY(?U:.5;<DJS"2S_JAPM4\R.]2@+Y
M*3/DF:J)91:H=3+?8VSTR2?6/ ^$#8O0060AA)9S0T6&U$^C7LL*9.:T:9N#
MK(B@Q2V6N]G:C'4#17.HD30_'2G(:D:M&Q%73,)=94Z]I:."-CI:"94Y.^9X
M"+[N[Q*PIB<F.I0SB/(G<^5)4>KB0Y9W>//DZM#!,,FC:!>8?J4%Q&([0IE:
MG-SP&6AB?J%[%=C,.6ME+4_2RSAZLLQ0WC94O5T+Y7.X'^<034H$?&,@0VN>
MZGYC\U]@'3K=OT.P10J_XB&ETW.U6?[#W6K^J\:5S/KV.AWQ_4]_D\DZ&\<4
M>^C8-.Y2?U.5=DZ95I4FPSIFW=^Q1_;)W@+^P/[9MHY/Z->T>]/8O!;_G]CO
M\4;-3HGK9=+?@Z)>*+Q*'* 9,.F%\GF1#6R$;H1]Q-[*L>.SXW-(8Y#F=<MT
MRXP!7/U3AS;OS@H6+18MUB7NC.-8YECV-=:)NB!,$";\@2@CH6&D8:37Y_^W
M1BS_\I"H_K\5J>@Q2:N=[4PNL\TSL( +-NC9_BEK</_BXO<;7'L]D8)0EE[Q
M5_)/'P<5S^@)VZV\AY2)7,.$554-##O%E2]/V68X:5]RM.51XF?ZX/TAU_PW
MB8+X3HB(K5+()QC'3VS>KKX?_T10NJ G,"71CI<JI64+?.TZO]AXB&:^.C(H
MY_LQI9Y($R8IM !%V/I@=>$!M$ -X[:\%Q-L1:&,:E\U?S%8KJJ06;K\,9AU
MS>UX,Z]7UT.3;+9_]D<8SUKAX\V#9U/JMX#'Y"C%7#3K["9]' A1V56!C8-(
M6+O&=_$:T-"%[H,:]B$K&4VO(,,WQ;> 9;E; ,+B%A 0?)%]"Y ZJ[\%^#+>
M H**!??:H.7XPJGVUW<>D/=ZL ]#S8:(NR&:/<3@0#$LT N+DF#P"<BZ^8($
M= %;]>Y_><USK=I_'5B9>@QJV&O^O^B";^[EKN]I@3,]0^,$Y2-1X6))S,OA
MF+L)MHZH(U@X]>M9.<;\/!F$YM/JY+IBJ%Q"/V1 *W&A^4"=;WG$/$J(=SBQ
M;@$SUM@8XFX.A9OJ#WZ,Z ^MUY>2NWY/UVDAE>-J3T<Y?([8/S=Z^^GU")1,
M?7)"ZX:9SXL7*9>A=8;AUV_1&C!)6F_1J>0A:3T?>;3 Z!WJ(VYBM7XCP5]"
MLRLP\F[QF]FAAH?#@RU[*@+O>,;9VAZG7_#0S!^3O12[Y+ 'T3?V/6@E<_ZF
M,_:.2/=(.,M=ZX:SX'[,V;=]%!O8-XO7=;63.BB:B-MHO/BY3,NSSPGGWTS.
M)="N1;O@8$%82N ;&VMP57T0_L!7)\4@9_; QZP\H? <&:$ARA)A@1;"& _)
M")M*,MGGQC6X#R$+=XI R] &BY+YTZ$D3I59Y#H'%]C'2NW4G9.1$B.=LW+,
M<@B0I&K5HKK\B)TBN>DGGR.%\H>?.<B9H*I_$J^U.O"_JC?!CA7JPE-1=HR"
M3<:I6Y(.F3CB&^@>OM"3#YK5-S5UT3S'1NXK>J2]L]&]5G*I*Z4\IE -,OK$
M&XB==Q>;VI_P%5]'[@SLL\@6>$JC['Z>"%78:'74Y>1F=^QL6WLXC+UXL_Q$
MC_VKN,HM /RBEQF*;:$ZC9_P#"<EYO4SY5?BRFZ#:NYEW]8M%Y1D*'T[.8_5
M>T/@$2D-(\/$TV/_BRG#B$Y'($W-@\WZ8MQW#G C[A9@6 K9NM?,^,S!]CG#
M/G037.Q-=0N(<+F+0TNTFT^P#,@TBCT2S&?YMC*"=\1;_MDK II;Q<B'_>=>
MD<=T;(<,<\N^R';9H1N<J7_RW_"].2TT*_8<-$9#PBO4;.DK;.DKXUYM_))F
M6=F50>W*OGPD[8[7"O6G7NHJ(8686YKLG0E<6.]+3WUS[G6'-,#+ULQ+)*RW
M57Z"2N/\/&F02WJ31HV3G/P<(JV;FK'[%((1ZL*O27U4ODQX"#B-M8WG/^6K
M +)EP(J._%28S.*^GN:O"]_/-ZJHJ6?2FQOX*JM*\/[B:IG6FY]P9=<0CO37
MF."#? >3<9[HU?=Q2(+*OSMJRVV_WM#$NR^\#;,2V;%6QG<H%_/63GGH66OB
M:MJU'YDN R]^@(-OXU%Q3KT4C,$&&[BB#FQM;P&5[/N>@GE6I=5SE/587XGG
M-F*??:>MDMD['JTE"@+CGY0$4!?79H(O,O>]GY5_M?E25!@49FI3P]/3\%/;
M3_O98Q]<96U\6[I05LFL;#JH4$:CU=*R1NY98W4@5X/R9 I'[31%#U]"=GF
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M,1+W4>W,^4SD8_61FW'59=G^9^(<=P?M6X!S(&%GG:!SH,F0A3"<X.-5V%T
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MB+2[Z^K,M ? $&^_<B] A<V F^*_;P%P-:+65"KZ5!1;ZAV0X;\L=5L=<$2
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M15=&)J(/]L$S*-&;8L24FF$<D@E:G0O+-,%\EKP%^*KVK;$:]'+H0<9/N'[
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M?21DKX^=_2.M$^+W7J3JQZH[-\H-V'(?Z-G=@>L^3N2UH7+Z>_J$K9ZR:4K
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M0#WS0TXS1/@\C:QX4D<[/;G<3^NTHRO^7A)1$18J-@-Q7@I_8Y.L7SG#/H&
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MD[()HD= 5[ESDXX9>WNVRJJBQKK?<G%36,8U1F74?XHEOA$.79?=!H)%90J
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MO"7R1N.(;N=4B,AE7FP(E .6M0\T-]C_()Y4S-H 9)W#XO<G.JU"X@,YMF%
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M4,7HOVA#T92Y3\[-.&9XDT.$[]"T+DT1D4!7AI&*Z__?! !02P,$%     @
M!H1<6J&>))-/M   M3,( !@   !S;6QR+3(P,C0Q,C,Q>&5X,3ED,2YH=&WL
MO7MWV[B2+_I5<#.S9YRS9+4DOY/>?98[<;I]IO,8V[W[]/WG+HB"+'0HDLV'
M%<VGOU4 2)$4):IH4Z0=[K73<2R1  I O>M7/_X_AX=7SHP[EIBP7^\^_L8F
MKA7-A1,RRQ<\A-\N9#AC=Z[G<8=]%+XO;9O][,O)O6!L..B?]H>C\_[@\/"G
M'^%=[\Q#KO.&C7X8G?\P&HQ.V.#BS>#DS>B,??G(#GZ_>_<:OST+YS;\5_#)
M3S_.1<B9->-^(,)_OOK][L/A^:N??@QE:(N??OPA_EM_=^Q.EC_].)$/+ B7
MMOCGJSGW[Z5S&+K>FZ.!%[Z%)W^ CW/?^7:XD)-P]F8X&/SCK<<G$^G<']IB
M&L)O^F?GJ]_Y\GZF?GDZ@E^Z@0PEK,87-@_E@\"W;QD[-09\T8N_-G6=\'#*
MY])>OOG/2U]R^S][__FKL!]$*"T./P?<"0X#X<OI?[Y57P[D_PAX#[S2EHXX
MG D]J_[PXJT>\XU9*GX['N9!!G(L;1DNW\SD9"(<^,)__-OY:'#T]L<?\(M
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MA^6L-!\K2H<Y#"M2?[0R9^@=2ZT=:+D]KV<3?[Y>S^%KREV:=PM<;SW:,DF
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M+0E?0-.1\55HH]!\O'BAG1Q/]<E]&=;C,TH;&W/GJQ]Y(9Z^MMS;+ONEU3!
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M$7V.8MBO^.#=I5[L"^RP8XZ- G-6,S+=[P1V8F$2^ZDN=.<77\3]8[<-F;V
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M?P\2Y/O<\MC]V89-_P/T-G>10)V,:YN'8M2;9@&\=]P.?76;TXGJ*VQ2R<:
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M3G3TK+@[]![;J6ZQ$O;=U/5Z52*056=;UUXU[J"$31QM.T%9VE2HC*K Q+5
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M.TNVC?(>-';L8-;4X)</PHF$>FJOYR EXD^4MTSM^''_A+S?MQ$8T<1U;V)
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M*U!H,087:Y*@8GUI]IK]OHC]954R$?/ZUNMV/M\\W*;CC4<Q(#!1H_FG[^Y
M$P-567Z_EEFOC7NQ;=P\]#B<DVNWW.4I\)C9 &4>5=J'']&A"%HF_@6Z%",S
MY=M)X/2N^1V&"_/'-=0[L[:!@4^FG_]14=BQ6D9\<EC4&/NOE&#'][YGL]'"
M9]MQZ>6AN*GH\K>V"$TWKV$GMONP(\UK8=[!Z4!3+_WP_[&F\S_XP1$_]\W>
MUW8+8;Q@QM6,M^J1XW\V[_J4T'$4-L8=BCCEM)VS%#L7W8YCX_U=P]S864,Z
MCK?MLO9LWM0:IQ$$($,$_("?4OS+??<;FKI=X]ILM:7I?M?%Z0(C4&+9KK[S
M7]\W>X/O^&@.DY!&$$2OWF!+#W=WS1[?/)_O)##\0U<8B-=2K3J*W\ NM/MW
M[7Y_%WX-5>\:P5>TKNEK\^ZAUP/)JNA$W+D#>QR[7,0]#?Q&%:*T^\#5D7Z[
M#[ME]A+[9%^;[K[7WM_LJSJ&7^&H9>_-+V:S!^*OMK5XYFH5648WOS5[0BWL
MF7COHN?O:[,->N>M*=0Z_6Y2&5W&%KG+-E(CM?M%LW.D?Z#JD!K:?(HU'<"8
M.N;WOJ3%,&Y,7-P28D6M;G^@*,%*P-L1 ZLE1*+O>R8>.56T"&G2N,:E6%>9
M!+?Y3\N\5\0D4+9Z"?L,]/HO[2OEB!%%RU8,L%*:4,-UZL<)D !CRC%BFG]3
M\0HBQM7U'T8PQ% O4+SB2.<1KQ[M*],S43'Y-<ZCZ@:@(41V4W(H.^"N60(>
MX:J$.3,[@U+VF.(51@/5Z)^NFW:G#)"]JD."LKG:ZLA=TI3%7BQ%2"4-PJN(
M$R(UTNH^]-3N3$HK8,4J(ZMIZ]-K]Z_;+778,]'4Z)G=&^U)-_K5LR0:5,:L
M*2IIU+51:N2<='9XQ$O_8# BH_V,WBNJ =3T%!%ODK$E=)U]13TW\IX)GT?K
M2[/W642=<EXQ^#\>:Q'6JG"<M:6O#(EK\.,WW#*7WI-^O]MJ<Q:<B$,FX[23
M'X#.#-H<C8B0PV[G]KO1[QIWJBP+M)1GM?0)HMM,OQ/K1MTA0AD++JOV1A15
MO!*J&U-&\:W[<'O-7<@EC*;3'YC-$B"ZR#^EOY4O90Q%_PZ ,UD&;%K16B'>
MM;?-MF)6.'$G_QH3!HH]0H]*<!\61K$2* D/%;6ZG>N'UC+RI(T \U:W=]WL
MM"1^*(.L2B<'Y'%7:U@/DMC4FIYA!C"R,*#VRW413D$09QOF.I"#/W$\%H*P
MCGAONZ [],P;L JP__"H )M@K[J=F]MVJZ0%D? ,\S\#CN6*!I^ 5)+^K)SD
MW)C%3 V:_S*1W@\F!H=7]IY":$I?LG"L7,DK$_?/MUX;.41*[%T)'A0UQ9Q$
MC;4K%P*I,?4H-9&(KZVFQIV1T]_4@,+$C; #OT,)KEH:%Y^X 11U$XJ1KGB;
MD]8%;@ZU"YWD;;AM]M1:(:T^Z V=P?>CG3!)\?51:H6KK=&]]09V5&+#]\ K
MW%(LF3UEHY=MT+W2-]+D),%?V]<I1TIK(/6A+!U56@DK"?)21D"()RIV;Q4S
MNBEV%DSY[4,?U,<2J/@4G;0TLU$U-$3DR+LSK]64&])H2F"O4U72*..(C(XK
M<_#--/63>MR9I8#/2HFG2U^][K)XW'H%^^-6$;%%BW>K([9(@RHAW!U=5-H'
MHRH+*!NZPA@4*M]."7*S# &C: ?2F7"$.M4QV\H\TZ0V]4>&.XKGI91@K<H-
MH/_8*$=K*>M2AOI\C[FH U4CO6KD/CP_4#\UHCJ@AB9MU#$NI'9ZYN=F3QE<
M13HW,EM:Y*3V,M3(*?NTJBZ%?3H4KM4*%8V@.2?@M8J>F+&IB%76O] NRAZ_
M[II]SML4 ?&Q6! GW>:'4-!CYS$@?/DE2&,]0U3NI:ON-4^*_XSE@SHBP?2S
MV6E]E\ .Z-7#X$NWU_Z_)B]:9'8X0:K!,U#CF-1M\UO?B(HEX5-QZG#B!SNP
M]QS8>P[L/>4+VF.2D%W6D->2R1G(]28BBYABQ65']\9 :ID,=P#(.,D9(AXW
M__W03%=9,[KW]]W>X*'3'GSGY!SM?E\M%U>[ 4AI0'"0J'@!*:UPMA2]38A"
M'$J)Z91FKKJ@)VE>=-U3I7U3269!F=^JMZUT4</L)5XNQ9)D(OJXQ$24Z?YJ
MSW#ZFDQ=F^)RPE_LGX[IE4<L#])*/^U*#5JJRXU:0P13Y8O<Y[.AN>Q.2F+X
M6[^".N[1]H]_Z7XS044EO(%0&R12W?Z-.\*SJ(T3^B+5]NW?$&;P]@L@Z$5C
M:U/07CVTOD3PJE1,,_)*8%!38*F4^*5^'AJJ_1B5II)1^=5S%[/0\E^,CA4N
M?&9X8Z/YZ#.&]>>WI*9J_:O3_79K7G\68+P4$ S^> =;P6P]E%,H2MES3,K
MW0E 1/+F?.W>/G0&S5Y;L>I)*23G)(2[0%V6,1C]01W.1*:8VU!"64_*4!XZ
MUXJ^5EK\HW-S^X!H5/W>R6RM:T/D,74[8 _>]O6#82/:QHVRD7,%M9H]$TL-
M(3U0,X_T2<#0\NEF_U^F(!/Z]X/9%R1L'=-$R!"F:MUQ%/..V8&5PP(@QZ8J
M01L1Y-@W_\WWIW8^.'5Q2XK4E99IO4/Q)]*Q5DR^(\+0%+4(,L.*NA91PD:C
MR $AP5)AAO8@F_L!(FR+#XD?TQHJ_TV6NY,KE5CZ@W-72G)?'G7B%2U$?8NM
M>JWY&N"HO%LLL;%"[E^99B?!>S8[&;<D#*9OFO\2&-!K)&A%5R?&8"3EF*QM
MVOK2Q;]=F2#\3:/?_MP1LYV^0W(!N- :NLP07O=_O#E^8]C,=:47/?Y9CI;_
M',47A)_>]ES7F@?L4_0/L4*O9G!E8P\I'PJW^S@0^ \^A/=@1GF+\-/8^<%&
MZ<"-Z&CD>0]]^-\HZ_F_B&S'<)3^8V8@+=A]0]_9SMN"R_W$?'S(E=8B-]F@
MSZML-6G<H?]#3KSL;?VDEN]4]H&<::<RZ\7';.;Y4\N%UCZS&?,MEUN!)3:\
MUL*X]SWTGWFS8+5A^@J]DET@]"HY7KAP'W"_?> ;=*WSHG'P7&0]%TTES\5G
M#X[<#-;"N+6>_S!:L"V@%2/TC'OF!][,<HU_+GPG&#DV!L>V\64,)DZ0>#^,
M9\=UC2$S'GE+;&0,7XQPP@S7>@[03X+_[H=6R)TF*##&'G3(@O?""8@FX]%Y
MPNZQ\9C9O&/6[,6P)YYCL_?>& 38L^$O7%AFSS?FOC.SG3G^%$ZLT)A:+X;/
M@H4;&LZ,MV3-YS!P"\<2-1YU!+_[9VJLA@=_]?%#LU2_="<Q>KQ/L.!\&7 0
MV"_LX\*!403&G/E3![X_,A:P([!_Z>G&:Q)ZS6"2V8\YC#UP8;:25<6/S^7*
MZM<!K=E(N]+$?MCN(G">F'ZU^<_,2="L<)8Q=T]LMBAAWKRQ]I' OM:^(@%*
M*?VS5<;"C]E(*"6Z!V-["S\,]$L:N$AA<?1/G*-V\$FTQ/%=HW]YH)W,_3)V
M7+A8K$?+F05P?;+HLFYYTSD\5U$8H@AD@>KU\2<J76+.0L=GM#!15K52\ZZ1
M\A5#[Y&A%J2_)53W^%8S?TR<H1,&7(T!K4U5')):QS/ ?C![H2I#*.&;9Q_U
M-S5!0FG' Y59;>4HK8BW0<,/GUD)@YJJW<"4)E1W'*4-57V%TH84VHK)N30Q
M\4M,F+"Z].N1"WL"IBE\P;%<-=V()MQ\_5,W\[B)#9;F&*ZWT)#B/&N:!@S$
M.J@<4M(S<0-:L:L #IXP:D'3GJ'#+I(J:1V$/P6:B8#IPC/2J@T6PS_10P 3
MB_(HN3W@+VCQ@L8;&);KHI, M!Y0!^Q%P/U@Z#GP&1K+T GN&@CBAA?!$8P+
M+$SLSI$Q7(0&#M5UP 8'32GTCKC^E']]:HV8,0)S$?HW?8$O0)>>'/;\-G@G
M6N/Z*CH99NS1"QWQVI'Q/%&_;A6N(.R+!W: 9J=&QS.FWL@9IQPOJ'?"FH^F
ML5\BNU5F4C%]ML"R]R/W#(< !FL<'Y&C27B*,+EC,7-9$."^Q/%"K_4?;5!9
M534(RI$>ONBW#50E+L76N8=3XXQ4A2YIRCS%4T6*?9NZRS(I.U-H][GJ94N:
M+"'/J^N%)(UFRG2S+)0Q57")!NSO12D'TIY8LT?]7CO%<T]I0HR$7S1PV8\6
MH</@+@\LU_)?CO"JLV&KLUD@;C]^3Z$28<F0!B@O3Y;KC)SP!1\.;&_.1' B
M?<%5U/?2B&#OQZ];-U8SKU2?@5IAB22"K0"ZH++,&"[/U/-9%#J:Q[%4$5_*
M!+Y [39&^.^1\>0Y/.[E6L]'^*)0:'TVM1P>>TM]A^\.4*-!75DP_.IX ;\
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MI9JW1[K$GM6"'A0OG>TM$$N.(D[1P4EI35DCJYKK#,27/3&"B24@.A*692$
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MTWW/4\&"D!,N'R:C4O[V?4<>(@J+PWQ43;O?\Q%!_UI5ID+H2DO>OHJ$@#
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MB!M#]0)%4GK-"0)CV:>!,@;*P) 2(Q^.@0*1T,"D0 RXE0%-&&!LGH@H(:;
MCU7[.=>\[ 0-2(4!7H&3[;F7YB;GD5,0^\U!-<7 S!DT8R1<U*?A(5'Y?1[_
M69![^$C(Y206&6 #8;;"0@-@"^)0K6OU(HLA8%$DE/ [D@6#/@%O-<<W *M"
MRP7) 2Z(=%P!P-274"Y19#:&AM7"'%-MH$0A00#PJP!D;CCC](FH24@LU=Q4
MX%[%0T*QT.L-6C9J&#65,K>T?8;I0]OQZOM@.EGS*=K8^=_ E$ LN0@&)!5#
M?H0B]/:84,T=K@ G(I0<_4\X@#F4PB0HCF(I!&,,R/C,A(FD,@6TPS"ME?0
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M9\[I-:95S\M<8G6,TIV?5L=%]\)2N2?QAPA; A5ET-#P99SZ+.Y*'@I- #Q
M%QL^MQM([*9(84)@ ITQ97[8>K#VG+>?:@=T"NDYUA <&H  [N(98,B=?)=@
M:_CL)K*9DC..*2ZCT_( 7Y<AD*>Y5 L.M?-$^;A'UZ ,T'N0_-_<I<3F[C58
MMS4K&X8 >*Z#2$E)<\/[U8_ZT!C"$O]:%N\IH,4PEX,ZKFAA557@KT"XDC7O
MU^'@9;"D=NMAC[BWKF_V_&MBO,*A*SW+\3O>=,N6AF,J ^93OK"U*B][/((.
M:_-5#ES-7>T61JUG]"&>4U=S6#T'<TWS?@AAYCJ8PX1]]6;'LIZ&1LG"\@%>
M+]DTM[IH4GY:]A,;UK(:W?D %C["4CJ#P-$GYSS4!;ZGZ_8:!"\>N25S'[>4
MBRE4UJH4)OZ&N&,Z\J+M_I[6J)9I?>&"P$7SK+FR;Z>]\RV![AN\AD#^P2Y[
M=M>N&3-,!(_)Z(9'!49#\L%OEXY#?;+_AS\NA&1_J_Y@PU<MEW.K@+@KDUZ+
MT<DRT88TNIYJ560,28'2_6HEU&XKKE>4>:8+BDB1\:!\;J\1!'\C<HTAK!4M
MKU_F0-4"GY%H#"R@3V=*L-+_O5ZS^VJY8GU9V^4;?ZVSY6Z%_A]02P,$%
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MMYKVGLO4-Y@X7:;3D$<WUQK'$Y,84'I0KXW&7<?U!U4VZ:$C4N005-\[:\+
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M\VGO;G;N]/=.AT:8!$Z'G?IW2>O+<'4Z#,4]TV:5P*>]E*NYR!PC<^_0S<T
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M=?(+&XUG---SW=[KX?ZUT$9$JYU*')&A%(-+=_Y@G;G(6""S# ):Y<H]PL3
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M,#(T,3(S,5]D968N>&UL4$L! A0#%     @ !H1<6KXO%SGAD   WD$( !4
M             ( !"64  '-M;'(M,C R-#$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   (  :$7%JJ@E$[QF   +G+!@ 5              "  1WV  !S;6QR+3(P
M,C0Q,C,Q7W!R92YX;6Q02P$"% ,4    "  &A%Q:+7OEP5< ! !@MB, %0
M            @ $65P$ <VUL<BTR,#(T,3(S,7@Q,&LN:'1M4$L! A0#%
M  @ !H1<6FL"EMIJ2 $ Q&4! !@              ( !H%<% '-M;'(M,C R
M-#$R,S%X,3!K,# V+FIP9U!+ 0(4 Q0    (  :$7%JAGB233[0  +4S"  8
M              "  4"@!@!S;6QR+3(P,C0Q,C,Q>&5X,3ED,2YH=&U02P$"
M% ,4    "  &A%Q:8^V3ZBX$  ""%   &               @ '%5 < <VUL
M<BTR,#(T,3(S,7AE>#(S9#$N:'1M4$L! A0#%     @ !H1<6E&SK*UM"
MEBH  !@              ( !*5D' '-M;'(M,C R-#$R,S%X97@S,60Q+FAT
M;5!+ 0(4 Q0    (  :$7%K@JR1[;P@  -0J   8              "  <QA
M!P!S;6QR+3(P,C0Q,C,Q>&5X,S%D,BYH=&U02P$"% ,4    "  &A%Q:/6JV
MK,@&  "Q(P  &               @ %Q:@< <VUL<BTR,#(T,3(S,7AE>#,R
M9#$N:'1M4$L! A0#%     @ !H1<6J)54H;9!@  R20  !@
M ( !;W$' '-M;'(M,C R-#$R,S%X97@S,F0R+FAT;5!+!08     #0 - '@#
(  !^> <    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>smlr-20241231x10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:smlr="http://semlerscientific.com/20241231"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="smlr-20241231.xsd" xlink:type="simple"/>
    <context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_8Bg3PzLN0UiL0idVDay18A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_dQ8SZLQckkq01f6d8teuYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_7MdStRIh3kKwwzJPpWFxcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_eItsRBJS3UqRPJXG0t2wwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_SU2XSK94YkGDlZDDBasXLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mDqBkPVNkU2MWw6rn8s8lA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_eBCEoRryQ0WqACbtbHRW9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KsDbaHOEh0G1GZmuHINO9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_PP2-ruBZD0aQuxrVIVT55A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUJvfYZkXkeH62F-h-9aEw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_jPaHxANL9EC28M6jZYsdEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_X8BtSj_gKEOEIpqdtxsxfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_0xY6gnE8qUybhgz-gxdNDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_JOF9RAV_fkuKYUMpAYeQQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_KeyPersonStockOptionPlan2007Member_6IjDjCrPDUm7EkmgVITtGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:KeyPersonStockOptionPlan2007Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_8_14_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_Hkgpul5BI0mLKNUjZAN8IA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-14</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_GbmeNOsf7EaK071-nE3ADg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_dA41U23jbUaIgfrnIFaEkA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_vvjiTdI4e0mUIjbWLapyOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_YXae_MH-f0WF5pBOJi-pJQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_S8qckvwft0-ZA0tONRcfFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate202308Member_ErqcZCu5GEuuVGLzwhazqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202308Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_4CDoFoOHw0GbAdFoHlt6Mg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_KiuY18k-9k-jS6iTZaYS0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_aqZhN0s0ZEyt9Xlfg5w8DA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_MakASwJL4Euo7dVHvkl2rA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">smlr:PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_aCUWSs44WUuNTnqFFLPMZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_f0cWWAE48EORHBh0d2T8Nw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_mGIHHxS_ZEuc6ViWxpMJ9Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_W64GlRtDm0icy9iIeB1Rwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">smlr:PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_SubsidiarySaleOfStockAxis_smlr_AtMarketOfferingMember_YtursobFMki79XI5UpMKsQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smlr:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_10_10_2023_To_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_wO80u8v0nkaVj9-6hCzGng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-10</startDate>
            <endDate>2023-10-10</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_muDgxFIJQE6WabppUkvg4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_ESWGS2AUDEyJokJaRyrByQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lEsvR7g5ukqjO6r8JvkH_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-15</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_g8RrY9ouOk6oIzBWDC62Bg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_nLhO4YNRgkCweluz_hqEUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_gI7SLj8d7kuf0rI7GEXCEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_crjDA4QUWkmjptpBegjFlA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ZO7co7_VOEuQO3x8dm2CXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_kIbRkUOXhkOuBCEbOunDpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyThreeMember_cSzr6YVDeUWRSAU2M9evow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">smlr:InvestmentInPrivateCompanyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_XS97Wf2QpUu9KcNGDWoQlQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">smlr:InvestmentInPrivateCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_1wPfvi5hA0-P18KQ9-gxVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">smlr:InvestmentInPrivateCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="As_Of_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_G3Anxea5Bk2Jp-whqZzF4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-10</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_BtMLgU4xhEumEB1mwGdN_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_Eph_Oj-oC0KZYpPYtIryAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_Y3YjBPtUtEWAFrFVUBX28A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_x1XWviIRvEuBTZOXDrOPnA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_ozb1tohPX0S-2MLZNTW-lw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_85lUGANk9Uq8MoWX1Ze-rw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_PxnEcaDrekmg5pbwORI6uA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_aDCxvJtt3Eygu9BuFeJ9gg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_WP1fZf0Tz0eBBidX-O4OKw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_5rkmbl4o0EOgcPQtPW8OMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_f78XzEjJR0SR98o4mMWU-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_zHwOkX4VfkWPEeVs-Z6SyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_hGBEk459TU6iXePXuBf5Gw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:PromissoryNoteFromPrivateCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_-L_MetT9sEqjsLb_hMB9Gw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:PromissoryNoteFromPrivateCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_X9WpoJSxJEq9lfFuf9gDtg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:PromissoryNoteFromPrivateCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_IcqC7PE9WUiygajKvbmwNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_652Bp3qhNUmUqYY-FX1Hug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorThreeMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_UUFOL2wzP06GTw4gaa2_sg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_etSv0JRJJUqLQpa2cgChVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_jjGYmF79EUmReh8pp371Ww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mGWVZoMD_0y5pa9bpBTRRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_sK_zCKyn3kegXLMJPUXfnw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerThreeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HyuAP9W00kqM60O3G6Ge3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_GNA9FYtql0C57IuiRvUncQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_Ii5xiNTqQk2AGTOsoCMLWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:CryptoAssetProviderTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">smlr:IntangibleDigitalAssetBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">smlr:InvestmentHoldingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_264-qjtGnkenys3niqGP3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:CryptoAssetProviderOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">smlr:IntangibleDigitalAssetBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">smlr:InvestmentHoldingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H04TlYqfWUuaMfxorUQLQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_O9-jwnOv6kOR0Av4_jnsew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_gghWsAhy2kyMxuzQyS23Xw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kWVgDU2vA0uq6eMrmrdy-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerTwoConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Y3y-lLd5iky9-ATGWL0gvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerThreeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_xdNkBEAT8k670omsTTSlEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mhgf8VqFf0-ZFpiL5hlFcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">smlr:CustomerOneConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_AUjfPFddUEiqVflwrXAltw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-17</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2013_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_ZY7-89lwZU2bZhYnLrUgKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-07-31</instant>
        </period>
    </context>
    <context id="As_Of_6_7_2012_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_nK7KeWh1p0uNi8atNqQgfg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-06-07</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_KNM3WXi-TU6wCTDDF5i12Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_uk7mInBKCUiVA3vFkCN5Vw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_9BDTT4lyYkSv1F0eAQlnCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_iI2SdgF49U2GUm8sENchpQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_j-idL8uTrE-R6vTgZEwaLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_vC_VgO3t6kyazyC5VS8ocA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_cISDtiIR7ESd_y3U1MPmAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">smlr:EngineeringAndProductDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_XwzfHWNHj0GlezhAcZYaZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_VkzoijKppEGZkDNPtg0efA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SyC6bd2xmUme3HPXw5Pazw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_aUVxgJ1xTECBjIC1ZpWucg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">smlr:EngineeringAndProductDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2024_To_6_30_2024_mJl5Eq6K00aJS7N8C_Ue-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_3_14_2022_kTG5qkwiMUq6Eg2gYGvIGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2022-03-14</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_VVd0MeR2FUGoVh93N0DsZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_IRpa9_pYhEyV44mQzXmw2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b8wtJ_BsM0unZVLTihfH6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ypheC2QZukKv7Unwz7OIBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_8_24_2024_UDRPHzEdyk6NV0QD-mKyjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2024-08-24</instant>
        </period>
    </context>
    <context id="Duration_10_1_2024_To_10_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_sIz0OcvO7UGv2AJKDirvCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smlr:StockIncentivePlan2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_L_t0elWRT0eyWfqFYrXTgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smlr:SingleReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smlr:SingleReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_StateAndLocalJurisdictionMember_l7TBs0ibWkKMa4_wC7X-XQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_FOoH5YxHtkWAVEIxCeAZTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_pgr5YBHMBk-EMl7wkzobAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-15</startDate>
            <endDate>2025-01-15</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_FPkR1egt1k-R8EHqo0rVVg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_PWcdPDmgeEWckhHocD2-3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">smlr:MonarchMedicalTechnologyLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">smlr:SecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_1_28_2025_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_ovxYPgBkWZ0i_kIROisQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:ConvertibleSeniorNote4.25Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-28</instant>
        </period>
    </context>
    <context id="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:ConvertibleSeniorNote4.25Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">smlr:ConvertibleSeniorNote4.25Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-28</instant>
        </period>
    </context>
    <context id="Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-14</instant>
        </period>
    </context>
    <context id="Duration_2_14_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Mua0Ot9Ko0CU_qSEjW_8uA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_rF8xp9fd-0m4m_wVJU1ZfQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2025_To_1_31_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Vh5xue5y_kiCARvRzIwtZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_a8zmf1i8pUefeL-g8olIgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H35aj8_a3U6JSHnHW9KxbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_fFOkoCt7H0Slv5JGrDqlBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HybD8uTHQkyIAhllhH3uCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tugyvnYiKEKXu7Ct7IkWtg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kPVNPU9aQEmGmH7B8LA6Hg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_PHgDVn-5Okel_mz_sU2Iaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">smlr:IntangibleDigitalAssetBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">smlr:InvestmentHoldingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_5_17_2023_To_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_GRfbzrpKSkafNwd0txmuIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">smlr:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-17</startDate>
            <endDate>2023-05-17</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2024_geCWm453AUejs3C95T9_VA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="As_Of_2_21_2025_aVqGtO1X_0mJsQc_NJ90xg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <instant>2025-02-21</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001554859</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">
        <measure>smlr:item</measure>
    </unit>
    <unit id="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w">
        <measure>smlr:customer</measure>
    </unit>
    <unit id="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">
        <measure>smlr:D</measure>
    </unit>
    <unit id="Unit_Standard_Vote_fmvi7R5wJUe0Kn3AIo8T4g">
        <measure>smlr:Vote</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_segment_Ijr0hkbG8kGjCrFIHbBeqw">
        <measure>smlr:segment</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      id="Hidden_24f232MLf0WXAte3iLkz3Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      id="Hidden__xwFuu4OhUO3C5yv5wtpCw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_4TGcvSMJT0OuhTrANG1qtw_2_1">0001554859</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_kyzR9Ok4HE2b2eJaV_cpaw_3_1">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      id="Hidden_UxmnUabbx06ExZiBAzKhVw">http://fasb.org/us-gaap/2024#Revenues</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Hidden_s161mzV-yUKVK4TP47TOUQ">http://fasb.org/us-gaap/2024#Revenues</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="Duration_4_1_2024_To_6_30_2024_mJl5Eq6K00aJS7N8C_Ue-w"
      id="Hidden_J8wOH7bw2UqoKIsy6ORpDQ">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202308Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:CryptoAssetNameExtensibleEnumeration
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Hidden_EtskwuOt8E-UAPDIhjG0PQ">http://semlerscientific.com/20241231#BitcoinMember</us-gaap:CryptoAssetNameExtensibleEnumeration>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      id="Hidden_xVAitRPWgkWwaTzZPw38ow">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      id="Hidden_ZCznBrDkRkiZHIq0TZrasQ">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      id="Hidden_2GncPSotZkeJ6j2K3RM9Gw">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_S8qckvwft0-ZA0tONRcfFw"
      decimals="2"
      id="Hidden_Tzy6P97uHUaeUF-cBrMSEA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_YXae_MH-f0WF5pBOJi-pJQ"
      decimals="4"
      id="Hidden_V32SFWmW3EWJ45UKw92nEg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0208</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_vvjiTdI4e0mUIjbWLapyOw"
      decimals="4"
      id="Hidden_8RoI3HM5VE6VepajHbnVVQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0417</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_vvjiTdI4e0mUIjbWLapyOw"
      decimals="4"
      id="Hidden_r6U7ShkGaEyl2_KE4RIe3w"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0417</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_rCwS5hUxaE-W79mE8GBaZQ">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_Ltq9RhrQ_UGsAou9M_O2Zg">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_XCXX3bqGu0SFdSci_MqfzA_1_0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_IzAJ5F_fb0ierSp6pQQBPw">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_CPni8b6K5kO-GhZ_pomXUA">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_IwxmQei2o0yf8DPlvUQj6Q">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_SK0uoZv6L0idyu6wBaDBzQ_7_0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_wEUX8d1-4EOTpAXBLLo6eA">001-36305</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_U7SvYFRMLEusSSD-ayfxVA">SEMLER SCIENTIFIC, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_brVmd9cGc0-4-X1lQhkDxQ_0_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_Bk0MHUQkakm4kAuwB6dXTw_0_2">26-1367393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_Li6m-NeHe0uMbY-53mHBMQ">2340-2348 Walsh Avenue, Suite 2344</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_vU8EqBDwqUuOsyRP9qhZxg">Santa Clara</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_cvf8UzS4TEKa2V-yIk9TUA">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_lh_Ny_sNQUq8PoAemwKV_A">95051</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_Z74RUI5bhUeOxn_PCAqg_A">877</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_hlemJOnxrkmeXvFVaYt9aw">774-4211</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_ijdOq2u090SLtfO7MM1AEQ_2_0">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_ldgLSl-mWkucESJiaVZytg_2_1">SMLR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_dyJDuKQ23EGY4-fLkUUm3g_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_0tywfMTxPUuboi2hgp8cgA">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_8xy-iFzYRkWwrSrMcDojbQ">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_tJIJ-jjBwEyDtqGiCwr2MQ">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_zXiCtlAOl0GyVaXofesmBg">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_MGYeUpicCEGDHpo2dlTONg_1_0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_Bbce-tCk1ESGhD7r9CVFNQ">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_jROR1rLJlE2bh7FCMt-9Dg_2_3">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_0MgkbcsmIE2WRELYHRGCmw">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_sTjh1cUkL02bm2XfdEcbsg">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_N8Sokzv6eUOS5fOJ62Sf7Q">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="As_Of_6_30_2024_geCWm453AUejs3C95T9_VA"
      decimals="0"
      id="Narr_KsL99MFD0US7R423ylXCZg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">164913715</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_2_21_2025_aVqGtO1X_0mJsQc_NJ90xg"
      decimals="INF"
      id="Narr_7UQagh_tkU25xcGvTHW_wQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">9596486</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_SEmH68gB7UqSsRUUXSzzsQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;We regularly assess risks from cybersecurity threats; monitor our information systems for potential vulnerabilities; and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program. To protect our information systems from cybersecurity threats, we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner. Our Information Technology or IT, department assesses risks based on probability and potential impact to key business systems and processes. Risks that are considered high are incorporated into our overall risk management program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;All employees receive cybersecurity training with job-specific topic considerations. Our IT team engages third-party vendors to assist with providing timely cybersecurity threat alerts in addition to monitoring cybersecurity threats and our defenses against cyberattacks. This monitoring includes the proactive identification of vulnerabilities in our systems with threat intelligence. The employees within our broader IT team who specialize in cybersecurity operations are responsible for coordinating and overseeing the activities of these third-party vendors.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;Cybersecurity threats, including those resulting from any previous cybersecurity incidents, have not materially affected our company, including our business strategy, results of operations, or financial condition. We do not believe that cybersecurity threats resulting from any previous cybersecurity incidents of which we are aware are reasonably likely to materially affect our company. Refer to the risk factor captioned &#x201c;&lt;i style="font-style:italic;"&gt;An information security incident, including a cybersecurity breach, could have a negative impact on our business or reputation&#x201d;&lt;/i&gt; in Part I, Item 1A. &#x201c;General Risk Factors&#x201d; for additional description of cybersecurity risks and potential related impacts on our company.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_8hFEqMvSMkSIN2txX9Uo1w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;We regularly assess risks from cybersecurity threats; monitor our information systems for potential vulnerabilities; and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program. To protect our information systems from cybersecurity threats, we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner. Our Information Technology or IT, department assesses risks based on probability and potential impact to key business systems and processes. Risks that are considered high are incorporated into our overall risk management program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;All employees receive cybersecurity training with job-specific topic considerations. Our IT team engages third-party vendors to assist with providing timely cybersecurity threat alerts in addition to monitoring cybersecurity threats and our defenses against cyberattacks. This monitoring includes the proactive identification of vulnerabilities in our systems with threat intelligence. The employees within our broader IT team who specialize in cybersecurity operations are responsible for coordinating and overseeing the activities of these third-party vendors.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_DOqUu5Cj60ugy0M5hiwgPA">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_FItRS5_MbEyjm7TKSycCBQ">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_vdEHupwODkGmJ3MPyQCPnw">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_lU_d1aWFBkqGPExxlOQT0w">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_bJxd3gDsEkmuz3f4P5ivWg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Our board of directors oversees our risk management process, including as it pertains to cybersecurity risks, directly and through its committees. The audit committee of the board oversees our risk management program, which focuses on the most significant risks we face in the short, intermediate, and long-term timeframe. Audit committee meetings include discussions of specific risk areas throughout the year, including, among others, those relating to cybersecurity threats, and reports from the chief technology officer or CTO on our enterprise risk profile on an annual basis. The audit committee reviews our cybersecurity risk profile with management on a periodic basis using key performance and/or risk indicators. These key performance indicators are metrics and measurements designed to assess the effectiveness of our cybersecurity program in the prevention, detection, mitigation, and remediation of cybersecurity incidents.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:13.5pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents. Our CTO is responsible for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_ptQrDBLeuUOPKy6jHezR4Q">The audit committee </cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_5Z2eHYHxAUiC41Frb04Z_A">Audit committee meetings include discussions of specific risk areas throughout the year, including, among others, those relating to cybersecurity threats, and reports from the chief technology officer or CTO on our enterprise risk profile on an annual basis. The audit committee reviews our cybersecurity risk profile with management on a periodic basis using key performance and/or risk indicators. These key performance indicators are metrics and measurements designed to assess the effectiveness of our cybersecurity program in the prevention, detection, mitigation, and remediation of cybersecurity incidents.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_q5D88fbwgkit3pgbAOGcAg">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_HnrW99YXZk-TQl9rtLxm_w">chief technology officer</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_U1Q7mqAlRUG2SYTT8gW1Ag">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents. Our CTO is responsible for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors.&lt;/p&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_8U4fZJ7rLUi_beDk_WfQTw">We take a risk-based approach to cybersecurity and have implemented cybersecurity policies throughout our operations that are designed to address cybersecurity threats and incidents</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_6fvN9xjCO0uJaDx95APOiA">Our CTO is responsible for the establishment and maintenance of our cybersecurity program, as well as the assessment and management of cybersecurity risks. Our current CTO has over 30 years of experience in information technology and possesses the requisite education, skills, experience, and industry certifications expected of an individual assigned to these duties. The CTO provides periodic updates on our cybersecurity risk profile to management and the audit committee of our board of directors</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_B7xcopYp30-FTQhUQUrGwQ">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg"
      id="Narr_2HDJGQvJ6UKT3Sund3oEdw">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg"
      id="Narr_N_t-6AQJ60uY4C_uT3wElw">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg"
      id="Narr_uvvSXd7DFU252zWEvm_GKA">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="Duration_10_1_2024_To_12_31_2024_gsoJ2KSqlk2qIPvAWJxZfg"
      id="Narr_y_smtFZDKk-KsmmLSfUVEg">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_8h6TPbS66kqXEAwXGq_tgw">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_l8c7ejviJEGb9XMthF-aCg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Equity Grant Policies and Procedures&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;From time to time, we award stock options to our employees, including our named executive officers, and have in the past also granted stock awards to consultants and our non-employee directors. We routinely re-evaluate the use of our equity incentive plans, including the administrative costs of such programs, when deciding the amount and types of equity awards to grant employees, consultants and our non-employee directors. Our current practice is to award certain key employees option grants on an annual basis, which are typically approved at a meeting of our compensation committee around the beginning of our fiscal year in connection with general compensation review. Non-employee directors receive annual grants as part of compensation under our non-employee director compensation policy. We do not routinely provide new hire grants to employees when they first join our Company, nor initial equity grants to non-employee directors when they first join our board, although we may choose to do so in the future. For additional information on our non-employee director compensation policy see above under the heading, &#x201c;&#x2014;Non-Employee Director Compensation Policy.&#x201d; Other than our non-employee director compensation policy, we do not otherwise maintain any policies on the timing of awards of stock options, stock awards, stock appreciation rights, or similar instruments with option-like features. Our compensation committee considers whether there is any material nonpublic information, or MNPI, about our company when determining the timing and terms of stock option awards and, where appropriate, has provided for grants to be effective after our public disclosure of MNPI (such as our 2024 non-employee director grants, which were bifurcated due to the expiration of the 2014 Plan prior to stockholder approval of the 2024 Plan, and thus timed to be effective after publication of our quarterly report on Form 10-Q for the quarter ended September 30, 2024). Our company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.&lt;/p&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_G_V_J85kfEewrJhErCE6-w">Our compensation committee considers whether there is any material nonpublic information, or MNPI, about our company when determining the timing and terms of stock option awards and, where appropriate, has provided for grants to be effective after our public disclosure of MNPI (such as our 2024 non-employee director grants, which were bifurcated due to the expiration of the 2014 Plan prior to stockholder approval of the 2024 Plan, and thus timed to be effective after publication of our quarterly report on Form 10-Q for the quarter ended September 30, 2024).</ecd:AwardTmgMethodTextBlock>
    <dei:AuditorFirmId
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_h_q5g96cU02nkKnvQGpmeA">243</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_oZB1nnZl8UqrDBbDKtfGbA">BDO USA, P.C.</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_GN3cGft5MEq8AG5hnQR-GQ">New York, NY</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_ii3qDDAN9kG0NH2CZy38hA_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">8819000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_vqa35Uc29kOX-fPcyQoz9g_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">57200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_03elHA6MjECBzomCFwK5FA_6_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">133000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_nlkHHBYMJEmsd9YpPOfYMA_6_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">132000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_dB-njaWIHk6NjbhAKxv88Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">199000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_MIppjHGSwUuILHJaovB-8Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">287000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_LMiVuGaNiUON_Xh1_1eolQ_7_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4378000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_vER9aRRQ-0aNquAGJrjESg_7_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6125000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_a3D_OM-hMUWzjF6Wp0DNeA_8_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6100000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_raNvlpOVyk2dfnE_t9iQlQ_9_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">358000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_7RyzYdABKkW9ow7cCTt8wg_9_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">445000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_wdJ8ScsmF0q6fIK_tKgYOA_10_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_4nPaxr3UBEiOb3pw0opzUw_10_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2042000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_0zCKbF1hy0qyZttjADzjvg_11_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">22688000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_N8K1qiNWb0iYVTiCh6F30w_11_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">65944000</us-gaap:AssetsCurrent>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_1s0Fkzt1lUuC7R4hlPal-w_12_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1423000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_DDFO8O9eSES62QyGFTB0WA_12_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2285000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_SvhvX_lYFUW-P3NpGBdiEw_13_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">487000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc__7G8NXFuD0O1UbFvZCD0OQ_13_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">720000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_ARo4VTWdWU6jtNP9Iqv4oQ_14_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_ND9ns2qYAkm0IiQOEQN5Sg_14_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:LongTermInvestments>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_yTkiHF5Ug0WBRZCueR1CsQ_15_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5372000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:CryptoAssetFairValueNoncurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_teReYf9fI0WwXEe_gZ1rbw_16_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValueNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_rpUa5656CUqtlMwr-2cW2A_17_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">85000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_s7aXIa3GAUKfgiBILKaLCg_17_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">270000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_5uEfIcCn8kijb7ikMTSqFA_18_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2962000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_gpPeSx2Lf0qKVWgifPGa8A_19_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">239828000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_eq65dfaQX0m41UumPLGOKQ_19_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">78065000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_gLSAKp_6o0ybWFsWkGygVg_23_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">140000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_RQbU-XpPg0uJnNIon6agYg_23_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">402000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_lUAkGflbF0yQxMsNErQzpQ_24_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5173000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_bTfNUR9RzEm3TeCo1MAbyA_24_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4502000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_wmWw-Uru2UWjBq5KBhW6SA_25_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">774000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_XTBhRY8XrUuksj_qBxAVUQ_25_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1120000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_7d4EqdqR30qNjlbHCGMzCQ_26_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">226000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_ts1ByeTeE0eqIwrFXBmk0w_26_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">176000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_Ykctx_mp-EGnu9AtJJa7nA_27_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6313000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_-kmDU2wE1UamKkAtFE8LOw_27_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_LZ5lWXTE10WXdroumlRREA_30_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2765000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_vQFtMM6TeEO8hXvpIQPGEw_31_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">70000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_CZ-Vj1M2-E2zmUp0NdDhmQ_32_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2765000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_1QOsSGA230-yfW6jh2nd2Q_32_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">70000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="INF"
      id="Narr_7Z5FmGy5Rk2vDrAuO2fSJQ"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_rnDsdzw_lUWnjkFDR_V-lA"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="INF"
      id="Narr_JbAH1mcmAUaqZP-2Peb_DA"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_lVUQii0BMU2PWau5O59xtQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_jb5F46zaMEm1ruKmkg9vIQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">9770908</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="INF"
      id="Narr_vrFG3vQmVEOyKCaVFdjjhQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7099441</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_j-LEyzalHESBDXC3MRFybg"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">9556486</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="INF"
      id="Narr_qKA3JclOTkywcRCNkD-oUw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">6885019</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_bmCwL2JuMUq_yekNbDEv4w"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">214422</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="INF"
      id="Narr_n30apIuMQEq0ulIQ7Csuaw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">214422</us-gaap:TreasuryStockCommonShares>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_0Ajwc11fNESueqVVUI0nog_35_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">9000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_IwEu9xXS-U-6HHgfc_g4iQ_35_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">7000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_HwcwlctrH0-JKicHhVAi7Q_36_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">130039000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_1PtJki88IUSDyIS5wRKzsQ_36_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">11985000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_fCnTpkyyOkSU-VnDSQV4ig_37_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">100702000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_oGIm6ez2jUycbJyy7UeBjw_37_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">59803000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_vP_u7b0Qs0q_IF_lNun4rA_38_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">230750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_k8KuUumvVUe0f6efQUwTug_38_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">71795000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_2rW449lZvk6Qe6IhhA1RgA_40_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">239828000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_bqgArbRex0qi3n5b64HmNw_40_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">78065000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_qX4uzbcGSkyfQGv4cAm0uQ_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">56294000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_Czn5LRYhWkuAK1n-AhcQuQ_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">68184000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_jNVZYpo13U2lh8niSacG8w_6_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4759000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_gudVPIY_YE67xPKMAWgmCg_6_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6984000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_ojMmBKTKt0K7IF091iu7tQ_7_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4792000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_rrBXkRpPX0qbrVRwQiAvqg_7_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5773000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_f6oTOAmop0yyho98gZWSmA_8_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">13078000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_eyUCpf1AHUyHqbW2cK1aZQ_8_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">18147000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_SnCY0ZQTU0y9LKicbgKbeg_9_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">12732000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_0Y9rZZkEk0OprlCRcqAHiw_9_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">14290000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_IEq8sW06hEWwjdj9wbFrvQ_10_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">734000</us-gaap:RestructuringCharges>
    <us-gaap:CostsAndExpenses
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_9m-aHykuu0uGqOs92xUHow_11_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">35361000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_JGQFp0Ea8UaKl34Lig0cCQ_11_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">45928000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_f4NMhyEHs0Kcgv8Cyapc5A_12_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20933000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_-DGtuOc1AEuWid_VToM1-Q_12_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">22256000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_Mcn3z1ZKsUyLm4RSqByFKw_13_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1877000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_CYDnK8cx2kyub907TiDR0g_13_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2471000</us-gaap:InvestmentIncomeInterestAndDividend>
    <smlr:ImpairmentLossesInvestments
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_VXbqAT31I0eOemDjl47PBg_14_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">337000</smlr:ImpairmentLossesInvestments>
    <smlr:FairValueAdjustmentOfNotesHeldForInvestment
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_OGJsLeg5dkCoMCV6xPfYYQ_15_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-128000</smlr:FairValueAdjustmentOfNotesHeldForInvestment>
    <smlr:FairValueAdjustmentOfNotesHeldForInvestment
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_2ajKgo10FUKOZtplXNnL5g_15_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">307000</smlr:FairValueAdjustmentOfNotesHeldForInvestment>
    <us-gaap:CryptoAssetUnrealizedGainLossNonoperating
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_hi4kkC3AbUKYUKngr3Mabw_16_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">24933000</us-gaap:CryptoAssetUnrealizedGainLossNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_V8Y7dvX1tEGM-8dTy2BRRg_17_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">13000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_9NbU9xh2rUSGDPfw5pwr2Q_17_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">17000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_TCBXoRU8ckmrndT3WiN_SQ_18_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">26951000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_Rd0SDbGjd0Cq5k17h80U5g_18_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1844000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_SRfmqXFaP0-XY2VgQugBqg_19_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">47884000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_GM3c2Ywj5U6Y0j16U8pUZA_19_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">24100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_U6aigezmPE2WWdjwwIAl7Q_20_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6985000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_XeHw8VX1z0eWo-64v3AitA_20_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3517000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_G3QaZoT40k2KZOik62oYiw_21_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_elCFGpt6z0mhxObAQXzKWQ_21_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Tc_3o5Tgx6iT06gtur3uOL71g_22_3"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">5.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="2"
      id="Tc_zzCBTLbHskWJoLrdDn-GhQ_22_6"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">3.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="0"
      id="Tc_EAm5g-XOQUSLq5tGVJCbPQ_23_3"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7228961</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="0"
      id="Tc_BomMB_uKJ0SUhjaQCcor0g_23_6"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">6732806</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Tc_mrCMTokr4Ee3sjjhRKd4uA_24_3"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">5.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="2"
      id="Tc_S9FO-35LvE2XDBh5GDJ1sw_24_6"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">2.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="0"
      id="Tc_iwhbR2kosUq18xGDmN4nmA_25_3"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7980118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="0"
      id="Tc_k5IGvTLL0kCVpc_EuS4NbQ_25_6"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7819159</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g"
      decimals="INF"
      id="Tc_NGMQ9hpocEm06V_AV3l8uw_5_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">6906544</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_fyKQZipu3kSrnPdU3hpN_g"
      decimals="-3"
      id="Tc_M5gkn0lLlk2OrG5mf3npAw_5_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">7000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_7MdStRIh3kKwwzJPpWFxcg"
      decimals="INF"
      id="Tc_3G9klJcBHUCDBrn6S3pjaw_5_7"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">214422</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_PP2-ruBZD0aQuxrVIVT55A"
      decimals="-3"
      id="Tc_-64sstefm0W9aDr2ybL0Tw_5_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">16449000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KsDbaHOEh0G1GZmuHINO9A"
      decimals="-3"
      id="Tc_2xku9NrloEKFvRV4nMPqCQ_5_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">39220000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA"
      decimals="-3"
      id="Tc_aGAg_GdfZk-RaiPy-wUfZw_5_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">55676000</us-gaap:StockholdersEquity>
    <smlr:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA"
      decimals="-3"
      id="Tc_bqTAFkksQEunK2eJtV0Eeg_6_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1949000</smlr:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants>
    <smlr:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_FVrX_qn04Eq2klUneg4lag_6_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1949000</smlr:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw"
      decimals="INF"
      id="Tc_HH1Jmwa7t0iDaqDZiMK-Ag_7_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">24295</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA"
      decimals="-3"
      id="Tc_5tmZNL4lTkiZBaAjKreJsw_7_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">860000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_evHXIcMhf0WK1kIAToxiZA_7_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">860000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw"
      decimals="INF"
      id="Tc_WoCMaDru_kiV38TPM22NIA_8_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">-114970</smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares>
    <smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA"
      decimals="-3"
      id="Tc_DWk8vihWJk-dOnEljdGA1Q_8_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-3510000</smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards>
    <smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_90EIirtJHESI5CV9M1Afjg_8_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-3510000</smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_phArzW1fPk2ohCK0HLUqQw"
      decimals="INF"
      id="Tc_MqHtdmzR10-A4PSwW-vWew_9_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">283572</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA"
      decimals="-3"
      id="Tc__rgF_HlCpUSjlFTJuJN3lg_9_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">51000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_cfA8Yk8_7EGwtmZrM3Z6Bw_9_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">51000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_F_kAwNRsLUqMBlYzz1kFtA"
      decimals="-3"
      id="Tc_Ro1egOD9QEiTMAM1va0Dwg_10_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">84000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_hspxpbrrK0GL11V64hetxQ_10_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">84000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_kIbRkUOXhkOuBCEbOunDpA"
      decimals="-3"
      id="Tc_hJ7VUXTw4kuCnmZE-GG3PQ_11_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc__SM3mWKRoEmN8OGcEsoi6A_11_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg"
      decimals="INF"
      id="Tc_gK-mzWucrkGbW3oWHwZgTw_12_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7099441</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg"
      decimals="-3"
      id="Tc_UbRiONE6M0qLUukx4T8kkw_12_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">7000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_dQ8SZLQckkq01f6d8teuYA"
      decimals="INF"
      id="Tc_gzbSqeesD0eQSmgGEcY8Jg_12_7"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">214422</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_eBCEoRryQ0WqACbtbHRW9A"
      decimals="-3"
      id="Tc_MDcVGUYQPkuPV0v_2oq5cQ_12_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">11985000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mDqBkPVNkU2MWw6rn8s8lA"
      decimals="-3"
      id="Tc_ggeu7TeqFkKM3_2OxhETYw_12_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">59803000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_TvYbtVq4E0GV8hXqVG-6Vg_12_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">71795000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg"
      decimals="INF"
      id="Tc_nPykaY0jBUGWrWdOSEHd3Q_5_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7099441</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CjrTIBZsU0OirM5G9Z6nzg"
      decimals="-3"
      id="Tc_2LIxJfKj4EugvlVl8QvlXg_5_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">7000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_dQ8SZLQckkq01f6d8teuYA"
      decimals="INF"
      id="Tc_jlmzNj3sWUGQbfcsXn2Eaw_5_7"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">214422</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_eBCEoRryQ0WqACbtbHRW9A"
      decimals="-3"
      id="Tc_dNDxBlFoL0uQ6zGrfLnd7Q_5_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">11985000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mDqBkPVNkU2MWw6rn8s8lA"
      decimals="-3"
      id="Tc_dJRuWF3RX0qXtYqJk0euyQ_5_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">59803000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_O_ikLeEGRk69bQ8NXLUMqw_5_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">71795000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ"
      decimals="INF"
      id="Tc_Wp3YisTFP0-fo_cveWVSdA_6_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">10500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"
      decimals="-3"
      id="Tc_3ufTSX0f5Uez8Z6FWv9t0Q_6_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_IBl-VHTZ9ESSyuZzGB0_xA_6_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ"
      decimals="INF"
      id="Tc_07dankq-iEG1nzb4EQ8e4A_7_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">2197988</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ"
      decimals="-3"
      id="Tc_RtBqlaZBIEyMtvRgnjuieQ_7_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"
      decimals="-3"
      id="Tc_EGfQdrQOQ0a6WORBMAE0aw_7_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">119602000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_d9aBx9iFgEW6ddLmO7XXwQ_7_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">119604000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"
      decimals="-3"
      id="Tc_RKDuDhmLzkKLRm0fw8DUyg_8_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_HL5bvfVUtkGFA4ZZQPjOSQ_8_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ"
      decimals="INF"
      id="Tc_FPxH6vu3MkOD_YaBs8N22Q_9_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">-34406</smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwardsShares>
    <smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"
      decimals="-3"
      id="Tc_f2c8P6esbUm0screJoHQzQ_9_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-874000</smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards>
    <smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_1KoZbrev-EKojXBqYYTD8A_9_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-874000</smlr:TaxesPaidRelatedToNetShareSettlementOfEquityAwards>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Mz8yviFsI0G_QK0N3qgkBQ"
      decimals="INF"
      id="Tc_SQdoaQ3N-UWtxc52hvNbLQ_10_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">497385</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"
      decimals="-3"
      id="Tc_ccZ8j7iWYEm9uqAoJ4F60g_10_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1464000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_QFInOohw60aoH4BkCWPJtw_10_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1464000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_0YBLQSBQbEmCXf_A0E9kqg"
      decimals="-3"
      id="Tc_dzdA0zDcLUCDqkanK7gGyQ_11_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">562000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_ET4msWZU6Umj9cSSWUIaEg_11_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">562000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ZO7co7_VOEuQO3x8dm2CXQ"
      decimals="-3"
      id="Tc_A1uVsM1j70uVSuQWaat8Kg_12_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc__tL0pM8J3kaWYgUf_BKXLw_12_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUJvfYZkXkeH62F-h-9aEw"
      decimals="INF"
      id="Tc_Ru9meTnerUSaomQUfK7mNw_13_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">9770908</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUJvfYZkXkeH62F-h-9aEw"
      decimals="-3"
      id="Tc_viBs7vuWAkC34Q6A1BXnpg_13_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">9000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_8Bg3PzLN0UiL0idVDay18A"
      decimals="INF"
      id="Tc_mavkLrMjEkSYTdJ2pvAfTw_13_7"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">214422</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_SU2XSK94YkGDlZDDBasXLw"
      decimals="-3"
      id="Tc_FQ2hj8HHw0-n44RjJowdnw_13_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">130039000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_eItsRBJS3UqRPJXG0t2wwg"
      decimals="-3"
      id="Tc_iFrtpwSLU0y7Ajm7xUue5Q_13_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">100702000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_kp73nCpmiEWqKCSytCcGAg_13_16"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">230750000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_SJ7j3X9mVkakcS_5abMXqA_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_KTRBtS3v3UebYndCIH7IFA_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_eNtf2Rkbq0OQ5cYoA1d8dQ_7_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">579000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_L9oc5lVrLkqNhLrnNCRq6Q_7_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">599000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_6hS3Vwr9YEWsWSkQmBRqsQ_8_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5727000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_RThs7KOSl0Oauf2Yj-73Ag_8_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-664000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_I4rm7jcBRkKUp3yd0NZc-g_9_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-298000</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_S1G6YNy8iE-LDr7T9oYtbA_9_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-369000</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <smlr:PrepaidLicensePurchasesWriteoff
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_fBr9IQDmikuHzrgkQXLlpg_10_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2476000</smlr:PrepaidLicensePurchasesWriteoff>
    <us-gaap:DebtSecuritiesTradingRealizedGain
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_8CVz8ao_pESX24Tk3C1qog_11_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">151000</us-gaap:DebtSecuritiesTradingRealizedGain>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_dWWNuQk9xU-Bi0Ldt2_0BA_12_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-88000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_STgV2uH_yEy4xTIcFZX-zg_12_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">268000</us-gaap:ProvisionForDoubtfulAccounts>
    <smlr:FairValueAdjustmentOfNotesHeldForInvestment
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_Vpc9k5vwnEOli3thJcvmtQ_13_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-128000</smlr:FairValueAdjustmentOfNotesHeldForInvestment>
    <smlr:FairValueAdjustmentOfNotesHeldForInvestment
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_bzdyuvvRIECRY-JgsSFuWA_13_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">307000</smlr:FairValueAdjustmentOfNotesHeldForInvestment>
    <us-gaap:CryptoAssetUnrealizedGainLossNonoperating
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_-bSybWROLEK_GAxyGqIg3w_14_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">24933000</us-gaap:CryptoAssetUnrealizedGainLossNonoperating>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_P_GMA3igh0imd91016Vn5g_15_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">862000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_QZDUtrF5UEOVbA1SE39kcQ_15_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">944000</us-gaap:ShareBasedCompensation>
    <smlr:ImpairmentLossesInvestments
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_3an2R0TWMU2npswjabe2Mw_16_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">337000</smlr:ImpairmentLossesInvestments>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_gtwKLp-fh0myioR1C_5idQ_18_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-1844000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_v4XsTgtdl0Ch9wOC0H0BNw_18_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2508000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_mLu-ZViFy0mYlQ3aCv0e3Q_19_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-88000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_zAxiRH-9QE2bbyMK-mRlnA_19_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-24000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_1KQP5h3Wj0av1JxjwQKV9g_20_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">865000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_cYwnzI2kJkCY8oS03-FNsQ_20_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">603000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_xMokTKKaSkOMl6xSnMIX3A_21_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-85000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_MBk3-PKsckGepL9Tf1o0JQ_21_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-96000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_CtWeixsJ3kujMjcYDc8KjA_22_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-262000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_-a7lCid-dUGYBr4VlP1sRw_22_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-433000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_QB3YcEpe-029ucl4gx_8wQ_23_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">671000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_hB33Q9gteUetEC32MXTQPQ_23_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-246000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_WFc0o0hJ80aaZUwWA96BPw_24_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-367000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_vK9T1h74fUyjSajyfYn_UQ_24_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-68000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_GXezlOhTJ0WKataRfrc4cg_25_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">24410000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_LmqLMrl8VUybNTDfwzuHtw_25_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">21330000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_349_ShYcm0mFf1VnQ_a7gQ_28_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">51000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_G69O1ivdeUesAhg4YmGMag_28_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">345000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_4YZFlsF2y0KRED0qFE22eA_29_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">500000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_oGOI6m4XokGiFayFr9wklQ_29_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentForAcquisitionCryptoAsset
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_aWfNM0xa8UuM43IUVK6EDg_30_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">189700000</us-gaap:PaymentForAcquisitionCryptoAsset>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_OErqNrJlL06ZwEiuNUPTdA_31_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">78093000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_tNBOAsQId0akVUHrSxntzw_32_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">57869000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <smlr:ProceedsFromPaymentsForEquipmentForLeases
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_GUVUZ0xVn02MV40pe84KKQ_33_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-269000</smlr:ProceedsFromPaymentsForEquipmentForLeases>
    <smlr:ProceedsFromPaymentsForEquipmentForLeases
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_sJHLPKiYBUCiVMLu6mMEfA_33_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">483000</smlr:ProceedsFromPaymentsForEquipmentForLeases>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_c-LkYD5Uc0-RjVDikmeyWg_34_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-189982000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_f9PKiWunNUSqAjzft5wBeA_34_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">18396000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_Em7jhUqhQ0KkRaDNirXvVA_37_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">119602000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_QzYBm1TgkkC-Y6No3lJYGg_38_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">874000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_rtjpNIjvpkebCJiGu8Jghg_38_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3510000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_-J1_bTyF80urFOuhvLpXIA_39_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1949000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_kddbQIYhyEWNbD8KCrwGUQ_40_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_LuXtQ2W96UOZrjsfJd6g1g_41_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1464000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_92n8x9kY6kyvCciyeGvlpw_41_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">51000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_eCo7hvdx-0KoUnAXhxKebQ_42_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">117192000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_4cUKATLmFUWqbqCdvwIg2A_42_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-5408000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_dJT0mlor_0C-sFVIIkkkQg_43_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-48380000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_iuV_9mKQfkmBIgOxtkDu9g_43_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">34318000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_fKOON5WAFUexZk6qS7zSDg_44_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">57332000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA"
      decimals="-3"
      id="Tc_leQRdcV4rkCI8NN3EV0CaA_44_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">23014000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_-fZcppec3kyi9sCAOHLtww_45_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">8952000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_E7g1RWAHHUCIxsCijYWB0g_45_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">57332000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_6vaXR-_AoEasgWim7TxBCQ_47_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2260000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_LsTrbZASgUGbACbanXyk0A_47_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4060000</us-gaap:IncomeTaxesPaid>
    <us-gaap:NatureOfOperations
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_814XYBOMlEWFmmUCMR5LFQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;1.&#160;&#160;&#160;&#160;The Company&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Semler Scientific Inc. (the &#x201c;Company&#x201d;) is a company developing and marketing technology products and services that assist its customers in evaluating and treating chronic diseases. The Company&#x2019;s patented and FDA cleared product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of PAD. The Company also invests in bitcoin and have adopted bitcoin as its primary treasury reserve asset. As an operating business, the Company uses cash flows as well as proceeds from equity and debt financings to accumulate bitcoin. The Company&#x2019;s healthcare technology solutions business is its predominant operational focus, providing cash flows and enabling it to pursue its bitcoin strategy.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_Gv6NkqkDfU61zVFD0_CeAQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;2.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies and Estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Basis for Presentation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Use of Estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"&gt;The preparation of the accompanying financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses, and related disclosures during the reporting period. Significant items subject to such estimates include allowance for credit losses, valuation of equipment on lease, recognition and measurement of current and deferred income taxes, valuation and recognition of investments and intangible assets and valuation of inventory. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:13.5pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, bitcoin, accounts receivable and trade payables. The Company maintains its cash and bitcoins with major financial institutions and reputed bitcoin traders. The Company&#x2019;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The cash and cash equivalents also include U.S. government money market fund accounts. Our bitcoins are held offline in cold storage with multiple third-party providers. The Company manages its accounts receivable credit risk through ongoing credit evaluation of its customers&#x2019; financial conditions. The Company generally does not require collateral from its customers.&#160;For information regarding the Company&#x2019;s significant customers and vendors, see Note 12 to financial statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Revenue Recognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company generates revenues primarily from the rental or license of its vascular testing product. The Company recognizes revenues from the licensing of its product primarily pursuant to agreements that automatically renew each&#160;month with revenue recognized on a daily convention basis or when the test is performed. The Company&#x2019;s arrangements with customers for its vascular testing product are normally on a&#160;month-to-month basis with fees billed at the rates established in the customer agreement, either on a fixed or variable (e.g. fee per test) basis, as earned. The &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;Company also recognizes revenue for hardware and supplies sales as of the date of shipment. Shipping and handling costs are included in cost of revenues in the statement of income. Payment terms of the customers are net 30 days. Semler replaces the defective sensors with no charge. Other than replacing the defective sensors there are no other obligations to the customers. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Cash and Cash Equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Cash and cash equivalents are comprised of highly liquid investments purchased with an initial maturity date of three&#160;months or less. Funds held as investments in money market funds are included within cash and cash equivalents.&lt;/span&gt;&#160;Restricted cash represents amounts pledged as cash security related to the use of credit cards.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Short-Term Notes Held for Investments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="color:#111111;background:#ffffff;"&gt;Short-term notes held for investments are&lt;/span&gt;&lt;b style="color:#111111;font-weight:bold;background:#ffffff;"&gt;&#160;&lt;/b&gt;&lt;span style="color:#111111;background:#ffffff;"&gt;those&lt;/span&gt;&lt;span style="color:#111111;background:#ffffff;"&gt; investment instruments that will mature within one year or which are expected to be liquidated within one year.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Accounts receivables are recorded at the invoiced amount, net of allowances for credit losses. T&lt;span style="background:#ffffff;"&gt;he allowance for credit losses is based on management&#x2019;s assessment of the collectability of accounts. The Company regularly reviews the adequacy of this allowance for credit losses by considering historical experience, the age of the accounts receivable balances, the credit quality of the customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect customers&#x2019; ability to pay to determine whether a specific reserve is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for credit losses when identified. Accounts receivable, net as of December 31, 2024, December 31, 2023 and December 31, 2022 was &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$4,378&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$6,125&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$3,884&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively, include &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$2,067&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,966&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1,735&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively, related to revenue recognized under ASC 606.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;As of December 31, 2024, the allowance for credit losses was $199. During t&lt;span style="color:#212529;background:#ffffff;"&gt;he year the Company provided an additional reserve of&#160;&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$135&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;and recovered&#160;or expensed credit losses of &lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$223&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;from customers. The allowance for credit losses as of December 31, 2023 was&#160;&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$287&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;. &lt;/span&gt;Credit losses related to ASC 606 receivables were $113 and $6 as of December 31, 2024 and December 31, 2023, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Inventory&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Inventory, which is made up of finished goods, is recorded at the lower of cost or net realizable value. Cost is determined on the first-in, first-out method. The Company periodically analyzes its inventory levels to identify inventory that has a cost basis in excess of its estimated realizable value and writes down such inventory as appropriate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Assets for Lease&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Assets for lease are recorded at cost. At December&#160;31, 2024 and 2023, assets for lease consisted of vascular testing devices, which are primarily leased to customers. The cost of such assets for lease is depreciated on a straight-line basis over 36 months for the units outstanding and recorded as cost of revenues.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of assets may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected undiscounted net cash flows associated with the related assets over their estimated remaining lives against their respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its assets for lease in this analysis. Impairment, if any, is &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intangible Digital Assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 350, &lt;i style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other&lt;/i&gt;. The Company has ownership of and control over its bitcoin and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoin. The Company&#x2019;s digital assets are initially recorded at cost and subsequently remeasured to fair value at the end of each reporting period, with changes recognized in other income, net.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company purchases bitcoins for long term investment. It intends to hold its digital assets for long term gains and treats them as long term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. A valuation allowance is recorded for unrealized capital losses. Bitcoins are stored in cold wallets. Average cost of wallet is used for calculating the unrealized gains or losses. See Note 9 to Financial Statements for additional information regarding the Company&#x2019;s purchases and sales of digital assets. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Property and Equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Capital assets are recorded at cost. The cost of such capital assets is depreciated on a straight-line basis over a term depending on the assigned category (described below) and recorded as depreciation for capital assets recorded in engineering and product development, sales and marketing and general and administrative expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December&#160;31, 2024 and 2023, capital assets are classified into one of the following categories:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;"&gt;Category Name&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;"&gt;Description&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Machinery &amp;amp; Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Manufacturing, R&amp;amp;D, or other non-office equipment&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Computer Equipment&#160;&amp;amp; Software&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Software, computers, monitors, printers and other related equipment.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Furniture&#160;&amp;amp; Fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Office equipment and furniture owned by the company&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Account Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Useful Life &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Machinery &amp;amp; Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Five years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Computer Equipment&#160;&amp;amp; Software&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Three years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Furniture&#160;&amp;amp; Fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Five years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of capital assets, may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected fair value of the related asset over the estimated remaining life against the respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its capital assets in this analysis. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Impairment of Long-Lived Assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset&#x2019;s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-15, &#x201c;Impairment or Disposal of Long-Lived Assets.&#x201d; ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Fair Value of Financial Instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of the fair value hierarchy under Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, Fair Value Measurement, are described as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Level 1 &lt;/i&gt;&#x2014; Unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Level 2 &lt;/i&gt;&#x2014; Inputs other than quoted prices included in Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Level 3 &lt;/i&gt;&#x2014; Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own models.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The financial instruments of the Company consist primarily of cash, U.S. government money market fund accounts, trade receivables, trade payables, bitcoins, and debt securities. Because carrying values of cash, trade receivables, and payables are equal to or approximate their fair value, the Company excluded them from the leveling requirements. U.S. government money market fund accounts are classified as Level 1&#160;due to their short-term nature, their market interest rates and also based on the fact that they are publicly traded. Bitcoins purchased for investments, which are included in Intangible digital assets are classified as Level 1 as the unadjusted quoted prices in active markets are used for the fair valuation. The Company also invests in non-convertible promissory notes and equity securities in a privately held company, which were recorded on cost basis. See Notes 7 and 8 to Financial Statements for more information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;The Company's privately held debt security is recorded at fair value on a recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company deems these assets as Level 3 within the fair value measurement framework. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;As of December 31, 2024, the Company valued the debt security at face value of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;. The original maturity date of December 6, 2024 was extended to January 17, 2025 and a partial amount of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$3.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million along with transaction fee of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$100&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and accrued interest of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$47&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; was collected on January 15, 2025. A new amended and restated secured convertible note for the balance of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million was signed on January 15, 2025 with new terms (see note 20 for the details). The fair value of the Company&#x2019;s privately held debt security was estimated at&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$&lt;/span&gt;5,000 as of December 31, 2024, in view of partial payment and a new note for the balance was signed&lt;span style="background:#ffffff;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Investment Valuation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s investments in equity in privately held companies without readily determinable fair values, which are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. As part of its assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If its qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgment and subjectivity.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt; The Company did not record any impairment during the year December 31, 2024. The Company recorded an impairment of &lt;/span&gt;$309 for the preferred stock investment in Mellitus Health, Inc (&#x201c;Mellitus&#x201d;) during the year ended December 31, 2023. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;"&gt;Deferred Revenue&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;Deferred revenue represents amounts billed to or collected from customers for which the related revenues have not been recognized because one or more of the revenue recognition criteria have not been met. The full amount is expected to be recognized as revenues within one&#160;year from the balance sheet date and, therefore, such deferred amounts have been classified as current liabilities in the balance sheets presented. The Company generally invoices its clients in advance of a rental period with payment due upon receipt of the invoice. Revenue recognized for the year ended December&#160;31, 2024 from amounts included in deferred revenue as of December 31, 2023 was $1,120. Revenue recognized for the year ended December&#160;31, 2023 from amounts included in deferred revenue as of December 31, 2022 was $1,160.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;"&gt;Advertising Costs&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company expenses advertising costs as incurred. Advertising expense incurred during the years ended December 31, 2024 and 2023 was $167 and $319, respectively. These costs are included in sales and marketing expenses in the statements of income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:13.5pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Research and Development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company expenses costs related to the research and development associated with the design, development, testing and enhancement of its products and services. Such expenses include salaries and related employee benefits, and fees paid to external service providers. The Company incurred Research and development expenses of $4,792 and $5,773 for the year ended December 31, 2024 and 2023, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Stock-Based Compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Stock-based compensation expense is measured based on the grant-date fair value of the stock-based awards. The Company recognizes stock-based compensation expense for the portion of each option grant or stock award that is expected to vest over the estimated period of service and vesting. The Company uses the Black-Scholes option pricing model as the method for determining the estimated grant-date fair value of stock options. The Black-Scholes option pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards, including the option&#x2019;s expected volatility. Forfeitures are recognized as incurred. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the grant. See Note 16 to financial statements for the details.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;"&gt;Employee Benefit Plan&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company has a savings plan that qualifies under Section&#160;401(k)&#160;of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;). Effective January 1, 2022, the Company started to match&#160;50% of employee&#x2019;s 401(k) deferral up to a maximum of&#160;6% of the employee&#x2019;s eligible earnings.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Income Taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the expected tax consequences attributable to the differences between financial reporting and the tax bases of existing assets and liabilities and net operating loss (&#x201c;NOL&#x201d;) carryforwards, and they are measured using enacted tax rates expected to be in effect when differences are expected to reverse. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Recently Issued Accounting Pronouncements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:bold;"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;In November 2023, the FASB issued &lt;span style="background:#ffffff;"&gt;Accounting Standards Update&lt;/span&gt; (&#x201c;ASU&#x201d;)&#160;2023-07&#160;&#x201c;Segment Reporting: Improvements to Reportable Segment Disclosures&#x201d;. This guidance expands public entities&#x2019; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#x2019;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an entity&#x2019;s financial statements. The Company adopted the new accounting standard for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s financial statements related disclosure.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;In December 2023, the FASB issued ASU No. 2023-08, &lt;i style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other&#x2014;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets&lt;/i&gt; (&#x201c;ASU 2023-08&#x201d;). ASU 2023-08 requires in-scope crypto assets to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning after December 15, 2024, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company early adopted &lt;span style="-sec-ix-hidden:Hidden_J8wOH7bw2UqoKIsy6ORpDQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;ASU 2023-08&lt;/span&gt;&lt;/span&gt; in the second quarter ended June 30, 2024, effective retroactively as of January 1, 2024 with no cumulative-adjustment to the retained earnings as of the beginning of the annual period of adoption.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements not yet adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:6pt;text-indent:18pt;margin:0pt;"&gt;In December 2023, the FASB issued ASU No. 2023-09,&lt;i style="font-style:italic;"&gt; Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning after December 15, 2024 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. Adoption of this update is not expected to have a significant impact on the Company&#x2019;s financial statements and related disclosures.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;In November 2024, the FASB issued ASU 2024-03,&lt;/span&gt;&lt;i style="font-style:italic;background:#ffffff;"&gt;&#160;"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.&lt;/i&gt;&lt;span style="background:#ffffff;"&gt;" This standard requires entities to disaggregate operating expenses into specific categories such as employee compensation, depreciation, and intangible asset amortization, by relevant expense caption on the statement of operations. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, which means that it will be effective for the Company&#x2019;s annual and interim reporting for the fiscal year ending December 31, 2028. Early adoption is permitted on either a prospective or retrospective basis. The Company is currently evaluating the impact of adopting ASU 2024-03 on its financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_2XeINhyGaESDe0lE9cZBjQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Basis for Presentation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_-EPIZkvnBEapaBLOZl5CGg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Use of Estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"&gt;The preparation of the accompanying financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses, and related disclosures during the reporting period. Significant items subject to such estimates include allowance for credit losses, valuation of equipment on lease, recognition and measurement of current and deferred income taxes, valuation and recognition of investments and intangible assets and valuation of inventory. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_dIFfhBNGzU-Dv-agWKvFAA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:13.5pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, bitcoin, accounts receivable and trade payables. The Company maintains its cash and bitcoins with major financial institutions and reputed bitcoin traders. The Company&#x2019;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The cash and cash equivalents also include U.S. government money market fund accounts. Our bitcoins are held offline in cold storage with multiple third-party providers. The Company manages its accounts receivable credit risk through ongoing credit evaluation of its customers&#x2019; financial conditions. The Company generally does not require collateral from its customers.&#160;For information regarding the Company&#x2019;s significant customers and vendors, see Note 12 to financial statements.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_iSvfcVYAQEigtndx68QXFA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Revenue Recognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company generates revenues primarily from the rental or license of its vascular testing product. The Company recognizes revenues from the licensing of its product primarily pursuant to agreements that automatically renew each&#160;month with revenue recognized on a daily convention basis or when the test is performed. The Company&#x2019;s arrangements with customers for its vascular testing product are normally on a&#160;month-to-month basis with fees billed at the rates established in the customer agreement, either on a fixed or variable (e.g. fee per test) basis, as earned. The &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;Company also recognizes revenue for hardware and supplies sales as of the date of shipment. Shipping and handling costs are included in cost of revenues in the statement of income. Payment terms of the customers are net 30 days. Semler replaces the defective sensors with no charge. Other than replacing the defective sensors there are no other obligations to the customers. &lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <smlr:RevenuePerformanceObligationPaymentTermsNumberOfDays
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Narr_35F9E4jtwkGGbp72nNh2VA"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">30</smlr:RevenuePerformanceObligationPaymentTermsNumberOfDays>
    <smlr:DefectiveProductReplacementCost
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_7je6ECJXaE62PyGherG-IQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</smlr:DefectiveProductReplacementCost>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_RQq3bmHna0-DBhB3w7MNcg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Cash and Cash Equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Cash and cash equivalents are comprised of highly liquid investments purchased with an initial maturity date of three&#160;months or less. Funds held as investments in money market funds are included within cash and cash equivalents.&lt;/span&gt;&#160;Restricted cash represents amounts pledged as cash security related to the use of credit cards.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_-yotMJXkJ0WGpQcyyPrydQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Short-Term Notes Held for Investments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="color:#111111;background:#ffffff;"&gt;Short-term notes held for investments are&lt;/span&gt;&lt;b style="color:#111111;font-weight:bold;background:#ffffff;"&gt;&#160;&lt;/b&gt;&lt;span style="color:#111111;background:#ffffff;"&gt;those&lt;/span&gt;&lt;span style="color:#111111;background:#ffffff;"&gt; investment instruments that will mature within one year or which are expected to be liquidated within one year.&lt;/span&gt;&lt;/p&gt;</us-gaap:FinanceLoanAndLeaseReceivablesHeldForInvestmentPolicy>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_CconJ8IGP0-X3lUjFJLauQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Accounts receivables are recorded at the invoiced amount, net of allowances for credit losses. T&lt;span style="background:#ffffff;"&gt;he allowance for credit losses is based on management&#x2019;s assessment of the collectability of accounts. The Company regularly reviews the adequacy of this allowance for credit losses by considering historical experience, the age of the accounts receivable balances, the credit quality of the customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect customers&#x2019; ability to pay to determine whether a specific reserve is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for credit losses when identified. Accounts receivable, net as of December 31, 2024, December 31, 2023 and December 31, 2022 was &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$4,378&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$6,125&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$3,884&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively, include &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$2,067&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,966&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1,735&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively, related to revenue recognized under ASC 606.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;As of December 31, 2024, the allowance for credit losses was $199. During t&lt;span style="color:#212529;background:#ffffff;"&gt;he year the Company provided an additional reserve of&#160;&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$135&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;and recovered&#160;or expensed credit losses of &lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$223&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;from customers. The allowance for credit losses as of December 31, 2023 was&#160;&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$287&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;. &lt;/span&gt;Credit losses related to ASC 606 receivables were $113 and $6 as of December 31, 2024 and December 31, 2023, respectively.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_cKiJPDRSYE-e8N234dZXlQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4378000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_QGZwHa2j2kGlGIqpA7W8BQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6125000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA"
      decimals="-3"
      id="Narr_HhuroLLR9kmDRGUqW7rNoQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3884000</us-gaap:AccountsReceivableNetCurrent>
    <smlr:ContractWithCustomerAccountsReceivableNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_xX_f_S5TNEa-M_DPBVLlqw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2067000</smlr:ContractWithCustomerAccountsReceivableNet>
    <smlr:ContractWithCustomerAccountsReceivableNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_iRZp_fZfYECK_LBNESaiAQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5966000</smlr:ContractWithCustomerAccountsReceivableNet>
    <smlr:ContractWithCustomerAccountsReceivableNet
      contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA"
      decimals="-3"
      id="Narr_Rv1tmsCZt06S6ncEzaDGLw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1735000</smlr:ContractWithCustomerAccountsReceivableNet>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_UyhUT4sXQkmkXqwDz3gmlw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">199000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <smlr:AccountsReceivableAllowanceForCreditLossAdditionalReserve
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_2_Pd7dJ1r0evUYrBVQ9How"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">135000</smlr:AccountsReceivableAllowanceForCreditLossAdditionalReserve>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_E_n-2kAkQEubW9pk8CTFYQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">223000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_Ori9yOm150alvl482kMONw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">287000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <smlr:ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_BaslISXMIkWyeSuXM-onqQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">113000</smlr:ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent>
    <smlr:ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_B87ekxVVe0eQ7KFNrcAzzg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6000</smlr:ContractWithCustomerAccountsReceivableAllowanceForCreditLossCurrent>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_K-0mSLsgh02hFlVGuPKysQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Inventory&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Inventory, which is made up of finished goods, is recorded at the lower of cost or net realizable value. Cost is determined on the first-in, first-out method. The Company periodically analyzes its inventory levels to identify inventory that has a cost basis in excess of its estimated realizable value and writes down such inventory as appropriate.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:LessorLeasesPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_Gi2gPl2aNEOHR43h1YHq_Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Assets for Lease&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Assets for lease are recorded at cost. At December&#160;31, 2024 and 2023, assets for lease consisted of vascular testing devices, which are primarily leased to customers. The cost of such assets for lease is depreciated on a straight-line basis over 36 months for the units outstanding and recorded as cost of revenues.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of assets may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected undiscounted net cash flows associated with the related assets over their estimated remaining lives against their respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its assets for lease in this analysis. Impairment, if any, is &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.&lt;/p&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_W64GlRtDm0icy9iIeB1Rwg"
      id="Narr_R95EeqOS6E-H0FOn7xV-5Q">P36M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_smlr_PropertyPlantAndEquipmentLessorAssetUnderOperatingLeaseMember_MakASwJL4Euo7dVHvkl2rA"
      id="Narr_fOrX2G_4-0C-l5b4A0IvrA">P36M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <smlr:IntangibleDigitalAssetsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_7yMOEfsasEWfkoSVWgdO2w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intangible Digital Assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 350, &lt;i style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other&lt;/i&gt;. The Company has ownership of and control over its bitcoin and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoin. The Company&#x2019;s digital assets are initially recorded at cost and subsequently remeasured to fair value at the end of each reporting period, with changes recognized in other income, net.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company purchases bitcoins for long term investment. It intends to hold its digital assets for long term gains and treats them as long term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. A valuation allowance is recorded for unrealized capital losses. Bitcoins are stored in cold wallets. Average cost of wallet is used for calculating the unrealized gains or losses. See Note 9 to Financial Statements for additional information regarding the Company&#x2019;s purchases and sales of digital assets. &lt;/p&gt;</smlr:IntangibleDigitalAssetsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_XtOeX9BHj0CZKhhllu7Pow">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Property and Equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Capital assets are recorded at cost. The cost of such capital assets is depreciated on a straight-line basis over a term depending on the assigned category (described below) and recorded as depreciation for capital assets recorded in engineering and product development, sales and marketing and general and administrative expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December&#160;31, 2024 and 2023, capital assets are classified into one of the following categories:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;"&gt;Category Name&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;margin:0pt;"&gt;Description&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Machinery &amp;amp; Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Manufacturing, R&amp;amp;D, or other non-office equipment&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Computer Equipment&#160;&amp;amp; Software&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Software, computers, monitors, printers and other related equipment.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Furniture&#160;&amp;amp; Fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Office equipment and furniture owned by the company&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Account Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Useful Life &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Machinery &amp;amp; Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Five years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Computer Equipment&#160;&amp;amp; Software&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Three years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Furniture&#160;&amp;amp; Fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Five years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company regularly reviews whether facts and circumstances exist which indicate that the carrying amounts of capital assets, may not be recoverable or that the useful life of assets are shorter or longer than originally estimated. The Company assesses the recoverability of its assets by comparing the projected fair value of the related asset over the estimated remaining life against the respective carrying amounts. The Company considers factors such as estimated usage and expected lives of its capital assets in this analysis. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. At December&#160;31, 2024 and 2023, there were no impairment indicators.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <smlr:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_ysmB9l1fQUypiNSM-c8fVw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At December&#160;31, 2024 and 2023, capital assets are depreciated based on the following estimated useful life for each category:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Account Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Useful Life &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Machinery &amp;amp; Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Five years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Computer Equipment&#160;&amp;amp; Software&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Three years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Furniture&#160;&amp;amp; Fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:3.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:48.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;Five years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</smlr:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_aCUWSs44WUuNTnqFFLPMZQ"
      id="Tc_n0nildnlwEemUwutvVsqmA_2_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember_4CDoFoOHw0GbAdFoHlt6Mg"
      id="Tc_n0nildnlwEemUwutvVsqmA_2_2_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_mGIHHxS_ZEuc6ViWxpMJ9Q"
      id="Tc_oGQxYOTIHEKL4sjfnsY3_w_3_2">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_aqZhN0s0ZEyt9Xlfg5w8DA"
      id="Tc_oGQxYOTIHEKL4sjfnsY3_w_3_2_2">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_f0cWWAE48EORHBh0d2T8Nw"
      id="Tc_hKcQqcZp1USyPr2-q-WOag_4_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_12_31_2024_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_KiuY18k-9k-jS6iTZaYS0Q"
      id="Tc_hKcQqcZp1USyPr2-q-WOag_4_2_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_yHtli0_LCUKZ3WruM-T-Ag">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Impairment of Long-Lived Assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset&#x2019;s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-15, &#x201c;Impairment or Disposal of Long-Lived Assets.&#x201d; ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals. &lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_tvDx57qGvEOO_GLgXXJUlQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Fair Value of Financial Instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of the fair value hierarchy under Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, Fair Value Measurement, are described as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Level 1 &lt;/i&gt;&#x2014; Unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Level 2 &lt;/i&gt;&#x2014; Inputs other than quoted prices included in Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Level 3 &lt;/i&gt;&#x2014; Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own models.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The financial instruments of the Company consist primarily of cash, U.S. government money market fund accounts, trade receivables, trade payables, bitcoins, and debt securities. Because carrying values of cash, trade receivables, and payables are equal to or approximate their fair value, the Company excluded them from the leveling requirements. U.S. government money market fund accounts are classified as Level 1&#160;due to their short-term nature, their market interest rates and also based on the fact that they are publicly traded. Bitcoins purchased for investments, which are included in Intangible digital assets are classified as Level 1 as the unadjusted quoted prices in active markets are used for the fair valuation. The Company also invests in non-convertible promissory notes and equity securities in a privately held company, which were recorded on cost basis. See Notes 7 and 8 to Financial Statements for more information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;The Company's privately held debt security is recorded at fair value on a recurring basis. The estimation of fair value for these investments requires the use of significant unobservable inputs, and as a result, the Company deems these assets as Level 3 within the fair value measurement framework. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;As of December 31, 2024, the Company valued the debt security at face value of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;. The original maturity date of December 6, 2024 was extended to January 17, 2025 and a partial amount of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$3.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million along with transaction fee of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$100&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and accrued interest of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$47&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; was collected on January 15, 2025. A new amended and restated secured convertible note for the balance of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million was signed on January 15, 2025 with new terms (see note 20 for the details). The fair value of the Company&#x2019;s privately held debt security was estimated at&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$&lt;/span&gt;5,000 as of December 31, 2024, in view of partial payment and a new note for the balance was signed&lt;span style="background:#ffffff;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <smlr:DebtSecurityFaceValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_yyfKhodQx0mYn4cOu1ZIsg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000000</smlr:DebtSecurityFaceValue>
    <smlr:ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount
      contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA"
      decimals="-5"
      id="Narr_fmyrg6p3ZUGKr59w_unVIA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3500000</smlr:ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount>
    <smlr:ProceedsFromTransactionFeeOfDebtSecurities
      contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA"
      decimals="-3"
      id="Narr_pESamiXsdEy2jveoUhE9Cw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">100000</smlr:ProceedsFromTransactionFeeOfDebtSecurities>
    <smlr:ProceedsRelatingToAccruedInterestOfDebtSecurities
      contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA"
      decimals="-3"
      id="Narr_9rX0Pj6T40KKTrGUf4uukA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">47000</smlr:ProceedsRelatingToAccruedInterestOfDebtSecurities>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lEsvR7g5ukqjO6r8JvkH_g"
      decimals="-5"
      id="Narr_Uu94bUFjtEOGlqnmklpohw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1500000</us-gaap:NotesReceivableNet>
    <us-gaap:DebtSecurities
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_uLtmNMC6Gk2WFNE5UMGLbw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000000</us-gaap:DebtSecurities>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_JftLfFRCyUCfttiOQCiq9Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Investment Valuation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s investments in equity in privately held companies without readily determinable fair values, which are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. As part of its assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If its qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgment and subjectivity.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt; The Company did not record any impairment during the year December 31, 2024. The Company recorded an impairment of &lt;/span&gt;$309 for the preferred stock investment in Mellitus Health, Inc (&#x201c;Mellitus&#x201d;) during the year ended December 31, 2023. &lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_iiwXAJ8iLEmWrOmHy7R48A"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">309000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_R8OAZvcn4U2VdGzft10GYg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;"&gt;Deferred Revenue&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;Deferred revenue represents amounts billed to or collected from customers for which the related revenues have not been recognized because one or more of the revenue recognition criteria have not been met. The full amount is expected to be recognized as revenues within one&#160;year from the balance sheet date and, therefore, such deferred amounts have been classified as current liabilities in the balance sheets presented. The Company generally invoices its clients in advance of a rental period with payment due upon receipt of the invoice. Revenue recognized for the year ended December&#160;31, 2024 from amounts included in deferred revenue as of December 31, 2023 was $1,120. Revenue recognized for the year ended December&#160;31, 2023 from amounts included in deferred revenue as of December 31, 2022 was $1,160.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_Qvvq1BENjESoLMtdeIZnCQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1120000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="Duration_1_1_2022_To_12_31_2022_IcqC7PE9WUiygajKvbmwNg"
      decimals="-3"
      id="Narr_ly8avF1qEUiE39RjeDHrww"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1160000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_cVUaU9UEYUueNGhg8U25uQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;"&gt;Advertising Costs&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company expenses advertising costs as incurred. Advertising expense incurred during the years ended December 31, 2024 and 2023 was $167 and $319, respectively. These costs are included in sales and marketing expenses in the statements of income.&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_39TCRU9QpES6345lorjMbA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">167000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_aMcOES85XkqTaxsZbFglQA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">319000</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_f1KWc_kzkUCcV19D12eSTQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Research and Development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company expenses costs related to the research and development associated with the design, development, testing and enhancement of its products and services. Such expenses include salaries and related employee benefits, and fees paid to external service providers. The Company incurred Research and development expenses of $4,792 and $5,773 for the year ended December 31, 2024 and 2023, respectively.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_mNlsiAeRNky5E4G7-qtbuQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4792000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_1XO2R-27REeP5nGFPmI1wA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5773000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_s-nBoWBQ9UGYQ5KIncwmqw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Stock-Based Compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Stock-based compensation expense is measured based on the grant-date fair value of the stock-based awards. The Company recognizes stock-based compensation expense for the portion of each option grant or stock award that is expected to vest over the estimated period of service and vesting. The Company uses the Black-Scholes option pricing model as the method for determining the estimated grant-date fair value of stock options. The Black-Scholes option pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards, including the option&#x2019;s expected volatility. Forfeitures are recognized as incurred. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the grant. See Note 16 to financial statements for the details.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPPolicy
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_Ho9_9hviPU2DxnzSXLpTgA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;"&gt;Employee Benefit Plan&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company has a savings plan that qualifies under Section&#160;401(k)&#160;of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;). Effective January 1, 2022, the Company started to match&#160;50% of employee&#x2019;s 401(k) deferral up to a maximum of&#160;6% of the employee&#x2019;s eligible earnings.&lt;/p&gt;</us-gaap:EmployeeStockOwnershipPlanESOPPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Narr_gyFNN0eETUKSkFHeU5Bi1g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Narr_JhxHcQxsR0GR1sU6J2uIWw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_LCzwpfLJz0Sj81nIlsIpuQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Income Taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the expected tax consequences attributable to the differences between financial reporting and the tax bases of existing assets and liabilities and net operating loss (&#x201c;NOL&#x201d;) carryforwards, and they are measured using enacted tax rates expected to be in effect when differences are expected to reverse. &lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_QDcwtcjKoUO9PuDOs1A7TA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Recently Issued Accounting Pronouncements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:bold;"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;In November 2023, the FASB issued &lt;span style="background:#ffffff;"&gt;Accounting Standards Update&lt;/span&gt; (&#x201c;ASU&#x201d;)&#160;2023-07&#160;&#x201c;Segment Reporting: Improvements to Reportable Segment Disclosures&#x201d;. This guidance expands public entities&#x2019; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#x2019;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an entity&#x2019;s financial statements. The Company adopted the new accounting standard for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s financial statements related disclosure.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;In December 2023, the FASB issued ASU No. 2023-08, &lt;i style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other&#x2014;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets&lt;/i&gt; (&#x201c;ASU 2023-08&#x201d;). ASU 2023-08 requires in-scope crypto assets to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning after December 15, 2024, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company early adopted &lt;span style="-sec-ix-hidden:Hidden_J8wOH7bw2UqoKIsy6ORpDQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;ASU 2023-08&lt;/span&gt;&lt;/span&gt; in the second quarter ended June 30, 2024, effective retroactively as of January 1, 2024 with no cumulative-adjustment to the retained earnings as of the beginning of the annual period of adoption.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements not yet adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:6pt;text-indent:18pt;margin:0pt;"&gt;In December 2023, the FASB issued ASU No. 2023-09,&lt;i style="font-style:italic;"&gt; Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning after December 15, 2024 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. Adoption of this update is not expected to have a significant impact on the Company&#x2019;s financial statements and related disclosures.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;In November 2024, the FASB issued ASU 2024-03,&lt;/span&gt;&lt;i style="font-style:italic;background:#ffffff;"&gt;&#160;"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.&lt;/i&gt;&lt;span style="background:#ffffff;"&gt;" This standard requires entities to disaggregate operating expenses into specific categories such as employee compensation, depreciation, and intangible asset amortization, by relevant expense caption on the statement of operations. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, which means that it will be effective for the Company&#x2019;s annual and interim reporting for the fiscal year ending December 31, 2028. Early adoption is permitted on either a prospective or retrospective basis. The Company is currently evaluating the impact of adopting ASU 2024-03 on its financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption
      contextRef="As_Of_6_30_2024_geCWm453AUejs3C95T9_VA"
      id="Narr_H_Mlo678kEGT5v5M2UKhOg">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2023_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate202308Member_ErqcZCu5GEuuVGLzwhazqA"
      decimals="-3"
      id="Narr_Ee0ThvbcbUeW3uI9vjbgSA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <smlr:AssetsForLeaseNetTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_R2LoiuOOCkmrFRR5sCaXrg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;3.&#160;&#160;&#160;&#160;Assets fo&lt;span style="font-weight:normal;"&gt;r&lt;/span&gt; Lease, net&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company provides financing of certain equipment through operating leases (see Note 13 to the financial statements). Assets for lease consist of the following:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&#160;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Assets for lease &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,522&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,375&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less: accumulated depreciation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,099)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,090)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Assets for lease, net &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,423&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,285&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Depreciation expense amounted to $296 and $307 for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Reduction to accumulated depreciation for returned items was $279 and $441 for the&#160;years ended December&#160;31, 2024 and December&#160;31, 2023, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $298 and $369 for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, total assets for lease, net, in use at customer locations were $295 and $489, respectively.&lt;/p&gt;</smlr:AssetsForLeaseNetTextBlock>
    <smlr:ScheduleOfAssetsForLeaseNetTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_25LWuDiQcUqZtU0uoIy0Yg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&#160;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Assets for lease &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,522&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,375&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less: accumulated depreciation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,099)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,090)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Assets for lease, net &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,423&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,285&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</smlr:ScheduleOfAssetsForLeaseNetTableTextBlock>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_T0YaJz-nPUmmNgOnf_L4Tg_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2522000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_9cxmj7JOHEec4XB0JQP0rA_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3375000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_o1MQDEvA3kqA9DM2bsXVRQ_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1099000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_12BBy_28UEW0rLk8W8rrpA_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1090000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_AVl3XoozzE6K3N08A2gHzg_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1423000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_pDP7i_3RlEGGfWkcniSE_A_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2285000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet>
    <us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_ddAgcSZNWESejRUyRBkU6g"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">296000</us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease>
    <us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_M9IWMXOPK0KpRzyCES1yXw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">307000</us-gaap:OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease>
    <smlr:AssetsForLeaseReductionToAccumulatedDepreciation
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_rnkZfTMRUkqycpDeafA6UQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">279000</smlr:AssetsForLeaseReductionToAccumulatedDepreciation>
    <smlr:AssetsForLeaseReductionToAccumulatedDepreciation
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_NQwgeE99gEi5i0ECLJxdTA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">441000</smlr:AssetsForLeaseReductionToAccumulatedDepreciation>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_4KFD1WgSFUuusmb-Ncz1Ig"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-298000</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_IQ9IeIvgd0-JOnMCWlhRdw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-369000</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <smlr:AssetsForLeaseCustomerLocation
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_2Z_EU36l-0ecAeuT9RA5_A"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">295000</smlr:AssetsForLeaseCustomerLocation>
    <smlr:AssetsForLeaseCustomerLocation
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_ljqWYLhAYkmgdJ6LEBZ_Pg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">489000</smlr:AssetsForLeaseCustomerLocation>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_xHsXs6zwD0m_rV0PvFyQTg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;4.&#160;&#160;&#160;&#160;Inventory&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;As of December 31, 2024 and 2023, the inventory balance was &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;$358&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; and &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;$445&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;, respectively. Inventory includes finished goods of sensors, light blocking bags and heel warmers.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_TuMza-JIFUqO1tzBzaZmdw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">358000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_LBCG_JFQnkujaMUsLNfOBQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">445000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_KO7ktiYD9022rNq1_MMRMw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;5.&#160;&#160;&#160;&#160;Property and Equipment, net&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Capital assets consist of the following:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&#160;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Property and equipment, gross&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,467&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,544&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less: accumulated depreciation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (980)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (824)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 487&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 720&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Depreciation expense amounted to $283 and $292 for the years ended December 31, 2024 and 2023, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_xYHs-ND-h0SEaZTWYND8ZQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&#160;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Property and equipment, gross&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,467&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,544&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less: accumulated depreciation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (980)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (824)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 487&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 720&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_2BJSysQaSEGl2yTft4JoQw_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1467000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_vVapmHuKoU6GkwE0gekIjQ_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1544000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_kU4_Z5Oy2UW6GcTw8SUSUQ_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">980000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_YpKgZoFpeUOB7YHX8thC4g_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">824000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_zQDjv1vdp0CvG9Oqn3WHuw_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">487000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_jQLyByDy-UOEl2iFwIk6yw_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">720000</us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_HFRhriccPEibSkJHsfFdUA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">283000</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_FjF62Nw4TEiOk0mn7n6cfg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">292000</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_frVN8W4bR0ufIFHokkUTqA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;6.&#160;&#160;&#160;&#160;Long-Term Investments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;Carrying value of non-marketable securities is measured as the total initial cost plus the cumulative net gain (loss). Carrying value of non-marketable equity investments consist of the following for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investments in SYNAPS Dx&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total long-term investments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In September 2020, the Company acquired a promissory note from NeuroDiagnostics Inc., which is doing business as SYNAPS Dx, in the principal amount of $500. Subsequently, in December 2020, the Company agreed to convert the promissory note, together with all accrued interest thereon, into shares of preferred stock of SYNAPS Dx as repayment in full of the promissory note. The value of the note exchanged for the shares of preferred stock of SYNAPS Dx held by the Company as of December 31, 2024 and 2023 was approximately $512. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The investments in SYNAPS Dx as of December 31, 2024 were recorded in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 321, &lt;i style="font-style:italic;"&gt;Investments &#x2013; equity securities,&lt;/i&gt; which provides that investments in equity securities in privately-held companies without readily determinable fair values are generally recorded at cost, plus or minus subsequent observable price changes in orderly transactions for identical or similar investments, less impairments. The Company elected the practical expedient permitted by ASC 321 and recorded the above investments on a cost basis. As a part of the assessment for impairment indicators, the Company considers significant deterioration in the earnings performance and overall business prospects of the investee as well as significant adverse changes in the external environment these investments operate. If qualitative assessment indicates the investments are impaired, the fair value of these equity securities would be estimated, which would involve a significant degree of judgement and subjectivity. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company assessed the investment for impairment in accordance with ASC 321. As of December 31, 2024, the Company determined that there was no impairment. A&lt;span style="color:#212529;background:#ffffff;"&gt;s of December 31, 2023, the Company determined that there was an impairment to the preferred stock investment in Mellitus and recorded an impairment of &lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$309&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;due to the following factors: 1) due to continued operating losses; 2) due to lack of revenue growth; and 3) delayed capital raise. The cumulative recorded impairment as of December 31, 2024, was &lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;$309&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_-3gPIoszA0ajVJjP8Vh08Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investments in SYNAPS Dx&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total long-term investments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2024_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_XS97Wf2QpUu9KcNGDWoQlQ"
      decimals="-3"
      id="Tc_iGtSG9-CbECg3FAlRSTBYg_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2023_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyTwoMember_1wPfvi5hA0-P18KQ9-gxVw"
      decimals="-3"
      id="Tc_Lb8R81JFbEuoWzhxpDA4vQ_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_CiPms6-fC0qQtHBziwPivA_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_3P0ERkYYJESAEVzCBurIVQ_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:LongTermInvestments>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_9_30_2020_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_hGBEk459TU6iXePXuBf5Gw"
      decimals="-3"
      id="Narr_zkUk7sXgsUqaRfLCMH-HfQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_X9WpoJSxJEq9lfFuf9gDtg"
      decimals="-3"
      id="Narr_xrb8btcuZES5OB_j27iwsw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_DebtInstrumentAxis_smlr_PromissoryNoteFromPrivateCompanyTwoMember_-L_MetT9sEqjsLb_hMB9Gw"
      decimals="-3"
      id="Narr_FXHm96OcgUirbW3_oiApbg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">512000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_Kju9t7qbY0qZiYpxZIMKJA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_ZIeSg0ZH2E2NJyP93VUraA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">309000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_gncWHk88rEy6k6pI0sFacQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">309000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_DGUG8RKG_kmTX-QSfCacaQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;7.    Fair Value Measurements&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;The following table presents fair value hierarchy of the Company&#x2019;s financial assets measured at fair value on a recurring basis:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:46.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value Hierarchy&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31, 2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;U.S. Government money market fund accounts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 3,638&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 3,638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in cash and cash equivalents)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bitcoin investments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in intangible digital assets)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 218,271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 218,271&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:18pt;"&gt;&lt;/span&gt; &lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.12%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.24%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;U.S. Government money market fund accounts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 41,373&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 41,373&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in cash and cash equivalents)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;U.S. Treasury bill&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 10,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 10,494&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in cash and cash equivalents)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investment in debt securities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in notes held for investment)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 41,373&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 10,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 56,239&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;Treasury bill was purchased on October 10, 2023, at a cost of&#160;$10,414, and fair value accretes to maturity date at an interest rate of&#160;5.35%. The treasury bill was classified as Level 2 as it is considered &#x201c;off the run&#x201d; because similar treasury bills were issued before the most recent issue and were outstanding as of December 31, 2023 and therefore not considered as liquid as other treasury bills with the same maturity date. As of December 31, 2023, the interest income recorded on these bills was&#160;$80.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The Company valued the debt securities at face value as of December 31, 2024 because the debt was to be repaid in January 2025. As of December 31, 2023, the Company valued the debt securities using a bond plus call option model reflecting the cash flow from the debt securities and assuming a&#160;5%&#160;probability of an equity financing, a&#160;75%&#160;probability of a change of control, and a&#160;20%&#160;probability of payment at maturity or an insolvency event. As of December 31, 2023, the fair value of the Company&#x2019;s privately held debt securities was estimated at $4,372.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The key inputs for the valuation model are:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3.94%-5.26%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cashflow discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;27.8&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected term in years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.25-2.92&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;120%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:69pt;"&gt;&lt;/span&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;The following table represents changes in the notes held for the investments with significant unobservable inputs:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.11%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Convertible Notes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Balance as of December 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Purchased &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Change in fair value of the notes held for investment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 128&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Balance as of December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_SLbiRcHiPUe6gKljnj2vDw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:46.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value Hierarchy&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31, 2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;U.S. Government money market fund accounts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 3,638&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 3,638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in cash and cash equivalents)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Bitcoin investments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in intangible digital assets)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 218,271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 218,271&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="display:inline-block;width:18pt;"&gt;&lt;/span&gt; &lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.12%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.24%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;U.S. Government money market fund accounts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 41,373&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 41,373&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in cash and cash equivalents)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;U.S. Treasury bill&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 10,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 10,494&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in cash and cash equivalents)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investment in debt securities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;(Included in notes held for investment)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:54.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 41,373&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 10,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 56,239&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ"
      decimals="-3"
      id="Tc_W9XmQ6LiT0KZx0qxrZAJFw_4_2"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3638000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA"
      decimals="-3"
      id="Tc_dUAXLZv4HEmNXMV1Tk7Huw_4_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3638000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:CryptoAssetFairValue
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ"
      decimals="-3"
      id="Tc_x4OnpeY79kmOPP8uuR_w8Q_6_2"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA"
      decimals="-3"
      id="Tc_7Ust-N_UJEeHxIgq4n7B7g_6_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_a_WFd3iaIUCbx28gEiv1sQ"
      decimals="-3"
      id="Tc_-BuwFnFx20uKQrXa2wWS_w_8_2"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">218271000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_2tgn4YVqJUK7HGRXbSRBpA"
      decimals="-3"
      id="Tc_hzPvRP9YcEOu2YRvWDyiig_8_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">218271000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_9BDTT4lyYkSv1F0eAQlnCg"
      decimals="-3"
      id="Tc_GvVjtr_pXUy27N-cp6J-Yw_3_2"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">41373000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw"
      decimals="-3"
      id="Tc_bNgLhe-eKEiFymS4tTfHHQ_3_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">41373000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:TradingSecuritiesDebt
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_uk7mInBKCUiVA3vFkCN5Vw"
      decimals="-3"
      id="Tc_yHJNWO4_L0Ok6vSNbOLF1g_5_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">10494000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:TradingSecuritiesDebt
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw"
      decimals="-3"
      id="Tc_P5zh7J8sokqL-GY6aQz-vw_5_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">10494000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_KNM3WXi-TU6wCTDDF5i12Q"
      decimals="-3"
      id="Tc_59o-yA8UAEG0Xl4Z9vFziA_7_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw"
      decimals="-3"
      id="Tc_zpOIosT0I0qSjIqbLx6jfA_7_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_9BDTT4lyYkSv1F0eAQlnCg"
      decimals="-3"
      id="Tc_U0Lkb6xgGUiDb1nhuMOPoQ_9_2"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">41373000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_uk7mInBKCUiVA3vFkCN5Vw"
      decimals="-3"
      id="Tc_pz4D_b3Dyki24ZlrrYB7NQ_9_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">10494000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_KNM3WXi-TU6wCTDDF5i12Q"
      decimals="-3"
      id="Tc_ZT9NYo0hckOtPI9GWjMPjw_9_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_NB3fc_NJ9kOuDXBwlmTdHw"
      decimals="-3"
      id="Tc_yYdBI1T-TE2D2C4c7y8-iQ_9_11"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">56239000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="Duration_10_10_2023_To_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_wO80u8v0nkaVj9-6hCzGng"
      decimals="-3"
      id="Narr_2R3vX-ZJ7E-3qXselJoi1Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">10414000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:InvestmentInterestRate
      contextRef="As_Of_10_10_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_G3Anxea5Bk2Jp-whqZzF4Q"
      decimals="4"
      id="Narr_ojbtchFojUSj0BO6rNaZiw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0535</us-gaap:InvestmentInterestRate>
    <us-gaap:DebtSecuritiesTradingRealizedGain
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_85lUGANk9Uq8MoWX1Ze-rw"
      decimals="-3"
      id="Narr_o-E8xignAkK9vfm2M4axBg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">80000</us-gaap:DebtSecuritiesTradingRealizedGain>
    <smlr:PercentageOfProbabilityOfEquityFinancing
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Narr_X6831wgDn0mfCZuCixcSEA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.05</smlr:PercentageOfProbabilityOfEquityFinancing>
    <smlr:PercentageOfProbabilityOfChangeOfControl
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Narr_H8oAJZMGo0eIx6GZdSWS6g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.75</smlr:PercentageOfProbabilityOfChangeOfControl>
    <smlr:PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Narr_3hUpWdxzz0GYoX6KLTFPDw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.20</smlr:PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent>
    <us-gaap:DebtSecurities
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_xk87vLkdLEufyp3poIPJxQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:DebtSecurities>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_s-UG3RevAk-rU0_MNUEWnQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.1%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3.94%-5.26%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cashflow discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;27.8&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected term in years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.25-2.92&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;120%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_PxnEcaDrekmg5pbwORI6uA"
      decimals="4"
      id="Narr_dJkGze4q3kqZCRsXNqfbZw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0394</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_WP1fZf0Tz0eBBidX-O4OKw"
      decimals="4"
      id="Narr_8nlXgOFJnEuVXXg3aw0AYQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0526</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_zHwOkX4VfkWPEeVs-Z6SyQ"
      decimals="1"
      id="Tc_fj1NvmCgZEeRrezxz6Rfcg_4_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">27.8</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_aDCxvJtt3Eygu9BuFeJ9gg"
      decimals="2"
      id="Narr_A2fAlzj7D0G17BkCYFLK2A"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.25</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="As_Of_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_5rkmbl4o0EOgcPQtPW8OMA"
      decimals="2"
      id="Narr_GQhv3QO_6kOaXygAr3UWvQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">2.92</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="As_Of_12_31_2023_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputPriceVolatilityMember_f78XzEjJR0SR98o4mMWU-w"
      decimals="0"
      id="Tc_44oxUHA9DUyJ9BVCofKFVA_6_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">120</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_MkQ9AF2ZGEW-xNkzwkI2wQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.11%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Convertible Notes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Balance as of December 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Purchased &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Change in fair value of the notes held for investment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 128&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:79.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Balance as of December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="As_Of_12_31_2023_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_x1XWviIRvEuBTZOXDrOPnA"
      decimals="-3"
      id="Tc_JcajdmyhL06sTvcxwmGkzw_2_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_ozb1tohPX0S-2MLZNTW-lw"
      decimals="-3"
      id="Tc_J8UbxTtAJkuaz9Yke5oiBw_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_ozb1tohPX0S-2MLZNTW-lw"
      decimals="-3"
      id="Tc_SUfU1hLIzk2poWes8tQijA_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">128000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="As_Of_12_31_2024_us-gaap_FairValueByAssetClassAxis_us-gaap_DebtSecuritiesMember_Y3YjBPtUtEWAFrFVUBX28A"
      decimals="-3"
      id="Tc_iXNaSpbDJ0K2HkJGpqfV0g_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FinancingReceivablesTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_qipC-leulU2gEjNzw2-JYg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;8.    Notes held for investment&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Notes receivable consist of the following for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Senior secured promissory notes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Secured convertible promissory notes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total notes held for investment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"&gt;In June 2022, the Company loaned Mellitus an aggregate of $1,000&#160;through the purchase of&#160;two&#160;senior secured promissory notes that bear interest at a rate of&#160;5% per annum, and mature in&#160;three years&#160;&lt;span style="white-space:pre-wrap;"&gt;unless accelerated due to an event of default as provided in the notes. Repayment of notes is secured by a first priority interest in all of Mellitus&#x2019; assets.  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;In December 2022, the Company entered into a senior convertible promissory note (also referred as debt security) arrangement with Monarch, providing Monarch with up to &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,000&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;in available funding, of which &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, in principal was drawn as of December 31, 2024. The Monarch debt security accrues interest at&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;10%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; per annum, payable monthly, and the principal balance was originally due December 6, 2024, with such due date extended to January 17, 2025 (refer to note 20 for additional information). The note along with up to &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$100&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;of transaction expenses is due and payable on the occurrence of an event of default or change of control unless accelerated due to the conversion into preferred stock prior thereto at the option of the Company. The Company has the option to extend the maturity date for&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;two&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;consecutive&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;one-year&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; terms. The Monarch debt security can be converted into Monarch&#x2019;s shares at the Company&#x2019;s option upon (a) an equity financing at Monarch, (b) upon a change of control at Monarch, or (c) at the Company&#x2019;s option at any time prior to the maturity date. If converted upon a change of control, the Company has the right to receive a cash payment equal to the balance of the Monarch debt security or the amount payable upon conversion into Monarch&#x2019;s shares. The Monarch debt security is redeemable at any time at Monarch&#x2019;s option or automatically upon an event of default (as defined in the note)&lt;/span&gt;. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;The Company made an irrevocable election to account for the Debt Securities using the fair value option under ASC 825 &#x2013; &lt;i style="font-style:italic;"&gt;Financial Instruments&lt;/i&gt; (&#x201c;ASC 825&#x201d;) and will measure the fair value of the Debt Securities in accordance with ASC 820. The Company made the fair value option election to present the Debt Securities in its entirety at fair value, which it &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;believes to be preferable to recognizing the host instrument at fair value under ASC 320 and potentially separately recognizing certain embedded features as bifurcated derivatives under ASC 815. As of December 31, 2024, the Company assessed and estimated the fair value of the Debt Security of Monarch to be $5,000 and Mellitus senior secured promissory notes to be $1,000. A&lt;span style="background:#ffffff;"&gt;s of December 31, 2023, the Company estimated the fair value of the Monarch debt security to be &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$4,372&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The Company recognizes interest income on the Monarch debt security, which is included in interest and dividend income in the statements of income. Accrued interest on the Monarch convertible promissory note was included in prepaid and other current assets. For the year ended December 31, 2024 and 2023, the Company recognized &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$483&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$449&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively, of interest income from Monarch debt security. The Company recognizes changes in fair value of the notes in the statements of income separately from the interest income. For the year ended December 31, 2024 and 2023, the Company recorded&#160;a change in fair value of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$128&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$307&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively, for the Monarch debt security&lt;/span&gt;.&lt;/p&gt;</us-gaap:FinancingReceivablesTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_OtfOn2ybBkK-rOnrLvDslQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Senior secured promissory notes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Secured convertible promissory notes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:66.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total notes held for investment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,100&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,372&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_g8RrY9ouOk6oIzBWDC62Bg"
      decimals="-3"
      id="Tc_wY8W0iUUTE-IzhJiWBH2Dg_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_gI7SLj8d7kuf0rI7GEXCEg"
      decimals="-3"
      id="Tc_plR0m_jG2kaZm_SlaNmgXQ_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_nLhO4YNRgkCweluz_hqEUw"
      decimals="-3"
      id="Tc__pKRgsizOE-XSHaSCA2uKQ_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5100000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_12_31_2023_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_crjDA4QUWkmjptpBegjFlA"
      decimals="-3"
      id="Tc_QE_-pQ2HMke1WdZ8kmEdOg_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_Mk7wlcAvOki4rmLbaVrHug_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6100000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_W6E_g68CPE-1Rm3Kns-lzg_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5372000</us-gaap:NotesReceivableNet>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag"
      decimals="-3"
      id="Narr_-iRPAQv6k06MCAusJtflCg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</us-gaap:PaymentsToAcquireNotesReceivable>
    <smlr:NumberOfNotesReceivable
      contextRef="As_Of_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_L_t0elWRT0eyWfqFYrXTgw"
      decimals="INF"
      id="Narr_8lILxu1eZUyg-mteSKiNWA"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">2</smlr:NumberOfNotesReceivable>
    <smlr:NotesReceivableInterestBearingInterestRate
      contextRef="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag"
      decimals="2"
      id="Narr_pdvRRGrJskyyHYCR5guviQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.05</smlr:NotesReceivableInterestBearingInterestRate>
    <smlr:NotesReceivableTerm
      contextRef="Duration_6_1_2022_To_6_30_2022_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_9EfkJJzmuk6DqfuNJjrmag"
      id="Narr_4gE_x-G2lki-OfQxywfoDA">P3Y</smlr:NotesReceivableTerm>
    <smlr:DebtSecurityMaximumAmountOfAvailableFunding
      contextRef="As_Of_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_pgr5YBHMBk-EMl7wkzobAA"
      decimals="-3"
      id="Narr_d1Clnv_mx0KFBcIVhLy1Ow"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000000</smlr:DebtSecurityMaximumAmountOfAvailableFunding>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_muDgxFIJQE6WabppUkvg4A"
      decimals="-3"
      id="Narr_Ns9NaqCOtE-3Foz2MiZ5lw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000000</us-gaap:PaymentsToAcquireNotesReceivable>
    <smlr:DebtSecurityInterestRate
      contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA"
      decimals="2"
      id="Narr_Q67_15OEXUOW-YaIU5Z2Og"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.10</smlr:DebtSecurityInterestRate>
    <smlr:DebtSecuritiesTransactionFee
      contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA"
      decimals="-3"
      id="Narr_3oY38ZgLH0efqJK-2R9f6Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">100000</smlr:DebtSecuritiesTransactionFee>
    <smlr:NumberOfConsecutiveTermsOptionToExtendMaturityDate
      contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA"
      decimals="INF"
      id="Narr_O4FbiS03NEePWza69nypgQ"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">2</smlr:NumberOfConsecutiveTermsOptionToExtendMaturityDate>
    <smlr:ExtensionPeriodOptionToExtendMaturityDate
      contextRef="Duration_12_1_2022_To_12_31_2022_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_rhRMn_o_K0uu-D5YTO_sTA"
      id="Narr_g05k_VFHCk-B9U-PC1OIuQ">P1Y</smlr:ExtensionPeriodOptionToExtendMaturityDate>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="As_Of_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_BtMLgU4xhEumEB1mwGdN_A"
      decimals="-3"
      id="Narr_pKfg70i2ZkyPY6Vy0fEtOg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:LongTermInvestments
      contextRef="As_Of_12_31_2024_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SeniorSecuredPromissoryNotesMember_us-gaap_InvestmentTypeAxis_smlr_InvestmentInPrivateCompanyThreeMember_cSzr6YVDeUWRSAU2M9evow"
      decimals="-3"
      id="Narr_mRNSPDq6Y0iWrRoQ2Hf-tA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</us-gaap:LongTermInvestments>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="As_Of_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_Eph_Oj-oC0KZYpPYtIryAA"
      decimals="-3"
      id="Narr_TCbOwmp7vEeUmV0jMfq6oQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4372000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <smlr:DebtSecurityInterestIncome
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_Rh4a9Te3jEaCuJOiaJbaeQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">483000</smlr:DebtSecurityInterestIncome>
    <smlr:DebtSecurityInterestIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_8k30niYTokyWzFAkCVFNEQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">449000</smlr:DebtSecurityInterestIncome>
    <smlr:DebtSecurityChangesInFairValue
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_FPkR1egt1k-R8EHqo0rVVg"
      decimals="-3"
      id="Narr_vtVaOKIhyEGbplgfbOnBJQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">128000</smlr:DebtSecurityChangesInFairValue>
    <smlr:DebtSecurityChangesInFairValue
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_PWcdPDmgeEWckhHocD2-3Q"
      decimals="-3"
      id="Narr_OuZd5MOm2UCzlHyKwwFidg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">307000</smlr:DebtSecurityChangesInFairValue>
    <us-gaap:CryptoAssetTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_Xrwe2Q3Ce0KaPPrClDy0eQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;9.&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;Intangible Digital Assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"&gt;In May 2024, the Company announced that its board of directors adopted bitcoin as its primary treasury reserve asset. Under this new treasury strategy, the Company purchases and holds bitcoins for long term investment purposes. The Company accounts for its bitcoin as an indefinite-lived intangible asset in accordance with ASC 350, &lt;i style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other&lt;/i&gt; and has ownership of and control over its bitcoin, which are included in Intangible digital assets in the Balance Sheets. As of December 31, 2024, there were no contractual restrictions on the sale of bitcoins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Bitcoin Investment&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"&gt;The Company early adopted ASU No. 2024-08 in the second quarter of 2024 effective retroactively as of January 1, 2024. See &lt;i style="font-style:italic;"&gt;Recently Adopted&lt;/i&gt; &lt;i style="font-style:italic;"&gt;Accounting Pronouncement&lt;/i&gt; in Note 2 to Financial Statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s bitcoin purchased for investment purpose are initially recorded at cost, inclusive of transaction costs and fees. Subsequently, &lt;span style="-sec-ix-hidden:Hidden_EtskwuOt8E-UAPDIhjG0PQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;the Company remeasures its bitcoin investment&lt;/span&gt;&lt;/span&gt; at fair value at the end of each reporting period with changes recognized in net income through &#x201c;Other income, net&#x201d; in the Company&#x2019;s Statements of Income. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intangible Assets Cost Basis&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;The Company uses average cost for computing capital gains or losses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The following table sets forth the units held, cost basis, and fair value of crypto assets held, as shown on the balance sheet as of December 31, 2024:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Units Held&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost Basis&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Intangible digital assets held:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Third party bitcoin custodians&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;2,298 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;189,700 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Dispositions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,298&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 189,700&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Reconciliation of fair value&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;/span&gt;The following table represents a reconciliation of the fair values of the Company&#x2019;s Intangible digital assets held for the year ended December 31, 2024:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For The Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Intangible digital assets held:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Beginning balance at fair value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 189,700&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Dispositions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Unrealized gain, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 29,766&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Unrealized loss, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,833)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:6pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:CryptoAssetTextBlock>
    <us-gaap:CryptoAssetHoldingTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_3Kzl_t5f6Uy5ycKakBdc-g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The following table sets forth the units held, cost basis, and fair value of crypto assets held, as shown on the balance sheet as of December 31, 2024:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Units Held&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost Basis&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Intangible digital assets held:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Third party bitcoin custodians&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;2,298 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;189,700 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Dispositions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:51.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,298&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 189,700&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CryptoAssetHoldingTableTextBlock>
    <us-gaap:CryptoAssetNumberOfUnits
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Tc_qrktr0OoD0G3R-Zb2ZeDdg_4_1"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">2298</us-gaap:CryptoAssetNumberOfUnits>
    <us-gaap:CryptoAssetCost
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_hZQbmpBx6EykFUWJFtAgog_4_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">189700000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_Gwvpxv6DnUeDAOSy_cDI6w_4_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetNumberOfUnits
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_W7mFGM3-UkiPxP5DZZT9SA_6_1"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2298000</us-gaap:CryptoAssetNumberOfUnits>
    <us-gaap:CryptoAssetCost
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_uG0Dn5EAx02zPvEl3PuNZA_6_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">189700000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_lZqdYnyBhkSP3crf69uRAQ_6_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetActivityTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Group_-CCdZ9x4SE-h9YmHfEjoAQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For The Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Intangible digital assets held:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Beginning balance at fair value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 189,700&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Dispositions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Unrealized gain, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 29,766&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Unrealized loss, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,833)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:20.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 214,633&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:6pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:CryptoAssetActivityTableTextBlock>
    <us-gaap:CryptoAssetAddition
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_Xc8hgurHuUyOuBVd781GJw_8_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">189700000</us-gaap:CryptoAssetAddition>
    <us-gaap:CryptoAssetUnrealizedGainNonoperating
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_ZsHz1EIdfkuQiGOsyaZ-Ww_10_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">29766000</us-gaap:CryptoAssetUnrealizedGainNonoperating>
    <us-gaap:CryptoAssetUnrealizedLossNonoperating
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_bmg4_soWH0esROHui8grXA_11_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4833000</us-gaap:CryptoAssetUnrealizedLossNonoperating>
    <us-gaap:CryptoAssetFairValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_vK7clI7JRU2zB0MFAJ0I_A_12_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValue>
    <smlr:OtherNoncurrentAssetsTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_OvZoZn-zq0iVcrTmOQdYmw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;background:#ffffff;"&gt;10.&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;Other non-current assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Other non-current includes right-of-use asset (&#x201c;ROU&#x201d;) of&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$65&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and long-term deposits of&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$20&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;as of December 31, 2024. As of December 31, 2023, &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_xVAitRPWgkWwaTzZPw38ow;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;ROU asset&lt;/span&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$150&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and miscellaneous receivable of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$100&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; and long term deposits balances of&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$20&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</smlr:OtherNoncurrentAssetsTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_WS_aR4S4NkWyH7D02XCpEQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">65000</us-gaap:OperatingLeaseRightOfUseAsset>
    <smlr:LongTermDeposits
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_3mr9dZHbXE25-Wk9-JY0QA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20000</smlr:LongTermDeposits>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_kSYJ2qDW9E2h6FjtonD8HA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">150000</us-gaap:OperatingLeaseRightOfUseAsset>
    <smlr:MiscellaneousReceivables
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_qN8Xsj-WxkaicAUl3qyToQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">100000</smlr:MiscellaneousReceivables>
    <smlr:LongTermDeposits
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_I4qtNgcyzEa3JSfrLMvFDw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20000</smlr:LongTermDeposits>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_RbPeXPPi3Euyp5C6_FKQtg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;11.&#160;&#160;&#160;&#160;Accrued Expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Accrued expenses consist of the following:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 3,743&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 2,008&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued Taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 1,991&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Miscellaneous Accruals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 521&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 503&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Accrued Expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 5,173&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,502&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_WFlucVv61kehFs8H1Esyuw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 3,743&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 2,008&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued Taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 1,991&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Miscellaneous Accruals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 521&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 503&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total Accrued Expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.88%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 5,173&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 4,502&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_hR0P8Fat0Eix2yXqbtTO0A_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3743000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_h1VW7hLc7UynlPC6qEOW7A_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2008000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_xWv8nhNIUE2wE0RZxPxsZQ_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">909000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_7k6pAywnG0GDCkUdk4JVZg_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1991000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_NEWJsmDqTEKMMqxcWocLDg_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">521000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_mvjyaPs9F0OsW56yOzoOCA_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">503000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_jtJ05fU7dkGr58Kahe9DhQ_6_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5173000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_rN1RHJLfKEG2NJ6n4-xc-A_6_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4502000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_gQWIRwatUEqmUZ_h-qS0dQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;12.&#160;&#160;&#160;&#160;Concentration of Credit Risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash, bitcoins and accounts receivable.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company maintains cash with major financial institutions. The Company&#x2019;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. &lt;span style="background:#ffffff;"&gt;The cash and cash equivalents also includes U.S. government money market fund accounts. As of December 31, 2024, the Company held deposits of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$5,314&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, which exceeded federal deposit corporation limits. The Company also invested in U.S. government money market accounts of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$3,638&lt;/span&gt;. The Company holds 2,298 bitcoins as of December 31, 2024, valued at $214,633. As of December 31, 2024, two providers accounted for 60% and 40% of the Company&#x2019;s total bitcoin holdings. &lt;span style="background:#ffffff;"&gt;Our bitcoins are held offline in cold storage with &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;multiple third-party providers. &lt;/span&gt;The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the&#160;year ended December&#160;31, 2024, two customers (including affiliates) accounted for 43.1% and 27.6% of the Company&#x2019;s revenue. For the year ended December 31, 2023, two customers accounted for 36.0%, and 34.9% of the Company&#x2019;s revenue. As of December 31, 2024, three customers accounted for 33.9%, 28.7% and 14% of the Company&#x2019;s accounts receivable. As of December 31, 2023, three customers accounted for 27.5%, 27.5% and 23.6% of the Company&#x2019;s accounts receivable.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;As of December 31, 2024, three vendors accounted for 29.4%, 16.7 and $15.6% of the Company&#x2019;s accounts payable. As of December 31, 2023, two vendors accounted for 24.0% and 10.1% of the Company&#x2019;s accounts payable.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:TimeDepositsAtCarryingValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_BLi4wal8TU2qJlNznifx4A"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5314000</us-gaap:TimeDepositsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_Zbq3fmm4LUu-rSiK1-ktmg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3638000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:CryptoAssetNumberOfUnits
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_GzWStsRoaEiwUTYl3FM7JA"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">2298</us-gaap:CryptoAssetNumberOfUnits>
    <us-gaap:CryptoAssetFairValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_pQXbct47YUOmLSDe5j017w"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">214633000</us-gaap:CryptoAssetFairValue>
    <smlr:ConcentrationRiskCryptoAssetNumberOfProviders
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_PHgDVn-5Okel_mz_sU2Iaw"
      decimals="INF"
      id="Narr_YfCEuzK1B0WpdP0wIpPtaQ"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">2</smlr:ConcentrationRiskCryptoAssetNumberOfProviders>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_264-qjtGnkenys3niqGP3A"
      decimals="2"
      id="Narr_r_yO2fQ6_EiIZtr0EZUDOQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_CounterpartyNameAxis_smlr_CryptoAssetProviderTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_smlr_IntangibleDigitalAssetBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_smlr_InvestmentHoldingConcentrationRiskMember_Ii5xiNTqQk2AGTOsoCMLWA"
      decimals="2"
      id="Narr_30oO9pNHM0G-vJ1nGeF69w"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.40</us-gaap:ConcentrationRiskPercentage1>
    <smlr:ConcentrationRiskNumberOfCustomers
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_fFOkoCt7H0Slv5JGrDqlBg"
      decimals="INF"
      id="Narr_WYAXHKtfX0qX2WLMn-pvsA"
      unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w">2</smlr:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HyuAP9W00kqM60O3G6Ge3A"
      decimals="3"
      id="Narr_qjvV2nUEckyaokrA7nXe9g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.431</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_jjGYmF79EUmReh8pp371Ww"
      decimals="3"
      id="Narr_6u8JeA3TwUmq92hd5A5NBw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.276</us-gaap:ConcentrationRiskPercentage1>
    <smlr:ConcentrationRiskNumberOfCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tugyvnYiKEKXu7Ct7IkWtg"
      decimals="INF"
      id="Narr_i55N87bwAk6XsecdQfFdgA"
      unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w">2</smlr:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_xdNkBEAT8k670omsTTSlEA"
      decimals="3"
      id="Narr_xRES-WxAakSC4UOYsfN8IA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_gghWsAhy2kyMxuzQyS23Xw"
      decimals="3"
      id="Narr_br6CPmAfBESiPgpgNgV2ow"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.349</us-gaap:ConcentrationRiskPercentage1>
    <smlr:ConcentrationRiskNumberOfCustomers
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HybD8uTHQkyIAhllhH3uCA"
      decimals="INF"
      id="Narr_83k2ItPEoEKkCVY1UNyNlw"
      unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w">3</smlr:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_GNA9FYtql0C57IuiRvUncQ"
      decimals="3"
      id="Narr_skIgfuVuDEWSH0_TrNp2tQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.339</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mGWVZoMD_0y5pa9bpBTRRg"
      decimals="3"
      id="Narr_RODX1U3a9ka3bTghK7249g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.287</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_sK_zCKyn3kegXLMJPUXfnw"
      decimals="3"
      id="Narr_LorTIn7t10S7Z9aOaDwWYg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.14</us-gaap:ConcentrationRiskPercentage1>
    <smlr:ConcentrationRiskNumberOfCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kPVNPU9aQEmGmH7B8LA6Hg"
      decimals="INF"
      id="Narr_RVnPSajnM0qY4W9WfPBwdg"
      unitRef="Unit_Standard_customer_wzEXmoTARkafwb4CW__c-w">3</smlr:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerOneConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_mhgf8VqFf0-ZFpiL5hlFcA"
      decimals="3"
      id="Narr_pV5I_UsNykW73pyxRcxHGw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.275</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerTwoConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kWVgDU2vA0uq6eMrmrdy-g"
      decimals="3"
      id="Narr_FLbkPcDSx0yBGGUSuh34Bw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.275</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_CustomerThreeConcentrationRiskMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Y3y-lLd5iky9-ATGWL0gvg"
      decimals="3"
      id="Narr_uRVz-B-qkkytFBltWrMv_g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.236</us-gaap:ConcentrationRiskPercentage1>
    <smlr:ConcentrationRiskNumberOfVendors
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_a8zmf1i8pUefeL-g8olIgA"
      decimals="INF"
      id="Narr_v8mgg1XhdECqyLx7RqNMkQ"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">3</smlr:ConcentrationRiskNumberOfVendors>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_etSv0JRJJUqLQpa2cgChVA"
      decimals="3"
      id="Narr_sV7oSOU6oUW5VK1HNEZ3DQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.294</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_652Bp3qhNUmUqYY-FX1Hug"
      decimals="3"
      id="Narr_ssF1pri1dkqQpP494udN3A"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.167</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_smlr_VendorThreeMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_UUFOL2wzP06GTw4gaa2_sg"
      decimals="3"
      id="Narr_9OnOauWsXUq3vc338bKidg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.156</us-gaap:ConcentrationRiskPercentage1>
    <smlr:ConcentrationRiskNumberOfVendors
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H35aj8_a3U6JSHnHW9KxbQ"
      decimals="INF"
      id="Narr_BwKME-b4ck6TqD2CLUIx5w"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">2</smlr:ConcentrationRiskNumberOfVendors>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorOneMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_O9-jwnOv6kOR0Av4_jnsew"
      decimals="3"
      id="Narr_OWMGdosc5kqyLDSsSk47rQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_smlr_VendorTwoMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_H04TlYqfWUuaMfxorUQLQA"
      decimals="3"
      id="Narr_0BJqG6c9BUuCfc97tHjiYA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.101</us-gaap:ConcentrationRiskPercentage1>
    <smlr:LeaseDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_lvRo7MEnH0Su3AEf2LoPbw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;13.&#160;&#160;&#160;&#160;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Lessee Arrangements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On July 31, 2020, the Company entered into a 61-month lease agreement for office space to use, as necessary, for office administration, lab space and assembly and storage purposes, located in Santa Clara, California. The Company took possession of the leased office space in September 2020, and the lease is effective through September 30, 2025. The discount rate determined for this lease was 2.5%.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2024, the remaining lease term is nine months with no options to renew. The Company recognized facilities lease expenses of $88 and $88 for the years ended December 31, 2024 and 2023, respectively. The following table summarizes the future minimum rental payments required under operating leases that had initial or remaining non-cancelable lease terms greater than one year as of December 31, 2024:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total undiscounted future minimum lease payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less: present value discount&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease expense in excess cash payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total ROU asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 65&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2024, the Company&#x2019;s &lt;span style="-sec-ix-hidden:Hidden_ZCznBrDkRkiZHIq0TZrasQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;ROU asset&lt;/span&gt;&lt;/span&gt; was $65, which is recorded on the Company&#x2019;s balance sheet as other non-current assets, and the Company&#x2019;s &lt;span style="-sec-ix-hidden:Hidden_2GncPSotZkeJ6j2K3RM9Gw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;current&lt;/span&gt;&lt;/span&gt; lease liabilities were $70, which were recorded on the Company&#x2019;s balance sheet as other short-term liabilities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Lessor Arrangements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company enters into contracts with customers for the Company&#x2019;s QuantaFlo&lt;sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;"&gt;&#xae;&lt;/sup&gt; product. The Company has determined these contracts meet the definition of a lease under Topic 842. The lease portfolio primarily consists of operating leases that are short-term in nature (monthly, quarterly or one year, all of which have renewal options). The Company made an accounting policy election to apply the practical expedient to not separate lease and eligible non-lease components. The lease component is the predominant component and consists of fees charged for use of the equipment over the period of the arrangement. The nature of the eligible non-lease component is primarily software support. The assets associated with these leasing arrangements are separately identified in the Balance Sheet as Assets for Lease and separately disclosed in Note 3 to the financial statements. During the year ended December 31, 2024 and 2023, the &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;Company recognized approximately $27,488 and $37,262, respectively, in lease revenue related to these arrangements, which is included in revenues on the Statements of Income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Variable-fee Revenue&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company recognizes revenues from variable-fee licenses (e.g., fee per test) and sales of hardware equipment and accessories in accordance with Topic 606. Total revenues from variable-fee licenses were approximately $25,955 and $28,992 for the years ended December 31, 2024 and 2023, respectively. Total revenues from sales of hardware and equipment accessories were approximately $2,851 and $1,930 for the years ended December 31, 2024 and 2023, respectively.&lt;/p&gt;</smlr:LeaseDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ"
      id="Narr_by0AEV5Yp0SVNNnf7_oybQ">P61M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="As_Of_7_31_2020__CdXShlhGUeChprMSlx1OQ"
      decimals="3"
      id="Narr_DnqYnWfwe0SxZBvkNpQrHg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.025</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      id="Narr_5fXENHGg3kqicezf2Mo4Zw">P9M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Narr_ka8ZBvFlIEWFg19yWKo34Q">false</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <us-gaap:OperatingLeaseCost
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_bU99oNPjY0GJq8CH7DdTOw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">88000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_84a9J6gfgEy_spRvaRXLWw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">88000</us-gaap:OperatingLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_jjveoyylTU-7aCiA3LVLIw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total undiscounted future minimum lease payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less: present value discount&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lease expense in excess cash payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total ROU asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0.05pt 0pt;"&gt; 65&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_aMpQ9yszZkSamL5rj-Hyiw_2_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">71000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_oASUWk7ohUGfaVCpxYBe_w_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">71000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_sXdk1GOcDUmpgCQHk9WyCA_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_sXQwvcphQUWkTftp200tpQ_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">70000</us-gaap:OperatingLeaseLiability>
    <smlr:OperatingLeaseExpensesInExcessOfCashPayments
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_afJzKOy8k0CKxNpR3eNxzw_6_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5000</smlr:OperatingLeaseExpensesInExcessOfCashPayments>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_IPirrrqijkOunRQEpe5n9g_7_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">65000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_bZBTUMncV0yIY6RMyZd4Rg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">65000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_O16tMEFqdEmNmPYJ3ASq7Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">70000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LeasePracticalExpedientLessorSingleLeaseComponent
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      id="Narr_r47F3pww2EGERAeNLoStzQ">true</us-gaap:LeasePracticalExpedientLessorSingleLeaseComponent>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_O-yLR2ifFU6oPx1GH0DRbA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">27488000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_EFvbOBtljkW9yynBIlB8qA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">37262000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_9jTkgd0xkk2GcnNC7Hekew"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">25955000</us-gaap:VariableLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_u_SXuWbvJkefT0reI-8G_w"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">28992000</us-gaap:VariableLeaseIncome>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_i0Lr5RQO2UCikpmf-bDzTQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2851000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_q0eUmdANaka4EyKkT5RDRw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1930000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_z7l0-eOGhUKGxBR0x1_Hyw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;14.&#160;&#160;Commitments and Contingencies&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Indemnification Obligations&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company&#x2019;s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company&#x2019;s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company is subject to various state sales and use tax audits and believes its current exposure could result in an estimated liability of up to $500. The Company did not record such estimated liability as of December 31, 2024, as it was not determined to be probable.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;background:#ffffff;"&gt;Legal Matters&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;From time to time, the Company may be subject to legal proceedings and claims in the ordinary course of business. The Company is not currently a party to any litigation the outcome of which, if determined adversely to it, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business, operating results, cash flows or financial condition.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;In July 2017, the Company received an initial civil investigative demand (&#x201c;CID&#x201d;) from the U.S. Department of Justice (&#x201c;DOJ&#x201d;) pursuant to the federal False Claims Act investigating whether the Company and others may have violated the False Claims Act by marketing tests on devices that use photoplethysmography technology as reimbursable by Medicare in alleged contravention of applicable laws and regulations.&#160;The Company cooperated with the investigation, along with subsequent CIDs received in February 2019, December 2021, April 2022 and April 2023 addressed to the Company or individual current or former employees related to the same investigation. In September &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;2024, DOJ shared certain information to which the Company responded in January and February 2025. On February 6, 2025, DOJ asked if the Company wished to engage in settlement discussions to resolve any potential claims by February 11, 2025 and if so that the Company make a settlement offer by such deadline.&#160;Prior to February 6, 2025, DOJ had not stated an intention to pursue a claim of wrongdoing against the Company.&#160;On February 11, 2025, the Company began initial settlement discussions with DOJ, but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.&#160;The Company does not believe the amount of loss can be reasonably estimated. The Company intends to vigorously defend itself in any such action.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <smlr:IncomeTaxExaminationsMaximumEstimatedLiability
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_ci1pTc7x5E6dr66bRdQgvw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">500000</smlr:IncomeTaxExaminationsMaximumEstimatedLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_FxEkMbVJMkqw3UaDhe6zTw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;15.&#160;&#160;Stockholders&#x2019; Equity&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has 50,000,000 authorized shares of capital stock, all of which are designated as common stock with par value of $0.001 per share.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"&gt;Each holder of shares of common stock is entitled to one vote for each share held.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;At-the-Market Offering&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On August 24, 2024, the Company&#x2019;s registration statement on Form S-3 became effective, which allowed it to offer and sell securities from time to time in one or more offerings, up to an aggregate value of $150.0 million, including under its June 2024 Controlled Equity Offering&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;SM&lt;/sup&gt; Sales Agreement with Cantor Fitzgerald &amp;amp; Co., pursuant to which the Company may offer and sell from time to time its common stock in an at-the-market (&#x201c;ATM&#x201d;) offering. &lt;span style="background:#ffffff;"&gt;Pursuant to this agreement, the Company agreed to pay the sales agent commissions for their services in acting as agent with respect to the sale of shares through the ATM offering program.&lt;/span&gt; &lt;span style="background:#ffffff;"&gt;The sales commission and expenses related to each of the ATM equity offering program are considered direct and incremental costs and are charged against &#x201c;Additional paid-in capital&#x201d; on the Balance Sheet in the period in which the corresponding shares are issued and sold.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"&gt;Through December 31, 2024, the Company had issued and sold a total of 2,197,988 shares of its common stock for aggregate gross proceeds of approximately $119.6 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Treasury Stock Acquired&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"&gt;On March 14, 2022, the Company&#x2019;s Board of Directors authorized a share repurchase program under which it may repurchase up to&#160;$20.0&#160;million of its outstanding common stock. Under this program the Company&#160;may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans or through the use of other techniques such as accelerated share repurchases. The timing and amount of any transactions will be subject to the discretion of the Company based upon market conditions and other opportunities that it may have for the use or investment of its cash balances. The repurchase program has no expiration date, does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. No purchases were made during the years ended December 31, 2024 and 2023.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Warrants Acquired- Related Party Transaction&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;On May 17, 2023, the Company repurchased outstanding warrants to acquire 76,875 shares of common stock from its chief executive officer at a cost of $1,949. The warrants, which were originally issued on June 7, 2012 (16,875&#160;shares) with an exercise price of $4.00&#160;per share and on July 31, 2013 (60,000&#160;shares), with an exercise price of $4.50&#160;per share, were amended in September 2015 and, as amended, had an expiration date of July 31, 2023. The $1,949&#160;aggregate cash purchase price reflects the difference between the aggregate exercise price of the warrants and the aggregate fair market value of the shares of common stock underlying the warrants, based on the closing price of a share &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;of the Company&#x2019;s common stock on May 16, 2023, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrants were cancelled and are no longer issued and outstanding.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_WqAvDLEbskywy_xtdHCZ_A"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_xEkwWRbR3UaybTpfF7ZBBA"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <smlr:NumberOfVotesForEachShare
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Narr_2flBQ1ZZx0upDiTNCQ654A"
      unitRef="Unit_Standard_Vote_fmvi7R5wJUe0Kn3AIo8T4g">1</smlr:NumberOfVotesForEachShare>
    <smlr:SaleOfStockValueAuthorized
      contextRef="As_Of_8_24_2024_UDRPHzEdyk6NV0QD-mKyjA"
      decimals="-5"
      id="Narr_jP4OQgDVakinuUx52H_Jng"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">150000000</smlr:SaleOfStockValueAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_SubsidiarySaleOfStockAxis_smlr_AtMarketOfferingMember_YtursobFMki79XI5UpMKsQ"
      decimals="INF"
      id="Narr_P-NcjuFcX0SSpf7ZY51ORw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">2197988</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_SubsidiarySaleOfStockAxis_smlr_AtMarketOfferingMember_YtursobFMki79XI5UpMKsQ"
      decimals="-5"
      id="Narr_vhZed-Yn6U61_4SLZ_MWOw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">119600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <srt:StockRepurchaseProgramAuthorizedAmount1
      contextRef="As_Of_3_14_2022_kTG5qkwiMUq6Eg2gYGvIGw"
      decimals="-5"
      id="Narr_6nSLbjHBykeATWnJibJXMQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="INF"
      id="Narr_KjKenVaUPkG603Y04vIxbA"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Narr_TP4Qg0-nnkae01mZwWN9nQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_AUjfPFddUEiqVflwrXAltw"
      decimals="INF"
      id="Narr_hJcDkfmxtUOxCPmHKLJMbg"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">76875</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <smlr:ClassOfWarrantOrRightValueRepurchased
      contextRef="Duration_5_17_2023_To_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_GRfbzrpKSkafNwd0txmuIg"
      decimals="-3"
      id="Narr_NPuuvTXzeECaVsgmaWDTDA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1949000</smlr:ClassOfWarrantOrRightValueRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_6_7_2012_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_nK7KeWh1p0uNi8atNqQgfg"
      decimals="INF"
      id="Narr_s3e0iKkgY0qAqr_D6c1WwQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">16875</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_6_7_2012_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_nK7KeWh1p0uNi8atNqQgfg"
      decimals="2"
      id="Narr_v1fqXWPvQE200eoIDY4pJQ"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">4</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="As_Of_7_31_2013_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_ZY7-89lwZU2bZhYnLrUgKg"
      decimals="INF"
      id="Narr_hvJUi2B_wEO2yJXQVYg3Iw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">60000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_7_31_2013_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_ZY7-89lwZU2bZhYnLrUgKg"
      decimals="2"
      id="Narr_-4jgk4mf30GFSjC3L9NbOw"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">4.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <smlr:ClassOfWarrantOrRightValueRepurchased
      contextRef="Duration_5_17_2023_To_5_17_2023_us-gaap_ClassOfWarrantOrRightAxis_smlr_CommonStockWarrantsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_GRfbzrpKSkafNwd0txmuIg"
      decimals="-3"
      id="Narr_URnexX5h2UCeEW4YQgDarw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1949000</smlr:ClassOfWarrantOrRightValueRepurchased>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_18LmXezipkSmI_71vKTzXg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;16.&#160;&#160;Stock Option Plan&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s stock-based compensation program is designed to attract and retain certain key employees while also aligning employees&#x2019; interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2014 Stock Incentive Plan (&#x201c;2014 Plan&#x201d;). Our board of directors adopted the 2024 Stock Option and Incentive Plan (the &#x201c;&lt;span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"&gt;2024 Plan&lt;/span&gt;&#x201d;) on August 14, 2024 and stockholder approval of the 2024 Plan became effective in October&#160;2024. In connection with expiration of the 2014 Plan in July 2024, the available share reserve (including any awards outstanding under the 2014 Plan that lapsed prior to stockholder approval of the new 2024 Plan) were transferred to the 2024 Plan upon stockholder approval thereof. The 2024 Plan provided that the aggregate number of shares of common stock that initially may be issued pursuant to awards granted under the 2024 Plan may not exceed 1,916,011 shares (the &#x201c;Share Reserve&#x201d;), along with any awards that transfer over from the 2014 Plan. In addition, the Share Reserve automatically increases on January 1st of each&#160;year, for a period of not more than 10&#160;years, beginning on January 1st of the&#160;year following the&#160;year in which the 2024 Plan became effective and ending on (and including) January 1, 2034, in an amount equal to 4% of the total number of shares of common stock outstanding on December&#160;31st of the preceding calendar&#160;year. The Company&#x2019;s board of directors may act prior to January 1st of a given&#160;year to provide that there will be no January 1st increase in the Share Reserve for such&#160;year or that the increase in the Share Reserve for such&#160;year will be a lesser number of shares of common stock than would otherwise occur. The Share Reserve is currently 3,172,399 shares as of December&#160;31, 2024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In light of stockholder approval of the 2024 Plan, the Company no longer grants equity awards under the 2014 Plan. As of December&#160;31, 2024, there were no shares available for future stock-based compensation grants under the 2014 plan. 2,155,895 shares of an aggregate total of 3,172,399 shares, are available for future stock-based compensation grants under the 2024 Plan.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Aggregate intrinsic value represents the difference between the closing market value as of December&#160;31, 2024 of the underlying common stock and the exercise price of outstanding options. A summary of the Company&#x2019;s stock option activity and related information for 2024 and 2023 is as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:60.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&#160;Outstanding&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Remaining&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intrinsic&#160;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Outstanding&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercise Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Term&#160;(In&#160;Years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In&#160;Thousands)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance, December 31, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,021,785&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3.84&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; 3.76&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 41,333&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 173,700&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 23.04&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options forfeited/cancelled&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (6,650)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (497,385)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3.42&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance, December&#160;31,&#160;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 691,450&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8.86&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3.21&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 31,209&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable as of December&#160;31,&#160;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 528,867&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4.43&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1.88&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 26,214&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;As of December 31, 2024,&#160;the fair value of unvested stock options was approximately&#160;$2,315. This unrecognized stock-based compensation expense is expected to be recorded over a weighted average period of&#160;3.35&#160;years.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-family:'inherit';"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#231f20;"&gt;, the Company awarded&#160;stock options of&#160;&lt;/span&gt;&lt;span style="color:#231f20;"&gt;173,700&lt;/span&gt;&lt;span style="color:#231f20;"&gt;&#160;to&#160;employees&#160;as compensation pursuant to the 2014 Plan. Of these &lt;/span&gt;&lt;span style="color:#231f20;"&gt;119,700&lt;/span&gt;&lt;span style="color:#231f20;"&gt; options,&#160;&lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_Tzy6P97uHUaeUF-cBrMSEA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;1/4&lt;/span&gt;&lt;/span&gt;th vest&#160;one&#160;year after the grant date and&#160;&lt;span style="-sec-ix-hidden:Hidden_V32SFWmW3EWJ45UKw92nEg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;1/48&lt;/span&gt;&lt;/span&gt;th for each month thereafter contingent upon the participant&#x2019;s continued service beginning on the initial vesting date and &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;"&gt;ending when the Vested Ratio equals 1/1. Grant date fair value of options granted to the employees for the year ended December 31, 2024 and 2023 was $1,792 and $316, respectively. Also during the year ended December 31, 2024, the Company awarded stock options of 54,000 to members of the board of directors pursuant to the 2014 Plan (the &#x201c;Director Options&#x201d;). Of these options, 1/&lt;span style="-sec-ix-hidden:Hidden_8RoI3HM5VE6VepajHbnVVQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;24&lt;/span&gt;&lt;/span&gt; vested immediately on the date of grant and 1/&lt;span style="-sec-ix-hidden:Hidden_r6U7ShkGaEyl2_KE4RIe3w;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;24&lt;/span&gt;&lt;/span&gt; for each month thereafter contingent upon participant&#x2019;s continued service beginning on the initial vesting date and ending when the vested ratio equals 1/1. The Director Options will be cancelled if not exercised by May 23, 2026. Grant date fair value of options granted to the non-employee directors for the year ended December 31, 2024 and 2023 was $559 and zero, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="color:#212529;"&gt;&#160;&lt;/span&gt;&lt;span style="color:#212529;"&gt;No&lt;/span&gt;&lt;span style="color:#212529;"&gt;&#160;stock-based compensation was capitalized or included in inventories for the years ended&#160;&lt;/span&gt;&lt;span style="color:#212529;"&gt;December 31&lt;/span&gt;&lt;i style="color:#212529;font-style:italic;"&gt;, &lt;/i&gt;&lt;span style="color:#212529;"&gt;2024&lt;/span&gt;&lt;i style="color:#212529;font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;span style="color:#212529;"&gt;and&lt;/span&gt;&lt;i style="color:#212529;font-style:italic;"&gt;&#160;&lt;/i&gt;&lt;span style="color:#212529;"&gt;2023&lt;/span&gt;&lt;i style="color:#212529;font-style:italic;"&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;The fair value of each option grant is estimated using the Black-Scholes option pricing model. The weighted-average assumptions used, and the calculated weighted average fair values of options are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2-7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;4.5%-4.9%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;4.14%-4.41%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;62.3%-77.2%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;69.0%-79.5%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected dividend rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Fair value of options granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$10.35-$14.97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$17.54-$19.04&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Total tax benefit from the exercise of stock options was $4,428 and $2,133 for the years ended December 31, 2024 and 2023, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-style:italic;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;white-space:pre-wrap;"&gt; Stock grants&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company granted 10,500 and 18,048 shares of fully vested stock to employees and board of directors in the year ended December 31, 2024 and 2023, respectively. Grant date fair value of the stock was $300 and $860 for the year ended December 31, 2024 and 2023, respectively. &lt;span style="display:inline-block;width:13.29pt;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has recorded an expense of $862 and $944 as it relates to stock-based compensation for the&#160;years ended December&#160;31, 2024 and 2023, respectively, which was allocated as follows based on the role and responsibility of the recipient in the Company:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cost of Revenues&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 42&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 8&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Engineering and Product Development&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 43&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 53&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Sales and Marketing&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 135&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 317&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;General and Administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 642&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 566&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 862&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 944&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_8_14_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_Hkgpul5BI0mLKNUjZAN8IA"
      decimals="INF"
      id="Narr_yeMuFvWZcESCT2x5uSOHJg"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">1916011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q"
      id="Narr_SuU5bcEljEWST2PRn8cjuQ">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <smlr:PercentageOfSharesReserveIncrease
      contextRef="Duration_10_1_2024_To_10_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_sIz0OcvO7UGv2AJKDirvCA"
      decimals="2"
      id="Narr_MwoL6yT8tkGS3Xj-Kp_NRA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.04</smlr:PercentageOfSharesReserveIncrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ"
      decimals="INF"
      id="Narr_pMErCBdgkkqw-G_QhIaG3Q"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">3172399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_KeyPersonStockOptionPlan2007Member_6IjDjCrPDUm7EkmgVITtGQ"
      decimals="INF"
      id="Narr_8EvDINLeDUOIKsbUlbBJKw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ"
      decimals="INF"
      id="Narr__--N3j_T7EiaVUVTV-kyRA"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">2155895</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ"
      decimals="INF"
      id="Narr_0Tk9vMqv10GTfQYXrrOvOA"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">3172399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_6ebg1ptagk6SsyKFOh_ZSw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:60.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Options&#160;Outstanding&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Remaining&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intrinsic&#160;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Outstanding&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercise Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Term&#160;(In&#160;Years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In&#160;Thousands)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance, December 31, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,021,785&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3.84&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; 3.76&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 41,333&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 173,700&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 23.04&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options forfeited/cancelled&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (6,650)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (497,385)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3.42&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &#x2014;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance, December&#160;31,&#160;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 691,450&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 8.86&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 3.21&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 31,209&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable as of December&#160;31,&#160;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 528,867&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4.43&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; &lt;/b&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1.88&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 26,214&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="INF"
      id="Tc_W6elFDvk1UCnbIkhSPKMow_7_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">1021785</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="2"
      id="Tc_7eHcLQs4K0qjpce1wMPs-g_7_5"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">3.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      id="Tc_yZ8zifOt4UaL6IdVNw8b7g_7_7">P3Y9M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_zivOnEl2mEGcDBomzloPWA_7_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">41333000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Tc_03tVD45RUUu4UXe5IF2Z8w_8_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">173700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Tc_NSXGaMcrBEuBGBEsR8ORJw_8_5"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">23.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Tc_nF6NVoFKI0y2THbxVH_tqQ_9_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">6650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Tc_YI7MFReaW0mpvERHnrEUEA_10_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">497385</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Tc_ewJ-zPPqJ0Cjav3w8wlYCQ_10_5"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">3.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Tc_i7xkmmrTm0Ovrr0h5qRV9w_11_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">691450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="2"
      id="Tc_pO1qCMZVm0eJzxbRVryM2g_11_5"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">8.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_FASgkxWNAEe4CD5MfMmVfQ_11_7">P3Y2M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_LGQ70j_lSkeVs5cKfeyhUw_11_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">31209000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="INF"
      id="Tc_DpesNuPKz0SveS1dpZRUBw_12_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">528867</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="2"
      id="Tc_-US3KoJIZESij-LdWsSINQ_12_5"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">4.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tc_j0dE0eqcQ0SG8LyZZt6tIw_12_7">P1Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_oA_GQEAte0ul8V5jHeGQLQ_12_10"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">26214000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="As_Of_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_4-sv2zGUSE-Uy1ZzDpkshQ"
      decimals="-3"
      id="Narr_a8Gk8CwRO0aBcGQ28xS7VQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2315000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q"
      id="Narr_hEYBylgN4EWh9BTQF8TFKQ">P3Y4M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_TYyUc1KOHka5LNUBfRWq4Q"
      decimals="INF"
      id="Narr_1F1mWPhOZUKAJLkO4CKwHg"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">173700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_JOF9RAV_fkuKYUMpAYeQQg"
      decimals="INF"
      id="Narr_hP4OSYnCi06fTW-u40zIzQ"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">119700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_S8qckvwft0-ZA0tONRcfFw"
      id="Narr_TbBSGZvsUkSNHvCBFF8BQA">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
      contextRef="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_IRpa9_pYhEyV44mQzXmw2g"
      decimals="-3"
      id="Narr_jgp5BHaEhESDTw1A5vHGjA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1792000</smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
      contextRef="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ypheC2QZukKv7Unwz7OIBQ"
      decimals="-3"
      id="Narr_t8rvRdBQh0-ZTvMNiZvVtA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">316000</smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_us-gaap_PlanNameAxis_smlr_StockIncentivePlan2014Member_0xY6gnE8qUybhgz-gxdNDQ"
      decimals="INF"
      id="Narr_HEUM_F2XH0OB4dvZ7G-OtA"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">54000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
      contextRef="As_Of_12_31_2024_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_VVd0MeR2FUGoVh93N0DsZA"
      decimals="-3"
      id="Narr_94Cgxe12YkaztwVh9YuMBA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">559000</smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
      contextRef="As_Of_12_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b8wtJ_BsM0unZVLTihfH6w"
      decimals="-3"
      id="Narr_nWOTMjbkzUK0Q7CDIzHEKw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_7hNY9oxDB0Wpz8CohpoiWw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_koSv66w8vEeLE9lMtZm_1w"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_TqQuBybow0qeYHwBIedDgA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2-7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;4.5%-4.9%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;4.14%-4.41%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;62.3%-77.2%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;69.0%-79.5%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected dividend rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Fair value of options granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$10.35-$14.97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$17.54-$19.04&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_GbmeNOsf7EaK071-nE3ADg"
      id="Narr_FxGKqH577UK3p05wNgcdHw">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_dA41U23jbUaIgfrnIFaEkA"
      id="Narr_udqhVWHUsUaZm0di21tUZA">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"
      id="Tc_SIrqSr0wyk62kDR7xZxKLQ_3_4">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ"
      decimals="3"
      id="Narr_E_5gSNKzDkSnn2144MGcLA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ"
      decimals="3"
      id="Narr_YRtaghoR6E2of6IHVXnVMg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"
      decimals="4"
      id="Narr_n0mxLiUhM0mVj1sW3-iTHg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"
      decimals="4"
      id="Narr_Ku4ruNkCdESaPGDTQcRL9w"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0441</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ"
      decimals="3"
      id="Narr_4TjxjYH_s0e9kvGWc9ypEA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.623</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ"
      decimals="3"
      id="Narr_8y9H30ZLkUaW5zGLOnoY5A"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.772</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"
      decimals="3"
      id="Narr_QYM0uehC9EGARkWWVcjPEQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"
      decimals="3"
      id="Narr_rUPlmYK-NkusGVuxz9w2yw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yJTn1JWoRkK8ccG9vrpGfQ"
      decimals="2"
      id="Tc_e6WiiAp3dESk4LaZ4FIDRA_6_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_OM4ojQMrvkaWRCVqpS42WA"
      decimals="2"
      id="Tc_G0qz0CJoaEOviE9BpS4Dww_6_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_GbmeNOsf7EaK071-nE3ADg"
      decimals="2"
      id="Narr_YhZpe2TcPkCEIkEgkNLCVw"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">10.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_dA41U23jbUaIgfrnIFaEkA"
      decimals="2"
      id="Narr_oqUH9zWodEqpYVGLFM_B-Q"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">14.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_jPaHxANL9EC28M6jZYsdEA"
      decimals="2"
      id="Narr_mD59W3dC80em3gpcDaYSoQ"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">17.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_X8BtSj_gKEOEIpqdtxsxfw"
      decimals="2"
      id="Narr_7StjgUpAokqFbAizEZ9bwQ"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">19.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_OgIP7TPWOUqqqqmFdr-23A"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4428000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_xu7GGYqK5Euy1ZFYlB3kmw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2133000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Narr_d4HT4RgMRUGH9aa0egJj5w"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">10500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="INF"
      id="Narr_vQJE0LEBGEaA7qNLCCTdKw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">18048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_T089l-CBkEGS0eQghyQAnQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">300000</smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue>
    <smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_0ft8dh03gUm2E9672jSecw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">860000</smlr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_gv2j2qTWo0SnUYj_4jXg4w"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">862000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_i0SNr7xXvk2DECJRlFcFKg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">944000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_9ETqhvx3h06rErkJIuqQrw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cost of Revenues&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 42&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 8&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Engineering and Product Development&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 43&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 53&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Sales and Marketing&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 135&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 317&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;General and Administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 642&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 566&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 862&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 944&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_vC_VgO3t6kyazyC5VS8ocA"
      decimals="-3"
      id="Tc_3sphbo6gHUC2-I9bA4pxEw_3_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">42000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SyC6bd2xmUme3HPXw5Pazw"
      decimals="-3"
      id="Tc_1wp-CUICPkGQMJrX13D7sA_3_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">8000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_cISDtiIR7ESd_y3U1MPmAQ"
      decimals="-3"
      id="Tc_H1v6XffKlkG7aGu3p5D7tA_4_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">43000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_smlr_EngineeringAndProductDevelopmentMember_aUVxgJ1xTECBjIC1ZpWucg"
      decimals="-3"
      id="Tc_6_rUcmKgrUe1HrAzCrO1SA_4_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">53000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_iI2SdgF49U2GUm8sENchpQ"
      decimals="-3"
      id="Tc_Dd38nOdsIUSzyB8bXOVXjQ_5_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">135000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_XwzfHWNHj0GlezhAcZYaZg"
      decimals="-3"
      id="Tc_e7L24uxFuECswlGaJdaeBA_5_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">317000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_j-idL8uTrE-R6vTgZEwaLw"
      decimals="-3"
      id="Tc_tMD5SURXWkiaRRYXChjvcw_6_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">642000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_VkzoijKppEGZkDNPtg0efA"
      decimals="-3"
      id="Tc_nxHj0XZWvkapL6vt6vkKvA_6_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">566000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_fSCoxBEQ0UOAEi7uacqAhQ_7_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">862000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_ySwj1xehnk6Ggsc9Vh3nuw_7_8"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">944000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_Gzw3baExS0aYkUmZs4gC3g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;17.&#160;&#160;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;  Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The components of the provision for income taxes are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Current tax provision:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Federal &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 948&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,576&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;State&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 605&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total current tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,181&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred tax provision:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Federal &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,015&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (680)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;State &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 16&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total deferred tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,727&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (664)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total income tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,517&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;A summary of the differences between the Company&#x2019;s effective income tax rate and the federal statutory income tax rate for the&#160;years ended December&#160;31, 2024 and 2023 are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Federal statutory rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;State income tax rate, net of federal benefit &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1.96&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2.04&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (8.32)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (7.98)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Permanent items&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.03)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.71)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.07)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 0.24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Effective income tax rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 14.54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 14.59&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax (liabilities) assets are comprised of the following at December&#160;31:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 188&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 268&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 208&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 385&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Accrual and reserves&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 180&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 251&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Research and development credits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 262&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,004&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,450&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Lease liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 17&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 38&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;     Total gross deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,998&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;     Less valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,998&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Right of use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (16)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Change in fair value of digital assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"&gt;Total deferred tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,974)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 24pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net deferred tax (liabilities) assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,765)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,962&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;Federal and California tax laws imposes significant restrictions on the utilization of net operating loss (&#x201c;NOL&#x201d;) carryforwards in the event of a change in ownership of the Company, as defined by Section 382 of the Code (&#x201c;Section 382&#x201d;). The Company completed a formal 382 study for the period from January 1, 2012 through June 30, 2019 and concluded that a change in ownership has likely occurred. The Company has no NOL carryforwards for Federal income &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;tax purposes and approximately $2,580 for California income tax purposes as of December 31, 2024. The state NOL carryforwards, if not utilized, will expire beginning in 2035 and extended to 2038. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2024 and 2023, the Company had $487 and $470, respectively, of unrecognized tax benefits (excluding interest and penalties) that, if recognized, would affect the effective tax rate. The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross Unrecognized Tax Benefits 2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross Unrecognized Tax Benefits 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Unrecognized tax benefits &#x2013; January 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 470&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross increases related to prior tax positions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross decreases related to prior tax positions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross increases related to current tax positions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 65&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Unrecognized tax benefits &#x2013; December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 487&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 470&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s policy is to recognize interest and penalty expenses related to uncertain tax positions in income tax expense, which was $155 and $87 for the years ended December 31, 2024 and 2023, respectively. The Company files income tax returns in the U.S. federal and various state tax jurisdictions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s tax years beginning in 2020 remain open for examination by the state tax authorities for four years. The Company&#x2019;s tax years beginning in 2021 remain open for examination by the federal tax authorities for three years. Tax years beginning in 2018 will remain open for examination from the date of utilization of any NOL or credits. The Company does not have any tax positions for which it is reasonably possible the total amount of gross unrecognized tax benefits will increase or decrease within 12 months of the year-ended December 31, 2024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;Before January 1, 2022, IRC &#xa7;174 provided a taxpayer may treat research or experimental expenditures which are paid or incurred by the taxpayer during the taxable year in connection with the taxpayer&#x2019;s trade or business as expenses.  As amended by TCJA, IRC &#xa7;174 provides that in a case of a taxpayer's specified research or experimental expenditures for any taxable year beginning after December 31, 2021, no deduction is allowed for such expenditures.  The expenditures must be charged to capital account and allowed an amortization deduction of such expenditures ratably over the 5-year period (15-year period in the case of any specified research expenditures which are attributable to foreign research). The Company capitalized &lt;/span&gt;$4,153 and $4,610 specified research or experimental expenditures for the year ended December 31, 2024 and 2023, respectively.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_7-5MdDEQkUapwESgdPzs4A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Current tax provision:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Federal &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 948&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,576&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;State&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 605&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total current tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,181&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred tax provision:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Federal &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,015&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (680)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;State &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 16&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total deferred tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,727&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (664)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total income tax provision&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,517&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_nJttjhIuB0S7APQPgXPwwQ_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">948000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_xggcG6ymik-5x3C0YEL5lQ_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3576000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_cMg34YZ5i0mS42w0Cxg6Zw_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">310000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_rA66DlIppEmmy-eHUE2fvg_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">605000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_GmwyuAN6i0my8wQWD-ZIHQ_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1258000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_Yi6bO7-mj0WeMZrP8ZSWXw_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4181000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_JWlt1h_5E0KxIChADqxpIg_7_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5015000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_NTJ_diGZ4kedPuyZzeUNwg_7_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-680000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_Ql7r3Z8IR02JWsNxLcKtXQ_8_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">712000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_oTJeQfG4zE-LmA6GZvvp4w_8_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">16000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_PGoErxUSJ0yQzaX_YmomkQ_9_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5727000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_8hFgcr2wOkmuaPzyyPmcrg_9_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-664000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_L0hmWKXJgker2cK6G-v3xQ_10_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6985000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_Aq20Ic5Dl0qI9WaUqxeI2g_10_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3517000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_MncvxaSFq02DSHAXmP2m7w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Federal statutory rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 21.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;State income tax rate, net of federal benefit &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1.96&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2.04&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (8.32)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (7.98)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Permanent items&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.03)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.71)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.07)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 0.24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Effective income tax rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 14.54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 14.59&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="4"
      id="Tc_S84-oQi79UmryMa9D4mSSg_2_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="4"
      id="Tc_uqBjEY78wk6mHgx0plIp_g_2_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="4"
      id="Tc_ks65EGpv3ESZVT9z4tqr_A_3_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0196</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="4"
      id="Tc_U-oJ7-1yTU-8kGN-3q-ydw_3_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0204</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="4"
      id="Tc_S8ZCfFMF9UGAItoQ18AypQ_4_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">-0.0832</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="4"
      id="Tc_od9PsgW3b0OagfcxmQCcgw_4_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">-0.0798</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="4"
      id="Tc_ZC90hhYgFE2E2PZ39NPrzw_5_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">-0.0003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="4"
      id="Tc_289_1sijakq_JF92bnac6A_5_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">-0.0071</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="4"
      id="Tc_DM4DHS2EUUWpxH8s4zJxXQ_6_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">-0.0007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="4"
      id="Tc_0h_ut_26hE6iRdLULcuU1w_6_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="4"
      id="Tc_rx0f3K0gyUi0OSu9ddtmhw_7_2"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.1454</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="4"
      id="Tc_--sf-W3J8kG6IeHknRIWTA_7_4"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.1459</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_DJJWF5dqa0OpwuKT1xfaTw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 188&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 268&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 208&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 385&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Accrual and reserves&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 180&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 251&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Research and development credits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 262&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,004&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,450&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Lease liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 17&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 38&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;     Total gross deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,998&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;     Less valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,998&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Right of use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (16)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Change in fair value of digital assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"&gt;Total deferred tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,974)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 24pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net deferred tax (liabilities) assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,765)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,962&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_9byT2JijQkO7_EjdJdI8ww_2_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">185000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_xpfQw3hpHEyD16JeZEjcng_2_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">188000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_BTQJpZ2FGkirAC5NsFLZFw_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">185000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_CPMQMX4_LkuMmDZGE5ilOA_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">268000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_3MkGYMX8Mk2RUdwtYzatJQ_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">208000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_uMp7gTU0F0CozAs6RExwcQ_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">385000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_PYCyq_zAkUSG7ccgOVF0QA_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">180000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_kAD0063Ev0OajuoOpUXV1Q_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">251000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_IvR5r3qQJE6mo0dzcw_aQw_6_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">251000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_rINntO6ZZUKbEpMPoqXXeQ_6_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">262000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_I7vEV4VWzUaPJAti5ftPSg_7_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">179000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_uoTPf7AAHUW46Lna9tGE6g_7_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">156000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_4ujYs3AtY0aKbzU0Sg0KgQ_8_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2004000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_TffXqiuf3EypyX3s95rhdA_8_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1450000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <smlr:DeferredTaxAssetsLeaseLiabilities
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_cNj4w4PLGUGu5a3pieV-Jg_9_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">17000</smlr:DeferredTaxAssetsLeaseLiabilities>
    <smlr:DeferredTaxAssetsLeaseLiabilities
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_e1x2MQu5lkGPLbNl1XjA1A_9_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">38000</smlr:DeferredTaxAssetsLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_MLcc1scCLEmWo1HAqvM6xA_10_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3209000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_NCe1kY4hI0aC1UXdFcl_Ww_10_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2998000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc__CLj_OICTkS_SCEz31XQaQ_11_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_dg1FPjhhEEusU8B_ptcpqQ_12_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3209000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_Nfbh0a9sOUiibUtEscPGdA_12_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2998000</us-gaap:DeferredTaxAssetsNet>
    <smlr:DeferredTaxAssetsRightOfUseAssets
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_lpoOHtCqq02olvsi1hX9oA_14_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">16000</smlr:DeferredTaxAssetsRightOfUseAssets>
    <smlr:DeferredTaxAssetsRightOfUseAssets
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_uuT0Z28Lb0SLEl5JQhDkig_14_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">36000</smlr:DeferredTaxAssetsRightOfUseAssets>
    <smlr:DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_bEwaDfTkAkmKhF7_awLvBQ_15_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5958000</smlr:DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets>
    <smlr:DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_Mtyu8E6HhkKN12DFEwds4Q_15_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</smlr:DeferredTaxLiabilitiesChangeInFairValueOfDigitalAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_Rojli6UxIUCOl_57aa1ZWg_16_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5974000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_x0SEw5RUY0uuwc5wYxXVIg_16_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">36000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_qj-6mzHlBku_5gsAobU1hw_17_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2765000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_8aUZ7XNK-ESnymtHNzwqOA_17_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2962000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="As_Of_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_ESWGS2AUDEyJokJaRyrByQ"
      decimals="-3"
      id="Narr_u9b3LQBrVE2ULAspSWh1Fg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_R9KwZmAK2UeZv2d1XXfDZg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2580000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Narr_NOu70sMReUGYnBtGR-3oeQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">487000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Narr_EY15Rx-QhkGe6L8JJngi-w"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">470000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_unerUdHTLEyqjToWb2P9Ow">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross Unrecognized Tax Benefits 2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross Unrecognized Tax Benefits 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Unrecognized tax benefits &#x2013; January 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 470&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross increases related to prior tax positions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross decreases related to prior tax positions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross increases related to current tax positions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 65&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Unrecognized tax benefits &#x2013; December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 487&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 470&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_-Q1ReIQ0VkuR8kVyG14U2g_2_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">470000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2022_Vl0CIfgvekuMEnzdS1osoA"
      decimals="-3"
      id="Tc_1WkRWHmyIUKlArgBtQMarg_2_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">401000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_auf8otFqWEG4JInPopQiBw_3_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_GShgM9_prkSG1qkRekYrew_3_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_JmBPUs7JiEm67xoHkXs58g_4_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_w8cltVa7ekGQ4rCLjeMr-w_4_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_iUtnRcVRXkOWZA454s-ojQ_5_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_PWdnPBF2KUyZ8IZfNceuCw_5_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">65000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2024_rFOZszfqeEC5fpm4RGoOvA"
      decimals="-3"
      id="Tc_kAGdMKEz3UOKXUMNpFDmXA_6_3"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">487000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2023_rBdzbQnF7k2t7Ln21Ju9mw"
      decimals="-3"
      id="Tc_nN_icrfO2EmB2pMOR2MgCQ_6_6"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">470000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_6BdM-SokXUyWFZtgfzlljA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">155000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_ddLoRau5VkGdtmZXHNAg0A"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">87000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <smlr:ExaminationOfCompanyTaxYears
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_StateAndLocalJurisdictionMember_l7TBs0ibWkKMa4_wC7X-XQ"
      id="Narr_ef-dRvpejUiWRWu7Wnotpg">P4Y</smlr:ExaminationOfCompanyTaxYears>
    <smlr:ExaminationOfCompanyTaxYears
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_TaxCreditCarryforwardAxis_us-gaap_DomesticCountryMember_FOoH5YxHtkWAVEIxCeAZTw"
      id="Narr_unbSWzOYt0qD6E0UDW5AgQ">P3Y</smlr:ExaminationOfCompanyTaxYears>
    <smlr:ResearchAndExperimentalExpendituresCapitalized
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Narr_eEiNyIshQ0auGMhti_Go_g"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4153000</smlr:ResearchAndExperimentalExpendituresCapitalized>
    <smlr:ResearchAndExperimentalExpendituresCapitalized
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Narr_6q8JwRlbtkC0sjfvZfsi1Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4610000</smlr:ResearchAndExperimentalExpendituresCapitalized>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_9SDPHPgYk0G3-5bqJ3B_QQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;18.&#160;&#160;&lt;b style="font-weight:bold;white-space:pre-wrap;"&gt;  Net Income Per Share, Basic and Diluted&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) represent net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.&lt;span style="background:#ffffff;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Basic and diluted net EPS is calculated as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:72.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:33.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;EPS&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;EPS&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Basic &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,228,961&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 40,899&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5.66&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,732,806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,583&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Common stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 751,157&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,086,353&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Diluted &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,980,118&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 40,899&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,819,159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,583&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2.63&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_nLTpVbhBT0yGaCCH5TnUfQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:72.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:33.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;EPS&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;EPS&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Basic &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,228,961&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 40,899&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5.66&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,732,806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,583&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Common stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 751,157&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,086,353&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Diluted &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,980,118&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 40,899&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt; &lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,819,159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,583&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2.63&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="0"
      id="Tc_XU3ZitmRlUGgOr53dDDBbA_4_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7228961</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_1jIJX17hPES8cdQsNNOaOg_4_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Tc_ZRjcg6ges0-BuGlkrLXm1g_4_8"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">5.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="0"
      id="Tc_FqZCW6mIcEabMJgvnj0KHw_4_10"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">6732806</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_CEOdYcGj5UirYM7JPvR3gw_4_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="2"
      id="Tc_JucC5PjMqUqnXNn4VCNQXA_4_16"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">3.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Tc_Mb3hjlU9PECGl8dXDJoJLA_5_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">751157</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_--zpjwdydESGC19uakxdcQ_5_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="INF"
      id="Tc_g3OtuXFXm0qGJm9CkuP93A_5_10"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">1086353</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_YrCDUnpx7UejTKgeQTDUxA_5_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">0</us-gaap:AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="0"
      id="Tc_zhwswxcQbk6nNR7ik3TX2w_6_2"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7980118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="-3"
      id="Tc_NrvLpgIcpUKJH0oUuTxTJg_6_5"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="2"
      id="Tc_f17W-Xu-Q0encw17lEy7xg_6_8"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">5.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="0"
      id="Tc_qoq5v6oRbUO0h2eeK0g1Ag_6_10"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">7819159</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="-3"
      id="Tc_PoTqxWTChUiLdqHnogAd1Q_6_13"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_12_31_2023_37XMx0KxXEuXdpS32xNexw"
      decimals="2"
      id="Tc_l2HD3Jrc50C6wGHakWr7zg_6_16"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">2.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_5LxwKWSbokiLgRs2nSIf2w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;19.&lt;/b&gt;&lt;/span&gt;&lt;b style="font-weight:bold;"&gt;Segment Information&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;"&gt;ASU No. 2023-07 topic 280, &#x201c;Segment Reporting&#x201d; establishes standards for reporting information about operating segments on a basis consistent with the Company&#x2019;s internal organization structure as well as information about services categories, business segments and major customers in financial statement. &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;The Company manages its business in &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;one&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; reportable operating segment, which is engaged in the manufacturing, marketing, and sales of its&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;patented and FDA cleared product, QuantaFlo.&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; &lt;/span&gt;&lt;span style="color:#212529;"&gt;In accordance with the &#x201c;Segment Reporting&#x201d; Topic 280, the Chief Executive Officer and President has been identified as the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. The &lt;/span&gt;CODM uses segment operating profit to allocate resources including employees, property and investments. The CODM also uses month-over-month expense variance analysis for cost control and for making decisions about allocating capital and personnel to the segment&lt;span style="font-size:12pt;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;"&gt;The following table breaks out the operations of the Company&#x2019;s single reportable segment information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 56,294&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 68,184&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Less:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Cost of revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,685&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,923&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Research and development &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,709&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,674&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Sales &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,895&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,777&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Sales operations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,946&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,702&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;General and administration&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 12,651&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 14,208&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 283&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 292&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Other segment expenses &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,192&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,352&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Segment operating profit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 22,256&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Interest income, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,877&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,471&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Impairment of investments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (337)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Change in fair value of notes held for investment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 128&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (307)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Change in fair value of digital assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 24,933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Other corporate income &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 17&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income before taxes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt; 47,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt; 24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Income tax expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,517&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 40,899&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,583&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Research and development include clinical affairs and HITRUST.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Other segment expenses include marketing, customer education, business development, and strategic streamlining.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Other corporate income represents unallocated income.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;"&gt;See note 12 to the financial statements for the customers accounted for 10% or more of the revenues and receivables.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;"&gt;As of December 31, 2024 and 2023, all assets of the Company were located in United States of America.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      decimals="INF"
      id="Narr_RbM7ZjKNtka0t91gFgGqdg"
      unitRef="Unit_Standard_segment_Ijr0hkbG8kGjCrFIHbBeqw">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_0clUoy29tk6ZWNqIuiqHoA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 56,294&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 68,184&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Less:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Cost of revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,685&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,923&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Research and development &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,709&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,674&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Sales &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 5,895&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,777&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Sales operations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,946&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,702&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;General and administration&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 12,651&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 14,208&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 283&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 292&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Other segment expenses &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 4,192&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 7,352&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Segment operating profit&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 22,256&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Interest income, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 1,877&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 2,471&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Impairment of investments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (337)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Change in fair value of notes held for investment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 128&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (307)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Change in fair value of digital assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 24,933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Other corporate income &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 17&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income before taxes&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt; 47,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt; 24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Income tax expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 3,517&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:56.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 40,899&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.3pt 0pt 0pt;"&gt; 20,583&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Research and development include clinical affairs and HITRUST.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Other segment expenses include marketing, customer education, business development, and strategic streamlining.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Other corporate income represents unallocated income.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_EWjKGJ5Shkib_U6cKX0aOQ_3_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">56294000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_7_6INa_PC0ekdalW_q0r-g_3_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">68184000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_JOAK3pLoYEOaDMDUB987_Q_5_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4685000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_8OMiIaqFdk-jFfu2cqlAjA_5_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6923000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_xxPrnWpCzka_DGz1I7yhhQ_6_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4709000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_XmXSriES6UqdrkhZ-otMpA_6_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5674000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_pwBgP2fCzUGoSxPBiXJULw_7_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5895000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_9dVLevIB4kCEQqiQCpXO8w_7_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">7777000</us-gaap:SellingExpense>
    <us-gaap:BusinessDevelopment
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_DwPRr-P9xECxpVaZXfh2VA_8_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2946000</us-gaap:BusinessDevelopment>
    <us-gaap:BusinessDevelopment
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_Ds4uMb2JwEWQE4qTXSwZUw_8_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3702000</us-gaap:BusinessDevelopment>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_foZzZwgl9E6LtFKa84rCpw_9_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">12651000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_FJuL8u-w2EeR0Ui_lZdK4g_9_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">14208000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_aROuwN7CjkuqTwFVK8h21Q_10_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">283000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_8Z5KuEax70SSbkoFiv2bFw_10_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">292000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_wFh5_Dbm6Uu4qKcIC94sAw_11_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">4192000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_odZ3h2FxI0yxWv5DBfUC-g_11_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">7352000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_8VACoIApn0iwljYItVMdXA_12_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20933000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_vn8stx_5skCvixZwp2smuA_12_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">22256000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_xRokIIKN9EWQdOWWWp75wQ_13_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1877000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_j3y1tj9NS0KOqI8TGwhK2Q_13_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">2471000</us-gaap:InvestmentIncomeInterestAndDividend>
    <smlr:ImpairmentLossesInvestments
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_36CtJrkBsUqM4pCa_qkYzw_14_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">337000</smlr:ImpairmentLossesInvestments>
    <smlr:FairValueAdjustmentOfNotesHeldForInvestment
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_bvKmAwHlWESyiXwUiXXc7w_15_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">-128000</smlr:FairValueAdjustmentOfNotesHeldForInvestment>
    <smlr:FairValueAdjustmentOfNotesHeldForInvestment
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_e7X1Wdp4VEaJJ2ozj7iNPA_15_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">307000</smlr:FairValueAdjustmentOfNotesHeldForInvestment>
    <us-gaap:CryptoAssetUnrealizedGainLossNonoperating
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_7K6UfNlvEk-I-UMPbmeClw_16_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">24933000</us-gaap:CryptoAssetUnrealizedGainLossNonoperating>
    <smlr:OtherCorporateIncomeExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_kVBAR9u5cUGIi4fGZG9yCw_17_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">13000</smlr:OtherCorporateIncomeExpense>
    <smlr:OtherCorporateIncomeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_qbkIZNxKm0WITTX7l8ux7w_17_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">17000</smlr:OtherCorporateIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_MxS2Pcp3f0SpFqzXEbRuxw_18_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">47884000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_i6QrhWrjBUaNxbduu3c_ZA_18_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">24100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_k894c0g9jkmcV9cTjG5XAw_19_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">6985000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_c9f7bqZu2E-k9e0RM0djhw_19_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3517000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      decimals="-3"
      id="Tc_bJSnFOIIOEOu1L_nsCxO-w_20_4"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">40899000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      decimals="-3"
      id="Tc_1GFvqJNlikC3cK4oaevXew_20_7"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">20583000</us-gaap:NetIncomeLoss>
    <us-gaap:SegmentReportingOtherItemCompositionDescription
      contextRef="Duration_1_1_2023_To_12_31_2023_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_WnxnbQvNCEqK0DOMqkYskg"
      id="Narr_3x-r1RPoOEquBt6qz5n_8w">Other segment expenses include marketing, customer education, business development, and strategic streamlining.</us-gaap:SegmentReportingOtherItemCompositionDescription>
    <us-gaap:SegmentReportingOtherItemCompositionDescription
      contextRef="Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_smlr_SingleReportableSegmentMember_nsEgwIk4D0-60AWcEgblpw"
      id="Narr_ptKQMzOew0OFBWHmBQ4ufA">Other segment expenses include marketing, customer education, business development, and strategic streamlining.</us-gaap:SegmentReportingOtherItemCompositionDescription>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_B4uIv8vpg0KCDXUEs1C2-A"
      id="Tb_WaMYY9fMskOgfSyRfZhqNQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="color:#212529;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;20.&lt;/b&gt;&lt;/span&gt;&lt;b style="color:#212529;font-weight:bold;"&gt;Subsequent Events&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#212529;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Offering of &lt;/b&gt;&lt;b style="font-weight:bold;"&gt;4.25%&lt;/b&gt;&lt;b style="font-weight:bold;"&gt; Convertible Senior Notes&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;On January 28, 2025, the Company completed its previously announced private offering of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$100.0&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million aggregate principal amount of its &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;4.25%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; Convertible Senior Notes due 2030, or the Notes, including the exercise in full of the initial purchasers&#x2019; option to purchase up to an additional &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$15.0&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated January 28, 2025, or the Indenture, between the Company and U.S. Bank Trust Company, National Association, as trustee.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The Notes are general senior, unsecured obligations of the Company and will mature on August 1, 2030, unless earlier converted, redeemed or repurchased. The Notes bear interest at a rate of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;4.25%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; per year, payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2025. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 1, 2030, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2025 (and only during such calendar quarter), if the last reported sale price of the Company&#x2019;s common stock, par value &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$0.001&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; per share, or the Common Stock, for at least &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;20&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; trading days (whether or not consecutive) during a period of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;30&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;130%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; of the conversion price for the Notes on each applicable trading day; (2) during the &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;five&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; business day period after any &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;10&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; consecutive trading day period, or the measurement period, in which the trading price (as defined in the Indenture) per &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; principal amount of the Notes for each trading day of the measurement period was less than &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;98%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; of the product of the last reported sale price of Common Stock and the conversion rate for the Notes on each such trading day; (3) if Semler calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after May 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company may satisfy its conversion obligation by paying and/or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company&#x2019;s election, in the manner and subject to the terms and conditions provided in the Indenture&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The conversion rate for the Notes will initially be &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;13.0826&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; shares of Common Stock per &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; principal amount of Notes, which is equivalent to an initial conversion price of approximately &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$76.44&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; per share of Common Stock. The initial conversion price of the Notes represents a premium of approximately &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;25.0%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; over the last reported sale price of the Common Stock on the Nasdaq Capital Market on January 23, 2025. The conversion rate for the Notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, it will, in certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes in connection with such a corporate event or convert its notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be. Initially, a maximum of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;1,635,320&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; shares of Common Stock may be issued upon conversion of the Notes, based on the initial maximum conversion rate of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;16.3532&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; shares of common stock per &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; principal amount of Notes&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The Company may not redeem the Notes prior to August 4, 2028. The Company may redeem for cash all or any portion of the Notes (subject to the partial redemption limitation described in the Indenture), at its option, on or after August 4, 2028 and prior to the 21st scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Common Stock has been at least &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;130%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; of the conversion price for the Notes then in effect for at least &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;20&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; trading days (whether or not consecutive) during any &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;30&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;100%&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"&gt;If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as set forth in the Indenture, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The following events are considered &#x201c;events of default&#x201d; under the Indenture:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;default in any payment of interest on any Note when due and payable and the default continues for a period of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;30 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;default in the payment of principal of any Note when due and payable at its stated maturity, upon optional redemption, upon any required repurchase, upon declaration of acceleration or otherwise;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;failure by the Company to comply with its obligation to convert the Notes in accordance with the Indenture upon exercise of a holder&#x2019;s conversion right, and such failure continues for &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;three&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; business days;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;failure by the Company to give (i) a fundamental change notice or notice of a make-whole fundamental change, in either case when due and such failure continues for &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;five&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; business days, or (ii) notice of a specified corporate transaction when due and such failure continues for &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;one&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; business day;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;failure by the Company to comply with its obligations in respect of any consolidation, merger or sale of assets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;failure by the Company to comply with any of its other agreements in the Notes or the Indenture for &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;60 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; after written notice of such failure from the trustee or the holders of at least &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;25%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; in principal amount of the Notes then outstanding;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;default by the Company or any of its significant subsidiaries (as defined in the Indenture) with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed with a principal amount in excess of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;$15.0&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; million (or its foreign currency equivalent), in the aggregate of the Company and/or any such significant subsidiary, whether such indebtedness now exists or shall hereafter be created, (i) resulting in such indebtedness becoming or being declared due and payable prior to its stated maturity date or (ii) constituting a failure to pay the principal of any such indebtedness when due and payable (after the expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, and in the cases of clauses (i) and (ii), such acceleration shall not have been rescinded or annulled or such failure to pay or default shall not have been cured or waived, or such &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;indebtedness is not paid or discharged, as the case may be, within &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;30 days&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; after written notice to the Company by the trustee or to the Company and the trustee by holders of at least &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;25%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt; in aggregate principal amount of the Notes then outstanding in accordance with the Indenture; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;certain events of bankruptcy, insolvency or reorganization of the Company or any of its significant subsidiaries&#x2019;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Neither the notes, nor any shares of the Company&#x2019;s common stock issuable upon conversion of the notes, have been registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons, absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Repayment of Senior Convertible Senior Note&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;On January 15, 2025, Monarch repaid $3,500, along with the transaction fees and accrued interest. At the same time, the Company entered into an Amended and Restated Secured Convertible Promissory Note (&#x201c;New Note&#x201d;) and related subordination agreement for the outstanding balance of $1,500 (&#x201c;Principal Amount&#x201d;). The New Note carries an interest rate of 15% payable monthly on 5&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;th&lt;/sup&gt; day of each month. Unless earlier repaid or converted, the New Note will mature and the outstanding Principal Amount, together with accrued and unpaid interest thereon and the transaction expenses (the &#x201c;Balance&#x201d;), shall be due and payable on the first to occur of (i) the occurrence of an Event of Default (as defined in the New Note), (ii) a Change of Control (as defined in the New Note) unless converted as set forth in the New Note or (iii) February 15, 2028 (the &#x201c;Maturity Date&#x201d;).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-family:'TimesNewRomanPSMT';visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="color:#212529;font-weight:bold;"&gt;Bitcoin Purchase Update&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;During the period January 1, 2025 and February 14, 2025, the Company purchased a total of approximately 894 bitcoins at an aggregate purchase price of approximately $90.7 million for an average purchase price of approximately $101,532 per bitcoin. See Note 9 to Financial Statements &#x201c;Intangible Digital Assets&#x201d; for further details.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;As of February 14, 2025, The Company held approximately 3,192 bitcoins that were acquired at an aggregate purchase price of $280.4 million and an average purchase price of approximately $87,854 per bitcoin, inclusive of fees and expenses. As of February 14, 2025, at 4 p.m. Eastern Time, the market price of one bitcoin reported on the Coinbase exchange (the Company&#x2019; principal market) was $97,505.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="color:#212529;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="4"
      id="Narr_QSDqEM4ASke8S1lBeYje-g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="-5"
      id="Narr_yb562RDHP0ukFfPn0NU-3g"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="4"
      id="Narr_rkbu75gmmkePAW3cVbCIuw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <smlr:DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="-5"
      id="Narr_-1BQtQZHz0SbvvpsYWugLg"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">15000000</smlr:DebtInstrumentMaximumAdditionalFaceAmountOnOptionExercised>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="4"
      id="Narr_NuRxlqo7tU-Q18BY7o9ZkQ"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="3"
      id="Narr_8-ktz7ESaUSM0eSG45hfXw"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_l_47iiTZ7EuP_7zOR__8CQ"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_oPRbIkE2VUOGwL9ua-ImQA"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_gKBSB6nBgkqutzVVk_vlfA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <smlr:DebtInstrumentConvertibleThresholdBusinessDays
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_bCeL_-p1ykGxfyztpOJlVw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">5</smlr:DebtInstrumentConvertibleThresholdBusinessDays>
    <smlr:DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_EUCq6ydCK0e3LMxdCDxZoQ"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">10</smlr:DebtInstrumentConvertibleThresholdConsecutiveTradingDaysPeriod>
    <smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="-3"
      id="Narr_QODY8r5pK02nwfRCQELi4w"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate>
    <smlr:DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_-gD63_einU2d5c43JhzbJg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.98</smlr:DebtInstrumentConvertibleThresholdPercentageOfProductOfStockPriceAndConversionPriceStockPriceTrigger>
    <smlr:DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="INF"
      id="Narr_INs1siSxM0KfUtPzsA_WUg"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">13.0826</smlr:DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts>
    <smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="-3"
      id="Narr_lWI5KemlqUSjSXJ5-fxAAw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="2"
      id="Narr_IQkGZxuiJE21W4RJcP4dUw"
      unitRef="Unit_Divide_USD_shares_F0_WJakLFUm8wINLPTpmqQ">76.44</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <smlr:DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="3"
      id="Narr_7sFHa_GypEeCGJOG6l-IZg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.25</smlr:DebtInstrumentConvertibleConversionPricePremiumPercentageOverLastReportedSalePrice>
    <smlr:DebtInstrumentConvertibleMaximumSharesIssuableUponConversion
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="INF"
      id="Narr_PQXwNjkbt0GPHuwKyuLbTg"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">1635320</smlr:DebtInstrumentConvertibleMaximumSharesIssuableUponConversion>
    <smlr:DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts
      contextRef="As_Of_1_28_2025_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_o_ovxYPgBkWZ0i_kIROisQ"
      decimals="INF"
      id="Narr_WyVek2qvgkiCV4m0gO-3Zw"
      unitRef="Unit_Standard_shares_iWCgmCr0CUe6K2FSsZ_xJg">16.3532</smlr:DebtInstrumentNumberOfEquityInstrumentsConvertiblePerBasePrincipalAmounts>
    <smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="-3"
      id="Narr_addGKhi4yEm8iyTOsnpQ3Q"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1000000</smlr:DebtInstrumentBasePrincipalAmountOnComputationOfConversionRate>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_Cr5t1JZDdEamIhDrzlQA4w"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_wd6IQHSfMU2Ma78dj0LnnA"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_jXlGhhT1fkOkOmarfpnnVw"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_IggdENDV9Ey6nXbpupxpOg"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <smlr:DebtInstrumentFundamentalChangeRepurchasePricePercentage
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_fbhP_OcRsU-vNc40WmP93A"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">1</smlr:DebtInstrumentFundamentalChangeRepurchasePricePercentage>
    <smlr:DebtInstrumentConvertibleDebtDefaultInterestPeriod
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      id="Narr_9pVvmH4nBU2alBvNfCAkTA">P30D</smlr:DebtInstrumentConvertibleDebtDefaultInterestPeriod>
    <smlr:DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_nNBw76L5kE-Qz_pG6p5YmA"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">3</smlr:DebtInstrumentConvertibleDebtDefaultOnConversionUponExerciseThresholdBusinessDays>
    <smlr:DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_f62io00R6027HrfPnh60rQ"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">5</smlr:DebtInstrumentConvertibleDebtDefaultFundamentalChangeNoticeThresholdBusinessDays>
    <smlr:DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="INF"
      id="Narr_cWLcMSjDFkC4LTeUuJu0Cw"
      unitRef="Unit_Standard_D_Iaz812RqbUurjlwlquBD8w">1</smlr:DebtInstrumentConvertibleDebtDefaultSpecifiedCorporateActionNoticeThresholdBusinessDays>
    <smlr:DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      id="Narr_JKgiv3Nt80uJJYF7cSzDXA">P60D</smlr:DebtInstrumentConvertibleDebtDefaultOnComplianceOfOtherAgreementsInIndenturePostWrittenNoticeFromTrustees>
    <smlr:DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_LpyhMCipLU2zvTHTTjcY-g"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.25</smlr:DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage>
    <smlr:DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount
      contextRef="As_Of_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_f8GXVbcVXE6FMt9QhnFBIA"
      decimals="-5"
      id="Narr_e4S7iUAbHEGAE_4l2KMAvQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">15000000</smlr:DebtInstrumentConvertibleDebtDefaultIndebtednessMinimumPrincipalAmount>
    <smlr:DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      id="Narr_F5L4frlZxUe60zdSw69fMQ">P30D</smlr:DebtInstrumentConvertibleDebtDefaultIndebtednessAccelerationClausePeriod>
    <smlr:DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage
      contextRef="Duration_1_28_2025_To_1_28_2025_us-gaap_DebtInstrumentAxis_smlr_ConvertibleSeniorNote425Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_oQMFuscdZUOVFFudg7gMQA"
      decimals="2"
      id="Narr_bHBsjBD-WUWyX_3RZ1uISw"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.25</smlr:DebtInstrumentConvertibleDebtDefaultPostWrittenNoticeFromHoldersOfOutstandingDebtMinimumPercentage>
    <smlr:ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount
      contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA"
      decimals="-3"
      id="Narr_LIrmp3JsY0qk7zJX07LGoA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">3500000</smlr:ProceedsFromMaturitiesOfDebtSecuritiesPartialAmount>
    <us-gaap:NotesReceivableNet
      contextRef="As_Of_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lEsvR7g5ukqjO6r8JvkH_g"
      decimals="-3"
      id="Narr_BA1wQ23uVUagz0dLyEGTew"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">1500000</us-gaap:NotesReceivableNet>
    <smlr:DebtSecurityInterestRate
      contextRef="Duration_1_15_2025_To_1_15_2025_srt_CounterpartyNameAxis_smlr_MonarchMedicalTechnologyLlcMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_smlr_SecuredConvertiblePromissoryNoteMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_18ZQ994wcEiCJxexQSm-tA"
      decimals="2"
      id="Narr_SF4xy_kcBEuDNY7y6y8WqA"
      unitRef="Unit_Standard_pure_XHZPuvX4YEmB2xwvPoncGA">0.15</smlr:DebtSecurityInterestRate>
    <smlr:CryptoAssetNumberOfUnitsPurchased
      contextRef="Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA"
      decimals="INF"
      id="Narr_3yp5Ode_bEuVIBbMXEy0_A"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">894</smlr:CryptoAssetNumberOfUnitsPurchased>
    <us-gaap:PaymentForAcquisitionCryptoAsset
      contextRef="Duration_1_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Z6hepVWpOkWABp0DNWqFOA"
      decimals="-5"
      id="Narr_NH3nRpeuQ0WYjcwjaEVcDw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">90700000</us-gaap:PaymentForAcquisitionCryptoAsset>
    <smlr:CryptoAssetAveragePurchasePrice
      contextRef="Duration_2_1_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_rF8xp9fd-0m4m_wVJU1ZfQ"
      decimals="0"
      id="Narr_6N0jkfHqCEqKDVoXtZwAdw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">101532</smlr:CryptoAssetAveragePurchasePrice>
    <smlr:CryptoAssetAveragePurchasePrice
      contextRef="Duration_1_1_2025_To_1_31_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Vh5xue5y_kiCARvRzIwtZQ"
      decimals="0"
      id="Narr_54HJkb2YDkGp67zMbDQNww"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">101532</smlr:CryptoAssetAveragePurchasePrice>
    <us-gaap:CryptoAssetNumberOfUnits
      contextRef="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q"
      decimals="INF"
      id="Narr_2u6L4UT89UOGyLGShU_mdA"
      unitRef="Unit_Standard_item_w7kZPBoE0EO2HTdVc4wB3Q">3192</us-gaap:CryptoAssetNumberOfUnits>
    <us-gaap:CryptoAssetCost
      contextRef="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q"
      decimals="-5"
      id="Narr_sjJWrEGEYEGwZLs2P1wRuw"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">280400000</us-gaap:CryptoAssetCost>
    <smlr:CryptoAssetAveragePurchasePrice
      contextRef="Duration_2_14_2025_To_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_Mua0Ot9Ko0CU_qSEjW_8uA"
      decimals="0"
      id="Narr__e0SM6uvd0-WVkhl0vPnMQ"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">87854</smlr:CryptoAssetAveragePurchasePrice>
    <smlr:CryptoAssetMarketPricePerCryptoAsset
      contextRef="As_Of_2_14_2025_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VTl4QqOwWEmJUgaAhb_d2Q"
      decimals="0"
      id="Narr_yjj-pC-iJEWHEWeZKEXdyA"
      unitRef="Unit_Standard_USD_s77KXUl6zEWxQE8-3KScOQ">97505</smlr:CryptoAssetMarketPricePerCryptoAsset>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
